Table of Contents

As filed with the Securities and Exchange Commission on October 18, 2007
Registration No. 333-          
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
 
Form F-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
 
 
 
 
Agria Corporation
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant’s name into English)
 
         
Cayman Islands   0115   Not Applicable
(State or other jurisdiction of
incorporation or organization)
  (Primary Standard Industrial
Classification Code Number)
  (I.R.S. Employer
Identification Number)
 
 
 
 
Room 706, 7/F, Huantai Building, No. 12A
South Street Zhongguancun
Haidian District, Beijing 100081, People’s Republic of China
(86-10) 6210 9288
(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
 
 
 
 
Law Debenture Corporate Services Inc.
400 Madison Avenue, 4th Floor
New York, New York 10017
(212) 750-6474
(Name, address, including zip code, and telephone number, including area code, of agent for service)
 
 
 
 
Copies to:
 
     
Z. Julie Gao, Esq.
Latham & Watkins LLP
41st Floor, One Exchange Square
8 Connaught Place, Central
Hong Kong
(852) 2522-7886
  Jonathan Stone, Esq.
Skadden, Arps, Slate, Meagher & Flom
42nd Floor, Edinburgh Tower
The Landmark
15 Queen’s Road Central
Hong Kong
(852) 3740-4700
 
 
 
 
Approximate date of commencement of proposed sale to the public:   as soon as practicable after the effective date of this registration statement.
 
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.   o
 
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   o   ­ ­
 
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   o   ­ ­
 
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   o   ­ ­
 
 
 
 
CALCULATION OF REGISTRATION FEE
 
             
Title of Each Class of
    Proposed Maximum Aggregate
    Amount of
Securities to be Registered     Offering Price(1)     Registration Fee
Ordinary shares, par value $0.0000001 per share (2)(3)
    $175,000,000     $5,373
             
 
(1) Estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(o) under the Securities Act of 1933.
(2) Includes ordinary shares initially offered and sold outside the United States that may be resold from time to time in the United States either as part of their distribution or within 40 days after the later of the effective date of this registration statement and the date the shares are first bona fide offered to the public, and also includes ordinary shares that may be purchased by the underwriters pursuant to an over-allotment option. These ordinary shares are not being registered for the purpose of sales outside the United States.
(3) American depositary shares issuable upon deposit of the ordinary shares registered hereby will be registered under a separate registration statement on Form F-6 (Registration No. 333- ). Each American depositary share represents       ordinary shares.
 
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to such Section 8(a), may determine.
 


Table of Contents

The information in this prospectus is not complete and may be changed. Neither we nor the selling shareholders may sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.
 
 
SUBJECT TO COMPLETION
PRELIMINARY PROSPECTUS DATED          , 2007
 
       American Depositary Shares
 
(AGRIA CORPORATION LOGO)
 
Agria Corporation
 
Representing       Ordinary Shares
 
 
 
 
This is an initial public offering of American depositary shares, or ADSs, of Agria Corporation, or Agria. Agria is offering       ADSs, and the selling shareholders disclosed in this prospectus are offering an additional       ADSs. Each ADS represents       ordinary share[s]. Agria will not receive any of the proceeds from the sale of ADSs by the selling shareholders.
 
 
Prior to this offering, there has been no public market for the American depositary share, or ADSs, of Agria. The initial public offering price of the ADSs is expected to be between $       and $       per ADS. We have applied to have the ADSs listed on the New York Stock Exchange under the symbol “GRO.”
 
 
The underwriters have an option to purchase up to       additional ADSs from Agria and an additional       ADSs from the selling shareholders at the initial public offering price less the underwriting discount to cover over-allotments of ADSs.
 
 
Investing in the ADSs involves risks. See “Risk Factors” on page 12.
 
 
                                 
                Proceeds,
       
          Underwriting
    Before
    [Proceeds, Before
 
    Price to
    Discounts and
    Expenses,
    Expenses, to the
 
    Public     Commissions     to Agria     Selling Shareholders]  
 
Per ADS
  $                  $                  $                  $               
Total
  $                  $                  $                  $               
 
 
Delivery of the ADSs evidenced by the ADRs will be made on or about          , 2007.
 
 
Neither the United States Securities and Exchange Commission nor any state securities commission or other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
 
 
 
 
Credit Suisse
 
 
 
 
HSBC Piper Jaffray CIBC World Markets
 
The date of this prospectus is          , 2007


Table of Contents

(PICTURE)

 


 

TABLE OF CONTENTS
 
         
    Page
 
  1
  12
  33
  34
  35
  36
  37
  38
  39
  44
  46
  70
  75
  90
  96
  102
  104
  107
  112
  119
  121
  126
  131
  132
  133
  134
  F-1
  EX-3.1 ARTICLES OF ASSOCIATION CURRENTLY IN EFFECT
  EX-3.2 AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
  EX-4.2 SPECIMEN CERTIFICATE FOR ORDINARY SHARES
  EX-4.4 EXCLUSIVE TECHNOLOGY AGREEMENT
  EX-4.5 EXCLUSIVE CONSULTANCY SERVICE AGREEMENT
  EX-4.6 PROPRIETARY TECHNOLOGY LICENSE AGREEMENT
  EX-4.7 POWER OF ATTORNEY
  EX-4.8 EQUITY PLEDGE AGREEMENT
  EX-4.9 EXCLUSIVE CALL OPTION AGREEMENT
  EX-4.10 EQUITY INTEREST OF PRIMALIGHTS III
  EX-4.11 LETTER OF UNDERTAKING
  EX-4.12 SPOUSE STATEMENT
  EX-4.13 SHARE PURCHASE AGREEMENT
  EX-4.14 SHAREHOLDERS AGREEMENT
  EX-4.15 REGISTRATION RIGHTS AGREEMENT
  EX-4.16 UNDERTAKING LETTER
  EX-4.17 DEED OF ADHERENCE
  EX-4.18 LEASE OF LAND
  EX-5.1 OPINION OF MAPLES AND CALDER
  EX-8.1 OPINION OF LATHAM & WATKINS LLP
  EX-10.1 2007 SHARE INCENTIVE PLAN
  EX-10.2 FORM OF INDEMNIFICATION AGREEMENT
  EX-10.3 FORM OF EMPLOYMENT AGREEMENT
  EX-21.1 SUBSIDIARIES OF THE REGISTRANT
  EX-23.1 CONSENT OF ERNST & YOUNG HUA MING
  EX-23.5 CONSENT OF SALLMANNS(FAR EAST) LTD
  EX-23.6 CONSENT OF TERRY MCCARTHY
  EX-23.7 CONSENT OF SHANGZHONG XU
  EX-23.8 CONSENT OF JIURAN ZHAO
  EX-99.1 CODE OF BUSINESS CONDUCT AND ETHICS
  EX-99.2 OPINION OF COMMERCE & FINANCE LAW OFFICES
 
 
You should rely only on the information contained in this document or to which we have referred you. We have not authorized anyone to provide you with information that is different. This document may only be used where it is legal to sell these securities. The information in this document may only be accurate on the date of this document.
 
Dealer Prospectus Delivery Obligation
 
Until      , 2007, all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer’s obligation to deliver a prospectus when acting as an underwriter and with respect to unsold allotments or subscriptions.


i


Table of Contents

 
PROSPECTUS SUMMARY
 
The following summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information and financial statements appearing elsewhere in this prospectus. We urge you to read the entire prospectus carefully, especially the risks of investing in our ADSs discussed under “Risk Factors,” before making an investment decision.
 
Our Company
 
We are a fast-growing China-based agri-solutions provider engaged in research and development, production and sale of upstream agricultural products. We currently offer corn seeds, sheep breeding products and seedling products. Our goal is to become a leading provider of a variety of agricultural upstream products to meet evolving demands of other participants in the agricultural industry, including producers of corn, sheep and other agricultural products that are used to manufacture products such as animal feed, mutton and wool. We have experienced substantial growth in revenues and profitability in recent years. Our total revenues increased from RMB152.3 million in 2004 to RMB489.7 million ($64.3 million) in 2006, representing a compound annual growth rate, or CAGR, of 79.3%. Our net income increased from RMB57.8 million in 2004 to RMB253.9 million ($33.4 million) in 2006, representing a CAGR of 109.6%. In the six months ended June 30, 2007, we generated total revenues of RMB279.4 million ($36.7 million) and net income of RMB143.4 million ($18.8 million). In 2006, we achieved gross margins of 41.1%, 72.9%, 79.7% from our corn seed, sheep breeding and seedling segments, respectively, while revenues from our corn seeds, sheep breeding and seedling segments accounted for 50.2%, 39.4% and 10.4%, respectively, of our total revenues. In the six months ended June 30, 2007, revenues from our corn seeds, sheep breeding and seedling segments accounted for 47.9%, 39.6% and 12.5%, respectively, of our total revenues.
 
We have access to approximately 27,000 acres of farmland in seven provinces, of which approximately 23,000 acres are used for production of our corn seeds, approximately 3,700 acres are used for our sheep farming and breeding activities and the remainder are used for our seedling production and research and development activities. The farmland to which we have access increased from approximately 5,000 acres as of December 31, 2004 to approximately 27,000 acres as of June 30, 2007. We own approximately 17,000 sheep consisting of nine types of purebred breeder sheep and our self-developed Primalights III hybrid sheep. In addition to our Primalights III hybrid sheep, we sell sheep breeding products which include frozen sheep semen, sheep embryos and breeder sheep. In 2006, we sold approximately 31,100 tonnes of corn seeds, 20.5 million straws of frozen sheep semen, 8,250 sheep embryos, 4,620 breeder sheep, 26,100 Primalights III hybrid sheep and a total of 21.6 million seedlings. In the six months ended June 30, 2007, we sold approximately 14,400 tonnes of corn seeds, 10.6 million straws of frozen sheep semen, 4,980 sheep embryos, 1,760 breeder sheep, 14,400 Primalights III hybrid sheep and a total of 11.6 million seedlings.
 
We grow corn seed products in seven provinces in China through contractual arrangements with village collectives and seed production companies under which we provide farming, harvesting and other technical guidance and supervision to farmers. We process and package corn seed products and then sell them to local and regional distributors. We produce sheep breeding products in five breeding bases located in Shanxi province and sell these products primarily to government-operated breed improvement and reproductive stations, or BIRS, breeding companies and other sheep reproductive stations and farms. Our corn seed and sheep breeding products are ultimately sold to and used by farmers in 14 provinces in China. We produce blackberry, raspberry and date seedlings and sell them directly to end users, such as municipal agencies and seedling companies. We also produce white bark pine seedlings for urban greenery.
 
We sell both proprietary and non-proprietary agricultural products. Our proprietary products are sold under our Primalights III brand, which we believe is a well-recognized brand among our customers and end users. We provide four proprietary strains of Primalights III corn seeds with different characteristics, such as high yield, disease resistance, drought resistance, high starch, and stress tolerance, to fit various climate zones in China. Sales of our proprietary corn seeds collectively accounted for approximately 55.8% and 64.6% of our total corn seed revenues in 2006 and the six months ended June 30, 2007, respectively. We have developed


1


Table of Contents

Primalights III hybrid sheep to meet the needs of our target markets in China. Primalights III hybrid sheep are a cross between certain high-fleshing foreign breeds and an adaptable and prevalent Chinese breed. Our research and development team works both independently and with agricultural, animal husbandry and forestry research and academic institutions in China to improve our existing products and to develop new ones. We will continue to engage in research and development across all three business segments to optimize our growing and production processes and to develop high-quality and commercially viable products.
 
Industry Background
 
China’s agricultural industry has grown substantially in recent years, driven by the growth of China’s overall economy. China’s agricultural output totaled RMB2,155 billion in 2006, accounting for 10.3% of China’s gross domestic product and representing a CAGR of 8.3% from 2001 to 2006, according to the National Bureau of Statistics of China. We believe that China’s agricultural industry will continue to grow since it remains at an early stage of modernization, with significant manual labor and lower usage of advanced machinery and irrigation than that of developed economies.
 
According to China Agriculture Yearbook 2006, China was the world’s second largest producer of corn, contributing approximately 19% of global corn production in 2005. As China’s economy continues to grow, demand for corn for animal feed and human dietary consumption is expected to increase. To meet the increasing demand for corn and to compete successfully with imported corn products, we believe Chinese farmers may be inclined to utilize better production methods, including utilizing hybrid corn seeds, to increase output and to improve the quality and attributes of their corn products. This in turn may lead to increasing demand for hybrid corn seeds with multiple attributes specifically developed for various climate zones in China.
 
In 2005, China had approximately 171 million sheep, the largest flock of any country in the world according to the Food and Agriculture Organization of the United Nations, or FAOSTAT, and consumed more mutton and wool than any other country, according to FAOSTAT and the International Wool Trade Organization. Rising affluence in China has led to increased meat consumption and production. Mutton production increased from 2.74 million tonnes in 2000 to 4.36 million tonnes in 2005, representing a CAGR of 9.7%. Mutton consumption, as a percentage of total meat consumption, increased from 4.2% in 2000 to 6.4% in 2005. Compared to sheep/goat flocks in developed countries, the sheep/goat flocks in China generally produce lower quality and quantities of wool and meat. As a result, China has been improving the quality of its sheep flock, which creates significant internal demand for breeder sheep, cost-effective production of related products and relevant scientific research.
 
Rapid urbanization, rising affluence and deteriorating environmental conditions in China have increased the need and desire for tree planting. New trees planted in China must be cultivated from seedlings since the China Forestry Bureau forbids the transplanting of natural forest. Increased disposable income of Chinese consumers and increasing recognition of the nutritional benefits of fruit berries have driven the demand for fruit berries in China. With its diverse geography and relatively low labor costs, China is well suited for the production of fruit berry trees as these trees can grow on land that is not suitable for other crops and fruit berry production is labor intensive.
 
Our Strengths and Strategies
 
We believe that the following strengths have contributed to our current market position:
 
  •  rapid growth as a provider of upstream agricultural products in China;
 
  •  a diversified portfolio of commercially successful products;
 
  •  operations in strategic locations where we have an extensive local knowledge and experience;
 
  •  strong marketing and customer support and extensive distribution network;
 
  •  effective operations management and quality control system;


2


Table of Contents

 
  •  strong research and development capabilities; and
 
  •  an experienced management team and skilled staff.
 
Our goal is to become a leading upstream provider of a variety of agricultural products to meet evolving demands of other participants in the agricultural industry, including producers of corn, sheep and other agricultural products that are used to manufacture products such as animal feed, mutton and wool. We intend to achieve our goal by implementing the following strategies:
 
  •  increase our product sales in existing and new geographic markets;
 
  •  increase the variety of our products within each of our business segments;
 
  •  expand our research and development capabilities; and
 
  •  selectively pursue strategic acquisitions and alliances and expand into new agricultural sectors.
 
Our Risks and Challenges
 
Our ability to achieve our goal and implement our strategies is subject to risks and uncertainties, including the following:
 
  •  natural or man-made disasters could damage our seed production, which would cause us to suffer production losses and a material reduction of our revenues;
 
  •  outbreaks of disease in livestock and/or food scares in China would materially and adversely affect our sheep breeding business;
 
  •  we primarily rely on arrangements with village collectives to produce our corn seed products, and if we are unable to continue these arrangements or enter into new arrangements with other village collectives to increase our production, our total land acreage devoted to corn seed production may decrease and our growth may be inhibited;
 
  •  our growth prospects may be materially and adversely affected if we are unable to continue to develop or acquire products to meet the demands of Chinese farmers or to produce our existing products in sufficient quantities;
 
  •  one or more of our distributors may engage in activities that are harmful to our brand and to our business; and
 
  •  our limited operating history makes it difficult to evaluate our future prospects and results of operations.
 
Please see “Risk Factors” and other information included in this prospectus for a discussion of these and other risks.


3


Table of Contents

Corporate History and Structure
 
We conduct substantially all of our operations in China through our contractual arrangements with our consolidated affiliated entity, Primalights III Agriculture Development Co., Ltd., or P3A, and our wholly-owned subsidiary in China, Aero-Biotech Science & Technology Co., Ltd., or Agria China. We commenced operations in January 2004 by acquiring the business of P3A, a limited liability company incorporated under the laws of the PRC in 2000. We established a holding company, Aero-Biotech Group Limited, or Aero-Biotech, under the laws of the British Virgin Islands in July 2005 to facilitate our future international fund-raising activities. We formed Agria China as a wholly-owned subsidiary under the laws of the PRC in March 2007 to focus on research and development and other corporate activities. In preparation of this offering, we incorporated Agria Corporation under the laws of the Cayman Islands in May 2007 as our proposed listing vehicle. Agria Corporation became the holding company of Aero-Biotech in June 2007 when all of the shareholders of Aero-Biotech exchanged their shares in Aero-Biotech for shares of Agria Corporation on a pro rata basis.


4


Table of Contents

The following diagram illustrates our corporate structure as of September 30, 2007:
 
(FLOW CHART)
 
PRC law currently prohibits a foreign entity or person from owning over 50% of any seed development and production business in China. We conduct our corn seed, sheep breeding and seedling businesses through contractual agreements with our consolidated affiliated entity, P3A, which holds the requisite licenses and permits for these businesses. Our contractual arrangements with P3A and its shareholders enable us to:
 
  •  exercise effective control over P3A;
 
  •  receive substantially all of the earnings and other economic benefits from P3A to the extent permissible under PRC law in consideration for the services provided by Agria China; and
 
  •  have an exclusive option to purchase all or part of the equity interests in P3A in each case when and to the extent permitted by PRC law.


5


Table of Contents

Corporate Information
 
Our principal executive offices are located at Room 706, 7/F, Huantai Building, No. 12A, South Street Zhongguancun, Haidian District, Beijing 100081, People’s Republic of China. Our telephone number at this address is +(8610) 6210-9288. Our registered office in the Cayman Islands is located at the offices of M&C Corporate Services Limited, PO Box 309GT, Ugland House, South Church Street, George Town, Grand Cayman, Cayman Islands. Our agent for service of process in the United States is Law Debenture Corporate Services Inc., 400 Madison Avenue, 4 th Floor, New York, New York 10017. Investors should contact us for any inquiries through the address and telephone number of our principal executive offices. Our principal website is expected to be www.agriacorp.com . The information contained on our website is not a part of this prospectus.


6


Table of Contents

Conventions That Apply to this Prospectus
 
Unless we indicate otherwise, all information in this prospectus reflects the following:
 
  •  no exercise by the underwriters of their option to purchase up to       additional ADSs representing       ordinary shares;
 
  •  conversion of all outstanding preferred shares into ordinary shares immediately prior to the closing of this offering; and
 
  •  all share and per share data have been adjusted to reflect a 10,000-for-1 share split of our ordinary shares and our preferred shares that became effective on August 15, 2007.
 
Except where the context otherwise requires and for purposes of this prospectus only:
 
  •  “we,” “us,” “our company,” “our” and “Agria” refer to Agria Corporation, a Cayman Islands company, and its predecessor entities, subsidiaries and consolidated affiliated entity;
 
  •  “P3A” refers to our consolidated affiliated entity, Primalights III Agriculture Development Co., Ltd., which is a limited liability company established in China;
 
  •  “China” or “PRC” refers to the People’s Republic of China, excluding, for purposes of this prospectus, Taiwan, Hong Kong and Macau;
 
  •  “shares” or “ordinary shares” refers to our ordinary shares, and “preferred shares” refers to our series A redeemable convertible preferred shares;
 
  •  “ADSs” refers to our American depositary shares, each of which represents       ordinary shares, and “ADRs” refers to the American depositary receipts that evidence our ADSs;
 
  •  all references to “RMB” or “Renminbi” are to the legal currency of China; all references to “$,” “dollars” and “U.S. dollars” are to the legal currency of the United States;
 
  •  “breeder sheep” refers to pure breed sheep that are used primarily in rapid reproduction or artificial reproduction methods to spread desired genes widely in a flock and have received official variety recognition in China or another country; and
 
  •  “upstream” refers to the production and sale of agricultural products (e.g., seeds, sheep semen and sheep embryos) to be used by other participants in the agricultural industry to produce other agricultural products, such as corn and sheep, which in turn are used to manufacture products, such as animal feed, mutton and wool.


7


Table of Contents

THE OFFERING
 
The following information assumes that the underwriters will not exercise their option to purchase additional ADSs in the offering, unless otherwise indicated.
 
Offering price
We currently estimate that the initial public offering price will be between $       and $       per ADS.
 
ADSs offered by us
       ADSs
 
ADSs offered by the selling shareholders
       ADSs
 
ADSs outstanding immediately after this offering
       ADSs
 
Ordinary shares outstanding immediately after this offering
       shares
 
The ADSs
Each ADS represents       ordinary shares, par value $0.0000001 per share.
 
• The depositary will hold the shares underlying your ADSs. You will have rights as provided in the deposit agreement.
 
• If, however, we declare dividends on our ordinary shares, the depositary will pay you the cash dividends and other distributions it receives on our ordinary shares, after deducting its fees and expenses.
 
• You may turn in your ADSs to the depositary in exchange for ordinary shares. The depositary will charge you fees for any exchange.
 
• We may amend or terminate the deposit agreement without your consent. If you continue to hold your ADSs, you agree to be bound by the deposit agreement as amended.
 
To better understand the terms of the ADSs, you should carefully read the “Description of American Depositary Shares” section of this prospectus. You should also read the deposit agreement, which is filed as an exhibit to the registration statement that includes this prospectus.
 
Over-allotment option
We and the selling shareholders have granted to the underwriters options, which are exercisable within 30 days from the date of this prospectus, to purchase up to an additional       ADSs.
 
Use of proceeds
Our net proceeds from this offering are expected to be approximately $       million, assuming an initial public offering price per ADS of $      , which is the midpoint of the estimated public offering price range. We plan to use the net proceeds we receive from this offering to fund capital expenditures and expansion of our business, expand our research and development capability and for other general corporate purposes, including funding potential strategic acquisitions. See “Use of Proceeds” for additional information.
 
We will not receive any of the proceeds from the sale of ADSs by the selling shareholders.


8


Table of Contents

 
Lock-up
We have agreed with the underwriters to a lock-up of shares for a period of 180 days after the date of this prospectus. In addition, our executive officers, directors and existing shareholders have also agreed with the underwriters to a lock-up of shares for a period of 180 days after the date of this prospectus. See “Shares Eligible For Future Sale” and “Underwriting.”
 
Listing
We have applied to have the ADSs listed on the New York Stock Exchange under the symbol “GRO.” Our ADSs and shares will not be listed on any other exchange or traded on any other automated quotation system.
 
Reserved ADSs
At our request, the underwriters have reserved for sale, at the initial public offering price, up to an aggregate of       ADSs to our directors, officers, employees, business associates and related persons through a directed share program.
 
Risk factors
See “Risk Factors” and other information included in this prospectus for a discussion of risks you should carefully consider before investing in our ADSs.
 
Depositary
The Bank of New York
 
The number of ordinary shares that will be outstanding immediately after this offering:
 
  •  assumes the conversion of all outstanding preferred shares into 2,400,000 ordinary shares immediately prior to the completion of this offering;
 
  •  assumes the underwriter’s over-allotment option is not exercised;
 
  •  excludes 7,500,000 ordinary shares issuable upon exercise of options outstanding as of the date of this prospectus, at a weighted average exercise price of US$2.912 per share; and
 
  •  excludes ordinary shares reserved for future issuances under our 2007 share incentive plan.


9


Table of Contents

Our Summary Consolidated Financial Data
 
You should read the following information in conjunction with our consolidated financial statements and related notes, “Selected Consolidated Financial Data” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this prospectus. Our historical results do not necessarily indicate results expected for any future periods.
 
The following summary consolidated financial information (except for net income per ADS) has been derived from our consolidated financial statements as of December 31, 2005 and 2006 and as of June 30, 2007 and for the years ended December 31, 2004, 2005 and 2006 and for the six months ended June 30, 2006 and 2007 included elsewhere in this prospectus. Our consolidated balance sheets as of December 31, 2005 and 2006, and the related consolidated statements of operation, cash flows and changes in shareholders’ equity for each of the years ended 2004, 2005 and 2006 have been audited by Ernst & Young Hua Ming, an independent registered public accounting firm, and have been prepared and presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. Our consolidated statement of operations data for the six months ended June 30, 2006 and 2007 and our consolidated balance sheet data as of June 30, 2007 have been derived from our unaudited consolidated financial statements included elsewhere in this prospectus. We have prepared the unaudited consolidated financial statements on the same basis as our audited consolidated financial statements. The unaudited financial information includes all adjustments, consisting only of normal and recurring adjustments, that we consider necessary for a fair presentation of our financial position and operating results for the periods presented. Our unaudited results for the six months ended June 30, 2007 may not be indicative of our results for the full year ending December 31, 2007.
 
                                                         
    For the Year Ended December 31,     For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
    RMB     RMB     RMB     $     RMB     RMB     $  
    (In thousands, except share, per share and per ADS data)  
 
Consolidated Statement of Operations Data:
                                                       
Revenues
                                                       
Corn seeds
    48,560       245,601       245,634       32,269       142,126       133,853       17,584  
Sheep breeding
    92,904       119,468       193,054       25,362       97,518       110,599       14,530  
Seedlings
    10,820       19,020       51,015       6,702       29,594       34,955       4,592  
                                                         
Total revenues
    152,284       384,089       489,703       64,333       269,238       279,407       36,706  
                                                         
Cost of revenues
                                                       
Corn seeds
    (33,311 )     (147,723 )     (144,730 )     (19,013 )     (81,378 )     (80,395 )     (10,562 )
Sheep breeding
    (31,196 )     (37,716 )     (52,287 )     (6,869 )     (26,629 )     (30,543 )     (4,012 )
Seedlings
    (9,053 )     (5,932 )     (10,357 )     (1,361 )     (4,212 )     (10,679 )     (1,403 )
                                                         
Total cost of revenues
    (73,560 )     (191,371 )     (207,374 )     (27,243 )     (112,219 )     (121,617 )     (15,977 )
                                                         
Gross profit
    78,724       192,718       282,329       37,090       157,019       157,790       20,729  
Operating expenses
    (16,635 )     (18,372 )     (25,169 )     (3,306 )     (13,610 )     (12,524 )     (1,646 )
                                                         
Operating profit
    62,089       174,346       257,160       33,784       143,409       145,266       19,083  
                                                         
Income before income tax
    57,772       169,080       253,903       33,356       142,110       143,351       18,832  
                                                         
Net income
    57,772       169,080       253,903       33,356       142,110       143,351       18,832  
                                                         
Earnings per ordinary share
                                                       
Basic
    0.58       1.69       2.54       0.33       1.42       1.43       0.19  
Diluted
    0.58       1.69       2.54       0.33       1.42       1.43       0.19  
Earnings per ADS(1)
                                                       
Basic
                                                                                          
Diluted
                                                                                     
Weighted average number of ordinary shares used in per share calculations:
                                                       
Basic
    100,000,000       100,000,000       100,000,000       100,000,000       100,000,000       100,000,000       100,000,000  
Diluted
    100,000,000       100,000,000       100,000,000       100,000,000       100,000,000       100,119,337       100,119,337  
Pro forma earnings per share: (2)
                                                       
—Basic and diluted on an as converted basis
                RMB2.48       US$0.33             RMB1.40       US$0.18  


10


Table of Contents

                                                         
    For the Year Ended December 31,     For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
    RMB     RMB     RMB     $     RMB     RMB     $  
    (In thousands, except share, per share and per ADS data)  
 
Weighted average number of ordinary shares outstanding used in computation of pro forma basic and diluted earnings per share
                102,400,000       102,400,000             102,400,000       102,400,000  
 
 
(1) Each ADS represents       ordinary shares.
 
(2) The pro forma earnings per share are calculated based on an assumption that the conversion of 2,400,000 Series A convertible redeemable preferred shares outstanding as of June 30, 2007 into the same number of ordinary shares had occurred on January 1, 2006 and 2007.
 
                                 
    As of December 31,
    As of June 30,
 
    2006     2007  
    RMB     $     RMB     $  
    (In thousands)  
 
Consolidated Balance Sheet Data:
                               
Cash and cash equivalents
    42,782       5,620       325,562       42,770  
Accounts receivable
    156,440       20,552       166,954       21,933  
Total assets
    490,476       64,434       871,500       114,490  
Total current liabilities
    127,344       16,729       344,636       45,275  
Series A Redeemable convertible preferred shares
                65,111       8,555  
Redeemable ordinary shares
                155,928       20,484  
Total shareholders’ equity
    354,136       46,523       296,829       38,994  

11


Table of Contents

 
RISK FACTORS
 
Investing in our ordinary shares and ADSs involves a high degree of risk. You should carefully consider the risks described below, together with the other information contained in this prospectus before making an investment decision. The trading prices of our ADSs could decline due to any of these risks or other factors and you may lose all or a part of your investment.
 
Risks Relating to Our Business
 
Our limited operating history makes it difficult to evaluate our future prospects and results of operations.
 
We have a limited operating history. Our consolidated affiliated entity, P3A, commenced operations in 2000 and first achieved profitability in 2002. Accordingly, you should consider our future prospects in light of the risks and uncertainties experienced by early stage companies in the highly fragmented agricultural industry in China. Some of these risks and uncertainties relate to our ability to:
 
  •  maintain our competitive position in China and compete in each of our business segments with Chinese and international companies, many of which have longer operating histories and greater financial resources than us;
 
  •  continue to offer commercially successful products to attract and retain a larger base of direct customers and ultimate users;
 
  •  retain access to the farmland we currently use for production of our products and obtain access to additional farmland for expansion;
 
  •  continue our existing arrangements with village collectives that grow our corn seed products and enter into new arrangements with additional village collectives;
 
  •  maintain effective control of our costs and expenses; and
 
  •  retain our management and skilled technical staff and recruit additional key employees.
 
If we are unsuccessful in addressing any of these risks and uncertainties, our business, financial condition and results of operations may be materially and adversely affected.
 
Natural or man-made disasters could damage our seed production, which would cause us to suffer losses of production and a material reduction of revenues.
 
We produce corn seeds through a network of approximately 54 village collectives and seed production companies that plant crops and harvest seeds for us on a contract basis. The sources of supply for our seeds are highly diverse but invariably subject to the risks associated with growing crops, including natural disasters such as drought, pestilence, plant diseases and insect infestations, and man-made disasters such as environmental contamination. Other man-made incidents may damage our products, such as arson or other acts that may adversely affect our corn seed inventory in the winter storage season. Furthermore, natural or man-made disasters may cause farmers to migrate from the farmland, which would decrease the number of end users of our products. We are particularly susceptible to disasters or other incidents in Shanxi province, where we have the greatest concentration of our operations. In the event of a widespread failure of a seed crop, we would likely sustain substantial loss of revenues and suffer substantial operating losses. We do not have insurance to protect against such a risk and we are not aware of the availability of any such insurance in China.
 
An outbreak of disease in livestock and/or food scares in China would materially and adversely affect our sheep breeding business.
 
Any major outbreak of disease in livestock in China, such as foot and mouth disease, is likely to result in significant disruptions to our business operations. A major epidemic within our farms, the onset of diseases and the preventive culling of our livestock could result in considerable losses to our flocks, which would materially and adversely affect our business and our profitability. Adverse publicity and concerns resulting


12


Table of Contents

from an outbreak of diseases in livestock may discourage consumers from purchasing mutton or related products. Such a reduction in demand would adversely impact our financial performance, regardless of whether our livestock has been directly affected by any disease.
 
We primarily rely on arrangements with village collectives to produce our corn seed products. If we were unable to continue these arrangements or enter into new arrangements with other village collectives, our total land acreage devoted to corn seed production would decrease and our growth would be inhibited.
 
As of June 30, 2007, we had access to approximately 27,000 acres of farmland in seven provinces mainly through contractual arrangements with village collectives. As we are legally prohibited from owning farmland, we typically lease the land owned by a village collective and enter into a seed production agreement with that village collective. These leases typically are twelve years in length, while the contracts to produce corn are typically one year in length, covering one growing season. In the event that prices for other crops increase, these village collectives may decide to farm other crops in breach of our leases and seed production agreements with them, or following expiration of our leases, lease the land to our competitors or others. If the land policy changes so that we are unable to continue to lease the land, if a significant number of village collectives refuse to lease the land to us at the expiration of their current leases, or if we are unable to find new villages collectives willing to lease their land to us and produce corn seeds for us, our business and results of operations would be materially and adversely affected. Any of these disruptions could materially and adversely affect our supply of corn seeds and our revenues. Such disruptions could also damage distributor relationships and farmer loyalty if we cannot supply them with the quantities and varieties of seeds that they expect. Moreover, due to competition for land suitable for leasing, we may be unable to lease the same land or other land at commercially reasonable prices. In the event that we have to pay more for leased land or are unable to lease sufficient land, our results of operations may be materially and adversely affected.
 
If our rights to lease land from village collectives were subject to a dispute, or if their legality or validity were challenged, our operations could be disrupted.
 
PRC law provides for the registration of land ownership and land-use rights and for the issuance of certificates evidencing land ownership or the right to use land. See “Regulation — Land Use Rights.” However, the administrative system for registration of land ownership and land-use rights is not well-developed in rural areas where most of our corn seed production bases are located. As a result, we are generally not able to verify through the land registry system the ownership or land-use rights of the parties from whom we have leased land. Despite our efforts to obtain representations from the village collectives that they own the land, possess land-use rights or have the right to sub-contract the land-use right on behalf of the holder of such rights, there is nevertheless a risk that they have not legally and validly granted the right to use the land to us. Moreover, there is a risk that the village collectives will, in breach of the terms of the applicable leases, enter into leases with other third parties in respect of land-use rights which they have previously granted to us, or that they have not entered into leases with third parties before entering into leases with us.
 
In addition, under PRC law, if a village collective plans to enter into a lease with a party that does not belong to the collective, the contract must first be approved by at least two thirds of the members of the village assembly or representatives of the villagers. The lease must then be submitted to the township government for approval before it becomes effective. There is a risk that the village collectives with which we have entered into leases, and which have generally advised us that the required village assembly meetings were convened and the leases were approved by the township government, have in fact not undertaken all required actions prior to entering into leases with us.
 
There is a risk that the legality or validity of our leases will be subject to dispute or challenge in the future. If our leases become subject to a dispute or challenge, our operations on such land could be suspended and we could lose our rights to use such land which would in turn reduce the amount of corn we are able to sell, which could have a material and adverse effect on our business, financial condition and results of operations.


13


Table of Contents

Our growth prospects may be materially and adversely affected if we are unable to develop or acquire new products or to produce our existing products in sufficient quantities.
 
The majority of our products are upstream products ultimately used by farmers in China. The profitability of our business depends on sustained and recurring orders from our direct customers, which include distributors, BIRS and other intermediaries. Reorder rates are uncertain due to several factors, many of which are beyond our control. These include changing customer preferences, competitive price pressures, our failure to develop new products to meet the evolving demands of farmers in China, the development of higher-quality products by our competitors, and general economic conditions. If we are unable to develop or acquire additional products that meet the demands of farmers in China, if our competitors develop products that are favored by farmers in China, or if we are unable to produce our existing products in sufficient quantities, our growth prospects may be materially and adversely affected and our revenues and profitability may decline.
 
One or more of our distributors could engage in activities that are harmful to our brand and to our business.
 
In provinces outside Shanxi, our corn seed products are sold primarily through distributors, and those distributors are responsible for ensuring that our products have the appropriate licenses to be sold to farmers in those provinces. If those distributors do not apply for and receive the appropriate licenses, their sales of our products in those provinces may be illegal, and we may be subject to government sanctions, including confiscation of illegal revenues and a fine of between two and three times the amount of such illegal revenues. Unlicensed sales in a province may also cause a delay for our other distributors in receiving a license from the authorities for that province, which could further adversely impact our sales in that province. In addition, distributors may sell our products under another brand that is licensed in a particular province if our product is not licensed there. If our products are sold under another brand, the purchasers will not be aware of our brand name, and we will be unable to cross-market other corn seed varieties or other products as effectively to these purchasers. Moreover, our ability to provide appropriate customer service to these purchasers will be negatively affected, and we may be unable to develop our local knowledge of the needs of these purchasers and their environment. Furthermore, if any of our distributors sell inferior corn seeds produced by other companies under our brand name, our brand and reputation could be harmed, which could make marketing of our branded corn seeds more difficult.
 
Our plans to increase our production capacity and expand into new markets may not be successful, which could adversely affect our operating results.
 
We plan to further our expansion efforts with increased production of existing products and new corn seed, sheep breeding and seedling products. This expansion has placed and will continue to place, substantial demands on our managerial, operational, technological and other resources. If we fail to manage the growth of our product offerings, operations and distribution channels effectively and efficiently, we could suffer a material and adverse effect on our operations and our ability to capitalize on new business opportunities, either of which could materially and adversely affect our operating results.
 
As part of our growth, we intend to expand the geographic areas in which our products are sold. Expansion into new markets may present operating and marketing challenges that are different from those that we currently encounter in our existing markets. If we are unable to anticipate the changing demands that expanding operations will impose on our production systems and distribution channels, or if we fail to adapt our production systems and distribution channels to changing demands in a timely manner, we could experience a decrease in revenues and an increase in expenses and our results of operations could be adversely affected.
 
It is difficult to predict our future performance because our revenues and operating results fluctuate significantly from period to period due in part to the nature of our business.
 
Our operating results may fluctuate due to a number of factors, many of which are beyond our control. Our quarterly and annual revenues and costs and expenses as a percentage of our revenues may be


14


Table of Contents

significantly different from our historical rates. Our operating results in future quarters may fall below expectations. The industry in which we operate is seasonal in nature. For example, the vast majority of our corn seed sales take place between October and May. The sales of most of our sheep breeding products occurs in the spring season from March to June and the fall season from August to November and the majority of our seedling products are sold mainly in the spring season from March to June and in the fall season from September to October. As a result, if we are unable to generate sufficient working capital from our cash flow from operations and working capital facilities, we may encounter liquidity difficulties during the period of July and August, which may have a material and adverse effect on our operations. The seasonal nature of our business causes our operating results to fluctuate from quarter to quarter. Any unexpected seasonal or other fluctuations could cause the price of our ADSs to fall. As a result, you may not be able to rely on comparisons of our quarterly operating results as an indication of our future performance.
 
In addition, the future sustainability and growth of our profits depend on our ability to secure sufficient orders from customers. An adverse change in market conditions may have material and adverse effects on our operating results if we cannot adjust our operating and marketing strategy to respond to such changes. Our results of operations may be materially and adversely affected by reduced orders and profit margins in the event of a slowdown in market demand, an increase in business competition, a decrease in government subsidies to farmers, increased costs, or for other reasons. As such, there is a risk that we will not be able to continue to maintain a similar level of profits.
 
Our financial results are sensitive to fluctuations in market prices of the products that we offer; in recent years, prices of our corn seed and breeder sheep in China have been declining.
 
The profitability of our operations is affected by the selling prices of our products. We benchmark the prices of our proprietary corn seed against the prevailing domestic market prices of corn seed of similar quality and attributes, and set the prices of the breeder sheep that we sell at prices comparable to similar breeder sheep in China. Historically, prices of corn seed, breeder sheep and other agricultural products in China have been volatile, primarily due to fluctuations in supply and demand. In the past three years, prices of our corn seed and breeder sheep in China have been declining. If the prices for such products continue to decline in the future, and we are unable sell more products and/or reduce our cost of sales, our revenues will decrease and our profitability will be adversely affected.
 
The Chinese agricultural market is highly competitive and our growth and results of operations may be adversely affected if we are unable to compete effectively.
 
The agricultural market in China is highly fragmented, largely regional and competitive and we expect competition to increase and intensify within the sector. We face significant competition in our corn seed and sheep breeding lines of business. Many of our competitors have greater financial, research and development and other resources than we have. Competition may also develop from consolidation or other market forces within the corn seed industry in China, and the privatization of corn seed producers that are currently operated by the local governments in China. According to the Opinion on Enhancement of Market Supervision regarding Seed Administration Reform issued by the General Office of the PRC State Council in May 2006, the agricultural administrative offices of local government were required to separate their governmental administrative functions from seed production activities by the end of June 2007 and, therefore, there may be more privately-owned seed companies in the future. Our competitors may be better able to take advantage of industry consolidation and acquisition opportunities than us. The reform and restructuring of state-owned equity in seed enterprises will likely lead to the reallocation of market share in the seed industry, and our competitors may increase their market share by participating in the restructuring of the state-owned seed companies. Such privatization would likely mean that these producers will need to develop more efficient and commercially viable business models in order to survive. In addition, the PRC government currently restricts foreign ownership of any domestic seed development and production business to no more than 50%. When and if such restrictions are lifted, multinational corporations engaged in the seed business may expand into the agricultural market in China. These companies have significantly greater financial, technological and other resources than us and may become our major competitors in China. As competition intensifies, our margins


15


Table of Contents

may be compressed by more competitive pricing in the short term and may continue to be compressed in the long term and we may lose our market share and experience a reduction in our revenues and profit.
 
If we are unable to estimate farmers’ future needs accurately, and to match our production to the demand of our direct customers, our business, financial condition and results of operations may be materially and adversely affected.
 
Due to the nature of the corn seed industry, we normally produce seeds according to our production plan before we sell and deliver corn seeds to distributors, which are our direct customers. Chinese farmers, the end users of our corn seed, generally make purchasing decisions for our products based on market prices, economic and weather conditions and other factors that we and our distributors may not be able to anticipate accurately in advance. If we fail to accurately estimate the volume and types of products sought by farmers, we may produce more seeds that are not in demand by our distributors resulting in aged seeds. In the event we decide not to sell the aged seeds due to our concerns about the quality of these seeds, the aged inventory could eventually be sold as corn for end uses at greatly reduced prices than seeds. Aged inventory could result in asset impairment, in which case we would suffer a loss and incur an increase in our operating expenses. On the other hand, if we underestimate demand, we may not able to satisfy our distributors’ demand for corn seeds, and thus damage our customer relations and end-user loyalty. Our failure to estimate farmers’ future needs and to match our production to the demand of our direct customers may materially and adversely affect our business, financial condition and results of operations.
 
If we are not able to recover all of the advances paid to contracted village collectives or if a substantial number of our customers fail to pay for our products, our liquidity and financial condition may be materially and adversely affected.
 
We provide advances to the contracted village collectives which grow corn seeds for us in return for their purchase of fertilizer and other production materials. At the end of the growing season, after we take delivery of corn seeds, we credit the advances against the purchase prices payable to the village collectives. If the village collectives fail to produce or deliver the contracted amounts of corn seeds by the end of each growing season, we may not be able to recover all of the advances paid to the village collectives and our financial condition may be materially and adversely affected.
 
Our sales contracts provide for upfront payments, which may be up to 100% of the purchase price, depending upon the payment history and creditworthiness of each customer, with the balance due within 180 days of delivery. As a result, some of our customers have 180 days’ credit to pay after we deliver our corn seeds. These customers may not have ready access to further sources of credit and therefore may have limited ability to withstand economic downturns. The lack of credit could prevent them from fulfilling their purchasing commitments with us, which in turn may cause liquidity issues for us and materially and adversely affect our financial condition.
 
The resources we devote to research and development may not result in commercially viable or competitive products.
 
Our success depends in part on our ability to develop new products. Research and development in the corn seed, sheep breeding and seedling industries is generally expensive and prolonged. For example, seed development takes at least five years, as measured from selection of the variety of seed for product development to launch of a new corn seed product on the market. Due to the uncertainties and complexities associated with seed and biotechnological research, corn seed products under development may not survive the development process, may not ultimately be commercially viable, and/or may not pass government testing in the relevant provinces. As a further example, a new breed of sheep takes at least several generations to stabilize. Our proprietary locally-bred sheep breed, the Primalights III hybrid sheep, is close to stabilization which will qualify it for application eligibility as a new breed in China, and we expect to apply for official variety recognition when our Primalights III hybrid sheep becomes eligible for application. We have not yet begun the application process to apply for the title of official breeder sheep, and it may take several years to complete and/or may not be successful. In addition, we have significantly less financial resources than many


16


Table of Contents

of our international competitors. If the resources we devote to research and development do not result in products that survive the development stage, do not result in products that we can sell to our customers, or do not pass government testing, our results of operations may be materially and adversely affected.
 
We may be subject to intellectual property rights claims or other claims in the future which could result in substantial costs and diversion of our financial and management resources away from our business.
 
We are subject to the risk that the products, technology and processes that we have developed in collaboration with institutes and universities infringe or will infringe upon patents, copyrights, trademarks or other intellectual property rights held by third parties. We may be subject to legal proceedings and claims relating to the intellectual property of others. If any such claim arises in the future, litigation or other dispute resolution proceedings may be necessary to retain our ability to offer our current and future products, which could result in substantial costs and diversion of our management resources and attention even if we prevail in contesting such claims. If we are found to have violated the intellectual property rights of others, we may be enjoined from using such intellectual property rights, incur additional costs to license or develop alternative products and be forced to pay fines and damages, any of which could materially and adversely affect our business and results of operations.
 
Our failure to protect our intellectual property rights may undermine our competitive position, and legal action to protect our intellectual property rights may be costly and divert our management resources.
 
We rely primarily on trademark, trade secret, copyright law and other contractual restrictions to protect our intellectual property. These afford only limited protection and the actions we take to protect our intellectual property rights may not be adequate. Third parties may infringe or misappropriate our proprietary technologies or other intellectual property rights, which could have a material adverse effect on our business, financial condition or operating results. Preventing unauthorized use of proprietary technology can be difficult and expensive. Also, litigation may be necessary to enforce our intellectual property rights, protect our trade secrets or determine the validity and scope of the proprietary rights of others. There is a risk that the outcome of such potential litigation will not be in our favor. Such litigation may be costly and may divert management attention as well as expend other resources which could otherwise have been devoted to our business. An adverse determination in any such litigation will impair our intellectual property rights and may harm our business, prospects and reputation. In addition, we have no insurance coverage against litigation costs and would have to bear all costs arising from such litigation to the extent we are unable to recover them from other parties. The occurrence of any of the foregoing may have a material adverse effect on our business, results of operations and financial condition.
 
Historically, implementation of PRC intellectual property-related laws has been lacking, primarily because of ambiguities in the PRC laws and difficulties in enforcement. Accordingly, intellectual property rights and confidentiality protections in China may not be as effective as in the United States or other countries, which increases the risk that we may not be able to adequately protect our intellectual property.
 
Our rights to some of the technologies used in our sheep breeding business and developed through collaborations with Shanxi Agriculture University are limited in scope. If we are unable to continue commercialization of our intellectual property, our sheep breeding business could suffer, which could materially and adversely affect our results of operations.
 
We cooperate with Shanxi Agriculture University in research and development for our sheep breeding business. Under a number of our agreements with Shanxi Agriculture University, the university holds the rights to claim authorship on the technological achievements and the rights “to apply for awards” for the technologies developed. We have the exclusive right to use, further develop and commercialize these technologies developed by Shanxi Agriculture University under these agreements. If Shanxi Agriculture University were to dispute our exclusive rights to use, further develop and commercialize these technologies, we may lose our ability to continue to employ such technologies in our sheep breeding business. If this were to occur, our sheep breeding operations could suffer and our results of operations could be adversely affected.


17


Table of Contents

Our senior management team has worked together for a short period of time, which may make it difficult for you to evaluate their effectiveness and ability to address challenges.
 
Due to our recent restructuring and additions to our corporate management team, certain of our senior management have worked together at our company for only a short period of time. For example, our chief financial officer joined us in February 2007, our chief technology officer joined us in May 2007, and our co-chief executive officer Kenneth Hua Huang joined us in July 2007. As a result, it may be difficult for you to evaluate the effectiveness of our senior management and their ability to address future challenges to our business. In addition, we plan to recruit qualified candidates with substantial experience in the global agricultural industry to further strengthen our senior management team. We may not be able to identify or recruit appropriate new senior management personnel with such experience and even if we can, such new senior management personnel may not be able to work with our existing management to effectively execute our growth strategy and address future challenges to our business.
 
Our business depends substantially on the continuing efforts of our management, and our business may be severely disrupted if we lose their services.
 
Our future success depends significantly upon the continued services of our management, especially in the case of our primary operating entity, P3A. We rely on our management’s experience in product development, business operations, and sales and marketing, and on their relationships with distributors and relevant government authorities. If one or more of our key management personnel are unable or unwilling to continue in their present positions, we may not be able to replace them easily or at all. The loss of the services of our key management personnel, in the absence of suitable replacements, could have a material adverse effect on our operations and financial condition, and we may incur additional expenses to recruit and train personnel. Each member of our management team has entered into an employment agreement with us, which contains confidentiality and non-competition provisions. If disputes arise between our management and us in light of the uncertainties within the PRC legal system, there is a risk that some of the provisions of these agreements may not be enforced or enforceable in China, where our managers reside and hold most of their assets.
 
We may not possess all the licenses required to operate our business, or may fail to maintain the licenses we currently hold. This could subject us to fines and other penalties, which could have a material adverse effect on our results of operations.
 
We are required to hold a variety of permits and licenses to conduct our corn seed business, sheep breeding and seedling businesses in China. We may not possess all the permits and licenses required for each of our business segments. In addition, there may be circumstances under which the approvals, permits or licenses granted by the governmental agencies are subject to change without substantial advance notice, and it is possible that we could fail to obtain the approvals, permits or licenses that are required to expand our business as we intend. Two permits held by P3A for production and business operations of breeding livestock and poultry, or Husbandry Permits, have expired and we are currently in the process of obtaining the renewals from the department authorized by the State Council. If we fail to obtain or to maintain such permits or licenses or renewals are granted with onerous conditions, we could be subject to fines and other penalties and be limited in the number or the quality of the products that we would be able to offer. As a result, our business, result of operations and financial condition could be materially and adversely affected.
 
If the sale of our self-developed Primalights III hybrid sheep is considered by relevant government authorities to constitute the sale of breeder sheep, we may be ordered to stop selling Primalights III hybrid sheep and be subject to other penalties.
 
We sell breeder sheep as well as our self-developed Primalights III hybrid sheep to our customers. We expect that we will be eligible to apply for new breed status for our Primalights III hybrid sheep in the near future. According to the PRC Animal Husbandry Law, which became effective on July 1, 2006, any new variety of livestock is subject to examination and approval by the National Commission for Livestock and Poultry Genetic Resources and can be marketed and sold as a new variety only after the variety is approved


18


Table of Contents

and announced by the Ministry of Agriculture. Before obtaining such approval, we are not allowed to market or sell Primalights III hybrid sheep as breeder sheep, but only as ordinary hybrid sheep. According to informal inquiries with relevant PRC authorities, we do not need to acquire additional licenses if we only sell ordinary hybrid sheep. In the past, we sold our Primalights III hybrid sheep together with our breeder sheep under our form contract for breeder sheep, and farmers may use our Primalights III hybrid sheep to breed sheep. Under applicable PRC law, if any person sells any kind of livestock as a new variety before obtaining necessary approval, such person may be ordered to stop selling the livestock and pay a fine up to three times the proceeds received from prior illegal sales, and all the proceeds received from prior illegal sales may be confiscated. In 2006, sales of our Primalights III hybrid sheep accounted for 9.0% of our total revenues. If our sale of Primalights III hybrid sheep is considered by the relevant government authority to be a sale of breeder sheep, we may be ordered to stop selling them, be subject to confiscation of the livestock and the illegal gains or have additional fines imposed, all of which may have a material and adverse effect on our business.
 
We may be subject to product quality or liability claims, which may cause us to incur litigation expenses and to devote significant management time to defending such claims and, if determined adversely to us, could require us to pay significant damage awards.
 
In addition to the genetic traits and the quality of our products, the performance of our corn seeds depends on climate, geographical areas, cultivation method, farmers’ degree of knowledge and other factors. At the same time, the viability of some farmland in China has deteriorated due to toxic and hazardous materials from farmers’ overuse of herbicides. Moreover, different production methods of corn seeds might result in inconsistent quality of corn seeds. These factors are beyond our control and can result in sub-optimal production yields. However, farmers generally attribute sub-optimal production yields to poor seed quality.
 
We may be subject to legal proceedings and claims from time to time relating to our seed quality. The defense of these proceedings and claims could be both costly and time-consuming and significantly divert the efforts and resources of our management personnel. An adverse determination in any such proceedings could subject us to significant liability. In addition, any such proceeding, even if ultimately determined in our favor, could damage our market reputation and prevent us from maintaining or increasing sales and market share. Protracted litigation could also result in our customers or potential customers deferring or limiting their purchase of our products.
 
Corn seed prices and sales volumes may decrease in any given year with a corresponding reduction in sales, margins and profitability.
 
During most of our limited operating history, the corn seed market has been stable in China. In the future, there may be periods of instability during which commodity prices and sales volumes may fluctuate greatly. Commodities can be affected by general economic conditions, weather, disease outbreaks and factors affecting demand, such as availability of financing, competition and trade restrictions. Our attempts to differentiate our products from those of other corn seed producers have not prevented the corn seed market from having the characteristics of a commodity market. As a result, the price that we are able to demand for our corn seed is dependent on the size of the supply of our corn seed and the corn seed of other producers. Therefore, the potential exists for fluctuation in supply, and consequently in price, in our own markets, even in the absence of significant external events that might cause volatility. As a result, the amount of revenue that we receive in any given year is subject to change. As production levels are determined prior to the time that the volume and the market price for orders is known, we may have too much or too little product available, which may materially and adversely affect our revenues, margins and profitability.
 
The advent of the genetic modification of corn seeds in China could adversely affect our business, causing us to lose business opportunities, market share and revenues.
 
We currently rely upon traditional methods of creating corn seed hybrids to develop new products. There has been a worldwide increase in the development and application of genetically modified agricultural


19


Table of Contents

products to increase the quality and quantity of crop yields. Advances in technology are increasingly allowing the use of gene modification to produce seeds that are more superior than those that are produced by traditional methods. Currently, the production and commercial sale of genetically modified corn seed is not allowed in China. However, if government policies change to allow genetically modified corn seeds, demand may develop for these products, and we expect that we will need to produce genetically modified products to meet customer demands.
 
Should the Chinese government change its policy with respect to genetically modified corn seeds, there is a risk that our current steps to respond to the potential competitive threat posed by genetically modified agricultural products, including our research and development activities with respect to genetically modified corn seeds, may not allow us to compete successfully. In particular, our competitors may have more advanced technology or may market genetically modified seed more successfully than us.
 
Any diversion of management attention to matters related to acquisitions or any delays or difficulties encountered in connection with integrating acquired operations may have a material and adverse effect on our business, results of operations, and/or financial condition.
 
We intend to acquire companies whose products, operations or resources are complementary to our existing business. These transactions are designed to contribute to our long-term growth. We intend to align such acquisitions into our growth strategies to generate sufficient value to justify their cost. We may not be successful in identifying, consummating and integrating future acquisitions, which could significantly impair our growth potential. Acquisitions also present other challenges, including issues relating to geographical coordination, personnel integration and retention of key management personnel, systems integration and the reconciliation of corporate cultures. Those activities and operations could divert management’s attention from our business or cause a temporary interruption of, or loss of momentum in, our business and the loss of key personnel from the acquired companies. Any diversion of management’s attention to matters related to acquisitions or any delays or difficulties encountered in connection with integrating acquired operations may have an adverse effect on our business, results of operations and/or financial condition.
 
Our future growth prospects may be affected if we are unable to obtain additional capital to finance future acquisitions.
 
We may require additional cash resources in order to make acquisitions. We plan to expand through acquisitions, but have not yet identified or investigated potential acquisition targets in detail. In general, the cost of an acquisition is unknown until the opportunity is analyzed, due diligence has been completed and negotiations are underway. If the cost of any such acquisition that our management deems appropriate is higher than our cash resources, we will need to seek additional cash resources, and may seek to sell additional equity or debt securities or borrow under credit facilities. The sale or issuance of additional equity securities could result in dilution to our shareholders. The incurrence of indebtedness would result in increased debt service obligations and could result in operating and financing covenants that would restrict our operations. We may not be able to obtain financing in amounts or on terms acceptable to us, if at all. We may also not be able to secure or repay debt incurred to fund acquisitions, especially if the acquisition does not result in the benefits we anticipated. As a result, our operating results and financial condition may be materially and adversely affected.
 
Failure to properly manage our storage system may result in damage to products in storage, thereby resulting in operating losses.
 
Corn seed and seedling storage entails significant risks associated with the storage environment, including moisture, temperature and humidity levels, deviations of which may result in damage of corn seeds and seedlings in stock. Our semen and embryo products for our sheep breeding business are generally stored in a frozen state and any problems affecting the temperatures or conditions under which they are stored could damage these products. Any significant damage to the products we have in storage could materially and adversely affect our results of operations.


20


Table of Contents

Failure to achieve and maintain effective internal controls could have a material and adverse effect on the trading price of our ADSs.
 
We will become subject to reporting obligations under the U.S. securities laws. The Securities and Exchange Commission, as required under Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, has adopted rules requiring public companies to include a report of management on the effectiveness of such companies’ internal control over financial reporting in their annual reports. In addition, an independent registered public accounting firm for a public company must report the effectiveness of our company’s internal control over financial reporting. These requirements will first apply to our annual report on Form 20-F for the fiscal year ending December 31, 2008. Management may not conclude that our internal control over financial reporting is effective. Moreover, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may issue a report that is qualified if such firm is not satisfied with our internal control over financial reporting or the level at which our controls are documented, designed, operated or reviewed, or if such firm interprets the relevant requirements differently from us. In addition, during the course of such evaluation, documentation and testing, we may identify deficiencies which we may not be able to remediate in time to meet the deadline imposed by the Sarbanes-Oxley Act for compliance with the requirements of Section 404.
 
We have been a private company with limited accounting personnel and other resources to address our internal controls and procedures. As a result, during the audit of our financial statements for the three years ended December 31, 2006, we and our independent registered public accounting firm identified a number of control deficiencies, including two material weaknesses, as defined in the Public Company Accounting Oversight Board’s Audit Standard No. 2. The material weaknesses identified by us and our independent auditors are our inadequate personnel resources, processes and documentation to address reporting requirement under U.S. GAAP, and our inadequate independent oversight over financial reporting due to the lack of an independent audit committee. If we fail to implement measures to remediate these material weaknesses and other control deficiencies in time to meet the deadline imposed by Section 404 of the Sarbanes-Oxley Act, including establishing an audit committee in the near future, we may not be able to conclude, on an ongoing basis, that we have effective internal control over financial reporting in accordance with the Sarbanes-Oxley Act. Moreover, effective internal controls, particularly those related to revenue recognition, are necessary for us to produce reliable financial reports and are important to help prevent fraud. As a result, any failure to achieve and maintain effective internal control over financial reporting could result in our inability to conclude we have effective internal control over financial reporting in accordance with the Sarbanes-Oxley Act, causing the loss of investor confidence in the reliability of our financial statements, which in turn could negatively impact the trading price of our ADSs. Furthermore, we may need to incur significant costs and use significant management and other resources in an effort to comply with Section 404 of the Sarbanes-Oxley Act and other requirements.
 
We have limited insurance coverage in China.
 
The insurance industry in China is still at an early stage of development. Insurance companies in China offer limited insurance products. Other than automobile insurance on certain vehicles and property and casualty insurance on some of our assets, we do not have insurance coverage on our other assets or inventories and we do not have insurance to cover our business or interruption of our business, litigation or product liability. We have determined that the costs of insuring for these risks and the difficulties associated with acquiring such insurance on commercially reasonable terms make it impractical for us to have such insurance. Any uninsured occurrence of loss or damage to property, litigation or business disruption may result in our incurring substantial costs and the diversion of resources, which could have an adverse effect on our operating results and financial condition.
 
Deficient railway transportation capacity in northern and northwestern China may result in an increase in our transportation-related costs and thus adversely affect our business.
 
The majority of our major production bases are located in the Shanxi, Gansu, Inner Mongolia and Xinjiang provinces of China. Railway transportation is currently the most cost-effective means to transport


21


Table of Contents

seeds throughout China. With China’s fast economic development and increasing demand for commercial transportation, the railway system in China is often overburdened, and deficient in terms of transportation capability. As our volume of freight increases year by year, our seeds may have to be transported by other means if the rail system cannot efficiently and cost-effectively manage the increasing volume of freight. We may not be able to pass the resulting increase in transportation costs to our customers through price increases of our products. The deficiencies of the railways may also result in delays, inefficient distribution of our products and a loss of goodwill among our customers or end users, all of which may materially and adversely affect our business and results of operations.
 
If we grant additional employee share options, restricted shares or other share incentives in the future, our net income could be adversely affected.
 
We have adopted a 2007 share incentive plan and granted 7,500,000 share options under the plan in July 2007. We are required to account for share-based compensation in accordance with Financial Accounting Standards Board Statement No. 123(R), Share-Based Payment, which requires a company to recognize, as an expense, the fair value of share options and other share-based compensation to employees based on the fair value of equity awards on the date of the grant (taking into account the prices payable by the award recipients), with the compensation expense recognized over the period in which the recipient is required to provide service in exchange for the equity award. If we grant additional options, restricted shares or other equity incentives in the future, we could incur significant compensation charges equal to the fair value of the additional options, restricted shares and other equity incentives (taking into account the prices payable by the award recipients) and our net income could be adversely affected.
 
Risks Related to Doing Business in China
 
If the Chinese government finds that the agreements that establish the structure for operating our Chinese businesses do not comply with Chinese governmental restrictions on foreign investment in the seed industry, or if these regulations or the interpretation of existing regulations change in the future, we could be subject to severe penalties or be forced to relinquish our interests in those operations.
 
Most of our operations are conducted through our contractual arrangements with our affiliated entity and its shareholders in China. PRC regulations currently restrict foreign ownership of corn seed companies. For a description of these regulations, see “Regulation — Seed Law, Animal Husbandry Law and Other Relevant Regulations — Seed Law and Other Relevant Regulations.” We have entered into contractual arrangements with the affiliated entity and its shareholders, all PRC citizens, which enable us to, among other things, exercise effective control over the affiliated entity, P3A. See “Corporate History and Structure — Our Corporate History and Structure — Our Contractual Arrangements with P3A and Its Shareholders.”
 
If we or either of our PRC subsidiary or affiliated entity or our corporate structure is found to be in violation of any existing or future PRC laws or regulations (for example, if we are deemed to be holding equity interests in an entity in which direct foreign ownership is restricted) the relevant PRC regulatory authorities, including the administration of industry and commerce, the administration of foreign exchange and relevant agencies of the Ministry of Commerce, would have broad discretion in dealing with such violations, including:
 
  •  revoking P3A’s business and operating licenses;
 
  •  confiscating relevant income and imposing fines and other penalties;
 
  •  discontinuing or restricting P3A’s operations in China;
 
  •  requiring us or P3A to restructure P3A’s ownership structure or operations;
 
  •  restricting or prohibiting our use of the proceeds of this offering to finance our businesses and operations in China; or
 
  •  imposing conditions or requirements with which we or our subsidiary or P3A may not be able to comply.


22


Table of Contents

 
The imposition of any of these penalties could result in a material and adverse effect on our ability to conduct our business.
 
The shareholders of P3A may breach our agreements with them or may have potential conflicts of interest with us, and we may not be able to enter further agreements to derive economic benefits from P3A, which may materially and adversely affect our business and financial condition.
 
The shareholders of P3A , our consolidated affiliated entity in the PRC, may breach or refuse to renew the existing contractual arrangements with us that allow us to effectively control P3A, and receive economic benefits from its operations. There is a risk that they will not always act in the best interests of our company. We do not have existing arrangements to address potential conflicts of interest between these individuals and our company. We rely on these individuals to abide by the contract laws of China and honor their contracts with us in order for us to effectively control P3A and to receive the economic benefits deriving from our contracts with them. If we cannot resolve any conflicts of interest or disputes between us and the shareholders of P3A or if the shareholders breach our agreements with them, we would have to rely on legal proceedings, which may result in disruption to our business. There is also substantial uncertainty as to the outcome of any such legal proceedings.
 
Any limitation of PRC law and regulations on the ability of our subsidiary and affiliated entity to make dividend or payments to us could have a material adverse effect on our ability to conduct our business.
 
Current PRC regulations permit our subsidiary to pay dividends to us only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, each of our subsidiary and our affiliated entity in China is required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory reserve until such reserve reaches 50% of its registered capital, and to further set aside a portion of its after-tax profits to fund the employee welfare fund at the discretion of the shareholders’ meeting or the board. These reserves are not distributable as cash dividends. Furthermore, if our subsidiary and our affiliated entity in China incur debt on their own behalf in the future, the loan agreements governing that debt may restrict their ability to pay dividends or make payments to us according to the contractual agreements. In addition, the PRC tax authorities may require us to adjust our taxable income under the contractual arrangements we currently have in place in a manner that would materially and adversely affect our subsidiary’s ability to pay dividends and other distributions to us. Any limitation on the ability of our subsidiary and our affiliated entity to distribute dividends or other payments to us could materially limit our ability to grow, make investments or acquisitions that could be beneficial to our businesses, or otherwise fund and conduct our business.
 
Under the current PRC tax law, dividend payments to foreign investors made by foreign-invested enterprises, or FIEs, are exempted from PRC withholding tax. Pursuant to the new PRC enterprise income tax law to be effective on January 1, 2008, however, dividends payable by a FIE to its foreign investors will be subject to a 20% withholding tax, unless any such foreign investor’s jurisdiction of incorporation has a tax treaty with China that provides for a different withholding arrangement. Our wholly-owned subsidiary in China, Agria China, is considered as an FIE and is directly owned by our intermediary holding company incorporated in Hong Kong. According to the Mainland and Hong Kong Special Administrative Region Arrangement on Avoiding Double Taxation or Evasion of Taxation on Income agreed between the Mainland and Hong Kong Special Administrative Region in August 2006, dividends paid by an FIE to its direct holding company in Hong Kong will be subject to withholding tax at a rate of no more than 5%. The new tax law contemplates the possibility of exemptions from withholding taxes for China-sourced income of FIEs. Since the PRC tax authorities have not promulgated any related implementation rules, it remains unclear whether we would be able to obtain exemptions from PRC withholding taxes for dividends distributed to us by Agria China.


23


Table of Contents

We benefit from certain PRC government incentives. Expiration of, changes to, disputes over or challenges against these incentives or protectionism arising from the incentives could adversely affect our operating results.
 
The Chinese government has provided various incentives to high-technology companies and agricultural companies in order to encourage development of the high-technology and agricultural industries. Such incentives include reduced tax rates, subsidies, and other measures. For example, P3A, our consolidated affiliated entity, is qualified as a “key technology enterprise” pursuant to the Shanxi Province 1311 Agricultural High Technology Project implemented by Shanxi Province since 2002. As a result, P3A has been exempted from the PRC enterprise income tax since 2002 based on the approval of the local tax authority in Shanxi. In addition, Agria China, our wholly-owned subsidiary established in March 2007 in China, has been approved as a new technology enterprise and enjoys the reduced enterprise income tax rate of 15%. Agria China also received the local tax authority’s approval on September 30, 2007 to be exempted from the EIT from 2007 to 2009 and to be subject to the reduced EIT rate of 7.5% from 2010 to 2012. When these tax benefits are changed adversely, or if the central government challenges the tax exemption enjoyed by P3A as a result of the Shanxi Province 1311 Agricultural High Technology Project, our effective tax rate will likely increase up to a maximum of 25% on our worldwide income, which could have a material adverse effect on our financial condition and results of operations.
 
The PRC government has in recent years reduced taxes and increased subsidies and other support across the agricultural industry. For instance, the government subsidizes farmers for their seed purchases, and has increased spending on rural infrastructure. Sales of agricultural products from producers to intermediaries or to farmers is exempt from PRC value-added tax. The discontinuance of preferential treatments granted by the Chinese government to the seed industry, could adversely affect our earnings.
 
In addition, subsidy policies may have an adverse effect on our ability to market our products, especially in provinces other than Shanxi where we are planning to increase our sales. Farmers can buy corn seeds designated as “high-quality” at subsidized prices, but the designation of seeds as “high-quality” is at the discretion of the local government, companies owned by the local government and local private seed companies. It is possible that this policy could result in preferential treatment for local seed producers, with locally produced seeds being designated as “high-quality” while ours are not designated as such. If such preferential treatment were to occur, the price for our seeds to farmers in those provinces would be higher than the subsidized local seeds, and our sales in that province could suffer, which could have a material and adverse effect on our results of operations.
 
Uncertainties with respect to the PRC legal system could adversely affect us.
 
We conduct our business primarily through our subsidiary and affiliated entity in China. Our operations in China are governed by PRC laws and regulations. Our subsidiaries are generally subject to laws and regulations applicable to foreign investments in China, and in particular, laws applicable to wholly foreign-owned enterprises. The PRC legal system is based on written statutes. Prior court decisions may be cited for reference but have limited precedential value.
 
Since 1979, PRC legislation and regulations have significantly enhanced the protections afforded to various forms of foreign investments in China. However, China has not developed a fully integrated legal system and recently enacted laws and regulations may not sufficiently cover all aspects of economic activities in China. In particular, because these laws and regulations are relatively new, and because of the limited volume of published decisions and their non-binding nature, the interpretation and enforcement of these laws and regulations involve uncertainties. In addition, the PRC legal system is based in part on government policies and internal rules (some of which are not published on a timely basis or at all) that may have a retroactive effect. As a result, we may not be aware of our violation of these policies and rules until some time after the violation. In addition, any litigation in China, regardless of outcome, may be protracted and result in substantial costs and diversion of resources and management attention.
 
Recent SAFE regulations relating to offshore investment activities by PRC residents may increase our administrative burden and restrict our overseas and cross-border investment activity. If our shareholders and


24


Table of Contents

beneficial owners who are PRC residents fail to make any required applications and filings under such regulations, we may be unable to distribute profits and may become subject to liability under PRC laws.
 
The PRC State Administration of Foreign Exchange, or SAFE, has promulgated several regulations, including Circular No. 75 issued in November 2005 and implementation rules issued in May 2007, requiring registrations with, and approvals from, PRC government authorities in connection with direct or indirect offshore investment activities by PRC residents. These regulations apply to our shareholders and beneficial owners who are PRC residents.
 
The SAFE regulations require registration of direct or indirect investments made by PRC residents in offshore companies. In the event that a PRC shareholder with a direct or indirect stake in an offshore parent company fails to make the required SAFE registration, the PRC subsidiaries of that offshore parent company may be prohibited from making distributions of profit to the offshore parent and from paying the offshore parent proceeds from any reduction in capital, share transfer or liquidation in respect of the PRC subsidiaries. Further, failure to comply with the various SAFE registration requirements described above could result in liability under PRC law for foreign exchange evasion.
 
We have requested our current beneficial owners who are PRC residents to make the necessary applications and filings as required under these regulations and under any implementing rules or approval practices that may be established under these regulations. However, as a result of the recent enactment of the regulations, lack of implementing rules and uncertainty concerning the reconciliation of the new regulations with other approval requirements, it remains unclear how these regulations, and any future legislation concerning offshore or cross-border transactions, will be interpreted, amended and implemented by the relevant government authorities. There is a risk that not all of our shareholders and beneficial owners who are PRC residents will comply with our request to make or obtain any applicable registration or approvals required by these regulations or other related legislation. The failure or inability of our PRC resident shareholders and beneficial owners to receive any required approvals or make any required registrations may subject us to fines and legal sanctions, restrict our overseas or cross-border investment activities, limit our PRC subsidiary’s ability to make distributions or pay dividends or affect our ownership structure, as a result of which our acquisition strategy and business operations and our ability to distribute profits to you could be materially and adversely affected. See “Regulation — Foreign Exchange.”
 
In addition, under the Implementation Rules of the Administrative Measures for Individual Foreign Exchange, or the Individual Foreign Exchange Rules, issued on January 5, 2007 by the SAFE, PRC citizens who are granted shares or share options by an overseas listed company according to its employee share option or share incentive plan are required, through the PRC subsidiary of such overseas listed company or any other qualified PRC agent, to register with the SAFE and complete certain other procedures related to the share option or other share incentive plan. Foreign exchange income received from the sale of shares or dividends distributed by the overseas listed company may be remitted into a foreign currency account of such PRC citizen or be exchanged into Renminbi. Our PRC citizen employees who have been granted share options, or PRC option holders, will be subject to the Individual Foreign Exchange Rules upon the listing of our ADSs on the New York Stock Exchange. If we or our PRC citizen employees fail to comply with these regulations, we or our PRC option holders may be subject to fines and legal sanctions.
 
Restrictions on currency exchange may limit our ability to utilize our revenues effectively.
 
The PRC government imposes controls on the convertibility of RMB into foreign currencies and, in certain cases, the remittance of currency out of China. We receive all of our revenues in RMB. Under our current structure, our income is primarily derived from dividend payments from our PRC subsidiary. Shortages in the availability of foreign currency may restrict the ability of our PRC subsidiary and our affiliated entity to remit sufficient foreign currency to pay dividends or other payments to us, or otherwise satisfy their foreign currency denominated obligations. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and expenditures from trade-related transactions, can be made in foreign currencies without prior approval from SAFE by complying with certain procedural requirements. However, approval from appropriate government authorities is required where RMB


25


Table of Contents

are to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of bank loans denominated in foreign currencies. The PRC government may also at its discretion restrict access in the future to foreign currencies for current account transactions. If the foreign exchange control system prevents us from obtaining sufficient foreign currency to satisfy our currency demands, we may not be able to pay dividends in foreign currencies to our shareholders, including holders of our ADSs.
 
Fluctuation in the value of RMB may have a material adverse effect on your investment.
 
The value of the RMB against the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in political and economic conditions. Effective from July 21, 2005, the RMB is no longer pegged solely to the US dollar. Instead, it is pegged to a basket of currencies, determined by the People’s Bank of China, against which it can rise or fall by as much as 0.3% each day. For example, on July 21, 2005, the RMB was revalued against the US dollar to approximately RMB8.11 to the US dollar, representing an upward revaluation of 2.1% of the RMB against the US dollar, as compared to the exchange rate on the previous day. On September 23, 2005, the PRC government widened the daily trading band for RMB against non-US dollar currencies from 1.5% to 3% to improve the flexibility of the new foreign exchange system. The exchange rate may become volatile, the RMB may be revalued further against the US dollar or other currencies or the RMB may be permitted to enter into a full or limited free float, which may result in an appreciation or depreciation in the value of the RMB against the US dollar or other currencies. This change in policy resulted in an approximately 8.0% appreciation in RMB against the US dollar between July 21, 2005 and June 30, 2007.
 
Our revenues and costs are mostly denominated in RMB, while a significant portion of our financial assets will be denominated in U.S. dollars after the completion of this offering. We rely entirely on dividends and other fees paid to us by our subsidiaries and our affiliated entity in China. Any significant revaluation of RMB may materially and adversely affect our cash flows, revenues, earnings and financial position, and the value of, and any dividends payable on, our ADSs in U.S. dollars. For example, an appreciation of RMB against the U.S. dollar would make any new RMB denominated investments or expenditures more costly to us, to the extent that we would need to convert U.S. dollars into RMB for such purposes.
 
We face risks related to health epidemics and other outbreaks, or acts of terrorism, which could result in reduced demand for our products or disrupt our operations.
 
Our business could be materially and adversely affected by the outbreak of avian flu, severe acute respiratory syndrome or another epidemic, or an act of terrorism. From time to time, there have been reports on the occurrences of avian flu in various parts of China, including a few confirmed human cases and deaths. Any prolonged recurrence of avian flu, severe acute respiratory syndrome or other adverse public health developments in China or elsewhere in Asia may have a material and adverse effect on our business operations. In addition, terrorist attacks, such as those that took place on September 11, 2001, geopolitical uncertainty and international conflicts, could have an adverse effect on our business operations. Any of these events could adversely affect China’s economy and cause an immediate and prolonged drop in consumer demand. An immediate and prolonged drop in consumer demand could severely disrupt our business operations and adversely affect our results of operations. Furthermore, a significant portion of our revenues are derived from government customers, which may reduce their spending on our products during a crisis, which could adversely affect our results of operations and could probably be difficult to recover once the threat has subsided.
 
The new PRC Property Rights Law may affect the perfection of the pledge in our pledge agreement with P3A and its shareholders.
 
Under the equity pledge agreement among P3A, the shareholders of P3A and Agria China, the shareholders of P3A have pledged all of their equity interests in P3A to Agria China. This pledge has been recorded on P3A’s shareholders registration book pursuant to the PRC Security Law. However, according to the PRC Property Rights Law, which became effective as of October 1, 2007, the pledge will not be effective if it is not registered with the relevant local administration for industry and commerce. P3A has applied for


26


Table of Contents

such registration, but the application has not been processed as no registration procedures are available. P3A will continue to attempt to register such pledge when the local administration for industry and commerce implements registration procedures in the future. However, if P3A is unable to do so, the pledge may be deemed ineffective under the PRC Property Rights Law.
 
The approval of the China Securities Regulatory Commission, or the CSRC, may be required in connection with this offering under a recently adopted PRC regulation. Any requirement to obtain prior CSRC approval could delay this offering and a failure to obtain this approval, if required, may create uncertainties for this offering and could have a material adverse effect on our business, operating results, reputation, prospects and trading price of our ADSs. The regulation also establishes more complex procedures for acquisitions conducted by foreign investors which could make it more difficult to pursue growth through acquisitions.
 
On August 8, 2006, six PRC regulatory agencies, namely, the Ministry of Commerce, the State Assets Supervision and Administration Commission, the State Administration for Taxation, the State Administration for Industry and Commerce, the CSRC and the SAFE, jointly adopted the Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the New M&A Rule, which became effective on September 8, 2006. This New M&A Rule purports, among other things, to require offshore special purpose vehicles formed for overseas listing purposes through acquisitions of PRC domestic companies and controlled by PRC companies or individuals, to obtain the approval of the CSRC prior to publicly listing their securities on an overseas stock exchange. On September 21, 2006, the CSRC published a notice on its official website specifying documents and materials required to be submitted to it by special purpose vehicles seeking CSRC approval of their overseas listings. While the application of the New M&A Rule remains unclear, we believe, based on the advice of our PRC counsel, Commerce & Finance Law Offices, that CSRC approval is not required in the context of this offering because (1) we are not a special purpose vehicle formed or controlled by PRC companies or PRC individuals, and (2) we established our PRC subsidiary by means of direct investment other than by merger or acquisition of PRC domestic companies. However, there is a risk that the relevant PRC government agencies, including the CSRC, may not reach the same conclusion as our PRC counsel. If the CSRC or other PRC regulatory body subsequently determines that we need to obtain the CSRC’s approval for this offering, we may face sanctions by the CSRC or other PRC regulatory agencies. In such event, these regulatory agencies may impose fines and penalties on our operations in the PRC, limit our operations in the PRC, delay or restrict the repatriation of the proceeds from this offering into the PRC or take other actions that could have a material adverse effect on our business, financial condition, results of operations, reputation and prospects, as well as the trading price of our ADSs. The CSRC or other PRC regulatory agencies may also take actions requiring us, or making it advisable for us, to halt this offering before settlement and delivery of the ADSs offered by this prospectus.
 
The New M&A Rule also established additional procedures and requirements that could make merger and acquisition activities by foreign investors more time-consuming and complex, including requirements in some instances that the Ministry of Commerce be notified in advance when a foreign investor acquires equity or assets of a PRC domestic enterprise. Complying with the requirements of the New M&A Rule to complete such transactions could be time-consuming, and any required approval processes, including obtaining approval from the Ministry of Commerce, may delay or inhibit our ability to complete such transactions, which could affect our ability to expand our business or maintain our market share.
 
According to the New M&A Rule and other PRC rules regarding foreign exchange, an offshore company’s shares can be used as consideration for acquisition of a domestic PRC company’s equity only under very limited circumstances. Prior approval from the Ministry of Commerce must be obtained before such a share swap can be done.
 
If the CSRC approval is required in connection with this offering, it could delay this offering and a failure to obtain this approval could have a material adverse effect on our business, operating results, reputation, prospects and trading price of our ADSs.


27


Table of Contents

Risks Related to the ADSs and this Offering
 
There has been no public market for our ADSs prior to this offering, and you may not be able to resell our ADSs at or above the price you paid, or at all.
 
Prior to this initial public offering, there has been no public market for our ADSs. Following the offering, our ordinary shares will not be listed on any exchange or quoted for trading on any over-the-counter trading system. We have applied to have our ADSs listed on the New York Stock Exchange. If an active trading market for our ADSs does not develop after this offering, the market price and liquidity of our ADSs will be materially and adversely affected. The initial public offering price for our ADSs is determined by negotiations between us and the underwriters and may bear no relationship to the market price for our ADSs after this initial public offering. An active trading market for our ADSs may not develop and the market price of our ADSs may decline below the initial public offering price.
 
The market price for our ADSs may be volatile.
 
The market price for our ADSs may be highly volatile and subject to wide fluctuations in response to factors including the following:
 
  •  announcements of technological or competitive developments;
 
  •  regulatory developments in our target markets affecting us, our customers or our competitors;
 
  •  actual or anticipated fluctuations in our quarterly operating results;
 
  •  changes in financial estimates by securities research analysts;
 
  •  changes in the economic performance or market valuations of other corn seed, sheep products or seedling companies;
 
  •  additions or departures of our executive officers and key personnel;
 
  •  fluctuations in the exchange rates between the U.S. dollar and RMB;
 
  •  release or expiration of lock-up or other transfer restrictions on our outstanding ADSs; and
 
  •  sales or perceived sales of additional ADSs.
 
In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are not related to the operating performance of particular companies. These market fluctuations may also have a material adverse effect on the market price of our ADSs.
 
Because the initial public offering price is substantially higher than our net book value per ADS, you will incur immediate and substantial dilution.
 
If you purchase ADSs in this offering, you will pay more for your ADSs than the amount paid by our existing shareholders for their ADSs on a per ADS basis. As a result, you will experience immediate and substantial dilution of approximately $       per ADS (assuming no exercise by the underwriters of options to acquire additional ADSs), representing the difference between our net book value per ADS as of      , after giving effect to this offering, and the initial public offering price of $       per ADS, the midpoint of the estimated price range. In addition, you may experience further dilution to the extent that our ADSs are issued upon the exercise of share options.
 
Substantial future sales or perceived sales of our ADSs in the public market could cause the price of our ADSs to decline.
 
Sales of our ADSs in the public market after this offering, or the perception that these sales could occur, could cause the market price of our ADSs to decline. Upon completion of this offering, we will have       ADSs outstanding. All ADSs sold in this offering will be freely transferable without restriction or additional registration under the Securities Act of 1933, as amended, or the Securities Act. The remaining ADSs


28


Table of Contents

outstanding after this offering will be available for sale, upon the expiration of the 180-day lock-up period beginning from the date of this prospectus, subject to volume and other restrictions as applicable under Rule 144 and Rule 701 under the Securities Act. In addition, we have granted registration rights to our private equity investor. Any or all of these shares may be released prior to expiration of the lock-up period at the discretion of the lead underwriter. To the extent shares are released before the expiration of the lock-up period and these shares are sold into the market, the market price of our ADSs could decline.
 
You may not have the same voting rights as the holders of our ordinary shares and may not receive voting materials in time to be able to exercise your right to vote.
 
Except as described in this prospectus and in the deposit agreement, holders of our ADSs will not be able to exercise voting rights attaching to the shares represented by our ADSs on an individual basis. Holders of our ADSs will appoint the depositary or its nominee to vote the shares represented by the ADSs. You may not receive voting materials in time to instruct the depositary to vote and it is possible that you, or persons who hold their ADSs through brokers, dealers or other third parties, will not have the opportunity to exercise a right to vote. Upon our written request, the depositary will mail to you a shareholder meeting notice which contains, among other things, a statement as to the manner in which your voting instructions may be given, including an express indication that such instructions may be given or deemed given to the depositary to give a discretionary proxy to a person designated by us if no instructions are received by the depositary from you on or before the response date established by the depositary. However, no voting instruction shall be deemed given and no such discretionary proxy shall be given with respect to any matter as to which we inform the depositary that (i) we do not wish such proxy given, (ii) substantial opposition exists, or (iii) such matter materially and adversely affect the rights of shareholders.
 
Under our deposit agreement, the depositary will give us a discretionary proxy to vote our ordinary shares underlying your ADSs at shareholders’ meetings if you do not vote, unless we have instructed the depositary that we do not wish a discretionary proxy to be given or any of the other situations specified under the deposit agreement takes place. The effect of this discretionary proxy is that you cannot prevent ordinary shares underlying your ADSs from being voted, absent the situations described above, and it may be more difficult for shareholders to influence the management of our company. Holders of our ordinary shares are not subject to this discretionary proxy.
 
Your right to participate in any future rights offerings may be limited, which may cause dilution to your holdings and you may not receive cash dividends if it is impractical to make them available to you.
 
We may from time to time distribute rights to our shareholders, including rights to acquire our securities. However, we cannot make rights available to you in the United States unless we register the rights and the securities to which the rights relate under the Securities Act or an exemption from the registration requirements is available. Also, under the deposit agreement, the depositary bank will not make rights available to you unless the distribution to ADS holders of both the rights and any related securities are either registered under the Securities Act or exempted from registration under the Securities Act. We are under no obligation to file a registration statement with respect to any such rights or securities or to endeavor to cause such a registration statement to be declared effective. Moreover, we may not be able to establish an exemption from registration under the Securities Act. Accordingly, you may be unable to participate in our rights offerings and may experience dilution in your holdings.
 
In addition, the depositary of our ADSs has agreed to pay to you the cash dividends or other distributions it or the custodian receives on our ordinary shares or other deposited securities after deducting its fees and expenses. You will receive these distributions in proportion to the number of ordinary shares your ADSs represent. However, the depositary may, at its discretion, decide that it is inequitable or impractical to make a distribution available to any holders of ADSs. For example, the depositary may determine that it is not practicable to distribute certain property through the mail, or that the value of certain distributions may be less than the cost of mailing them. In these cases, the depositary may decide not to distribute that property and you will not receive that distribution.


29


Table of Contents

We are a Cayman Islands company and because judicial precedent regarding the rights of shareholders is more limited under Cayman Islands law than that under U.S. law, you may have less protection for your shareholder rights than you would under U.S. law.
 
Our corporate affairs are governed by our amended and restated memorandum and articles of association, the Cayman Islands Companies Law and the common law of the Cayman Islands. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as that from English common law, which has persuasive, but not binding, authority on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a less developed body of securities laws than the United States. In addition, some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate law than the Cayman Islands.
 
As a result of all of the above, public shareholders of our company may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or controlling shareholders of our company than they would as shareholders of a U.S. public company.
 
Our management will have considerable discretion as to the use of the net proceeds to be received by us from this offering.
 
We have allocated much of the net proceeds of this offering to be received by us for acquisitions and general corporate purposes. Our management will have considerable discretion in the application of the net proceeds received by us. You will not have the opportunity, as part of your investment decision, to assess whether proceeds are being used appropriately. You must rely on the judgment of our management regarding the application of the net proceeds of this offering. The net proceeds may be used for corporate purposes that do not improve our efforts to maintain profitability or increase our share price. The net proceeds from this offering may be placed in investments that do not produce income or that lose value.
 
We are controlled by a small group of existing shareholders, whose interests may differ from other shareholders.
 
Brothers Capital Limited and its subsidiaries collectively hold 84.6% of our total outstanding shares on an as-converted basis, and will hold           of our total outstanding shares immediately following the completion of this offering, assuming no exercise of the underwriters’ over-allotment option. Mr. Guanglin Lai, our chairman and co-chief executive officer is the sole owner of Brothers Capital Limited and Mr. Lai and Mr. Zhaohua Qian, a director of our company, are the only directors of Brothers Capital Limited. This concentration of ownership may discourage, delay or prevent a change in control of our company, which could deprive our shareholders of an opportunity to receive a premium for their shares as part of a sale of our company and might reduce the price of our ADSs. In addition, because Brothers Capital Limited controls our company, it is able to take actions that may not be in the best interests of other shareholders. These actions may be taken even if they are opposed by our other shareholders, including those who purchase ADSs in this offering. We do not have any existing arrangements with any of our shareholders to address potential conflicts of interests between these shareholders and our company and none of our shareholders have entered into non-compete agreements. There is a risk that our existing shareholders may not always act in the best interests of our company.
 
Our memorandum and articles of association will contain anti-takeover provisions that could adversely affect the rights of holders of our ordinary shares and ADSs.
 
We intend to adopt an amended and restated articles of association that will become effective immediately upon the closing of this offering. We have included certain provisions in our new memorandum and articles of


30


Table of Contents

association that could limit the ability of others to acquire control of our company, and deprive our shareholders of the opportunity to sell their shares at a premium over the prevailing market price by discouraging third parties from seeking to obtain control of our company in a tender offer or similar transactions.
 
We have included the following provisions in our new articles that may have the effect of delaying or preventing a change of control of our company:
 
  •  Our board of directors has the authority to establish from time to time one or more series of preferred shares without action by our shareholders and to determine, with respect to any series of preferred shares, the terms and rights of that series, including the designation of the series; the number of shares of the series; the dividend rights, dividend rates, conversion rights, voting rights; and the rights and terms of redemption and liquidation preferences.
 
  •  Our board of directors may issue a series of preferred shares without action by our shareholders to the extent of available authorized but unissued preferred shares. Accordingly, the issuance of preferred shares may adversely affect the rights of the holders of the ordinary shares. Issuance of preference shares may dilute the voting power of holders of ordinary shares.
 
  •  Subject to applicable regulatory requirements, our board of directors may issue additional ordinary shares or rights to acquire ordinary shares without action by our shareholders to the extent of available authorized but unissued shares.
 
You may have difficulty enforcing judgments obtained against us.
 
We are a Cayman Islands company and most of our assets are located outside of the United States. Most of our current operations are conducted in the PRC. In addition, most of our directors and officers are nationals and residents of countries other than the United States. A substantial portion of the assets of these persons are located outside the United States. As a result, it may be difficult for you to effect service of process within the United States upon these persons. It may also be difficult for you to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws against us and our officers and directors, most of whom are not residents in the United States and the substantial majority of whose assets are located outside of the United States. In addition, there is uncertainty as to whether the courts of the Cayman Islands or the PRC would recognize or enforce judgments of U.S. courts. See “Enforceability of Civil Liabilities.”
 
We may be classified as a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. holders of our ADSs or ordinary shares.
 
We do not expect to be treated as a passive foreign investment company, or PFIC, for our current taxable year ending December 31, 2007. However, we must make a separate determination each year as to whether we are a PFIC, and accordingly, there is a risk that we may be a PFIC for our current taxable year or any future taxable year. A non-U.S. corporation will be considered a PFIC for any taxable year if either (1) at least 75% of its gross income is passive income or (2) at least 50% of the value of its assets is attributable to assets that produce or are held for the production of passive income. If we were treated as a PFIC for any taxable year during which a U.S. person held an ADS or an ordinary share, certain adverse U.S. federal income tax consequences could apply to that U.S. person. See “Taxation — United States Federal Income Taxation — Passive Foreign Investment Company.”


31


Table of Contents

FORWARD-LOOKING STATEMENTS
 
This prospectus contains forward-looking statements that involve risks and uncertainties. All statements other than statements of historical facts are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements.
 
You can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely to” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include:
 
  •  our anticipated growth strategies, including expanding sales into new regions, increasing the farmland to which we have access, and expanding our product offerings;
 
  •  our strategy to expand our research and development capability;
 
  •  the growth in demand in China for high-quality corn seeds, sheep and seedlings;
 
  •  our future business development, results of operations and financial condition;
 
  •  changes in our revenues, cost and expense items;
 
  •  our ability to attract customers and end users and enhance our brand recognition;
 
  •  future changes in government regulations affecting our business, including regulation of genetically modified corn; and
 
  •  trends and competition in the corn seed, sheep breeding and seedling industries.
 
You should thoroughly read this prospectus and the documents that we refer to in this prospectus with the understanding that our actual future results may be materially different from and worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements. Other sections of this prospectus include additional factors which could adversely impact our business and financial performance. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for our management to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
 
You should not rely upon forward-looking statements as predictions of future events. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


32


Table of Contents

 
USE OF PROCEEDS
 
We estimate that we will receive net proceeds from this offering of approximately $       million or approximately $       million if the underwriters exercise their option to purchase additional ADSs in full, after deducting underwriting discounts and the estimated offering expenses payable by us. These estimates are based upon an assumed initial offering price of $       per ADS, the midpoint of the range shown on the front cover page of this prospectus. We will not receive any of the proceeds from the sale of ADSs by the selling shareholders. A $1.00 increase (decrease) in the assumed initial public offering price of $       per ADS would increase (decrease) the net proceeds of this offering by $       million, assuming the sale of       ADSs at $       per ADS, the midpoint of the range shown on the front cover page of this prospectus and after deducting underwriting discounts and commissions and the estimated offering expenses payable by us.
 
The primary purposes of this offering are to create a public market for our shares for the benefit of all shareholders, retain talented employees by providing them with equity incentives and obtain additional capital.
 
We intend to use the net proceeds we will receive from this offering as follows:
 
  •  approximately $50 million to fund expansion of our production capacity through leasing of additional land and acquisitions of new facilities and equipment;
 
  •  approximately $15 million to fund establishment of our research and development center and expansion of our research and development capability;
 
  •  approximately $27 million to repay the shareholder’s loan;
 
  •  approximately $3.5 million to repay all of our bank loans; and
 
  •  the remainder for general corporate purposes, including funding potential strategic acquisitions, although we have not entered into any agreement with respect to any acquisition.
 
As of the date of this prospectus, we cannot specify with certainty the particular uses for the net proceeds we will receive upon the completion of this offering.
 
The foregoing represents our current intentions to use and allocate the net proceeds of this offering based upon our present plans and business conditions. Our management, however, will have significant flexibility and discretion to apply the net proceeds of this offering. If an unforeseen event occurs or business conditions change, we may use the proceeds of this offering differently than as described in this prospectus.
 
Pending use of the net proceeds, we intend to hold our net proceeds in demand deposits or invest them in interest-bearing government securities.


33


Table of Contents

 
DIVIDEND POLICY
 
We have no present plan to declare and pay any dividends on our shares or ADSs in the near future. We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business.
 
We are a holding company incorporated in the Cayman Islands. We rely on dividends from our subsidiary in China. Current PRC regulations permit our subsidiary to pay dividends to us only out of its accumulated profits, if any, determined in accordance with PRC accounting standards and regulations. In addition, our subsidiary in China is required to set aside a certain amount of its accumulated after-tax profits each year, if any, to fund certain statutory reserves. These reserves may not be distributed as cash dividends. Further, if our subsidiary in China incur debt on its own behalf, the instruments governing the debt may restrict its ability to pay dividends or make other payments to us.
 
Our board of directors has complete discretion as to whether to distribute dividends, subject to the approval of our shareholders. Even if our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that the board of directors may deem relevant. If we pay any dividends, we will pay our ADS holders to the same extent as holders of our ordinary shares, subject to the terms of the deposit agreement, including the fees and expenses payable thereunder. See “Description of American Depositary Shares.” Cash dividends on our ordinary shares, if any, will be paid in U.S. dollars.


34


Table of Contents

 
CAPITALIZATION
 
The following table sets forth our capitalization as of June 30, 2007:
 
  •  on an actual basis;
 
  •  on a pro forma basis to reflect the automatic conversion of all of our outstanding preferred shares into 2,400,000 ordinary shares and the cessation of the redeemable ordinary shares redemption rights immediately upon the closing of this offering; and
 
  •  on a pro forma as adjusted basis to reflect the automatic conversion of all of our outstanding preferred shares into 2,400,000 ordinary shares and the cessation of the redeemable ordinary shares redemption rights immediately upon the closing of this offering, and the sale of       ordinary shares in the form of ADSs by us in this offering at an assumed initial public offering price of       per share, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.
 
You should read this table together with our consolidated financial statements and the related notes included elsewhere in this prospectus and the information under “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
 
                                                 
    As of June 30, 2007  
                            Pro Forma
    Pro Forma
 
    Actual     Actual     Pro Forma     Pro Forma     As Adjusted(1)     As Adjusted(1)  
    RMB     $     RMB     $     RMB     $  
    (In thousands, except share and per share data)  
Series A Redeemable convertible preferred shares (par value US$0.0000001 per share; 100,000,000 shares authorised; 2,400,000 shares issued and outstanding, actual, with aggregate amount of liquidation preference totaling US$10,000,000; pro forma nil)
    65,111       8,555                              
Redeemable ordinary shares (par value US$0.0000001 per share; 6,250,000 shares issued and outstanding; pro forma nil)
    155,928       20,484                              
Shareholders’ equity:
                                               
Ordinary shares (par value US$0.0000001 per share; 499,900,000,000 shares authorized; 93,750,000 shares issued and outstanding, actual; 102,400,000 shares outstanding, pro forma)
                                       
Additional paid-in capital(2)
                85,253       11,200                  
Statutory reserves
    76,953       10,109       76,953       10,109                  
Retained earnings
    219,876       28,885       355,662       46,724                  
Total shareholders’ equity(2)
    296,829       38,994       517,868       68,033                            
                                                 
Total capitalization(2)
    517,868       68,033       517,868       68,033                            
                                                 
 
 
(1) The pro forma as adjusted information discussed above is illustrative only. Our additional paid-in capital, total shareholders’ equity (deficit) and total capitalization following the completion of this offering are subject to adjustment based on the actual initial public offering price and other terms of this offering determined at pricing.
 
(2) Assuming the number of ADSs offered by us as set forth on the cover page of this prospectus remains the same, and after deduction of underwriting discounts and commissions and the estimated offering expenses payable by us, a $1.00 increase (decrease) in the assumed initial public offering price of $       per ADS would increase (decrease) each of additional paid-in capital, total shareholders’ equity and total capitalization by $       million.


35


Table of Contents

 
DILUTION
 
Our net tangible book value as of June 30, 2007 was approximately $       per share, and $       per ADS. Net tangible book value per share represents the amount of total tangible assets, minus the amount of total liabilities, divided by the total number of ordinary shares outstanding. Dilution is determined by subtracting net tangible book value per ordinary share from the assumed public offering price per ordinary share.
 
Without taking into account any other changes in such net tangible book value after June 30, 2007, other than to give effect to (i) the conversion of all of our preferred shares into 2,400,000 ordinary shares, which will occur automatically upon the closing of this offering, and (ii) our sale of the       ADSs offered in this offering, at an assumed initial public offering price of $       per ADS, the midpoint of the estimated public offering price range, and after deduction of underwriting discounts and commissions and estimated offering expenses (assuming the over-allotment option is not exercised), our pro forma net tangible book value at June 30, 2007 would have been $       per outstanding ordinary share, including ordinary shares underlying our outstanding ADSs, or $       per ADS. This represents an immediate increase in net tangible book value of $       per ordinary share, or $       per ADS, to existing shareholders and an immediate dilution in net tangible book value of $       per ordinary share, or $       per ADS, to purchasers of ADSs in this offering.
 
The following table illustrates the dilution on a per ordinary share basis assuming that the initial public offering price per ordinary share is $       and all ADSs are exchanged for ordinary shares:
 
         
Assumed initial public offering price per ordinary share
  $         
Net tangible book value per ordinary share
  $         
         
Amount of dilution in net tangible book value per ordinary share to new investors in the offering
  $         
         
Amount of dilution in net tangible book value per ADS to new investors in the offering
  $         
         
 
A $1.00 increase (decrease) in the assumed public offering price of $       per ADS would increase (decrease) our pro forma net tangible book value after giving effect to the offering by $       million, the pro forma net tangible book value per ordinary share and per ADS after giving effect to this offering by $       per ordinary share and $       per ADS and the dilution in pro forma net tangible book value per ordinary share and per ADS to new investors in this offering by $       per ordinary share and $       per ADS, assuming no change to the number of ADSs offered by us as set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and other offering expenses.
 
The following table summarizes, on a pro forma basis as of June 30, 2007, the differences between the shareholders as of June 30, 2007 and the new investors with respect to the number of ordinary shares purchased from us, the total consideration paid and the average price per ordinary share paid at an assumed initial public offering price of $       per ADS before deducting estimated underwriting discounts and commissions and estimated offering expenses. The total number of ordinary shares does not include       ADSs issuable pursuant to the exercise of the over-allotment option granted to the underwriters. The pro forma information discussed above is illustrative only. Our net tangible book value following the completion of this offering is subject to adjustment based on the actual initial public offering price of our ADSs and other terms of this offering determined at pricing.
 
                                                 
    Ordinary Shares Purchased*     Total Consideration     Average Price per
    Average Price per
 
    Number     Percent     Amount     Percent     Ordinary Share     ADS  
 
Existing shareholders
                        %   $                     %   $            $         
New investors
                                                                             
                                                 
Total
                        %   $                     %                
                                                 
 
 
* The number of ordinary shares purchased by existing shareholders takes into account the conversion of all of our preferred shares into 2,400,000 ordinary shares and the cessation of the redeemable ordinary shares redemption rights immediately upon the closing of this offering.
 
The discussion and tables above also assume no exercise of any outstanding stock options. As of September 30, 2007, there were 7,500,000 ordinary shares issuable upon exercise of outstanding stock options at a weighted average exercise price of $2.912 per share, and there were 12,500,000 ordinary shares available for future issuance upon the exercise of future grants under our 2007 share incentive plan. To the extent that any of these options are exercised, there will be further dilution to new investors.


36


Table of Contents

 
EXCHANGE RATE INFORMATION
 
Our business is conducted in China and substantially all of our revenues are denominated in RMB. However, periodic reports made to shareholders will be expressed in U.S. dollars using the then current exchange rates. This prospectus contains translations of RMB amounts into U.S. dollars at specific rates solely for the convenience of the reader. The conversion of RMB into U.S. dollars in this prospectus is based on the noon buying rate in The City of New York for cable transfers of RMB as certified for customs purposes by the Federal Reserve Bank of New York. Unless otherwise noted, all translations from RMB to U.S. dollars and from U.S. dollars to RMB in this prospectus were made at a rate of RMB7.6120 to $1.00, the noon buying rate in effect as of June 29, 2007. We make no representation that any RMB or U.S. dollar amounts could have been, or could be, converted into U.S. dollars or RMB, as the case may be, at any particular rate, at the rates stated below, or at all. The PRC government imposes control over its foreign currency reserves in part through direct regulation of the conversion of RMB into foreign exchange and through restrictions on foreign trade. On October 17, 2007, the noon buying rate was RMB7.5156 to $1.00.
 
The following table sets forth information concerning exchange rates between the RMB and the U.S. dollar for the periods indicated. These rates are provided solely for your convenience and are not necessarily the exchange rates that we used in this prospectus or will use in the preparation of our periodic reports or any other information to be provided to you. The source of these rates is the Federal Reserve Bank of New York.
 
                                 
    Noon Buying Rate  
Period
  Period End     Average(1)     Low     High  
    (RMB per $1.00)  
 
2002
    8.2800       8.2772       8.2800       8.2700  
2003
    8.2767       8.2771       8.2800       8.2765  
2004
    8.2765       8.2768       8.2774       8.2764  
2005
    8.0702       8.1826       8.2765       8.0702  
2006
    7.8041       7.9579       8.0702       7.8041  
2007
                               
Six months ended June 30, 2007
    7.6120       7.7014       7.8127       7.6120  
April
    7.7090       7.7247       7.7345       7.7090  
May
    7.6516       7.6773       7.7065       7.6463  
June
    7.6120       7.6333       7.6680       7.6120  
July
    7.5720       7.5757       7.6055       7.5580  
August
    7.5462       7.5734       7.6181       7.5420  
September
    7.4928       7.5196       7.5540       7.4928  
October (through October 17, 2007)
    7.5156       7.5099       7.5158       7.5000  
 
 
(1) Annual averages are calculated from month-end rates. Monthly averages are calculated using the average of the daily rates during the relevant period.


37


Table of Contents

 
ENFORCEABILITY OF CIVIL LIABILITIES
 
We were incorporated in the Cayman Islands in order to enjoy the following benefits:
 
  •  political and economic stability;
 
  •  an effective judicial system;
 
  •  a favorable tax system;
 
  •  the absence of exchange control or currency restrictions; and
 
  •  the availability of professional and support services.
 
However, certain disadvantages accompany incorporation in the Cayman Islands. These disadvantages include:
 
  •  the Cayman Islands has a less-developed body of securities laws as compared to the United States and these securities laws provide significantly less protection to investors; and
 
  •  Cayman Islands companies may not have the standing to sue before the federal courts of the United States.
 
Our constituent documents do not contain provisions requiring that disputes, including those arising under the securities laws of the United States, between us, our officers, directors and shareholders, be arbitrated.
 
All of our operations are conducted in China, and substantially all of our assets are located in China. A majority of our directors and officers are nationals or residents of jurisdictions other than the United States and a substantial portion of their assets are located outside the United States. As a result, it may be difficult for a shareholder to effect service of process within the United States upon these persons, or to enforce against us or them judgments obtained in United States courts, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States.
 
We have appointed Law Debenture Corporate Services Inc., 400 Madison Avenue, 4th Floor, New York, New York 10017, as our agent upon whom process may be served in any action brought against us under the securities laws of the United States.
 
Maples and Calder, our counsel as to Cayman Islands law, and Commerce & Finance Law Offices, our counsel as to PRC law, have advised us, respectively, that there is uncertainty as to whether the courts of the Cayman Islands and China, respectively, would:
 
  •  recognize or enforce judgments of United States courts obtained against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States; or
 
  •  entertain original actions brought in each respective jurisdiction against us or our directors or officers predicated upon the securities laws of the United States or any state in the United States.
 
Our Cayman Islands counsel has further advised us that a final and conclusive judgment in the federal or state courts of the United States under which a sum of money is payable, other than a sum payable in respect of taxes, fines, penalties or similar charges, may be subject to enforcement proceedings as a debt in the courts of the Cayman Islands under the common law doctrine of obligation.
 
Commerce & Finance Law Offices has advised us that the recognition and enforcement of foreign judgments are provided for under PRC Civil Procedures Law. PRC courts may recognize and enforce foreign judgments in accordance with the requirements of PRC Civil Procedures Law based either on treaties between China and the country where the judgment is made, or on reciprocity between jurisdictions. Commerce & Finance Law Offices has advised us further that under PRC law, a foreign judgment, which does not otherwise violate basic legal principles, state sovereignty, safety or social public interest, may be recognized and enforced by a PRC court, based either on treaties between China and the country where the judgment is made or on reciprocity between jurisdictions. As China does not have any treaty or other reciprocal arrangements with the United States or Cayman Islands that provide for recognition and enforcement of foreign judgments, it is generally difficult to recognize and enforce in China a judgment rendered by a court in either of these two jurisdictions.


38


Table of Contents

 
CORPORATE HISTORY AND STRUCTURE
 
Our Corporate History and Structure
 
We conduct substantially all of our operations in China through our contractual arrangements with P3A as described below, and through Agria China which is our wholly-owned subsidiary in China. We commenced operations in January 2004 by acquiring the business of P3A, a limited liability company incorporated under the laws of the PRC in 2000. We established a holding company, Aero-Biotech, under the laws of the British Virgin Islands in July 2005 to facilitate our future international fund-raising activities. We formed Agria China as a wholly-owned subsidiary under the laws of the PRC in March 2007 to focus on research and development and other corporate activities. In preparation of this offering, we incorporated Agria Corporation under the laws of the Cayman Islands in May 2007 as our proposed listing vehicle. Agria Corporation became the holding company of Aero-Biotech in June 2007 when all of the shareholders of Aero-Biotech exchanged their shares in Aero-Biotech for shares of Agria Corporation on a pro rata basis.


39


Table of Contents

The following diagram illustrates our corporate structure as of September 30, 2007:
 
(FLOW CHART)
 
PRC law currently prohibits a foreign entity or person from owning over 50% of any seed production business in China. We conduct our corn seed, sheep breeding and seedling businesses through contractual arrangements with P3A, which holds the requisite licenses and permits for these businesses, and we may amend these arrangements at any time. Our contractual arrangements with P3A and its shareholders enable us to:
 
  •  exercise effective control over P3A;
 
  •  receive substantially all of the earnings and other economic benefits from P3A to the extent permissible under PRC law in consideration for the services provided by Agria China; and


40


Table of Contents

 
  •  have an exclusive option to purchase all or part of the equity interests in P3A in each case when and to the extent permitted by PRC law.
 
In addition, P3A’s shareholders have executed a letter of undertaking to remit all of the dividends and other distributions received from P3A to Agria China, subject to satisfaction of their personal income tax and other statutory obligations arising from receiving such dividends or other distributions.
 
Our Contractual Arrangements with P3A and Its Shareholders
 
Under PRC laws, each of Agria China and P3A is an independent legal person and neither of them is exposed to liabilities incurred by the other party. Other than pursuant to the contractual arrangements between Agria China and P3A, P3A does not transfer any other funds generated from its operations to Agria China. P3A has four record shareholders, consisting of Ms. Juan Li who is the wife of Mr. Guanglin Lai, our chairman of the board of directors, our co-chief executive officer and a beneficial owner of our ordinary shares, Mr. Zhaohua Qian who is our director and a beneficial owner of our ordinary shares, Mr. Zhixin Xue who is our chief operating officer and director, and Mr. Mingshe Zhang who has been involved in the management of P3A. All four shareholders of P3A are PRC citizens and do not receive any compensation from us for holding shares of P3A. Mr. Zhaohua Qian, a shareholder of P3A, and Mr. Guanglin Lai, who is the husband of another shareholder of P3A, Ms. Juan Li, are the directors of Brothers Capital Limited, which is the largest shareholder of our company. Agria China’s relationship with P3A and its shareholders is governed by the following contractual arrangements entered into on June 8, 2007. The powers of attorney, the equity pledge agreement and the exclusive call option agreement enable Agria China to effectively control P3A. The exclusive technology development, technical support and service agreement, the exclusive consultancy service agreement, the proprietary technology license agreement and the letter of undertaking, the terms of which may be amended from time to time, enable Agria China to receive substantially all of P3A’s earnings and other economic benefits to the extent permissible under PRC law.
 
Power of Attorney.   Each shareholder of P3A has executed a power of attorney to appoint our director, Mr. Zhaohua Qian as his/her attorney-in-fact to exercise all of his/her rights as a shareholder of P3A as provided under the PRC law and the articles of association of P3A, including voting rights, the rights to transfer any or all of its equity interest in P3A and the right to appoint the general manger of P3A. The appointment of Mr. Zhaohua Qian as attorney-in-fact will remain effective during the operation term of P3A until (i) the termination of the exclusive call option agreement (see below), (ii) the resignation of Mr. Zhaohua Qian from Agria China, or (iii) notice from Agria China to replace Mr. Zhaohua Qian with another person.
 
Equity Pledge Agreement.   Under the equity pledge agreement among P3A, the shareholders of P3A and Agria China, the shareholders of P3A pledged all of their equity interests in P3A to Agria China to guarantee P3A’s performance of its obligations under the exclusive technology development, technical support and service agreement, the proprietary technology license agreement, the exclusive consultancy service agreement and the exclusive call option agreement. If P3A or any of its shareholders breaches its respective contractual obligations under any of these principal agreements, Agria China, as pledgee, will be entitled to certain rights, including the right to sell or auction the pledged equity interests. During the term of this agreement, the shareholders of P3A may not transfer their respective equity interests to any third party or create other pledges or rights over the equity interests that may have an adverse effect on the rights of Agria China as pledgee. The equity pledge agreement will terminate when all the principal agreements are terminated or fully performed.
 
Exclusive Call Option Agreement.   Under the exclusive call option agreement among the shareholders of P3A, P3A and Agria China, the shareholders of P3A irrevocably granted Agria China an exclusive option to purchase from P3A’s shareholders, to the extent permitted under PRC law, all of the equity interests in P3A for the higher of (i) RMB100,000 and (ii) the minimum amount of consideration permitted by applicable law. To the extent permitted by the PRC law, Agria China or its designated person has sole discretion to decide when to exercise the option and when to buy all or part of the equity interests in P3A.
 
Exclusive Technology Development, Technical Support and Service Agreement.   Under the exclusive technology development, technical support and service agreement between P3A and Agria China, Agria China is the exclusive provider of technology development, technical support and services to P3A relating to P3A’s


41


Table of Contents

agricultural business. P3A will not accept these services from any third party without the prior consent of Agria China. Agria China owns the rights to any intellectual property developed by Agria China in the performance of this agreement. P3A pays to Agria China service fees of 20% of the annual net profit of P3A after each accounting year. The payments of fees are secured by the equity interests in P3A under the equity pledge agreement. This agreement is effective during the operation term of P3A unless terminated by Agria China or by either party due to the other party’s breach of the agreement according to the early termination provisions of the agreement. This agreement may be amended at any time by P3A and Agria China. Through the power of attorney granted by the shareholders of P3A to an individual designated by Agria China, Agria China has the ability to cause P3A to amend the agreement and intends to do so as needed.
 
Exclusive Consultancy Service Agreement.   Under the exclusive consultancy service agreement between P3A and Agria China, P3A exclusively engages Agria China to provide consultancy services including but not limited to the administration model, operational plans and market research and development. P3A will not accept any of these services from any third party without the prior consent of Agria China. P3A pays Agria China a consultancy service fee of RMB3 million each year upon P3A’s confirmation of the list of services provided by Agria China for that year. The payments of fees are secured by the equity interests in P3A under the equity pledge agreement. This agreement is effective during the operation term of P3A unless terminated by Agria China or by either party due to the other party’s breach of the agreement according to the early termination terms of the agreement. This agreement may be amended at any time by P3A and Agria China. Through the power of attorney granted by the shareholders of P3A to an individual designated by Agria China, Agria China has the ability to cause P3A to amend the agreement and intends to do so as needed.
 
Proprietary Technology License Agreement.   Under the proprietary technology license agreement between P3A and Agria China, Agria China licenses to P3A the exclusive rights to use 20 technologies listed in the appendix of the agreement that are related to the sheep breeding business. Agria China owns the intellectual property rights developed by P3A in the performance of this agreement. P3A pays Agria China license fees of RMB2.72 million before December 31 of each year. The payments of fees are secured by the equity interests in P3A under the equity pledge agreement. This agreement is effective during the operation term of P3A unless terminated by either party according to the early termination terms of the agreement. This agreement may be amended at any time by P3A and Agria China. Through the power of attorney granted by the shareholders of P3A to an individual designated by Agria China, Agria China has the ability to cause P3A to amend the agreement and intends to do so as needed.
 
Letter of Undertaking.   The shareholders of P3A have executed a letter of undertaking to irrevocably undertake that unless otherwise limited by laws, regulations or legal proceedings, they will remit all of the dividends and other distributions received from P3A to Agria China, subject to satisfaction of their personal income tax and other statutory obligations arising from receiving such dividends or other distributions. The spouse of each shareholder has consented to the foregoing undertaking.
 
In the opinion of Commerce and Finance Law Offices, our PRC legal counsel:
 
  •  our shareholding structures, both currently and immediately after giving effect to this offering, are in compliance with existing PRC laws and regulations;
 
  •  the contractual arrangements among Agria China and P3A and its shareholders governed by PRC law as described under “Corporate History and Structure” in this prospectus are valid, binding and enforceable, and will not result in any violation of PRC laws or regulations currently in effect; and
 
  •  the business operations of Agria China and P3A, as described in this prospectus, are in compliance with existing PRC laws and regulations in all material respects.
 
We have been advised by our PRC legal counsel, however, that there are substantial uncertainties regarding the interpretation and application of current and future PRC laws and regulations. The uncertainties include how the PRC government may interpret the restriction of foreign ownership of corn seed development and production companies and whether foreign companies may conduct the corn seed development and production businesses through contractual arrangements with domestic companies engaging in such businesses. Accordingly, there can be no assurance that the PRC regulatory authorities will not in the future take a view


42


Table of Contents

that is contrary to the above opinion of our PRC legal counsel. We have been further advised by our PRC counsel that if the PRC government finds that the agreements that establish the structure for operating our PRC agricultural business do not comply with PRC government restrictions on foreign investment in the agricultural businesses, we could be subject to severe penalties. In addition, under PRC Property Rights Law which will become effective on October 1, 2007, an equity pledge is required to be registered with the relevant administration for industry and commerce in order to become effective.
 
For more information in this regards, see “Risk Factors — Risks Related to Doing Business in China — If the Chinese government finds that the agreements that establish the structure for operating our Chinese businesses do not comply with Chinese governmental restrictions on foreign investment in the seed industry, or if these regulations or the interpretation of existing regulations change in the future, we could be subject to severe penalties or be forced to relinquish our interests in those operations,” and “Risk Factors — Risks Related to Doing Business in China — Uncertainties with respect to the PRC legal system could adversely affect us.”


43


Table of Contents

 
SELECTED CONSOLIDATED FINANCIAL DATA
 
You should read the following information in conjunction with our consolidated financial statements and related notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this prospectus.
 
The following selected consolidated financial information (except for net income per ADS) has been derived from our consolidated financial statements included elsewhere in this prospectus. Our consolidated statement of operations data for the years ended December 31, 2004, 2005 and 2006 and our balance sheet data as of December 31, 2005 and 2006 have been derived from our consolidated financial statements for the relevant periods which have been audited by Ernst & Young Hua Ming, an independent registered public accounting firm, and are prepared and presented in accordance with U.S. GAAP. Our consolidated statement of operations data for the six months ended June 30, 2006 and 2007 and our consolidated balance sheet data as of June 30, 2007 have been derived from our unaudited consolidated financial statements included elsewhere in this prospectus. Our consolidated balance sheet data as of December 31, 2004 have been derived from our unaudited consolidated financial statements which are not included in this prospectus. We have prepared the unaudited consolidated financial information on the same basis as our audited consolidated financial statements. The unaudited financial information includes all adjustments, consisting only of normal and recurring adjustments, that we consider necessary for a fair presentation of our financial position and operating results for the periods presented. Our historical results do not necessarily indicate results expected for any future periods. In addition, our unaudited results for the six months ended June 30, 2007 may not be indicative of our results for the full year ending December 31, 2007.
 
                                                         
    For the Year Ended December 31,     For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
    RMB     RMB     RMB     $     RMB     RMB     $  
    (In thousands, except share, per share and per ADS data)  
 
Consolidated Statement of Operations Data:
                                               
Revenues
                                                       
Corn seeds
    48,560       245,601       245,634       32,269       142,126       133,853       17,584  
Sheep breeding
    92,904       119,468       193,054       25,362       97,518       110,599       14,530  
Seedlings
    10,820       19,020       51,015       6,702       29,594       34,955       4,592  
                                                         
Total revenues
    152,284       384,089       489,703       64,333       269,238       279,407       36,706  
                                                         
Cost of revenues
                                                       
Corn seeds
    (33,311 )     (147,723 )     (144,730 )     (19,013 )     (81,378 )     (80,395 )     (10,562 )
Sheep breeding
    (31,196 )     (37,716 )     (52,287 )     (6,869 )     (26,629 )     (30,543 )     (4,012 )
Seedlings
    (9,053 )     (5,932 )     (10,357 )     (1,361 )     (4,212 )     (10,679 )     (1,403 )
                                                         
Total cost of revenues
    (73,560 )     (191,371 )     (207,374 )     (27,243 )     (112,219 )     (121,617 )     (15,977 )
                                                         
Gross profit
    78,724       192,718       282,329       37,090       157,019       157,790       20,729  
                                                         
Operating (expenses) income
                                                       
Selling expenses
    (4,874 )     (11,349 )     (14,031 )     (1,843 )     (7,542 )     (7,937 )     (1,043 )
General and administrative
    (6,015 )     (4,199 )     (7,472 )     (982 )     (3,445 )     (3,562 )     (468 )
Research and development
    (7,203 )     (2,974 )     (3,746 )     (492 )     (2,623 )     (1,025 )     (135 )
Government grants
    1,457       150       80       11                    
                                                         
Total operating expenses
    (16,635 )     (18,372 )     (25,169 )     (3,306 )     (13,610 )     (12,524 )     (1,646 )
                                                         
Operating profit
    62,089       174,346       257,160       33,784       143,409       145,266       19,083  
Interest income
    115       218       280       37       150       150       20  
Interest expense
    (4,731 )     (5,537 )     (4,923 )     (647 )     (2,414 )     (2,239 )     (294 )
Other expense
    (37 )     (7 )                              
Other income
    336       60       1,386       182       965       174       23  


44


Table of Contents

                                                         
    For the Year Ended December 31,     For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
    RMB     RMB     RMB     $     RMB     RMB     $  
    (In thousands, except share, per share and per ADS data)  
 
Income before income tax
    57,772       169,080       253,903       33,356       142,110       143,351       18,832  
Income tax
                                         
                                                         
Net income
    57,772       169,080       253,903       33,356       142,110       143,351       18,832  
                                                         
Earnings per ordinary share
                                                       
Basic
    RMB0.58       RMB1.69       RMB2.54       US$0.33       RMB1.42       RMB1.43       US$0.19  
Diluted
    RMB0.58       RMB1.69       RMB2.54       US$0.33       RMB1.42       RMB1.43       US$0.19  
Earnings per ADS(1)
                                                       
Basic
                                                                                          
Diluted
                                                                                          
Weighted average number of ordinary shares used in per share calculations:
                                                       
Basic
    100,000,000       100,000,000       100,000,000       100,000,000       100,000,000       100,000,000       100,000,000  
Diluted
    100,000,000       100,000,000       100,000,000       100,000,000       100,000,000       100,119,337       100,119,337  
Pro forma earnings per share: (2)
                                                       
—Basic and diluted on an as converted basis
                RMB2.48       US$0.33             RMB1.40       US$0.18  
Weighted average number of ordinary shares outstanding used in computation of pro forma basic and diluted earnings per share
                102,400,000       102,400,000             102,400,000       102,400,000  
 
 
(1) Each ADS represents [•] ordinary shares.
 
(2) The pro forma earnings per share are calculated based on an assumption that the conversion of 2,400,000 Series A convertible redeemable preferred shares outstanding as of June 30, 2007 into the same number of ordinary shares of the Company had occurred on January 1, 2006 and 2007.
 
The following table presents a summary of our consolidated balance sheet data as of December 31, 2005 and 2006 and as of June 30, 2007:
 
                                         
    As of December 31,     As of June 30,  
    2005     2006     2007  
    RMB     RMB     $     RMB     $  
    (In thousands)  
 
Consolidated Balance Sheet Data:
                                       
Cash and cash equivalents
    29,477       42,782       5,620       325,562       42,770  
Accounts receivable
    67,200       156,440       20,552       166,954       21,933  
Total assets
    351,866       490,476       64,434       871,500       114,490  
Total current liabilities
    141,532       127,344       16,729       344,636       45,275  
Series A Redeemable convertible preferred shares
                      65,111       8,555  
Redeemable ordinary shares
                      155,928       20,484  
Additional paid-in capital
    6,262       8,098       1,064              
Total shareholders’ equity
    208,834       354,136       46,523       296,829       38,994  

45


Table of Contents

 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the section entitled “Selected Consolidated Financial Data” and our consolidated financial statements and the related notes included elsewhere in this prospectus. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” and elsewhere in this prospectus .
 
Overview
 
We are a fast-growing China-based agri-solutions provider engaged in research and development, production and sale of upstream agricultural products. We currently provide corn seed, sheep breeding products and seedling products. Our goal is to become a leading provider of a variety of agricultural upstream products to meet evolving demands of other participants in the agricultural industry, including producers of corn, sheep and other agricultural products that are used to manufacture products such as animal feed, mutton and wool. We have experienced substantial growth in revenues and profitability in recent years. Our corn seed and sheep breeding products are ultimately sold to and used by farmers in 14 provinces in China. Our total revenues increased from RMB152.3 million in 2004 to RMB489.7 million ($64.3 million) in 2006, representing a CAGR of 79.3%, and our net income increased from RMB57.8 million in 2004 to RMB253.9 million ($33.4 million) in 2006, representing a CAGR of 109.6%. In the six months ended June 30, 2007, we generated total revenues of RMB279.4 million ($36.7 million) and net income of RMB143.4 million ($18.8 million). In 2006, revenues from our corn seed, sheep breeding and seedling segments accounted for 50.2%, 39.4% and 10.4%, respectively, of our total revenues. In the six months ended June 30, 2007, revenues from our corn seeds, sheep breeding and seedling segments accounted for 47.9%, 39.6% and 12.5%, respectively, of our total revenues.
 
We provide four proprietary strains of Primalights III corn seed products, consisting of Primalights III — 591, Primalights III — 391, Primalights III — 891 and Primalights III — 28, which contributed approximately 55.8% of our total corn seed revenues in 2006. We have access to approximately 23,000 acres of farmland in seven provinces for corn seed production. Our corn seed products are grown through contractual arrangements with village collectives and seed production companies under which we provide farming, harvesting and other technical guidance and supervision and the farmers grow and harvest corn seeds. In addition to our proprietary products, we are the exclusive distributor in the Shanxi province of four varieties of corn seed produced by other seed companies outside of the Shanxi province. We also produce and sell four popular generic corn seeds. We sell our corn seed products to local and regional distributors inside and outside of the Shanxi province. Revenues derived from our corn seed segment accounted for 31.9%, 63.9%, 50.2% and 47.9% of our total revenues in 2004, 2005, 2006 and the six months ended June 30, 2007, respectively. We achieved gross margins of 31.4%, 39.9%, 41.1% and 39.9% from our corn seed segment in 2004, 2005, 2006 and the six months ended June 30, 2007, respectively.
 
Our sheep breeding segment consists primarily of the production and sale of frozen sheep semen, sheep embryos, breeder sheep and our self-developed Primalights III hybrid sheep. We currently own approximately 6,100 breeder sheep, approximately 9,700 Primalights III hybrid sheep and approximately 900 breeder goats. We operate five breeding bases which occupy a total of approximately 3,700 acres of land in the Shanxi province where we maintain propagation bases and pasture land for our flocks. We sell our sheep breeding products primarily to BIRS, breeding companies and other sheep reproductive stations. Revenues derived from our sheep breeding segment accounted for 61.0%, 31.1%, 39.4% and 39.6% of our total revenues in 2004, 2005, 2006 and the six months ended June 30, 2007, respectively. We achieved gross margins of 66.4%, 68.4%, 72.9% and 72.4% from our sheep breeding segment in 2004, 2005, 2006 and the six months ended June 30, 2007, respectively.
 
Our seedling segment primarily comprises the sale of four types of seedlings, namely, blackberry and raspberry, date and white bark pine. We sell our seedling products directly to end users, such as municipal


46


Table of Contents

government agencies and plantation nurseries. Revenues derived from our seedling segment accounted for 7.1%, 5.0%, 10.4% and 12.5% of our total revenues in 2004, 2005, 2006 and the six months ended June 30, 2007, respectively. We achieved gross margins of 16.3%, 68.8%, 79.7% and 69.4% from our seedling segment in 2004, 2005, 2006 and the six months ended June 30, 2007, respectively.
 
Factors Affecting Our Results of Operations
 
We believe the following factors have had, and we expect that they will continue to have, a significant effect on our results of operations:
 
Demand for Our Upstream Agricultural Products
 
The growth of our business has benefited, and is expected to continue to benefit, from the increasing demand for our upstream agricultural products. This demand is in turn driven by demand for corn, high quality sheep, raspberries, blackberries, dates and pine trees.
 
China has experienced a rapid increase in demand for corn for animal feed and human consumption, primarily due to population growth and industrial development. According to the China National Grain and Oil Information Center, corn consumption in China has increased from 115.3 million tonnes in 2000 to 137.5 million tonnes in 2006 and is expected to reach 150.0 million tonnes in 2010. Furthermore, demand for hybrid corn seeds producing corn with high-yield, drought or pest resistance, high oil content or other advantageous attributes has increased more significantly than the increase in demand for more generic corn seeds.
 
According to FAOSTAT, China consumes more mutton than any other country and its demand for mutton and sheep wool has increased rapidly. For example, mutton consumption in China increased from 2.5 million tonnes in 2000 to 5.1 million tonnes in 2005. Compared to sheep in more developed countries, sheep in China generally tend to produce lower qualities and quantities of wool and meat. As a result, China has been upgrading the quality of its sheep flock, which creates significant internal demand for breeder sheep, low-cost production of related products and relevant scientific research.
 
Changes in the affluence of Chinese consumers and recognition of the nutritional benefits of berry fruit worldwide is driving demand for fruit berries for human consumption. Demand for dates has been driven by both domestic consumption and by increasing exports to countries such as Singapore, Japan and Korea. As a result of the rapid urbanization, rising affluence of households in China and a deteriorating environmental situation, the need for urban greenery has increased rapidly. White bark pine is suitable for urban plantation in the northern part of China because it is evergreen.
 
Expansion of Our Production Capacity
 
Expansion of production capacity is essential to the growth of our business. We have expanded our production capacity in the corn seed segment by obtaining access to additional farmland in seven provinces in China. As of June 30, 2007, we had access to approximately 23,000 acres of farmland for corn seed production, compared to approximately 16,400 acres, 13,000 acres and 5,000 acres as of December 31, 2006, 2005 and 2004, respectively. We expand our production capacity of the sheep breeding segment by increasing the size of our sheep flocks. We currently own approximately 6,100 breeder sheep, approximately 9,700 Primalights III hybrid sheep and approximately 900 breeder goats. We expect to expand our production capacity of the seedling segment by increasing the number of our seedling-growing staff.
 
The investment in expanding our production capacity requires significant capital expenditure, however, and whether our expansion strategy is successful will depend primarily on whether our sales volumes grow alongside our growing production capacity. If our capacity expansion exceeds the growth in demand for our products, we may not be able to generate sufficient returns from our capacity expansion and our business and financial condition will suffer.


47


Table of Contents

Pricing of Our Products
 
The profitability of our operations is affected by the selling prices of our products. A majority of our products are ultimately sold to farmers in China, who are extremely price sensitive. Farmers may choose among different products with comparable quality primarily based on the differences in prices. In light of this, we have tried to reduce the distribution layers between us and farmers to a minimum, which we believe has enabled us to price our products to maintain our competitive market position.
 
Prices of corn seed, sheep breeding, seedling and other agricultural products in China have historically been volatile, reflecting overall economic conditions which affect the budgeting and buying patterns of end users. In general, changes in the prices of our products are the result of changes in supply and demand in the markets in which we operate. Changes in the domestic demand in China result primarily from population growth, changes in dietary habits and availability of similar and competing agricultural products.
 
We set the prices for our proprietary corn seed products higher than the prices of the generic corn seed and other corn seed that we distribute. We benchmark the prices of our proprietary corn seed against the prevailing PRC domestic market prices of corn seed of similar quality and attributes. The prices of our generic corn seed are based on the prevailing market prices of other comparable generic corn seeds and are subject to more significant competitive price pressure compared to our proprietary products. The prices of the other corn seed that we distribute are determined by our negotiations with the seed companies.
 
We set the prices of Primalights III hybrid sheep substantially lower than those of the purebred foreign sheep. Our Primalights III hybrid sheep, even though not officially recognized as breeder sheep in China, are sold at prices comparable to domestic breeder sheep and the prices depend primarily on market demand for our Primalights III sheep. The selling prices of our Primalights III hybrid sheep have remained relatively stable since 2004. We may be able to increase the price of our Primalights III hybrid sheep if we receive official variety recognition of such sheep as breeder sheep in China. The selling prices of our breeder sheep, frozen semen and embryos are based on prevailing market prices of similar products and have experienced fluctuations in recent years.
 
In pricing our proprietary Primalights #1 and Primalights #2 date seedlings, we use the prevailing market prices of generic date seedlings as benchmarks. The selling prices of our raspberry and blackberry and white bark pine seedlings are based on prevailing market prices.
 
Ability to Market and Sell Corn Seed Products with Higher Margins
 
We believe that our future success in the corn seed segment will depend on our ability to develop, market and sell our proprietary corn seed products. Compared to generic corn seed and other corn seed that we distribute, proprietary corn seed products have higher profit margins. We have produced and sold not only our own proprietary corn seed but generic corn seed and distributed or produced corn seed for other seed companies. We have done so in order to accumulate experience in growing corn seed, developing our distribution network and effectively operating a corn seed business. The sales of our proprietary products accounted for 28.5%, 55.6%, 55.8% and 64.6% of our revenues in the corn seed segment in 2004, 2005, 2006 and the six months ended June 30, 2007, respectively. We plan to increase sales of our existing proprietary corn seed products and develop, market and sell additional proprietary corn seed products in order to seek relatively higher margins than generic products.
 
Seasonality
 
The agricultural industry is seasonal in nature and we experience quarterly fluctuations in our results of operations. The vast majority of our corn seeds are sown by the village collectives between April and May. During this period, we have significant cash flow needs to provide advances to the village collectives for their purchase of fertilizer and other production materials. The majority of our corn seed sales take place between October and May. The sales of the majority of our sheep breeding products takes place in the spring season from March to June and the fall season from August to November and the majority of our seedling products are sold mainly in the spring season from March to June and in the fall season from September to October. As


48


Table of Contents

a result, we need to carefully budget and plan our liquidity requirements for the periods from March to May. See “Risk Factors — Risks Relating to Our Business — It is difficult to predict our future performance because our revenues and operating results fluctuate significantly from period to period due in part to the nature of our business.”
 
Competition
 
The agricultural industry in China is highly fragmented, largely regional and competitive and we expect competition to increase and intensify. We face significant competition in our corn seed segment. Our ability to compete successfully in our corn seeds and sheep breeding business segments largely depends on our ability to differentiate our corn seed and sheep breeding products from competing products and to a lesser extent, our ability to control our costs of operation so that we can price our products competitively. Corn seeds and breeder sheep are commodities which are interchangeable among products of similar quality and attributes and are subject to significant competitive price pressures. We may face increasing competition in the corn seed industry as a result of the privatization of corn seed producers that are currently owned or operated by state-owned enterprises. We may also need to further expand our production capacity and enhance our product offerings in order to compete with existing and new competitors successfully. We have so far experienced limited competition in our seedling segment. However, the entry barriers for seedling companies are relatively low, and we may face competition from new players in this sector. As competition intensifies, margins may be compressed by more competitive pricing in the long term if such an increased level of competition continues. See “Risk Factors — Risks Relating to Our Business — The Chinese agricultural market is highly competitive and our growth and results of operations may be adversely affected if we are unable to compete effectively.”
 
PRC Government Support for the Agricultural Industry
 
The success of our business depends to a large extent on the existence and the level of PRC government support for production of agricultural products. The PRC government has implemented various favorable policies and provided incentives to agricultural companies in China, lowered fees and taxes in the agricultural industry, and increased spending on rural infrastructure, including providing subsidies to farmers and establishing and maintaining BIRS and other government-run entities to provide distribution and other support to farmers.
 
In addition, as a “key technology enterprise” in Shanxi province, P3A has been exempt from the PRC enterprise income tax, or EIT, based on the approval of the local tax authority since 2002. It has also been exempt from the PRC value-added tax, or VAT, since 2002 pursuant to the relevant PRC regulations and policies regarding the VAT applicable to producers of certain agricultural products. See “— Taxation.”
 
Revenues
 
We generated total revenues of RMB152.3 million, RMB384.1 million, RMB489.7 million, and RMB279.4 million ($36.7 million) in 2004, 2005, 2006 and the six months ended June 30, 2007, respectively. We derive our revenues from our corn seed, sheep breeding and seedling segments. The following table sets forth the revenues generated by each of the three business segments in 2004, 2005, 2006 and the six months ended June 30, 2006 and 2007, both as an absolute amount and as a percentage of total revenues.
 
                                                                                                 
    For the Year Ended December 31,     For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
    RMB     %     RMB     %     RMB     $     %     RMB     %     RMB     $     %  
    (In thousands except percentages)  
 
Revenues:
                                                                                               
Corn seeds
    48,560       31.9 %     245,601       63.9 %     245,634       32,269       50.2 %     142,126       52.8 %     133,853       17,584       47.9 %
Sheep breeding
    92,904       61.0       119,468       31.1       193,054       25,362       39.4       97,518       36.2       110,599       14,530       39.6  
Seedlings
    10,820       7.1       19,020       5.0       51,015       6,702       10.4       29,594       11.0       34,955       4,592       12.5  
                                                                                                 
Total revenues
    152,284       100.0 %     384,089       100.0 %     489,703       64,333       100.0 %     269,238       100.0 %     279,407       36,706       100.0 %
                                                                                                 


49


Table of Contents

Corn Seed Segment
 
Revenues from our corn seed segment have constituted, and are expected to continue to constitute, a significant portion of our total revenues in the foreseeable future. We generate revenues from sales of our proprietary corn seed products, generic corn seed products and other corn seed products that we produce or distribute for other seed companies. We recognize revenues from sales of our corn seed products upon delivery of the products to our customers. We typically enter into sales contracts with our customers two months in advance of delivery. Our sales contracts provide for upfront payments, which may be up to 100% of the purchase price, depending upon the payment history and creditworthiness of each customer, with the balance due within 180 days after delivery. The corn seed sales price agreed upon as of the date of a sales contract is final and not subject to adjustment. We are not contractually obligated to accept sales returns and do not provide customers with price protection. We provide our customers with limited product warranties. Under our limited product warranty, if a customer claims that our products are defective and an independent third-party chosen by us and the customer determines that our products are defective, we will compensate the customer for its loss. To date, we have not had any material warranty claims relating to our product quality.
 
Revenues from sales of these corn seed products are determined by the total sales volume and average selling prices of our products. The sales volume of our corn seed products is in turn affected by our corn seed production capacity, sales and marketing efforts, brand recognition and changes in demand for our products. Farmers in China are the ultimate users of our corn seeds. Sales of our corn seeds depend primarily on recurring orders from our existing distributors and our introduction of new products and expansion into new markets, which in turn depend primarily on farmers’ perception of the quality, attributes and prices, of our corn seeds. The average selling prices of our corn seed products are affected by our product mix and market prices of comparable products. The prices of our proprietary corn seed products are higher than the prices of the generic corn seeds and other corn seeds that we distribute. The following table sets forth our revenues derived from sales of proprietary corn seeds and non-proprietary corn seeds, respectively, in absolute amounts and as percentages of our revenues from corn seeds and our total revenues for each of the three years ended December 31, 2006 and the six months ended June 30, 2006 and 2007:
 
                                                                                                                                         
                                                                For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
          % of
                % of
                      % of
                % of
                      % of
       
          Corn
    % of
          Corn
    % of
                Corn
    % of
          Corn
    % of
                Corn
    % of
 
          Seed
    Total
          Seed
    Total
                Seed
    Total
          Seed
    Total
                Seed
    Total
 
    RMB     Revenues     Revenues     RMB     Revenues     Revenues     RMB     $     Revenues     Revenues     RMB     Revenues     Revenues     RMB     $     Revenues     Revenues  
    (In thousands except percentages)  
 
Revenues:
                                                                                                                                       
Proprietary Corn Seeds
    13,822       28.5 %     9.1 %     136,534       55.6 %     35.5 %     137,062       18,006       55.8 %     28.0 %     74,197       52.2 %     27.6 %     86,421       11,353       64.6 %     30.9 %
Non-proprietary Corn Seeds
    34,738       71.5       22.8       109,067       44.4       28.4       108,572       14,263       44.2       22.2       67,929       47.8       25.2       47,432       6,231       35.4       17.0  
                                                                                                                                         
Total
    48,560       100.0 %     31.9 %     245,601       100.0 %     63.9 %     245,634       32,269       100.0 %     50.2 %     142,126       100.0 %     52.8 %     133,853       17,584       100.0 %     47.9 %
                                                                                                                                         


50


Table of Contents

 
Sheep Breeding Segment
 
Our sheep breeding segment consists primarily of the production and sale of frozen sheep semen, sheep embryos, breeder sheep and our Primalights III hybrid sheep. The following table sets forth our revenues derived from sales of each of these products in absolute amounts and as percentages of our revenues from sheep breeding products and our total revenues for the three years ended December 31, 2006 and the six months ended June 30, 2006 and 2007:
 
                                                                                                                                         
                                                                For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
          % of
                % of
                      % of
                % of
                      % of
       
          Sheep
    % of
          Sheep
    % of
                Sheep
    % of
          Sheep
    % of
                Sheep
    % of
 
          Breeding
    Total
          Breeding
    Total
                Breeding
    Total
          Breeding
    Total
                Breeding
    Total
 
    RMB     Revenues     Revenues     RMB     Revenues     Revenues     RMB     $     Revenues     Revenues     RMB     Revenues     Revenues     RMB     $     Revenues     Revenues  
    (In thousands except percentages)  
 
Revenues:
                                                                                                                                       
Frozen semen
    52,427       56.4 %     34.4 %     67,359       56.4 %     17.6 %     120,395       15,817       62.4 %     24.6 %     60,214       61.7 %     22.3 %     70,807       9,302       64.0 %     25.3 %
Embryos
    12,601       13.6       8.3       5,133       4.3       1.3       9,366       1,230       4.8       1.9       5,252       5.4       2.0       5,481       720       5.0       2.0  
Breeder sheep
    26,262       28.3       17.3       27,669       23.2       7.2       18,909       2,484       9.8       3.9       10,235       10.5       3.8       10,660       1,401       9.6       3.8  
Primalights III hybrid sheep
    1,614       1.7       1.0       19,307       16.1       5.0       44,384       5,831       23.0       9.0       21,817       22.4       8.1       23,651       3,107       21.4       8.5  
                                                                                                                                         
Total
    92,904       100.0 %     61.0 %     119,468       100.0 %     31.1 %     193,054       25,362       100.0 %     39.4 %     97,518       100.0 %     36.2 %     110,599       14,530       100.0 %     39.6 %
                                                                                                                                         
 
We recognize revenues from sales of our sheep breeding products upon delivery of the products to our customers. Payments for our frozen semen and embryos are due upon delivery to our customers based on our contracts with customers. Our sales contracts for breeder sheep and Primalights III hybrid sheep generally provide for payment periods ranging from payment upon delivery to three months after the sales, depending upon our assessment of the credit worthiness and the payment history of and our relationship with the customer. The sales price agreed upon as of the date of a sales order or sales agreement is final and is not subject to adjustments. We are not contractually obligated to accept sales returns and do not provide customers with price protection.
 
Our revenues from sales of our sheep breeding products are determined by the total sales volume and average selling prices of the products we sell. The sales volume of our sheep breeding products is in turn affected by our production capacity, sales and marketing efforts, brand recognition, changes in demand for our sheep breeding products and the availability of sheep breeding products in the PRC domestic market. We set the prices of our self-developed Primalights III hybrid sheep substantially lower than those of the purebred foreign sheep and the prices of our Primalights III hybrid sheep are comparable to prices of domestic breeder sheep depending primarily on market demand for our Primalights III hybrid sheep. The selling prices of our breeder sheep, frozen semen and embryo products are based on prevailing market prices.
 
Seedling Segment
 
We primarily produce and sell four types of seedlings: blackberry, raspberry, date and white bark pine seedlings. We recognize revenues from sales of our seedling products upon our delivery of the seedling products to our customers. A majority of our sales contracts provide for advance payments of approximately 50% of the sales price with the balance due within 180 days after the delivery. The seedling sales price agreed upon as of the date of sales orders or sales agreements is final. Our sales contracts for certain types of seedlings provide specified growth criteria. Our customers agree to pay us an additional fee if these criteria are met, which generally takes place within one month after delivery of our seedlings products. We recognize this additional fee as revenues when the specified growth criteria and other revenue recognition criteria are met. We are not contractually obligated to accept sales returns and do not provide customers with price protection.
 
Our revenues from sales of our seedling products depend on the total sales volume, our product offerings and average selling prices of seedling products. The sales volume of our seedling products is in turn affected by our production capacity, sales and marketing efforts, brand recognition, demand for our seedling products


51


Table of Contents

and the availability of seedling products in the PRC domestic market. Our proprietary seedling products are priced higher than non-proprietary seedling products.
 
Cost of Revenues
 
Corn Seed Segment
 
Cost of revenues for our corn seed segment primarily consists of the costs that we pay to the village collectives for the seeds they are contracted to grow for us, amortization of purchased technology know-how, depreciation of building and equipment and direct labor cost. At the beginning of each growing season, we provide parent seeds to the village collectives to grow for us under contractual arrangements. Our contractual agreements generally contain terms ranging from five to twelve years. We also provide advances to the village collectives for their purchase of fertilizer and other production materials. At the end of the growing season, after we take delivery of corn seeds, we credit the advances against the costs and recognize the balance as cost of inventory and subsequently recognize this balance as cost of revenues upon sales of corn seeds. We anticipate that cost of revenues for our corn seed segment will continue to increase as we continue to increase our corn seed sales. If the village collectives fail to produce or deliver the contracted amounts of corn seeds by the end of each growing season, we may not be able to recover all of the advances we paid and our financial condition could suffer.
 
Sheep Breeding Segment
 
Cost of revenues for our breeder sheep and Primalights III hybrid sheep primarily consists of cost of feeds, depreciation of buildings and equipment, amortization of purchased technology know-how, and materials used to raise sheep and direct labor cost. Feeds are the ingredients used to feed the purebred foreign sheep and the domestic sheep. Depreciation cost primarily consists of depreciation of fences, corrals, sorting pens, lambing pens, water facilities and handling facilities. Direct labor cost comprises the salaries and compensation for our employees who feed the sheep.
 
Cost of revenues for sales of our frozen semen and embryos mainly consists of cost of feeds, depreciation of breeder sheep and equipment and materials used to collect semen and embryos and direct labor cost. Feeds are the ingredients used to feed our breeder sheep. Depreciation cost primarily consists of depreciation of breeder sheep and depreciation of building structure such as fences, corrals, sorting pens, lambing pens, water and handling facilities, raw materials used for semen and embryo collection and preservation, medical supplies, mineral additives and consumables. Direct labor cost comprises the salaries and compensation for our employees who feed the sheep and who collect semen and embryos. We anticipate that the cost of revenues for our sheep breeding segment will continue to increase as we continue to expand our sales of sheep breeding products.
 
Seedling Segment
 
Cost of revenues for our seedling segment primarily consists of depreciation of trees and equipment, cost of nutritional and medical materials used to grow seedlings and direct labor cost. Depreciation cost includes depreciation of nurseries, water facilities and harvesting equipment and other machinery used to grow and harvest seedlings. Raw materials used to grow seedlings include mineral additives and other consumables. Direct labor cost comprises salaries and compensation for our staff who attend to the seedlings on a regular basis. We anticipate that cost of revenues for our seedling segment will continue to increase as we continue to expand our operations.


52


Table of Contents

Operating Expenses
 
Our operating expenses consist of sales and marketing expenses, general and administrative expenses and research and development expenses. The following table sets forth the components of our operating expenses, both in absolute amounts and as percentages of total operating expenses for the periods indicated:
 
                                                                                                 
    For the Years Ended December 31,     For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
    RMB     %     RMB     %     RMB     $     %     RMB     %     RMB     $     %  
    (In thousands except percentages)  
 
Operating (expenses) income:
                                                                                               
Selling expenses
    (4,874 )     (29.3 )%     (11,349 )     (61.8 )%     (14,031 )     (1,843 )     (55.7 )%     (7,542 )     (55.4 )%     (7,937 )     (1,043 )     (63.4 )%
General and administrative
    (6,015 )     (36.2 )     (4,199 )     (22.8 )     (7,472 )     (982 )     (29.7 )     (3,445 )     (25.3 )     (3,562 )     (468 )     (28.4 )
Research and development
    (7,203 )     (43.3 )     (2,974 )     (16.2 )     (3,746 )     (492 )     (14.9 )     (2,623 )     (19.3 )     (1,025 )     (135 )     (8.2 )
Government grants
    1,457       8.8       150       0.8       80       11       0.3                                
                                                                                                 
Total operating expenses
    (16,635 )     (100.0 )%     (18,372 )     (100.0 )%     (25,169 )     (3,306 )     (100.0 )%     (13,610 )     (100.0 )%     (12,524 )     (1,646 )     (100.0 )%
                                                                                                 
 
Sales and Marketing Expenses.   Our sales and marketing expenses primarily consist of our expenses of advertising in newspapers, on television and in magazines, salaries and compensation for our sales personnel, promotion expenses and other related marketing expenses. We expect to continue to increase our sales and marketing expenditure in the foreseeable future.
 
General and Administrative Expenses.   Our general and administrative expenses primarily consist of compensation and benefits for administrative, finance and human resources personnel, depreciation, provisions for bad debts, travel and other expenses associated with our corporate and administrative activities. We expect that our general and administrative expenses will increase as we add additional personnel and incur additional costs related to the growth of our business. We also expect to incur additional general and administrative expenses as a result of becoming a listed public company upon completion of this offering.
 
Research and Development Expenses.   Research and development expenses primarily consist of expenses related to development of our proprietary products, salaries and benefits of our research and development personnel, fees paid to our research partners, costs of raw materials used in our research and development activities, as well as other overhead incurred by our research and development personnel. We expect to increase our research and development expenditure in the foreseeable future.
 
Government Grants.   Government grants consist of the grants that P3A receives from the local government authorities in connection with its operations in the agricultural industry. The amount and timing of government grants are determined at the discretion of the relevant government authorities. Government grants are recognized as other operating income upon receipt and when all the conditions relating to the grants are met.
 
Share-based Compensation Expenses.   Since we adopted the 2007 share incentive plan in July 2007, we have granted options to purchase a total of 7,500,000 ordinary shares to our officers, directors and employees. We had not granted any options or other equity incentives to any employee, director or consultant before July 2007.
 
We will determine share-based compensation expenses based on the fair value of the options as of the date of grant and amortize such expenses over the vesting period of the options. A change in the amount of share-based compensation expenses will primarily affect our operating expenses, net income and earnings per share.
 
We have engaged Sallmanns (Far East) Limited, or Sallmanns, an independent appraiser, to assess the fair value of our options and ordinary shares underlying the options. Determining the fair value of options and ordinary shares requires making complex and subjective judgments regarding projected financial and operating results, our unique business risks, the liquidity of our shares and our operating history and prospects at the time of grant.


53


Table of Contents

In assessing the fair value of our ordinary shares, Sallmanns considered the following principal factors:
 
  •  the nature of our business and the contracts and agreements relating to our business;
 
  •  our financial conditions;
 
  •  the economic outlook in general and the specific economic and competitive elements affecting our business;
 
  •  the growth of our operations; and
 
  •  our financial and business risks.
 
Sallmanns used the binomial model to estimate the fair value of the options granted on July 4, 2007. Sallmanns determined that the fair value of our ordinary shares was US$3.40 per share as of the date of grant, which was determined using income approach by applying appropriate discount rate to future free cash flows that are based on 5-year financial projections developed by our company. The other assumptions used in Sallmanns’ binomial model were 5.16% average risk-free rate of return, 7.81 years of weighted average expected option life, 32.22% estimated volatility rate and no dividend yield.
 
Sallmanns used the binomial model to estimate the fair value of the options granted on July 19, 2007. Sallmanns determined that the fair value of our ordinary shares was US$3.48 per share as of the date of grant, which was determined using income approach by applying appropriate discount rate to future free cash flows that are based on 5-year financial projections developed by our company. The other assumptions used in Sallmanns’ binomial model were 5.04% average risk-free rate of return, 4.87 years of weighted average expected option life, 32.36% estimated volatility rate and no dividend yield.
 
The income approach used by Sallmanns involved applying appropriate discount rates to discount cash flows that were based on our earnings forecasts. The major assumptions used by Sallmanns in deriving the fair value of our ordinary shares were consistent with our business plan and outlook. Other major assumptions used by Sallmanns in determining the fair value of our ordinary share as of July 4, 2007 and July 19, 2007 included the following:
 
  •  Weighted average costs of capital, or WACC: WACC of 15.86% as at July 4, 2007 was used. This was the combined result of the changes in risk-free rate and industry average beta and our company-specific risks.
 
  •  Weighted average costs of capital, or WACC: WACC of 15.83% was used as at July 19, 2007. This was the combined result of the changes in risk-free rate and industry average beta and our company-specific risks.
 
Sallmanns also used other general assumptions, including the following: no material changes in the existing political, legal, fiscal and economic conditions and agriculture industry in China; our ability to retain competent management and key personnel to support our ongoing operations; and no material deviation in market conditions from economic forecasts.
 
For the options to purchase 7,500,000 ordinary shares that we granted to our officers, directors and employees on July 4, 2007 and July 19, 2007, total unrecognized compensation costs are estimated to be approximately US$11.4 million based on a preliminary assessment of the fair value of the awarded options. The compensation expenses are to be recognized as a charge to expense over the vesting period of four years from the respective grant dates.
 
Taxation
 
We are incorporated in the Cayman Islands. Under the current law of the Cayman Islands, we are not subject to income or capital gains tax. In addition, dividend payments are not subject to withholding tax in the Cayman Islands.


54


Table of Contents

Hong Kong Income Tax
 
Companies in Hong Kong are subject to a profit tax at the rate of 17.5% on assessable profit determined under relevant Hong Kong tax regulations. Our subsidiary in Hong Kong did not have any assessable profits that would be subject to the profit tax for each of the three years ended December 31, 2004, 2005, 2006 and for the six months ended June 30, 2006 and 2007. In addition, dividend payments are not subject to withholding tax in Hong Kong.
 
PRC Enterprise Income Tax (EIT)
 
PRC EIT is generally assessed at the rate of 33% of taxable income. P3A, our consolidated affiliated entity, is qualified as a “key technology enterprise” under the Shanxi Province 1311 Agricultural High Technology Project implemented by Shanxi province since 2002, thus P3A has been exempted from PRC EIT since 2002 based on the approval of the local tax authority in Shanxi. Agria China, our wholly-owned subsidiary established in March 2007 in China, has been approved as a new technology enterprise and enjoys the reduced EIT rate of 15%. In addition, Agria China received the local tax authority’s approval on September 30, 2007 to be exempted from the EIT from 2007 to 2009 and to be subject to the reduced EIT rate of 7.5% from 2010 to 2012.
 
On March 16, 2007, the National People’s Congress of China enacted the Enterprise Income Tax Law, or the new tax law, which will become effective on January 1, 2008. Under the new tax law, foreign-invested enterprises, or FIEs, and domestic companies will be subject to EIT at a uniform rate of 25% and the current tax exemption, reduction and preferential treatments which are applicable only to FIEs will be revoked. However, any enterprises established before the promulgation of the new tax law that are entitled to preferential tax treatments for a fixed period will continue to be entitled to such preferential tax treatment until the expiration of such period. If the fixed period has not commenced because of operating losses, it will be deemed to commence in 2008. Moreover, under the new tax law, enterprises organized under the laws of jurisdictions outside China with their de facto management bodies located within China may be considered PRC resident enterprises and therefore subject to PRC enterprise income tax at the rate of 25% on their worldwide income. The new tax law, however, does not define the term “de facto management bodies.” If a majority of the members of our management team continue to be located in China after the effective date of the new tax law, we may be considered a PRC resident enterprise and therefore subject to PRC enterprise income tax at the rate of 25% on our worldwide income.
 
PRC Value-Added Tax (VAT)
 
In accordance with the relevant tax laws in the PRC, VAT is levied on the invoiced value of sales and is payable by purchasers. A PRC company is required to remit the VAT it collects to the tax authority but may deduct the VAT it has paid on eligible purchases. P3A has been exempt from VAT since 2002 pursuant to the relevant PRC regulations and policies regarding the VAT applicable to producers of certain agricultural products.
 
Our Selected Quarterly Results of Operations
 
The following table presents our selected unaudited quarterly results of operations for the eight quarters through June 30, 2007. This quarterly financial information should be read together with our consolidated financial statements and related notes included elsewhere in this prospectus. We have prepared the unaudited consolidated quarterly financial information on the same basis as our audited consolidated financial statements. This quarterly financial information reflects all adjustments, consisting only of normal recurring adjustments, that we consider necessary for a fair presentation of our financial position and operating results for the periods presented. Our operating results for any quarter are not necessarily indicative of results that may be expected for any future period.
 


55


Table of Contents

                                                                 
    For the Three Months Ended  
    September 30,
    December 31,
    March 31,
    June 30,
    September 30,
    December 31,
    March 31,
    June 30,
 
    2005     2005     2006     2006     2006     2006     2007     2007  
    (in RMB thousands)  
 
Consolidated Statement of Operations Data
                                                               
Revenues:
                                                               
Corn seeds
    1,355       90,541       85,330       56,796       6,137       97,371       92,986       40,867  
Sheep breeding
    29,164       29,721       25,444       72,074       52,868       42,668       19,748       90,851  
Seedlings
    3,194       3,283       9,332       20,262       12,254       9,167       5,960       28,995  
                                                                 
Total revenues
    33,713       123,545       120,106       149,132       71,259       149,206       118,694       160,713  
                                                                 
Cost of revenues:
                                                               
Corn seeds
    (1,560 )     (41,325 )     (45,806 )     (35,572 )     (5,489 )     (57,863 )     (53,257 )     (27,138 )
Sheep breeding
    (9,727 )     (9,553 )     (8,311 )     (18,318 )     (13,054 )     (12,604 )     (6,336 )     (24,207 )
Seedlings
    (811 )     (870 )     (328 )     (3,884 )     (2,995 )     (3,150 )     (1,153 )     (9,526 )
                                                                 
Total cost of revenues
    (12,098 )     (51,748 )     (54,445 )     (57,774 )     (21,538 )     (73,617 )     (60,746 )     (60,871 )
                                                                 
Gross profit
    21,615       71,797       65,661       91,358       49,721       75,589       57,948       99,842  
                                                                 
Operating (expenses) income:
                                                               
Selling expenses
    (1,699 )     (3,311 )     (3,510 )     (4,032 )     (2,402 )     (4,087 )     (3,560 )     (4,377 )
General and administrative
    (453 )     (1,104 )     (1,356 )     (2,089 )     (1,243 )     (2,784 )     (1,645 )     (1,917 )
Research and development
    (368 )     (368 )     (1,310 )     (1,313 )     (562 )     (561 )     (513 )     (512 )
Government grants
          150                   80                    
                                                                 
Total operating expenses
    (2,520 )     (4,633 )     (6,176 )     (7,434 )     (4,127 )     (7,432 )     (5,718 )     (6,806 )
                                                                 
Operating profit
    19,095       67,164       59,485       83,924       45,594       68,157       52,230       93,036  
                                                                 
Interest income
    74       76       60       90       63       67       79       71  
Interest expense
    (1,443 )     (1,290 )     (1,059 )     (1,355 )     (1,345 )     (1,164 )     (1,400 )     (839 )
Other income
    5       54       66       899       79       342             174  
                                                                 
Income before income tax
    17,731       66,004       58,552       83,558       44,391       67,402       50,909       92,442  
Income tax
                                               
                                                                 
Net income
    17,731       66,004       58,552       83,558       44,391       67,402       50,909       92,442  
                                                                 
 
The agricultural industry is seasonal in nature and our quarterly revenues and costs and expenses as a percentage of our revenues have been affected by the seasonal fluctuations and seasonable variations in demands for our products.
 
Typically, the vast majority of our corn seed sales, which contribute to a significant portion of our quarterly revenues, take place between October and May. The production of most of our sheep breeding products occurs mainly in the spring season from February to June and in the fall season from August to November and the majority of our seedling products are sold mainly in the spring season from April to June and in the fall season from September to October. As a result, our revenues typically reach seasonal peaks in the second and fourth quarters of a year, while our revenues are relatively low in the third quarter. We expect such seasonal fluctuations to continue in the foreseeable future.


56


Table of Contents

Results of Operations
 
The following table sets forth a summary of our consolidated results of operations for the periods indicated. This information should be read together with our consolidated financial statements and related notes included elsewhere in this prospectus. The operating results in any period are not indicative of the results that may be expected for any future period.
 
                                                                                                 
    For the Years Ended December 31,     For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
          % of
          % of
                % of
          % of
                % of
 
    RMB     Revenues     RMB     Revenues     RMB     $     Revenues     RMB     Revenues     RMB     $     Revenues  
    (In thousands except percentages)  
 
                                                                                                 
Revenues:
                                                                                               
Corn seeds
    48,560       31.9 %     245,601       63.9 %     245,634       32,269       50.2 %     142,126       52.8 %     133,853       17,584       47.9 %
Sheep breeding
    92,904       61.0       119,468       31.1       193,054       25,362       39.4       97,518       36.2       110,599       14,530       39.6  
Seedlings
    10,820       7.1       19,020       5.0       51,015       6,702       10.4       29,594       11.0       34,955       4,592       12.5  
                                                                                                 
Total revenues
    152,284       100.0 %     384,089       100.0 %     489,703       64,333       100.0 %     269,238       100.0 %     279,407       36,706       100.0 %
                                                                                                 
Cost of revenues:
                                                                                               
Corn seeds
    (33,311 )     (21.9 )%     (147,723 )     (38.5 )%     (144,730 )     (19,013 )     (29.5 )%     (81,378 )     (30.2 )%     (80,395 )     (10,562 )     (28.8 )%
Sheep breeding
    (31,196 )     (20.5 )     (37,716 )     (9.8 )     (52,287 )     (6,869 )     (10.7 )     (26,629 )     (9.9 )     (30,543 )     (4,012 )     (10.9 )
Seedlings
    (9,053 )     (5.9 )     (5,932 )     (1.5 )     (10,357 )     (1,361 )     (2.1 )     (4,212 )     (1.6 )     (10,679 )     (1,403 )     (3.8 )
                                                                                                 
Total cost of revenue
    (73,560 )     (48.3 )%     (191,371 )     (49.8 )%     (207,374 )     (27,243 )     (42.3 )%     (112,219 )     (41.7 )%     (121,617 )     (15,977 )     (43.5 )%
                                                                                                 
Gross profit
    78,724       51.7 %     192,718       50.2 %     282,329       37,090       57.7 %     157,019       58.3 %     157,790       20,729       56.5 %
                                                                                                 
Operating (expenses) income:
                                                                                               
Selling expenses
    (4,874 )     (3.2 )%     (11,349 )     (3.0 )%     (14,031 )     (1,843 )     (2.9 )%     (7,542 )     (2.8 )%     (7,937 )     (1,043 )     (2.8 )%
General and administrative
    (6,015 )     (4.0 )     (4,199 )     (1.0 )     (7,472 )     (982 )     (1.5 )     (3,445 )     (1.3 )     (3,562 )     (468 )     (1.3 )
Research and development
    (7,203 )     (4.7 )     (2,974 )     (0.8 )     (3,746 )     (492 )     (0.8 )     (2,623 )     (1.0 )     (1,025 )     (135 )     (0.4 )
Government grants
    1,457       0.9       150       0.0       80       11       0.0                                
                                                                                                 
Total operating expenses
    (16,635 )     (11.0 )%     (18,372 )     (4.8 )%     (25,169 )     (3,306 )     (5.2 )%     (13,610 )     (5.1 )%     (12,524 )     (1,646 )     (4.5 )%
                                                                                                 
Operating profit
    62,089       40.7 %     174,346       45.4 %     257,160       33,784       52.5 %     143,409       53.2 %     145,266       19,083       52.0 %
Interest income
    115       0.1       218       0.1       280       37       0.1       150       0.1       150       20       0.0  
Interest expense
    (4,731 )     (3.1 )     (5,537 )     (1.5 )     (4,923 )     (647 )     (1.1 )     (2,414 )     (0.9 )     (2,239 )     (294 )     (0.8 )
Other income
    299       0.2       53       0.0       1,386       182       0.3       965       0.4       174       23       0.1  
                                                                                                 
Income before income tax
    57,772       37.9 %     169,080       44.0 %     253,903       33,356       51.8 %     142,110       52.8 %     143,351       18,832       51.3 %
Income tax
                                                                       
                                                                                                 
Net income
    57,772       37.9 %     169,080       44.0 %     253,903       33,356       51.8 %     142,110       52.8 %     143,351       18,832       51.3 %
                                                                                                 
 
Six Months Ended June 30, 2007 Compared to Six Months Ended June 30, 2006
 
Revenues.   Our total revenues increased by 3.8% from RMB269.2 million in the six months ended June 30, 2006 to RMB279.4 million ($36.7 million) in the six months ended June 30, 2007, resulting primarily from the increase in revenues from our sheep breeding segment and, to a lesser extent, our seedling segment. The increase in our total revenues was partly offset by the decrease in revenues from our corn seed segment.
 
Revenues from our corn seeds segment decreased by 5.8% from RMB142.1 million to RMB133.9 million ($17.6 million) in the six months ended June 30, 2007 compared with the six months ended June 30, 2006, primarily resulting from (1) a decrease in the selling prices of both our proprietary corn seeds and our generic corn seeds and other corn seeds that we distributed, due to the intense competition in the corn seed market; for example, the average unit sales price of our proprietary product Primalights III — 891, which contributed 33.7% of our revenues from the corn seed segment in the six months ended June 30, 2007, decreased by 6.0%, from the six months ended June 30, 2006 to the six months ended June 30, 2007, and (2) a decrease in the selling volume of our corn seeds, due to the early commencement of warm spring season in northern China in


57


Table of Contents

2007. In anticipation of the earlier than usual spring seedtime, our customers started to stock corn seeds at the end of 2006, which in turn reduced our sales volume in the first quarter of 2007.
 
Revenues from our sheep breeding segment increased by 13.4% from RMB97.5 million in the six months ended June 30, 2006 to RMB110.6 million ($14.5 million) in the six months ended June 30, 2007, primarily due to (1) an increase of RMB10.6 million in revenues from frozen semen, mainly as a result of a 34% increase in average unit sales price of frozen semen from the six months ended June 30, 2006 to the six months ended June 30, 2007, partly offset by a decrease in sales volume of frozen semen in the six months ended June 30, 2007, and (2) an increase of RMB1.8 million in revenues from Primalights III hybrid sheep, as a result of an increase in the sales volume of Primalights III hybrid sheep, partly offset by a decrease of 9.6% in the average sales price of Primalights III hybrid sheep due to the decrease in the prevailing market price for breeder sheep.
 
Revenues from our seedling segment increased by 18.2% from RMB29.6 million in the six months ended June 30, 2006 to RMB35.0 million ($4.6 million) in the six months ended June 30, 2007, primarily due to the additional varieties of seeding products that we offered in the six months ended June 30, 2007.
 
Cost of Revenues and Gross Profit.   Total cost of revenues increased by 8.4% from RMB112.2 million in the six months ended June 30, 2006 to RMB121.6 million ($16.0 million) in the six months ended June 30, 2007. The increase in our cost of revenues was due primarily to the increase in cost of revenues from our seedling segment and, to a lesser extent, our sheep breeding segment. As a result, our gross profit increased slightly from RMB157.0 million in the six months ended June 30, 2006 to RMB157.8 million ($20.7 million) in the six months ended June 30, 2007.
 
Cost of revenues from our corn seed segment decreased by 1.2% from RMB81.4 million in the six months ended June 30, 2006 to RMB80.4 million ($10.6 million) in the six months ended June 30, 2007, primarily due to a decrease in the sales volume of our generic corn seed products, which was partly offset by the higher percentage of sales of third-party corn seeds that we distributed in 2007. Third-party corn seeds generally have had higher cost of revenues and lower gross margins than other proprietary corn seed products. Gross profit from this segment decreased by 11.9% from RMB60.7 million in the six months ended June 30, 2006 to RMB53.5 million ($7.0 million) in the six months ended June 30, 2007 primarily due to the reduction in the selling prices of corn seeds sold by us and the higher percentage of sales of third-party corn seeds that we distributed.
 
Cost of revenues from our sheep breeding segment increased by 14.7% from RMB26.6 million in the six months ended June 30, 2006 to RMB30.5 million ($4.0 million) in the six months ended June 30, 2007, which was in line with the increase in revenues from our sheep breeding segment. Gross profit from this segment increased by 13.0% from RMB70.9 million in the six months ended June 30, 2006 to RMB80.1 million ($10.5 million) in the six months ended June 30, 2007 primarily due to an increase in the average sales price of frozen semen.
 
Cost of revenues from our seedling segment increased by 154.8% from RMB4.2 million in the six months ended June 30, 2006 to RMB10.7 million ($1.4 million) in the six months ended June 30, 2007, primarily due to the significant increase in depreciation of trees and cost of nutritional and medical materials, as a result of the increase in sales volume of our new seedling products which have higher cost of revenues than our existing seedling products. Gross profit from this segment decreased by 4.3% from RMB25.4 million in the six months ended June 30, 2006 to RMB24.3 million ($3.2 million) in the six months ended June 30, 2007 due to the higher percentage of sales of new seedling products with lower profit margins.
 
Operating Expenses
 
Selling Expenses.   Our selling expenses increased by 5.3% from RMB7.5 million in the six months ended June 30, 2006 to RMB7.9 million ($1.0 million) in the six months ended June 30, 2007. This increase resulted primarily from (1) an increase of RMB0.2 million in commissions due to an increase in our revenues and (2) an increase of RMB0.2 million in advertisement expenses.


58


Table of Contents

 
General and Administrative Expenses.   Our general and administrative expenses increased by 3.4% from RMB3.4 million in the six months ended June 30, 2006 to RMB3.6 million ($0.5 million) in the six months ended June 30, 2007. The increase resulted primarily from an increase of RMB2.0 million in professional service fees, salaries, traveling expenses and rental expenses related to the establishment of Agria Corporation and Agria China, partly offset by (1) a reversal of RMB1.2 million bad debt provision recorded in a previous period, as we subsequently collected the outstanding debts in full in the six months ended June 30, 2007 and (2) a decrease of RMB0.3 million in corporate expenses.
 
Research and Development Expenses.   Our research and development expenses decreased by 61.5% from RMB2.6 million in the six months ended June 30, 2006 to RMB1.0 million ($0.1 million) in the six months ended June 30, 2007. The decrease was primarily caused by the research and development expense of RMB1.5 million that we incurred in the six months ended June 30, 2006 that we did not incur in the six months ended June 30, 2007.
 
Operating Profit.   As a result of the foregoing factors, our operating profit increased by 1.3% from RMB143.4 million in the six months ended June 30, 2006 to RMB145.3 million ($19.1 million) in the six months ended June 30, 2007.
 
Other Income.   Our other income decreased from RMB965,000 in the six months ended June 30, 2006 to RMB174,000 ($23,000) in the six months ended June 30, 2007. This decrease was due primarily to a decrease of RMB0.8 million in the sales of sheep dung, a by-product of our sheep products.
 
Net Income.   As a result of the foregoing factors, our net income increased from RMB142.1 million in the six months ended June 30, 2006 to RMB143.4 million ($18.8 million) in the six months ended June 30, 2007.
 
Year Ended December 31, 2006 Compared to Year Ended December 31, 2005
 
Revenues.   Our total revenues increased by 27.5% from RMB384.1 million in 2005 to RMB489.7 million ($64.3 million) in 2006, resulting primarily from the increase in revenues from our sheep breeding segment and, to a lesser extent, our seedling segment.
 
Revenues from our corn seed segment remained unchanged at RMB245.6 million ($32.3 million) in 2006 compared with 2005, primarily due to an increase of RMB0.5 million in revenues from our proprietary corn seeds, offset by a decrease of RMB0.5 million in revenues from our generic corn seeds and other corn seeds that we distributed. Sales volume of our proprietary corn seeds increased from 12,310 tonnes in 2005 to 14,457 tonnes in 2006. To increase our production capacity, we expanded the farmland to which we had access for our corn seed production from 12,980 acres in 2005 to approximately 16,460 acres in 2006. Increase in sales volume of our proprietary corn seeds was offset by a reduction of the selling price of our proprietary corn seeds due to changes in demand and supply and our effort to expand our market share. The average unit sales price of our proprietary products Primalights III — 591, Primalights III — 391, Primalights III — 891 and Primalights III — 28 decreased by 4.1%, 8.0%, 15.5% and 12.3%, respectively, from 2005 to 2006. The decrease in revenues from non-proprietary corn seeds resulted from a decrease of average selling prices, which was partially offset by the increase in sales volume.
 
Revenues from our sheep breeding segment increased by 61.6% from RMB119.5 million in 2005 to RMB193.1 million ($25.4 million) in 2006, primarily due to (1) an increase of RMB25.1 million in revenues from Primalights III hybrid sheep, as a result of a significant increase in sales volume of Primalights III hybrid sheep, partly offset by a decrease in sales volume of the breeder sheep we sold in 2006; (2) an increase of RMB53.0 million in revenues from frozen semen, as a result of an increase in sales volume as we continued to develop the Shanxi and Inner Mongolia markets and expanded into the Hebei, Shaanxi and Heilongjiang provinces; and (3) an increase of RMB4.2 million in revenues from embryos, as a result of a significant increase in sales volume of embryos.
 
Revenues from our seedling segment increased by 168.2% from RMB19.0 million in 2005 to RMB51.0 million ($6.7 million) in 2006, primarily due to a significant increase of sales volume which was attributable to (1) an increase in sales volume of our date seedlings as we strengthened our marketing efforts;


59


Table of Contents

(2) a change in our product mix; and (3) the grafting operations commenced in 2006 which contributed revenues of RMB3.0 million.
 
Cost of Revenues and Gross Profit.   Total cost of revenues increased by 8.4% from RMB191.4 million in 2005 to RMB207.4 million ($27.2 million) in 2006. The increase in our cost of revenues was due primarily to the increase in cost of revenues from our sheep breeding segment and, to a lesser extent, our seedling segment. Our gross profit increased by 46.5% from RMB192.7 million in 2005 to RMB282.3 million ($37.1 million) in 2006.
 
Cost of revenues from our corn seed segment decreased by 2.0% from RMB147.7 million in 2005 to RMB144.7 million ($19 million) in 2006, primarily due to the lower percentage of sales of third-party corn seeds that we distributed in 2006. Third party corn seeds generally have had higher cost of revenues than other corn seed products. Gross profit from this segment increased by 3.1% from RMB97.9 million in 2005 to RMB100.9 million ($13.3 million) in 2006 primarily due to the increased weight of sales of proprietary corn seeds which yielded higher profit margins than generic seeds, partly offset by the reduction in the selling prices of proprietary corn seeds.
 
Cost of revenues from our sheep breeding segment increased by 38.7% from RMB37.7 million in 2005 to RMB52.3 million ($6.9 million) in 2006, primarily due to the increase in cost of feeds and depreciation of purebred foreign sheep and buildings, as a result of the increase in sales volume of Primalights III hybrid sheep and frozen semen. Gross profit from this segment increased by 72.2% from RMB81.8 million in 2005 to RMB140.8 million ($18.5 million) in 2006 due to the significant increase in sales volume of frozen semen and Primalights III hybrid sheep.
 
Cost of revenues from our seedling segment increased by 76.3% from RMB5.9 million in 2005 to RMB10.4 million ($1.4 million) in 2006, primarily due to the increase in depreciation of trees and cost of nutritional and medical materials, as a result of the increase in sales volume of seedlings. Gross profit from this segment increased by 210.7% from RMB13.1 million in 2005 to RMB40.7 million ($5.3 million) in 2006 due to an increase in sales volume of Primalights #1 and Primalights #2 date seedlings and the commencement of our grafting operations.
 
Operating Expenses
 
Selling Expenses.   Our selling expenses increased by 23.6% from RMB11.3 million in 2005 to RMB14.0 million ($1.8 million) in 2006. This increase resulted primarily from an increase of RMB2.1 million in salaries and benefits for our sales personnel, which was primarily caused by an increase in the commissions that we paid due to an increase in our sales volume.
 
General and Administrative Expenses.   Our general and administrative expenses increased by 78.6% from RMB4.2 million in 2005 to RMB7.5 million ($1.0 million) in 2006. The increase resulted primarily from (1) an increase of RMB1.4 million in corporate expense which was in line with the expansion of business; (2) an increase of RMB0.8 million in salaries and benefits for our administrative, finance and human resources personnel; and (3) an increase of RMB0.6 million in travel expenses.
 
Research and Development Expenses.   Our research and development expenses increased by 26.0% from RMB3.0 million in 2005 to RMB3.7 million ($0.5 million) in 2006. The increase was primarily caused by (1) our increased spending on developing new products in cooperation with our research and development partners from RMB2.7 million in 2005 to RMB3.0 million ($0.4 million); and (2) an increase in the salaries and benefits of our research and development personnel from RMB0.3 million in 2005 to RMB0.7 million ($0.1 million).
 
Government Grants.   We received RMB0.2 million government grants in 2005, compared with RMB80,000 government grants received in 2006. The amount and timing of government grants were determined at the discretion of the relevant government authorities.
 
Operating Profit.   As a result of the foregoing factors, our operating profit from operations increased by 47.5% from RMB174.3 million in 2005 to RMB257.1 million ($33.8 million) in 2006.


60


Table of Contents

Net Income.   As a result of the foregoing factors, our net income increased by 50.2% from RMB169.1 million in 2005 to RMB253.9 million ($33.4 million) in 2006.
 
Year Ended December 31, 2005 Compared to Year Ended December 31, 2004
 
Revenues.   Our total revenues increased by 152.2% from RMB152.3 million in 2004 to RMB384.1 million in 2005, resulting primarily from the significant increase in revenues from our corn seed segment.
 
Revenues from our corn seed segment increased significantly by 405.8% from RMB48.6 million in 2004 to RMB245.6 million in 2005, primarily due to a significant increase of 22,178 tonnes in sales volume which primarily resulted from a significant increase in sales volume of our proprietary corn seeds from 1,152 tonnes in 2004 to 12,310 tonnes in 2005 and, to a lesser extent, an increase in sales volume of our non-proprietary corn seeds from 4,402 tonnes in 2004 to 15,422 tonnes in 2005. The increase in sales volume of our proprietary corn seeds was primarily due to (1) a significant increase in sales volume of Primalights III — 891; and (2) the addition of three newly-developed proprietary products, Primalights III — 591, Primalights III — 391 and Primalights III — 28, to our corn seed product offerings which contributed an aggregate of RMB26.5 million in revenues in 2005. To increase our production capacity, we expanded the farmland to which we had access for our corn seed production from approximately 5,000 acres in 2004 to approximately 13,000 acres in 2005.
 
Revenues from our sheep breeding segment increased by 28.6% from RMB92.9 million in 2004 to RMB119.5 million in 2005, primarily due to (1) an increase of RMB17.7 million in revenues from sales of Primalights III hybrid sheep due to a significant increase in sales volume of Primalights III hybrid sheep; (2) the addition of Small-tailed Han Sheep to our breeder sheep offerings in 2005; and (3) an increase of RMB14.9 million in revenues from frozen semen, due to an increase in sales volume of frozen semen as we continued to develop the Shanxi and Inner Mongolia markets. The increase in revenues from sheep breeding and frozen semen was partly offset by a decrease of RMB7.5 million in revenues from embryos.
 
Revenues from our seedling segment increased by 75.8% from RMB10.8 million in 2004 to RMB19.0 million in 2005, primarily due to a significant increase of sales volume.
 
Cost of Revenues and Gross Profit.   Our cost of revenues increased by 160.2% from RMB73.6 million in 2004 to RMB191.4 million in 2005. The increase in our cost of revenues was due primarily to the increase in cost of revenues from our corn seed segment. Our gross profit increased by 144.8% from RMB78.7 million in 2004 to RMB192.7 million in 2005.
 
Cost of revenues from our corn seed segment increased by 343.5% from RMB33.3 million in 2004 to RMB147.7 million in 2005, primarily due to an increase in the costs paid to the farmers for the seeds they grew for us, as a result of the increase in sales volume of our corn seeds, especially our proprietary corn seeds. Gross profit from this segment increased by 541.9% from RMB15.2 million in 2004 to RMB97.9 million in 2005 due to an increase in sales volume and an increased proportion of sales of proprietary corn seeds which yielded higher profit margins.
 
Cost of revenues from our sheep breeding segment increased by 20.9% from RMB31.2 million in 2004 to RMB37.7 million in 2005, primarily due to the increase in cost of feeds and depreciation of purebred foreign sheep, buildings and equipment, as a result of the increase in sales volume of breeder sheep, Primalights III hybrid sheep and frozen semen. Gross profit from this segment increased by 32.5% from RMB61.7 million in 2004 to RMB81.8 million in 2005 due to the significant increase in sales volume of frozen semen.
 
Cost of revenues from our seedling segment decreased by 34.5% from RMB9.1 million in 2004 to RMB5.9 million in 2005, primarily due to the fair value recognition of assets (including the inventory of seedlings) and liabilities of P3A as of December 31, 2003 as a result of our acquisition. This resulted in an increase in the value of inventory in the amount of RMB 2.3 million as of December 31, 2003. When such inventories were sold in 2004, the cost of revenues was increased accordingly. Gross profit from this segment increased by 640.7% from RMB1.8 million in 2004 to RMB13.1 million in 2005 due to the significant


61


Table of Contents

increase in sales volume of Primalights #1 and Primalights #2 date seedlings which yielded high profit margins and the commencement of our grafting operations.
 
Operating Expenses
 
Selling Expenses.   Our selling expenses increased by 132.8% from RMB4.9 million in 2004 to RMB11.3 million in 2005. This increase was due primarily to (1) an increase of RMB4.8 million in salaries and benefits for our sales personnel, which was primarily caused by an increase in the sales commissions that we paid due to an increase in our sales volumes; and (2) an increase of RMB1.1 million in our promotional expenses, as we continued to expand our promotional activities.
 
General and Administrative Expenses.   Our general and administrative expenses decreased by 30.2% from RMB6.0 million in 2004 to RMB4.2 million in 2005 primarily due to the one-time payment of RMB2.9 million to the former shareholders of P3A in 2004 in connection with our acquisition of P3A. The impact was partly offset by the increase of RMB1.2 million in bad debt provision.
 
Research and Development Expenses.   Our research and development expenses decreased by 58.7% from RMB7.2 million in 2004 to RMB3.0 million in 2005. The decrease was primarily because there were fewer research and development projects in 2005.
 
Government Grants.   We received RMB1.5 million government grants in 2004, compared with RMB0.2 million government grants received in 2005. The amount and timing of government grants were determined at the discretion of the relevant government authorities.
 
Operating Profit.   As a result of the foregoing factors, our operating profit from operations increased by 180.8% from RMB62.1 million in 2004 to RMB174.3 million in 2005.
 
Net Income.   As a result of the foregoing factors, our net income increased by 192.7% from RMB57.8 million in 2004 to RMB169.1 million in 2005.
 
Liquidity and Capital Resources
 
Our principal source of liquidity has been cash generated from operating activities and financing activities, consisting of bank borrowings and loans from related parties. As of June 30, 2007, we had RMB325.6 million ($42.8 million) in cash and cash equivalents. Our cash and cash equivalents consist of cash on hand and bank deposits, which are unrestricted as to withdrawal or use. Although we consolidate the results of P3A, we can only receive cash payments from P3A pursuant to our contractual arrangements with P3A and its shareholders. See “Related Party Transactions — Contractual Arrangements with P3A and Its Shareholders.”
 
Inventories and accounts receivable are the two principal components of our current assets. Our inventories were RMB58.0 million ($7.6 million) and RMB53.3 million ($7.0 million) as of December 31, 2006 and June 30, 2007, respectively. Our inventories decreased by RMB4.7 million ($0.6 million) from December 31, 2006 to the six months ended June 30, 2007 primarily due to a decrease of RMB15.6 million in our corn seeds inventories, as a result of the seasonality of the seed time and harvest time of our corn seeds. We primarily collect corn seeds from our contracted village collectives from September through February of the next year and sell the corn seeds to our customers prior to the spring seedtime from April to May. As a result, our corn seeds inventories generally reach seasonal peaks at the end of each year. The decrease was partly offset by (1) an increase of RMB8.8 million in our breeder sheep inventories primarily due to our relatively lower inventories in the winter season, and (2) an increase of RMB3.1 million in our seedling inventories as we maintained relatively lower seedling inventories in the winter season. Our accounts payable remained relatively stable from December 31, 2006 to June 30, 2007.
 
Our accounts receivable were RMB156.4 million ($20.5 million) and RMB167.0 million ($21.9 million) as of December 31, 2006 and June 30, 2007, respectively. Accounts receivable were a significant component of our current assets in the six months ended June 30, 2007. The increase in our accounts receivable was primarily due to (1) an increase in our sales of seedlings and sheep breeding products; (2) the shift in our


62


Table of Contents

payment terms for sales of seedlings and sheep breeding products. In 2006, when selling seedling and sheep breeding products, we generally required our customers to make variable upfront payments, which may be up to 100% of the purchase prices; starting from 2007, as a measure to maintain our market share and competitive advantages, we no longer require such upfront payments from our major customers and our long-term customers and (3) our provision of longer credit terms for our major customers and our long-term customers in order to attract more purchase orders and recurring business.
 
We incurred capital expenditures of RMB70.5 million ($9.3 million) and RMB32.3 million ($4.2 million) in 2006 and the six months ended June 30, 2007, respectively. Our capital expenditures were made primarily to purchase land use rights for our production base, fixed assets, other assets and technologies. Our capital expenditures are primarily funded by cash provided from operating activities. For the second half of 2007, we expect to incur capital expenditures of approximately RMB193.9 million ($25.5 million).
 
We have not encountered any difficulties in meeting our cash obligations to date. We believe that our current cash and cash equivalents, anticipated cash flow from operations, as well as the net proceeds we expect to receive from this offering will be sufficient to meet our anticipated cash needs for the foreseeable future. We may, however, require additional cash due to changing business conditions or other future developments, including any investments or acquisitions that we may pursue. If our existing cash is insufficient to meet our requirements, we may seek to sell additional equity securities, debt securities or borrow from lending institutions. We cannot assure you that financing will be available in the amounts we need or on terms acceptable to us, if at all. Any sale of additional equity securities, including convertible debt securities, would dilute our shareholders. The incurrence of debt would divert cash from working capital and capital expenditures to service debt obligations and could result in operating and financial covenants that restrict our operations and our ability to pay dividends to our shareholders. If we are unable to obtain additional equity or debt financing as required, our business operations and prospects may suffer.
 
The following table sets forth a summary of our cash flows for the periods indicated:
 
                                                         
    For the Year Ended December 31,     For the Six Months Ended June 30,  
    2004     2005     2006     2006     2007  
    RMB     RMB     RMB     $     RMB     RMB     $  
    (In thousands)  
 
Net cash provided by operating activities
    58,062       140,447       162,051       21,289       73,316       94,234       12,380  
Net cash used in investing activities
    (51,197 )     (99,130 )     (51,309 )     (6,741 )     (15,318 )     (27,134 )     (3,565 )
Net cash used in financing activities
    (1,160 )     (32,849 )     (97,437 )     (12,800 )     (39,095 )     215,680       28,335  
Net increase in cash and cash equivalents
    5,705       8,468       13,305       1,748       18,903       282,780       37,150  
Cash and cash equivalents at the beginning of the year
    15,304       21,009       29,477       3,872       29,477       42,782       5,620  
Cash and cash equivalents at the end of the year
    21,009       29,477       42,782       5,620       48,380       325,562       42,770  
 
Operating Activities
 
Net cash provided by operating activities in the six months ended June 30, 2007 was RMB94.2 million ($12.4 million), resulting primarily from (1) our net income of RMB143.4 million ($18.8 million); (2) an
add-back of non-cash expenses including depreciation of fixed assets and other assets of RMB4.8 million ($0.6 million) and amortization of intangible assets of RMB2.6 million ($0.3 million), respectively, and (3) an add-back of imputed interest on ultimate controlling shareholder’s loan of RMB1.0 million ($0.1 million). The foregoing effects were offset in part by (1) an increase in prepayments and other current assets of RMB54.1 million ($7.1 million) primarily due to the increase in advances to village collectives; (2) an increase in accounts receivable of RMB9.3 million ($1.2 million) due to an increase in our sales and the longer credit terms provided to selected customers in order to attract larger orders from them and (3) a


63


Table of Contents

decrease of RMB6.2 million ($0.8 million) in accounts payable due primarily to the decrease in our inventories purchases.
 
Net cash provided by operating activities in 2006 was RMB162.1 million ($21.3 million). Net cash provided by our operating activities in 2006 resulted primarily from (1) our net income of RMB253.9 million ($33.4 million), (2) an add-back of non-cash expenses including depreciation of fixed assets and other assets of RMB8.9 million ($1.2 million) and amortization of intangible assets of RMB4.5 million ($0.6 million), respectively, and (3) a decrease in our inventories of RMB24.7 million ($3.2 million) as a result of the increase in our sales of corn seeds and seedlings and the decrease in our inventory purchases from farmers in order to lower our storage costs. The foregoing effects were offset in part by (1) an increase in accounts receivable of RMB90.8 million ($11.9 million) due to a significant increase in our sales and the longer credit terms provided to selected customers in order to attract bigger orders from them, (2) a decrease of RMB29.2 million ($3.8 million) in accounts payable due primarily to the decrease in our inventory purchases from farmers, and (3) an increase in prepayments and other current assets of RMB14.5 million ($1.9 million) primarily due to the increase in advances to village collectives.
 
Net cash provided by operating activities in 2005 amounted to RMB140.4 million. Net cash provided by our operating activities in 2005 resulted primarily from (1) our net income of RMB169.1 million, (2) an add-back of non-cash expenses including depreciation of fixed assets and other assets of RMB8.1 million and amortization of intangible assets of RMB3.3 million, respectively, (3) an increase in accounts payable of RMB38.7 million due to the increase in our inventory purchases from farmers, and (4) an increase in accrued expenses and other expenses of RMB2.8 million due to the unpaid sales commission and directors’ bonus. The foregoing effects were offset by other factors including (1) an increase in accounts receivable of RMB50.7 million due to a significant increase in our sales and (2) an increase in inventory of RMB40.0 million.
 
Net cash provided by operating activities in 2004 was RMB58.1 million, resulting primarily from (1) our net income of RMB57.8 million, (2) an add-back of non-cash expenses including depreciation of fixed assets of RMB 5.1 million, and (3) an increase in accounts payable and accrued expenses and other liabilities of RMB9.2 million and RMB3.2 million, respectively. The foregoing effects were offset by other factors including (1) an increase in accounts receivable of RMB11.0 million, and (2) an increase in prepayments, deposits and other receivables of RMB11.8 million.
 
Investing Activities
 
Net cash used in investing activities in the six months ended June 30, 2007 was RMB27.1 million ($3.6 million), due primarily to the cash outflows for (1) purchases of fixed assets and other assets of RMB16.3 million ($2.1 million) and (2) acquisition of intangible assets such as land use rights and technology of RMB11.8 million ($1.5 million).
 
Net cash used in investing activities in 2006 was RMB51.3 million ($6.7 million), due primarily to the cash outflows from (1) purchases of fixed assets and other assets of RMB43.7 million ($5.7 million) and (2) acquisition of intangible assets such as land use rights and technology of RMB16.2 million ($2.1 million). These cash outflows were offset in part by our receipt of proceeds of RMB9.5 million ($1.2 million) from the disposal of fixed assets and other assets.
 
Net cash used in investing activities was RMB99.1 million in 2005, resulting primarily from cash outflows from (1) acquisition of intangible assets such as land use rights and technology of RMB61.8 million and (2) purchases of fixed assets and other assets of RMB37.4 million.
 
Net cash used in investing activities was RMB51.2 million in 2004, resulting primarily from purchases of fixed assets and other assets of RMB49.5 million.
 
Financing Activities
 
Net cash provided by our financing activities was RMB215.7 million ($28.3 million) in the six months ended June 30, 2007, resulting primarily from (1) a loan of RMB222.4 million ($29.2 million) from a


64


Table of Contents

shareholder in connection with the funding of the registered capital of Agria China, and (2) our proceeds from issuance of preference shares and ordinary share redemption rights of RMB76.2 million ($10 million). These cash inflows were partly offset by (1) our dividend payment to shareholders of RMB50.5 million ($6.6 million) and (2) repayment of short-term borrowings of RMB36.9 million ($4.8 million).
 
Net cash used in our financing activities was RMB97.4 million ($12.8 million) in 2006, resulting primarily from (1) our dividend payment to shareholders of RMB110.4 million ($14.5 million) and (2) repayment of bank loans and loans from record shareholders of P3A of RMB22.3 million ($2.9 million) and RMB10.0 million ($1.3 million) respectively. These cash outflows were partly offset by new bank loans of RMB45.3 million ($6.0 million).
 
Net cash used in our financing activities amounted to RMB32.8 million in 2005. Net cash used in financing activities in 2005 resulted primarily from (1) our dividend payment to shareholders of RMB24.3 million, and (2) repayment of bank loans and loans from record shareholders of P3A of RMB24.3 million and RMB10.8 million respectively. These cash outflows were partly offset by new bank loans of RMB26.5 million.
 
Net cash used in our financing activities was RMB1.2 million in 2004, resulting primarily from repayment of bank loans and loans from record shareholders of P3A of RMB11.0 million and RMB9.6 million respectively, partly offset by new bank loans of RMB19.4 million.
 
Contractual Obligations and Commercial Commitments
 
The following table sets forth our contractual obligations and commercial commitments as of December 31, 2006:
 
                                                 
          Payment Due by December 31,  
    Total     2007     2008     2009     2010     Thereafter  
    (in RMB thousands)  
 
Short-term borrowings(1)
    39,311       39,311                          
Operating lease obligations(2)
    40,591       4,217       4,231       2,891       499       28,753  
Purchase obligations(3)
    338,482       32,138       30,974       30,974       30,974       213,422  
Other long-term liabilities reflected on the balance sheet
    8,996             204       204       204       8,384  
                                                 
Total
    427,380       75,666       35,409       34,069       31,677       250,559  
                                                 
 
The following table sets forth our contractual obligations and commercial commitments as of June 30, 2007:
 
                                                 
          Payment Due  
          Six
       
          months
       
          ending
       
          December 31,     Year ending December 31,  
    Total     2007     2008     2009     2010     Thereafter  
    (in RMB thousands)  
 
Short-term borrowings(1)
    8,881       8,881                          
Operating lease obligations(2)
    157,698       35,057       46,435       45,095       1,366       29,745  
Purchase obligations(3)
    446,738       20,854       41,708       41,708       41,708       300,760  
Other long-term liabilities reflected on the balance sheet
    8,996             204       204       204       8,384  
                                                 
Total
    622,313       64,792       88,347       87,007       43,278       338,889  
                                                 
 
 
(1) Includes short term borrowings, current portion of long-term debt and future interest obligations.
 
(2) Includes lease obligations for our office premises and buildings under non-cancelable leases.


65


Table of Contents

 
(3) Represents commitments for the purchase of corn seeds, property, plant and equipment and acquired intangible assets and payments for research and development services. These commitments are not recorded on our balance sheet as of December 31, 2006 or June 30, 2007, as we have not received related goods or services or taken title to the properties.
 
Other than the obligations set forth above, we did not have any long-term debt obligations, operating lease obligations, purchase obligations or other long-term liabilities as of December 31, 2006 and June 30, 2007.
 
Indebtedness
 
As of December 31, 2005 and 2006, we had RMB15.4 million and RMB38.4 million ($5.0 million), respectively, in outstanding borrowings. As of December 31, 2005 and 2006, RMB12.9 million and RMB36.9 million ($4.8 million), respectively, of our outstanding borrowings obtained from financial institutions were due within one year (excluding current portion of long-term borrowings). Our short-term borrowings outstanding as of December 31, 2005 and 2006 bore an average annual interest rate of 9.49% and 7.054%, respectively. As of December 31, 2006, RMB8.4 million ($1.1 million) of our short-term borrowings were guaranteed by Taiyuan Relord Enterprise Development Group Co., Ltd., or Taiyuan Relord, a related party of P3A RMB4.5 million ($0.6 million) of our short-term borrowings were jointly guaranteed by Taiyuan Relord and Taiyuan Haoyu Material Co., Ltd., and RMB24.0 million ($3.2 million) of our short-term borrowings were secured by the date trees owned by P3A, our consolidated affiliated entity.
 
As of December 31, 2005 and 2006, we had RMB2.5 million and RMB1.5 million ($0.2 million), respectively, in long-term bank borrowings (including current portion of such borrowings). These borrowings were obtained from financial institutions. As of December 31, 2006, our outstanding long-term bank borrowings bore a fixed interest rate of 5.76% and were guaranteed by Taiyuan Chuangxin Credit Guarantee Company, an independent guarantee company. We paid certain fees to it for providing the guarantee.
 
As of June 30, 2007, we had RMB8.4 million ($1.1 million) in outstanding borrowing. Our outstanding borrowing was obtained from a financial institution and is due within one year after the date of borrowing. The borrowing, which is guaranteed by Taiyuan Relord, bears an annual interest rate of 11.448%.
 
As of December 31, 2006 and June 30, 2007, the amount due to our controlling shareholder, Brothers Capital Limited, was RMB30.0 million ($3.9 million) and RMB255.7 million ($33.6 million), respectively.
 
Off-balance Sheet Commitments and Arrangements
 
We have guaranteed a short-term bank loan in the amount of RMB1.5 million extended to Taiyuan Relord on June 30, 2007. We did not receive any fee for providing the guarantee. The bank loan is repayable on December 27, 2007 and the guarantee will be released when the bank loan is repaid.
 
We have guaranteed a short-term bank loan in an amount of RMB1.5 million extended to Taiyuan Relord on December 31, 2006 and a short-term bank loan in amount of RMB2.0 million extended to Taiyuan Baojia on December 31, 2006. These bank loans were repaid and the guarantees were released subsequent to December 31, 2006. Such off-balance sheet arrangements were not material to our liquidity, capital resources, market risk support, credit risk support or other benefits. We did not have any revenues, expenses or cash flows arising from providing such guarantees, and the termination of such arrangements did not have any material effect on us. The maximum amount of undiscounted payments we would have had to make in the event of default by the borrowers was RMB3.5 million as of December 31, 2006. In accordance with FIN 45 “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others,” a guarantor must recognize a liability for the fair value of the obligations it assumes under certain guarantees. We have determined the fair value of the guarantees in each of the periods to be insignificant. Accordingly, we have not recorded any liabilities for these guarantees as of December 31, 2006 and June 30, 2007.
 
We have not entered into any derivative contracts that are indexed to our own shares and classified as shareholder’s equity, or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit,


66


Table of Contents

liquidity or market risk support to such entity. Moreover, we do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.
 
Concentration of Risks
 
Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. As of December 31, 2006 and June 30, 2007, substantially all of the Company’s cash and cash equivalents were managed by several financial institutions. Accounts receivable are typically unsecured and are derived from revenue earned from customers in China. The risk with respect to accounts receivables is mitigated by credit evaluations the Company performs on its customers and ongoing monitoring process on outstanding balances.
 
Current vulnerability due to certain other concentrations
 
The Company’s operations may be adversely affected by significant political, economic and social uncertainties in the PRC. Although the PRC government has been pursuing economic reform policies for more than 20 years, no assurance can be given that the PRC government will continue to pursue such policies or that such policies may not be significantly altered, especially in the event of a change in leadership, social or political disruption or unforeseen circumstances affecting the PRC’s political, economic and social conditions. There is also no guarantee that the PRC government’s pursuit of economic reforms will be consistent or effective.
 
Substantially all of the Company’s businesses are transacted in RMB, which is not freely convertible into foreign currencies. On January 1, 1994, the PRC government abolished the dual rate system and introduced a single rate of exchange as quoted daily by the People’s Bank of China. However, the unification of the exchange rates does not imply the convertibility of RMB into United States dollars or other foreign currencies. All foreign exchange transactions continue to take place either through the People’s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People’s Bank of China. Approval of foreign currency payments by the People’s Bank of China or other institutions requires submitting a payment application form together with suppliers’ invoices, shipping documents and signed contracts.
 
Critical Accounting Policies
 
We prepare financial statements in accordance with U.S. GAAP, which requires us to make judgments, estimates and assumptions that affect (i) the reported amounts of our assets and liabilities, (ii) the disclosure of our contingent assets and liabilities at the end of each fiscal period and (iii) the reported amounts of revenues and expenses during each fiscal period. We continually evaluate these judgments and estimates based on our own historical experience, knowledge and assessment of current business and other conditions, our expectations regarding the future based on available information and assumptions that we believe to be reasonable, which together form our basis for making judgments about matters that are not readily apparent from other sources. Since the use of estimates is an integral component of the financial reporting process, our actual results could differ from those estimates. Significant estimates reflected in the Company’s financial statements include, but are not limited to, allowance for doubtful accounts, useful lives of fixed assets, intangible assets, and imputed interest on related party loan. Some of our accounting policies require a higher degree of judgment than others in their application.
 
The selection of critical accounting policies, the judgments and other uncertainties affecting application of those policies and the sensitivity of reported results to changes in conditions and assumptions are factors that should be considered when reviewing our financial statements. We believe the following accounting policy involves the most significant judgments and estimates used in the preparation of our financial statements.


67


Table of Contents

Principles of Consolidation
 
The consolidated financial statements include the financial statements of the Company, its subsidiaries and a variable interest entity, or VIE, for which the Company is the primary beneficiary. All significant inter-company transactions and balances between the Company, its subsidiaries and its VIE are eliminated upon consolidation.
 
FIN46-R defines and identifies VIE if it has (1) equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support from other parties, (2) equity investors that cannot make significant decisions about the entity’s operations, or that do not absorb the expected losses or receive the expected returns of the entity or (3) equity investors that have voting rights that are not proportionate to their economic interests and substantially all the activities of the entity involved, or are conducted on behalf of, an investor with a disproportionately small voting interest. A VIE is consolidated by its primary beneficiary, which is the party involved with the VIE that has a majority of the expected losses or a majority of the expected residual returns or both. Through the various contractual arrangements with P3A (the Company’s VIE) and its shareholders, Agria China has the ability to (i) exercise effective control over P3A through its ability to exercise all the rights of P3A’s shareholders, including voting and transfer rights; (ii) receive substantially all of P3A’s earnings and other economic benefits to the extent permissible under PRC law; the management of Agria China intends to do so; and (iii) exercise an exclusive option to purchase all or part of the equity interests in P3A held by the shareholders, to the extent permitted under PRC law. Agria China has the ability to cause P3A to change the terms of the various service arrangements at any time such that it can receive substantially all of P3A’s earnings and other economic benefits. Also, Agria China has the right to receive from P3A’s shareholders any dividends or distributions that they receive. See “Corporate History and Structure.” Based on the above, we have determined that we are the primary beneficiary of P3A and have consolidated its financial results.
 
Accounts Receivable
 
An allowance for doubtful accounts is recorded in the period in which a loss is determined not to be probable based on an assessment of specific evidence indicating troubled collection, historical experience, account balance aging and prevailing economic conditions. An accounts receivable is written off after all collection efforts have ceased. Our ability to make an accurate assessment of our allowance for doubtful accounts is impacted by various factors such as rapid changes in the business environment that will affect our customers’ ability to pay us and the need to exercise judgment in assessing conditions that may indicate troubled collection.
 
Property, Plant and Equipment, Intangible Assets and Other Assets (“Long-lived Assets”)
 
In addition to the original cost of long-lived assets, the recorded value of these assets is impacted by a number of policy elections, including estimated useful lives, residual values and impairment charges. Statement of Financial Accounting Standards No. 142 provides that intangible assets that have finite lives will be amortized over their estimated useful lives. Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long-lived Assets” requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable from its undiscounted future cash flow. In estimating the useful lives and impairment events relating to our long-lived assets, we considered factors such as the intended use of such assets, technological advancements in similar long-lived assets and market conditions that could affect our ability to recover the carrying value of our long-lived assets. If different judgments or estimates had been utilized, material differences could have resulted in the amount and timing of the impairment charge.
 
Revenue Recognition
 
The Group’s primary business activity is to produce and sell corn seeds, sheep breeding products and seedlings. The Company records revenue when the criteria of Staff Accounting Bulletin No. 104 “Revenue


68


Table of Contents

Recognition” are met. These criteria include all of the following: persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectibility is reasonably assured.
 
More specifically, the Group’s sales arrangements are evidenced by individual sales agreements for each transaction. The customer takes title and assumes the risks and rewards of ownership of the products upon delivery of products which generally occurs at shipping point. Other than warranty obligations, the Company does not have any substantive performance obligations to deliver additional products or services to the customers. The product sales price stated in the sales contract is final and not subject to adjustment. The Company generally does not accept sales returns and does not provide customers with price protection. The Company assesses a customer’s creditworthiness before accepting sales orders. Based on the above, the Company records revenue related to product sales upon delivery of the product to the customers.
 
For certain sales transactions involving seedlings, the customer will pay an additional fee if the seedlings meet specified growth criteria pursuant to the terms of the contract. These growth criteria represent contingent performance conditions. Accordingly, provided all other revenue recognition criteria are met, the contingent fee is recognized as revenue only when the growth criteria are met, which generally takes place within one month of delivery of the seedlings.
 
Contingencies
 
Our consolidated affiliated entity, P3A, has been exempted from enterprise income tax since 2002 based on the approval received from the local tax authority in Shanxi. P3A expects to continue to enjoy this income tax exemption until its exemption status is modified or repealed by the relevant tax authority based on our legal counsel’s assessment of the existing PRC tax law.
 
Recent Accounting Pronouncements
 
In June 2006, the Financial Accounting Standards Board (“FASB”) issued Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FAS 109, Accounting for Income Taxes” (“FIN 48”), to create a single model to address accounting for uncertainty in tax positions. FIN 48 clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. FIN 48 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006. The Company will adopt FIN 48 as of January 1, 2007, as required. The cumulative effect of adopting FIN 48 will be recorded in retained earnings (or other appropriate components of equity or net assets in the statement of financial position as applicable) in the year of adoption. The Company is currently assessing the impact, if any, that FIN 48 will have on its financial statements.
 
In September 2006, the FASB issued SFAS No. 157 “Fair Value Measurements.” SFAS No. 157 establishes a framework for measuring fair value in generally accepted accounting principles, clarifies the definition of fair value within that framework, and expands disclosures about the use of fair value measurements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. The Company is currently assessing the impact, if any, that SFAS No. 157 will have on its financial statements.
 
In February 2007, the FASB issued FASB Statement No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — Including an amendment of FASB Statement No. 115”, (“SFAS 159”). This Statement permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. SFAS 159 is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. The Company is currently assessing the impact of this new standard on its financial statements.


69


Table of Contents

 
INDUSTRY BACKGROUND
 
China’s Agricultural Industry
 
China’s economy has grown rapidly in recent years. According to the National Bureau of Statistics of China, China’s gross domestic product in 2006 was RMB20.9 trillion ($2.7 trillion), which represented growth at a CAGR of 13.8% from 2001 to 2006, making China one of the fastest growing economies in the world. China’s agricultural industry has also grown significantly, driven by the growth of the overall economy. According to the China Statistical Abstract, in 2006, China’s agricultural output totaled RMB2,155 billion ($283.1 billion), accounting for 10.3% of gross domestic product and representing growth at a CAGR of 8.3% from 2001 to 2006. The increase in China’s agricultural production is the result of an increase in the consumption of food products such as crops and meat proteins for human and animal nutrition, as well as food products for industrial uses, such as fuels and materials. However, while domestic production has grown, it has not kept pace with consumption, resulting in imports of many agricultural products such as corn seed and sheep.
 
Despite its recent rapid growth, the agricultural industry in China remains at an early stage of modernization, with significant manual labor and less usage of advanced machinery and irrigation than that of developed economies. In an effort to modernize and promote development of the agricultural industry in China, the Chinese government has provided substantial financial support to agricultural and related businesses through low interest loans, preferential tax treatments, financial subsidies and other measures. In the meantime, Chinese farmers are increasingly using improved production techniques and products, including hybrid seeds and sheep breeding products.
 
Corn Industry
 
China is the world’s second largest corn producer after the United States. In 2005, it produced approximately 131 million tonnes of corn, or 19% of total global production. Coincident with the growth of its economy and the agricultural industry, corn production in China has grown at a CAGR of 4.3% from 2000 to 2005, more than twice than the growth rate of the United States.
 
Top Five Corn Production Countries (2005)
 
                                         
                Production Volume
  Corn Consumption
Ranking
 
Countries
  Annual Production Volume   Annual Yield   CAGR (from 2000 to 2005)   per Capita (2005)
        (Million tonnes)   (Kg/hectare)       (g/capita/day)
 
  1     USA     280.2       9,316       2.0 %     158  
  2     China     131.1       5,001       4.3 %     29  
  3     Brazil     34.9       3,040       1.7 %     78  
  4     Mexico     20.5       2,563       1.8 %     326  
  5     Argentina     19.5       7,117       4.0 %     36  
 
 
Source:  China Agriculture Yearbook 2006, FAOSTAT
 
Corn is used primarily as animal feed, particularly for chickens and pigs, as well as food for human consumption. According to the China National Grain and Oil Information Center, in 2005 and 2006, 71.2% of China’s total corn production was used to produce animal feed, 20.4% was used for industrial purposes to produce corn starch, alcohol and ethanol, and approximately 5.3% was used as food for human consumption.


70


Table of Contents

The increasing demand for corn in China has been partially driven by the increasing demand for animal feed, which in turn has been driven by the significant growth in meat consumption as a result of the recent rapid growth in per capita disposable income in China. The following chart shows the growth in per capita annual household income and meat consumption in China from 2000 to 2005.
 
Per Capita Household Income and Meat Consumption in China
 
(PERFORMANCE GRAPH)
 
                                                 
Year
  2000   2001   2002   2003   2004   2005
Total Meat Consumption (million tonnes)
    60.4       63.5       67.9       71.3       75.5       78.8  
Meat Consumption per Capita (kg)
    47.7       49.8       52.9       55.2       58.1       60.3  
 
 
Source : FAOSTAT, China National Bureau of Statistics
 
In addition to increased demand for use in animal feed, China has experienced a rapid increase in demand for corn for industrial uses, such as the production of starch, alcohol (including fuel ethanol), gourmet powder, crystal-glucose and lysine. According to the China National Grain & Oil Information Centre, during the period from the year ended October 31, 2001 to the year ended October 31, 2006, the industrial consumption of corn in China grew at a CAGR of 17.1%, the fastest among all categories of corn use during the same period. China used 27.0 million tonnes of corn for industrial use in the year ended October 31, 2006, which accounted for 19.6% of total corn consumption, as compared to 9.1% in the year ended October 31, 2001.
 
For more than two decades, China was one of the world’s largest net corn exporting countries. However, due to the rapid increase in domestic demand for corn in China, China now exports significantly less corn than it used to and its imports of corn have increased considerably. In 2006, China imported 65,125 tonnes of corn, 15.7 times the amount in 2005. While corn exports were still more than three million tonnes in 2006, they were 81% lower than in 2003.
 
Corn Exports and Imports in China
 
                                                         
Year
  2000     2001     2002     2003     2004     2005     2006  
 
Corn Export (million tonnes)
    10.5       6.0       11.7       16.4       2.3       8.6       3.1  
Corn Import (thousand tonnes)
    0.3       36.0       6.3       0.1       2.3       3.9       65.1  
 
 
Source:  China Customs


71


Table of Contents

 
Despite a relatively small increase in the acreage of land used for corn production, corn production in China has increased at a faster rate than corn planting area during the period from 2000 to 2005.
 
Corn Production in China
 
                                                         
                                        CAGR
 
Year
  2000     2001     2002     2003     2004     2005     (2000-2005)  
 
Production Volume (million tonnes)
    106.0       114.1       121.3       115.8       130.3       131.1       4.3 %
Planting Area (million hectares)
    23.1       24.3       24.6       24.1       25.4       26.4       2.7 %
 
 
Source:  China Agriculture Yearbook 2006
 
We believe production of, and demand for, corn are likely to continue to rise as China’s economy further develops, driven by increasing demand across all major uses of corn. Given limitations on land available for corn production, we believe use of hybrid corn seeds that can produce corn with characteristics such as high-yielding, drought or pest resistance, or high oil content is also likely to continue to increase. As competition for suitable land in China for other crops continues while demand for corn increases, Chinese farmers may be inclined to utilize better production methods to increase yields and improve the quality and attributes of their corn products. According to the China Agriculture Yearbook 2006, in 2005, average corn production per hectare in China was 5,001 kg compared to an average of 9,316 kg per hectare in the United States. Increasing use of high quality corn seeds specifically developed for local conditions may improve corn yields in China. According to FAOSTAT, in 2005, China’s corn consumption per capita per day was 29 grams, which was substantially lower than that of other major corn production countries, such as the U.S., Brazil and Mexico, whose corn consumption per capita per day was 158 grams, 78 grams and 326 grams, respectively. We believe the relatively lower corn consumption per capita in China, coupled with the rapid increase in domestic demand for corn, demonstrates significant potential for China’s corn market to further grow.
 
Corn prices in China have generally fluctuated to follow the global trend. For instance, the average corn price in China increased by 42.3% from RMB0.96 ($0.13) per kilogram in 2000 to RMB1.36 ($0.18) per kilogram in 2006, while the average corn price on the Chicago Board of Trade, or CBT, increased by 28.4% from $1.87 per bushel in 2000 to $2.41 per bushel in 2006. The following charts set forth daily corn prices in China and on CBT for the periods indicated.
 
     
Price in China
  CBT Price
     
(CHART)
  (CHART)
Source: China Animal Husbandry Statistics
  Source: CBT - No. 2 Yellow Corn SPOT Price


72


Table of Contents

Sheep and Goat Husbandry Industry
 
According to FAOSTAT, in 2005, China had approximately 171 million sheep and 196 million goats, the largest flocks of their kind, and China consumed more mutton and wool than any other country. The following charts set forth the sheep and goat flocks of top 10 countries in 2005.
 
 
     
Sheep Flock of Top 10 Countries (2005)
  Goat Flock of Top 10 Countries (2005)
(sheep in millions)
  (goats in millions)
     
(CHART)
  (CHART)
Source:  FAOSTAT
  Source:  FAOSTAT
 
The rising affluence in China has led to increased meat consumption and production, including consumption of mutton. According to FAOSTAT, mutton production in China increased at a CAGR of 9.7% from 2.74 million tonnes in 2000 to 4.36 million tonnes in 2005, mutton consumption as a percentage of total meat consumption in China increased from 4.2% in 2000 to 6.4% in 2005, and domestic mutton price in China increased from RMB9,627.0 ($1,264.7) per ton in 1995 to RMB19,590.5 ($2,573.6) per ton in 2005. The following charts set forth the mutton and wool consumption data of selected countries.
 
Top Mutton Consumption Countries (2005)
 
         
    Total Mutton
 
Country
  Consumption  
    (’000 tonnes)  
 
China
    5,074  
India
    696  
Pakistan
    545  
Iran
    525  
Sudan
    384  
UK
    355  
Turkey
    306  
Australia
    293  
Nigeria
    249  
Spain
    238  
 
 
Source: FAOSTAT
 
Top Wool Consumption Countries (2006)*
 
         
    Total Wool
 
Country/Region
  Consumption  
    (’000 tonnes)  
 
China
    425  
EU25
    260  
Former Soviet Union Countries
    85  
Japan
    18  
USA
    14  
Others
    447  
         
World Total
    1,249  
 
 
Source: International Wool Trade Organization; Economist Intelligence Unit
 
* Year ended June 30, 2006
 
China’s flocks are concentrated in Inner Mongolia, Henan, Shandong and Xinjiang. The average flock size per sheep farm is far smaller than in other major sheep producing countries such as Australia or New Zealand. Due to the relatively small flock size in China, it is not economically viable for each sheep farm to own breeder sheep/goats. As a result, Chinese farmers do not typically own their own breeder sheep/goats and, instead, tend to use artificial insemination and other cost-effective breeding techniques.


73


Table of Contents

Compared to the sheep/goat flocks of developed countries, China’s flocks on average produce lower quality and quantity of wool and meat. According to FAOSTAT, in 2005, the average meat produced per sheep in China was approximately 15 kg compared to an average of 20.0 kg in Australia and 20.0 kg in the United Kingdom. China has been improving the quality of its sheep/goat flocks, which has created significant demand for breeder sheep/breeder goats and related cost-effective breeding products as well as relevant scientific research. This demand creates opportunities for companies that are engaged in research and commercialization of breeding products, such as frozen sheep semen, embryos, breeder sheep and goats. Breeder sheep and goats are used in rapid reproduction or artificial reproduction methods to spread desired genes widely in a flock. According to China Customs, 12,958 breeder sheep and 10,475 breeder goats were imported into China from 2000 to 2005. We believe domestically-developed breeder sheep with high reproductive capability, good local adaptability and reasonable prices and related sheep breeding products will be in high demand in China.
 
Seedling Industry
 
The rapid urbanization, rising affluence and deteriorating environmental condition in China have increased the need for urban tree planting. Urbanization causes rapid growth of city spaces, creating the need for urban greening. Many local governments in China responded by planting trees in public places. According to the 2001 and 2006 National Greenery Status Reports of China, as of March 2006, national urban green coverage rate was 32.54% (compared to 28.15% in 2001), green land rate was 28.51% (compared to 23.67% in 2001) and public green land per capita was 7.89 square meters, which represented an increase of 15.5% over that of 2001. In addition, property developers are also responding to consumer demand for more green space within their property developments. The China Forestry Bureau forbids the transplanting of natural forest, and therefore, new trees to be planted in China must be cultivated from seedlings.
 
Similarly, due to the deteriorating environmental condition in many areas in China, the Chinese government is introducing and providing support to a number of tree planting programs in rural areas. One of the programs is the “Reducing Farmland and Developing Forest” program. According to the National Greenery Status Report of China, this tree planting program covered approximately 9.33 million acres of land in 2005.
 
In December 1981, the State Council of China promulgated the Guidelines relating to the Voluntary Planting Campaign, which encourages PRC citizens to participate in a national planting program. According to the 2006 Report on National Green Land released by the Office of the National Planting Committee, 2.16 billion trees were planted in 2006 in China.
 
The demand for fruit berries for human consumption is increasing due to the increased disposable income of Chinese consumers and the increasing recognition of the nutritional benefits of fruit berries. With its diverse geography and relatively low labor costs, China is well suited for the production of such plants as many fruit trees can grow on land that is not suitable for other crops and fruit berry production is labor intensive.


74


Table of Contents

 
BUSINESS
 
Overview
 
We are a fast-growing China-based agri-solutions provider engaged in the research and development, production and sale of upstream agricultural products. We currently offer corn seeds, sheep breeding products and seedling products. Our goal is to become a leading provider of a variety of agricultural upstream products to meet evolving demands of other participants in the agricultural industry, including producers of corn, sheep and other agricultural products that are used to manufacture consumer products, such as animal feed, mutton and wool. We have experienced substantial growth in revenues and profitability in recent years. Our total revenues increased from RMB152.3 million in 2004 to RMB489.7 million ($64.3 million) in 2006, representing a CAGR, of 79.3%, and our net income increased from RMB57.8 million in 2004 to RMB253.9 million ($33.4 million) in 2006, representing a CAGR of 109.6%. In the six months ended June 30, 2007, we generated total revenues of RMB279.4 million ($36.7 million) and net income of RMB143.4 million ($18.8 million). In 2006, we achieved gross margins of 41.1% , 72.9%, 79.7% from our corn seed, sheep breeding and seedling segments, respectively, while revenues from our corn seeds, sheep breeding and seedling segments accounted for 50.2%, 39.4% and 10.4%, respectively, of our total revenues. In the six months ended June 30, 2007, revenues from our corn seeds, sheep breeding and seedling segments accounted for 47.9%, 39.6% and 12.5%, respectively, of our total revenues.
 
We have access to approximately 27,000 acres of farmland in seven provinces, of which approximately 23,000 acres are used for production of our corn seeds, approximately 3,700 acres are used for our sheep farming and breeding activities and the remainder are used for our seedling production and research and development activities. The farmland to which we had access increased from approximately 5,000 acres as of December 31, 2004 to approximately 27,000 acres as of June 30, 2007. We own approximately 17,000 sheep consisting of nine types of purebred breeder sheep and our self-developed Primalights III hybrid sheep. In addition to our Primalights III hybrid sheep, we sell sheep breeding products which include frozen sheep semen, sheep embryos and breeder sheep. In 2006, we sold approximately 31,100 tonnes of corn seeds, 20.5 million straws of frozen sheep semen, 8,250 sheep embryos, 4,620 breeder sheep, 26,100 Primalights III hybrid sheep and a total of 21.6 million seedlings. In the six months ended June 30, 2007, we sold approximately 14,400 tonnes of corn seeds, 10.6 million straws of frozen sheep semen, 4,980 sheep embryos, 1,760 breeder sheep, 14,400 Primalights III hybrid sheep and a total of 11.6 million seedlings.
 
We grow corn seed products in seven provinces in China through contractual arrangements with village collectives and seed production companies under which we provide farming, harvesting and other technical guidance and supervision to farmers. We process and package corn seed products and then sell them to local and regional distributors. We produce sheep breeding products in five breeding bases located in Shanxi province and sell these products primarily to government-operated breed improvement and reproductive stations, or BIRs, breeding companies and other sheep reproduction stations and farms. Our corn seed and sheep breeding products are ultimately sold to and used by farmers in 14 provinces in China. We produce blackberry, raspberry and date seedlings and sell them directly to end users, such as municipal agencies and seedling companies. We also produce white bark pine seedlings for urban greenery. Our business is seasonal in nature. The vast majority of our corn seeds sales take place between October and May, the sales of most of our sheep breeding products occurs mainly in the spring season from March to June and the fall season from August to November and the majority of our seedling products are sold mainly in the spring season from March to June and in the fall season from September to October.
 
We sell both proprietary and non-proprietary agricultural products. Our proprietary products are sold under our Primalights III brand, which we believe is a well-recognized brand among our customers and end users. We own four proprietary strains of Primalights III corn seeds with different characteristics, such as high yield, disease resistance, drought resistance, high starch, and stress tolerance, to fit various climate zones in China. Sales of our proprietary corn seeds collectively accounted for approximately 55.8% of our total corn seed revenues in 2006. We have developed Primalights III hybrid sheep to meet the needs of our target markets in China. Primalights III hybrid sheep are a cross between certain high-fleshing foreign breeds and an adaptable and prevalent Chinese breed. Our research and development team works both independently and


75


Table of Contents

with agricultural, animal husbandry and forestry research and academic institutions in China to improve our existing products and to develop new ones. We will continue to engage in research and development across all three business segments to optimize our growing and production processes and to develop high-quality and commercially viable products.
 
We conduct substantially all of our operations in China through our contractual arrangements with P3A which is our consolidated affiliated entity, and through Agria China which is our wholly-owned subsidiary in China. We commenced operations in January 2004 by acquiring the business of P3A, a limited liability company incorporated under the laws of the PRC in 2000. We established a holding company, Aero-Biotech, under the laws of the British Virgin Islands in July 2005 to facilitate our future international fundraising activities. We formed Agria China as a wholly-owned subsidiary under the laws of the PRC in March 2007 to focus on research and development and other corporate activities. In preparation for this offering, we incorporated Agria Corporation under the laws of the Cayman Islands in May 2007 as our proposed listing vehicle. Agria Corporation became the holding company of Aero-Biotech in June 2007 when all of the shareholders of Aero-Biotech exchanged their shares in Aero-Biotech for shares of Agria Corporation on a pro rata basis.
 
Competitive Strengths
 
We believe that the following strengths have contributed to our current market position:
 
Fast-Growing China-based Agri-Solutions Provider.   We are a fast growing China-based agri-solutions provider engaged in the research and development, production and sale of upstream agricultural products in China. Since 2004, we have expanded the production capacity in the corn seed segment by obtaining access to additional farmland across major geographic regions in China. We currently have access to approximately 27,000 acres of farmland in seven provinces for corn seed production, compared to 5,000 acres in 2004. We have expanded the production capacity of the sheep breeding segment by increasing the size of our sheep flocks. We currently own approximately 7,000 breeder sheep/goats and approximately 9,700 Primalights III hybrid sheep, compared to approximately 7,700 breeder sheep and approximately 3,800 Primalights III hybrid sheep in 2004. As a result, we have experienced substantial growth since 2004. Our total revenues increased from RMB152.3 million in 2004 to RMB489.7 million ($64.3 million) in 2006, representing a CAGR of 79.3%, and our net income increased from RMB57.8 million in 2004 to RMB253.9 million ($33.4 million) in 2006, representing a CAGR of 109.6%. In the six months ended June 30, 2007, we generated total revenues of RMB279.4 million ($36.7 million) and net income of RMB143.4 million ($18.8 million). During the period from September 20, 2007 to October 11, 2007, we secured customer contracts to sell a total of approximately 13,956 tonnes of our proprietary corn seeds and approximately 16,246 tonnes of our non-proprietary corn seeds.
 
A Diversified Portfolio of Commercially Successful Products.   We have a diversified portfolio of commercially successful products covering three upstream agribusiness segments, namely, corn seed, sheep breeding and seedlings products. Within each of our three agribusiness segments, we produce a diverse array of products:
 
  •  We produce four types of proprietary corn seed products with one or more of the following special characteristics: high yield, disease resistance; drought resistance; high starch content; and stress tolerance. We are developing more varieties of corn seeds with these characteristics, as well as seeds for corn with a high oil content and pest resistance corn.
 
  •  We produce sheep breeding products from various well-recognized foreign pure breeds including Poll Dorset, Suffolk, Texel, Merino and Dorper, as well as domestic pure breed sheep. Our sheep breeding business consists primarily of the production and sale of frozen semen, embryos, purebred breeder sheep and our Primalights hybrid III sheep.
 
  •  We produce a selected variety of seedlings including raspberry, blackberry, date and white bark pine, using advanced techniques such as tissue culture technologies for date, raspberry and blackberry seedlings, nutritional technologies for pine, and branch grafting for date seedlings.


76


Table of Contents

 
We believe our diverse portfolio of products provides us with a number of advantages, including the following:
 
  •  We have multiple growth areas within each of our three agribusiness segments.
 
  •  The diversity of our products may mitigate risks arising from one particular segment of our agribusiness.
 
  •  We share management, marketing and research and development resources across our product lines, including working with academic and research institutions that engage in research across different agricultural product lines.
 
Strategic Locations and Extensive Local Knowledge and Experience.   Our core production base is strategically located in Shanxi province in the northern region of China, which is one of the largest corn seed production areas in China and is highly suited to growing corn seeds, breeding sheep and growing seedling products due to its geographical and climate conditions. In addition, we have a winter production base for parent corn seed development in Hainan province, China’s most southerly province. This base enables us to harvest an additional generation of seeds within each twelve-month period. We have a deep understanding of the needs and preferences of the local markets where our products are sold (in particular the Shanxi market) as a result of our established presence in these markets. Our understanding of these local markets is enhanced by our proactive educational outreach and problem-solving consultations with distributors and farmers, giving us strong familiarity with the local natural environment and the needs of local farmers.
 
Strong Marketing and Customer Support and Extensive Distribution Network.   We believe we have established marketing and distribution systems that have contributed to our past growth.
 
  •  We have dedicated teams that provide marketing and customer service at the pre-sales, sales and post-sales stages. We organize site visits and field demonstrations to educate farmers and distributors. Our customer service at the sales stage includes assisting customers in selecting the products suitable for their particular needs. When sales are carried out by distributors, we work to ensure that the distributors have a solid knowledge of our products, the needs of our end customers, and how our products serve those needs. Our customer service at the post-sales stage includes continued consultation and site visits to both farmers and distributors.
 
  •  We also have an extensive third-party distribution network for our corn seeds, consisting of over 110 local and regional distributors in 12 provinces. Similarly, we distribute our sheep breeding products through an extensive network of breed improvement and reproductive stations, plant cultivation companies and government operated entities within Shanxi that serve farmers directly. We sell our seedling products through different distribution channels for each of our seedling products. Our distribution network for our three business segments covers 15 provinces throughout China.
 
Effective Operations Management and Quality Control System.   We have received an ISO 9001/2000 International Quality Management System Certificate for our operations management system. Our quality management for the production of our corn seed, sheep breeding and seedling products involves rigorous quality control and inspection procedures. For corn seed production, we carefully select parent seeds before growing seeds on a mass scale. During the entire production process, we continually provide technical guidance to the village collectives and seed production companies that are contracted to grow our seeds, and we supervise the production and harvest process. We also apply quality control and management standards to the production of our sheep breeding and seedling products.
 
Strong Research and Development Capabilities.   We focus our research and development efforts on developing agricultural products with large potential markets and which meet the evolving needs of farmers. Approximately 20% of our research and development staff members have Ph.D. degrees. We have developed proprietary products and technologies, including our Primalights III hybrid sheep, our Primalights III corn seed and Primalights III date varieties. We also have cooperated with many outstanding research institutions and universities, including Shanxi Academy of Agricultural Sciences, Shanxi Agricultural University, Chinese Academy of Forestry, Sichuan Agricultural University and Henan Agricultural University, and we have 20


77


Table of Contents

products under joint development with these institutions and universities. Our strong research and development capabilities allow us to use sophisticated sheep husbandry techniques, such as semen cryogenics, artificial insemination, or AI, embryo-splitting, multiple ovulation and embryo transplants, or MOET, estrus synchronization and frequent reproduction as well as diet formulation and disease prevention.
 
Experienced Management Team and Skilled Staff.   Our management team has extensive experience in the agricultural industry in China, with a proven track record of developing and selling corn seeds, sheep breeding products and seedlings. Members of our management team include the vice chairman of the Food Research Institute of Shanxi, directors of the Sheep Breeding Association of China and a director of the Husbandry Association of China. Most of the members have worked together since 2003. We also employ a skilled staff with extensive experience in agriculture and husbandry industries. In addition, we plan to recruit qualified candidates with substantial experience in the global agricultural industry to further strengthen our senior management team.
 
Strategies
 
Our goal is to become the leading provider of a variety of agricultural upstream products. We intend to achieve our goal by implementing the following strategies:
 
Increase Our Product Sales to Existing and New Geographic Markets.   We intend to continue to grow all of our agribusiness segments by selectively expanding our product sales in existing and new geographic markets. We believe that there is a significant market opportunity in the regions in which we currently operate as a result of the fragmented nature of the market, the growing economy and the increasing demand for upstream agricultural products. We believe that we can increase our sales in these regions by capturing market share from our local and multinational competitors. We also plan to grow our business by entering new markets. For example, we currently produce corn seed products that are primarily suited to four corn growing regions in China, namely, the North, the Northwest, the Southwest and the Yellow River and Huai River regions. We intend to expand the geographic spread of our markets to include the other two corn production regions of China, namely, the Southern Mountain region, which includes Guangdong, Fujian, Zhejiang, Jiangxi, Hunan and Hubei, as well as the plateau of Qinghai and Tibet. For sheep breeding products, we intend to expand sales to additional provinces which are well suited to sheep rearing and production, including the northern, northeastern and central regions of China, such as Ningxia, Jilin, Liaoning, Xinjiang and Qinghai. To support this expansion, we intend to increase our land acreage as well as the size of our breeder sheep flock.
 
Expand the Variety of Our Products.   We plan to expand the variety of our corn seed, sheep breeding and seedling products.
 
  •  We currently offer corn seed products that are suited to four corn growing regions in China, namely, the North, the Northwest, the Southwest and the Yellow-Huai River Valley regions. We have produced seed types with different traits, such as high-yield, disease-resistant corn, drought-resistant corn and high-starch, and severe stress-tolerant corn. We plan to develop corn seeds that are suitable for the remaining two corn growing regions in China, namely, the Southern Mountain and the Plateau of Qinghai and Tibet regions, to cover all major corn plantation areas in China. Within each of the regions, we plan to further enhance the existing characteristics of our products by developing additional attributes such as a high-yield of oil and pest-resistance, as well as improving the existing traits we have developed.
 
  •  We plan to expand our breeding business to cultivate cashmere breeder goats for semen and embryo production, as well as to grow flocks of cashmere goats for the production of super-fine cashmere.
 
  •  We plan to grow herb seedlings for use in healthcare-related products and to produce a new type of date tree that is expected to have an extended lifespan.
 
Expand Our Research and Development Capabilities.   We plan to devote more resources to our own internal research and development as well as to collaborations with institutions and universities to expand


78


Table of Contents

our product portfolio. We intend to increase the number of our research and development staff dedicated to each of our business segments. In addition to the existing Shanxi Primalights III Biotech Engineering Academy, we also plan to establish another research center in Beijing and to acquire experimental fields in Beijing. Furthermore, we plan to develop more collaborations with domestic and international institutions and universities as well as inviting visiting scholars to our research centers.
 
While genetically modified, or GM, corn is currently not permitted to be commercially produced in China, it is widely sold in the United States and in many other industrialized nations. We believe that GM corn has significant advantages over traditional corn in the areas of pest resistance, drought resistance and growth in arid areas and with higher yields. We believe that there may be a market for GM corn seeds in China in the future. We plan to conduct research into GM corn seeds through collaboration with research and development institutions in order to be prepared to quickly move into the GM market if PRC law comes to permit such a market.
 
Selectively Pursue Strategic Acquisitions and Alliances and Expand into New Agricultural Sectors.   We plan to make strategic acquisitions and enter into alliances that will complement our business. Many parts of the agricultural product markets in China are fragmented, creating opportunities for acquisitions and alliances. We believe that as the Chinese market continues to grow and becomes more sophisticated, smaller companies will face growing competitive pressure and they will need to make capital investments to keep pace with technological advances, which may cause them to seek partners with greater resources. Given the fragmented nature of the agricultural industry in China, we believe there will be opportunities for acquisitions of complementary businesses and other businesses. The key characteristics of our acquisition or alliance candidates will include companies that:
 
  •  have access to more land resources in different climate zones to broaden our geographic presence;
 
  •  add additional or complementary product varieties;
 
  •  add additional or complementary business lines;
 
  •  add expanded distribution capabilities to enhance our sales or increase our market penetration; and
 
  •  have access to more advanced agricultural technologies.
 
Our Products
 
We specialize in three types of products: corn seeds, sheep breeding products and seedlings. We currently offer 20 corn seed products, 34 sheep breeding products and 17 seedling products in 15 provinces in China. In 2006, sales of corn seed, sheep breeding and seedling products accounted for 50.2%, 39.4% and 10.4%, respectively, of our total revenues. In the six months ended June 30, 2007, sales of corn seed, sheep breeding and seedling products accounted for 47.9%, 39.6% and 12.5%, respectively, of our total revenues.
 
Corn Seeds
 
In 2006, we sold approximately 31,100 tonnes of corn seed products. We currently produce four types of proprietary corn seed products: Primalights III — 591, Primalights III — 391, Primalights III — 891 and Primalights III — 28, which collectively contributed to 55.8% of our total corn seed revenues in 2006. In addition to our proprietary products, we are the exclusive distributor in Shanxi for four varieties of corn seed produced by other seed companies outside Shanxi. We also produce and sell four popular generic corn seeds whose intellectual property rights have expired in China. We plan to focus on the production and sale of our


79


Table of Contents

proprietary products to achieve greater profitability. The chart below provides selected summary information about our proprietary corn seed products:
 
         
Products
 
Attributes
 
Areas Suitable for Growth
 
Primalights III — 591
  High starch, resistant to severe weather, geographically adaptable corn   Anhui, Gansu, Guizhou, Hebei, Heilongjiang, Henan, Hubei, Hunan, Inner Mongolia, Jiangxi, Jilin, Liaoning, Ningxia, Shaanxi, Shandong, Shanxi, Sichuan, Yunnan
Primalights III — 391
  Drought-resistant corn   Hebei, Heilongjiang, Inner Mongolia, Jilin, Liaoning, Qinghai, Shanxi, Tibet
Primalights III — 891
  High-yielding, disease-resistant corn   Anhui, Guizhou, Hebei, Heilongjiang, Henan, Hubei, Hunan, Inner Mongolia, Jiangxi, Jilin, Liaoning, Shaanxi, Shandong, Shanxi, Sichuan, Yunnan
Primalights III — 28
  High-yielding corn   Anhui, Guizhou, Hebei, Heilongjiang, Henan, Hubei, Hunan, Inner Mongolia, Jiangxi, Jilin, Liaoning, Shaanxi, Shandong, Shanxi, Sichuan, Yunnan
 
As of June 30, 2007, we had access to a total of approximately 23,000 acres of farmland in the Shanxi, Inner Mongolia, Gansu, Xinjiang, Ningxia, Shannxi and Hainan provinces for production of our corn seeds. We use Hainan province as our winter propagation base to produce and select parent seeds that are used to produce hybrid seeds, allowing us to harvest an additional generation of seeds within each twelve-month period. In the hybridization process, two generations of seeds per 12 months period presents an advantage by allowing the hybridization process to proceed through generations more quickly enabling us to develop and commercialize new corn seed varieties more rapidly.
 
Sheep Breeding Products
 
Our sheep breeding business consists primarily of the production and sale of frozen semen, embryos, breeder sheep and our Primalights III hybrid sheep. In 2006, sales of our frozen semen, embryos, breeder sheep and Primalights III hybrid sheep accounted for 62.4% , 4.8% , 9.8% and 23.0%, respectively, of our total revenues from our sheep breeding business.
 
Our frozen sheep semen products are primarily used for artificial insemination to produce breeder sheep or sheep for mutton or wool. Sheep semen is collected and frozen in plastic straws. In 2006, we sold a total of 20.5 million straws of frozen semen.
 
Our sheep embryos products are primarily used for embryo transplants to produce breeder sheep or sheep for mutton or wool. Embryos are collected from pregnant breeder ewes and are frozen in plastic straws. In 2006, we sold a total of approximately 8,250 straws of embryos.
 
We own approximately 6,100 breeder sheep including Poll Dorset, Suffolk, Texel, Merino and Dorper sheep, domestic Small-tailed Han sheep. We also have approximately 9,700 Primalights III hybrid sheep and approximately 900 breeder goats including foreign pure breed Boer goats and domestic goats. In addition to producing frozen semen and embryos, in 2006, we sold a total of approximately 30,731 sheep, of which 4,621 were pure foreign breed and 26,110 were our self-developed Primalights hybrid III sheep. Our Primalights III hybrid sheep is a crossbreed between foreign superior-fleshing sheep breeds and a domestic breed, which has high reproductive capability and good local adaptability. It has been used by farmers to cross breed with their own sheep in order to improve their mutton production yields.
 
We operate five breeding bases which occupy 3,700 acres of land in various parts of Shanxi province where we maintain propagation bases and pasture land for our flocks. We also acquired the land use rights to 3,650 acres of land as our breeding base and pasturing area. We initially obtained our sheep flock by purchasing pure foreign breeds, including Poll Dorset, Texel, Suffolk, Merino and Dorper sheep, from sources outside of China. Although we now primarily breed sheep among our existing herd, we continue to periodically purchase sheep to augment the diversity of our sheep gene pool. The Poll Dorset sheep , Suffolk sheep , Texel sheep and Primalights III hybrid sheep are usually raised by farmers for mutton; the Merino sheep for mutton and wool; and the Dorper sheep for mutton and skin.


80


Table of Contents

Seedlings
 
We primarily produce and sell four types of seedlings, blackberries and raspberries, dates and white bark pine. We have four seedling propagation bases that occupy approximately 380 acres of land that we have leased or acquired the land use rights for between five and 46 years.
 
Blackberries and Raspberries
 
We use tissue culture technology to conduct virus-free rapid propagation for the production of blackberry and raspberry seedlings. The raspberry and blackberry seedling varieties we have developed can grow under cold and dry weather conditions in rough soil with a strong sprouting ability.
 
Dates
 
We use tissue culture technology to conduct virus-free rapid propagation for the production of date seedlings. In addition, since date trees are usually very tall such that nutrients cannot be efficiently transported to the higher branches, we use grafting techniques to change the attributes of date trees to lower their height. This enables us to produce and pick more dates at reduced labor costs.
 
White Bark Pine
 
We produce seedlings for evergreen white bark pine. This is one of the preferred plants for urban plantation in the northern part of China as a result of its evergreen color which does not turn brown or grey in the winter like many other pine species found in this part of China. The China Forestry Bureau forbids the transplanting of natural forest, and therefore, all such trees must to be cultivated from seedlings.
 
Research and Development
 
We believe that our future success depends on our ability to provide high quality and advanced products to our customers. We place strong emphasis on research and development to enhance the quality and competitiveness of our products. We conduct research and development through both our in-house research and development team and in cooperation with various universities and research institutions. See “— Intellectual Property.” We have also acquired a number of technologies from third parties.
 
Our own research and development team consists of 20 research professionals and staff, among which 17 have advanced degrees including four with doctorate degrees. Our research and development professionals and staff are specialized in areas including agricultural biotechnology, livestock husbandry and forestry. For example, our chief scientist for our corn seed segment, Dr. Keming Zhao, has received numerous scientific awards at the provincial and national level and has been awarded a research fellowship by the State Council. Dr. Zhao is also a member of the National Corn Committee and the chief consultant for the Shanxi Committee of Corn Expert. Our chief scientist for our sheep breeding segment, Dr. Jianxin Zhang, is a director for the China Sheep Society and a director of the China Society of Ecological Environment. Dr. Zhang holds a Ph.D. degree in animal genetics from the College of Husbandry at the Shanxi University of Agricultural Sciences. The head of P3A’s research and development team, Ligang Kuang is a vice chair of the Shanxi Academy of Forestry, a vice chair of the Shanxi Association of Dates and a director of the Shanxi Forestry Society. Mr. Kuang holds one patent, nine scientific awards and has published numerous scientific papers. We plan to establish a new research and development facility in Beijing to broaden our market reach and to produce more commercially attractive products. Our in-house research and development team has developed some of our proprietary technologies. See “— Intellectual Property.”
 
We collaborate with a number of universities and research institutions to develop advanced technologies, including Shanxi Agriculture University, Shanxi Livestock Breeding Center, Shanxi Academy of Agriculture Sciences Institute of Crop Sciences, Shanxi Academy of Agricultural Sciences Institute of Animal Sciences, the Genetics Research Institute of Shanxi Agriculture Academy, the Chinese Academy of Forestry, the Forestry College of Shanxi Agricultural University and Henan Agricultural University. Our past efforts with these research institutes and organizations have resulted in the development of new varieties of corn seeds,


81


Table of Contents

new and advanced corn growing and sheep breeding technologies, technologies for growing seedlings and various auxiliary technologies. See “— Intellectual Property.”
 
Corn Seeds
 
At present, we have five experimental breeding stations and 48 demonstration bases. We have a large collection of germplasm from which we have generated approximately 21,000 crosses, of which 289 have been chosen as potential hybrid seed candidates for further testing for seed approval. We have four proprietary corn seed varieties developed through acquisition and self-development efforts, and more than 20 are currently being tested by the relevant government agency for yield and other characteristics.
 
We have been focusing on developing our own proprietary high-yield hybrid corn varieties with multi-resistance characteristics and wide geographical adaptability by using conventional hybridization techniques, including “second cycle line” and “backcross inbreeding.” We mainly use the second cycle line breeding methodology, which is widely used in China, for our seed corn inbred line selection. Backcross inbreeding is also used as a shortcut in line selection. Backcross inbreeding with a narrow genetic basic population is the second most commonly used methodology in China.
 
Although we do not currently sell genetically modified, or GM, products, we plan to set up pilot research programs on GM corn and establish relationships with various research and academic institutions in China to develop GM corn seeds.
 
Sheep Breeding
 
In addition to the sheep breeding technologies developed by our own team, we have been cooperating with research and academic institutions to improve our sheep breeding technologies. We provide funding to research and academic institutions, which in turn, collaborate with us to identify and to conduct research and development on advanced and efficient sheep breeding technologies.
 
We currently maintain 21 technologies for breeding sheep that were developed by our own research and development team, through collaborations with research institutions or through acquisition from third parties. See “— Intellectual Property.” Most of the technologies are used or will be used on breeding sheep for both mutton and cashmere, or for mutton, cashmere and skins. Some of our leading technologies include technologies involved in semen cryogenic, artificial insemination, or AI, embryo-splitting, multiple ovulation and embryo transplants, or MOET, and estrus synchronization.
 
Our proprietary, locally-bred sheep, the Primalights III hybrid sheep, is an offspring produced by cross-breeding the foreign superior-fleshing sheep breeds and a domestic breed. Primalights III hybrid sheep have early sexual maturity, high reproductive capability, large bodies, fast growth with superior fleshing and are more disease-resistant than most of other domestic varieties of sheep. A new breed takes at least several generations to stabilize. Our Primalights III hybrid sheep is close to stabilization which will qualify for application eligibility as a new breed in China and we expect to apply for official variety recognition when the Primalights III hybrid sheep becomes eligible for application. The application for the title of official breeder sheep may take several years and we have not begun the application process. We believe recognition as an official new breed could further increase the popularity of our Primalights III hybrid sheep among sheep farmers.
 
Seedlings
 
We have developed industrialized tissue culture technologies that enables us to produce a large amount of seedlings by cultivating plant tissue for virus-free rapid propagation, and to help ensure high volumes of seedlings. We use grafting techniques to change the attributes of date trees to lower their height, which enables a higher production of dates per tree and a lower labor cost for the picking of the dates since the dates are within easy reach. The Primalights III #1 and #2 dates are large and sweet with relatively high nutritious value compared to typical dates in China. We and the Chinese Academy of Forestry have developed a special


82


Table of Contents

nutrition formula to boost the growth and transplantation survival rate of white bark pine seedling. See “— Our Products — Seedlings.”
 
Product Development and Production Process
 
Corn Seeds
 
The product development and production process for our proprietary corn seed products primarily consists of the following steps:
 
Step 1.  Development of Proprietary Corn Variety.   We use hybrid breeding technology to develop our proprietary varieties of corn seeds. The steps in the hybridization process are as follows:
 
  •  Identification of appropriate parental genes.   We identify the desired genetic characteristics in existing corn varieties and use those seeds as the parent or grandparent generation in developing crosses of corn varieties. We currently have approximately 6,700 varieties of potential parent or grandparent genes.
 
  •  Development of inbreds from the parental populations.   We often use second cycle inbreeding and backcross inbreeding to establish the parent lines and molecular marker techniques to select the lines with desired attributes.
 
  •  Evaluation of inbreds in experimental hybrid combinations.   We cross the parental corn genes by growing both varieties (a “mother” gene corn and a “father” gene corn) together in one field. We repeat this process many times in various combinations, examining which crosses produce the most likely commercially viable corn seeds. We have produced approximately 21,000 crosses.
 
  •  Identification of superior hybrid combinations.   We use molecular-marker-assisted selection to identify a few combinations that we consider to be superior hybrids and which have the likeliest commercial value. We have identified approximately 290 combinations that we believe may have commercial value.
 
  •  Multi-location testing of the pre-commercial hybrids.   We develop those varieties that we believe are superior and test them in various locations and conditions to study their traits and determine their commercial viability, including for which regions and conditions they are most suited.
 
Step 2.  Government Examination and Approval of New Variety.
 
After we have developed a new variety, we need to apply for the relevant governmental approval for commercial production and sale in China. The approval can be applied for and granted at the provincial level or the national level. However, seeds that have been approved at the provincial level can only be distributed in the province in which the approval was issued. An approval at the national level allows the approved seed to be distributed nationwide. A minimum of six years, including three years to obtain approval and three years to develop the first crop of seeds for commercial distribution, are required to bring a seed variety to market after it has been developed.
 
Seeds developed outside of China must also follow the same examination and approval procedures before they can be distributed in China.
 
Step 3.  Production of Parent Seeds.
 
After the new variety is approved by the relevant government, the production process includes two stages, the production of the parent seeds and mass production of the hybrid corn seeds. We use the Hainan province as our winter propagation base to select and produce parent seeds, allowing us to harvest an added generation within one year. The added generation allows the hybridization process to proceed faster through the required number of generations.


83


Table of Contents

 
Step 4.  Production of Hybrid Corn Seeds.
 
We produce our corn seeds by entering into arrangements with approximately 54 village collectives and other seed production companies, to whom we provide parent seeds as well as farming, harvesting and other technical guidance and supervision. We operate our corn seed business through our “company + base + farmer” model, which means we provide parent seeds to village collectives on the basis of an arrangement that includes leasing of the land from the village collectives and contracting for the propagation of corn seeds with the village collectives. The village collectives in turn arrange for the farmers in the village to work on the land and to produce corn seeds according to the contract that we have with the village collectives. We usually provide advances to the farmers for their purchase of fertilizer and other production materials. At the end of each growing season, we purchase from the village collectives the seeds they produce on our leased land and deduct the payment for the parent seeds and other advances we have provided. We then sell the seeds to distributors. In order to maintain the quality of our products, we require these local farmers to comply with our instructions and to meet our quality standards for us to purchase the corn seeds grown by them. We engage in similar arrangements with six seed production companies.
 
Sheep Breeding Products
 
The production process of our sheep breeding products is described below.
 
Frozen Sheep Semen
 
We generally take the following steps to collect our frozen semen:
 
  •  Cleaning and sterilization.   The extraction process begins with our workers cleaning and disinfecting themselves, the sheep and sterilizing the equipment used.
 
  •  Semen extraction.   Semen is collected with a collection receptacle and examined for contaminants. It is also analyzed for sperm density and motility at the same laboratory. If the sperm collected does not attain the required standard of vivacity, it is immediately discarded.
 
  •  Dilution.   Collected sperm which meets the required standards is diluted or extended with a specially-formulated solution in order to enhance the sperm survival rate and extend the life of the sperm during the cooling process. This process also helps to increase the volume and efficiency of the extracted semen.
 
  •  Tubing and storage.   After the dilution process, the sheep semen is cooled, frozen and packed for storage. Generally, the diluted sheep semen is stored in plastic straws, each containing over 100 million sperm. These plastic straws are then placed into a freezing machine that is cooled by liquid nitrogen. The temperature is progressively reduced to approximately negative 35°C to negative 40°C, for the purpose of deactivating sperm cells to prevent damage by the second stage of the freezing process. The temperature of the diluted sheep semen is then further reduced to approximately negative 197°C, in preparation for long-term storage.
 
Sheep Embryos
 
Embryos are collected from pregnant breeder ewes and are frozen in plastic straws. We generally take the following steps to collect our frozen embryos:
 
  •  Cleaning and sterilization.   Prior to each collection, workers must disinfect themselves and put on special garments. All surgical equipment are sterilized and the sheep are sprayed with sanitizing fluid.
 
  •  Superovulation.   We use hormone treatments to stimulate the ovulation in ewes to increase the production of eggs and to better manage the timing of estrus in the ewes. The recognition of estrus by the operator during this period of superovulation, which lasts for approximately seven days, is critical because insemination must be carried out during this period to achieve successful fertilization of the eggs at the stage of ovulation.


84


Table of Contents

 
  •  Artificial insemination.   Plastic straws containing semen are fitted into an insemination gun which is used to introduce semen beyond the cervix of the donor ewe. Usually, the insemination of the superovulated ewe will be carried out within 12 to 24 hours after the beginning of estrus.
 
  •  Surgery and flushing.   This is the most important process for embryo collection. A two-way catheter is inserted into the donor ewe, for flushing fluid to be introduced into the uterine horn or fallopian tube to flush out the embryos of the donor ewe. At this stage, special care is taken to ensure that all flushing fluid is recovered and that the donor ewe is subject to minimum stress and trauma. The fertilized embryos are subsequently flushed out with this fluid.
 
  •  Processing and evaluation.   After the flushing fluid is collected, it is then taken to a laboratory for inspection of the embryos under a microscope. The fertilized embryos collected are evaluated for their quality and classified by grades based on the potential likelihood of viability if transplanted to a recipient ewe.
 
  •  Freezing and storage.   Embryos can be transferred immediately upon recovery and evaluation or cooled, frozen and packed for storage by procedures similar to those used for sheep semen. Generally, one embryo is contained in each plastic straw. The frozen and dormant embryos kept in liquid nitrogen can be stored without significant impairment for an indefinite period and can be ready for use by thawing the plastic straw in warm water for a few seconds.
 
Sheep
 
We breed pure foreign breeder sheep and our Primalights III hybrid sheep in our breeding bases. We developed our Primalights III hybrid sheep by crossbreeding rams of a selected foreign pure breed sheep and ewes of a domestic breed, and use the next generation ewe to crossbreed with another foreign pure breed ram. A new breed takes at least several generations to stabilize. We believe the Primalights III hybrid sheep is close to stabilization. The crossbred Primalights III hybrid sheep have high reproductive capability, large bodies, fast growth with superior fleshing and are more disease-resistant than most of other domestic varieties of sheep, and good local adaptability.
 
Seedlings
 
Blackberries and Raspberries
 
We use tissue culture technology to conduct virus-free rapid propagation for the production of blackberry and raspberry seedlings. The raspberry and blackberry seedling varieties we have developed can grow under cold and dry weather conditions in rough soil with a strong sprouting ability.
 
Dates
 
We use tissue culture technology to conduct virus-free rapid propagation for the production of date seedlings. With this technology, we take plant tissue and place them in bottles with gelatinous culture where we grow them for 30 to 40 days. Then we move them into pots with soil and grow them for three to six months into seedlings. After they grow into seedlings, we move them indoors to a propagation base for between one and three and half years for further cultivation before selling the seedlings to plantation centers. In addition to the tissue culture technology, we also use grafting techniques to change the attributes of date trees to lower their height, so that nutrients can be more efficiently transported to the higher branches and dates can be picked from lower branches at reduced labor costs.
 
White Bark Pine
 
We collaborated with the Chinese Academy of Forestry and developed technologies that can speed up the growth of the white bark pine seedlings. Usually it takes at least three years for the white bark seedlings to grow large enough for sale. By contrast, our seedlings are ready to be sold only one or two years after planting. This rapid growth is possible because we use a special nutrition bag which wraps the roots of the seedling and contains concentrated nutrients that enable the seedling to grow stronger, faster and with a higher survival rate.


85


Table of Contents

White bark pine trees are typically used by local governments for urban planting. We grow white bark pine tree seedlings and sell them to a related party, Taiyuan Relord, which in turn grows the seedlings to trees before they are ready to be sold for urban planting.
 
Marketing and Customer Support
 
Our product marketing and our customer support are closely linked. We market our corn products through pre-sale training, demonstrations and presentations to distributors, farmers and other potential customers. We invite distributors and other potential customers for site visits to demonstration bases and distribute advertising materials introducing our products, planting technology and other modern agricultural production technologies. We also hold free seminars at which we introduce our products and technologies and provide technical guidance to our customers for growing corn. We advertise our corn seed products through traditional advertising media such as television and newspapers. Additionally, we also communicate our brand name through product labeling and the distribution of brochures and other advertising materials to distributors and farmers.
 
We market our sheep breeding products by arranging site visits for and distributing manuals and information to potential customers. For example, we provide information about our sheep breeding products to BIRS that are owned by the local government. We introduce and promote our seedling products by inviting potential customers for site visits. We share our experience and knowledge on sheep husbandry and cultivation of seedlings with our customers, including nutrition and technology information, particularly with respect to the prevention of disease. As of December 31, 2006, our sales and marketing team was comprised of over 50 employees.
 
Sales and Distribution
 
Since our inception, we have worked continuously to build and maintain our sales and distribution networks. We have established good relationships with leading corn seeds distributors in almost every local market within Shanxi Province and an increasing number of distributors outside Shanxi Province.
 
Our corn seed and sheep breeding products are sold to our direct customers which in turn sell to end users listed below:
 
         
Products
 
Direct Customers
 
End Users
 
Corn seeds
  Local and regional distributors   Farmers
Frozen sheep semen
  Breed Improvement and Reproductive Stations, or BIRS; Veterinary stations; Breeding companies; Large sheep farms   Other breeding companies; Farmers; Sheep farms
Sheep embryos
  Breeding companies; Large sheep farms   Other breeding companies; Sheep farms
Foreign pure-bred breeder sheep; Primalights III hybrid sheep   Government poverty alleviation and good-breed promotion projects; Husbandry Bureaus; Breeding companies; Large sheep farms   Breeding companies; Sheep farms; Farmers
 
Our corn seed products are ultimately sold to and used by farmers in 12 provinces in China, including Shanxi, Inner Mongolia, Hebei, Henan, Shaanxi, Shandong, Liaoning, Hubei, Hunan, Heilongjiang, Jilin and Sichuan, and our sheep breeding products are ultimately sold to and used by farmers in seven provinces in China, including Shanxi, Inner Mongolia, Hebei, Henan, Gansu, Ningxia and Shaanxi. Our seedling products are sold directly to end users in Shanxi and Yunnan, including municipal agencies and seedling companies, plantations, agricultural development companies and farmers.
 
Corn Seeds
 
Our corn seeds are primarily sold to distributors directly, and are ultimately sold to farmers through our distributors. In Shanxi province, we have approximately 70 distributors. Outside of Shanxi province, we have approximately 40 distributors in 11 provinces across China. We generally engage one distributor within each identified local market. Our distributors buy our corn seeds at a wholesale price established by us. They usually place orders two months before delivery, make deposit payments during the two months’ period, and


86


Table of Contents

pay the remaining amounts within the prescribed period. Our distributors either sell our seed products to sub-distributors or sell them directly to farmers.
 
Sheep Breeding Products
 
Our frozen semen products are primarily sold directly to BIRS, our embryo products are mainly sold directly to large sheep farms, and our breeder sheep and Primalights III hybrid sheep are primarily sold to government poverty alleviation and good-breed promotion projects.
 
Our sheep breeding products are ultimately sold to farmers through BIRS which are administered and supported by the government, and provide breeding products, facilities and services to farmers counties and villages in seven provinces in China. While our products have in the past been sold primarily to customers located in Shanxi province and Inner Mongolia, we have expanded the sales of our sheep breeding products to Gansu, Hebei, Ningxia, Henan and Shaanxi provinces.
 
In 2006, we had approximately 260 direct customers for our sheep breeding products within and outside Shanxi province, the majority of which were intermediary customers who planned to sell the products on to final customers. Our primary model of distribution for our sheep breeding products in Shanxi province is through BIRS and government poverty alleviation and good-breed promotion projects, which are government-owned and funded entities that sell breeding products to farmers and often provide the farmers with services such as artificial insemination. We have well-developed relationships with BIRS and government poverty alleviation projects in many locations in Shanxi.
 
Seedlings
 
Our seedling department had relationships with approximately 40 customers as of December 31, 2006. Our seedling distribution is accomplished in a different manner for each of our three seedling products: raspberry and blackberry, date and white bark pine. We sell most of our raspberry and blackberry seedlings to plantation nurseries and municipal agencies. We distribute our date seedlings to farms. University and government research institutions with which we collaborate on seedling development also help us with promoting sales and planting of Primalights #1 and Primalights III #2 date seedlings. We typically sell our white bark pine seedlings to Taiyuan Relord, which is a related party. See “Related Party Transactions — Other Transactions with P3A and Its Affiliates.”
 
Quality Control
 
We have received an ISO 9001/2000 International Quality Management System Certificate. Our internal quality controls are implemented according to the requirements of ISO 9001/2000 quality management systems. We believe our product quality standards are generally higher than the national industry standards in China.
 
Transportation
 
We primarily sell our products at our facilities, and our customers come to our facilities to take their deliveries. For our corn seed business, we collect the corn seeds from the village collectives and transport them using our trucks to the storage and processing centers. Then the distributors take delivery and load the corn seeds at our storage facilities and transport those goods in their own trucks.
 
Competition
 
The agricultural industry in China is highly fragmented, largely regional and competitive. We expect competition to increase and intensify. We face significant competition in our corn seed business segment. Many of our competitors have greater financial, research and development and other resources than we have. However, we believe we distinguish ourselves as a company with a portfolio of fast growing upstream agribusinesses.


87


Table of Contents

Corn Seeds
 
We compete with both domestic and multinational companies in the corn seed business. The market is highly fragmented and intensively competitive. Our domestic competitors in the seed industry include Denghai Seed Joint Stock Limited Company, Beijing Denong Seed Company Limited and Shangxi Tunyu Seed Science and Technology Joint Stock Limited Company, etc. We compete with these companies based on our product quality, price, attributes of our proprietary corn seeds products, brand recognition and distribution channels.
 
We also compete with small domestic seed companies in the geographic areas in which they operate. These seed companies operate only in their respective local markets and sell seeds to local customers. However, they are often well established within their locales, have local government support and understand local farmers’ needs, giving them a competitive advantage in their locales.
 
The multinational seed companies we compete against, including Pioneer, Monsanto and Sygenta, have greater financial, technical and other resources available to them, and have access to high-quality corn seeds.
 
Sheep/Goat Breeding
 
We compete with various local sheep/goat farms in our sheep/goat breeding business. Our strongest competitor in this market is Tianjin Jisheng Sheep Breeding Center. Our other competitors in the industry include Hualiang Group, Fumin Muslim Food Co., Ltd., Zhongtian Group and Tianxing Sheep Co., Ltd.. We compete with these companies based on our breeding technologies, attributes of our sheep breeding products and our Primalights III sheep, price, brand recognition and economics of scale of our sheep breeding business.
 
Seedlings
 
We compete with various local seedling companies in Shanxi. We compete with these companies based on our technological capabilities and the size of our greenhouses and nurseries. Because we offer a range of services and produce a range of products to different sectors in the seedling industry, and in part due to the lack of comprehensive official statistics, we are not aware of any dominant competition from any single source in the seedling industry.
 
Intellectual Property
 
Many elements of our proprietary information, such as production processes, technologies, know-how and data, are not patentable in China. We rely primarily on a combination of trade secrets, trademarks, and confidentiality agreements with employees and third parties to protect our intellectual property.
 
Corn Seeds
 
We have proprietary rights to four types of seed corns including Primalights III — 891, Primalights III — 591, Primalights III — 391 and Primalights III — 28, of which we developed Primalights III — 28 and acquired the other three types. New crop seeds must pass examination and approval by national or provincial governmental authorities before they are marketed and distributed. The examination and approval committees usually consist of professionals and experts from the agricultural and forestry government agencies. Primalights III — 891, Primalights III — 591, Primalights III — 391 and Primalights III — 28 have passed the examination and approval from the Shanxi Crop Variety Examination and Approval Committee. We have approximately 20 types of seed corns that are currently being tested and verified by the Shanxi provincial agricultural authorities. Once they pass the test and verification, these types of corn may be marketed and distributed in Shanxi.
 
Sheep Breeding
 
Through self-development or collaboration with research institutes, we own 21 sheep breeding technologies and technical know-how that relate to semen cryogenics, MOET, AI, molecular marker technologies in sheep breeding, sex identification of embryos, diet formulation, and disease prevention. These technologies and accumulated valuable technical know-how allow us to ensure the quality of our sheep breeding products and to maximize productivity in various stages of sheep breeding process.


88


Table of Contents

Seedlings
 
We have tissue culture technologies for the propagation of raspberry, blackberry and date seedlings through collaborations with the Chinese Academy of Forestry and the Forestry College of the Shanxi Agricultural University.
 
Employees
 
We had 333 full-time employees and 185 temporary employees as of June 30, 2007. We had 233, 233 and 283 full-time employees and 68, 165 and 235 temporary employees as of December 31, 2004, 2005 and 2006, respectively. Our temporary employees are usually hired seasonally because of the seasonality of our business. The following table sets forth the number of employees for each of our three business segments and our corporate offices as of June 30, 2007:
 
                 
    Number of Full-time
  Percentage of
    Employees   Total Employees
 
Seed Department
    109       32.7 %
Breeding Department
    113       34.0  
Seedling Department
    46       13.8  
Administration
    65       19.5  
                 
Total
    333       100.0 %
                 
 
We have entered into employment agreements with our full-time employees. Our management and research and development staff have signed non-compete agreements with us and are prohibited from engaging in any activities that compete with our business during the period of their employment with us. Furthermore, the employment contracts with our officers or managers generally include a covenant that prohibits them from engaging in any activities that compete with our business for three years after the period of their employment with us.
 
None of our employees are registered under collective bargaining agreements. We currently do not have a labor union. We consider our relations with our employees to be good.
 
Insurance
 
We maintain automobile insurance on certain vehicles. We do not have insurance coverage on our other assets, inventories, business and product liability, interruption of business, or key-employees. See “Risk Factors — Risks Relating to Our Business — We have limited insurance coverage in China.”
 
Facilities
 
Our principal executive offices are located in Beijing. We operate farms, breeding centers, propagation centers and other facilities on approximately 27,000 acres of land, mostly through lease of land use rights as well as acquisition of land use rights.
 
We lease approximately 23,000 acres of land for our corn seed production, primarily from village collectives. These leases are typically for terms of 12 years. As of June 30, 2007, we acquired the land use rights of approximately 3,650 acres of land as our breeding base and pasturing area, and entered into long-term lease agreements with the local government and the village collectives for 50 acres of land for our sheep breeding business with average terms of 15 years. We acquired and leased land use rights of 330 acres of land for seedling production. These leases are for terms of five to 46 years.
 
Legal Proceedings
 
We are not currently a party to any material litigation or other legal proceedings and are not aware of any pending or threatened litigation or legal proceedings that may have a material adverse impact on our business, financial condition or results of operations.


89


Table of Contents

 
REGULATION
 
This section sets forth a summary of the most significant regulations or requirements that affect our business activities in China.
 
Agriculture Law
 
On July 2, 1993, the PRC promulgated the Agriculture Law which sets forth certain principles and various measures designed to ensure the steady development of the agricultural industry. For example, the production or operation of agricultural products that affect the health of people or animals, such as seeds, must meet registration and approval requirements of the PRC laws and regulations. The Agriculture Law was revised on December 28, 2002 and became effective on March 1, 2003.
 
Seed Law, Animal Husbandry Law and Other Relevant Regulations
 
Seed Law and Other Relevant Regulations
 
The crop seed business is a highly regulated industry in the PRC. In July 2000, the Seed Law was enacted to foster the use of seed resources; to control the selection, production, use of seeds and to regulate related business operations; to protect the legal rights of producers, business operators and users of seeds; to promote seed quality; to drive the industrialization processes of seeds and to accelerate the development of the planting and forestry industries. The Seed Law became effective on December 1, 2000 and was amended on August 28, 2004.
 
Under the Seed Law, major crop seeds and tree varieties are subject to examination and approval as a pre-condition of their popularization. An applicant may apply directly for examination and approval at either the national or provincial level. Committees composed of professional experts have been established separately by the State Council’s agriculture and forestry administrative departments and the provincial governments for the examination and approval of crop and tree varieties. Major crop seed varieties that are verified and approved by the State Council’s committee and the National Crop Variety Examination and Approval Committee may be marketed and distributed nationwide. Varieties that received provincial approval are only permitted to be marketed and distributed within the approved province.
 
For seed production, a permission-based system is currently in practice pursuant to the Administrative Regulation on Permission of Production and Operation of Crop Seeds, which was issued on February 26, 2001 and revised on July 1, 2004. A company engaged in the production of seeds must obtain a production license, which is issued at either the provincial or local levels, entitling the licensee to engage in seed production in the permitted area. The level of issuing authority required for a production license varies based on the types of seeds to be produced. The production license also specifies the types of seeds the license holder may produce, the geographic region of the seed production and the term of the production license.
 
For seed distribution, a company must obtain a distribution license in order to distribute seeds in permitted areas. Generally, a distribution license is issued at the county level or above. A seed company must obtain a distribution license from the provincial government to distribute major crop seeds in that province, and a distribution license from the national government for national distribution.
 
Animal Husbandry Law and Other Relevant Regulations
 
According to the PRC’s Animal Husbandry Law which was promulgated on December 29, 2005 and became effective on July 1, 2006, popularization of any new variety of livestock is subject to examination and approval by the National Commission of Animal Genetic Resources. Approved varieties will be announced by the Ministry of Agriculture and be eligible for popularization.
 
Pursuant to the Animal Husbandry Law, entities or individuals engaged in production of breeder livestock or poultry, or engaged in the commercial production of new born livestock or poultry, must obtain a Permit for the Production and Business Operation of Breeding Livestock and Poultry (the “Husbandry Permit”). Entities and individuals engaged in the production of ova, frozen sperm, embryos or other genetic materials must


90


Table of Contents

obtain a Husbandry Permit from the State Council’s the stockbreeding and veterinary administrative departments through their respective provincial governments. The approval level of the Husbandry Permit varies depending on the permitted scope and content.
 
In addition to the Animal Husbandry Law, the Administrative Regulation of Breeders was issued on April 15, 1994, and Implementing Rules of Administrative Regulation of Breeders issued on January 5, 1998 and revised July 1, 2004. These regulations specify conditions and requirements that must be satisfied by breeding farms regarding their technologies, facilities, quarantine measures, livestock and poultry inspection systems and livestock and poultry distribution. We believe our sheep breeding farms meet the conditions required under the applicable regulations.
 
Supervision of Agricultural Products Quality and Safety
 
On March 10, 2005, the Ministry of Agriculture issued the Measures for the Supervision and Spot Check of Agricultural Seed Quality, which became effective on May 1, 2005, and which permit the government’s administrations of agriculture at the county level or above to organize relevant seed administration and seed quality inspection institutions to sample and inspect agricultural seeds that are produced and sold. A seed production and operation company that does not meet inspection standards must recall any seeds that have been sold. Such companies may not conduct sales until they meet inspection standards. A legal representative of the seed company must circulate information on the inspection to all employees, and the company must determine why the seeds failed to meet inspection standards and implement corrective measures. Such measures include improving quality control processes, submission of rectification reports and submitting to subsequent examinations by the administration of agriculture. Our seeds have not been recalled in any inspections by the government authorities thus far.
 
Under the PRC Law on Agricultural Product Quality Safety, issued on April 29, 2006 and which became effective November 1, 2006, an entity engaged in the production of agricultural products must establish production records and retain data relating to production.
 
Under the PRC Law on Animal Epidemic Prevention, issued on July 3, 1997 and which became effective January 1, 1998, animals and/or animal products to be sold or transported require quarantine certificates and quarantine inspection marks or seals. Shanxi Province’s Regulations on Animal Epidemic Prevention require business operators to report to their local supervisory institutions or animal quarantine officers of animal epidemic prevention where such operators are domiciled, and submit to inspections and quarantines of animals and animal products. The level of inspection varies depending on the uses for such animals or animal products.
 
Under the Regulations on Plant Quarantine, issued on January 3, 1983 and revised on May 13, 1992, plants and plant products listed in quarantine catalogues are subject to quarantine inspections before they are transported from a county administration area where an epidemic occurs. Plant seeds, seedlings or other propagating materials are subject to quarantine inspections prior to transportation.
 
Land Use Rights
 
All land in the PRC is either state-owned or collectively owned, depending on the location of the land. All land in the urban areas of a city or town is state-owned, and all land in the rural areas of a city or town and all rural land is, unless otherwise specified by law, collectively owned. The state has the right to reclaim land in accordance with law if required for the benefit of the public. Although all land in the PRC is owned by the state or by collectives, private individuals and businesses and other organizations are permitted to hold, lease and develop land for which they are granted land use rights.
 
National Legislation on Land
 
In April 1988, the constitution of the PRC was amended by the National People’s Congress to allow for the transfer of land use rights for value. In December 1988, the Land Administration Law of the PRC was amended to permit the transfer of land use rights for value.


91


Table of Contents

Under the Interim Regulations of the People’s Republic of China on Grant and Transfer of the Right to Use State-owned Urban Land (“Interim Regulations on Grant and Transfer”) promulgated in May 1990, local governments at or above county level have the power to grant land use rights for specific purposes and for a definite period to a land user pursuant to a contract for the grant of land use rights against payment of a grant premium.
 
Under the Interim Regulations on Grant and Transfer, all local and foreign enterprises are permitted to acquire land use rights unless the law provides otherwise. The state may not reclaim lawfully granted land use rights prior to expiration of the term of grant. If public interest requires repossession by the state under special circumstances during the term of grant, compensation will be paid by the state. A land grantee may lawfully transfer, mortgage or lease its land use rights to a third party for the remainder of the term of grant.
 
Upon expiration of the term of grant, renewal is possible subject to the execution of a new contract for the grant of land use rights and payment of a premium. If the term of the grant is not renewed, the land use rights and ownership of any buildings erected on the land will revert to the state without compensation.
 
Transfer and Lease of State-owned Land Use Rights
 
After land use rights relating to a particular area of land have been granted by the state, unless any restriction is imposed, the party to whom such land use rights have been granted may transfer, lease or mortgage such land use rights for a term not exceeding the term which has been granted by the state. The difference between a transfer and a lease is that a transfer involves the vesting of the land use rights by the transferor in the transferee during the term for which such land use rights are vested in the transferor. A lease, on the other hand, does not involve a transfer of such rights by the lessor to the lessee. Furthermore, a lease, unlike a transfer, does not usually involve the payment of a premium. Instead, a rent is payable during the term of the lease. Land use rights cannot be transferred, leased or mortgaged if the provisions of the land grant contract, with respect to the prescribed period and conditions of investment, development and use of the land, have not been complied with. In addition, different areas of the PRC have different conditions which must have been fulfilled before the respective land use rights can be transferred, leased or mortgaged.
 
All transfers, mortgages and leases of land use rights must be evidenced by a written contract registered with the relevant local land bureau at municipality or county level. Upon a transfer of land use rights, all rights and obligations contained in the contract pursuant to which the land use rights were originally granted by the state are deemed to be incorporated as part of the terms and conditions of such transfer, depending on the nature of the transaction.
 
Under Article 37 of the PRC Law on Administration of Urban Real Estate (the “Urban Real Estate Law”), real property that has not been registered and a title certificate for which has not been obtained in accordance with the law cannot be transferred. Under Article 38 of the Urban Real Estate Law, if land use rights are acquired by means of grant, the following conditions must have been met before the land use rights may be transferred: (1) the premium for the grant of land use rights must have been paid in full in accordance with the land grant contract and a land use rights certificate must have been obtained; (ii) investment or development must have been made or carried out in accordance with terms of the land grant contract; (iii) more than 25% of the total amount of investment or development must have been made or completed; and (iv) where the investment or development involves a large tract of land, conditions for use of the land for industrial or other construction purpose have been confirmed.
 
Regulation on Collective-owned Land
 
According to the PRC Law on Land Administration, adopted by the National People’s Congress on June 25, 1986, and amended on August 28, 2004, land in rural and suburban areas, except for that stipulated by laws as being owned by the State, is collectively owned by rural residents. Land collectively owned by rural residents is contracted to and operated by members of the respective collective economic entity for uses such as plantation, forestry, livestock husbandry or fishery productions. Before any land collectively owned by rural residents is contracted to a unit or individual not from the collective economic entity, it must be agreed by at least two-thirds of the members of the villager committee meeting or at least two-thirds of the villager


92


Table of Contents

representatives, and be submitted to the people’s government at the township level for approval. The land use rights of collectively owned land must not be granted, assigned or leased to any party for any non-agricultural uses.
 
Foreign Ownership Restrictions in the Seed Industry
 
Currently, the PRC restricts foreign ownership of domestic businesses engaged in the seed industry. According to the Foreign Investment Industrial Guidance Catalogue, which became effective on January 1, 2005, the development and production of crop seeds falls into the category of a restricted foreign investment industry. Direct legal ownership by foreign investors of businesses engaged in the development and production of food crop hybrid seeds is limited to no more than 50%. In addition, the breeding and planting of China’s rare precious breeds in plants, husbandry and/or aquatic products, and the production and development of genetically modified plant seeds are considered prohibited foreign investment industries.
 
In accordance with the Regulation on the Approval and Registration of Foreign Investment Enterprises in Agricultural Seed Industry, issued and effective on September 8, 1997, investors may establish foreign-invested crop seed companies provided that they have satisfied the following requirements: (i) the company’s PRC investors must have obtained necessary approvals for crop seed production and operation and submitted the business to any necessary examinations; (ii) the foreign investors must be equipped with relatively advanced research breeding capabilities, seed production technologies and good corporate management, and possess a positive business reputation; (iii) the investors must be able to introduce or adopt outstanding domestic or foreign species or seed resources, advanced seeds technologies and facilities; (iv) the registered capital of companies engaged in the production of cereal, cotton and oil products seeds must be no less than $2 million, and the registered capital of companies engaged in the production of other crop seeds must be no less than $0.5 million; and (iv) the company’s PRC investors’ equity ownership in the foreign-invested cereal, cotton and oil products seeds enterprises must be more than 50%. Pursuant to this regulation, foreign investors are not permitted to establish foreign-invested crop seed distribution enterprises or wholly foreign-owned crop seed enterprises in China.
 
We engage in the seed production business through contractual arrangements with our consolidated affiliated entity, P3A. See “Corporate History and Structure.” Our wholly-owned subsidiary, Agria China, does not engage in the seed production business.
 
Intellectual Property
 
The PRC Trademark Law, adopted on August 23, 1982 and revised on October 27, 2001, protects the proprietary rights of registered trademarks. The State Administration for Industry and Commerce’s Trademark Office handles trademark registrations and grants an initial term of rights of ten years to registered trademarks. Upon the initial term’s expiration, a second term of ten years may be granted under a renewal. Trademark license agreements must be filed with the Trademark Office or a regional office. In addition, if a registered trademark is recognized as a well-known trademark in a specific case, the proprietary right of the trademark holder may be extended beyond the registered sphere of products and services to which the trademark relates.
 
Under the Patent Law of PRC, which was revised on August 25, 2000, animal and plant varieties may not be protected under patents, but the production methodology of animal and plant varieties may be patented. Producers of plant and animal varieties may seek protection for their rights to new varieties under the Protection of New Varieties of Plants Regulation.
 
The Protection of New Varieties of Plants Regulation was promulgated by the State Council on March 20, 1997, and became effective on October 1, 1997. The administrative departments of the State Council in charge of agriculture and forestry are, according to their respective functions, jointly responsible for the acceptance and examination of applications for the rights to new varieties of plants and grant such rights to new varieties of plants which satisfy the requirements under the regulations. An entity or individual that has completed the production, sale or dissemination of a new variety of plant which has been granted a variety right will have an exclusive right in its protected variety. Unless otherwise provided for in these regulations, without a license


93


Table of Contents

from the owner of the variety right, no other entity or individual may use such variety for commercial purposes.
 
Foreign Currency Exchange
 
Pursuant to the Foreign Currency Administration Rules promulgated on January 29, 1996 and amended January 14, 1997, as well as various regulations issued by SAFE and other relevant PRC government authorities, the RMB is freely convertible into a foreign currency for current account items, including trade-related receipts and payments, interest and dividends, but not for capital account items, such as direct equity investments, loans and repatriation of investment, unless prior approval from the State Administration of Foreign Exchange or a local branch has been obtained. Transactions that occur within the PRC must be settled in RMB. Unless otherwise approved, PRC companies must repatriate foreign currency payments received from abroad and domestic enterprises must convert all of their foreign currency receipts into RMB. Foreign-invested enterprises may retain foreign exchange in accounts with designated foreign exchange banks subject to a cap set by the SAFE or its local branch.
 
Dividend Distribution
 
The principal regulations governing distribution of dividends of wholly-owned enterprises include the Wholly Foreign-owned Enterprise Law, promulgated by the National People’s Congress on April 12, 1986 and amended on October 31, 2000, and the Wholly Foreign-owned Enterprise Law Implementing Rules, promulgated by the National People’s Congress on December 12, 1990 and amended on April 12, 2001. Under these regulations, foreign-invested enterprises in the PRC may pay dividends only out of their accumulated profits, if any, as determined in accordance with PRC accounting standards and regulations. Additionally, enterprises are required to set aside certain amounts of their accumulated profits each year, if any, to contribute to certain reserve funds. These reserves are not distributable as cash dividends.
 
Under the current PRC tax law, dividend payments to foreign investors made by foreign-invested enterprises, or FIEs, are exempted from PRC withholding tax. Pursuant to the new PRC enterprise income tax law to be effective on January 1, 2008, however, dividends payable by a FIE to its foreign investors will be subject to a 20% withholding tax, unless any such foreign investor’s jurisdiction of incorporation has a tax treaty with China that provides for a different withholding arrangement. According to Mainland and Hong Kong Special Administrative Region Arrangement on Avoiding Double Taxation or Evasion of Taxation on Income agreed between the Mainland and Hong Kong Special Administrative Region in August 2006, dividends payable by a FIE to its foreign investors will be subject to no more than 5% tax. Although the new tax law contemplates the possibility of exemptions from withholding taxes for China-sourced income of FIEs, the PRC tax authorities have not promulgated any related implementation rules and it remains unclear whether we would be able to obtain exemptions from PRC withholding taxes for dividends distributed to us by Agria China.
 
Foreign Exchange
 
In October 2005, the SAFE issued the Notice on Issues Relating to the Administration of Foreign Exchange in Fund-raising and Return Investment Activities of Domestic Residents Conducted via Offshore Special Purpose Companies, or SAFE Notice 75, which became effective as of November 1, 2005, and was further supplemented by an implementation notice issued by the SAFE on November 24, 2005. SAFE Notice 75 suspends the implementation of two prior regulations promulgated in January and April of 2005 by the SAFE. SAFE Notice 75 states that PRC residents, whether natural or legal persons, must register with the relevant local SAFE branch prior to establishing or taking control of an offshore entity established for the purpose of overseas equity financing involving onshore assets or equity interests held by them. The term “PRC legal person residents” as used in SAFE Notice 75 refers to those entities with legal person status or other economic organizations established within the territory of the PRC. The term “PRC natural person residents” as used in SAFE Notice 75 includes all PRC citizens and all other natural persons, including foreigners, who habitually reside in the PRC for economic benefit. The SAFE implementation notice of November 24, 2005 further clarifies that the term “PRC natural person residents” as used under SAFE Notice 75 refers to those


94


Table of Contents

“PRC natural person residents” defined under the relevant PRC tax laws and those natural persons who hold any interests in domestic entities that are classified as “domestic-funding” interests.
 
PRC residents are required to complete amended registrations with the local SAFE branch upon: (i) injection of equity interests or assets of an onshore enterprise to the offshore entity, or (ii) subsequent overseas equity financing by such offshore entity. PRC residents are also required to complete amended registrations or filing with the local SAFE branch within 30 days of any material change in the shareholding or capital of the offshore entity, such as changes in share capital, share transfers and long-term equity or debt investments, and providing security. PRC residents who have already incorporated or gained control of offshore entities that have made onshore investment in the PRC before SAFE Notice 75 was promulgated must register their shareholding in the offshore entities with the local SAFE branch on or before March 31, 2006.
 
Under SAFE Notice 75, PRC residents are further required to repatriate into the PRC all of their dividends, profits or capital gains obtained from their shareholdings in the offshore entity within 180 days of their receipt of such dividends, profits or capital gains. The registration and filing procedures under SAFE Notice 75 are prerequisites for other approval and registration procedures necessary for capital inflow from the offshore entity, such as inbound investments or shareholders loans, or capital outflow to the offshore entity, such as the payment of profits or dividends, liquidating distributions, equity sale proceeds, or the return of funds upon a capital reduction.
 
In May 2007, the SAFE issued the Operating Procedures of Notice on Issues Relating to the Administration of Foreign Exchange in Fund-raising and Return Investment Activities of Domestic Residents Conducted via Offshore Special Purpose Companies, or SAFE 106 Notice, which became effective as of May 29, 2007. The SAFE 106 Notice provided detailed operating procedures for implementing the SAFE 75. Under the SAFE 106 Notice, establishing or taking control of an offshore special purpose company without prior registration with the relevant local SAFE branch will be deemed as evasion of foreign exchange control or other illegal acts, and may be subject to penalties according to regulations on foreign exchange control and other relevant regulations.
 
New M&A Rule
 
On August 8, 2006, six PRC regulatory agencies, namely, the PRC Ministry of Commerce, the State Assets Supervision and Administration Commission, or SASAC, the State Administration for Taxation, the State Administration for Industry and Commerce, the CSRC, and the SAFE, jointly adopted the Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the New M&A Rule, which became effective on September 8, 2006. This New M&A Rule purports, among other things, to require offshore special purpose vehicles, or SPVs, formed for overseas listing purposes through acquisitions of PRC domestic companies and controlled by PRC companies or individuals, to obtain the approval of the CSRC prior to publicly listing their securities on an overseas stock exchange. On September 21, 2006, the CSRC published a notice on its official website specifying documents and materials required to be submitted to it by SPVs seeking CSRC approval of their overseas listings.
 
While the application of this new regulation remains unclear, we believe, based on the advice of our PRC counsel, Commerce & Finance Law Offices, that CSRC approval is not required in the context of this offering because we established our PRC subsidiary by means of direct investment other than by merger or acquisition of PRC domestic companies. See “Risk Factors — Risks Related to Doing Business in China — The approval of the China Securities Regulatory Commission, or the CSRC, may be required in connection with this offering under a recently adopted PRC regulation. Any requirement to obtain prior CSRC approval could delay this offering and a failure to obtain this approval, if required, may create uncertainties for this offering and could have a material adverse effect on our business, operating results, reputation, prospects and trading price of our ADSs. The regulation also establishes more complex procedures for acquisitions conducted by foreign investors which could make it more difficult to pursue growth through acquisitions.”


95


Table of Contents

 
MANAGEMENT
 
Directors and Executive Officers
 
The following table sets forth information regarding our executive officers and directors as of the date of this prospectus. The business address for each of the directors except for Dr. Duyk and executive officers is Room 706, 7/F, Huantai Building, No. 12A, South Street Zhongguancun, Haidian District, Beijing 100081, People’s Republic of China. The business address for Dr. Duyk is TPG Growth, 345 California St, Suite 3300, SF, CA 94104, USA.
 
                 
Directors and Executive Officers
 
Age
 
Position/Title
 
Guanglin Lai
  43   Chairman of the Board/Co-Chief Executive Officer
Zhaohua Qian
  40   Director
Zhixin Xue
  45   Director/Chief Operating Officer
Gary Kim Ting Yeung
  41   Director/Chief Financial Officer
Geoffrey Duyk
  48   Director
Terry McCarthy
  63   Independent Director Appointee
Shangzhong Xu
  57   Independent Director Appointee
Jiuran Zhao
  45   Independent Director Appointee
Kenneth Hua Huang
  45   Co-Chief Executive Officer
Juliana H. Xu
  31   Chief Technology Officer
Weizhong Wang
  44   Chief Strategy Officer
 
Mr. Guanglin Lai has served as our chairman of the board of directors since June 2007 and as our co-chief executive officer since September 2007. Mr. Lai is also a director of Brothers Capital Limited, which is our largest shareholder. Mr. Lai founded Aero-Biotech Group Limited in 2005 and is a director of this company. Mr. Lai devotes approximately 80% of his time to attend to our business affairs. Prior to that, in 2002, Mr. Lai founded Ace Choice Management Limited, a company that specializes in promoting business and investment activities between the PRC and other countries. From 2000 to 2002, Mr. Lai was managing director of Shenzhen Keding Venture Capital Management Co., Ltd., a venture investment management company. Mr. Lai is the chairman of the audit and nomination committees and a member of the remuneration committee of KXD Digital Entertainment Ltd., a Singapore-listed company that manufactures and sells audiovisual entertainment products. Mr. Lai holds a bachelor’s of business degree in accounting from Monash University, Melbourne, Australia and is a certified public accountant in Australia.
 
Mr. Zhaohua Qian has served as our director since June 2007. Mr. Qian is also a director and the president of Brothers Capital Limited, which is our largest shareholder. Mr. Qian has served as the president of Ace Choice Management Limited since 2002. He is a director of the Husbandry Association of China. Mr. Qian holds a bachelor’s degree in computer science from University of Science and Technology of Beijing.
 
Mr. Zhixin Xue has served as our chief operating officer since June 2007 and as our director since August 2007. Mr. Xue is also the chairman of the board of P3A, our consolidated affiliated entity in China and has served in that position since 2000. Mr. Xue also serves as the chairman of the board of Taiyuan Relord, one of the former shareholders of P3A. Mr. Xue devotes approximately 80% of his time to attend to our business affairs. Mr. Xue was selected as one of the “National Outstanding Entrepreneurs” in 2005, was named as one of the “Outstanding Entrepreneurs of Shanxi Province” in 2005 and one of the “Outstanding Entrepreneurs of Taiyuan” successively from 2002 to 2005 by the local governments. Mr. Xue is a member of the Shanxi Committee of the Chinese People’s Political Consultative Conference, a political advisory body in China. Mr. Xue holds a bachelor of science degree in medicine from Shanxi Medical College.
 
Mr. Gary Kim Ting Yeung has served as our chief financial officer since February 2007 and as our director since September 2007. Prior to joining us, Mr. Yeung was an audit senior manager at PricewaterhouseCoopers, or PwC. Mr. Yeung worked at PwC from 1991 until January 2007. While at PwC,


96


Table of Contents

Mr. Yeung participated in various assignments, including statutory annual audits, financial due diligence and preparing PRC companies for listings of their shares on overseas markets such as the United States, Hong Kong and Singapore. Mr. Yeung is a fellow of the Hong Kong Institute of Certified Public Accountants and the Association of Chartered Certified Accountants. Mr. Yeung holds a bachelor’s degree in accounting from the University of Ulster.
 
Dr. Geoffrey Duyk has served as our director since August 2007. He is the managing director of TPG Growth. From 1996 to 2003, Dr. Duyk was president of research & development and a director of Exelixis Inc. From 1993 to 1996, he was one of the founding scientific staff at Millennium Pharmaceuticals. Prior to that, Dr. Duyk was an assistant professor at Harvard Medical School in the Department of Genetics and an assistant investigator at the Howard Hughes Medical Institute. Dr. Duyk is a council member of the National Human Genome Research Institute at the National Institutes of Health. He also serves on the scientific advisory boards of the NHGRI DNA Sequencing Advisory Panel; the KOMP Global Mouse TKO project (as chair), Expressed Sequenced Consortium; Advisory Panel Cancer Genome Anatomy Project (as co-chair); Program in Genomics Applications (NHBLI); the Bioethics Advisory Group at Case Western Reserve University; the Spinal Muscular Atrophy Foundation; WIL Laboratories; VLST; and FoldRx. Dr. Duyk holds a bachelor’s degree from Wesleyan University and Ph.D. and M.D. degrees from Case Western Reserve University.
 
Mr. Terry McCarthy will serve as our independent director immediately upon completion of this offering. Mr. McCarthy invests in and consults companies doing business in China. He is currently the chairman of audit committee for Solarfun Power Holdings, LTD, a NASDAQ listed company, as well as a director of another privately held company based in China. From 1985 to 2006, Mr. McCarthy worked for Deloitte & Touche LLP in San Jose, California in various roles as a managing partner, tax partner-in-charge and client services partner. From 1993 to 1995, he managed a national reengineering program and software development project for Deloitte and participated in the acquisition and development of Deloitte’s tax software company. Beginning in 1999, he worked extensively with companies entering the China market and, from 2003 to 2006, he was deputy managing partner of the Deloitte US Chinese Services Group. In 1976, Mr. McCarthy co-founded Hayes, Perisho & McCarthy, Inc., a CPA firm in Silicon Valley in California, where he was an audit partner and president when the firm was sold to Touche Ross in 1985. From 1972 to 1976, he held several audit positions at Hurdman & Cranstoun, CPAs, including senior audit manager working with SEC and privately held clients. He received a bachelor’s degree from Pennsylvania State University, an MBA degree from the University of Southern California and a master’s degree in taxation from Golden Gate University.
 
Dr. Shangzhong Xu will serve as our independent director immediately upon the effectiveness of our registration statement on Form F-1, of which this prospectus is a part. Dr. Xu is the director of the Research Institute of Genetic Breeding and a researcher at the Beijing Research Institute of Husbandry Veterinary Science of the Chinese Agricultural Scientific Academy. Dr. Xu specializes in animal genetic breeding and its industrialization, breeding planning, breeder evaluation and marker genes. He established the open nucleus breeding system to conduct breeding selection. Dr. Xu is also the managing director of the Generic Breeding Branch and Genetic Marker Branch of the China Husbandry Veterinary Science Association. Dr. Xu received his Ph.D degree in animal genetic breeding from Beijing Agricultural University and took advanced courses at Michigan State University.
 
Dr. Jiuran Zhao will serve as our independent director immediately upon the effectiveness of our registration statement on Form F-1, of which this prospectus is a part. Since 1997, Dr. Zhao has served as the managing director of the Maize Center of the Agricultural and Forestry Scientific Research Academy in China. From 1986 to 1997, Dr. Zhao worked at the Crop Center of the Agricultural and Forestry Scientific Research Academy, where he began as a researcher, became a vice director and later became the director. Dr. Zhao specializes in the genetic breeding and industrialization of maize and other varieties of crops as well as DNA fingerprint techniques. He is also an agricultural consultant to the Beijing municipal government, the director of the maize expert group of Ministry of Culture of China, a vice director of the China Crop Association, the leader of the National Maize Cultivation Group, a member of the Examination Committee of the Plantation New Variety of Ministry of Culture and an expert for The International Union for the Protection


97


Table of Contents

of New Varieties of Plants. Dr. Zhao received his Ph.D. degree in crop generic breeding from China Agricultural University.
 
Mr. Kenneth Hua Huang has served as our co-chief executive officer since July 2007. Prior to joining us, from September 2005 to June 2007, Mr. Huang was the chief representative in China at Union Switch & Signal Inc., a wholly-owned subsidiary of Ansaldo Signal N.V. engaged in the design and manufacturing of railroad equipment and systems, where he established the company’s office in China and served as the head of its China operations. From 2002 to 2005, Mr. Huang served as the country sales manager of GE Rail China. From 2000 to 2002, Mr. Huang was a senior vice president in charge of all sales and operations at 8848.net (China), Ltd., a company that provides business-to-business and business-to-consumer e-commerce services in China. Mr. Huang holds a bachelor’s degree in communications from Xi’an Jiaotong University and a master’s degree in computer application from Beijing Agriculture University.
 
Dr. Juliana H. Xu has served as our chief technology officer since May 2007. Prior to joining us, from 2004 to 2005, she was a research scientist at Avon Products Inc.’s global research and development center where she led a team in charge of developing products for the Asian market. She also worked at TPG Growth Asia in 2006 and Tianjin Biochip Co., Ltd., a biotech company, in 2007 prior to joining us. Dr. Xu received her bachelor of science in biochemistry from Grove City College, Pennsylvania, an MBA degree from Hong Kong University of Science and Technology and a Ph.D. degree in molecular biology from Cornell University.
 
Dr. Weizhong Wang has served as our chief strategy officer since July 2007. From 2000 to 2007, Dr. Wang served as chairman and president of Denong Seed Science and Technology Development Company, a company that engages in the development, production and marketing of corn, rice, cotton and other agricultural products in China. Dr. Wang holds a Ph.D. degree in agricultural economics from the Chinese Academy of Agriculture.
 
Employment Agreements
 
We have entered into employment agreements with each of our senior executive officers. We may terminate a senior executive officer’s employment for cause, at any time, without notice or remuneration, for certain acts of the officer, including, but not limited to, a conviction or plea of guilty to a felony, negligent or dishonest acts to our detriment or misconduct or a failure to perform agreed duties. A senior executive officer may, upon one-month advance written notice, terminate his or her employment if there is a material reduction in his or her authority, duties and responsibilities, if there is a material reduction in his or her salary or if such resignation is approved by our board of directors. Furthermore, we may, upon advance written notice, terminate a senior executive officer’s employment at any time without cause. Each senior executive officer is entitled to certain benefits upon termination without cause as is expressly required by the jurisdiction in which the executive is based.
 
Each senior executive officer has agreed to hold in strict confidence any trade secrets or confidential information of our company. Each officer agrees to faithfully and diligently serve our company in accordance with the employment agreement and the guidelines, policies and procedures of our company approved from time to time by our board of directors. Each officer also agreed not to compete with the business (as defined in the employment agreement) of our company for a period of two years after he ceases to be employed by our company.
 
Board of Directors
 
Our board of directors currently consists of five directors and will consist of eight directors immediately after the completion of this offering. A director is not required to hold any shares in the company by way of qualification. A director may vote with respect to any contract or transaction in which he or she is materially interested provided the nature of the interest is disclosed prior to its consideration and any vote on such contract or transaction. The directors may exercise all the powers of the company to borrow money, mortgage its undertaking, property and uncalled capital, and issue debentures or other securities whenever outright or as security for any debt, liability or obligation of the company or of any third party.


98


Table of Contents

Committees of the Board of Directors
 
Prior to the closing of this offering, we intend to establish three committees under the board of directors: the audit committee, the compensation committee and the corporate governance and nominating committee. We intend to adopt a charter for each of the three committees prior to the closing of this offering. Each committee’s members and functions are described below.
 
Audit Committee.   Our audit committee will consist of Mr. Terry McCarthy, Dr. Jiuran Zhao and Dr. Shangzhong Xu, all of whom satisfy the independence requirements of Section 303A of the Corporate Governance Rules of the New York Stock Exchange and meet the independence standards under Rule 10A-3 under the Securities Exchange Act of 1934, as amended. Mr. McCarthy will be the chair of our audit committee. The audit committee will oversee our accounting and financial reporting processes and the audits of the financial statements of our company. The audit committee will be responsible for, among other things:
 
  •  selecting the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors;
 
  •  reviewing with the independent auditors any audit problems or difficulties and management’s response;
 
  •  reviewing and approving all proposed related party transactions, as defined in Item 404 of Regulation S-K under the Securities Act;
 
  •  discussing the annual audited financial statements with management and the independent auditors;
 
  •  reviewing major issues as to the adequacy of our internal controls and any special audit steps adopted in light of material control deficiencies;
 
  •  annually reviewing and reassessing the adequacy of our audit committee charter;
 
  •  meeting separately and periodically with management and the independent auditors; and
 
  •  reporting regularly to the board of directors.
 
Compensation Committee.   Our compensation committee will consist of Mr. Zhaohua Qian, Dr. Jiuran Zhao and Dr. Shangzhong Xu. Dr. Zhao and Dr. Xu satisfy the “independence” requirements of Section 303A of the Corporate Governance Rules of the New York Stock Exchange. Mr. Qian will be the chair of our compensation committee. The compensation committee will assist the board in reviewing and approving the compensation structure, including all forms of compensation, relating to our directors and executive officers. Our chief executive officer may not be present at any committee meeting during which his compensation is deliberated. The compensation committee will be responsible for, among other things:
 
  •  reviewing and recommending total compensation packages to the board for our three most senior executives;
 
  •  approving and overseeing the total compensation packages for our other executives other than the three most senior executives;
 
  •  reviewing and recommending director compensation to the board; and
 
  •  periodically reviewing and approving any long-term incentive compensation or equity plans, programs or similar arrangements, annual bonuses, employee pension and welfare benefit plans.
 
Corporate Governance and Nominating Committee.   Our corporate governance and nominating committee will consist of Mr. Guanglin Lai, Dr. Jiuran Zhao and Dr. Shangzhong Xu. Dr. Zhao and Dr. Xu satisfy the “independence” requirements of Section 303A of the Corporate Governance Rules of the New York Stock Exchange. Mr. Lai will be the chair of our corporate governance and nominating committee. The corporate governance and nominating committee will assist the board of directors in selecting qualified


99


Table of Contents

individuals to become our directors and in determining the composition of the board and its committees. The corporate governance and nominating committee will be responsible for, among other things:
 
  •  selecting and recommending nominees for election or re-election to the board or appointments to fill any vacancy;
 
  •  annually reviewing with the board the current composition of the board with regards to characteristics such as independence, age, skills, experience and availability of service to us;
 
  •  selecting and recommending to the names of directors the board to serve as members of the audit committee, the compensation committee, and the corporate governance and nominating committee;
 
  •  periodically advising the board with regard to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to the board on all matters of corporate governance and on any remedial action to be taken; and
 
  •  monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance.
 
Duties of Directors
 
Under Cayman Islands law, our directors have a fiduciary duty of loyalty to act honestly in good faith with a view to our best interests. Our directors also have a duty to exercise the skill they actually possess with such care and diligence that a reasonably prudent person would exercise in comparable circumstances. In fulfilling their duty of care to us, our directors must ensure compliance with our memorandum and articles of association. A shareholder has the right to seek damages if a duty owed by our directors is breached.
 
Terms of Directors and Officers
 
Our officers are elected by and serve at the discretion of the board of directors. Our current directors are not subject to a term of office and hold office until their resignation, death or incapacity or until their respective successors have been elected and qualified in accordance with our shareholders agreement and our articles of association. Our independent director, Mr. Terry McCarthy is subject to an initial term of two years after his appointment becomes effective, and the other two independent directors, Dr. Jiuran Zhao and Dr. Shangzhong Xu, are not subject to a term of office after their appointments become effective. A director will be removed from office automatically if, among other things, the director (i) becomes bankrupt or makes any arrangement or composition with his creditors or (ii) dies or is found by our company to be or become of unsound mind.
 
Compensation of Directors and Executive Officers
 
For the year ended December 31, 2006, we paid an aggregate of approximately RMB934,400 ($122,754) in cash to our executive officers, and we did not pay any cash compensation to our non-executive directors. We have not set aside any amount to provide pension, retirement or similar benefits for our directors and executive officers.
 
Share Incentives
 
2007 Share Incentive Plan.   We have adopted a 2007 Share Incentive Plan to attract and retain the best available personnel, provide additional incentives to employees, directors and consultants and promote the success of our business. Our board of directors has authorized the issuance of up to 15,000,000 ordinary shares upon exercise of awards granted under our plan, plus an increase of 5,000,000 shares when and if the 15,000,000 ordinary shares plan has been fully used pursuant to the awards granted under the plan and the board approves such increase.


100


Table of Contents

The following table summarizes, as of the date of this prospectus, the options granted to our directors and executive officers and other individuals as a group.
 
                                 
    Ordinary Shares
                   
    Underlying
    Exercise Price
          Date of
 
Name
  Options Awarded     ($/Share)     Date of Grant     Expiration  
 
Zhaohua Qian
    600,000       2.40       July 4, 2007       July 4, 2017  
Zhixin Xue
    600,000       2.40       July 19, 2007       July 19, 2017  
Kenneth Hua Huang
    600,000       2.40       July 19, 2007       July 19, 2017  
Gary Kim Ting Yeung
    600,000       2.40       July 4, 2007       July 4, 2017  
Juliana H. Xu
    600,000       2.40       July 19, 2007       July 19, 2017  
Weizhong Wang
    400,000       2.40       July 19, 2007       July 19, 2017  
Other individuals as a group
    2,500,000       2.40       July 19, 2007       July 19, 2017  
      1,600,000       4.80       July 19, 2007       July 19, 2017  
 
The following paragraphs summarize the terms of our 2007 Share Incentive Plan:
 
Plan Administration.   Our board of directors, or a committee designated by our board or directors, will administer the plan. The committee or the full board of directors, as appropriate, will determine the provisions and terms and conditions of each option grant.
 
Award Agreements.   Options and other share incentives granted under our plan are evidenced by an award agreement, as applicable, that sets forth the terms, conditions and limitations for each grant. In addition, the award agreement also provide that securities granted are subject to a 180-day lock-up period following the effective date of a registration statement filed by us under the Security Act, if so requested by us or any representative of the underwriters in connection with any registration of the offering of any of our securities.
 
Eligibility.   We may grant awards to employees, directors and consultants of our company or any of our related entities, which include our subsidiaries or any entities in which we hold a substantial ownership interest.
 
Acceleration of Options upon Corporate Transactions.   The outstanding options will terminate and accelerate upon occurrence of a change-of-control corporate transaction where the successor entity does not assume our outstanding options under the plan. In such event, each outstanding option will become fully vested and immediately exercisable, and the transfer restrictions on the awards will be released and the repurchase or forfeiture rights will terminate immediately before the date of the change-of-control transaction, provided that the grantee’s continuous service with us shall not be terminated before that date.
 
Term of the Options.   The term of each option grant shall be stated in the stock option agreement, provided that the term shall not exceed 10 years from the date of the grant.
 
Vesting Schedule.   In general, the plan administrator determines, or the stock option agreement specifies, the vesting schedule. The share options have a vesting term of four years.
 
Transfer Restrictions.   Options to purchase our ordinary shares may not be transferred in any manner by the optionee other than by will or the laws of succession and may be exercised during the lifetime of the optionee only by the optionee.
 
Termination of the Plan.   Unless terminated earlier, the plan will terminate automatically in 2017. Our board of directors has the authority to amend or terminate the plan subject to shareholder approval to the extent necessary to comply with applicable law. However, no such action may (i) impair the rights of any optionee unless agreed by the optionee and the plan administrator or (ii) affect the plan administrator’s ability to exercise the powers granted to it under our plan.


101


Table of Contents

 
PRINCIPAL AND SELLING SHAREHOLDERS
 
The following table sets forth information with respect to the beneficial ownership of our ordinary shares, assuming conversion of all of our preferred shares into ordinary shares, as of the date of this prospectus, by:
 
  •  each of our directors and executive officers;
 
  •  each person known to us to own beneficially more than 5.0% of our ordinary shares; and
 
  •  each selling shareholder.
 
                                                 
    Ordinary Shares
             
    Beneficially Owned
             
    Prior to
    Ordinary Shares Being
    Shares Beneficially Owned
 
    This Offering     Sold in This Offering     After This Offering(1)  
    Number(2)     %(3)     Number     %     Number     %  
 
Directors and Executive Officers:
                                               
Guanglin Lai (4)
    86,630,000       84.6                                
Zhaohua Qian (5)
    86,630,000       84.6                                  
Zhixin Xue
                                   
Kenneth Hua Huang
                                   
Gary Kim Ting Yeung
                                   
Juliana H. Xu
                                   
Weizhong Wang
                                   
All directors and executive officers as a group (6)
    86,630,000       84.6                                
Principal and Selling Shareholders:
                                               
Brothers Capital Limited (7)
    86,630,000       84.6                                  
Investment funds affiliated with TPG, represented by TPG Growth AC Ltd. and TPG Biotech II, Ltd. (8)
    8,650,000       8.4                   8,650,000          
Dubai Investment Group L.L.C. (9)
    6,600,000       6.4                   6,600,000          
 
 
(1) Assumes that the underwriters do not exercise the over-allotment option and no other change to the number of ADSs offered by us as set forth on the cover page of this prospectus.
 
(2) Beneficial ownership is determined in accordance with Rule 13d-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended, and includes voting or investment power with respect to the securities.
 
(3) For each person and group included in this table, percentage ownership is calculated by dividing the number of shares beneficially owned by such person or group by the sum of 102,400,000, being the number of ordinary shares outstanding as of this prospectus, and the number of ordinary shares underlying share options held by such person or group that are exercisable within 60 days after the date of this prospectus, if any. Percentage ownership after this offering is calculated by dividing the number of shares beneficially owned by such person or group by the sum of          , being the number of ordinary shares outstanding immediately after the completion of this offering, and the number of ordinary shares underlying share options held by such person or group that are exercisable within 60 days after the date of this prospectus, if any, assuming that underwriters will not exercise their option to purchase additional ADSs in the offering.
 
(4) Includes 86,630,000 ordinary shares owned by Brothers Capital Limited, a British Virgin Islands company of which Mr. Lai is a director. The business address of Mr. Lai is Room 706, 7/F, Huantai Building, No. 12A, South Street Zhongguancw Haidian District, Beijing 100081, People’s Republic of China.
 
(5) Includes 86,630,000 ordinary shares held by Brothers Capital Limited of which Mr. Qian is a director and the president. Mr. Qian disclaims beneficial ownership of these shares. The business address of Mr. Qian is Room 706, 7/F, Huantai Building, No. 12A, South Street Zhongguancw Haidian District, Beijing 100081, People’s Republic of China.


102


Table of Contents

 
(6) Certain directors and executive officers have been granted options pursuant to our 2007 Share Incentive Plan. No such options are exercisable within 60 days after the date of the prospectus. See “Management — Share Incentives.”
 
(7) Brothers Capital Limited is a company incorporated in the British Virgin Islands with two directors, Guanglin Lai and Zhaohua Qian. The registered address of Brothers Capital Limited is Palm Grove House, P.O. Box 438, Road Town, Tortola, British Virgin Islands.
 
(8) Includes 4,170,000 ordinary shares and 1,600,000 ordinary shares convertible from series A preferred shares held by TPG Growth AC Ltd. and 2,080,000 ordinary shares and 800,000 ordinary shares convertible from series A preferred shares held by TPG Biotech II, Ltd. TPG Biotech II, Ltd. is a company incorporated in the Cayman Islands, whose sole shareholder is TPG Biotechnology Partners II, L.P., a Delaware limited partnership, which is managed by its general partner, TPG Biotechnology GenPar II, L.P., a Delaware limited partnership, which is managed by its general partner, TPG Biotech Advisors II, LLC, a Delaware limited liability company, whose sole member is TPG Ventures Holdings, LLC, a Delaware limited liability company, whose managing member is TPG Ventures Partners, L.P., a Delaware limited partnership, which is managed by its general partner, TPG Ventures Professionals, L.P., a Delaware limited partnership, which is managed by its general partner, Tarrant Advisors, Inc., a Texas company, whose sole shareholder is Tarrant Capital Advisors, Inc., a Delaware company, whose shareholders are David Bonderman and James Coulter. TPG Growth AC Ltd. is a company incorporated in the Cayman Islands, whose sole shareholder is TPG Star, L.P., a Delaware limited partnership, which is managed by its general partner, TPG Star GenPar, L.P., a Delaware limited partnership, which is managed by its general partner, TPG Star Advisors, LLC, a Delaware limited liability company, whose sole member is TPG Ventures Holdings, LLC, whose managing member is TPG Ventures Partners, L.P., which is managed by its general partner, TPG Ventures Professionals, L.P., which is managed by its general partner, Tarrant Advisors, Inc., whose sole shareholder is Tarrant Capital Advisors, Inc., whose shareholders are David Bonderman and James Coulter. The registered address for both of these companies is c/o M&C Corporate Services Limited, PO Box 309GT, Ugland House, South Church Street, George Town, Grand Cayman, Cayman Islands.
 
(9) Dubai Investment Group L.L.C. is a company incorporated in United Arab Emirates and controlled by Saud Ahmad Abdulrahman Ba’alawi. The address for Dubai Investment Group L.L.C. is Level 38, Emirates Towers (Offices), P.O. Box 73311 Sheikh Zayed Road, Dubai, United Arab Emirates.
 
As of the date of this prospectus, none of our outstanding Series A preferred shares and ordinary shares was held by record holders in the United States. None of our shareholders has informed us that it is affiliated with a registered broker-dealer, or is in the business of underwriting securities.
 
None of our existing shareholders has different voting rights from other shareholders after the closing of this offering. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company.


103


Table of Contents

 
RELATED PARTY TRANSACTIONS
 
Contractual Arrangements with P3A and Its Shareholders
 
PRC law currently restricts foreign ownership of a seed business in China. We conduct our business primarily through Agria China’s contractual arrangements with P3A and its shareholders. See “Corporate History and Structure” for a description of these contractual arrangements.
 
Other Transactions with P3A and Its Affiliates
 
On June 8, 2007, an agreement on equity interests of P3A was entered into among P3A, P3A’s five former shareholders and P3A’s four current shareholders, and China Victory International Holdings Limited, which is our wholly-owned subsidiary. This agreement confirms that P3A’s former shareholders do not have any outstanding rights or obligations with respect to P3A. Under the agreement, P3A’s current shareholders have agreed to cause the individuals nominated by Agria China to be elected as P3A’s directors and to grant a voting proxy to the individual(s) designated by Agria China to vote on all matters subject to shareholder approval at P3A’s shareholder meetings. In addition, P3A’s current shareholders are prohibited from transferring, pledging or otherwise disposing of their equity interests in P3A without prior written consent of China Victory. P3A’s current shareholders have also agreed to enter into and cause P3A to enter into a series of agreements, including service agreement, share pledge agreement and exclusive option agreement, with Agria China in form and substance satisfactory to Agria China, and not to sign any contract relating to P3A or to distribute any dividends without the prior written consent of Agria China. Concurrently with the execution of this agreement, P3A, P3A’s current shareholders and Agria China entered into a series of contractual arrangements as described in “Corporate History and Structure.”
 
On June 8, 2007, P3A and Agria China entered into a proprietary technology transfer agreement, whereby P3A transferred to Agria China certain proprietary technologies owned by P3A. Agria China has agreed to pay RMB13.6 million to P3A in consideration for this technology transfer.
 
On June 8, 2007, P3A and Primalights III Biotech Engineer Academy, or P3A Academy, entered into a proprietary technology transfer agreement, whereby P3A Academy transferred to P3A all of the proprietary technologies that P3A Academy had developed or acquired. P3A was not required to make any new payment for this transfer, as it had been funding P3A Academy’s research and development activities.
 
On October 25, 2006, P3A and Taiyuan Relord, a related party, entered into a transfer of forest ownership agreement, pursuant to which Taiyuan Relord transferred to P3A 200,200 date trees at the price of RMB43.6 million and leased to P3A four pieces of land with the total size of approximately 165 acres where the date trees grow upon at the rent of RMB1.2 million each year starting from November 2007.
 
P3A entered into a lease agreement with Taiyuan Relord on October 25, 2006 for the lease of a piece of land for growing date trees. The term of the lease is 45 years. The annual rent under the lease is RMB673,000.
 
On June 28, 2007, Brothers Capital Limited, our controlling shareholder, made a loan of US$20.2 million at interest rate of 7% per annum to our subsidiary, China Victory International Holdings Limited to enable China Victory to fund the registered capital of its directly wholly-owned subsidiary, Agria China, as required under applicable PRC law. The loan is repayable to Brothers Capital Limited at the earlier of demand by Brothers Capital Limited or June 28, 2008.
 
We guaranteed a short-term bank loan in the amount of RMB1.5 million extended to Taiyuan Relord on June 30, 2007. We did not receive any fee for providing the guarantee. The bank loan is repayable on December 27, 2007 and the guarantee will be released when the bank loan is repaid.
 
We typically sell our white bark pine seedlings to Taiyuan Relord, which was one of the former shareholders of P3A and is currently an affiliate of P3A. Our chief operating officer is the sole shareholder of Taiyuan Relord.


104


Table of Contents

Private Placement
 
On June 22, 2007, we issued and sold 2,400,000 shares of Series A preferred shares at a purchase price of $4.1667 per share in a private placement. The investors in the private placement were TPG Growth AC Ltd. (which purchased 1,600,000 preferred shares from us) and TPG Biotech II, Ltd. (which purchased 800,000 preferred shares from us) (together, “TPG”). TPG was an unrelated third party prior to its investment in our Series A preferred shares. The value of the Series A preferred shares was determined based on arm’s-length negotiations between TPG and us and was approved by our board of directors. Each Series A preferred share is convertible into our ordinary shares at the option of the holders at any time before the completion of this offering. Holders of our Series A preferred shares have the right to receive an annual dividend of 8% if this offering is not consummated prior to July 31, 2008. However, if this offering is consummated prior to July 31, 2008, then such holders shall not be entitled to receive any dividend. Concurrently with our issuance and sale of Series A preferred shares to TPG, Brother Capital Limited, the largest shareholder of our company, transferred and sold 4,170,000 and 2,080,000 ordinary shares to TPG Growth AC Ltd. and TPG Biotech II, Ltd., respectively.
 
In August 2007, our shareholders authorized a 10,000-for-1 share split of our ordinary shares and our preferred shares. Upon the effecting of the share split, TPG Growth AC Ltd. held 1,600,000 Series A preferred shares and 4,170,000 ordinary shares and TPG Biotech II, Ltd. held 800,000 Series A preferred shares and 2,080,000 ordinary shares.
 
Registration Rights Agreement
 
We and TPG have entered into a registration rights agreement dated June 22, 2007. Under the terms of this agreement, TPG (and certain subsequent transferees of TPG) may, at any time following 180 days after an initial public offering by us, require us to effect up to two registrations (and unlimited registrations on Form F-3) of ordinary shares held by such parties, subject to certain offering size limitations. The agreement also grants to TPG (and certain subsequent transferees of TPG) “piggyback” registration rights, other than in connection with a registration by us pursuant to a stock option plan or other employee benefit plan, a registration on Form S-8 or a registration relating to a corporate reorganization. In the event we use reasonable best efforts but are unable to register our shares, we have no liabilities to these shareholders. We, TPG and Dubai Investment Group L.L.C., or DIG, entered into a deed of adherence dated August 30, 2007 whereby DIG agreed to comply with and be bound by all of the provisions of the registration rights agreement in all respects as if DIG were a party to the agreement and were named therein as a party, and on the basis that references therein to holders of registrable securities shall include a separate reference to DIG, and the ordinary shares (and any other shares of capital stock) held by DIG shall constitute registrable securities. The deed of adherence superseded and replaced any prior understanding, agreement or statement of intent, in each case written or oral, of any kind and every nature with respect to DIG’s registration rights. The purpose of the deed of adherence was to ensure that the eligible shareholders have the same registration rights under the same agreement.
 
Undertaking Agreement
 
On June 22, 2007, we entered into an agreement with Brothers Capital Limited and TPG, whereby each party to the agreement agreed to use its reasonable best efforts to cause each of our shareholders to enter into a new agreement regarding share transfers, our memorandum and articles of association and a new registration rights agreement as soon as possible but no later than the public filing date of this registration statement. Such agreements would clarify the relationship between our memorandum and articles of association and certain investment agreements of our shareholders as well as grant each of our shareholders substantially similar rights and obligations with respect to transfer and preemption as well as equivalent piggyback and demand (to the extent such shareholder currently enjoys demand registration rights under an existing agreement) registration rights.


105


Table of Contents

Shareholders Agreement
 
We, Brothers Capital Limited and TPG have entered into a shareholders agreement dated June 22, 2007. Under this shareholders agreement, our board of directors shall comprise six directors, including five directors designated by Brothers Capital Limited and one director jointly designated by the purchasers. The purchasers have the right to nominate one independent director, subject to the approval of our board of directors. The shareholders agreement also imposes certain restrictions on a transfer of shares by Brothers Capital Limited and the purchasers, and grants preemptive rights to the purchasers except with respect to this offering and certain other issuances. Brothers Capital Limited and the purchasers each have certain rights of first refusal and co-sale rights with respect to certain proposed share transfers by the purchasers or Brothers Capital Limited, as applicable. In addition, if this offering is not a completed offering prior to December 31, 2008, the purchasers, acting jointly, shall have the right, for 90 days thereafter, to require us to redeem or purchase all shares purchased by them pursuant to the private placement by delivering a written notice to us. Such rights, and other rights and obligations of Brothers Capital Limited and the purchasers under the shareholders agreement, will terminate upon the completion of this offering, except for limited exceptions related to confidential information.
 
Employment Agreements
 
See “Management — Employment Agreements.”
 
Share Incentives
 
See “Management — Share Incentives.”


106


Table of Contents

DESCRIPTION OF SHARE CAPITAL
 
We are a Cayman Islands exempted company and our affairs are governed by our memorandum and articles of association, as amended and restated from time to time, and the Companies Law (2007 Revision) of the Cayman Islands (the “Companies Law”).
 
As of September 30, 2007, our authorized share capital was $50,000 consisting of (i) 499,900,000,000 ordinary shares with a par value of $0.0000001 each, of which 100,000,000 shares are issued and outstanding; (ii) 100,000,000 Series A preferred shares authorized with a par value of $0.0000001 each, of which 2,400,000 are issued and outstanding. All of our issued and outstanding Series A preferred shares will automatically convert into 2,400,000 ordinary shares automatically upon the closing of this offering.
 
We have adopted an amended and restated memorandum and articles of association, which will become effective immediately prior to the completion of this offering and replace the current memorandum and articles of association in its entirety. The following are summaries of material provisions of our amended and restated memorandum and articles of association and the Companies Law insofar as they relate to the material terms of our shares.
 
Ordinary Shares
 
General.   All of our outstanding ordinary shares are fully paid and non-assessable. Certificates representing the ordinary shares are issued in registered form. Our shareholders who are nonresidents of the Cayman Islands may freely hold and vote their shares.
 
Dividends.   The holders of our ordinary shares are entitled to such dividends as may be declared by our board of directors subject to the Companies Law.
 
Voting Rights.   Each ordinary share is entitled to one vote on all matters upon which the ordinary shares are entitled to vote. Voting at any shareholders’ meeting is conducted by a show of hands unless a poll is demanded. A poll may be demanded by our chairman or any shareholder holding at least 10% of the shares given a right to vote at the meeting, present in person or by proxy.
 
A quorum required for a meeting of shareholders consists of shareholders holding an aggregate of at least one-third of our voting share capital present in person or by proxy or, if a corporation or other non-natural person, by its duly authorized representative. Shareholders’ meetings may be convened by our board of directors on its own initiative or upon a request to the directors by shareholders holding in aggregate at least one-third of our voting share capital. Advance notice of at least seven days is required for the convening of our shareholders’ meetings.
 
An ordinary resolution to be passed by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast in a general meeting, while a special resolution requires a unanimous written resolution. A special resolution is required for important matters such as altering the amount of our authorized share capital and amending our articles of association.
 
Transfer of Shares.   Subject to the restrictions of our memorandum and articles of association, as applicable, any of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved by our board.
 
Our board of directors may, in its sole discretion, decline to register any transfer of any ordinary share unless (a) the transfer is from the shareholder to such shareholder’s affiliate, or (b) the transfer complies with the shareholder’s transfer obligations and restrictions under applicable law and our articles of association.


107


Table of Contents

If our directors refuse to register a transfer they shall, within two months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal. The registration of transfers may be suspended and the register closed at such times and for such periods as our board of directors may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register closed for more than 45 days in any year.
 
Liquidation.   If we are wound up, the liquidator may, with the sanction of a special resolution and any other sanction required by the Companies Law, divide among our shareholders in specie or kind the whole or any part of our assets (whether they shall consist of property of the same kind or not) and may, for such purpose, set such value as the liquidator deems fair upon any property to be divided and may determine how such division shall be carried out as between the shareholders or different classes of shareholders. The liquidator may also vest any part of these assets in trustees upon such trusts for the benefit of the shareholders as the liquidator shall think fit, but so that no shareholder will be compelled to accept any assets, shares or other securities upon which there is a liability.
 
Calls on Shares and Forfeiture of Shares.   Our board of directors may from time to time make calls upon shareholders for any amounts unpaid on their shares in a notice served to such shareholders at least 14 days prior to the specified time and place of payment. The shares that have been called upon and remain unpaid on the specified time are subject to forfeiture.
 
Redemption of Shares.   Subject to the provisions of the Companies Law, we may issue shares on terms that are subject to redemption at our option on such terms and in such manner as may be determined by special resolution.
 
Variations of Rights of Shares.   All or any of the special rights attached to any class of shares may, subject to the provisions of the Companies Law, be varied either with the written consent of a majority holders of the issued shares of that class or with the sanction of a special resolution passed at a general meeting of the holders of the shares of that class.
 
Inspection of Books and Records.   Holders of our ordinary shares will have no general right under Cayman Islands law to inspect or obtain copies of our list of shareholders or our corporate records. However, we will file our annual audited financial statements in accordance with the Companies Law.
 
Preferred Shares
 
Immediately prior to the closing of this offering, each outstanding share of our preferred shares will be converted into one share of ordinary share.
 
After the closing of this offering, our board of directors will have the authority, without shareholder approval, to issue up to a total of 50,000,000,000 shares of preferred shares in one or more series. Our board of directors may establish the number of shares to be included in each such series and may set the designations, preferences, powers and other rights of the shares of a series of preferred shares. While the issuance of preferred shares provides us with flexibility in connection with possible acquisitions or other corporate purposes, it could, among other things, have the effect of delaying, deferring or preventing a change of control transaction and could adversely affect the market price of our ADSs. We have no current plan to issue any preferred shares.
 
History of Securities Issuances
 
The following is a summary of securities issuances by us during the past three years.
 
Ordinary Shares.   On June 13, 2007, we issued 10,000 ordinary shares to Brothers Capital Limited upon incorporation. On June 21, 2007, we issued 76,740,000 ordinary shares to Brothers Capital Limited, 10,000,000 ordinary shares to Morgan Finanz Capital Limited, 10,000,000 ordinary shares to Ariya Capital Partners Limited and 3,250,000 ordinary shares to Dubai Investment Group L.L.C in exchange for the same


108


Table of Contents

number of ordinary shares in Aero-Biotech contributed to us by these shareholders. Morgan Finanz Capital Limited and Ariya Capital Partners Limited are wholly owned by Brothers Capital Limited.
 
Preferred Shares.   On June 22, 2007, we issued 1,600,000 Series A preferred shares to TPG Growth AC Ltd. and 800,000 Series A preferred shares to TPG Biotech II, Ltd.
 
Options.   As of September 30, 2007, we have granted options to purchase a total of 7,500,000 ordinary shares to certain directors and executive officers. See “Management — Share Incentives.”
 
Differences in Corporate Law
 
The Companies Law is modeled after that of the United Kingdom but does not follow many recent United Kingdom statutory enactments. In addition, the Companies Law differs from laws applicable to United States corporations and their shareholders. Set forth below is a summary of the significant differences between the provisions of the Companies Law applicable to us and the laws applicable to companies incorporated in the United States and their shareholders.
 
Mergers and Similar Arrangements.   Cayman Islands law does not provide for mergers as that expression is understood under United States corporate law. However, there are statutory provisions that facilitate the reconstruction and amalgamation of companies, provided that the arrangement is approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that:
 
  •  the statutory provisions as to majority vote have been met;
 
  •  the shareholders have been fairly represented at the meeting in question;
 
  •  the arrangement is such that a businessman would reasonably approve; and
 
  •  the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Law.
 
When a take-over offer is made and accepted by holders of 90.0% of the shares within four months, the offerer may, within a two month period, require the holders of the remaining shares to transfer such shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed unless there is evidence of fraud, bad faith or collusion.
 
If the arrangement and reconstruction is thus approved, the dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of United States corporations, providing rights to receive payment in cash for the judicially determined value of the shares.
 
Shareholders’ Suits.   We are not aware of any reported class action or derivative action having been brought in a Cayman Islands court. In principle, we will normally be the proper plaintiff and a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, exceptions to the foregoing principle apply in circumstances in which:
 
  •  a company is acting or proposing to act illegally or ultra vires;
 
  •  the act complained of, although not ultra vires, could be effected duly if authorized by more than a special resolution that vote which has not been obtained; and
 
  •  those who control the company are perpetrating a “fraud on the minority.”


109


Table of Contents

 
Indemnification.   Cayman Islands law does not limit the extent to which a company’s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.
 
We intend to adopt an amended and restated memorandum and articles of association upon the closing of this offering. Under our amended and restated memorandum and articles of association, we may indemnify our directors, officers, employees and agents against expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by such persons in connection with actions, suits or proceedings to which they are party or are threatened to be made a party by reason of their acting as our directors, officers, employees or agents. To be entitled to indemnification, these persons must have acted in good faith and in the best interest and not contrary to the interest of our company, and must not have acted in a manner willfully or grossly negligent and, with respect to any criminal action, they must have had no reasonable cause to believe their conduct was unlawful. Our amended and restated memorandum and articles of association may also provide for indemnification of such person in the case of a suit initiated by our company or in the right of our company.
 
We intend to enter into indemnification agreements with our directors and executive officers to indemnify them to the fullest extent permitted by applicable law and our articles of association, from and against all costs, charges, expenses, liabilities and losses incurred in connection with any litigation, suit or proceeding to which such director is or is threatened to be made a party, witness or other participant.
 
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us under the foregoing provisions, we have been advised that in the opinion of the Securities and Exchange Commission, or the SEC, such indemnification is against public policy as expressed in the Securities Act and therefore is unenforceable.
 
Registration Rights
 
Pursuant to our registration rights agreement entered into on June 22, 2007, we have granted certain registration rights to holders of our registrable securities, which include holders of our Series A preferred shares and ordinary shares issued to the holders of our Series A preferred share as of the date of the agreement, as well as certain holder of our ordinary shares. Set forth below is a description of the registration rights granted under the agreement.
 
Demand Registration Rights.   At any time commencing six months after this offering, holders of at least 50% of registrable securities have the right to demand that we file a registration statement covering the offer and sale of their securities. We, however, are not obligated to effect a demand registration (1) after we have already effected two demand registrations, (2) during the period beginning on the 60th day prior to our good faith estimate of the filing date of, and ending on the 180th day after the effective date of, a public offering of our securities initiated by us, (3) if the securities to be registered can be registered on Form F-3, or (4) in any particular jurisdiction in which we would be required to execute a general consent to service of process in effecting such registration, unless we are already subject to service in such jurisdiction and except as may be required under the U.S. Securities Act of 1933. We have the right to defer filing of a registration statement for up to 90 days if we provide the requesting holders a certificate signed by either our chief executive officer or chairman of the board of directors stating that in the good faith judgment of the board of directors that filing of a registration statement will be seriously detrimental to us and our shareholders for such registration statement to be effect at such time, but we cannot exercise the deferral right more than once in any 12-month period and we cannot register any securities for the account of ourselves or any other shareholder during such 90-day period.
 
Piggyback Registration Rights.   If we propose to file a registration statement for a public offering of our securities other than, among other things, pursuant to an F-3 registration statement or other than relating to a stock option plan or a corporate reorganization, then we must offer holders of registrable securities an opportunity to include in the registration all or any part of their registrable securities. The underwriters of any


110


Table of Contents

underwritten offering will have the right to limit the number of shares having registration rights to be included in the registration statement.
 
Form F-3 Registration Rights.   When we are eligible for use of Form F-3, holders of our registrable securities then outstanding have the right to request that we file a registration statement under Form F-3. We are not obligated to file a registration statement on Form F-3 (1) if we have, within the twelve month period preceding the date of such request, already effected one registration on Form F-3 for the holders of our registrable securities, (2) in any particular jurisdiction in which we would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance. We have the right to defer filing of a registration statement for up to 90 days if we provide the requesting holders a certificate signed by either our chief executive officer or chairman of the board of directors stating that in the good faith judgment of the board of directors that filing of a registration statement will be seriously detrimental to us and our shareholders for such registration statement to be effect at such time, but we cannot exercise the deferral right more than once in any 12-month period and we cannot register any securities for the account of ourselves or any other shareholder during such 90-day period.
 
Expenses of Registration.   We will pay all expenses, other than underwriting discounts and commissions, relating to any demand, piggyback or F-3 registration.


111


Table of Contents

 
DESCRIPTION OF AMERICAN DEPOSITARY SHARES
 
American Depositary Shares
 
The Bank of New York, as depositary, will register and deliver American Depositary Shares, or ADSs. Each ADS will represent       shares (or a right to receive       shares) deposited with the Hong Kong office of The Hongkong and Shanghai Banking Corporation Limited, as custodian for the depositary. Each ADS will also represent any other securities, cash or other property which may be held by the depositary. The depositary’s corporate trust office at which the ADSs will be administered is located at 101 Barclay Street, New York, N.Y. 10286. The Bank of New York’s principal executive office is located at One Wall Street, New York, N.Y. 10286.
 
You may hold ADSs either (A) directly (i) by having an American Depositary Receipt, or ADR, which is a certificate evidencing a specific number of ADSs, registered in your name, or (ii) by holding ADSs in the Direct Registration System, or DRS or (B) indirectly through your broker or other financial institution. If you hold ADSs directly, you are an ADS holder. This description assumes you hold your ADSs directly. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADR holders described in this section. You should consult with your broker or financial institution to find out what those procedures are.
 
The DRS is a system administered by The Depository Trust Company, or DTC pursuant to which the depositary may register the ownership of uncertificated ADSs, which ownership shall be evidenced by periodic statements issued by the depositary to the ADS holders entitled thereto.
 
As an ADS holder, we will not treat you as one of our shareholders and you will not have shareholder rights. Cayman Islands law governs shareholder rights. The depositary will be the holder of the shares underlying your ADSs. As a holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary and you, as an ADS holder, and the beneficial owners of ADSs set out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs.
 
The following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of ADR. Directions on how to obtain copies of those documents are provided in the section of this prospectus headed “Where You Can Find Additional Information.”
 
Dividends and Other Distributions
 
How will you receive dividends and other distributions on the shares?
 
The depositary has agreed to pay to you the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, after deducting its fees and expenses. You will receive these distributions in proportion to the number of shares your ADSs represent.
 
  •  Cash.   The depositary will convert any cash dividend or other cash distribution we pay on the shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the U.S. dollars to the United States. If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those ADR holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest.
 
Before making a distribution, any withholding taxes, or other governmental charges that must be paid will be deducted. See the section of this prospectus headed “Taxation.” It will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some or all of the value of the distribution.


112


Table of Contents

 
  •  Shares.   The depositary may distribute additional ADSs representing any shares we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It will sell shares which would require it to deliver a fractional ADS and distribute the net proceeds in the same way as it does with cash. If the depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new shares.
 
  •  Rights to purchase additional shares.   If we offer holders of our securities any rights to subscribe for additional shares or any other rights, the depositary may make these rights available to you. If the depositary decides it is not lawful and feasible to make the rights available but that it is practical to sell the rights, the depositary may sell the rights and distribute the proceeds in the same way as it does with cash. The depositary will allow rights that are not distributed or sold to lapse. In that case, you will receive no value for them.
 
If the depositary makes rights available to you, it will exercise the rights and purchase the shares on your behalf. The depositary will then deposit the shares and deliver ADSs to you. It will only exercise rights if you pay it the exercise price and any other charges the rights require you to pay.
 
Because rights offerings are offerings of securities, we cannot make rights available to you in the United States unless we register the rights and the securities to which the rights relate under the Securities Act or an exemption from the registration requirements is available. Also, under the deposit agreement, the depositary will not make rights available to you unless the distribution to ADS holders of both the rights and any related securities are either registered under the Securities Act or exempted from registration under the Securities Act. If rights are made available to you pursuant to an exemption from the registration requirements of the Securities Act, transfers and cancellation of ADSs represented by shares purchased upon exercise of rights may be restricted so as to ensure compliance with the conditions or requirements of the exemption.
 
  •  Other Distributions.   The depositary will send to you anything else we distribute on deposited securities by any means it thinks is equitable and practical. If it cannot make the distribution in that way, the depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Or, it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities (other than ADSs) to you unless it receives satisfactory evidence from us that it is legal to make that distribution.
 
The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. This means that you may not receive the distributions we make on our shares or any value for them if it is illegal or impractical for us to make them available to you .
 
Deposit, Withdrawal and Cancellation
 
How are ADSs issued?
 
The depositary will deliver ADSs if you or your broker deposit shares or evidence of rights to receive shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons entitled thereto.
 
How do ADS holders cancel an American Depositary Share?
 
You may turn in your ADSs at the depositary’s corporate trust office. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the shares and any other deposited securities underlying the ADSs to you or a person you designate at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its corporate trust office, if feasible.


113


Table of Contents

How do ADS holders interchange between Certificated ADSs and Uncertificated ADSs?
 
You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will send you a statement confirming that you are the owner of uncertificated ADSs. Alternatively, upon receipt by the depositary of a proper instruction from a holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to you an ADR evidencing those ADSs.
 
Voting Rights
 
How do you vote?
 
You may instruct the depositary to vote the Deposited Securities, but only if we ask the depositary to ask for your instructions. Otherwise, you won’t be able to exercise your right to vote unless you withdraw the shares. However, you may not know about the meeting enough in advance to withdraw the shares.
 
If we ask for your instructions, the depositary will notify you of the upcoming vote and arrange to deliver our voting materials to you. The materials will (1) describe the matters to be voted on and (2) explain how you may instruct the depositary to vote the shares or other deposited securities underlying your ADSs as you direct, including an express indication that such instruction may be given or deemed given if no instruction is received, to the depositary to give a discretionary proxy to a person designated by us. For instructions to be valid, the depositary must receive them on or before the date specified. The depositary will try, as far as practical, subject to the laws of the Cayman Islands and of the Memorandum and Articles of Association, to vote or to have its agents vote the shares or other deposited securities as you instruct. The depositary will only vote or attempt to vote as you instruct. If no instructions are received by the depositary from any owner with respect to any of the deposited securities represented by the ADSs on or before the date established by the depositary for such purpose, the depositary shall deem the owner to have instructed the depositary to give a discretionary proxy to a person designated by us with respect to such deposited securities, and the depositary shall give a discretionary proxy to a person designated by us to vote such deposited securities. No such instruction shall be deemed given and no such discretionary proxy shall be given with respect to any matter that we inform the depositary we do not wish such proxy given, where substantial opposition exists or if such matter materially and adversely affects the rights of holders of the shares.
 
We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote your shares. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. This means that you may not be able to exercise your right to vote and there may be nothing you can do if your shares are not voted as you requested.
 
In order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to deposited securities, if we request the depositary to act, we shall give the depositary notice of any such meeting and details concerning the matters to be voted upon not less than 45 days in advance of the meeting date.
 
Fees and Expenses
 
Persons depositing or withdrawing shares must pay : For :
 
$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)
• Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property
 
• Cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates
 
$0.02 (or less) per ADS
• Any cash distribution to you


114


Table of Contents

 
A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs
• Distribution of securities distributed to holders of deposited securities which are distributed by the depositary to ADS holders
 
$0.02 (or less) per ADSs per calendar year
• Depositary services
 
Registration or transfer fees
• Transfer and registration of shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw shares
 
Expenses of the depositary
• Cable, telex and facsimile transmissions (when expressly provided in the deposit agreement)
 
• converting foreign currency to U.S. dollars
 
Taxes and other governmental charges the depositary or the custodian have to pay on any ADS or share underlying an ADS, for example, stock transfer taxes, stamp duty or withholding taxes
• As necessary
 
Any charges incurred by the depositary or its agents for servicing the deposited securities
• As necessary
 
Payment of Taxes
 
You will be responsible for any taxes or other governmental charges payable on your ADSs or on the deposited securities represented by any of your ADSs. The depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by your ADSs until such taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to you any proceeds, or send to you any property, remaining after it has paid the taxes.
 
Reclassifications, Recapitalizations and Mergers
 
     
If we:   Then:
 
•   Change the nominal or par value of our shares
  The cash, shares or other securities received by the depositary will become deposited securities. Each
•   Reclassify, split up or consolidate any of the deposited securities
  ADS will automatically represent its equal share of the new deposited securities.
•   Distribute securities on the shares that are not distributed to you
  The depositary may, and will if we ask it to, distribute some or all of the cash, shares or other securities it received. It may also deliver new ADSs or ask you to surrender your outstanding ADSs in
•   Recapitalize, reorganize, merge, liquidate, sell all or substantially all of our assets, or take any similar action
  exchange for new ADSs identifying the new deposited securities.
 
Amendment and Termination
 
How may the deposit agreement be amended?
 
We may agree with the depositary to amend the deposit agreement and the ADSs without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental


115


Table of Contents

charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADS holders, it will not become effective for outstanding ADSs until 30 days after the depositary notifies ADS holders of the amendment. At the time an amendment becomes effective, you are considered, by continuing to hold your ADS, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended .
 
How may the deposit agreement be terminated?
 
The depositary will terminate the deposit agreement at our direction by mailing notice of termination to the ADS holders then outstanding at least 60 days prior to the date fixed in such notice for such termination. The depositary may also terminate the deposit agreement by mailing notice of termination to us and the ADS holders then outstanding if at any time 30 days shall have expired after the depositary shall have delivered to the Company a written notice of its election to resign and a successor depositary shall not have been appointed and accepted its appointment. In this case, the depositary will mail a notice of termination to the ADS holders at least 30 days prior to the termination date.
 
After termination, the depositary and its agents will do the following under the deposit agreement but nothing else: collect distributions on the deposited securities, sell rights and other property, and deliver shares and other deposited securities upon cancellation of ADSs. Four months after termination, the depositary may sell any remaining deposited securities by public or private sale. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement for the pro rata benefit of the ADS holders that have not surrendered their ADSs. It will not invest the money and has no liability for interest. The depositary’s only obligations will be to account for the money and other cash. After termination our only obligations will be to indemnify the depositary and to pay fees and expenses of the depositary that we agreed to pay.
 
Limitations on Obligations and Liability
 
Limits on our Obligations and the Obligations of the Depositary; Limits on Liability to Holders of ADSs
 
The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary. We and the depositary:
 
  •  are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith;
 
  •  are not liable if either of us is prevented or delayed by law or circumstances beyond our control from performing our obligations under the deposit agreement;
 
  •  are not liable if either of us exercises discretion permitted under the deposit agreement;
 
  •  have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other party;
 
  •  may rely upon any documents we believe in good faith to be genuine and to have been signed or presented by the proper party.
 
In the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances.
 
Waiver of Jury Trial
 
Under the deposit agreement, by holding ADSs, the ADS holders agree to irrevocably waive, to the fullest extent permitted by applicable law, any right you may have to a trial by jury in any suit, action or proceeding against us and/or the depositary directly or indirectly relating to, among other things, the shares, the ADSs, the deposit agreement or any securities, transactions or any other question contemplated or arising in connection with the deposit agreement.


116


Table of Contents

Requirements for Depositary Actions
 
Before the depositary will deliver or register a transfer of an ADS, make a distribution on an ADS, or permit withdrawal of shares, the depositary may require:
 
  •  payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities;
 
  •  satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and
 
  •  compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents.
 
The depositary may refuse to deliver ADSs or register transfers of ADSs generally when the transfer books of the depositary or our transfer books are closed or at any time if the depositary or we think it advisable to do so.
 
Your Right to Receive the Shares Underlying your ADRs
 
You have the right to cancel your ADSs and withdraw the underlying shares at any time except:
 
  •  When temporary delays arise because: (i) the depositary has closed its transfer books or we have closed our transfer books; (ii) the transfer of shares is blocked to permit voting at a shareholders’ meeting; or (iii) we are paying a dividend on our shares.
 
  •  When you or other ADS holders seeking to withdraw shares owe money to pay fees, taxes and similar charges.
 
  •  When it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of shares or other deposited securities.
 
This right of withdrawal may not be limited by any other provision of the deposit agreement.
 
Pre-release of ADSs
 
The deposit agreement permits the depositary to deliver ADSs before deposit of the underlying shares. This is called a pre-release of the ADSs. The depositary may also deliver shares upon cancellation of pre-released ADSs (even if the ADSs are canceled before the pre-release transaction has been closed out). A pre-release is closed out as soon as the underlying shares are delivered to the depositary. The depositary may receive ADSs instead of shares to close out a pre-release. The depositary may pre-release ADSs only under the following conditions: (1) before or at the time of the pre-release, the person to whom the pre-release is being made represents to the depositary in writing that it or its customer owns the shares or ADSs to be deposited; (2) the pre-release is fully collateralized with cash or other collateral that the depositary considers appropriate and (3) the depositary must be able to close out the pre-release on not more than five business days’ notice. In addition, the depositary will limit the number of ADSs that may be outstanding at any time as a result of pre-release, although the depositary may disregard the limit from time to time, if it thinks it is appropriate to do so.
 
Direct Registration System
 
In the Deposit Agreement, all parties to the Deposit Agreement acknowledge that the DRS and Profile Modification System, or Profile, will apply to uncertificated ADSs upon acceptance thereof to DRS by the Depository Trust Company. DRS is the system administered by DTC pursuant to which the depositary may register the ownership of uncertificated American Depositary Shares, which ownership shall be evidenced by periodic statements issued by the depositary to the ADS holders entitled thereto. Profile is a required feature of DRS which allows a DTC participant, claiming to act on behalf of an ADS holder, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of


117


Table of Contents

that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register such transfer.
 
In connection with and in accordance with the arrangements and procedures relating to the DRS/Profile, the parties to the Deposit Agreement understand that the depositary will not verify, determine or otherwise ascertain that the DTC participant which is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and delivery described in the paragraph above has the actual authority to act on behalf of the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the Deposit Agreement, the parties agree that the depositary’s reliance on and compliance with instructions received by the depositary through the DRS/Profile System and in accordance with the Deposit Agreement, shall not constitute negligence or bad faith on the part of the Depositary.


118


Table of Contents

 
SHARES ELIGIBLE FOR FUTURE SALE
 
Upon completion of this offering, we will have outstanding       ADSs representing approximately      % of our ordinary shares in issue. All of the ADSs sold in this offering will be freely transferable by persons other than our “affiliates” without restriction or further registration under the Securities Act. Sales of substantial amounts of our ADSs in the public market could adversely affect prevailing market prices of our ADSs. Prior to this offering, there has been no public market for our ordinary shares or the ADSs, and while application has been made for the ADSs to be listed on the New York Stock Exchange, we cannot assure you that a regular trading market will develop in the ADSs. We do not expect that a trading market will develop for our ordinary shares not represented by the ADSs.
 
Lock-Up Agreements
 
We have agreed that we will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, or file with the SEC a registration statement under the Securities Act relating to, any ADSs or shares of ordinary shares, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, without the prior written consent of the representatives for a period of 180 days after the date of this prospectus.
 
Our officers, directors and all of our existing shareholders have agreed that they will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any ADSs or shares of ordinary shares or securities convertible into or exchangeable or exercisable for any ADSs or shares of ordinary shares, enter into a transaction that would have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of our ADSs, whether any of these transactions are to be settled by delivery of our ADSs or other securities, in cash or otherwise, or publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement, without, in each case, the prior written consent of the representatives for a period of 180 days after the date of this prospectus.
 
The 180-day lock-up period is subject to adjustment under certain circumstances. If in the event that either (1) during the last 17 days of the initial “lock-up” period, we release earnings results or material news or a material event relating to us occurs or (2) prior to the expiration of the “lock-up” period, we announce that we will release earnings results during the 16-day period beginning on the last day of the “lock-up” period, then in either case the expiration of the “lock-up” will be extended until the expiration of the 18-day period beginning on the date of the release of the earnings results or the occurrence of the material news or event, as applicable, unless the representatives waive, in writing, such an extension.
 
Rule 144
 
In general, under Rule 144 as currently in effect, a person (or persons whose shares are aggregated) who has beneficially owned our ordinary shares for at least one year, is entitled to sell within any three-month period a number of ordinary shares that does not exceed the greater of the following:
 
  •  1% of the then outstanding ordinary shares, in the form of ADSs or otherwise, which will equal approximately       ordinary shares immediately after this offering; or
 
  •  the average weekly trading volume of our ordinary shares in the form of ADSs or otherwise, during the four calendar weeks preceding the date on which notice of the sale is filed with the Securities and Exchange Commission.
 
Sales under Rule 144 must be made through unsolicited brokers’ transactions. They are also subject to manner of sale provisions, notice requirements and the availability of current public information about us.
 
Rule 144(k)
 
Under Rule 144(k), a person who is not our affiliate at any time during the three months preceding a sale, and who has beneficially owned the ordinary shares, in the form of ADSs or otherwise, proposed to be sold


119


Table of Contents

for at least two years, including the holding period of any prior owner other than an affiliate, is entitled to sell those ordinary shares without complying with the manner of sale, public information, volume limitation or notice provisions of Rule 144. Therefore, unless otherwise restricted, “144(k) shares” may be sold at any time.
 
Rule 701
 
In general, under Rule 701 of the Securities Act as currently in effect, each of our employees, consultants or advisors who purchases our ordinary shares from us in connection with a compensatory stock plan or other written agreement executed prior to the completion of this offering is eligible to resell such ordinary shares in reliance on Rule 144, but without compliance with some of the restrictions, including the holding period, contained in Rule 144.
 
Registration Rights
 
Upon completion of this offering, certain holders of our ordinary shares or their transferees will be entitled to request that we register their shares under the Securities Act, following the expiration of the lock-up agreements described above. See “Description of Share Capital — Registration Rights.”


120


Table of Contents

 
TAXATION
 
The following summary of the material Cayman Islands and United States federal income tax consequences of an investment in our ADSs or ordinary shares is based upon laws and relevant interpretations thereof in effect as of the date of this registration statement, all of which are subject to change. This summary does not deal with all possible tax consequences relating to an investment in our ADSs or ordinary shares, such as the tax consequences under state, local and other tax laws. To the extent that the discussion relates to matters of Cayman Islands tax law, it constitutes the opinion of Maples and Calder, our special Cayman Islands counsel. Based on the facts and subject to the limitations set forth herein, the statements of law or legal conclusions under the caption “— United States Federal Income Taxation” constitute the opinion of Latham & Watkins LLP, our special U.S. counsel, as to the material United States federal income tax consequences of an investment in the ADSs or ordinary shares.
 
Cayman Islands Taxation
 
The Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation and there is no taxation in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to the Company levied by the Government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or brought within the jurisdiction of the Cayman Islands. The Cayman Islands is not party to any double tax treaties. There are no exchange control regulations or currency restrictions in the Cayman Islands.
 
United States Federal Income Taxation
 
The following discussion describes the material U.S. federal income tax consequences to U.S. Holders (defined below) under present law of an investment in the ADSs or ordinary shares. This summary applies only to U.S. Holders that hold the ADSs or ordinary shares as capital assets and that have the U.S. dollar as their functional currency. This discussion is based on the tax laws of the United States as in effect on the date of this registration statement and on U.S. Treasury regulations in effect, as of the date of this registration statement, as well as judicial and administrative interpretations thereof available on or before such date. All of the foregoing authorities are subject to change, and it is possible that such change will apply retroactively and affect the tax consequences described below.
 
The following discussion does not deal with the tax consequences to any particular investor or to persons in special tax situations such as:
 
  •  certain financial institutions;
 
  •  insurance companies;
 
  •  broker dealers;
 
  •  traders that elect to mark to market;
 
  •  tax-exempt entities;
 
  •  persons liable for alternative minimum tax;
 
  •  persons holding an ADS or ordinary share as part of a straddle, hedging, conversion or integrated transaction;
 
  •  persons that actually or constructively own 10% or more of our voting stock;
 
  •  persons who acquired ADSs or ordinary shares pursuant to the exercise of any employee stock options or otherwise as compensation; or
 
  •  persons holding ADSs or ordinary shares through partnerships or other pass-through entities.
 
WE RECOMMEND THAT PROSPECTIVE PURCHASERS CONSULT THEIR TAX ADVISORS ABOUT THE APPLICATION OF THE U.S. FEDERAL TAX RULES TO THEIR PARTICULAR CIRCUMSTANCES AS WELL AS THE STATE AND LOCAL AND FOREIGN TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF ADSs OR ORDINARY SHARES.


121


Table of Contents

The discussion below of the U.S. federal income tax consequences to “U.S. Holders” will apply if you are the beneficial owner of ADSs or ordinary shares and you are, for U.S. federal income tax purposes,
 
  •  an individual who is a citizen or resident of the United States;
 
  •  a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized under the laws of the United States, any state or the District of Columbia;
 
  •  an estate whose income is subject to U.S. federal income taxation regardless of its source; or
 
  •  a trust that (1) is subject to the primary supervision of a court within the United States and the control of one or more U.S. persons or (2) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.
 
If you are a partner in a partnership or other entity taxable as a partnership that holds ADSs or ordinary shares, your tax treatment generally will depend on your status and the activities of the partnership.
 
The discussion below assumes that the representations contained in the deposit agreement are true and that the obligations in the deposit agreement and any related agreement will be complied with in accordance with the terms. If you hold ADSs, you should be treated as the holder of the underlying ordinary shares represented by those ADSs for U.S. federal income tax purposes.
 
The U.S. Treasury has expressed concerns that intermediaries in the chain of ownership between the holder of an ADS and the issuer of the security underlying the ADS may be taking actions that are inconsistent with the beneficial ownership of the underlying shares (for example, pre-releasing ADSs to persons who do not have the beneficial ownership of the securities underlying the ADSs). Accordingly, the availability of the reduced tax rate for dividends received by certain non-corporate U.S. Holders (discussed below) could be affected by actions taken by intermediaries in the chain of ownership between the holder of ADSs and our company if as a result of such actions the holders of ADSs are not properly treated as beneficial owners of underlying shares.
 
Taxation of Dividends and Other Distributions on the ADSs or Ordinary Shares
 
Subject to discussions below under “—Passive Foreign Investment Company,” the gross amount of all our distributions to you with respect to the ADSs or ordinary shares will be included in your gross income as ordinary dividend income on the date of actual or constructive receipt by the depositary, in the case of ADSs, or by you, in the case of ordinary shares, but only to the extent that the distribution is paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). Such dividends will not be eligible for the dividends-received deduction allowed to corporations in respect of dividends received from other U.S. corporations.
 
With respect to non-corporate U.S. Holders, including individual U.S. Holders, for taxable years beginning before January 1, 2011, dividends will be “qualified dividend income” that is taxed at the lower applicable capital gains rate, provided that certain conditions are satisfied, including (1) the ADSs or ordinary shares are readily tradable on an established securities market in the United States, (2) we are not a passive foreign investment company (as discussed below) for either our taxable year in which the dividend is paid or the preceding taxable year, and (3) certain holding period requirements are met. United States Treasury Department guidance indicates that our ADSs, upon listing on the New York Stock Exchange (but not our ordinary shares), will be readily tradable on an established securities market in the United States. There can be no assurance that our ADSs will be considered readily tradable on an established securities market in later years. We recommend that you consult your tax advisors regarding the availability of the lower rate for dividends paid with respect to our ADSs or ordinary shares.
 
Dividends will constitute foreign source income for foreign tax credit limitation purposes. If the dividends are qualified dividend income (as discussed above), the amount of the dividend taken into account for purposes of calculating the foreign tax credit limitation generally will be limited to the gross amount of the dividend, multiplied by the reduced rate divided by the highest rate of tax normally applicable to dividends. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes of income. For this purpose, dividends distributed by us with respect to the ADSs or ordinary shares generally


122


Table of Contents

will constitute “passive category income” or, in the case of certain U.S. Holders, constitute “general category income.”
 
To the extent that the amount of the distribution exceeds our current and accumulated earnings and profits (determined under U.S. federal income tax principles), it will be treated first as a tax-free return of your tax basis in your ADSs or ordinary shares, and to the extent the amount of the distribution exceeds your tax basis, the excess will be taxed as capital gain. We do not intend to calculate our earnings and profits under U.S. federal income tax principles. Therefore, a U.S. Holder can expect that a distribution will be reported as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as capital gain under the rules described above.
 
Taxation of a Disposition of ADSs or Ordinary Shares
 
Subject to discussions below under “Passive Foreign Investment Company,” you will recognize capital gain or loss on any sale, exchange or other taxable disposition of an ADS or ordinary share equal to the difference between the amount realized (in U.S. dollars) for the ADS or ordinary share and your tax basis (in U.S. dollars) in the ADS or ordinary share. If you are a non-corporate U.S. holder (such as an individual), you will be eligible for reduced tax rates if you have held the ADSs or ordinary shares for more than a year. The deductibility of capital losses is subject to limitations. Any such gain or loss that you recognize will be treated as U.S. source gain or loss for foreign tax credit limitation purposes, subject to exceptions and limitations.
 
Passive Foreign Investment Company
 
Although it is not clear how the contractual arrangements between us and our affiliated entity will be treated for purposes of the PFIC rules, we do not expect to be treated as a PFIC for U.S. federal income tax purposes for our current taxable year ended December 31, 2007. However, PFIC status is a factual determination (rather than a legal conclusion) for each taxable year which cannot be made until the close of the taxable year, and therefore our actual PFIC status for 2007 will not be determinable until the close of the 2007 taxable year. Accordingly, there is no guarantee that we will not be a PFIC for the 2007 taxable year or for any future taxable year. A non-U.S. corporation is considered a PFIC for any taxable year if either:
 
  •  at least 75% of its gross income is passive income, or
 
  •  at least 50% of the value of its assets (based on an average of the quarterly values of the assets during a taxable year) is attributable to assets that produce or are held for the production of passive income (the “asset test”).
 
We will be treated as owning our proportionate share of the assets and earning our proportionate share of the income of any other corporation in which we own, directly or indirectly, 25% or more (by value) of the stock.
 
We must make a separate determination each year as to whether we are a PFIC. As a result, it is possible that our PFIC status will change. In particular, because the total value of our assets for purposes of the asset test generally will be calculated using the market price of our ADSs and ordinary shares, our PFIC status will depend in large part on the market price of our ADSs and ordinary shares. Accordingly, it is possible that fluctuations in the market price of the ADSs and ordinary shares will result in our being a PFIC for any year. In addition, the composition of our income and assets will be affected by how, and how quickly, we spend the cash we raise in this offering. If we are a PFIC for any year during which you hold ADSs or ordinary shares, we will continue to be treated as a PFIC for all succeeding years during which you hold ADSs or ordinary shares, absent a special election. For instance, if we cease to be a PFIC, you can avoid some of the adverse effects of the PFIC regime by making a deemed sale election with respect to the ADSs or ordinary shares, as applicable. If we are a PFIC for any taxable year and any of our foreign subsidiaries is also a PFIC, a U.S. Holder would be treated as owning a proportionate amount (by value) of the shares of the lower-tier PFIC for purposes of the application of these rules. You are urged to consult your tax advisors about the application of the PFIC rules to any of our subsidiaries.
 
If we are a PFIC for any taxable year during which you hold ADSs or ordinary shares, you will be subject to special tax rules with respect to any “excess distribution” that you receive and any gain you realize from a sale or other disposition (including a pledge) of the ADSs or ordinary shares, unless you make a


123


Table of Contents

“mark-to-market” election as discussed below. Distributions you receive in a taxable year that are greater than 125% of the average annual distributions you received during the shorter of the three preceding taxable years or your holding period for the ADSs or ordinary shares will be treated as an excess distribution. Under these special tax rules:
 
  •  the excess distribution or gain will be allocated ratably over your holding period for the ADSs or ordinary shares,
 
  •  the amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we were a PFIC, will be treated as ordinary income, and
 
  •  the amount allocated to each other year will be subject to the highest tax rate in effect for that year and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.
 
The tax liability for amounts allocated to years prior to the year of disposition or “excess distribution” cannot be offset by any net operating losses for such years, and gains (but not losses) realized on the sale of the ADSs or ordinary shares cannot be treated as capital, even if you hold the ADSs or ordinary shares as capital assets.
 
Alternatively, a U.S. Holder of “marketable stock” (as defined below) in a PFIC can make a mark-to-market election for such stock of a PFIC to elect out of the tax treatment discussed in the two preceding paragraphs. If you make a mark-to-market election for the ADSs or ordinary shares, you will include in income each year an amount equal to the excess, if any, of the fair market value of the ADSs or ordinary shares as of the close of your taxable year over your adjusted basis in such ADSs or ordinary shares. You are allowed a deduction for the excess, if any, of the adjusted basis of the ADSs or ordinary shares over their fair market value as of the close of the taxable year. However, deductions are allowable only to the extent of any net mark-to-market gains on the ADSs or ordinary shares included in your income for prior taxable years. Amounts included in your income under a mark-to-market election, as well as gain on the actual sale or other disposition of the ADSs or ordinary shares, are treated as ordinary income. Ordinary loss treatment also applies to the deductible portion of any mark-to-market loss on the ADSs or ordinary shares, as well as to any loss realized on the actual sale or disposition of the ADSs or ordinary shares, to the extent that the amount of such loss does not exceed the net mark-to-market gains previously included for such ADSs or ordinary shares. Your basis in the ADSs or ordinary shares will be adjusted to reflect any such income or loss amounts. If you make a mark-to-market election, the tax rules that apply to distributions by corporations which are not PFICs would apply to distributions by us, except that the lower applicable capital gains rate for qualified dividend income discussed above under ‘— Taxation of Dividends and Other Distributions on the ADSs or Ordinary Shares” would not apply.
 
The mark-to-market election is available only for “marketable stock,” which is stock that is traded in other than de minimis quantities on at least 15 days during each calendar quarter (“regularly traded”) on a qualified exchange or other market, as defined in applicable U.S. Treasury regulations. We expect that the ADSs will be listed on the New York Stock Exchange and, consequently, if you are a holder of ADSs and the ADSs are regularly traded on the New York Stock Exchange, the mark-to-market election would be available to you were we to be or become a PFIC.
 
If a non-U.S. corporation is a PFIC, a holder of shares in that corporation can avoid taxation under the rules described above by making a “qualified electing fund” election to include its share of the corporation’s income on a current basis, or a “deemed sale” election once the corporation no longer qualifies as a PFIC. However, you can make a qualified electing fund election with respect to your ADSs or ordinary shares only if we agree to furnish you annually with certain tax information, and we do not intend to prepare or provide such information.
 
If you hold ADSs or ordinary shares in any year in which we are a PFIC, you will be required to file Internal Revenue Service Form 8621 regarding distributions received on the ADSs or ordinary shares and any gain realized on the disposition of the ADSs or ordinary shares.
 
We recommend that you consult your tax advisor regarding the application of the PFIC rules to your investment in ADSs or ordinary shares.


124


Table of Contents

Information Reporting and Backup Withholding
 
Dividend payments with respect to ADSs or ordinary shares and proceeds from the sale, exchange or redemption of ADSs or ordinary shares will be subject to information reporting to the Internal Revenue Service and possible U.S. backup withholding at a current rate of 28%, unless the conditions of an applicable exception are satisfied. Backup withholding will not apply to a U.S. Holder who furnishes a correct taxpayer identification number and makes any other required certification or who is otherwise exempt from backup withholding. U.S. Holders who are required to establish their exempt status can provide such certification on Internal Revenue Service Form W-9. We recommend that U.S. Holders consult their tax advisors regarding the application of the U.S. information reporting and backup withholding rules.
 
Backup withholding is not an additional tax. Amounts withheld as backup withholding can be credited against your U.S. federal income tax liability, and you can obtain a refund of any excess amounts withheld under the backup withholding rules by timely filing the appropriate claim for refund with the Internal Revenue Service and furnishing any required information.


125


Table of Contents

 
UNDERWRITING
 
Under the terms and subject to the conditions contained in an underwriting agreement dated      , we have agreed to sell to the underwriters named below, for whom Credit Suisse Securities (USA) LLC of Eleven Madison Avenue, New York, NY 10010 is acting as representative, the following respective numbers of ADSs:
 
         
    Number of
 
Underwriter
  ADSs  
 
Credit Suisse Securities (USA) LLC
            
HSBC Securities (USA) Inc. 
            
Piper Jaffray & Co. 
            
CIBC World Markets Corp. 
            
         
Total
            
         
 
The underwriting agreement provides that the underwriters are obligated to purchase all the ADSs in the offering if any are purchased, other than those ADSs covered by the over-allotment option described below. The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may be increased or the offering may be terminated.
 
We have granted to the underwriters a 30-day option to purchase on a pro rata basis up to       additional ADSs at the initial public offering price less the underwriting discounts and commissions. The option may be exercised only to cover any over-allotments of ADSs.
 
The underwriters propose to offer the ADSs initially at the public offering price on the cover page of this prospectus and to selling group members at that price less a selling concession of $       per ADS. The underwriters and selling group members may allow a discount of $       per ADS on sales to other broker/dealers. After the initial public offering the representative may change the public offering price and concession and discount to broker/dealers.
 
The following table summarizes the compensation and estimated expenses we will pay:
 
                                 
    Per ADS     Total  
    Without
    With
    Without
    With
 
    Over-Allotment     Over-Allotment     Over-Allotment     Over-Allotment  
 
Underwriting discounts and commissions paid by us
  $            $            $            $         
Expenses payable by us
  $            $            $            $         
 
The underwriters have informed us that they do not expect sales to accounts over which the underwriters have discretionary authority to exceed 5% of the ADSs being offered.
 
We have agreed that we will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, or file with the Securities and Exchange Commission a registration statement under the Securities Act of 1933 (the “Securities Act”) relating to, any of our ADSs or shares of our common stock or securities convertible into or exchangeable or exercisable for any of our ADSs or shares of our common stock, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, without the prior written consent of Credit Suisse Securities (USA) LLC for a period of 180 days after the date of this prospectus[, except issuances pursuant to the exercise of employee stock options outstanding on the date hereof ]. However, in the event that either (1) during the last 17 days of the “lock-up” period, we release earnings results or material news or a material event relating to us occurs or (2) prior to the expiration of the “lock-up” period, we announce that we will release earnings results during the 16-day period beginning on the last day of the “lock-up” period, then in either case the expiration of the “lock-up” will be extended until the expiration of the 18-day period beginning on the date of the release of the earnings results or the occurrence of the material news or event, as applicable, unless Credit Suisse Securities (USA) LLC waives, in writing, such an extension.
 
Our officers, directors and all of our existing shareholders have agreed that they will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any of our ADSs or shares of our


126


Table of Contents

common stock or securities convertible into or exchangeable or exercisable for any of our ADSs or shares of our common stock, enter into a transaction that would have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of our ADSs or common stock, whether any of these transactions are to be settled by delivery of our ADSs, common stock or other securities, in cash or otherwise, or publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement, without, in each case, the prior written consent of Credit Suisse Securities (USA) LLC for a period of 180 days after the date of this prospectus. However, in the event that either (1) during the last 17 days of the “lock-up” period, we release earnings results or material news or a material event relating to us occurs or (2) prior to the expiration of the “lock-up” period, we announce that we will release earnings results during the 16-day period beginning on the last day of the “lock-up” period, then in either case the expiration of the “lock-up” will be extended until the expiration of the 18-day period beginning on the date of the release of the earnings results or the occurrence of the material news or event, as applicable, unless Credit Suisse Securities (USA) LLC waives, in writing, such an extension.
 
Credit Suisse Securities (USA) LLC has no present intent or understandings, tacit or explicit, to release these “lock-ups” early.
 
The underwriters have reserved for sale at the initial public offering price up to       ADSs for our directors, officers, employees, business associates and related persons through a directed share program. The number of ADSs available for sale to the general public in the offering will be reduced to the extent these persons purchase the reserved ADSs. Any reserved ADSs not so purchased will be offered by the underwriters to the general public on the same terms as the other ADSs.
 
We and the selling shareholders have agreed to indemnify the underwriters against liabilities under the Securities Act, or contribute to payments that the underwriters may be required to make in that respect.
 
We have applied to list the ADSs on the New York Stock Exchange under the symbol “GRO.”
 
Dr. Juliana Xu, our chief technology officer, is married to an employee of Credit Suisse (Hong Kong) Limited, an affiliate of Credit Suisse Securities (USA) LLC.
 
In connection with the offering the underwriters may engage in stabilizing transactions, over-allotment transactions, syndicate covering transactions, and penalty bids in accordance with Regulation M under the Securities Exchange Act of 1934, or the “Exchange Act.”
 
  •  Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum.
 
  •  Over-allotment involves sales by the underwriters in excess of the number of ADSs the underwriters are obligated to purchase, which creates a syndicate short position. The short position may be either a covered short position or a naked short position. In a covered short position, the number of ADSs over-allotted by the underwriters is not greater than the number of ADSs that they may purchase in the over-allotment option. In a naked short position, the number of ADSs involved is greater than the number of ADSs in the over-allotment option. The underwriters may close out any covered short position by either exercising their over-allotment option and/or purchasing ADSs in the open market.
 
  •  Syndicate covering transactions involve purchases of the ADSs in the open market after the distribution has been completed in order to cover syndicate short positions. In determining the source of ADSs to close out the short position, the underwriters will consider, among other things, the price of ADSs


127


Table of Contents

  available for purchase in the open market as compared to the price at which they may purchase ADSs through the over-allotment option. If the underwriters sell more ADSs than could be covered by the over-allotment option, a naked short position, the position can only be closed out by buying ADSs in the open market. A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the ADSs in the open market after pricing that could adversely affect investors who purchase in the offering.
 
  •  Penalty bids permit the representative to reclaim a selling concession from a syndicate member when the ADSs originally sold by the syndicate member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.
 
These stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price of our ADSs or preventing or retarding a decline in the market price of the ADSs. As a result the price of our ADSs may be higher than the price that might otherwise exist in the open market. These transactions may be effected on the New York Stock Exchange or otherwise and, if commenced, may be discontinued at any time.
 
A prospectus in electronic format [may][will] be made available on the web sites maintained by one or more of the underwriters, or selling group members, if any, participating in this offering and one or more of the underwriters participating in this offering may distribute prospectuses electronically. The representative may agree to allocate a number of ADSs to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the underwriters and selling group members that will make internet distributions on the same basis as other allocations.
 
We expect that delivery of our ADSs will be made against payment therefor on or about      , 2007.
 
There has been no public market for our ordinary shares or ADSs prior to this offering. We and the underwriters will negotiate the initial offering price. In determining the price, we and the underwriters expect to consider a number of factors in addition to prevailing market conditions, including:
 
  •  the history of and prospects for the industry in which, and the companies with which, we compete generally;
 
  •  an assessment of our management;
 
  •  our present operations;
 
  •  our historical results of operations;
 
  •  the trend of our revenues and earnings; and
 
  •  our earnings prospects.
 
We and the underwriters will consider these and other relevant factors in relation to the price of similar securities of generally comparable companies. Neither we nor the underwriters can assure investors that an active trading market will develop for the ADSs, or that the ADSs will trade in the public market at or above the initial offering price.
 
The ADSs to be sold outside of the United States have not been registered under the Securities Act for their offer and sale as part of the initial distribution in the offering. These ADSs initially will be offered outside the United States in compliance with Regulation S under the Securities Act. These ADSs have, however, been registered under the Securities Act solely for purposes of their resale in the United States in transactions that require registration under the Securities Act. This prospectus may also be used in connection with resales of such ADSs in the United States to the extent such resales would not be exempt from registration under the Securities Act.
 
No action has been taken in any jurisdiction by us or by any underwriter that would permit a public offering of the ADSs or the possession, circulation or distribution of this prospectus or any other material relating to us or the ADSs, in any jurisdiction where action for that purpose is required, other than in the United States. Accordingly, the ADSs may not be offered or sold, directly or indirectly, and neither this


128


Table of Contents

prospectus nor any other offering material or advertisements in connection with the ADSs may be distributed or published, in or from any country or jurisdiction except in compliance with any applicable rules and regulations of any such country or jurisdiction. Persons who receive this prospectus are advised by us and the underwriters to inform themselves about, and to observe any restrictions as to, the offering and the ADSs and the distribution of this prospectus.
 
We will not offer to sell any ordinary shares or ADSs to any member of the public in the Cayman Islands.
 
United Kingdom.   The ADSs may not be offered to the public in the United Kingdom within the meaning of section 102B of the Financial Services and Markets Act 2000 (as amended), or the FSMA, except to legal entities which have been authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities or otherwise in circumstances which do not require the publication by the company of a prospectus within the meaning of the Prospectus Rules of the Financial Services Authority. Any invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) has only been communicated or caused to be communicated and will only be communicated or caused to be communicated to persons who have professional experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 or in circumstances in which section 21 of the FSMA would not apply to us if we were not an authorized person. In addition, all applicable provisions of the FSMA with respect to anything done in relation to the ADSs in, from or otherwise involving the United Kingdom, have been or will be complied with.
 
Hong Kong.   Each underwriter has represented and agreed that:
 
(a) it has not offered or sold and will not offer or sell in Hong Kong, by means of any document, any ADSs other than (1) to “professional investors” as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (2) in other circumstances which do not result in the document being a “prospectus” as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance; and
 
(b) it has not issued or had in its possession for the purposes of issue, and will not issue or have in its possession for the purposes of issue, whether in Hong Kong or elsewhere, any advertisement, invitation or document relating to the ADSs, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to the ADSs which are or are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” as defined in the Securities and Futures Ordinance and any rules made under that Ordinance.
 
Japan.   The ADSs have not been and will not be registered under the Securities and Exchange Law of Japan and may not be offered or sold, directly or indirectly, in Japan or to, or for the account or benefit of, any resident of Japan or to, or for the account or benefit of, any person for reoffering or resale, directly or indirectly, in Japan or to, or for the account or benefit of, any resident of Japan, except (1) pursuant to an exemption from the registration requirements of, or otherwise in compliance with, the Securities and Exchange Law of Japan and (2) in compliance with any other relevant law and regulations of Japan.
 
Singapore.   This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the ADSs may not be offered or sold or made the subject of an invitation for subscription or purchase nor may this prospectus be circulated or distributed, nor any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the ADSs, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the “SFA”), (ii) to a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the. conditions, specified in Section 275 of the SFA or (iii) ’otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.


129


Table of Contents

Where the ADSs are subscribed or purchased under Section 275 of the SFA by a relevant person which is:
 
(A) a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or
 
(B) a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,
 
shares, debentures and units of shares and debentures of that corporation or the beneficiaries’ rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the ADSs pursuant to an offer made under Section 275 of the SFA except:
 
(1) to an institutional investor (for corporations, under Section 274 of the SFA) or to a relevant person defined in Section 275(2) of the SFA, or to any person pursuant to an offer that is made on terms that such shares, debentures and units of shares and debentures of that corporation or such rights and interest in that trust are acquired at a consideration of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by exchange or securities or other assets, and further for corporations, in accordance with the conditions specified in Section 275 of the SFA;
 
(2) where no consideration is or will be given for the transfer; or
 
(3) where the transfer is by operation of law.
 
European Economic Area.   Any ADSs that are offered in any Member State of the European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”) shall, in order to comply with the Prospectus Directive that has been implemented in that Relevant Member State (the “Relevant Implementation Date”), only be offered to the public in that Relevant Member State following the publication of a prospectus in relation to the ADSs which has been approved by the competent authority in that Relevant Member State or, where appropriate, approved in another Relevant Member State and notified to the competent authority in that Relevant Member State, all in accordance with the Prospectus Directive, except that an offer to purchase the ADSs may, with effect from and including the Relevant Implementation Date, be made in that Relevant Member State at any time:
 
(a) to legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities;
 
(b) to any legal entity which has two or more of (1) an average of at least 250 employees during the last financial year; (2) a total balance sheet of more than 43,000,000 and (3) an annual net turnover of more than 50,000,000, as shown in its last annual or consolidated accounts; or
 
(c) in any other circumstances which do not require the publication by the Issuer of a prospectus pursuant to Article 3 of the Prospectus Directive.
 
For the purposes of this provision, the expression an “offer of ADSs to the public” in relation to any ADSs in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the ADSs to be offered so as to enable an investor to decide to purchase or subscribe the ADSs, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State and the expression “Prospectus Directive” means Directive 2003/71/IEC and includes any relevant implementing measure in each Relevant Member State.
 
The address of Credit Suisse Securities (USA) LLC is Eleven Madison Avenue, New York, NY 10010; the address of HSBC Securities (USA) Inc. is 452 Fifth Avenue, New York, NY 10018; the address of Piper Jaffray & Co. is Suite 800, 800 Nicollet Mall, Minneapolis, MN 55402; and the address of CIBC World Markets Corp. is 300 Madison Avenue, New York, NY 10017.


130


Table of Contents

 
EXPENSES RELATING TO THIS OFFERING
 
Set forth below is an itemization of the total expenses, excluding underwriting discounts and commissions, that we and the selling shareholders expect to incur in connection with this offering. With the exception of the SEC registration fee, the Financial Industry Regulatory Authority filing fee and the New York Stock Exchange listing fee, all amounts are estimates.
 
         
SEC Registration Fee
  $         
New York Stock Exchange Listing Fee
            
Financial Industry Regulatory Authority Filing Fee
            
Printing Expenses
            
Legal Fees and Expenses
            
Accounting Fees and Expenses
            
Miscellaneous
            
         
Total
  $         
         
 
[Expenses will be borne in proportion to the numbers of ADSs sold in the offering by us and the selling shareholders, respectively.]


131


Table of Contents

 
LEGAL MATTERS
 
The validity of the ADSs and certain other legal matters in connection with this offering will be passed upon for us by Latham & Watkins LLP. Certain legal matters in connection with this offering will be passed upon for the underwriters by Skadden, Arps, Slate, Meagher & Flom LLP. The validity of the ordinary shares represented by the ADSs offered in this offering will be passed upon for us by Maples and Calder. Legal matters as to PRC law will be passed upon for us by Commerce & Finance Law Offices and for the underwriters by Jingtian & Gongcheng Attorneys at Law. Latham & Watkins LLP may rely upon Maples and Calder with respect to matters governed by Cayman Islands’ law and Commerce & Finance Law Offices with respect to matters governed by PRC law. Skadden, Arps, Slate, Meagher & Flom LLP may rely upon Jingtian & Gongcheng Attorneys at Law with respect to matters governed by PRC law.


132


Table of Contents

 
EXPERTS
 
Our consolidated financial statements as of December 31, 2005 and 2006, and for each of the three years in the period ended December 31, 2006 included in this prospectus have been audited by Ernst & Young Hua Ming, independent registered public accounting firm, as set forth in their report appearing herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing.
 
The office of Ernst & Young Hua Ming is located at 21 st  Floor, Hua Run Building, No. 5001 Shen Nan East Road, Shenzhen, People’s Republic of China.
 
The statements included in this prospectus under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” to the extent they relate to the determination of fair value of our ordinary shares and share options on the relevant grant dates, have been reviewed and confirmed by Sallmanns (Far East) Limited, an independent appraiser. The address of Sallmanns (Far East) Limited is 22/F, Siu On Centre, 188 Lockhart Road, Wanchai, Hong Kong.


133


Table of Contents

 
WHERE YOU CAN FIND ADDITIONAL INFORMATION
 
We have filed with the Securities and Exchange Commission a registration statement on Form F-1, including relevant exhibits and securities under the Securities Act with respect to underlying ordinary shares represented by the ADSs, to be sold in this offering. We have also filed with the SEC a related registration statement on F-6 to register the ADSs. This prospectus, which constitutes a part of the registration statement, does not contain all of the information contained in the registration statement. You should read the registration statement on Form F-1 and its exhibits and schedules for further information with respect to us and our ADSs.
 
Immediately upon completion of this offering we will become subject to periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we will be required to file reports, including annual reports on Form 20-F, and other information with the SEC. As a foreign private issuer, we are exempt from the rules of the Exchange Act prescribing the furnishing and content of proxy statements to shareholders. All information filed with the SEC can be inspected and copied at the public reference facilities maintained by the SEC at Room 1580, 100 F Street, N.E., Washington, D.C. 20549. You can request copies of these documents, upon payment of a duplicating fee, by writing to the SEC. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference rooms. You may also obtain additional information online at the SEC’s website at www.sec.gov .


134


Table of Contents

 
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 
         
    Page
 
Consolidated financial statements
   
  F-2
  F-3
  F-4
  F-5
  F-6
  F-7
Unaudited Interim Condensed Consolidated Financial Statements
   
  F-29
  F-30
  F-32
  F-33
  F-34
 


F-1


Table of Contents

 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
To the Board of Directors and Shareholders
Agria Corporation
 
We have audited the accompanying consolidated balance sheets of Agria Corporation and its subsidiaries (together, the “Company”) as of December 31, 2005 and 2006, and the related consolidated statements of operations, cash flows and changes in shareholders’ equity for each of the three years in the period ended December 31, 2006. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Agria Corporation and its subsidiaries at December 31, 2005 and 2006 and the consolidated results of their operations and their cash flows for each of the three years in the period ended December 31, 2006, in conformity with U.S. generally accepted accounting principles.
 
/s/ Ernst & Young Hua Ming
Shenzhen, People’s Republic of China
July 15, 2007


F-2


Table of Contents

AGRIA CORPORATION

CONSOLIDATED BALANCE SHEETS
As of December 31, 2005 and 2006
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollar (“US$”),
except for number of shares)
 
                                 
    Note     2005     2006     2006  
          (RMB)     (RMB)     (US$)  
 
ASSETS
Current assets:
                               
Cash and cash equivalents
            29,477       42,782       5,620  
Restricted cash
            1,508              
Accounts receivable (net of allowance for doubtful accounts of RMB1,921 and RMB3,467 (US$455) at December 31, 2005 and 2006, respectively)
    3       67,200       156,440       20,552  
Inventories
    4       82,659       58,007       7,620  
Prepayments and other current assets
    5       8,113       22,584       2,967  
Amounts due from related parties
    15       1,605       1,059       139  
                                 
Total current assets
            190,562       280,872       36,898  
                                 
Non-current assets:
                               
Property, plant and equipment, net
    6       42,965       40,126       5,271  
Investment
            205       205       27  
Intangible assets, net
    7       62,793       74,437       9,779  
Other assets, net
    8       55,341       94,836       12,459  
                                 
Total non-current assets
            161,304       209,604       27,536  
                                 
Total assets
            351,866       490,476       64,434  
                                 
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
                               
Short-term bank borrowings
    9       12,900       36,900       4,848  
Long-term bank borrowing, current portion
    9       1,000       1,500       197  
Accounts payable
            60,392       27,161       3,568  
Accrued expenses and other liabilities
    10       13,484       14,907       1,958  
Amounts due to shareholder
    15       29,992       29,992       3,940  
Amounts due to related parties
    15       23,764       16,884       2,218  
                                 
Total current liabilities
            141,532       127,344       16,729  
                                 
Non-current liabilities:
                               
Long-term bank borrowing, non-current portion
    9       1,500              
Amount due to related parties
    15             8,996       1,182  
                                 
Total non-current liabilities
            1,500       8,996       1,182  
                                 
Total liabilities
            143,032       136,340       17,911  
                                 
Commitments and contingencies
    18                          
Shareholders’ equity:
                               
Ordinary shares (par value US$0.0000001 per share; 499,900,000,000 shares authorized; 100,000,000 shares issued and outstanding at December 31, 2005 and 2006)
    11                    
Additional paid-in capital
            6,262       8,098       1,064  
Statutory reserves
    12       38,695       76,953       10,109  
Retained earnings
            163,877       269,085       35,350  
                                 
Total shareholders’ equity
            208,834       354,136       46,523  
                                 
Total liabilities and shareholders’ equity
            351,866       490,476       64,434  
                                 
 
The accompanying notes are an integral part of the consolidated financial statements.


F-3


Table of Contents

AGRIA CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS
For the years ended December 31, 2004, 2005 and 2006
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollar (“US$”),
except for number of shares and per share data)
 
                                         
    Note     2004     2005     2006     2006  
          (RMB)     (RMB)     (RMB)     (US$)  
 
Revenue:
                                       
Corn seeds
            48,560       245,601       245,634       32,269  
Sheep breeding products
            92,904       119,468       193,054       25,362  
Seedlings (including related party amounts of RMBnil, RMB2,183, RMB2,980)
            10,820       19,020       51,015       6,702  
                                         
Total revenue
            152,284       384,089       489,703       64,333  
                                         
Cost of revenue:
                                       
Corn seeds
            (33,311 )     (147,723 )     (144,730 )     (19,013 )
Sheep breeding products
            (31,196 )     (37,716 )     (52,287 )     (6,869 )
Seedlings (including related party amounts of RMBnil, RMB835, RMB1,036)
            (9,053 )     (5,932 )     (10,357 )     (1,361 )
                                         
Total cost of revenue
            (73,560 )     (191,371 )     (207,374 )     (27,243 )
                                         
Gross profit
            78,724       192,718       282,329       37,090  
                                         
Operating income (expense):
                                       
Selling expenses
            (4,874 )     (11,349 )     (14,031 )     (1,843 )
General and administrative expenses
            (6,015 )     (4,199 )     (7,472 )     (982 )
Research and development expenses
            (7,203 )     (2,974 )     (3,746 )     (492 )
Government grants
            1,457       150       80       11  
                                         
Total operating expenses
            (16,635 )     (18,372 )     (25,169 )     (3,306 )
                                         
Operating profit
            62,089       174,346       257,160       33,784  
Interest income
            115       218       280       37  
Interest expense (including related party amounts of RMB4,093, RMB4,117, RMB2,511)
            (4,731 )     (5,537 )     (4,923 )     (647 )
Other expense
            (37 )     (7 )            
Other income
            336       60       1,386       182  
                                         
Income before income tax
            57,772       169,080       253,903       33,356  
Income tax
    13                          
                                         
Net income
            57,772       169,080       253,903       33,356  
                                         
Earnings per share:
                                       
Basic and diluted
    14       RMB    0.58       RMB    1.69       RMB    2.54     US$     0.33  
                                         
Weighted average number of ordinary shares outstanding:
                                       
Basic and diluted
    14       100,000,000       100,000,000       100,000,000       100,000,000  
                                         
Pro forma earnings per share:
                                       
Basic and diluted on an as converted basis
                        RMB2.48     US$ 0.33  
                                         
Weighted average number of ordinary shares outstanding used in computation of:
                                       
Pro forma basic and diluted EPS
                        102,400,000       102,400,000  
                                         
 
The accompanying notes are an integral part of the consolidated financial statements.


F-4


Table of Contents

AGRIA CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS
For the years ended December 31, 2004, 2005 and 2006
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollar (“US$”))
 
                                 
    2004     2005     2006     2006  
    (RMB)     (RMB)     (RMB)     (US$)  
 
Cash flows from operating activities:
                               
Net income
    57,772       169,080       253,903       33,356  
Adjustments to reconcile net income to net cash provided by operating activities:
                               
Loss (gain) on disposal of property, plant and equipment and other assets
    42       21       (185 )     (24 )
Depreciation
    5,133       8,091       8,855       1,163  
Amortisation of intangible assets
    338       3,293       4,535       596  
Allowance for doubtful accounts
    200       1,469       1,546       203  
Write-down of inventories to net realisable value
    1,893                    
Imputed interest on ultimate controlling shareholder’s loan
    1,674       1,674       1,836       241  
Imputed interest on amounts due to related parties
    2,419       2,443       675       89  
Bonus expense
    2,914                    
Changes in operating assets and liabilities:
                               
Restricted cash
    (2,000 )     492       1,508       198  
Accounts receivable
    (10,980 )     (50,672 )     (90,786 )     (11,927 )
Inventories
    (2,492 )     (39,992 )     24,651       3,238  
Prepayments and other current assets
    (11,825 )     4,635       (14,471 )     (1,901 )
Amounts due from related parties
    489       (1,589 )     1,446       190  
Accounts payable
    9,175       38,747       (29,233 )     (3,840 )
Accrued expenses and other liabilities
    3,245       2,760       950       125  
Amounts due to shareholders
    3       (13 )            
Amounts due to related parties
    62       8       (3,179 )     (418 )
                                 
Net cash provided by operating activities
    58,062       140,447       162,051       21,289  
                                 
Cash flows from investing activities:
                               
Acquisition of property, plant and equipment and other assets (including related party amounts of RMB12,450, RMB14,450, RMB38,180)
    (49,527 )     (37,357 )     (43,699 )     (5,741 )
Acquisition of intangible assets
    (1,670 )     (61,773 )     (16,180 )     (2,126 )
Proceeds from disposal of property, plant and equipment and other assets
                9,470       1,244  
Loan to related parties
                (900 )     (118 )
                                 
Net cash used in investing activities
    (51,197 )     (99,130 )     (51,309 )     (6,741 )
                                 
Cash flows from financing activities:
                               
Proceeds from short-term borrowings
    15,900       26,500       45,300       5,951  
Repayment of short-term borrowings
    (11,000 )     (23,300 )     (21,300 )     (2,798 )
Proceeds from long-term borrowings
    3,500                    
Repayment of long-term borrowings
          (1,000 )     (1,000 )     (131 )
Dividends paid
          (24,269 )     (110,437 )     (14,508 )
Repayment of loan to related parties
    (9,560 )     (10,780 )     (10,000 )     (1,314 )
                                 
Net cash used in financing activities
    (1,160 )     (32,849 )     (97,437 )     (12,800 )
                                 
Net increase in cash and cash equivalents
    5,705       8,468       13,305       1,748  
Cash and cash equivalents at the beginning of year
    15,304       21,009       29,477       3,872  
                                 
Cash and cash equivalents at the end of year
    21,009       29,477       42,782       5,620  
                                 
Supplemental disclosure of cash flow information:
                               
Cash received during the year for interest
    115       218       280       37  
Cash paid during the year for interest
    641       1,288       2,284       300  
Non-cash acquisition of property, plant and equipment and other assets
    37,161       5,947       31,168       4,095  
                                 
 
The accompanying notes are an integral part of the consolidated financial statements.


F-5


Table of Contents

AGRIA CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
For the years ended December 31, 2004, 2005 and 2006
(Amounts in thousands of Renminbi (“RMB”) except for number of shares)
 
                                                         
          Number of
          Additional
          Retained
    Total
 
          Ordinary
    Ordinary
    Paid-in
    Statutory
    Earnings/
    Shareholders’
 
    Note     Shares     Shares     Capital     Reserves     (Deficit)     Equity  
                (RMB)     (RMB)     (RMB)     (RMB)     (RMB)  
 
Balance as of January 1, 2004
            100,000,000                         (11 )     (11 )
Imputed interest on ultimate controlling shareholder’s loan
                        1,674                   1,674  
Net income for the year
                                    57,772       57,772  
Appropriation of statutory reserves
                              12,142       (12,142 )      
                                                         
Balance as of December 31, 2004
            100,000,000             1,674       12,142       45,619       59,435  
Bonus expense paid by ultimate controlling shareholder
    16                   2,914                   2,914  
Imputed interest on ultimate controlling shareholder’s loan
                        1,674                   1,674  
Net income for the year
                                    169,080       169,080  
Appropriation of statutory reserves
                              26,553       (26,553 )      
Dividends paid
                                    (24,269 )     (24,269 )
                                                         
Balance as of December 31, 2005
            100,000,000             6,262       38,695       163,877       208,834  
Imputed interest on ultimate controlling shareholder’s loan
                        1,836                   1,836  
Net income for the year
                                    253,903       253,903  
Appropriation of statutory reserves
                              38,258       (38,258 )      
Dividends paid
                                    (110,437 )     (110,437 )
                                                         
Balance as of December 31, 2006
            100,000,000             8,098       76,953       269,085       354,136  
                                                         
Balance as of December 31, 2006, in US
                          1,064       10,109       35,350       46,523  
                                                         
 
The accompanying notes are an integral part of the consolidated financial statements.


F-6


Table of Contents

AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006
 
1.   Organization and Basis of Presentation
 
Primalights III Modern Agriculture Development Co., Ltd (“P3A”), a company incorporated under the laws of the People’s Republic of China (the “PRC”) on April 20, 2000, is involved in the development, production and sale of corn seeds, sheep breeding products and seedlings. In October 2003, China Victory International Holdings Limited (“China Victory”), a company incorporated under the laws of Hong Kong, entered into a purchase agreement (the “Acquisition”) with the shareholders of P3A to acquire all of the dividend and voting rights in P3A without obtaining legal ownership over its ordinary shares. The Acquisition was structured in this manner because PRC law and regulations limits foreign ownership to less than 50% of certain types of businesses including P3A. As a result of the Acquisition, China Victory became the primary beneficiary of P3A and therefore, consolidates its financial results.
 
In June 2007, China Victory underwent certain restructuring events wherein it transferred its voting rights in P3A into its newly incorporated and wholly-owned subsidiary, Aero-Biotech Science & Technology Co., Ltd (the “WOFE”). In addition, the WOFE entered into an equity pledge agreement, exclusive call option agreement, power of attorney agreements and exclusive consultancy service, technology license and other service agreements with P3A and its shareholders. Together, these contractual agreements enable the WOFE to: a) exercise effective control over P3A through its ability to exercise all the rights of P3A’s shareholders, including voting and transfer rights; b) receive substantially all of the earnings and other economic benefits to the extent permissible under PRC law and the management of the Group intends to do so; and c) have an exclusive option to purchase all or part of the equity interests in P3A held by the shareholders, to the extent permitted under PRC law for the higher of RMB100,000 or the minimum amount of consideration permitted by PRC law. The power of attorney agreements allow the WOFE to cause P3A to change the terms of the consultancy service, technology license and other service agreements at any time. In addition, P3A’s shareholders have entered into an agreement to remit all of the dividends and other distributions received from P3A to the WOFE, subject to satisfaction of P3A shareholders’ personal income tax and other statutory obligations arising from receiving such dividends or other distributions. Through the WOFE, China Victory continues to consolidate P3A.
 
On August 1, 2005, the controlling shareholder of China Victory exchanged his entire equity interest in the company in return for all of the shares in Aero-Biotech Group Limited (“Aero-Biotech”), a company established under the laws of the British Virgin Islands (the “BVI”). As a result of the exchange, the controlling shareholder maintained his 100% controlling interest in China Victory immediately before and after the exchange. Also, on June 21, 2007, the controlling shareholder along with the minority shareholder of Aero-Biotech exchanged their entire equity interest in the company in return for all the equity interest in Agria Corporation (the “Company”), a company established under the laws of the Cayman Islands, on a pro-rata basis. As a result of the exchange, the shareholders’ respective interest in the Company was identical to their respective interest in Aero-Biotech immediately prior to the share exchange. The above noted share exchange transactions have been accounted for as reorganizations of entities under common control in a manner similar to a pooling-of-interest. Accordingly, these transactions have been accounted for at historical cost. These consolidated financial statements reflect the financial position and operating results of the Company and its subsidiaries and a variable interest entity (collectively the “Group”) as if the above transactions were completed on January 1, 2004. All share and per share data have been presented to give retroactive effect to these share exchanges.


F-7


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
As at December 31, 2006, the Company’s subsidiaries consist of the following entities:
 
                     
    Date of
  Place of
  Percentage of
     
Name
  incorporation   incorporation   shareholdings     Principal Activities
 
Aero-Biotech Group Limited
  July 6, 2005   BVI     100 %   Investment holding
China Victory International Holdings Limited
  September 19, 2003   Hong Kong     100 %   Investment holding
 
As at December 31, 2006, the consolidated financial statements of the Company also include the following variable interest entity which comprises substantially all of the Group’s operations:
 
             
    Date of
  Place of
   
Name
  incorporation   incorporation   Principal Activities
 
Primalights III Modern Agriculture Development Co., Ltd. 
  April 20, 2000   PRC   Development, production and sale of
            corn seeds, sheep breeding products
and seedlings
 
2.   Summary of Significant Accounting Policies
 
Principles of Consolidation
 
The consolidated financial statements include the financial statements of the Company, its subsidiaries and a variable interest entity (“VIE”) for which the Company is the primary beneficiary. All significant inter-company transactions and balances between the Company, its subsidiaries and its VIE are eliminated upon consolidation.
 
Foreign Currency
 
The functional currency of the Company, its subsidiary and VIE is RMB as determined based on the criteria of Statement of Financial Accounting Standard (“SFAS”) No. 52 “Foreign Currency Translation.” The reporting currency of the Company is also RMB. Transactions denominated in foreign currencies are remeasured into the functional currency at the exchange rates prevailing on the transaction dates. Foreign currency denominated financial assets and liabilities are remeasured at the balance sheet date exchange rate. Exchange gains and losses are included in foreign exchange gains and losses in the consolidated statements of operations.
 
Convenience Translation
 
Translations of amounts from RMB into United States dollars for the convenience of the reader were calculated at the noon buying rate of US$1.00 to RMB7.6120 on June 29, 2007 in The City of New York for cable transfers of RMB as certified for customs purposes by the Federal Reserve Bank of New York. No representation is made that the RMB amounts could have been, or could be, converted into United States dollars at such rate.
 
Use of Estimates
 
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from these estimates. Significant estimates and assumptions reflected in the Company’s financial statements include, but are not limited to, allowance for doubtful accounts, useful lives of property plant and equipment, consolidation of VIE and intangible assets.


F-8


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
Cash and Cash Equivalents
 
Cash and cash equivalents consist of cash on hand and bank deposits, which are unrestricted as to withdrawal and use.
 
Restricted Cash
 
Restricted cash represents the amounts of cash held by a bank, which are not available for the Company’s use and is pledged as security for outstanding bank acceptance notes payable. The restriction on cash is expected to be released within the next twelve months.
 
Accounts Receivable
 
An allowance for doubtful accounts is recorded in the period in which a loss is determined to be probable based on an assessment of specific evidence indicating troubled collection, historical experience, account balance aging and prevailing economic conditions. An accounts receivable is written off after all collection efforts have ceased.
 
Inventories
 
Inventories are stated at the lower of cost or market value. Cost is determined by the weighted average method. Raw materials and supplies consist of feed ingredients, packaging materials and operating supplies, while work-in-progress and finished goods include direct materials, direct labor and an allocation of manufacturing overhead costs.
 
Property, plant and equipment
 
Property, plant and equipment are stated at cost and are depreciated using the straight-line method over the estimated useful lives of the assets, as follows:
 
     
Buildings
  20 years
Plant and machinery
  5-10 years
Furniture and office equipment
  5 years
Motor vehicles
  6 years
 
Repair and maintenance costs are charged to expense when incurred, whereas the cost of renewals and betterments that extend the useful life of fixed assets are capitalized as additions to the related assets. Retirement, sale and disposals of assets are recorded by removing the cost and accumulated depreciation with any resulting gain or loss reflected in the consolidated statements of operations.
 
All facilities purchased or constructed which require a period of time before completion are accounted for as construction-in-progress. Construction-in-progress is recorded at acquisition cost, including cost of facilities, installation costs and interest costs. Capitalization of interest costs ceases when the asset is substantially complete and ready for its intended use, at which point, the construction-in-progress is to be transferred to fixed assets. Interest capitalized for the year ended December 31, 2004, 2005 and 2006 amounted to RMB382,723, RMB52,603 and RMB329,756, respectively.


F-9


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
Other assets
 
Other assets, which represent breeder sheep and date trees for producing seedlings, are stated at the cost of acquisition and are depreciated using the straight-line method over their estimated useful lives as follow:
 
     
Breeder sheep
  5 years
Date trees
  30-46 years
 
We estimated the useful lives of breeder sheep by taking into account the sheep’s normal breeding lifecycle. We estimated the useful lives of date trees by taking into account the topography of where the date trees are planted which directly impacts their ability to produce seedlings.
 
Repair and maintenance costs are charged to expense when incurred. Depreciation cost of breeder sheep and date trees is allocated to related cost of inventories. Abnormal losses in breeder sheep and date trees are written off in the period in which such losses occur.
 
Intangible Asset
 
Land use rights
 
Prepaid land use rights are recorded at the amount paid less accumulated amortization. Amortization is provided on a straight-line basis over the term of the agreement ranging from 20 to 46 years.
 
Acquired technology
 
Acquired intangible assets which consist primarily of purchased technologies know-how related to the production of corn seeds and breeder sheep are stated at cost less accumulated amortization. Amortization is calculated on a straight-line basis over the estimated useful lives of 5 years.
 
Investment
 
Investment represents equity investment in a private rural credit cooperation which is recorded at cost. Distributions received, other than for return of capital, are recorded as other income in the statement of operations. The investment is not readily marketable and a quoted market price is not readily available. The Company assesses its investments for other than temporary impairments when indicators of impairment arise, including adverse changes to financial condition and market environment of the investee.
 
Revenue Recognition
 
The Group’s primary business activity is to produce and sell corn seeds, sheep breeding products and seedlings. The Company records revenue when the criteria of Staff Accounting Bulletin No. 104 “Revenue Recognition” are met. These criteria include all of the following: persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectibility is reasonably assured.
 
More specifically, the Group’s sales arrangements are evidenced by individual sales agreements for each transaction. The customer takes title and assumes the risks and rewards of ownership of the products upon delivery of products which generally occurs at shipping point. Other than warranty obligations, the Company does not have any substantive performance obligations to deliver additional products or services to the customers. The product sales price stated in the sales contract is final and not subject to adjustment. The Company generally does not accept sales returns and does not provide customers with price protection. The Company assesses a customer’s creditworthiness before accepting sales orders. Based on the above, the Company records revenue related to product sales upon delivery of the product to the customers.


F-10


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
For certain sales transactions involving seedlings, the customer will pay an additional fee if the seedlings meet specified growth criteria pursuant to the terms of the contract. These growth criteria represent contingent performance conditions. Accordingly, provided all other revenue recognition criteria are met, the contingent fee is recognized as revenue only when the growth criteria are met, which generally takes place within one month of delivery of the seedlings.
 
Cost of Revenue
 
Cost of revenue includes direct and indirect production costs, as well as transportation and handling costs for products sold.
 
Research and Development Costs
 
Research and development costs are expensed as incurred.
 
Advertising Expenditure
 
Advertising costs are expensed when incurred and are included in “selling expenses”. Advertising expenses were RMB991,000, RMB2,078,745 and RMB2,205,465 (US$289,735) for each of the years ended December 31, 2004, 2005 and 2006, respectively.
 
Government Grants
 
Government grants are recognized as other income upon receipt and when all the conditions attached to the grants have been met.
 
Income Taxes
 
The Company follows the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the period in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized in income in the period that includes the enactment date.
 
Comprehensive income
 
Comprehensive income is defined as the change in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners. For the three years ended December 31, 2006, comprehensive income equals net income.
 
Leases
 
Leases are classified at inception date as either a capital lease or an operating lease. A lease is a capital lease if any of the following conditions exist: a) ownership is transferred to the lessee by the end of the lease term, b) there is a bargain purchase option, c) the lease term is at least 75% of the property’s estimated remaining economic life or d) the present value of the minimum lease payments at the beginning of the lease term is 90% or more of the fair value of the leased property to the lessor at the inception date. A capital lease is accounted for as if there was an acquisition of an asset and an incurrence of an obligation at the inception


F-11


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
of the lease. All other leases are accounted for as operating leases wherein rental payments are expensed over the lease term. The Company has no capital leases for any of the periods stated herein.
 
Earnings Per Share
 
Earnings per share are calculated in accordance with SFAS No. 128, “Earnings Per Share.” Basic earnings per ordinary share is computed by dividing income attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the period. Diluted earnings per ordinary share reflects the potential dilution that could occur if securities or other contracts to issue ordinary shares were exercised or converted into ordinary shares. There were no dilutive securities in issue during any of the periods presented.
 
Impairment of Long-lived Assets
 
The Company evaluates its long-lived assets or asset group, including finite-lived intangibles, for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying amount of a group of long-lived assets may not be recoverable. When these events occur, the Company evaluates the impairment by comparing the carrying amount of the assets to future undiscounted net cash flows expected to result from the use of the assets and their eventual disposition. If the sum of the expected undiscounted cash flow is less than the carrying amount of the assets, the Group would recognize an impairment loss based on the excess of the carrying amount of the asset group over its fair value, generally based on discounted cash flows.
 
Fair Value of Financial Instruments
 
The carrying amounts of accounts receivable, accounts and notes payable, other liabilities, short-term bank borrowings and amounts due to/from related companies and shareholders approximate their fair value due to the short-term maturity of these instruments.
 
The long-term bank borrowings approximate their fair value as their interest rates approximate market interest rates.
 
Segment reporting
 
The Company follows SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information” for its segment reporting.
 
The Company operates and manages its business in three segments. The accounting policies used in its segment reporting are the same as those used in the preparation of its consolidated financial statement. The Company primarily generates its revenues from customers in the PRC. Accordingly, no geographical segments are presented.
 
Recent Accounting Pronouncements
 
In June 2006, the Financial Accounting Standards Board (“FASB”) issued Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FAS 109, Accounting for Income Taxes” (“FIN 48”), to create a single model to address accounting for uncertainty in tax positions. FIN 48 clarifies the accounting for income taxes, by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. FIN 48 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006. The Company will adopt FIN 48 as of January 1, 2007, as required. The cumulative effect of adopting FIN 48 will be recorded in retained earnings (or other appropriate components of equity or net assets in the statement of financial position as applicable) in


F-12


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
the year of adoption. The Company is currently assessing the impact, if any, that FIN 48 will have on its financial statements.
 
In September 2006, the FASB issued SFAS No. 157 “Fair Value Measurements.” SFAS No. 157 establishes a framework for measuring fair value in generally accepted accounting principles, clarifies the definition of fair value within that framework, and expands disclosures about the use of fair value measurements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. The Company is currently assessing the impact, if any, that SFAS No. 157 will have on its financial statements.
 
In February 2007, the FASB issued FASB Statement No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — Including an amendment of FASB Statement No. 115”, (“SFAS 159”). This Statement permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. SFAS 159 is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. The Company is currently assessing the impact of this new standard on its financial statements.
 
Concentration of risks
 
Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. As of December 31, 2006, substantially all of the Company’s cash and cash equivalents were deposited in several financial institutions. Accounts receivable are typically unsecured and are derived from revenue earned from customers in China. The risk with respect to accounts receivables is mitigated by credit evaluations the Company performs on its customers and ongoing monitoring process on outstanding balances.
 
Current vulnerability due to certain other concentrations
 
The Company’s operations may be adversely affected by significant political, economic and social uncertainties in the PRC. Although the PRC government has been pursuing economic reform policies for more than 20 years, no assurance can be given that the PRC government will continue to pursue such policies or that such policies may not be significantly altered, especially in the event of a change in leadership, social or political disruption or unforeseen circumstances affecting the PRC’s political, economic and social conditions. There is also no guarantee that the PRC government’s pursuit of economic reforms will be consistent or effective.
 
Substantially all of the Company’s businesses are transacted in RMB, which is not freely convertible into foreign currencies. On January 1, 1994, the PRC government abolished the dual rate system and introduced a single rate of exchange as quoted daily by the People’s Bank of China. However, the unification of the exchange rates does not imply the convertibility of RMB into United States dollars or other foreign currencies. All foreign exchange transactions continue to take place either through the People’s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People’s Bank of China. Approval of foreign currency payments by the People’s Bank of China or other institutions requires submitting a payment application form together with suppliers’ invoices, shipping documents and signed contracts.


F-13


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
3.   Accounts receivable
 
Accounts receivable consist of the following:
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Accounts receivable
    69,121       159,907       21,007  
Less: Allowance for doubtful accounts
    (1,921 )     (3,467 )     (455 )
                         
      67,200       156,440       20,552  
                         
 
                                 
    2004     2005     2006     2006  
    (RMB’000)     (RMB’000)     (RMB’000)     (US$’000)  
 
Movements in allowance for doubtful accounts:
                               
Balance at the beginning of the year
    (252 )     (452 )     (1,921 )     (252 )
Provision for doubtful collection
    (200 )     (1,469 )     (1,546 )     (203 )
                                 
Balance at the end of the year
    (452 )     (1,921 )     (3,467 )     (455 )
                                 
 
4.   Inventories
 
Inventories consist of the following:
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Raw materials and supplies
    5,680       8,707       1,144  
Work in progress
    11,997       9,348       1,228  
Finished goods
    64,982       39,952       5,248  
                         
      82,659       58,007       7,620  
                         
5.   Prepayments and other current assets
 
Prepayments and other current assets consist of the following:
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Advances to suppliers
    5,637       16,352       2,148  
Other receivables (Note 18)
    1,957       4,070       535  
Others
    519       2,162       284  
                         
Total
    8,113       22,584       2,967  
                         
 
The advances to suppliers as at December 31, 2005 represented prepayments for purchases of corn seeds. The advances to suppliers as at December 31, 2006 represented advances to the village collectives for growing corn seeds for the Company. All the advances are non-interest bearing and applied to reduce the cost of future inventory supplied.


F-14


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
6.   Property, plant and equipment, net
 
Property, plant and equipment consist of the following:
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Buildings
    32,559       32,559       4,277  
Plant and machinery
    8,033       6,908       907  
Furniture and office equipment
    997       1,004       132  
Motor vehicles
    1,554       1,554       204  
Construction in progress
    4,708       5,038       662  
                         
      47,851       47,063       6,182  
Less: Accumulated depreciation
    (4,886 )     (6,937 )     (911 )
                         
      42,965       40,126       5,271  
                         
 
Depreciation expense was RMB1,571,111, RMB2,488,756 and RMB2,865,086 (US$376,391) for each of the years ended December 31, 2004, 2005 and 2006, respectively.
 
7.   Intangible assets, net
 
Intangible assets as of December 31, 2005 consist of the following:
 
                         
    Gross Carrying
    Accumulated
    Net Carrying
 
    Value     Amortization     Value  
    (RMB’000)     (RMB’000)     (RMB’000)  
 
Land use rights
    55,934       (1,925 )     54,009  
Acquired technology
    10,931       (2,147 )     8,784  
                         
Balance, end of year
    66,865       (4,072 )     62,793  
                         
 
Intangible assets as of December 31, 2006 consist of the following:
 
                                 
    Gross Carrying
    Accumulated
    Net Carrying
    Net Carrying
 
    Value     Amortization     Value     Value  
    (RMB’000)     (RMB’000)     (RMB’000)     (US$’000)  
 
Land use rights
    67,874       (4,102 )     63,772       8,378  
Acquired technology
    15,171       (4,506 )     10,665       1,401  
                                 
Balance, end of year
    83,045       (8,608 )     74,437       9,779  
                                 
 
Amortization expense for the years ended December 31, 2004, 2005 and 2006 were RMB338,458, RMB3,293,337 and RMB4,535,278(US$595,806), respectively.
 
Land use rights represent amounts paid for the rights to use three parcels of land in the PRC. Two of these were purchased from individual third parties with lease terms of 20 years and 30 years, respectively, with a total purchase consideration of RMB67,353,653. The remaining parcel of land amounted to RMB520,000 was purchased from Shanxi Sanmu Ecology Agriculture Development Co., Ltd. (“Shanxi Sanmu”), a related party, with a lease term of 46 years (Note 15).


F-15


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
Expected amortization expense on these intangible assets for each of the next five years and thereafter is as follows:
 
                 
Year ending December 31
  (RMB’000)     (US$’000)  
 
2007
    5,012       659  
2008
    4,787       629  
2009
    4,291       564  
2010
    2,925       384  
2011
    2,210       290  
Thereafter
    55,212       7,253  
                 
      74,437       9,779  
                 
 
8.   Other assets, net
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Breeder sheep
    26,531       10,892       1,431  
Date trees
    38,212       91,012       11,956  
                         
      64,743       101,904       13,387  
Less: Accumulated depreciation
    (9,402 )     (7,068 )     (928 )
                         
      55,341       94,836       12,459  
                         
 
Depreciation expense was RMB3,562,033, RMB5,602,699 and RMB5,989,304 (US$786,824) for each of the years ended December 31, 2004, 2005 and 2006, respectively.
 
As of December 31, 2006, date trees with net book value of RMB52,703,119 (US$6,923,689) were pledged as security for short-term bank borrowings of RMB24,000,000 (US$3,152,916) (Note 9).
 
In 2006, the Company purchased date trees from Taiyuan Relord Enterprise Development Group Co., Ltd. (“Taiyuan Relord”), a company owned by a director of P3A in exchange for RMB52,800,000(US$6,936,416) (Note 15).
 
9.   Bank borrowings
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Total bank borrowings
    15,400       38,400       5,045  
                         
Comprised of:
                       
Short-term
    12,900       36,900       4,848  
Long-term, current portion
    1,000       1,500       197  
                         
      13,900       38,400       5,045  
Long-term, non-current portion
    1,500              
                         
      15,400       38,400       5,045  
                         


F-16


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
All bank borrowings are denominated in RMB. As of December 31, 2005, short-term bank borrowings were from three banks repayable through June 25, 2006, and bearing a weighted average interest rate of 9.49% per annum. Short-term bank borrowings of RMB8.4 million were guaranteed by Taiyuan Relord. Short-term bank borrowing of RMB4.5 million was jointly guaranteed by Taiyuan Relord and one independent third party.
 
As of December 31, 2006, short-term bank borrowings were from three banks repayable through June 20, 2007, and bearing a weighted average interest rate of 7.054% per annum. Short-term bank borrowing of RMB8,400,000 was guaranteed by Taiyuan Relord. Short-term bank borrowing of RMB4,500,000 was jointly guaranteed by Taiyuan Relord and two independent third parties. Short-term bank borrowing of RMB24,000,000 was secured by the date trees owned by P3A (Note 8). The Group did not pay any fees to obtain the guarantees in relation to short-term bank borrowings in 2005 and 2006.
 
The long-term bank borrowing outstanding at December 31, 2005 and 2006 bore a fixed interest rate of 5.76% per annum. The borrowing was guaranteed by an independent guarantee company. The Group paid a fee of RMB350,000 to the guarantor which is amortised over the loan period using the effective interest rate method.
 
10.   Accrued expenses and other liabilities
 
The components of accrued expenses and other liabilities are as follows:
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Note payable (a)
    3,000              
Welfare, education and union fund
    2,400       4,037       530  
Withholding individual income tax
    2,936       6,105       802  
Sales commission due to sales staff
    1,286       1,286       169  
Advance from customers
    1,527       856       113  
Advertisement expense
    931       420       55  
Government fund
    566       572       75  
Others
    838       1,631       214  
                         
      13,484       14,907       1,958  
                         
 
  (a)  Note payable was issued to purchase corn seeds. The note was non-interest bearing and secured with a pledge in restricted cash. The note was repaid and the pledge was released in 2006.
 
11.   Ordinary shares
 
                         
Shares
  2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Authorised:
                       
499,900,000,000 ordinary shares of US$0.0000001 each
                       
Issued and outstanding:
                       
100,000,000 ordinary shares with par value of US$0.0000001 each
                 
                         


F-17


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
12.   Statutory reserves
 
According to the Company Law of the PRC and the Articles of Association of P3A, it is required to provide the following statutory reserves which are appropriated from its net profit as reported in its PRC statutory financial statements:
 
  (i)  Statutory common reserve fund
 
P3A is required each year to transfer 10% of the profit after tax as reported in its PRC statutory financial statements to the statutory common reserve fund, except where the fund has reached 50% of the registered capital of P3A. This fund can be used to make up any losses incurred or be converted into paid-in capital, provided that the fund does not fall below 25% of the registered capital.
 
  (ii)  Statutory common welfare fund
 
P3A is required each year to transfer 5% of the profit after tax as reported in its PRC statutory financial statements to the statutory common welfare fund. This fund is used for the collective welfare of the staff and workers of P3A.
 
The statutory common reserve fund and statutory common welfare fund are not distributable except upon liquidation.
 
13.   Income taxes
 
The Company and Aero-Biotech are tax exempt companies.
 
China Victory is subject to applicable profits tax rate of 17.5%. China Victory does not have any taxable income and income tax liability for each of the years ended December 31, 2004, 2005 and 2006.
 
P3A is subject to PRC income tax on its taxable income as reported in their PRC statutory accounts adjusted in accordance with relevant PRC income tax laws.
 
P3A was approved as one of the Key enterprises under the Shanxi Province Agricultural Technology Project “1311” (“Project “1311”) by the Shanxi Province in 2002. According to the approval document for income tax exemption issued by the Local Tax Bureau of Taiyuan, Shanxi on February 28, 2002, based on the tax document “ CaiShuiZi(94)001” issued by the Ministry of Finance and the State Tax Bureau and “The Notice regarding the Implementation of the Five Supplementary Measures for Project “1311” by the People’s Government of Shanxi Province” , P3A meets the relevant requirements for income tax exemption and is entitled to full exemption from income tax commencing January 1, 2002. The income tax exemption will continue to apply to P3A until modified or repealed by the taxation authorities.


F-18


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
A reconciliation between taxes computed by applying the statutory income tax rate of 15% applicable to the Group’s PRC operations to income tax expense is:
 
                                 
    2004     2005     2006     2006  
    (RMB’000)     (RMB’000)     (RMB’000)     (US$’000)  
 
Income before income tax
    57,772       169,080       253,903       33,356  
                                 
Income tax computed at the applicable statutory tax rate of 15%
    8,666       25,362       38,085       5,003  
Non-deductible expenses
    3,182       3,073       2,813       370  
Effect of income tax exemption
    (11,848 )     (28,435 )     (40,898 )     (5,373 )
                                 
Income tax expense reported in the consolidated statements of operations
                       
                                 
 
There are no deferred tax assets or liabilities because the Group is exempt from income taxes for the foreseeable future.
 
The benefit of the tax exemption per basic and diluted earnings per share is as follows:
 
                                 
    2004     2005     2006     2006  
    (RMB)     (RMB)     (RMB)     (US$)  
 
Basic and diluted
    0.12       0.28       0.41       0.05  
                                 
 
14.   Earnings per Share
 
Basic and diluted earnings per share for each of the years presented are calculated as follows:
 
                                 
    2004     2005     2006     2006  
    (RMB)     (RMB)     (RMB)     (US$)  
    (Amounts in thousands except for number of shares and per share data)  
 
Net income attributable to ordinary shareholders (numerator), basic and diluted
    57,772       169,080       253,903       33,356  
                                 
Number of Shares (denominator):
                               
Weighted average number of ordinary shares outstanding used in calculating basic income per share
    100,000,000       100,000,000       100,000,000       100,000,000  
                                 
Net income per share — basic and diluted
    RMB0.58       RMB1.69       RMB2.54     US$ 0.33  
                                 
 
On June 21, 2007, the Company issued 100,000,000 ordinary shares to the shareholders of Aero-Biotech to exchange for their entire equity interest in Aero-Biotech which has been presented on a retroactive basis for all years presented.
 
On June 22, 2007, the Company issued the preference shares (Note 20) that will automatically be converted into one fully paid ordinary share upon the completion of IPO. Assuming the conversion had


F-19


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
occurred “on a hypothetical basis” on January 1, 2006, the pro-forma basic and diluted earnings per share for the year ended December 31, 2006 are calculated as follows:
 
                 
    2006     2006  
    (RMB)     (US$)  
    (Amounts in thousands except for number of shares and per share data)  
 
Net income attributable to ordinary shareholders (numerator), basic and diluted
    253,903       33,356  
                 
Number of Shares (denominator):
               
Weighted average number of ordinary shares outstanding used in calculating basic income per share
    100,000,000       100,000,000  
Effect of Series A redeemable convertible preferred shares
    2,400,000       2,400,000  
Weighted average number of ordinary shares outstanding used in calculating diluted income per share
    102,400,000       102,400,000  
                 
Earnings per share — basic and diluted
    RMB2.48       US$0.33  
                 
 
15.   Related Party Transactions
 
     
Name of Related Parties
 
Relationship with the Group
 
Taiyuan Relord
  A company owned by a director of P3A
Shanxi Sanmu
  A subsidiary of Taiyuan Relord
Taiyuan Baojia Agriculture Science & Technology Development Co., Ltd.
(“Taiyuan Baojia”)
  A subsidiary of Taiyuan Relord
Xue Zhi Xin
  A director of P3A
Zhang Ming She
  A director of P3A
Yan Lv
  A director of P3A
Liu Jin Bin
  A director of P3A
 
(1) The Company had the following related party transactions during the years presented:
 
                                 
    2004     2005     2006     2006  
    (RMB’000)     (RMB’000)     (RMB’000)     (US$’000)  
 
Sales of seedlings to:
                               
Taiyuan Relord
          2,183       2,980       391  
                                 
Purchase of date trees from:
                               
Taiyuan Relord
                52,800       6,936  
Shanxi Sanmu
    38,212                    
                                 
      38,212             52,800       6,936  
                                 
Purchase of land use right from:
                               
Shanxi Sanmu
    520                    
                                 


F-20


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
                                 
    2004     2005     2006     2006  
    (RMB’000)     (RMB’000)     (RMB’000)     (US$’000)  
 
Repayment of loans borrowed from:
                               
Zhang Ming She
    2,560       5,430       4,000       525  
Xue Zhi Xin
    1,000       640       4,000       525  
Yan Lv
    6,000       4,710       2,000       263  
                                 
      9,560       10,780       10,000       1,313  
                                 
Loan advanced to Taiyuan Baojia
                900       118  
                                 
 
P3A entered into an operating lease agreement with Taiyuan Relord on October 25, 2006 for the lease of a piece of land for growing date trees. The term of the lease is 45 years. Annual land lease expense is approximately RMB673,000 per year. The related operating lease commitment has been included in the disclosure of operating lease commitment in note 18.
 
(2) The Company had the following related party balances at the end of the year:
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Amounts due from related parties:
                       
Taiyuan Relord
    1,590              
Taiyuan Baojia
          900       118  
Zhang Ming She(i)
          52       7  
Xue Zhi Xin(i)
          53       7  
Yan Lv(i)
          39       5  
Liu Jin Bin(i)
    15       15       2  
                         
      1,605       1,059       139  
                         
Average balance during the year
    810       1,332       175  
                         
Amounts due to related parties:
                       
Included in current liabilities
                       
Taiyuan Relord
          16,884       2,218  
Shanxi Sanmu(ii)
    14,061              
Zhang Ming She(ii)
    3,919              
Xue Zhi Xin(ii)
    3,900              
Yan Lv(ii)
    1,884              
                         
      23,764       16,884       2,218  
                         
Average balance during the year
    35,154       20,324       2,670  
                         

F-21


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Amounts due to related parties:
                       
Included in non-current liabilities
                       
Taiyuan Relord
          8,996       1,182  
                         
Average balance during the year
          4,498       591  
                         
Amount due to a shareholder(iii)
    29,992       29,992       3,940  
                         
Average balance during the year
    29,992       29,992       3,940  
                         
 
The balances with related parties are unsecured, non-interest bearing and due within one year.
 
(i) The balances represent cash advances paid to directors for reimbursable company expenses.
 
(ii) The balances represent loans advanced by the directors and a related party to P3A which carried effective interest rates ranging from 5.49% to 5.76%, and were fully repaid in 2006.
 
(iii) Imputed interest, calculated using incremental borrowing rates ranging from 5.58% to 6.12%, amounting to RMB1.67 million, RMB1.67 million and RMB1.84 million for the years ending December 31, 2004, 2005 and 2006, respectively, were recorded with an offsetting credit to Additional Paid-in Capital.
 
(3) P3A guaranteed a short term bank loan amounted to RMB1,500,000 and RMB1,500,000 borrowed by Taiyuan Relord at December 31, 2005 and 2006 respectively. P3A also guaranteed a short term bank loan amounted to RMB2,000,000 borrowed by Taiyuan Baojia at December 31, 2006 (Note 18).
 
16.   Contribution from controlling shareholder
 
As part of the acquisition of P3A (Note 1), China Victory agreed to pay a bonus to certain key employees, which include all of the selling shareholders, of P3A. The annual bonus is contingent upon and only payable if the controlling shareholder of China Victory receives dividends from P3A. The amount of the bonus is calculated based on 4% of dividends received, if any, from P3A. If P3A achieves 20% or 30% growth in both revenue and profit growth, then the bonus will increase by 8% and 12% respectively. The key employees will only receive the bonus payment if they continue to be employees of P3A at the time such payment is made.
 
For the year ended December 31, 2004, a bonus accrual of RMB2,914,200 was recorded to general and administrative expense. In 2005, the controlling shareholder of the Group paid the bonus on behalf of China Victory. Accordingly, this payment has been recorded as a contribution to shareholders’ equity.
 
In April 2004, China Victory and the key employees agreed to terminate the bonus rights commencing January 1, 2005. No consideration was paid by the Group or the shareholders of the Group to cancel the bonus rights because the decision to pay the bonus was always at the discretion of the Group.
 
17.   Employee defined contribution plan
 
Chinese labor regulations require companies in the PRC to participate in a government mandated defined contribution plan pursuant to which certain pension benefits, medical care, unemployment insurance, employee housing fund and other welfare benefits are provided to employees, and to make contributions to the government for these benefits based on a certain percentage of the employees’ salaries. P3A is required to make contributions to the government mandated defined contribution plan for these benefits based on 28% of the employees’ salaries. The Company has no legal obligation for the benefits beyond the contributions made.

F-22


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
The total amounts for such employee benefits, which were expensed as incurred, were RMB610,871, RMB666,314 and RMB996,923 (US$130,967) respectively for each of the years ended December 31 2004, 2005 and 2006, respectively.
 
18.   Commitments and contingencies
 
Operating lease commitments
 
Payments under operating leases for land and building, which are mainly used to grow seedlings, are expensed on a straight-line basis over the periods of their respective leases. The terms of the leases do not contain rent escalation or contingent rents and have lease periods ranging from 3 to 45 years. Future minimum lease payments for each of the next five years and thereafter, under all non-cancelable operating leases are as follows:
 
                 
Year ending December 31
  (RMB’000)     (US$’000)  
 
2007
    4,217       554  
2008
    4,231       556  
2009
    2,891       380  
2010
    499       66  
2011
    430       56  
Thereafter
    28,323       3,721  
                 
      40,591       5,333  
                 
 
Total rental expense was RMB61,201, RMB1,649,247 and RMB3,312,021 (US$435,105) for the years ended December 31, 2004, 2005 and 2006, respectively.
 
Purchase commitments
 
Purchase commitments represent service agreements entered into with village collectives and corn seed companies to grow corn seeds. The terms of the agreements have periods ranging from 5 to 12 years. Future minimum purchase payments for each of the next five years and thereafter, under all non-cancelable agreements are as follows:
 
                 
Year ending December 31
  (RMB’000)     (US$’000)  
 
2007
    30,974       4,069  
2008
    30,974       4,069  
2009
    30,974       4,069  
2010
    30,974       4,069  
2011
    30,191       3,966  
Thereafter
    183,231       24,072  
                 
      337,318       44,314  
                 
 
Total purchase cost was RMB nil, RMB nil and RMB28,392,925 (US$3,730,022) for the years ended December 31, 2004, 2005 and 2006, respectively.
 
Investment commitment
 
As part of the acquisition of P3A (Note 1), China Victory agreed to provide not less than HK$10 million funding in a future project that Taiyuan Relord, one of the selling shareholders of P3A, may enter into. The


F-23


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
acquisition agreement does not specify the date when such investment needs to be made or any details of the investments. No investment has been made by China Victory. In May 2007, China Victory and Taiyuan Relord signed an agreement to cancel the investment commitment. No consideration was paid to cancel the commitment.
 
Acquisition of building
 
At December 31, 2005 and 2006, the Company had commitments of RMB1,163,800 (US$152,890) related to the acquisition of property to be used as the Company’s office. The commitment for acquisition of the building is expected to be settled in 2007.
 
Enterprise Income Tax
 
All PRC incorporated entities are subject to enterprise income tax regulations promulgated by the Ministry of Finance and the State Tax Bureau of the PRC. P3A has not recorded any current or deferred income taxes in reliance on an enterprise income tax exemption notice received from the Local Tax Bureau of Taiyuan in the province of Shanxi and a legal opinion received from Shanxi Cheng Kai Law Firm, confirming P3A’s enterprise income tax exemption status under existing PRC tax regulation. Based on the above, management believes that it is unlikely that the Ministry of Finance and the Sate Tax Bureau will challenge P3A’s enterprise income tax exemption status.
 
Individual Income Tax Withholdings
 
Based on existing PRC tax regulations, P3A is required to withhold and remit income taxes from its employees. Failure to do so would subject the company to a penalty of 50% to 300% of the actual withholding tax amount. P3A did not remit employee income taxes for the years ended December 31, 2004, 2005 and 2006. P3A estimated that the most likely outcome will result in a 150% penalty assessment; therefore an accrual of RMB817,351, RMB2,118,441 and RMB3,168,711 was recorded for the years ended December 31, 2004, 2005 and 2006, respectively. The taxation authorities may assess the maximum amount which would exceed the accrued amount by RMB817,351, RMB2,118,441 and RMB3,168,711 for the years ended December 31, 2004, 2005 and 2006, respectively. P3A obtained written agreements from its employees that they will reimburse the company for tax penalty assessed over 50% of the withholding tax amount. Accordingly, a receivable amounting to RMB544,901, RMB1,412,294 and RMB2,112,474 was recorded for the years ended December 31, 2004, 2005 and 2006, respectively (Note 5).
 
Guarantees
 
P3A guaranteed short term bank loans totaling RMB3,500,000 borrowed by Taiyuan Relord and Taiyuan Baojia, its related parties (Note 15) at December 31, 2006. P3A did not receive any fee for providing the guarantees. These bank loans were repaid and the guarantees were released subsequent to December 31, 2006.
 
P3A guaranteed short term bank loans of Taiyuan Relord and independent third parties which amounted to RMB1,500,000 and RMB2,000,000 respectively at December 31, 2005. P3A did not receive any fee for providing the guarantees. These bank loans were repaid and the guarantees were released subsequent to December 31, 2005.
 
In accordance with FIN 45 “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others,” guarantor must recognize a liability for the fair value of the obligations it assumes under certain guarantees. The maximum amount of undiscounted payments P3A would have had to make in the event of default by the original borrowers is RMB3,500,000 at December 31, 2006. The Company has determined the fair value of the guarantees in each of the years to be


F-24


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
insignificant. Accordingly, the Company has not recorded any liabilities for these agreements as of December 31, 2005 and 2006.
 
The Company does not have any recourse under the agreement to recover any payment required by the guarantees from the original borrowers.
 
19.   Segment reporting
 
The Company is engaged in the development, production and sale of corn seeds, sheep breeding products and seedlings. In accordance with SFAS No. 131, “Disclosures About Segments of an Enterprise and Related Information”, the Company’s chief operating decision maker evaluates segment performance based on revenue and cost of revenue by segment. The Company has determined that it has three operating and reportable segments which are corn seeds, sheep breeding products and seedlings.
 
The revenue, cost of revenue and gross profit by segment is as follows:
 
Year ended December 31, 2004
 
                                 
          Sheep
             
          Breeding
             
    Corn Seeds     Products     Seedlings     Consolidated  
    (RMB’000)     (RMB’000)     (RMB’000)     (RMB’000)  
 
Revenue
    48,560       92,904       10,820       152,284  
Cost of revenue
    (33,311 )     (31,196 )     (9,053 )     (73,560 )
                                 
Gross profit
    15,249       61,708       1,767       78,724  
Unallocated operating expenses
                            (16,635 )
Unallocated non-operating expense
                            (4,317 )
                                 
Income before income tax
                            57,772  
                                 
 
Year ended December 31, 2005
 
                                 
          Sheep
             
    Corn Seeds     Breeding     Seedlings     Consolidated  
    (RMB’000)     (RMB’000)     (RMB’000)     (RMB’000)  
 
Revenue
    245,601       119,468       19,020       384,089  
Cost of revenue
    (147,723 )     (37,716 )     (5,932 )     (191,371 )
                                 
Gross profit
    97,878       81,752       13,088       192,718  
Unallocated operating expenses
                            (18,372 )
Unallocated non-operating expenses
                            (5,266 )
                                 
Income before tax
                            169,080  
                                 


F-25


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
Year ended December 31, 2006
 
                                 
          Sheep
             
    Corn Seeds     Breeding     Seedlings     Consolidated  
    (RMB’000)     (RMB’000)     (RMB’000)     (RMB’000)  
 
Revenue
    245,634       193,054       51,015       489,703  
Cost of revenue
    (144,730 )     (52,287 )     (10,357 )     (207,374 )
                                 
Gross profit
    100,904       140,767       40,658       282,329  
Unallocated operating expenses
                            (25,169 )
Unallocated non-operating expense
                            (3,257 )
                                 
Income before tax
                            253,903  
                                 
 
Year ended December 31, 2006
 
                                 
          Sheep
             
    Corn Seeds     Breeding     Seedlings     Consolidated  
    (US$’000)     (US$’000)     (US$’000)     (US$’000)  
 
Revenue
    32,269       25,362       6,702       64,333  
Cost of revenue
    (19,013 )     (6,869 )     (1,361 )     (27,243 )
                                 
Gross profit
    13,256       18,493       5,341       37,090  
Unallocated operating expenses
                            (3,306 )
Unallocated non-operating expense
                            (428 )
                                 
Income before tax
                            33,356  
                                 
 
The Company had no customers which accounted for 10% or more of the Company’s revenues for any of the years presented in the consolidated financial statements.
 
All of the Company’s sales are made to customers located in the PRC and all of the Company’s long-lived assets are located in the PRC. The Company does not allocate such assets to individual segments.
 
20.   Subsequent Events
 
a)   Impact of the new tax law in the PRC
 
During the 5th Session of the 10th National People’s Congress, which was concluded on March 16, 2007, the PRC Enterprise Income Tax Law (“the New Enterprise Income Tax Law”) was approved and will become effective on January 1, 2008. The New Enterprise Income Tax Law introduces a wide range of changes which include, but are not limited to, the unification of the income tax rate for domestic-invested and foreign-invested enterprises at 25%. Since the detailed implementation and administrative rules and regulations have not yet been announced, the financial impact of the New Enterprise Income Tax Law to the Company cannot be reasonably determined at this stage.
 
b)   Convertible preferred shares issuance
 
On June 22, 2007, the Company issued 2,400,000 Series A convertible preferred shares to two third party investors in exchange for total considerations of US$10,000,000. Each Series A preferred share is convertible, at the option of the holder thereof, at any time after the date of issuance of such share, into one ordinary share, and is entitled to the dividend declared by the Company on a pro-rata basis. In addition, the holders of preferred shares shall have the right to receive an annual dividend of 8% if an initial public offering of the Company’s ordinary shares is not consummated prior to July 31, 2008. If an initial public offering is consummated prior to


F-26


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
July 31, 2008, then such shares shall not be entitled to receive any dividend. If for any reason the Company has not completed an initial public offering on or prior to December 31, 2008, the purchasers shall have the right at any time to require the Company to redeem all of the convertible preferred shares for cash at their principal value. In connection with our sale of 2,400,000 Series A preferred shares, the Company and the purchasers entered into a registration rights agreement. Under the terms of this agreement, the purchasers may, at any time following 180 days after an initial public offering by the Company, require the Company to effect up to two registrations (and unlimited registrations on Form F-3) of ordinary shares held by such parties.
 
c)   Share Option Plan
 
On July 4, 2007, the Company’s shareholders approved the “2007 Share Incentive Plan” (the “Plan”). Under the Plan, the Company may issue up to 20,000,000 ordinary shares of par value US$0.0000001 per share to the directors, employees and non-employees of the Company and its subsidiaries (the “Participants”). The objective of the Plan is to provide the Participants with the opportunity to acquire proprietary interests in the Company and to encourage the Participants to work towards enhancing the value of the Company and its shares for the benefit of the Company and its shareholders as a whole. The Plan will expire on July 4, 2017.
 
The exercise price and vesting conditions of the share options will be determined by the compensation committee of the board of directors. The Plan also requires certain adjustments to the aggregate number of share and the exercise price of the share options when certain events occur, including but not limited to share split and amalgamation.
 
By a resolution of the board of directors on July 4, 2007, 7,000,000 share options were authorized to be granted to certain employees, directors and non-employees. The share options have an exercise price of US$4.80 per share and have a graded vesting term of five years based on service conditions. For share options granted to employees and directors, the Company will account for these share options in accordance with SFAS 123(R) “Share-Based Payment” and will allocate the fair value of the share options to compensation expense over the vesting term on a straight-line basis. For share options granted to non-employees, the Company will account for these share options in accordance with EITF 96-18 “Accounting for Equity Instruments That Are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services”. The Company, assisted by an independent valuation firm, is currently in the process of valuing these share options.
 
20.   Subsequent Events (continued)
 
d)   Establishment of a new subsidiary
 
Aero-Biotech Science & Technology Co., Ltd., a wholly-owned subsidiary of China Victory, was incorporated in the PRC with a registered capital of US$29,200,000 on March 29, 2007 (Note 1).
 
e)   Loan from the controlling shareholder
 
China Victory obtained a loan from the controlling shareholder of the Company on June 28, 2007 in the amount of US$20,200,000 bearing a fixed interest rate of 7% per annum, which is repayable within one year.
 
21.   Condensed Financial Information of the Company
 
Under PRC laws and regulations, P3A is restricted in its ability to transfer certain of its net assets to the Company in the form of dividend payments, loans, or advances. The amounts restricted include paid up capital and statutory reserve, as determined pursuant to PRC generally accepted accounting principles, totaling RMB91,953,000 (US$12,080,005) as of December 31, 2006.


F-27


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2004, 2005 and 2006 — (Continued)
 
Statements of operations
 
                                 
    2004     2005     2006     2006  
    (RMB’000)     (RMB’000)     (RMB’000)     (US$’000)  
 
Revenue
                       
Cost of revenue
                       
                                 
Gross profit
                       
Operating expenses
                       
                                 
Operating profit
                       
Equity in profit of subsidiaries and variable interest entity
    57,772       169,080       253,903       33,356  
                                 
Income before income tax
    57,772       169,080       253,903       33,356  
Income tax
                       
                                 
Net income
    57,772       169,080       253,903       33,356  
                                 
Net income attributable to ordinary shareholders
    57,772       169,080       253,903       33,356  
                                 
 
Balance sheets
 
                         
    2005     2006     2006  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Investment in subsidiaries and variable interest entity
    208,834       354,136       46,523  
                         
Shareholders’ Equity
                       
Ordinary shares (par value US$0.0000001 per share: 499,900,000,000 shares authorized; 100,000,000 shares issued and outstanding at December 31, 2005 and 2006)
                 
Additional paid-in capital
    6,262       8,098       1,064  
Retained earnings
    202,572       346,038       45,459  
                         
Total shareholders’ equity
    208,834       354,136       46,523  
                         
 
(a)   Basis of presentation
 
In the Company-only financial statements, the Company’s investment in subsidiaries and variable interest entity is stated at cost plus equity in undistributed earnings of subsidiaries since inception. The Company-only financial statements should be read in conjunction with the Company’s consolidated financial statements.
 
The Company records its investment in its subsidiaries and variable interest entity under the equity method of accounting as prescribed in APB Opinion No. 18, “The Equity Method of Accounting for Investments in Common Stock.” Such investment is presented on the balance sheet as “Investment in subsidiaries and variable interest entity” and share of their profit or loss as “Equity in profit (loss) of subsidiaries and variable interest entity” on the statements of operations.
 
Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted.
 
No cash flow statements are presented because the Company did not have any cash flow transactions in any of the years presented.


F-28


Table of Contents

AGRIA CORPORATION

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
As of December 31, 2006 and June 30, 2007
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollar (“US$”),
except for number of shares)
 
                                                 
                            Pro-forma Shareholders’ Equity (Note 2)  
          December 31
    June 30
    June 30
    June 30
    June 30
 
    Note     2006     2007     2007     2007     2007  
          (RMB)     (RMB)
    (US$)
    (RMB)
    (US$)
 
                (unaudited)     (unaudited)     (unaudited)     (unaudited)  
ASSETS
Current assets:
                                               
Cash and cash equivalents
            42,782       325,562       42,770                  
Accounts receivable (net of allowance for doubtful accounts of RMB3,467 and RMB1,980 (US$260) at December 31, 2006 and June 30, 2007, respectively)
    3       156,440       166,954       21,933                  
Inventories
    4       58,007       53,270       6,998                  
Prepayments and other current assets
    5       22,584       76,672       10,072                  
Amounts due from related parties
    17       1,059       167       22                  
                                                 
Total current assets
            280,872       622,625       81,795                  
                                                 
Non-current assets:
                                               
Property, plant and equipment, net
    6       40,126       40,146       5,274                  
Investment
            205       205       27                  
Intangible assets, net
    7       74,437       85,838       11,277                  
Deferred share issuance costs
    8             14,304       1,879                  
Other assets, net
    9       94,836       108,382       14,238                  
                                                 
Total non-current assets
            209,604       248,875       32,695                  
                                                 
Total assets
            490,476       871,500       114,490                  
                                                 
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
                                               
Short-term bank borrowings
    10       36,900       8,400       1,104                  
Long-term bank borrowing, current portion
    10       1,500                              
Accounts payable
            27,161       26,552       3,488                  
Accrued expenses and other liabilities
    11       14,907       31,670       4,160                  
Dividend payable
                  6,304       828                  
Amounts due to a shareholder
    17       29,992       255,730       33,596                  
Amounts due to related parties
    17       16,884       15,980       2,099                  
                                                 
Total current liabilities
            127,344       344,636       45,275                  
                                                 
Non-current liabilities:
                                               
Amounts due to related parties
    17       8,996       8,996       1,182                  
                                                 
Total non-current liabilities
            8,996       8,996       1,182                  
                                                 
Total liabilities
            136,340       353,632       46,457                  
                                                 
Commitments and contingencies
    19                                          
Series A Redeemable convertible preferred shares (par value US$0.0000001 per share; 100,000,000 shares authorised; nil and 2,400,000 shares issued and outstanding at December 31, 2006 and June 30, 2007 with aggregate amount of liquidation preference totaling US$10,000,000, respectively; pro forma nil)
    12             65,111       8,555              
                                                 
Redeemable ordinary shares (par value US$0.0000001 per share; nil and 6,250,000 shares issued and outstanding at December 31, 2006 and June 30, 2007, respectively; pro forma nil)
    13             155,928       20,484              
Shareholders’ equity:
                                               
Ordinary shares (par value US$0.0000001 per share; 499,900,000,000 shares authorized; 100,000,000 and 93,750,000 shares issued and outstanding at December 31, 2006 and June 30, 2007; 102,400,000 shares outstanding proforma)
    14                                
Additional paid-in capital
            8,098                   85,253       11,200  
Statutory reserves
            76,953       76,953       10,109       76,953       10,109  
Retained earnings
            269,085       219,876       28,885       355,662       46,724  
                                                 
Total shareholders’ equity
            354,136       296,829       38,994       517,868       68,033  
                                                 
Total liabilities, preferred shares and shareholders’ equity
            490,476       871,500       114,490                  
                                                 
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.


F-29


Table of Contents

AGRIA CORPORATION

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the six months ended June 30, 2006 and 2007
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollar (“US$”),
except for number of shares and per share data)
 
                                 
          Six Months Ended June 30  
    Note     2006     2007     2007  
          (RMB)
    (RMB)
    (US$)
 
          (unaudited)     (unaudited)     (unaudited)  
 
Revenue:
                               
Corn seeds
            142,126       133,853       17,584  
Sheep breeding products
            97,518       110,599       14,530  
Seedlings (including related party amounts of RMBnil and RMB3,300 (US$434) for the six months ended June 30, 2006 and 2007, respectively)
            29,594       34,955       4,592  
                                 
Total revenue
            269,238       279,407       36,706  
                                 
Cost of revenue:
                               
Corn seeds
            (81,378 )     (80,395 )     (10,562 )
Sheep breeding products
            (26,629 )     (30,543 )     (4,012 )
Seedlings (including related party amounts of RMBnil and RMB842 (US$111) for the six months ended June 30, 2006 and 2007, respectively)
            (4,212 )     (10,679 )     (1,403 )
                                 
Total cost of revenue
            (112,219 )     (121,617 )     (15,977 )
                                 
Gross profit
            157,019       157,790       20,729  
                                 
Operating expense:
                               
Selling expenses
            (7,542 )     (7,937 )     (1,043 )
General and administrative expenses
            (3,445 )     (3,562 )     (468 )
Research and development expenses
            (2,623 )     (1,025 )     (135 )
                                 
Total operating expenses
            (13,610 )     (12,524 )     (1,646 )
                                 
Operating profit
            143,409       145,266       19,083  
Interest income
            150       150       20  
Interest expense (including related party amounts of RMB1,437 and RMB1,315 (US$173) for the six months ended June 30, 2006 and 2007, respectively)
            (2,414 )     (2,239 )     (294 )
Other income
            965       174       23  
                                 
Income before income tax
            142,110       143,351       18,832  
Income tax
    15                    
                                 
Net income
            142,110       143,351       18,832  
                                 
Earnings per share:
    16                          
—Basic
            RMB1.42       RMB1.43       US$0.19  
                                 
—Diluted
            RMB1.42       RMB1.43       US$0.19  
                                 
Weighted average number of ordinary shares outstanding:
    16                          
—Basic
            100,000,000       100,000,000       100,000,000  
                                 
—Diluted
            100,000,000       100,119,337       100,119,337  
                                 


F-30


Table of Contents

                                 
          Six Months Ended June 30  
    Note     2006     2007     2007  
          (RMB)
    (RMB)
    (US$)
 
          (unaudited)     (unaudited)     (unaudited)  
 
Pro forma earnings per share:
    16                          
—Basic and diluted on an as converted basis
                    RMB1.40       US$0.18  
                                 
Weighted average number of ordinary shares outstanding used in computation of:
    16                          
—Pro forma basic and diluted EPS
                    102,400,000       102,400,000  
                                 
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.


F-31


Table of Contents

AGRIA CORPORATION

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the six months ended June 30, 2006 and 2007
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollar (“US$”))
 
                         
    Six Months Ended June 30  
    2006     2007     2007  
    (RMB)
    (RMB)
    (US$)
 
    (unaudited)     (unaudited)     (unaudited)  
 
Cash flows from operating activities:
                       
Net income
    142,110       143,351       18,832  
Adjustments to reconcile net income to net cash provided by operating activities:
                       
Depreciation
    4,580       4,756       625  
Amortisation of intangible assets
    2,112       2,600       342  
Allowance for (reversal of) doubtful accounts
    515       (1,241 )     (195 )
Imputed interest on ultimate controlling shareholder’s loan
    918       1,000       131  
Imputed interest on amounts due to related parties
    519       314       41  
Changes in operating assets and liabilities:
                       
Restricted cash
    1,508              
Accounts receivable
    (60,254 )     (9,273 )     (1,186 )
Inventories
    42,036       4,737       622  
Prepayments and other current assets
    (30,738 )     (54,088 )     (7,105 )
Amounts due from related parties
    586       (8 )     (1 )
Accounts payable
    (28,848 )     (6,177 )     (811 )
Accrued expenses and other liabilities
    (1,889 )     4,836       635  
Amounts due to shareholders
          3,366       442  
Amounts due to related parties
    161       61       8  
                         
Net cash provided by operating activities
    73,316       94,234       12,380  
                         
Cash flows from investing activities:
                       
Acquisition of property, plant and equipment and other assets (including related party amounts of RMB1,120 and RMB1,280 (US$168) for the six months ended June 30, 2006 and 2007, respectively)
    (3,478 )     (16,274 )     (2,138 )
Acquisition of intangible assets
    (10,940 )     (11,760 )     (1,545 )
(Loan to) repayment from a related party
    (900 )     900       118  
                         
Net cash used in investing activities
    (15,318 )     (27,134 )     (3,565 )
                         
Cash flows from financing activities:
                       
Proceeds from issuance of preference shares and ordinary share redemption rights
          76,155       10,005  
Payment of deferred initial public offering costs
          (2,377 )     (312 )
Proceeds from short-term borrowings
    36,900       8,400       1,104  
Repayment of short-term borrowings
    (12,900 )     (36,900 )     (4,848 )
Repayment of long-term borrowings
          (1,500 )     (197 )
Dividends paid
    (53,095 )     (50,470 )     (6,630 )
Loan from shareholder
          222,372       29,213  
Repayment of loan to related parties
    (10,000 )            
                         
Net cash provided by (used in) financing activities
    (39,095 )     215,680       28,335  
                         
Net increase in cash and cash equivalents
    18,903       282,780       37,150  
Cash and cash equivalents at the beginning of period
    29,477       42,782       5,620  
                         
Cash and cash equivalents at the end of period
    48,380       325,562       42,770  
                         
Supplemental disclosure of cash flow information:
                       
Cash paid during the year for interest (net of interest capitalized)
    914       799       105  
Non-cash acquisition of property, plant and equipment and other assets
    900       5,568       731  
                         
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.


F-32


Table of Contents

AGRIA CORPORATION

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN
SHAREHOLDERS’ EQUITY
For the six months ended June 30, 2006 and 2007
(Amounts in thousands of Renminbi (“RMB”) except for number of shares)
 
                                                 
    Number of
          Additional
                Total
 
    Ordinary
    Ordinary
    Paid-in
    Statutory
    Retained
    Shareholders’
 
    Shares     Shares     Capital     Reserves     Earnings     Equity  
    (unaudited)     (RMB)
    (RMB)
    (RMB)
    (RMB)
    (RMB)
 
          (unaudited)     (unaudited)     (unaudited)     (unaudited)     (unaudited)  
 
Balance as of December 31, 2005
    100,000,000             6,262       38,695       163,877       208,834  
Imputed interest on ultimate controlling shareholder’s loan
                918                   918  
Net income for the six months
                            142,110       142,110  
Dividends declared
                            (53,095 )     (53,095 )
                                                 
Balance as of June 30, 2006
    100,000,000             7,180       38,695       252,892       298,767  
                                                 
Balance as of December 31, 2006
    100,000,000             8,098       76,953       269,085       354,136  
Imputed interest on ultimate controlling shareholder’s loan
                1,000                   1,000  
Net income for the six months
                            143,351       143,351  
Capital contribution from a shareholder (Note 13)
                7,426                   7,426  
Issue of redemption rights to redeemable ordinary shares (Note 13)
                3,618                   3,618  
Reclassification of ordinary shares subject to redemption (Note 13)
    (6,250,000 )           (20,142 )           (135,786 )     (155,928 )
Dividends declared
                            (56,774 )     (56,774 )
                                                 
Balance as of June 30, 2007
    93,750,000                   76,953       219,876       296,829  
                                                 
Balance as of June 30, 2007, in US$
                        10,109       28,885       38,994  
                                                 
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.


F-33


Table of Contents

AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS
 
1.   The Company and Basis of Presentation
 
The accompanying unaudited interim condensed consolidated financial statements of Agria Corporation (the “Company”), its wholly-owned subsidiaries and its variable interest entity (collectively, referred to as the “Group”) have been prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”) for interim financial information using accounting policies that are consistent with those used in the preparation of the Group’s audited financial statements for the year ended December 31, 2006. Accordingly, these financial statements do not include all of the information and footnotes required by US GAAP for complete financial statements.
 
In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all normal recurring adjustments necessary to present fairly the financial position, operating results and cash flows of the Group for each of the periods presented. The results of operations for the six months ended June 30, 2007 are not necessarily indicative of results to be expected for the full year of 2007 due in part to the seasonality of the Group’s business. The consolidated balance sheet as of December 31, 2006 was derived from the audited financial statements at that date but does not include all of the disclosures required by US GAAP for complete financial statements. These interim condensed consolidated financial statements should be read in conjunction with the Group’s consolidated financial statements and related notes for the year ended December 31, 2006.
 
The Group is principally engaged in development, production and sale of corn seeds, sheep breeding products and seedlings. The Group’s principal operations and geographic market are in the People’s Republic of China (the “PRC”).
 
As of June 30, 2007, the Company’s subsidiaries consist of the following entities:
 
                     
    Date of
  Place of
  Percentage of
     
Name
  Incorporation   Incorporation   Shareholdings     Principal Activities
 
Aero Biotech Science & Technology Co., Ltd. 
  March 29, 2007   PRC     100 %   Research and development
Aero-Biotech Group Limited
  July 6, 2005   BVI     100 %   Investment holding
China Victory International Holdings Limited
  September 19, 2003   Hong Kong     100 %   Investment holding
 
As of June 30, 2007, the Company consolidates the following variable interest entity which comprises substantially all of the Company’s operations:
 
             
    Date of
  Place of
   
Name
  Incorporation   Incorporation   Principal Activities
 
             
Primalights III Modern Agriculture
Development Co., Ltd. (“P3A”)
  April 20, 2000   PRC   Development, production and sale of
            corn seeds, sheep breeding products
and seedlings
 
2.   Summary of Significant Accounting Policies
 
Principles of Consolidation
 
The Group’s interim condensed consolidated financial statements include the financial statements of the Company, its subsidiaries and the VIE for which the Company is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and the VIE have been eliminated upon consolidation.


F-34


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
Use of Estimates
 
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from these estimates. Significant estimates and assumptions reflected in the Company’s financial statements include, but are not limited to, allowance for doubtful accounts, useful lives of property plant and equipment, consolidation of VIE, intangible assets and valuation of financial instruments.
 
Accounting for Uncertain Income Tax Positions
 
In June 2006, the Financial Accounting Standards Board (“FASB”) issued Interpretation No. 48, “Accounting for uncertainty in Income Taxes, an interpretation of FAS 109, Accounting for Income Taxes” (“FIN 48”), which became effective on January 1, 2007 for the Group. FIN 48 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is more likely than not of being realized upon ultimate settlement. The Group’s adoption of FIN 48 did not result in any adjustment to the opening balance of the Group’s retained earnings as of January 1, 2007 nor did it have any impact on the Group’s financial statements for the six months ended June 30, 2007.
 
The Company adopts the policy to classify interest to be paid on any underpayment of income taxes in interest expense and penalties to other operating expenses. No such amounts have been incurred.
 
Based on existing PRC tax regulations, the tax years of P3A for the years ended December 31, 2004, 2005 and 2006 remain subject to examination by the tax authorities.
 
Advertising Expenditure
 
Advertising costs are expensed when incurred and are included in “selling expenses”. Advertising expenses were RMB1,180,800 and RMB1,362,000 (US$178,928) for each of the six months ended June 30, 2006 and 2007, respectively.
 
Convenience Translation
 
Translations of amounts from RMB into United States dollars for the convenience of the reader were calculated at the noon buying rate of US$1.00 to RMB7.6120 on June 29, 2007 in The City of New York for cable transfers of RMB as certified for customs purposes by the Federal Reserve Bank of New York. No representation is made that the RMB amounts could have been, or could be, converted into United States dollars at such rate.
 
Earnings per Share
 
Earnings per share is calculated in accordance with SFAS No. 128, “Earnings Per Share.” Basic earnings per ordinary share is computed by dividing income attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the period. Diluted earnings per ordinary share reflects the potential dilution that could occur if securities or other contracts to issue ordinary shares were exercised or converted into ordinary shares. Ordinary shares issuable upon the conversion of the redeemable, convertible preferred shares are included in the computation of diluted income per ordinary share on an “if-converted” basis, when the impact is dilutive.


F-35


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
  Unaudited Pro Forma Shareholders’ Equity
 
If an initial public offering (“IPO”) is completed, all of the Series A Redeemable convertible preferred shares (see Note 12) outstanding will automatically convert into 2,400,000 shares of ordinary shares, based on the shares of Series A Redeemable convertible preferred shares outstanding at June 30, 2007. Also if an IPO is completed, the 6,250,000 redeemable ordinary shares (see Note 13) outstanding will cease to be redeemable. Unaudited pro forma shareholders’ equity, as adjusted for the assumed conversion of the Series A Redeemable convertible preferred shares and the cessation of the redeemable ordinary shares redemption rights, is set forth on the consolidated balance sheet.
 
3.   Accounts receivable
 
Accounts receivable consist of the following:
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Accounts receivable
    159,907       168,934       22,193  
Less: Allowance for doubtful accounts
    (3,467 )     (1,980 )     (260 )
                         
      156,440       166,954       21,933  
                         
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Movements in allowance for doubtful accounts:
                       
Balance at the beginning of the period
    (1,921 )     (3,467 )     (455 )
Provision for doubtful collection
    (1,546 )            
Reversal of provision due to subsequent collection
          1,241       163  
Write-off
          246       32  
                         
Balance at the end of the period
    (3,467 )     (1,980 )     (260 )
                         
 
4.   Inventories
 
Inventories consist of the following:
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Raw materials and supplies
    8,707       7,071       929  
Work in progress
    9,348       13,329       1,751  
Finished goods
    39,952       32,870       4,318  
                         
      58,007       53,270       6,998  
                         


F-36


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
5.   Prepayments and other current assets
 
Prepayments and other current assets consist of the following:
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Advances to suppliers
         16,352            69,414            9,120  
Other receivables (Note 19)
    4,070       5,286       694  
Others
    2,162       1,972       258  
                         
Total
    22,584       76,672       10,072  
                         
 
The advances to suppliers as at December 31, 2006 and June 30, 2007 represents advances to village collectives for growing corn seeds for the Company. All the advances are non-interest bearing and will be applied to reduce the cost of future inventory supplied.
 
6.   Property, plant and equipment, net
 
Property, plant and equipment consist of the following:
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Buildings
         32,559            32,559            4,277  
Plant and machinery
    6,908       6,908       908  
Furniture and office equipment
    1,004       1,612       212  
Motor vehicles
    1,554       2,210       290  
Construction in progress
    5,038       5,223       686  
                         
      47,063       48,512       6,373  
Less: Accumulated depreciation
    (6,937 )     (8,366 )     (1,099 )
                         
      40,126       40,146       5,274  
                         
 
Depreciation expense is RMB1,364,919 and RMB1,427,823 (US$187,575) for each of the six months ended June 30, 2006 and 2007, respectively.
 
Interest capitalized for the six months ended June 30, 2006 and 2007 amounts to RMB161,940 and RMB185,087 (US$24,315), respectively.
 
7.   Intangible assets, net
 
Intangible assets as of December 31, 2006 consist of the following:
 
                         
    Gross
    Accumulated
    Net Carrying
 
    Carrying Value     Amortization     Value  
    (RMB’000)     (RMB’000)     (RMB’000)  
 
Land use rights
         67,874            (4,102 )          63,772  
Acquired technology
    15,171       (4,506 )     10,665  
                         
Balance, end of year
    83,045       (8,608 )     74,437  
                         


F-37


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
Intangible assets as of June 30, 2007 consist of the following:
 
                                 
    Gross
    Accumulated
    Net Carrying
    Net Carrying
 
    Carrying Value     Amortization     Value     Value  
    (RMB’000)     (RMB’000)     (RMB’000)     (US$’000)  
 
Land use rights
         76,274            (5,190 )          71,084            9,339  
Acquired technology
    20,771       (6,017 )     14,754       1,938  
                                 
Balance, end of period
    97,045       (11,207 )     85,838       11,277  
                                 
 
Amortization expense for the six months ended June 30, 2006 and 2007 is RMB2,112,222, and RMB2,599,555 (US$341,507), respectively.
 
Expected amortization expense on these intangible assets for each of the next five years and thereafter is expected to be as follows:
 
                 
    (RMB’000)     (US$’000)  
 
Six months ending December 31
               
2007
    4,263       560  
Year ending December 31
               
2008
    10,422       1,369  
2009
    9,310       1,223  
2010
    4,643       610  
2011
    3,928       516  
Thereafter
    53,272       6,999  
                 
      85,838       11,277  
                 
 
8.   Deferred share issuance cost
 
Deferred share issuance costs represent incremental costs incurred by the Group directly attributable to the Company’s IPO. The share issuance costs will be charged against the gross proceeds of such offering.
 
9.   Other assets, net
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Breeder sheep
    10,892       27,765       3,648  
Date trees
         91,012            91,012            11,956  
                         
      101,904       118,777       15,604  
Less: Accumulated depreciation
    (7,068 )     (10,395 )     (1,366 )
                         
      94,836       108,382       14,238  
                         
 
Depreciation expense is RMB3,215,171 and RMB3,327,764 (US$437,173) for each of the six months ended June 30, 2006 and 2007, respectively.
 
As of December 31, 2006, date trees with net book value of RMB52,703,119 were pledged as security for short-term bank borrowings of RMB24,000,000 (Note 10). This pledge was released when the bank borrowing was repaid in full during the six months ended June 30, 2007.


F-38


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
10.   Bank borrowings
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Total bank borrowings
    38,400       8,400       1,104  
                         
Comprised of:
                       
Short-term
    36,900       8,400       1,104  
Long-term, current portion
    1,500              
                         
      38,400       8,400       1,104  
Long-term, non-current portion
                 
                         
      38,400       8,400       1,104  
                         
 
All bank borrowings are denominated in RMB. During the six months ended June 30, 2007, the Group obtained a short-term bank borrowing of RMB8,400,000 bearing an interest rate of 11.448% per annum which was guaranteed by Taiyuan Relord. The Group did not pay any fees to obtain the guarantees in relation to the short-term bank borrowing in 2007.
 
The long-term bank borrowing outstanding at December 31, 2006 bears a fixed interest rate of 5.76% per annum and was repaid in April 2007.
 
11.   Accrued expenses and other liabilities
 
The components of accrued expenses and other liabilities are as follows:
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Welfare, education and union fund
    4,037       5,032       661  
Withholding individual income tax
    6,105       7,952       1,045  
Sales commission due to sales staff
    1,286       2,044       269  
Advance from customers
    856       856       112  
Government fund
    572       575       75  
Advertisement expense
    420              
Share issuance costs (Note 8)
          11,927       1,567  
Others
    1,631       3,284       431  
                         
      14,907       31,670       4,160  
                         
 
12.   Series A Redeemable convertible preferred shares
 
On June 22, 2007, the Company issued 2,400,000 Series A Redeemable convertible preferred shares to two third party investors in exchange for total consideration of US$10,000,000 (RMB76,154,878). Each Series A preferred share is convertible, at the option of the holder thereof, at any time after the date of issuance of such share, into one ordinary share. The preferred share conversion price shall be adjusted for any stock dividends, splits, consolidation, certain issuances. If an IPO is completed, all of the Series A Redeemable convertible preferred shares outstanding will automatically convert into ordinary shares of the Company.


F-39


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
Beginning on August 1, 2008, the holders of preferred shares shall have the right to receive annual cumulative dividends of 8% if a qualifying IPO of the Company’s ordinary shares is not consummated prior to July 31, 2008; otherwise no dividend is payable to the holders.
 
If the Company has not completed a qualifying IPO on or prior to December 31, 2008, the investors have the right at any time within 90 days after December 31, 2008 to require the Company to redeem all of the convertible preferred shares for cash equal to their principal value plus any accrued but unpaid dividends. The redemption right shall terminate 90 days following December 31, 2008.
 
In connection with our sale of the Series A Redeemable, convertible preferred shares, the Company and the purchasers entered into a registration rights agreement. Under the terms of this agreement, the purchasers may, at any time following 180 days after an initial public offering by the Company, require the Company to use reasonable best efforts to effect up to two registrations (and unlimited registrations on Form F-3) of ordinary shares held by such parties. In the event the Company uses reasonable best efforts and is unable to register the shares, the Company has no further obligations to these shareholders.
 
Upon the occurrence of a liquidation event, redemption payment or liquidation distribution, each holder of preferred shares shall be entitled to receive, prior and in preference to any distribution of any of the assets or surplus funds of the Company to the holders of the ordinary share, an amount equal to the preferred shares purchase price per share plus all accrued but unpaid dividends.
 
The preferred shares have been classified as mezzanine equity because their redemption is contingent on occurrence of an event that is not within the control of the Company. The preferred shares are not currently redeemable because the contingent redemption event has not occurred and to date, the Company has determined that it is not probable of occurring. An accretion charge to increase the preferred shares’ carrying value of US$8,549,862 (RMB65,111,477) at the date of issuance to the US$10,000,000 (RMB76,154,878) redemption amount will only be recorded to retained earnings when redemption is deemed probable.
 
The Company has determined there are no embedded derivatives subject to bifurcation because the embedded conversion option and the contingent redemption option do not meet the net settlement or payment provision under paragraph 6c of FAS133. There is also no beneficial conversion feature related to the issuance of preferred shares as the estimated fair value of the ordinary shares is less than the effective conversion price on the date of issuance.
 
On August 15, 2007, the Company effected a 10,000 for 1 share split whereby each Series A redeemable convertible preferred share with an original par value of US$0.001 per share is exchanged for 10,000 new Series A redeemable convertible preferred shares, each with a par value of US$0.0000001 per share. The authorized number of preferred shares of the Company increased from 10,000 to 100,000,000. All share and per share data are presented to give retroactive effect to the share split.
 
13.   Redeemable ordinary shares
 
On June 22, 2007, the controlling shareholder of the Company sold 6,250,000 of his ordinary shares of the Company to two third party investors in exchange for cash. The Company issued to those investors a redemption right related to the shares purchased, whereby if an IPO is not completed prior to or on December 31, 2008, the investors can require the Company to redeem the ordinary shares at an amount equal to the purchase price (US$20 million) paid to the controlling shareholder of the Company. The occurrence of the event giving rise to redemption is not within the Company’s control, accordingly the redeemable ordinary shares are classified in mezzanine equity.


F-40


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
14.   Ordinary shares
 
On August 15, 2007, the Company effected a 10,000 for 1 share split whereby each ordinary share with an original par value of US$0.001 per share is exchanged for 10,000 new ordinary shares, each with a par value of US$0.0000001 per share. The authorized number of the ordinary shares increases to 499,900,000,000. All share and per share data are presented to give retroactive effect to the share split.
 
15.   Income taxes
 
The Company and Aero-Biotech are tax exempt companies.
 
China Victory is subject to applicable profits tax rate of 17.5%. China Victory does not have any taxable income and income tax liability for each of the six months ended June 30, 2006 and 2007.
 
P3A is subject to PRC income tax on its taxable income as reported in its PRC statutory accounts adjusted in accordance with relevant PRC income tax laws.
 
P3A was approved as one of the Key enterprises under the Shanxi Province Agricultural Technology Project “1311” (“Project “1311”) by the Shanxi Province in 2002 which entitled P3A to income tax exemption. The income tax exemption will continue to apply to P3A until modified or repealed by the taxation authorities.
 
A reconciliation between taxes computed by applying the statutory income tax rate of 15% applicable to the Group’s operations to income tax expense is presented below:
 
                         
    Six Months Ended June 30  
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Income before income tax
    142,110       143,351       18,832  
                         
Income tax computed at the applicable statutory tax rate of 15%
    21,317       21,503       2,825  
Non-deductible expenses
    1,855       2,344       308  
Effect of income tax exemption
    (23,172 )     (23,847 )     (3,133 )
                         
Income tax expense reported in the consolidated statements of operations
                 
                         
 
There are no deferred tax assets or liabilities because the Group is exempt from income taxes for the foreseeable future.
 
The benefit of the tax exemption on basic and diluted earnings per share is as follows:
 
                         
    Six Months Ended June 30  
    2006     2007     2007  
    (RMB)     (RMB)     (US$)  
 
Basic and diluted
    0.23       0.24       0.03  
                         


F-41


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
16.   Earnings per Share
 
Basic and diluted earnings per share for each of the six months presented are calculated as follows:
 
                         
    Six Months Ended June 30  
    2006     2007     2007  
    (RMB)     (RMB)     (US$)  
    (Amounts in thousands except for number of shares and per share data)  
 
Net income attributable to ordinary shareholders (numerator), basic and diluted
    142,110       143,351       18,832  
                         
Number of Shares (denominator):
                       
Weighted average number of ordinary shares outstanding used in calculating basic income per share
    100,000,000       100,000,000       100,000,000  
Effect of Series A redeemable convertible preferred shares
          119,337       119,337  
                         
Weighted average number of ordinary shares outstanding used in calculating diluted income per share
    100,000,000       100,119,337       100,119,337  
                         
Earnings per share — basic
    RMB1.42       RMB1.43       US$0.19  
                         
Earnings per share — diluted
    RMB1.42       RMB1.43       US$0.19  
                         
 
Pro forma earnings per share
 
On June 22, 2007, the Company issued Series A convertible redeemable preference shares (Note 12) that will automatically be converted into one fully paid ordinary share of the Company upon the completion of a qualifying IPO. Assuming the conversion had occurred “on a hypothetical” basis on January 1, 2007, the pro-forma basic and diluted earnings per share for the six month ended June 30, 2007 are calculated as follows:
 
                 
    Six Months Ended June 30,2007  
    (RMB)     (US$)  
    (Amounts in thousands except for number of shares and per share data)  
 
Net income attributable to ordinary shareholders (numerator), basic and diluted
    143,351       18,832  
                 
Number of Shares (denominator):
               
Weighted average number of ordinary shares outstanding used in calculating basic income per share
    100,000,000       100,000,000  
Conversion of Series A redeemable convertible preferred shares
    2,400,000       2,400,000  
                 
Weighted average number of ordinary shares outstanding used in calculating basic and diluted income per share
    102,400,000       102,400,000  
                 
Pro forma earnings per share — basic and diluted
    RMB 1.40       US$0.18  
                 


F-42


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
17.   Related Party Transactions
 
     
Name of Related Parties
 
Relationship with the Group
 
Taiyuan Relord
  A company owned by a director of P3A
Shanxi Sanmu
  A subsidiary of Taiyuan Relord
Taiyuan Baojia Agriculture Science & Technology Development Co., Ltd. (“Taiyuan Baojia”)
  A subsidiary of Taiyuan Relord
Xue Zhi Xin
  A director of P3A
Zhang Ming She
  A director of P3A
Yan Lv
  A director of P3A (note (i))
Liu Jin Bin
  A director of P3A (note (i))
Cui Ya Chao
  Employee of Aero Biotech Science & Technology Co., Ltd.
 
 
Note (i): Yan Lv and Liu Jin Bin ceased to be a director of P3A from April 18, 2007.
 
(1) The Company had the following significant related party transactions during the periods presented:
 
                         
    Six Months Ended June 30  
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Sales of seedlings to:
                       
Taiyuan Relord
          3,300       433  
                         
Repayment of loans borrowed from:
                       
Zhang Ming She
    4,000              
Xue Zhi Xin
    4,000              
Yan Lv
    2,000              
                         
      10,000              
                         
Loan advanced to Taiyuan Baojia
    900              
                         
Repayment of loan advanced to Taiyuan Baojia
          900       118  
                         


F-43


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
(2) The Company had the following related party balances at the end of the period:
 
                         
    December 31
    June 30
    June 30
 
    2006     2007     2007  
    (RMB’000)     (RMB’000)     (US$’000)  
 
Amounts due from related parties:
                       
Taiyuan Baojia
    900              
Zhang Ming She(i)
    52       71       9  
Xue Zhi Xin(i)
    53       53       7  
Yan Lv(i)
    39       28       4  
Liu Jin Bin(i)
    15       15       2  
                         
      1,059       167       22  
                         
Amounts due to related parties included in current liabilities:
                       
Taiyuan Relord
    16,884       14,181       1,863  
Cui Ya Chao(ii)
          1,799       236  
                         
      16,884       15,980       2,099  
                         
Amounts due to related parties included in non-current liabilities:
                       
Taiyuan Relord
    8,996       8,996       1,182  
                         
Amount due to a shareholder(iii)
    29,992       255,730       33,596  
                         
 
The balances with related parties are unsecured, non-interest bearing and due within one year unless otherwise specified.
 
(i) The balances represent cash advances paid to directors for reimbursable company expenses.
 
(ii) The balance represents cash advanced from an employee for reimbursable company expenses.
 
(iii) China Victory obtained a loan from the controlling shareholder of the Company on June 28, 2007 in the amount of US$20,200,000 (RMB153,833,100) bearing a fixed interest rate of 7% per annum, which is repayable within one year. In addition, China Victory also obtained an interest free advance from the controlling shareholder of the Company on June 28, 2007 in the amount of US$9,000,000 (RMB68,539,500), which was repaid on July 6, 2007. The purpose of the borrowing from the controlling shareholder of the Company is to provide the Company funding needed to set up Aero Biotech Science & Technology Co., Ltd.
 
Imputed interest, calculated using incremental borrowing rates ranging from 6.12% to 6.57%, amounting to RMB0.9 million and RMB1.0 million for the six months ended June 30, 2006 and 2007, respectively, were recorded with an offsetting credit to Additional Paid-in Capital.
 
(3) P3A guaranteed a short term bank loan amounting to RMB1,500,000 and RMB1,500,000 borrowed by Taiyuan Relord at December 31, 2006 and June 30, 2007 respectively. P3A also guaranteed a short term bank loan amounting to RMB2,000,000 borrowed by Taiyuan Baojia at December 31, 2006 (Note 19). The guarantee provided on the loan borrowed by Taiyuan Baojia was released during the six months ended June 30, 2007.
 
18.   Employee defined contribution plan
 
Chinese labor regulations require companies in the PRC to participate in a government mandated defined contribution plan pursuant to which certain pension benefits, medical care, unemployment insurance, employee


F-44


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
housing fund and other welfare benefits are provided to employees, and to make contributions to the government for these benefits based on a certain percentage of the employees’ salaries. P3A is required to make contributions to the government mandated defined contribution plan for these benefits based on 28% of the employees’ salaries. The Company has no legal obligation for the benefits beyond the contributions made. The total amounts for such employee benefits, which were expensed as incurred, were RMB498,461 and RMB485,333 (US$63,759) respectively for each of the six months ended June 30, 2006 and 2007, respectively.
 
19.   Commitments and contingencies
 
  Operating lease commitments
 
Payments under operating leases for land and building, which are mainly used for sheep breeding and to grow seedlings, are expensed on a straight-line basis over the period of their respective leases. The terms of the leases do not contain rent escalation or contingent rents and have lease periods ranging from 3 to 45 years. Future minimum lease payments for each of the next five years and thereafter, under all non-cancelable operating leases are as follows:
 
                 
    (RMB’000)     (US$’000)  
 
Six months ending December 31
               
2007
    35,057       4,606  
Year ending December 31
               
2008
    46,435       6,100  
2009
    45,095       5,924  
2010
    1,366       180  
2011
    1,144       150  
Thereafter
    28,601       3,757  
                 
      157,698       20,717  
                 
 
Total rental expense was RMB1,125,594 and RMB3,884,057 (US$510,254) for the six months ended June 30, 2006 and 2007, respectively.


F-45


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
  Purchase commitments
 
Purchase commitments represent service agreements entered into with village collectives and corn seed companies to grow corn seeds on behalf of the Company. The terms of the agreements have periods ranging from 5 to 12 years. Future minimum purchase payments for each of the next five years and thereafter, under all non-cancelable agreements are as follows:
 
                 
    (RMB’000)     (US$’000)  
 
Six months ending December 31
               
2007
    20,854       2,740  
Year ending December 31
               
2008
    41,708       5,479  
2009
    41,708       5,479  
2010
    41,708       5,479  
2011
    40,926       5,377  
Thereafter
    259,834       34,135  
                 
      446,738       58,689  
                 
 
Total purchase cost was RMB12,905,875 and RMB19,389,608 (US$2,547,242) for the six months ended June 30, 2006 and 2007, respectively.
 
  Enterprise Income Tax
 
All PRC incorporated entities are subject to enterprise income tax regulations promulgated by the Ministry of Finance and the State Tax Bureau of the PRC. P3A has not recorded any current or deferred income taxes in reliance on an enterprise income tax exemption notice received from the Local Tax Bureau of Taiyuan in the province of Shanxi and a legal opinion received from Shanxi Cheng Kai Law Firm, confirming P3A’s enterprise income tax exemption status under existing PRC tax regulation. Based on the above, management believes that it is unlikely that the Ministry of Finance and the Sate Tax Bureau will challenge P3A’s enterprise income tax exemption status.
 
  Individual Income Tax Withholdings
 
Based on existing PRC tax regulations, P3A is required to withhold and remit income taxes from its employees. Failure to do so would subject the company to a penalty of 50% to 300% of the actual withholding tax amount. P3A did not remit employee income taxes for the six months ended June 30, 2006 and 2007. P3A estimated that the most likely outcome will result in a 150% penalty assessment; therefore an accrual of RMB1,770,808 and RMB1,824,015 was recorded for the six months ended June 30, 2006 and 2007, respectively. The taxation authorities may assess the maximum amount which would exceed the accrued amount by RMB1,770,808 and RMB1,824,015 for the six months ended June 30, 2006 and 2007, respectively. P3A obtained written agreements from its employees that they will reimburse the company for tax penalty assessed over 50% of the withholding tax amount. Accordingly, a receivable amounting to RMB1,180,539 and RMB1,216,010 was recorded for the six months ended June 30, 2006 and 2007, respectively (Note 5).
 
The Company has contacted the relevant tax authority to remediate the situation. Currently the Company is waiting for tax authority to provide further guidance so that the Company can settle the tax obligations.


F-46


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
  Guarantees
 
P3A guaranteed short term bank loans totaling RMB3,500,000 borrowed by Taiyuan Relord and Taiyuan Baojia, its related parties (Note 17) at December 31, 2006. P3A did not receive any fee for providing the guarantees. These bank loans were repaid and the guarantees were released subsequent to December 31, 2006.
 
P3A guaranteed a short term bank loan of Taiyuan Relord which amounted to RMB1,500,000 at June 30, 2007 (Note 17). P3A did not receive any fee for providing the guarantee. The bank loan is repayable on December 27, 2007 and the guarantee will be released at the time when the bank loan is repaid.
 
In accordance with FIN 45 “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others,” guarantor must recognize a liability for the fair value of the obligations it assumes under certain guarantees. The maximum amount of undiscounted payments P3A would have had to make in the event of default by the original borrowers is RMB1,500,000 at June 30, 2007. The Company has determined the fair value of the guarantees in each of the periods to be insignificant. Accordingly, the Company has not recorded any liabilities for these agreements as of December 31, 2006 and June 30, 2007.
 
The Company does not have any recourse under the agreement to recover any payment required by the guarantee from the original borrower.
 
20.   Segment reporting
 
The Company is engaged in the development, production and sale of corn seeds, sheep breeding products and seedlings. In accordance with SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information”, the Company’s chief operating decision maker evaluates segment performance based on revenue and cost of revenue by segment. The Company has determined that it has three operating and reportable segments which are corn seeds, sheep breeding products and seedlings.
 
The revenue, cost of revenue and gross profit by segment are as follows:
 
Six Months Ended June 30, 2006
 
                                 
          Sheep
             
          Breeding
             
    Corn Seeds     Products     Seedlings     Consolidated  
    (RMB’000)     (RMB’000)     (RMB’000)     (RMB’000)  
 
Revenue
    142,126       97,518       29,594       269,238  
Cost of revenue
    (81,378 )     (26,629 )     (4,212 )     (112,219 )
                                 
Gross profit
    60,748       70,889       25,382       157,019  
Unallocated operating expenses
                            (13,610 )
Unallocated non-operating expense
                            (1,299 )
                                 
Income before income tax
                            142,110  
                                 
 
Six Months Ended June 30, 2007


F-47


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
                                 
          Sheep
             
          Breeding
             
    Corn Seeds     Products     Seedlings     Consolidated  
    (RMB’000)     (RMB’000)     (RMB’000)     (RMB’000)  
 
Revenue
    133,853       110,599       34,955       279,407  
Cost of revenue
    (80,395 )     (30,543 )     (10,679 )     (121,617 )
                                 
Gross profit
    53,458       80,056       24,276       157,790  
Unallocated operating expenses
                            (12,524 )
Unallocated non-operating expense
                            (1,915 )
                                 
Income before income tax
                            143,351  
                                 
 
                                 
          Sheep
             
          Breeding
             
    Corn Seeds     Products     Seedlings     Consolidated  
    (US$’000)     (US$’000)     (US$’000)     (US$’000)  
 
Revenue
    17,584       14,530       4,592       36,706  
Cost of revenue
    (10,562 )     (4,012 )     (1,403 )     (15,977 )
                                 
Gross profit
    7,022       10,518       3,189       20,729  
Unallocated operating expenses
                            (1,646 )
Unallocated non-operating expense
                            (251 )
                                 
Income before income tax
                            18,832  
                                 
 
The Company had no customers which accounted for 10% or more of the Company’s revenues for any of the periods presented.
 
All of the Company’s sales are made to customers located in the PRC and all of the Company’s long-lived assets are located in the PRC. The Company does not allocate such assets to individual segments.
 
21.   Subsequent Events
 
a)   Share Option Plan
 
On July 4, 2007, the Company’s shareholders approved the “2007 Share Incentive Plan” (the “Plan”). Under the Plan, the Company may issue up to 20,000,000 ordinary shares of par value US$0.0000001 per share to the directors, employees and non-employees of the Group (the “Participants”). The objective of the Plan is to provide the Participants with the opportunity to acquire proprietary interests in the Company and to encourage the Participants to work towards enhancing the value of the Company and its shares for the benefit of the Company and its shareholders as a whole. The Plan will expire on July 4, 2017.
 
The exercise price and vesting conditions of the share options will be determined by the compensation committee of the board of directors. The Plan also requires certain adjustments to the aggregate number of share and the exercise price of the share options when certain events occur, including but not limited to share split and amalgamation.
 
By a resolution of the board of directors on July 4, 2007, 7,000,000 share options were authorized to be granted to certain employees and directors (the “July 4 Options”). The share options have an exercise price of US$4.80 per share and have a graded vesting term of five years based on service conditions. The key terms of July 4 Options were communicated to a director grantee and an employee grantee on July 4, 2007. No such communication was made to the remaining grantees included in July 4 Option. By a resolution of the board of


F-48


Table of Contents

 
AGRIA CORPORATION
 
NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS — (Continued)
 
directors on July 19, 2007, the July 4 Options were amended. The number of share options that are authorized to be granted to certain employees and directors was changed to 7,500,000. As a result of the amendments, 5,900,000 of the share options granted have an exercise price of US$2.40 per share and 1,600,000 of the share options granted have an exercise price of US$4.80 per share. The share options have a graded vesting term of four years based on service conditions. The amended key terms of the options were communicated to grantees shortly after July 19, 2007.
 
For share options granted to employees and directors, the Company will account for these share options in accordance with SFAS 123(R) “Share-Based Payment” and will allocate the fair value of the share options to compensation expense over the vesting term on a straight-line basis over the requisite service period for the entire award with the amount of compensation expense recognized at any date not less than the portion of the grant-date value of the award that is vested at that date. The Company, assisted by an independent valuation firm, is currently in the process of determining the total share-based compensation expenses to be recognized related to our unvested share options.


F-49


Table of Contents

(PICTURE)

 


Table of Contents

 
 
American Depositary Shares
 
 
(AGRIA CORPORATION LOGO)
 
Agria Corporation
 
 
Representing           Ordinary Shares
 
 
Credit Suisse
 


Table of Contents

PART II
 
INFORMATION NOT REQUIRED IN PROSPECTUS
 
ITEM 6.    INDEMNIFICATION OF DIRECTORS AND OFFICERS.
 
Cayman Islands law does not limit the extent to which a company’s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences or committing a crime. Our Articles of Association provide for indemnification of officers and directors for losses, damages, costs and expenses incurred in their capacities as such, except through their own dishonesty, fraud, willful neglect or default.
 
Pursuant to the form of indemnification agreements to be filed as Exhibit 10.2 to this Registration Statement, we will agree to indemnify our directors and officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being such a director or officer.
 
The form of Underwriting Agreement to be filed as Exhibit 1.1 to this Registration Statement will also provide for indemnification of us and our officers and directors.
 
Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the “Securities Act”) may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
 
ITEM 7.    RECENT SALES OF UNREGISTERED SECURITIES.
 
During the past three years, we have issued the following securities (including options to acquire our ordinary shares). We believe that each of the following issuances was exempt from registration under the Securities Act in reliance on Regulation S under the Securities Act or pursuant to Section 4(2) of the Securities Act regarding transactions not involving a public offering.
 
                         
                  Underwriting
 
    Date of Sale or
    Number of
  Consideration
  Discount and
 
Purchaser
  Issuance     Securities*   (US$)   Commission  
 
Brothers Capital Limited
    June 13, 2007     10,000 ordinary shares   0.001     Not applicable  
Brothers Capital Limited
    June 21, 2007     76,740,000 ordinary shares   7.675     Not applicable  
TPG Growth AC Ltd. 
    June 22, 2007     1,600,000 preferred shares   6,666,667     Not applicable  
TPG Biotech II, Ltd. 
    June 22, 2007     800,000 preferred shares   3,333,333     Not applicable  
Directors, officers and other employees
    July 19, 2007 **   Options to purchase
5,900,000 ordinary shares
  2.40 per share     Not applicable  
            Options to purchase
1,600,000 ordinary shares
  4.80 per share     Not applicable  
 
 
* The share numbers have been adjusted to reflect a 10,000-for-1 share split of our ordinary shares and our preferred shares that became effective on August 15, 2007.
 
** Our board of directors initially granted options on July 4, 2007 and amended the material terms of the options on July 19, 2007.


II-1


Table of Contents

ITEM 8.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.
 
(a) Exhibits
 
  See Exhibit Index beginning on page II-5 of this registration statement.
 
(b) Financial Statement Schedules
 
  Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the Consolidated Financial Statements or the Notes thereto.
 
ITEM 9.    UNDERTAKINGS.
 
The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreements, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.
 
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item 6, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
 
The undersigned registrant hereby undertakes that:
 
(1) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant under Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.
 
(2) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.


II-2


Table of Contents

SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Beijing, People’s Republic of China, on October 18, 2007.
 
AGRIA CORPORATION
 
  By: 
/s/  Guanglin Lai
Name: Guanglin Lai
  Title:  Chairman of the Board and Co-Chief Executive Officer
 
POWER OF ATTORNEY
 
Each person whose signature appears below constitutes and appoints each of Guanglin Lai and Gary Kim Ting Yeung as an attorney-in-fact, each with full power of substitution, for him or her in any and all capacities, to do any and all acts and all things and to execute any and all instruments which said attorney and agent may deem necessary or desirable to enable the registrant to comply with the Securities Act of 1933, as amended (the “Securities Act”), and any rules, regulations and requirements of the Securities and Exchange Commission thereunder, in connection with the registration under the Securities Act of ordinary shares of the registrant (the “Shares”), including, without limitation, the power and authority to sign the name of each of the undersigned in the capacities indicated below to the Registration Statement on Form F-1 (the “Registration Statement”) to be filed with the Securities and Exchange Commission with respect to such Shares, to any and all amendments or supplements to such Registration Statement, whether such amendments or supplements are filed before or after the effective date of such Registration Statement, to any related Registration Statement filed pursuant to Rule 462(b) under the Securities Act, and to any and all instruments or documents filed as part of or in connection with such Registration Statement or any and all amendments thereto, whether such amendments are filed before or after the effective date of such Registration Statement; and each of the undersigned hereby ratifies and confirms all that such attorney and agent shall do or cause to be done by virtue hereof.
 
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
 
             
Signature
 
Title
 
Date
 
         
/s/  Guanglin Lai

Name: Guanglin Lai
  Chairman of the Board and
Co-Chief Executive Officer
(principal executive officer)
  October 18, 2007
         
/s/  Kenneth Hua Huang

Name: Kenneth Hua Huang
  Co-Chief Executive Officer   October 18, 2007
         
/s/  Gary Kim Ting Yeung

Name: Gary Kim Ting Yeung
  Chief Financial Officer
(principal financial and accounting officer) and Director
  October 18, 2007
         
/s/  Zhaohua Qian

Name: Zhaohua Qian
  Director   October 18, 2007


II-3


Table of Contents

             
Signature
 
Title
 
Date
 
         
/s/  Zhixin Xue

Name: Zhixin Xue
  Director and Chief Operating Officer   October 18, 2007
         
/s/  Geoffrey Duyk

Name: Geoffrey Duyk
  Director   October 18, 2007
         
/s/  Jasmine Marrero

Name: Jasmine Marrero
Title: Manager, Law Debenture Corporate Services Inc.
  Authorized U.S.
Representative
  October 18, 2007


II-4


Table of Contents

AGRIA CORPORATION
 
EXHIBIT INDEX
 
         
Exhibit
   
Number
 
Description of Document
 
  1 .1†   Form of Underwriting Agreement.
  3 .1   Memorandum and Articles of Association of the Registrant, as currently in effect.
  3 .2   Amended and Restated Memorandum and Articles of Association of the Registrant.
  4 .1†   Registrant’s Specimen American Depositary Receipt (included in Exhibit 4.3).
  4 .2   Registrant’s Specimen Certificate for Ordinary Shares.
  4 .3†   Form of Deposit Agreement among the Registrant, the Depositary and [Owners and Holders] of the American Depositary Shares.
  4 .4   English translation of Exclusive Technology Development, Technology Support and Technology Services Agreement, dated June 8, 2007.
  4 .5   English translation of Exclusive Consultancy Service Agreement, dated June 8, 2007.
  4 .6   English translation of Proprietary Technology License Agreement, dated June 8, 2007.
  4 .7   English translation of Power of Attorney, dated June 8, 2007.
  4 .8   English translation of Equity Pledge Agreement, dated June 8, 2007.
  4 .9   English translation of Exclusive Call Option Agreement, dated June 8, 2007.
  4 .10   English translation of Agreement on Equity Interest of Primalights III Agriculture Development Co., Ltd., dated June 8, 2007.
  4 .11   English translation of Letter of Undertaking, dated July 13, 2007.
  4 .12   English translation of Spouse Statement, dated July 13, 2007.
  4 .13   Share Purchase Agreement, dated June 22, 2007, in respect of the sale of shares of the Registrant.
  4 .14   Shareholders Agreement, dated June 22, 2007.
  4 .15   Registration Rights Agreement, dated June 22, 2007.
  4 .16   Undertaking Letter, dated June 22, 2007.
  4 .17   Deed of Adherence, dated August 30, 2007
  4 .18   English translation of Lease of Land between P3A and Taiyuan Relord, dated October 25, 2006.
  5 .1   Opinion of Maples and Calder regarding the validity of the Ordinary Shares being registered.
  8 .1   Opinion of Latham & Watkins LLP regarding certain U.S. tax matters.
  10 .1   2007 Share Incentive Plan.
  10 .2   Form of Indemnification Agreement with the Registrant’s Directors.
  10 .3   Form of Employment Agreement.
  21 .1   Subsidiaries of the Registrant.
  23 .1   Consent of Ernst & Young Hua Ming, Independent Registered Public Accounting Firm.
  23 .2   Consent of Maples and Calder (included in Exhibit 5.1).
  23 .3   Consent of Latham & Watkins LLP (included in Exhibit 8.1).
  23 .4   Consent of Commerce & Finance Law Offices (included in Exhibit 99.2).
  23 .5   Consent of Sallmanns (Far East) Ltd.
  23 .6   Consent of Terry McCarthy.
  23 .7   Consent of Shangzhong Xu.
  23 .8   Consent of Jiuran Zhao.
  24 .1   Powers of Attorney (included on signature page).
  99 .1   Code of Business Conduct and Ethics of the Registrant.
  99 .2   Opinion of Commerce & Finance Law Offices.
 
To be filed by amendment


II-5

EXHIBIT 3.1

THE COMPANIES LAW (2004 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES

SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES

OF

ASSOCIATION

OF


AGRIA CORPORATION


(Adopted by Special Resolution dated June 22, 2007)

1

THE COMPANIES LAW (2004 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES

SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION
OF
AGRIA CORPORATION

(Adopted by Special Resolution on June 22, 2007)

1 The name of the Company is AGRIA CORPORATION.

2 The registered office of the Company shall be at the offices of M&C Corporate Services Limited, PO Box 309GT, Ugland House, South Church Street, George Town, Grand Cayman, Cayman Islands, or at such other place as the Directors may from time to time decide.

3 The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by the Companies Law (2004 Revision) or as the same may be revised from time to time, or any other law of the Cayman Islands.

4 The liability of each Member is limited to the amount from time to time unpaid on such Member's shares.

5 The share capital of the Company is US$50,000 divided into 49,990,000 Ordinary Shares of a par value of US$0.001 each and 10,000 Preferred Shares of a par value of US$0.001 each.

6 The Company has power to register by way of continuation as a body corporate limited by shares under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.

7 Capitalised terms that are not defined in this Memorandum of Association bear the same meaning as those given in the Amended and Restated Articles of Association of the Company, as amended from time to time.

1

THE COMPANIES LAW (2004 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES

SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION
OF
AGRIA CORPORATION
(Adopted by Special Resolution on June 22, 2007)

INTERPRETATION

1 In these Articles Table A in the First Schedule to the Statute does not apply and, unless there is something in the subject or context inconsistent therewith:

"ADDITIONAL SHARES"              means all Ordinary Shares or other shares
                                 issued by the Company after the Closing Date
                                 other than the issuance of (i) Ordinary Shares
                                 issued or issuable at any time upon conversion
                                 of Preferred Shares; (ii) securities or options
                                 to acquire securities to officers, directors,
                                 and employees of, and consultants to, the
                                 Company, pursuant to share purchase or share
                                 option plans or arrangements or other incentive
                                 share arrangements as approved by the Board of
                                 Directors, including the 2007 Stock Option
                                 Plan; (iii) Ordinary Shares as a dividend or
                                 distribution with respect to the Preferred
                                 Shares; (iv) Ordinary Shares issued pursuant to
                                 a Qualified Public Offering; (v) equity
                                 securities issued in an acquisition in
                                 accordance with Article 27.1.10; (vi) the
                                 issuance of any equity or equity-linked
                                 securities (or any instruments convertible into
                                 or exchangeable for any such securities) not to
                                 exceed in the aggregate 20% of the Ordinary
                                 Shares outstanding (on an as-converted basis)
                                 immediately following the Closing and (vii) as
                                 described in Article 22.3 ("Adjustments for
                                 Dividends, Splits, Subdivisions, Combinations,
                                 or Consolidation of Ordinary Shares").

"AFFILIATE"                      means, with respect to any person, any person
                                 that, alone or together with any other person,
                                 directly or indirectly through one or more
                                 intermediaries, controls or is controlled by,
                                 or is under common control with, such person.
                                 For purposes of this definition, "control"
                                 means, when used with respect to any person,
                                 the possession, directly or indirectly, of the
                                 power to direct or cause the direction of the
                                 management and policies of such person,

1

                                 whether through the ownership of voting
                                 securities, by contract, or otherwise, and the
                                 terms "controlling" and "controlled" have
                                 meanings correlative to the foregoing.

"ARTICLES"                       means these articles of association of the
                                 Company as originally registered or as from
                                 time to time amended by Special Resolution.

"AUDITOR"                        means the person for the time being performing
                                 the duties of auditor of the Company (if any).

"BOARD OF DIRECTORS"             means the board of directors of the Company.

"CLOSING"                        means the date on which the Investors pay for
                                 certain Preferred Shares and Ordinary Shares
                                 and became Members of the Company pursuant to
                                 the Share Purchase Agreement.

"COMPANY"                        means the above named company.

"DIRECTORS"                      means the directors for the time being of the
                                 Company.

"DIVIDEND"                       includes an interim dividend.

"ELECTRONIC RECORD"              has the same meaning as in the Electronic
                                 Transactions Law (2003 Revision).

"ELIGIBLE ORDINARY               means the entities or individuals that hold
SHAREHOLDERS"                    Ordinary Shares both immediately prior to the
                                 Closing and as of the date of any distribution
                                 of Pre-Closing Retained Earnings.

"ENCUMBRANCE"                    means any claim, charge, easement, encumbrance,
                                 lease, covenant, security, deed of trust, lien,
                                 pledge, rights of others, security interest or
                                 restriction (whether on voting, sale, transfer,
                                 disposition, or otherwise), whether imposed by
                                 contract, agreement, understanding, law, equity
                                 or otherwise

"INVESTORS"                      means, collectively, TPG Growth AC Ltd. and TPG
                                 Biotech II, Ltd.

"LIQUIDATION EVENT"              (i) any liquidation, dissolution, or winding up
                                 of the Company, whether voluntary or not, (ii)
                                 a sale, transfer or lease of all or
                                 substantially all of the assets of the Company
                                 (or any series of related transactions
                                 resulting in such sale, transfer or lease of
                                 all or substantially all of the assets of the
                                 Company), (iii) a consolidation, corporate
                                 reorganization, merger, amalgamation, scheme of
                                 arrangement, tender offer or share purchase of
                                 the Company (except for a merger exclusively to
                                 reincorporate the Company in another
                                 jurisdiction), unless the shareholders of the
                                 Company immediately prior to any such
                                 transaction are holders of

2

                                 a majority of the voting power of the surviving
                                 corporation or acquiring corporation
                                 immediately thereafter, and (iv) the transfer
                                 (whether by merger, consolidation,
                                 amalgamation, scheme of arrangement or
                                 otherwise) in one transaction or a series of
                                 related transactions to a person or group of
                                 affiliated persons (other than an underwriter
                                 of the Company's securities) of the Company's
                                 securities if after such transfer such person
                                 or group of affiliated persons would hold a
                                 majority of the Company's outstanding voting
                                 stock.

"MEMBER"                         has the same meaning as in the Statute.

"MEMORANDUM"                     means the memorandum of association of the
                                 Company.

"ORDINARY RESOLUTION"            means a resolution passed by a simple majority
                                 of the Members as, being entitled to do so,
                                 vote in person or, where proxies are allowed,
                                 by proxy at a general meeting, and includes a
                                 unanimous written resolution. In computing the
                                 majority when a poll is demanded regard shall
                                 be had to the number of votes to which each
                                 Member is entitled by the Articles.

"ORDINARY SHARE"                 means each ordinary share of the Company, par
                                 value of US$0.001 per share.

"PER NEW SHARE PURCHASE PRICE"   means the price per Series A Preferred Share
                                 paid by the Investors and is equal to
                                 US$41,667.

"PER OLD SHARE PURCHASE PRICE"   means the price the Investors paid to Brothers
                                 Capital for each Ordinary Share.

"PRE-CLOSING RETAINED            means the retained earnings of the Company as
EARNINGS"                        of the last day of the calendar month preceding
                                 the Closing, as determined by an interim review
                                 by the Company's independent accountants.

"PREFERRED SHARE"                means each Series A Preferred Share of the
                                 Company, par value of US$0.001 per share.

"QUALIFYING IPO"                 means a firm commitment underwritten public
                                 offering pursuant to an effective registration
                                 statement on Form F-1 under the United States
                                 Securities Act of 1933, as amended, or a
                                 similar public offering of Ordinary Shares in a
                                 jurisdiction and on a recognized securities
                                 exchange outside of the United States,
                                 provided, that such public offering in terms of
                                 price, offering proceeds and regulatory
                                 approval is in the Board of Directors' opinion,
                                 reasonably equivalent to the aforementioned
                                 public offering in the United States covering
                                 the offer and sale of Ordinary Shares for the
                                 account of the Company to the public, and such
                                 public offering (whether in the United States
                                 or in a jurisdiction outside the

3

                                 United States) would result in aggregate
                                 proceeds to the Company in excess of US$75
                                 million (before deduction for underwriters
                                 commissions and expenses) at a minimum
                                 pre-money valuation (calculated on an issued
                                 and outstanding share basis) of: (i) US$320
                                 million, if the closing of such offering occurs
                                 on or prior to January 1, 2008 or (ii) US$350
                                 million, if the closing of such offering occurs
                                 after January 1, 2008.

"REGISTER OF MEMBERS"            means the register maintained in accordance
                                 with the Statute and includes (except where
                                 otherwise stated) any duplicate Register of
                                 Members.

"REGISTERED OFFICE"              means the registered office for the time being
                                 of the Company.

"SEAL"                           means the common seal of the Company and
                                 includes every duplicate seal.

"SHARE" and "SHARES"             means a share or shares in the Company and
                                 includes a fraction of a share.

"SHAREHOLDERS AGREEMENT"         means the shareholders agreement to be entered
                                 into among Brothers Capital, the Investors and
                                 the Company, which provides certain rights and
                                 obligations of the Company and the other
                                 parties thereto.

"SHARE PURCHASE AGREEMENT"       means the share purchase agreement to be
                                 entered into among Brothers Capital, the
                                 Investors, China Victory International Holdings
                                 Limited, Aero Biotech Science & Technology Co.,
                                 Ltd., Primalights III Agriculture Development
                                 Co., Ltd. and the Company, pursuant to which
                                 the Company will issue Preferred Shares and
                                 Brothers Capital will sell Ordinary Shares to
                                 the Investors.

"SPECIAL RESOLUTION"             has the same meaning as in the Statute, and
                                 includes a unanimous written resolution.

"STATUTE"                        means the Companies Law (2004 Revision) of the
                                 Cayman Islands.

"SUBSIDIARY"                     means, with respect to any given entity, any
                                 company, partnership or other entity (a) where
                                 more than 50% of the shares or other interests
                                 entitled to vote in the election of directors
                                 thereof are held, directly or indirectly, by
                                 the given entity, (b) in respect of which more
                                 than a 50% interest in the profits or capital
                                 thereof are owned or controlled directly or
                                 indirectly by the given entity or through one
                                 or more Subsidiaries of the given entity, (c)
                                 in respect of which the power to direct the
                                 management and policies thereof, whether
                                 directly or indirectly, through the ownership
                                 of voting

4

securities, by contract or otherwise, is held
by the given entity, or (d) whose assets, or
any portion thereof, are consolidated with the
net earnings of the Company and are recorded on
the books of the Company for financial
reporting purposes in accordance with generally
accepted accounting principles in the United
States.

2 In the Articles:

2.1 words importing the singular number include the plural number and vice versa;

2.2 words importing the masculine gender include the feminine gender;

2.3 words importing persons include corporations;

2.4 "written" and "in writing" include all modes of representing or reproducing words in visible form, including in the form of an Electronic Record;

2.5 references to provisions of any law or regulation shall be construed as references to those provisions as amended, modified, re-enacted or replaced from time to time;

2.6 any phrase introduced by the terms "including", "include", "in particular" or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms;

2.7 headings are inserted for reference only and shall be ignored in construing these Articles; and

2.8 in these Articles Section 8 of the Electronic Transactions Law (2003 Revision) shall not apply.

COMMENCEMENT OF BUSINESS

3 The business of the Company may be commenced as soon after incorporation as the Directors shall see fit.

4 The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in or about the formation and establishment of the Company, including the expenses of registration.

ISSUE OF SHARES

5 Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company in general meeting) and without prejudice to any rights attached to any existing Shares, the Directors may allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share) with or without preferred, deferred or other rights or restrictions, whether in regard to Dividend, voting, return of capital or otherwise and to such persons, at such times and on such other terms as they think proper.

6 The Company shall not issue Shares to bearer.

5

REGISTER OF MEMBERS

7 The Company shall maintain or cause to be maintained the Register of Members in accordance with the Statute.

CLOSING REGISTER OF MEMBERS OR FIXING RECORD DATE

8 For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or any adjournment thereof, or Members entitled to receive payment of any Dividend, or in order to make a determination of Members for any other purpose, the Directors may provide that the Register of Members shall be closed for transfers for a stated period which shall not in any case exceed forty days. If the Register of Members shall be closed for the purpose of determining Members entitled to notice of, or to vote at, a meeting of Members the Register of Members shall be closed for at least ten days immediately preceding the meeting.

9 In lieu of, or apart from, closing the Register of Members, the Directors may fix in advance or arrears a date as the record date for any such determination of Members entitled to notice of, or to vote at any meeting of the Members or any adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any Dividend or in order to make a determination of Members for any other purpose.

10 If the Register of Members is not so closed and no record date is fixed for the determination of Members entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a Dividend, the date on which notice of the meeting is sent or the date on which the resolution of the Directors declaring such Dividend is adopted, as the case may be, shall be the record date for such determination of Members. When a determination of Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment thereof.

CERTIFICATES FOR SHARES

11 A Member shall only be entitled to a share certificate if the Directors resolve that share certificates shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. Share certificates shall be signed by one or more Directors or other person authorised by the Directors. The Directors may authorise certificates to be issued with the authorised signature(s) affixed by mechanical process. All certificates for Shares shall be consecutively numbered or otherwise identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer shall be cancelled and subject to these Articles no new certificate shall be issued until the former certificate representing a like number of relevant Shares shall have been surrendered and cancelled.

12 The Company shall not be bound to issue more than one certificate for Shares held jointly by more than one person and delivery of a certificate to one joint holder shall be a sufficient delivery to all of them.

6

13 If a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms (if any) as to evidence and indemnity and on the payment of such expenses reasonably incurred by the Company in investigating evidence, as the Directors may prescribe, and (in the case of defacement or wearing out) upon delivery of the old certificate.

TRANSFER OF SHARES

14 Subject to Article 16, Shares are transferable, and the Directors may decline to register any transfer of Shares, including any transfer that is not made in accordance with Article 16. If the Directors refuse to register a transfer they shall notify the transferee within two weeks of such refusal.

15 The instrument of transfer of any Share shall be in writing and shall be executed by or on behalf of the transferor (and if the Directors so require, signed by the transferee). The transferor shall be deemed to remain the holder of a Share until the name of the transferee is entered in the Register of Members.

16 Restrictions on Transfers.

16.1 General restrictions.

16.1.1 During the period commencing from the Closing and ending on the closing of the Qualifying IPO (the "Restricted Period"), Brothers Capital shall not (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of (whether with or without consideration, directly or indirectly, voluntarily or involuntarily, by operation of law or otherwise) any Shares now owned or hereafter acquired by it to any person (whether such Shares or any such securities are then owned by such person or are thereafter acquired), or (ii) enter into any swap, derivative or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Shares or such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Shares or such other securities, in cash or otherwise (each such action described in clause (i) or (ii) above, a "Transfer"), other than (i) a Transfer made pursuant to Articles 16.2 or 16.3, (ii) a Transfer to any individual that is a member of such Member's (or, if such Member is not a natural person, the ultimate beneficial owner of such Member) immediate family (i.e., spouses, parents and children), any trust, tax shelter or other entity established for bona fide estate or tax planning purposes of such Member (or, if such Member is not a natural person, the ultimate beneficial owner of such Member) or any member of such Member's (or, if such Member is not a natural person, the ultimate beneficial owner of such Member) immediate family, or any Affiliate, or (iii) a Transfer to Mr. Qian Zhaohua or an entity wholly-owned by Mr. Qian Zhaohua (each, a "Permitted Transferee"); provided, however, that any Permitted Transferee, simultaneously with such Transfer, agrees in writing to be bound as a Member by all of the provisions

7

of these Articles, provided, further, that if any Permitted Transferee to whom any Shares have been transferred ceases to be a Permitted Transferee of the transferring Member, such Shares shall be transferred back to the transferring Member immediately prior to the time such person ceases to be a Permitted Transferee of such transferring Member. In addition to any Transfers pursuant to clauses
(i), (ii) and (iii) of this Article 16.1.1, prior to a Qualifying IPO, Brothers Capital may Transfer Ordinary Shares, not to exceed in the aggregate 20% of the Ordinary Shares outstanding immediately following the Closing, in one or more Transfers. Any Transfer or Transfers in accordance with the preceding sentence may be made without complying with Articles 16.2 or 16.3.

16.1.2 Prior to the end of the Restricted Period, no Investor shall Transfer any Shares now owned or hereafter acquired by it to any person, other than (i) a Transfer made pursuant to Article 16.2 or 16.3, (ii) a Transfer to a Permitted Transferee or (iii) a Transfer made pursuant to Article 26 ("Mandatory Redemption"). Notwithstanding anything to the contrary in these Articles, no Investor shall, and each Investor shall cause any Permitted Transferee not to, Transfer any Shares now owned or hereafter acquired by it to any direct or indirect competitor of the Company or any of its Subsidiaries.

16.2 Rights of First Refusal.

16.2.1 Brothers Capital hereby grants to each of the Investors, and each of the Investors hereby grants to Brothers Capital, a right of first refusal (the "Right of First Refusal") with respect to sales during the Restricted Period by such granting Member (an "Offering Member") of Shares now owned or hereafter acquired by it. During the Restricted Period, each time that an Offering Member proposes to Transfer all or part of its Shares to any other person (the "Proposed Transferee"), such Offering Member shall, prior to consummating any such Transfer, give written notice (the "Offer Notice") to each of the Members entitled to the Right of First Refusal (the "Offeree Members") in accordance with the following provisions.

16.2.2 The Offering Member shall deliver an Offer Notice to each of the Offeree Members stating (i) that the Offering Member has received a binding offer from the Proposed Transferee(s), (ii) the number and description of the Shares proposed to be transferred pursuant to the binding offer from the Proposed Transferee(s), (iii) the proposed price and terms and conditions upon which each Proposed Transferee offers to purchase such Shares, (iv) the name and address of each Proposed Transferee, and (v) an offer to sell to the Offeree Members such Shares set forth in the Offer Notice at the same price per Share and on the same terms and conditions as offered by the Proposed Transferee(s). The Offer Notice shall also include a copy of any written proposal, term sheet or letter of intent or other agreement relating to the proposed Transfer.

8

16.2.3 By delivering a written notification to the Offering Member within 15 calendar days after receipt of the Offer Notice (the "Exercise Period"), each Offeree Member may elect to purchase, at the price and on the terms and conditions specified in the Offer Notice, up to its percentage share of the total number of Shares proposed to be transferred as specified in the Offer Notice, which shall be equal to the number of such Shares, multiplied by a fraction, the numerator of which shall be the number of Shares (on an as-converted basis) then owned by such Offeree Member and the denominator of which shall be the total number of Shares (on an as-converted basis) then owned by all of the Offeree Members. The Offering Member shall promptly, in writing, inform each Offeree Member that elects to purchase all the Shares available to it (a "Fully-Exercising Member") of any other Offeree Member's failure to do likewise. During the five-day period commencing after such information is given, each Fully-Exercising Member may elect to purchase up to its share of any unsubscribed Shares, which shall be equal to the number of such unsubscribed Shares multiplied by a fraction, the numerator of which shall be the number of Shares (on an as-converted basis) then owned by such Fully-Exercising Member and the denominator of which shall be the total number of Shares (on an as-converted basis) then owned by all of the Fully-Exercising Members. The Offering Member shall repeat the process set forth in the immediately preceding two sentences until there remains either (i) no unsubscribed Shares, or (ii) no Fully-Exercising Member electing to purchase its proportionate share of the unsubscribed Shares during such five-day period.

16.2.4 If all Shares that the Offeree Members are entitled to purchase pursuant to this Article 16.2 are not elected to be purchased as provided in Article 16.2.3, the Offering Member may, subject to the Co-Sale Rights (as defined below) provided in Article 16.3, during the 90-day period following the expiration of the last offering period provided in Article 16.2.3, sell the remaining unsubscribed portion of such Shares to the Proposed Transferee(s) at a price not less than, and upon terms and conditions no more favorable to the Proposed Transferee(s) than, those specified in the Offer Notice. If the Offering Member does not sell the Shares within such 90-day period, the Right of First Refusal provided hereunder shall be deemed to be revived and such Shares may not be offered unless first reoffered to the Offeree Members in accordance herewith.

16.2.5 Valuation of Property.

(a) Should the purchase price offered by the Proposed Transferee(s) as specified in the Offer Notice be payable in property other than cash or cancellation of existing indebtedness, the Offeree Members shall have the right to pay the purchase price in cash, with such payment to be equal in amount to the fair market value of such property.

9

(b) If the Offering Member and the Offeree Members cannot agree on the fair market value of such property within 10 days after the receipt of the Offer Notice by the Offeree Members, the valuation shall be made by an appraiser of internationally recognized standing jointly selected by the Offering Member and the majority in interest of the Offeree Members, if any, exercising their Right of First Refusal (voting together on an as-converted basis) within 15 days after the receipt of the Offer Notice by the Offeree Members, or, if they cannot agree on an appraiser within 15 days after the receipt of the Offer Notice by the Offeree Members, each shall select an appraiser of internationally recognized standing and the two appraisers shall designate an additional appraiser of internationally recognized standing, who shall make the valuation within 30 days after the receipt of the Offer Notice by the Offeree Members, and whose appraisal shall be determinative of such value.

(c) The cost of such appraisal shall be borne 50% by the Offering Member and 50% by the Offeree Members, with that portion of the cost borne by the Offeree Members to be borne pro rata by each, based on the number of offered Shares (on an as-converted basis) such Offeree Member has elected to purchase pursuant to this Article 16.2.

(d) If the value of the purchase price offered by the Proposed Transferee(s) and specified in the Offer Notice is not determined within the Exercise Period specified in Article 16.2.3, the Exercise Period shall be extended to the 10th day following the date the appraisal is made pursuant to this Article 16.2.

16.3 Co-Sale Rights.

16.3.1 Brothers Capital hereby grants to each of the Investors, and each of the Investors hereby grants to Brothers Capital, a right of co-sale (the "Co-Sale Right") with respect to sales during the Restricted Period by such granting Member (a "Proposed Transferor") of Shares now owned or hereafter acquired by it. During the Restricted Period, if any Proposed Transferor proposes to Transfer any Shares now owned or hereafter acquired by it to any Proposed Transferee in any transaction after complying with Article 16.2, to the extent the Offeree Members do not exercise their Rights of First Refusal as to all of the Shares offered pursuant to Article 16.2, each Member entitled to the Co-Sale Right (a "Co-Seller") shall have the right to sell to the Proposed Transferee, at the same price per Share and upon the same terms and conditions as the Transfer by the Proposed Transferor, up to the number of whole Shares that is equal to the number derived by multiplying (i) the aggregate number of Shares (on an as-converted basis) to be acquired by the Proposed Transferee in the Transfer by
(ii) a fraction, the numerator of which is the aggregate number of Shares (on an

10

as-converted basis) held by such Co-Seller, and the denominator of which is the aggregate number of Shares (on an as-converted basis) held by the Proposed Transferor plus the aggregate number of Shares (on an as-converted basis) held by all Co-Sellers. The Proposed Transferor shall notify all Co-Sellers in writing of each such proposed Transfer promptly following the expiration of the last offering period provided in Article 16.2.3. Such notice (the "Transfer Notice") shall set forth: (w) the description and number of Shares proposed to be transferred, (x) the name and address of each Proposed Transferee, (y) the proposed amount of consideration and terms and conditions offered by each Proposed Transferee, and (z) that the Proposed Transferee has been informed of the Co-Sale Right provided for in this Article 16.3 and has agreed to purchase the Shares in accordance with the terms hereof. Each Member of then currently convertible, exchangeable or exercisable rights to acquire Shares shall be given an opportunity to exercise such rights prior to the consummation of any proposed Transfer subject to the terms of this Article 16.3 and participate in such Transfer as a Member.

16.3.2 The Co-Sale Right may be exercised by a Co-Seller by delivery of a written notice to the Proposed Transferor (the "Co-Sale Notice") within 15 days following its receipt of the Transfer Notice (the "Co-Sale Period"). The Co-Sale Notice shall state the number and description of Shares that such Co-Seller proposes to include in such Transfer to the Proposed Transferee determined as aforesaid. If the Proposed Transferee does not purchase Shares from such Co-Seller at the same price and on the same terms and conditions as purchases from the Proposed Transferor, then the Proposed Transferor shall not be permitted to Transfer any Shares to the Proposed Transferee in the proposed Transfer unless and until, simultaneously with such Transfer, the Proposed Transferor shall purchase from such Co-Seller such Shares that such Co-Seller would otherwise be entitled to sell to the Proposed Transferee pursuant to its Co-Sale Rights for the same consideration and on the same terms and conditions as the Transfer described in the Transfer Notice.

16.3.3 At the expiration of the Co-Sale Period, the Proposed Transferor shall have the right to transfer to the Proposed Transferee(s) the number of Shares proposed to be transferred, less the number of Shares to be sold by the Co-Seller(s) pursuant to the Co-sale Notice(s), on terms and conditions no more favorable to the Proposed Transferor than those stated in the Transfer Notice specified in Article 16.3.1. If such Transfer is not consummated within the 90-day period provided in Article 16.2.4, any Shares that continue to be held by the Proposed Transferor after such period shall again be subject to the provisions of this Article 16.3.

16.3.4 The share certificate or certificates and instruments of transfer of each participating Co-Seller shall be transferred to the Proposed Transferee in consummation of the sale of the Shares pursuant to the terms and conditions specified in the Transfer Notice and the agreement for the Transfer of the Shares, and the Proposed Transferee shall concurrently therewith remit to each such Co-Seller that portion of the sale proceeds to which such Co-Seller

11

is entitled by reason of its participation in such sale. The Company shall be obliged to register the transfer upon delivery by the Proposed Transferee of the relevant share certificate or certificates and instruments of transfer.

16.4 Excluded Transactions.

16.4.1 Anything to the contrary herein notwithstanding, the provisions of Articles 16.2 and 16.3 shall not apply to (i) Transfers pursuant to a Qualifying IPO, (ii) Transfers by any Member to any of its Permitted Transferees that agrees in writing to be bound as a Member by all of the provisions of these Articles, provided, however, that if any Permitted Transferee to whom any Shares have been transferred ceases to be a Permitted Transferee of the transferring Member, such Shares shall be transferred back to the transferring Member immediately prior to the time such person ceases to be a Permitted Transferee of such transferring Member, or (iii) in the case of the Investors, Transfers pursuant to the Investors' exercise of their Redemption Rights under Article 26 ("Mandatory Redemption").

16.5 Lock-up Agreements.

16.5.1 Each Member (including the Investors) hereby agrees that it will not, for a period of 180 days following the date of the closing of the Company's Qualifying IPO, Transfer any Shares now owned or hereafter acquired by it to any person.

16.5.2 Each of the Company and the Members hereby agrees that it will comply with a reasonable lock-up period as may be determined in good faith by the lead underwriter(s) in the Qualifying IPO.

16.5.3 This Article 16.5 shall not apply to (x) any Transfer by a Member to a Permitted Transferee of such Member or (y) the sale of any Shares by the Company or a Member to an underwriter pursuant to an underwriting agreement in connection with the Company's Qualifying IPO. In addition, this Article 16.5 shall not apply to Transfers by the Company (A) in connection with registrations on Form F-4 or S-8 or any successor or similar forms thereto, (B) in connection with registrations for the offer and sale to employees pursuant to any employee stock plan or other employee benefit plan arrangement as unanimously approved by the Board of Directors and (C) of securities to be issued solely in an acquisition or business combination. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters for the Qualifying IPO shall apply to all Members subject to such agreements pro rata based on the number of Shares subject to such agreements.

16.6 Preemptive Rights.

16.6.1 The Company hereby grants to the Investors a preemptive right (the "Preemptive Right") with respect to future sales by the Company of its Shares

12

or other voting securities during the Restricted Period. Each time during the Restricted Period that the Company proposes to offer any Shares or other voting securities, the Company shall first make an offering of such Shares or other securities to the Investors in accordance with the following provisions:

(a) Sale Notice. The Company shall deliver to the Investors a notice stating its bona fide intention to offer such Shares or other voting securities, the description and number of such Shares or other voting securities to be offered, the full description thereof and the price and terms and conditions upon which it proposes to offer such Shares or other voting securities (the "Sale Notice").

(b) Exercise of Preemptive Rights. Within 15 calendar days after receipt of the Sale Notice, by written notification to the Company, each Investor may elect to purchase, at the price and on the terms and conditions specified in the Sale Notice, up to such electing Investor's share of the Shares or other voting securities offered, which shall be equal to such number of Shares or other voting securities multiplied by a fraction, the numerator of which shall be the number of Ordinary Shares (on an as-converted basis) then owned by such electing Investor and the denominator of which shall be the total number of Ordinary Shares (on an as-converted basis) then issued and outstanding.

(c) Non-Exercise. If an Investor does not elect to obtain all Shares or other voting securities that such Investor is entitled to obtain pursuant to Article paragraph (b) above, the Company may, during the 90-day period following the expiration of the period provided in paragraph (b) above, offer the remaining unsubscribed portion of such Shares or other voting securities to any person at a price not less than, and upon terms and conditions no more favorable to the offeree than those specified in the Sale Notice. If the Company does not enter into an agreement for the sale of such Shares or other voting securities within such period, or if such sale is not consummated within 90 days of the execution of such agreement, the Preemptive Right provided hereunder shall be deemed to be revived and such Shares or other voting securities shall not be offered unless first reoffered to the Investors in accordance with this Article 16.6.

(d) Excluded Transactions. The Preemptive Right in this Article 16.6 shall not be applicable to the issuance of (i) securities issued pursuant to a Qualifying IPO; (ii) options to purchase Ordinary Shares (and any Ordinary Shares issued upon the exercise thereof), share appreciation rights, dividend equivalent rights, restricted shares, restricted share units, share payments and deferred shares to officers, directors and employees of the Company, pursuant to share incentive plans designated and approved by the Board of Directors; (iii) Ordinary

13

Shares issued as a dividend or distributed with respect to, or upon conversion of, the Preferred Shares; (iv) Ordinary Shares issued in connection with any merger or acquisition transaction approved by the Board of Directors; (v) future issuances in connection with the establishment of a strategic business relationship approved by the Board of Directors; (vi) Preferred Shares issued pursuant to the Share Purchase Agreement and (vii) the issuance of any equity or equity-linked securities (or any instruments convertible into or exchangeable for any such securities) not to exceed in the aggregate 20% of the Ordinary Shares outstanding (on an as-converted basis) immediately following the Closing.

(e) Limitations. The Preemptive Right in this Article 16.6 shall terminate at the earlier of (i) the occurrence of a Qualifying IPO, or (ii) when the Investors cease to own Shares representing, in the aggregate, at least 25% of the Shares purchased by the Investors pursuant to the Share Purchase Agreement.

AUTHORIZED CAPITAL

17 The authorized capital of the Company is US$50,000, divided into 49,990,000 Ordinary Shares of par value of US$0.001 each and 10,000 Preferred Shares of par value of US$0.001 each.

CLASS AND NUMBER OF SHARES

18 The share capital of the Company is made up of two classes of shares, divided into 49,990,000 Ordinary Shares, and 10,000 Preferred Shares.

PREFERENCES OF THE PREFERRED SHARES

19 Preference Dividend.

19.1 The holders of each Preferred Share shall be entitled to receive cumulative dividends, out of any assets legally available therefor, prior and in preference to any declaration or payment of any dividend (whether in cash, in property or in shares of the capital of the Company) on the Ordinary Shares other than a dividend pursuant to Article 130 ("Certain Dividends"), at the rate of 8% of the Per New Share Purchase Price (as adjusted for any share dividends, combinations or splits with respect to such shares) per annum payable in U.S. dollars no later than March 31 of the year following the calendar year that such dividends accrue, provided, that if a Qualifying IPO occurs before July 31, 2008, then such Preferred Shares shall not be entitled to such 8% annual dividend. If a Qualifying IPO occurs after July 31, 2008 then such Preferred Shares shall entitled to such 8% annual dividend from and after such date. No dividend, whether in cash, in property or in shares of the capital of the Company, other than a dividend pursuant to Article 130 ("Certain Dividends"), shall be declared or paid on any Ordinary Shares unless and until all accrued dividends have been paid in full on the Preferred Shares.

20 Liquidation.

14

20.1 Upon the occurrence of a Liquidation Event, redemption payments or liquidation distributions to the Members of the Company shall be made in the following manner to the extent permitted by Cayman Islands law:

20.1.1 Each holder of Preferred Shares shall be entitled to receive, prior and in preference to any distribution of any of the assets or surplus funds of the Company to the holders of the Ordinary Shares, an amount per Preferred Share then held by such holder equal to (i) the Per New Share Purchase Price (as adjusted for share dividends, splits, combinations and recapitalizations), plus (ii) an amount equal to all accrued but unpaid dividends on such Shares.

20.1.2 After payments described in 20.1.1 have been made to the holders of the Preferred Shares in full, the remaining assets and funds of the Company available for distribution to Members shall be distributed ratably among all of the holders of Ordinary Shares.

21 Voting Rights.

21.1 At any general meeting of the Company, the holder of each Preferred Share shall be entitled to the number of votes, in respect of such Share, equal to the number of Ordinary Shares into which such Preferred Share could be converted at the record date for determination of the Members entitled to vote at such general meeting, or, if no such record date is established, at the date such vote is taken or any written consent of Members is solicited.

22 Conversion.

22.1 Right to Convert. Immediately after the Closing and subject to Articles 22.3 and 22.4, each Preferred Share shall be convertible, at the option of the holder thereof, at any time after the date of issuance of such share, at the office of the Company or any transfer agent for such Preferred Share, into one fully-paid and non-assessable Ordinary Share.

22.2 Automatic Conversion. Each Preferred Share shall automatically be converted into one fully-paid and non-assessable Ordinary Share upon a Qualifying IPO, subject to the adjustment provided in Articles 22.3 and 22.4. Conversion of the Preferred Shares under this Article shall be effected in such manner as the Directors of the Company shall from time to time determine. Without prejudice to the generality of the foregoing, any of the Preferred Shares to be converted under this Article may be effected by redemption or repurchase of such Preferred Shares out of (A) the capital paid up on such Preferred Shares or (B) the funds of the Company which would otherwise be available for dividend or distribution or (C) the proceeds of a fresh issue of shares made for the purpose, or any combination of (A), (B) and/or (C), with the proceeds of redemption or repurchase thereof applied as payment in full for the subscription of the relevant number of Ordinary Shares.

22.3 Adjustments for Dividends, Splits, Subdivisions, Combinations, or Consolidation of Ordinary Shares. In the event the number of outstanding Ordinary Shares shall be increased by a share dividend payable in Ordinary Shares, subdivision, or other similar

15

transaction occurring after the Closing, into a greater number of Ordinary Shares, the Ordinary Shares issuable upon conversion of Preferred Shares then in effect shall, concurrently with the effectiveness of such event, be increased in proportion to the percentage increase in the outstanding number of Ordinary Shares. In the event the number of outstanding Ordinary Shares shall be decreased by a combination, consolidation, or other similar transaction occurring after the Closing into a lesser number of Ordinary Shares, the Ordinary Shares issuable upon conversion of Preferred Shares then in effect shall, concurrently with the effectiveness of such event, be decreased in proportion to the percentage decrease in the outstanding number of Ordinary Shares.

22.4 Adjustments on Issuance of Additional Shares. Notwithstanding the foregoing and without prejudice to the generality of Article 27 ("Protective Provisions"), if the Company shall issue any Additional Shares at a subscription price per Ordinary Share (on an as-converted basis) less than the Preferred Share Conversion Price (such Preferred Share Conversion Price is initially equal to the Per New Share Purchase Price, thereafter, as adjusted from time to time), in effect on the date of and immediately prior to such issuance, the Preferred Share Conversion Price, shall be reduced, concurrently with such issuance, to a price (calculated to the nearest cent) to be determined as set forth below. The mathematical formula for determining the adjusted Preferred Share Conversion Price is as follows and is subject to the more detailed textual description set forth thereafter:

AP = OP * (OS + (NP/OP))/(OS + NS)

WHERE:

AP = adjusted Preferred Share Conversion Price

OP = old Preferred Share Conversion Price

OS = the number of outstanding Ordinary Shares immediately before the Additional Shares are issued or sold

NP = the total consideration received for the issuance or sale of Additional Shares

NS = the number of Additional Shares issued or sold

The newly adjusted Preferred Share Conversion Price shall be an amount equal to the price determined by multiplying the old Preferred Share Conversion Price, by a fraction:

(i) the numerator of which shall be the number of Ordinary Shares outstanding immediately prior to such issuance plus the number of Ordinary Shares that the aggregate consideration received by the Company for the total number of Additional Shares would purchase at the old Preferred Share Conversion Price; and

16

(ii) the denominator of which shall be the sum of the number of Ordinary Shares outstanding immediately prior to such issuance plus the number of such Additional Shares so issued;

REDEMPTION AND REPURCHASE OF SHARES

23 Subject to the provisions of the Statute the Company may issue Shares that are to be redeemed or are liable to be redeemed at the option of the Member or the Company. The redemption of such Shares shall be effected in such manner as the Company may, by Special Resolution, determine before the issue of the Shares.

24 Subject to the provisions of the Statute, the Company may purchase its own Shares (including any redeemable Shares) provided that the Members shall have approved the manner of purchase by Ordinary Resolution.

25 The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner permitted by the Statute, including out of capital.

26 Mandatory Redemption.

26.1 If for any reason the Company has not completed a Qualifying IPO on or prior to December 31, 2008, the Investors (and/or any of its Affiliates who acquired the Shares from the Investors after the Closing in accordance with the Shareholders Agreement), acting jointly, shall have the right at any time to require the Company to redeem all of the Shares the Investor subscribed for and purchased pursuant to the Share Purchase Agreement and any Ordinary Shares issued upon conversion of the Preferred Shares by delivering a written notice to the Company.

26.2 The Investors' right to exercise the redemption right with respect to this Article 26 shall terminate 90 days following December 31, 2008. Within 10 days after the delivery of the notice described above, the Investors may, upon written notice to the Company, withdraw and rescind such notice, whereupon the Investors' and/or their Affiliates' redemption right described above shall be deemed not to have been exercised.

26.3 The aggregate redemption purchase price shall be equal to (i) 100% of the purchase price paid by the Investors to both the Company and Brothers Capital pursuant to the Share Purchase Agreement plus (ii) an amount equal to all accrued but unpaid dividends on all such Shares, provided that the redemption price shall be ratably reduced to take account of any previous transfers by the Investors in accordance with Articles 14, 15 and 16 hereof.

COVENANTS

27 Protective Provisions.

17

27.1 Subject to Article 27.2 and applicable laws, the Company shall not take and shall prevent its Subsidiaries from taking, and each Member shall take all such action as a shareholder of the Company necessary to prevent the Company and its Subsidiaries from taking, any of the following actions or any action directly or indirectly in furtherance of any of the following actions, in each case unless such action is approved by the Investors:

27.1.1 any amendment of the memorandum of association, articles of association, articles of incorporation, certificate of incorporation, bylaws and any charter, partnership agreements, joint venture agreement or other organizational documents (together, "Organizational Documents") of any of the Company's Subsidiaries that will adversely affect the rights of the Investors, any material change in the purposes of the establishment or business scope of the Company or any of its Subsidiaries, or any change in the place of incorporation of the Company or any of its Subsidiaries;

27.1.2 any merger, consolidation, business combination, spin-off or recapitalization of the Company or any of its Subsidiaries, or the sale or lease of all or substantially all of the assets of the Company or any of its Subsidiaries, in one transaction or a series of transactions;

27.1.3 the liquidation, dissolution or winding up of, or the suspension of payments or assignment to creditors by any of the Company's Subsidiaries;

27.1.4 any filing of a voluntary petition in bankruptcy or commencement of a voluntary legal procedure for reorganization, arrangement, adjustment, relief or composition of indebtedness, the consent to the entry of an order for relief in an involuntary case or the application for or consent to the appointment of a receiver, liquidator, assignee, custodian or trustee or similar official of the Company or any of its Subsidiaries;

27.1.5 any change in the share capital of any of the Company's Subsidiaries, or the authorization, issuance, sale or entering into of any agreement related to the issuance of any equity or equity-linked securities (or any instruments convertible into or exchangeable for any such securities, or any options, rights or warrants to acquire any such securities or instruments) of any of the Company's Subsidiaries, or the amendment of any term of any equity securities of any of the Company's Subsidiaries;

27.1.6 any sale, transfer, pledge or disposition, in one transaction or a series of transactions, by the Company of any capital shares or other equity interests of any of its Subsidiaries;

27.1.7 any redemption, purchase or other acquisition by the Company or any of its Subsidiaries of any of its securities;

27.1.8 any payment or declaration of any distribution or dividend on or with respect to any capital shares or other equity interests of the Company or any of its Subsidiaries, except pursuant to Article 130 ("Certain Dividends");

18

27.1.9 except for arrangements with Taiyuan Relord Enterprise Development Group Co., Ltd. (chinese characters) relating to seedlings, any transaction or a series of related transactions or a series of related transactions exceeding US$50,000 in any 12-month period between the Company or any of its Subsidiaries on the one hand, and any employee, officer, director or equityholder of the Company or any of its Subsidiaries, or any member of his or her immediate family, or any Affiliate of an equityholder of the Company or any Subsidiary on the other, except for compensatory transactions approved by the Board of Directors;

27.1.10 any purchase by the Company or any of its Subsidiaries of the capital stock of any corporation, the voting interest in any partnership, joint venture or other entity, or material assets of another entity, or the making of any loan or advance to any such entity, unless the total consideration (including cash, equity issued and debt assumed) to be paid by the Company or its Subsidiaries does not exceed US$3,000,000;

27.1.11 other than in the ordinary course of business, any sale, transfer, pledge or disposition of, in one transaction or a series of related transactions, any assets of the Company or any of its Subsidiaries exceeding US$1,000,000;

27.1.12 other than in the ordinary course of business, any creation, assumption or incurrence of any Encumbrance on the assets of the Company or any of its Subsidiaries in one transaction or a series of related transactions with a value in excess of US$1,000,000;

27.1.13 the sale, transfer, assignment, pledge or disposition of, in one transaction or a series of related transactions, any material permit or license used in the businesses of the Company or any of its Subsidiaries;

27.1.14 any incurrence, creation or guarantee or the entering into of any agreement for the incurrence, creation or guarantee, in one transaction or a series of related transactions, by the Company or any of its Subsidiaries of any long-term or short-term indebtedness, obligations or liabilities (but excluding from the foregoing any trade debts) which individually or in the aggregate exceeds US$1,000,000, or the entering into of any off-balance sheet transaction by the Company or any of its Subsidiaries, or the amendment of any material term of such indebtedness, obligations or liabilities or off-balance sheet transactions in a manner adverse to the Company or any of its Subsidiaries;

27.1.15 any change in the Company's or any of its Subsidiaries' fiscal year, accounting method or accounting practices, except such changes as are necessary to comply with changes to the generally accepted accounting principles adopted by the Company or such Subsidiary;

19

27.1.16 the establishment of the annual budgets of the Company and any of its Subsidiaries, and any capital expenditure not provided for in such budgets in excess of US$1,000,000;

27.1.17 the selection or change of the Company's independent accountants; or

27.1.18 any matter related to the Company's initial public offering, including (i) the choice of the listing venue, provided that the Investors hereby consent to the selection of the New York Stock Exchange or the Nasdaq Stock Market as the listing venue, and (ii) the selection of underwriters, which shall be made by the Company but which shall be reasonably acceptable to the Investors.

27.2 The rights of the Investors provided in Articles 27 and 97 ("Appointment and Removal of Directors") and shall terminate at the earlier of (i) the occurrence of a Qualifying IPO, or (ii) when the Investors cease to own Shares representing, in the aggregate, at least 50% of the Shares purchased by the Investors pursuant to the Share Purchase Agreement.

VARIATION OF RIGHTS OF SHARES

28 If at any time the share capital of the Company is divided into different classes of Shares, the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that class) may, subject to the provisions of Article 27 ("Protective Provisions"), whether or not the Company is being wound up, be varied with the consent in writing of the holders of three-quarters of the issued Shares of that class, or with the sanction of a Special Resolution passed at a general meeting of the holders of the Shares of that class.

29 The provisions of these Articles relating to general meetings shall apply to every class meeting of the holders of one class of Shares except that the necessary quorum shall be one person holding or representing by proxy at least one third of the issued Shares of the class and that any holder of Shares of the class present in person or by proxy may demand a poll.

30 The rights conferred upon the holders of the Shares of any class issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by the creation or issue of further Shares ranking pari passu therewith.

COMMISSION ON SALE OF SHARES

31 The Company may, in so far as the Statute permits, pay a commission to any person in consideration of his subscribing or agreeing to subscribe whether absolutely or conditionally for any Shares of the Company. Such commissions may be satisfied by the payment of cash and/or the issue of fully or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage as may be lawful.

20

NON RECOGNITION OF TRUSTS

32 The Company shall not be bound by or compelled to recognise in any way (even when notified) any equitable, contingent, future or partial interest in any Share, or (except only as is otherwise provided by these Articles or the Statute) any other rights in respect of any Share other than an absolute right to the entirety thereof in the registered holder.

LIEN ON SHARES

33 The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether presently payable or not) by such Member or his estate, either alone or jointly with any other person, whether a Member or not, but the Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of a transfer of any such Share shall operate as a waiver of the Company's lien thereon. The Company's lien on a Share shall also extend to any amount payable in respect of that Share.

34 The Company may sell, in such manner as the Directors think fit, any Shares on which the Company has a lien, if a sum in respect of which the lien exists is presently payable, and is not paid within fourteen clear days after notice has been given to the holder of the Shares, or to the person entitled to it in consequence of the death or bankruptcy of the holder, demanding payment and stating that if the notice is not complied with the Shares may be sold.

35 To give effect to any such sale the Directors may authorise any person to execute an instrument of transfer of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or his nominee shall be registered as the holder of the Shares comprised in any such transfer, and he shall not be bound to see to the application of the purchase money, nor shall his title to the Shares be affected by any irregularity or invalidity in the sale or the exercise of the Company's power of sale under these Articles.

36 The net proceeds of such sale after payment of costs, shall be applied in payment of such part of the amount in respect of which the lien exists as is presently payable and any residue shall (subject to a like lien for sums not presently payable as existed upon the Shares before the sale) be paid to the person entitled to the Shares at the date of the sale.

CALL ON SHARES

37 Subject to the terms of the allotment the Directors may from time to time make calls upon the Members in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each Member shall (subject to receiving at least fourteen days notice specifying the time or times of payment) pay to the Company at the time or times so specified the amount called on the Shares. A call may be revoked or postponed as the Directors may determine. A call may be required to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon him notwithstanding the subsequent transfer of the Shares in respect of which the call was made.

21

38 A call shall be deemed to have been made at the time when the resolution of the Directors authorising such call was passed.

39 The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof.

40 If a call remains unpaid after it has become due and payable, the person from whom it is due shall pay interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the Directors may determine, but the Directors may waive payment of the interest wholly or in part.

41 An amount payable in respect of a Share on allotment or at any fixed date, whether on account of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all the provisions of these Articles shall apply as if that amount had become due and payable by virtue of a call.

42 The Directors may issue Shares with different terms as to the amount and times of payment of calls, or the interest to be paid.

43 The Directors may, if they think fit, receive an amount from any Member willing to advance all or any part of the monies uncalled and unpaid upon any Shares held by him, and may (until the amount would otherwise become payable) pay interest at such rate as may be agreed upon between the Directors and the Member paying such amount in advance.

44 No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of a Dividend declared in respect of any period prior to the date upon which such amount would, but for such payment, become payable.

FORFEITURE OF SHARES

45 If a call remains unpaid after it has become due and payable the Directors may give to the person from whom it is due not less than fourteen clear days notice requiring payment of the amount unpaid together with any interest, which may have accrued. The notice shall specify where payment is to be made and shall state that if the notice is not complied with the Shares in respect of which the call was made will be liable to be forfeited.

46 If the notice is not complied with any Share in respect of which it was given may, before the payment required by the notice has been made, be forfeited by a resolution of the Directors. Such forfeiture shall include all Dividends or other monies declared payable in respect of the forfeited Share and not paid before the forfeiture.

47 A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred to any person the Directors may authorise some person to execute an instrument of transfer of the Share in favour of that person.

22

48 A person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to pay to the Company all monies which at the date of forfeiture were payable by him to the Company in respect of those Shares together with interest, but his liability shall cease if and when the Company shall have received payment in full of all monies due and payable by him in respect of those Shares.

49 A certificate in writing under the hand of one Director or officer of the Company that a Share has been forfeited on a specified date shall be conclusive evidence of the fact as against all persons claiming to be entitled to the Share. The certificate shall (subject to the execution of an instrument of transfer) constitute a good title to the Share and the person to whom the Share is disposed of shall not be bound to see to the application of the purchase money, if any, nor shall his title to the Share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the Share.

50 The provisions of these Articles as to forfeiture shall apply in the case of non payment of any sum which, by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the Share or by way of premium as if it had been payable by virtue of a call duly made and notified.

TRANSMISSION OF SHARES

51 If a Member dies the survivor or survivors where he was a joint holder, and his legal personal representatives where he was a sole holder, shall be the only persons recognised by the Company as having any title to his interest. The estate of a deceased Member is not thereby released from any liability in respect of any Share, which had been jointly held by him.

52 Any person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation or dissolution of a Member (or in any other way than by transfer) may, upon such evidence being produced as may from time to time be required by the Directors, elect either to become the holder of the Share or to have some person nominated by him as the transferee. If he elects to become the holder he shall give notice to the Company to that effect, but the Directors shall, in either case, have the same right to decline or suspend registration as they would have had in the case of a transfer of the Share by that Member before his death or bankruptcy, as the case may be.

53 If the person so becoming entitled shall elect to be registered himself as holder he shall deliver or send to the Company a notice in writing signed by him stating that he so elects.

54 A person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution of the holder (or in any other case than by transfer) shall be entitled to the same Dividends and other advantages to which he would be entitled if he were the registered holder of the Share. However, he shall not, before being registered as a Member in respect of the Share, be entitled in respect of it to exercise any right conferred by membership in relation to meetings of the Company and the Directors may at any time give notice requiring any such person to elect either to be registered himself or to transfer

23

the Share. If the notice is not complied with within ninety days the Directors may thereafter withhold payment of all Dividends, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with.

AMENDMENTS OF MEMORANDUM AND ARTICLES OF ASSOCIATION AND ALTERATION OF CAPITAL

55 Subject to Article 27 ("Protective Provisions"), the Company may by Ordinary Resolution:

55.1 increase the share capital by such sum as the resolution shall prescribe and with such rights, priorities and privileges annexed thereto, as the Company in general meeting may determine;

55.2 consolidate and divide all or any of its share capital into Shares of larger amount than its existing Shares;

55.3 by subdivision of its existing Shares or any of them divide the whole or any part of its share capital into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value; and

55.4 cancel any Shares that at the date of the passing of the resolution have not been taken or agreed to be taken by any person.

56 All new Shares created in accordance with the provisions of the preceding Article shall be subject to the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise as the Shares in the original share capital.

57 Subject to the provisions of the Statute, and the provisions of these Articles as regards the matters to be dealt with by Ordinary Resolution, the Company may by Special Resolution:

57.1 change its name;

57.2 alter or add to these Articles;

57.3 alter or add to the Memorandum with respect to any objects, powers or other matters specified therein; and

57.4 reduce its share capital and any capital redemption reserve fund.

REGISTERED OFFICE

58 Subject to the provisions of the Statute, the Company may by resolution of the Directors change the location of its Registered Office.

24

GENERAL MEETINGS

59 All general meetings other than annual general meetings shall be called extraordinary general meetings.

60 The Company shall, if required by the Statute, in each year hold a general meeting as its annual general meeting, and shall specify the meeting as such in the notices calling it. The annual general meeting shall be held at such time and place as the Directors shall appoint and if no other time and place is prescribed by them, it shall be held at the Registered Office on the second Wednesday in December of each year at ten o'clock in the morning. At these meetings the report of the Directors (if any) shall be presented.

61 The Company may hold an annual general meeting, but shall not (unless required by Statute) be obliged to hold an annual general meeting.

62 The Directors may call general meetings, and they shall on a Members requisition forthwith proceed to convene an extraordinary general meeting of the Company.

63 A Members requisition is a requisition of Members of the Company holding at the date of deposit of the requisition not less than ten per cent. in par value of the capital of the Company which as at that date carries the right of voting at general meetings of the Company.

64 The requisition must state the objects of the meeting and must be signed by the requisitionists and deposited at the Registered Office, and may consist of several documents in like form each signed by one or more requisitionists.

65 If the Directors do not within twenty-one days from the date of the deposit of the requisition duly proceed to convene a general meeting to be held within a further twenty-one days, the requisitionists, or any of them representing more than one-half of the total voting rights of all of them, may themselves convene a general meeting, but any meeting so convened shall not be held after the expiration of three months after the expiration of the said twenty-one days.

66 A general meeting convened as aforesaid by requisitionists shall be convened in the same manner as nearly as possible as that in which general meetings are to be convened by Directors.

NOTICE OF GENERAL MEETINGS

67 At least five days' notice shall be given of any general meeting. Every notice shall be exclusive of the day on which it is given or deemed to be given and of the day for which it is given and shall specify the place, the day and the hour of the meeting and the general nature of the business and shall be given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general meeting of the Company shall, whether or not the notice specified in this regulation has been given and whether or not the provisions of the Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed:

25

67.1 in the case of an annual general meeting, by all the Members (or their proxies) entitled to attend and vote thereat; and

67.2 in the case of an extraordinary general meeting, by a majority in number of the Members (or their proxies) having a right to attend and vote at the meeting, being a majority together holding not less than ninety five per cent. in par value of the Shares giving that right.

68 The accidental omission to give notice of a general meeting to, or the non receipt of notice of a meeting by, any person entitled to receive notice shall not invalidate the proceedings of that meeting.

PROCEEDINGS AT GENERAL MEETINGS

69 No business shall be transacted at any general meeting unless a quorum is present. Two Members being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorised representative or proxy shall be a quorum unless the Company has only one Member entitled to vote at such general meeting in which case the quorum shall be that one Member present in person or by proxy or (in the case of a corporation or other non-natural person) by a duly authorised representative or proxy.

70 A person may participate at a general meeting by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other. Participation by a person in a general meeting in this manner is treated as presence in person at that meeting.

71 A resolution (including a Special Resolution) in writing (in one or more counterparts) signed by all Members for the time being entitled to receive notice of and to attend and vote at general meetings (or, being corporations, signed by their duly authorised representatives) shall be as valid and effective as if the resolution had been passed at a general meeting of the Company duly convened and held.

72 If a quorum is not present within half an hour from the time appointed for the meeting or if during such a meeting a quorum ceases to be present, the meeting, if convened upon the requisition of Members, shall be dissolved and in any other case it shall stand adjourned to the same day in the next week at the same time and place or to such other day, time or such other place as the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting the Members present shall be a quorum.

73 The chairman, if any, of the board of Directors shall preside as chairman at every general meeting of the Company, or if there is no such chairman, or if he shall not be present within fifteen minutes after the time appointed for the holding of the meeting, or is unwilling to act, the Directors present shall elect one of their number to be chairman of the meeting.

26

74 If no Director is willing to act as chairman or if no Director is present within fifteen minutes after the time appointed for holding the meeting, the Members present shall choose one of their number to be chairman of the meeting.

75 The chairman may, with the consent of a meeting at which a quorum is present, (and shall if so directed by the meeting), adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place. When a general meeting is adjourned for thirty days or more, notice of the adjourned meeting shall be given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice.

76 A resolution put to the vote of the meeting shall be decided on a poll.

77 A poll shall be taken as the chairman directs, and the result of the poll shall be deemed to be the resolution of the general meeting at which the poll was demanded.

78 Subject to Article 27 ("Protective Provisions"), in the case of an equality of votes, whether on a show of hands or on a poll, the chairman shall be entitled to a second or casting vote.

VOTES OF MEMBERS

79 Subject to Article 21 ("Voting Rights"), on a poll every Member shall have one vote for every Share of which he is the holder.

80 In the case of joint holders of record the vote of the senior holder who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders, and seniority shall be determined by the order in which the names of the holders stand in the Register of Members.

81 A Member of unsound mind, or in respect of whom an order has been made by any court, having jurisdiction in lunacy, may vote, whether on a show of hands or on a poll, by his committee, receiver, curator bonis, or other person on such Member's behalf appointed by that court, and any such committee, receiver, curator bonis or other person may vote by proxy.

82 No person shall be entitled to vote at any general meeting or at any separate meeting of the holders of a class of Shares unless he is registered as a Member on the record date for such meeting nor unless all calls or other monies then payable by him in respect of Shares have been paid.

83 No objection shall be raised to the qualification of any voter except at the general meeting or adjourned general meeting at which the vote objected to is given or tendered and every vote not disallowed at the meeting shall be valid. Any objection made in due time shall be referred to the chairman whose decision shall be final and conclusive.

27

84 Votes may be cast either personally or by proxy. A Member may appoint more than one proxy or the same proxy under one or more instruments to attend and vote at a meeting. Where a Member appoints more than one proxy the instrument of proxy shall state which proxy is entitled to vote on a show of hands.

85 A Member holding more than one Share need not cast the votes in respect of his Shares in the same way on any resolution and therefore may vote a Share or some or all such Shares either for or against a resolution and/or abstain from voting a Share or some or all of the Shares and, subject to the terms of the instrument appointing him, a proxy appointed under one or more instruments may vote a Share or some or all of the Shares in respect of which he is appointed either for or against a resolution and/or abstain from voting.

PROXIES

86 The instrument appointing a proxy shall be in writing, be executed under the hand of the appointor or of his attorney duly authorised in writing, or, if the appointor is a corporation under the hand of an officer or attorney duly authorised for that purpose. A proxy need not be a Member of the Company.

87 The instrument appointing a proxy shall be deposited at the Registered Office or at such other place as is specified for that purpose in the notice convening the meeting, or in any instrument of proxy sent out by the Company

87.1 not less than 48 hours before the time for holding the meeting or adjourned meeting at which the person named in the instrument proposes to vote; or

87.2 in the case of a poll taken more than 48 hours after it is demanded, be deposited as aforesaid after the poll has been demanded and not less than 24 hours before the time appointed for the taking of the poll; or

87.3 where the poll is not taken forthwith but is taken not more than 48 hours after it was demanded be delivered at the meeting at which the poll was demanded to the chairman or to the secretary or to any director;

provided that the Directors may in the notice convening the meeting, or in an instrument of proxy sent out by the Company, direct that the instrument appointing a proxy may be deposited (no later than the time for holding the meeting or adjourned meeting) at the Registered Office or at such other place as is specified for that purpose in the notice convening the meeting, or in any instrument of proxy sent out by the Company. The chairman may in any event at his discretion direct that an instrument of proxy shall be deemed to have been duly deposited. An instrument of proxy that is not deposited in the manner permitted shall be invalid.

88 The instrument appointing a proxy may be in any usual or common form and may be expressed to be for a particular meeting or any adjournment thereof or generally until revoked. An instrument appointing a proxy shall be deemed to include the power to demand or join or concur in demanding a poll.

28

89 Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy was executed, or the transfer of the Share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer was received by the Company at the Registered Office before the commencement of the general meeting, or adjourned meeting at which it is sought to use the proxy.

CORPORATE MEMBERS

90 Any corporation or other non-natural person which is a Member may in accordance with its constitutional documents, or in the absence of such provision by resolution of its directors or other governing body, authorise such person as it thinks fit to act as its representative at any meeting of the Company or of any class of Members, and the person so authorised shall be entitled to exercise the same powers on behalf of the corporation which he represents as the corporation could exercise if it were an individual Member.

SHARES THAT MAY NOT BE VOTED

91 Shares in the Company that are beneficially owned by the Company shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number of outstanding Shares at any given time.

DIRECTORS

92 There shall be a board of Directors consisting of seven Directors (exclusive of alternate Directors)and, subject to Article 97 ("Appointment and Removal of Directors"), the Company may from time to time by Ordinary Resolution increase or reduce the limits in the number of Directors.

POWERS OF DIRECTORS

93 Subject to the provisions of the Statute, the Memorandum and the Articles and to any directions given by Special Resolution, the business of the Company shall be managed by the Directors who may exercise all the powers of the Company. No alteration of the Memorandum or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid if that alteration had not been made or that direction had not been given. A duly convened meeting of Directors at which a quorum is present may exercise all powers exercisable by the Directors.

94 All cheques, promissory notes, drafts, bills of exchange and other negotiable instruments and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed as the case may be in such manner as the Directors shall determine by resolution.

95 The Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any Director who has held any other salaried office or place of profit with the Company or to his widow or dependants and may make contributions to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.

29

96 Subject to Article 27 ("Protective Provisions"), the Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its undertaking, property and uncalled capital or any part thereof and to issue debentures, debenture stock, mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the Company or of any third party.

APPOINTMENT AND REMOVAL OF DIRECTORS

97 Appointment and Removal of Directors.

97.1 Each Member agrees that it will vote, or cause to be voted, all Shares and other voting securities of the Company now owned or hereafter acquired by it so as to elect to the Board of Directors five designees nominated by Brothers Capital, and one designee nominated by the Investors. The Investors shall also have the right to nominate one independent director, subject to the approval by the Board of Directors.

97.2 If any of Brothers Capital or the Investors shall notify the other Members of its decision to remove one or more of its designated designees, each Member shall vote all of the Shares and other voting securities of the Company owned or held of record by it so as to remove such Director or Directors. Except as provided in the immediately preceding sentence, no Director designated by any of Brothers Capital or the Investors shall be removed from the Board of Directors unless the designating party of such Director consents to such removal.

97.3 If a Brothers Capital designee or the Investor designee shall cease to serve on the Board of Directors (whether by reason of death, resignation, removal or otherwise), the party that designated such Director shall be entitled to designate a successor Director, nominated in accordance with this Article, to fill the vacancy created thereby. Each Member shall vote all of the Shares and other voting securities of the Company owned or held of record by it so as to elect such designee as a Director.

97.4 One nominee of the Investors (the "Observer"), nominated by the Investors shall be entitled to attend and observe, in a non-voting capacity, all meetings of the Board of Directors and any committee thereof, and shall receive notice of all such meetings as if the Observer were a Director of the Company, or a member of such committee, as applicable.

VACATION OF OFFICE OF DIRECTOR

98 The office of a Director shall be vacated if:

98.1 he gives notice in writing to the Company that he resigns the office of Director; or

98.2 if he absents himself (without being represented by proxy or an alternate Director appointed by him) from three consecutive meetings of the board of Directors without special leave of absence from the Directors, and they pass a resolution that he has by reason of such absence vacated office; or

30

98.3 if he dies, becomes bankrupt or makes any arrangement or composition with his creditors generally; or

98.4 if he is found to be or becomes of unsound mind; or

98.5 if all the other Directors of the Company (being not less than two in number) resolve that he should be removed as a Director.

PROCEEDINGS OF DIRECTORS

99 The quorum for the transaction of the business of the Directors may be fixed by the Directors, and unless so fixed shall be four if there are four or more Directors, three if there are three or more Directors, two if there are two or more Directors, and shall be one if there is only one Director. A person who holds office as an alternate Director shall, if his appointor is not present, be counted in the quorum. A Director who also acts as an alternate Director shall, if his appointor is not present, count twice towards the quorum.

100 Subject to the provisions of the Articles, the Directors may regulate their proceedings as they think fit. Questions arising at any meeting shall be decided by a majority of votes. In the case of an equality of votes, the chairman shall have a second or casting vote. A Director who is also an alternate Director shall be entitled in the absence of his appointor to a separate vote on behalf of his appointor in addition to his own vote.

101 A person may participate in a meeting of the Directors or committee of Directors by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other at the same time. Participation by a person in a meeting in this manner is treated as presence in person at that meeting. Unless otherwise determined by the Directors the meeting shall be deemed to be held at the place where the chairman is at the start of the meeting.

102 A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of a committee of Directors (an alternate Director being entitled to sign such a resolution on behalf of his appointor) shall be as valid and effectual as if it had been passed at a meeting of the Directors, or committee of Directors as the case may be, duly convened and held.

103 A Director or alternate Director may, or other officer of the Company on the requisition of a Director or alternate Director shall, call a meeting of the Directors by at least two days' notice in writing to every Director and alternate Director which notice shall set forth the general nature of the business to be considered unless notice is waived by all the Directors (or their alternates) either at, before or after the meeting is held.

104 The continuing Directors may act notwithstanding any vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant to these Articles as the necessary quorum of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to that number, or of summoning a general meeting of the Company, but for no other purpose.

31

105 The Directors may elect a chairman of their board and determine the period for which he is to hold office; but if no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time appointed for holding the same, the Directors present may choose one of their number to be chairman of the meeting.

106 All acts done by any meeting of the Directors or of a committee of Directors (including any person acting as an alternate Director) shall, notwithstanding that it be afterwards discovered that there was some defect in the appointment of any Director or alternate Director, or that they or any of them were disqualified, be as valid as if every such person had been duly appointed and qualified to be a Director or alternate Director as the case may be.

107 A Director but not an alternate Director may be represented at any meetings of the board of Directors by a proxy appointed in writing by him. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be deemed to be that of the appointing Director.

PRESUMPTION OF ASSENT

108 A Director of the Company who is present at a meeting of the board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless his dissent shall be entered in the minutes of the meeting or unless he shall file his written dissent from such action with the person acting as the chairman or secretary of the meeting before the adjournment thereof or shall forward such dissent by registered post to such person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director who voted in favour of such action.

DIRECTORS' INTERESTS

109 A Director may hold any other office or place of profit under the Company (other than the office of Auditor) in conjunction with his office of Director for such period and on such terms as to remuneration and otherwise as the Directors may determine.

110 A Director may act by himself or his firm in a professional capacity for the Company and he or his firm shall be entitled to remuneration for professional services as if he were not a Director or alternate Director.

111 A Director or alternate Director of the Company may be or become a director or other officer of or otherwise interested in any company promoted by the Company or in which the Company may be interested as shareholder or otherwise, and no such Director or alternate Director shall be accountable to the Company for any remuneration or other benefits received by him as a director or officer of, or from his interest in, such other company.

112 In addition to further restrictions set forth in these Articles (including but not limited to Article 97 ("Appointment and Removal of Directors")), no person shall be disqualified from the office of Director or alternate Director or prevented by such office from contracting with the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or transaction entered into by or on behalf of the Company

32

in which any Director or alternate Director shall be in any way interested be or be liable to be avoided, nor shall any Director or alternate Director so contracting or being so interested be liable to account to the Company for any profit realised by any such contract or transaction by reason of such Director holding office or of the fiduciary relation thereby established. A Director (or his alternate Director in his absence) shall be at liberty to vote in respect of any contract or transaction in which he is interested provided that the nature of the interest of any Director or alternate Director in any such contract or transaction shall be disclosed by him at or prior to its consideration and any vote thereon.

113 A general notice that a Director or alternate Director is a shareholder, director, officer or employee of any specified firm or company and is to be regarded as interested in any transaction with such firm or company shall be sufficient disclosure for the purposes of voting on a resolution in respect of a contract or transaction in which he has an interest, and after such general notice it shall not be necessary to give special notice relating to any particular transaction.

MINUTES

114 The Directors shall cause minutes to be made in books kept for the purpose of all appointments of officers made by the Directors, all proceedings at meetings of the Company or the holders of any class of Shares and of the Directors, and of committees of Directors including the names of the Directors or alternate Directors present at each meeting.

DELEGATION OF DIRECTORS' POWERS

115 The Directors may delegate any of their powers to any committee consisting of one or more Directors. They may also delegate to any managing director or any Director holding any other executive office such of their powers as they consider desirable to be exercised by him provided that an alternate Director may not act as managing director and the appointment of a managing director shall be revoked forthwith if he ceases to be a Director. Any such delegation may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion of their own powers and may be revoked or altered. Subject to any such conditions, the proceedings of a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying.

116 The Directors may establish any committees, local boards or agencies or appoint any person to be a manager or agent for managing the affairs of the Company and may appoint any person to be a member of such committees or local boards. Any such appointment may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion of their own powers and may be revoked or altered. Subject to any such conditions, the proceedings of any such committee, local board or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying.

33

117 The Directors may by power of attorney or otherwise appoint any person to be the agent of the Company on such conditions as the Directors may determine, provided that the delegation is not to the exclusion of their own powers and may be revoked by the Directors at any time.

118 The Directors may by power of attorney or otherwise appoint any company, firm, person or body of persons, whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory of the Company for such purpose and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Directors under these Articles) and for such period and subject to such conditions as they may think fit, and any such powers of attorney or other appointment may contain such provisions for the protection and convenience of persons dealing with any such attorneys or authorised signatories as the Directors may think fit and may also authorise any such attorney or authorised signatory to delegate all or any of the powers, authorities and discretions vested in him.

119 The Directors may appoint such officers as they consider necessary on such terms, at such remuneration and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors may think fit. Unless otherwise specified in the terms of his appointment an officer may be removed by resolution of the Directors or Members.

ALTERNATE DIRECTORS

120 Any Director (other than an alternate Director) may by writing appoint any other Director, or any other person willing to act, to be an alternate Director and by writing may remove from office an alternate Director so appointed by him.

121 An alternate Director shall be entitled to receive notice of all meetings of Directors and of all meetings of committees of Directors of which his appointor is a member, to attend and vote at every such meeting at which the Director appointing him is not personally present, and generally to perform all the functions of his appointor as a Director in his absence.

122 An alternate Director shall cease to be an alternate Director if his appointor ceases to be a Director.

123 Any appointment or removal of an alternate Director shall be by notice to the Company signed by the Director making or revoking the appointment or in any other manner approved by the Directors.

124 An alternate Director shall be deemed for all purposes to be a Director and shall alone be responsible for his own acts and defaults and shall not be deemed to be the agent of the Director appointing him.

NO MINIMUM SHAREHOLDING

125 No Directors are required to hold Shares.

34

REMUNERATION OF DIRECTORS

126 The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall determine. The Directors shall also be entitled to be paid all travelling, hotel and other expenses properly incurred by them in connection with their attendance at meetings of Directors or committees of Directors, or general meetings of the Company, or separate meetings of the holders of any class of Shares or debentures of the Company, or otherwise in connection with the business of the Company, or to receive a fixed allowance in respect thereof as may be determined by the Directors, or a combination partly of one such method and partly the other.

127 The Directors may by resolution approve additional remuneration to any Director for any services other than his ordinary routine work as a Director. Any fees paid to a Director who is also counsel or solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to his remuneration as a Director.

SEAL

128 The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority of the Directors or of a committee of the Directors authorised by the Directors. Every instrument to which the Seal has been affixed shall be signed by at least one person who shall be either a Director or some officer or other person appointed by the Directors for the purpose.

129 The Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals each of which shall be a facsimile of the common Seal of the Company and, if the Directors so determine, with the addition on its face of the name of every place where it is to be used.

130 A Director or officer, representative or attorney of the Company may without further authority of the Directors affix the Seal over his signature alone to any document of the Company required to be authenticated by him under seal or to be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever.

DIVIDENDS, DISTRIBUTIONS AND RESERVE

131 Subject to the Statute and Articles 19 ("Preference Dividend") and 27 ("Protective Provisions"), the Directors may declare Dividends and distributions on Shares in issue and authorise payment of the Dividends or distributions out of the funds of the Company lawfully available therefor. No Dividend or distribution shall be paid except out of the realised or unrealised profits of the Company, or out of the share premium account or as otherwise permitted by the Statute.

132 Subject to Articles 19 ("Preference Dividend") and 133 ("Certain Dividends"), the holders of Ordinary Shares and Preferred Shares shall be entitled to receive dividends when and as declared by the Board of Directors.

133 Certain Dividends.

35

133.1 To the extent any Pre-Closing Retained Earnings have not been distributed to the Eligible Ordinary Shareholders as of the Closing, the Company may, after the Closing, distribute such undistributed Pre-Closing Retained Earnings to the Eligible Ordinary Shareholders, by way of one or more interim dividends or otherwise.

133.2 The Investors shall not be entitled to participate in, or approve or disapprove, the declaration and payment of any undistributed Pre-Closing Retained Earnings, irrespective of whether or not the Investors have converted any or all of their Preferred Shares to Ordinary Shares prior to such declaration or payment.

134 Subject to Article 132, if any Share is issued on terms providing that it shall rank for Dividend as from a particular date, that Share shall rank for Dividend accordingly.

135 The Directors may deduct from any Dividend or distribution payable to any Member all sums of money (if any) then payable by him to the Company on account of calls or otherwise.

136 The Directors may declare that any Dividend or distribution be paid wholly or partly by the distribution of specific assets and in particular of shares, debentures, or securities of any other company or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as they think expedient and in particular may issue fractional Shares and fix the value for distribution of such specific assets or any part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust the rights of all Members and may vest any such specific assets in trustees as may seem expedient to the Directors.

137 Any Dividend, distribution, interest or other monies payable in cash in respect of Shares may be paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered address of the holder or, in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such person and to such address as such holder or joint holders may in writing direct. Every such cheque or warrant shall be made payable to the order of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, bonuses, or other monies payable in respect of the Share held by them as joint holders.

138 No Dividend or distribution shall bear interest against the Company.

139 Any Dividend which cannot be paid to a Member and/or which remains unclaimed after six months from the date of declaration of such Dividend may, in the discretion of the Directors, be paid into a separate account in the Company's name, provided that the Company shall not be constituted as a trustee in respect of that account and the Dividend shall remain as a debt due to the Member. Any Dividend which remains unclaimed after a period of six years from the date of declaration of such Dividend shall be forfeited and shall revert to the Company.

36

CAPITALISATION

140 The Directors may capitalise any sum standing to the credit of any of the Company's reserve accounts (including share premium account and capital redemption reserve fund) or any sum standing to the credit of profit and loss account or otherwise available for distribution and to appropriate such sum to Members in the proportions in which such sum would have been divisible amongst them had the same been a distribution of profits by way of Dividend and to apply such sum on their behalf in paying up in full unissued Shares for allotment and distribution credited as fully paid-up to and amongst them in the proportion aforesaid. In such event the Directors shall do all acts and things required to give effect to such capitalisation, with full power to the Directors to make such provisions as they think fit for the case of Shares becoming distributable in fractions (including provisions whereby the benefit of fractional entitlements accrue to the Company rather than to the Members concerned). The Directors may authorise any person to enter on behalf of all of the Members interested into an agreement with the Company providing for such capitalisation and matters incidental thereto and any agreement made under such authority shall be effective and binding on all concerned.

BOOKS OF ACCOUNT

141 The Directors shall cause proper books of account to be kept with respect to all sums of money received and expended by the Company and the matters in respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets and liabilities of the Company. Proper books shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true and fair view of the state of the Company's affairs and to explain its transactions.

142 The Directors shall from time to time determine whether and to what extent and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors and no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by Statute or authorised by the Directors or by the Company in general meeting.

143 The Directors may from time to time cause to be prepared and to be laid before the Company in general meeting profit and loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by law.

AUDIT

144 The Directors may appoint an Auditor of the Company who shall hold office until removed from office by a resolution of the Directors, and may fix his or their remuneration.

145 Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers of the Company and shall be entitled to require from the Directors and officers of the Company such information and explanation as may be necessary for the performance of the duties of the Auditor.

37

146 Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an exempted company, and at any other time during their term of office, upon request of the Directors or any general meeting of the Members.

NOTICES

147 Notices shall be in writing and may be given by the Company to any Member either personally or by sending it by courier, post, cable, telex, fax or e-mail to him or to his address as shown in the Register of Members (or where the notice is given by e-mail by sending it to the e-mail address provided by such Member). Any notice, if posted from one country to another, is to be sent airmail.

148 Where a notice is sent by courier, service of the notice shall be deemed to be effected by delivery of the notice to a courier company, and shall be deemed to have been received on the third day (not including Saturdays or Sundays or public holidays) following the day on which the notice was delivered to the courier. Where a notice is sent by post, service of the notice shall be deemed to be effected by properly addressing, pre paying and posting a letter containing the notice, and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or public holidays) following the day on which the notice was posted. Where a notice is sent by cable, telex or fax, service of the notice shall be deemed to be effected by properly addressing and sending such notice and shall be deemed to have been received on the same day that it was transmitted. Where a notice is given by e-mail service shall be deemed to be effected by transmitting the e-mail to the e-mail address provided by the intended recipient and shall be deemed to have been received on the same day that it was sent, and it shall not be necessary for the receipt of the e-mail to be acknowledged by the recipient.

149 A notice may be given by the Company to the person or persons which the Company has been advised are entitled to a Share or Shares in consequence of the death or bankruptcy of a Member in the same manner as other notices which are required to be given under these Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the bankrupt, or by any like description at the address supplied for that purpose by the persons claiming to be so entitled, or at the option of the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred.

150 Notice of every general meeting shall be given in any manner hereinbefore authorised to every person shown as a Member in the Register of Members on the record date for such meeting except that in the case of joint holders the notice shall be sufficient if given to the joint holder first named in the Register of Members and every person upon whom the ownership of a Share devolves by reason of his being a legal personal representative or a trustee in bankruptcy of a Member of record where the Member of record but for his death or bankruptcy would be entitled to receive notice of the meeting, and no other person shall be entitled to receive notices of general meetings.

38

WINDING UP

151 If the Company shall be wound up, and the assets available for distribution amongst the Members shall be insufficient to repay the whole of the share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the Members in proportion to the par value of the Shares held by them. If in a winding up the assets available for distribution amongst the Members shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares in respect of which there are monies due, of all monies payable to the Company for unpaid calls or otherwise. This Article is without prejudice to the rights of the holders of Shares issued upon special terms and conditions.

152 If the Company shall be wound up the liquidator may, with the sanction of a Special Resolution of the Company and any other sanction required by the Statute, divide amongst the Members in kind the whole or any part of the assets of the Company (whether they shall consist of property of the same kind or not) and may for that purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members. The liquidator may, with the like sanction, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the Members as the liquidator, with the like sanction, shall think fit, but so that no Member shall be compelled to accept any asset upon which there is a liability.

INDEMNITY

153 Every Director or officer of the Company shall be indemnified out of the assets of the Company against any liability incurred by him as a result of any act or failure to act in carrying out his functions other than such liability (if any) that he may incur by his own actual fraud or wilful default. No such Director or officer shall be liable to the Company for any loss or damage in carrying out his functions unless that liability arises through the actual fraud or wilful default of such Director or officer. References in this Article to actual fraud or wilful default mean a finding to such effect by a competent court in relation to the conduct of the relevant party.

FINANCIAL YEAR

154 Unless the Directors otherwise prescribe, the financial year of the Company shall end on 31st December in each year and, following the year of incorporation, shall begin on 1st January in each year.

TRANSFER BY WAY OF CONTINUATION

155 If the Company is exempted as defined in the Statute, it shall, subject to the provisions of the Statute and with the approval of a Special Resolution, have the power to register by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.

39

Exhibit 3.2

THE COMPANIES LAW (2007 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES

AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION

OF

AGRIA CORPORATION

Adopted by Special Resolution
passed on 5 October 2007 and

effective immediately prior to completion of the Company's initial public offering of ordinary shares represented by American Depositary Shares

1. The name of the Company is AGRIA CORPORATION.

2. The Registered Office of the Company shall be at the offices of M&C Corporate Services Limited, P.O. Box 309 GT, Ugland House, South Church Street, George Town, Grand Cayman, Cayman Islands, or at such other place as the Directors may from time to time decide.

3. The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by the Companies Law (2007 Revision) or as the same may be revised from time to time, or any other law of the Cayman Islands.

4. The liability of each Member is limited to the amount from time to time unpaid on such Member's shares.

5. The authorized share capital of the Company is US$50,000 divided into 500,000,000,000 shares of a nominal or par value of US$0.0000001 each. The Company has the power to redeem or purchase any of its shares and to increase or reduce the said capital subject to the provisions of the Companies Law (2007 Revision) and the Articles of Association and to issue any part of its capital, whether original, redeemed or increased with or without any preference, priority or special privilege or subject to any postponement of rights or to any conditions or restrictions and so that unless the conditions of issue shall otherwise expressly declare every issue of shares whether declared to be preference or otherwise shall be subject to the powers hereinbefore contained.

6. The Company has the power to register by way of continuation as a body corporate limited by shares under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.

7. Capitalized terms that are not defined in this Amended and Restated Memorandum of Association bear the same meaning as those given in the Amended and Restated Articles of Association of the Company adopted by Special Resolution passed on 5 October 2007 and effective immediately prior to completion of the Company's initial public offering of ordinary shares represented by American Depositary Shares.


THE COMPANIES LAW (2007 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES

AMENDED AND RESTATED ARTICLES OF ASSOCIATION

OF

AGRIA CORPORATION

Adopted by Special Resolution
passed on 5 October 2007 and

effective immediately prior to completion of the Company's initial public offering of ordinary shares represented by American Depositary Shares

INTERPRETATION

1. In these Articles, unless otherwise defined, the defined terms shall have the meanings assigned to them as follows:

"ARTICLES"

the Amended and Restated Articles of Association adopted by Special Resolution on 5 October 2007 and effective immediately prior to completion of the Company's initial public offering of ordinary shares represented by American Depositary Shares, as from time to time altered or added to in accordance with the Statutes and these Articles;

"BOARD"

the board of Directors of the Company;

"BUSINESS DAY"

a day (excluding Saturdays or Sundays), on which banks in Hong Kong, Beijing and New York are open for general banking business throughout their normal business hours;

"COMMISSION"

Securities and Exchange Commission of the United States of America or any other federal agency for the time being administering the Securities Act;

"COMPANIES LAW"

the Companies Law (2007 Revision) of the Cayman Islands and any statutory amendment or re-enactment thereof. Where any provision of the Companies Law is referred to, the reference is to that provision as amended by any law for the time being in force;


"COMPANY"

Agria Corporation, a Cayman Islands company limited by shares;

"COMPANY'S WEBSITE"

the website of the Company, the address or domain name of which has been notified to Members;

"DIRECTORS" AND "BOARD OF DIRECTORS" AND "BOARD"

the directors of the Company for the time being, or as the case may be, the Directors assembled as a Board or as a committee thereof;

"ELECTRONIC"

the meaning given to it in the Electronic Transactions Law (2003 Revision) of the Cayman Islands and any amendment thereto or re-enactments thereof for the time being in force and includes every other law incorporated therewith or substituted therefore;

"ELECTRONIC COMMUNICATION"

electronic posting to the Company's Website, transmission to any number, address or internet website or other electronic delivery methods as otherwise decided and approved by not less than two-thirds of the vote of the Board;

"IN WRITING"

includes writing, printing, lithograph, photograph, type-writing and every other mode of representing words or figures in a legible and non-transitory form and, only where used in connection with a notice served by the Company on Members or other persons entitled to receive notices hereunder, shall also include a record maintained in an electronic medium which is accessible in visible form so as to be useable for subsequent reference;

"MEMBER"

a person whose name is entered in the Register of Members as the holder of a share or shares;

"MEMORANDUM OF ASSOCIATION"

the Memorandum of Association of the Company, as amended and re-stated from time to time;

"MONTH"

calendar month;

"ORDINARY RESOLUTION"

a resolution:

2

(a) passed by a simple majority of votes cast by such Members as, being entitled to do so, vote in person or, in the case of any Member being an organization, by its duly authorized representative or, where proxies are allowed, by proxy at a general meeting of the Company; or

(b) approved in writing by all of the Members entitled to vote at a general meeting of the Company in one or more instruments each signed by one or more of the Members and the effective date of the resolution so adopted shall be the date on which the instrument, or the last of such instruments if more than one, is executed;

"ORDINARY SHARES"

shares of par value of US$0.0000001 each in the capital of the Company with the rights set out in these Articles;

"PAID UP"

paid up as to the par value and any premium payable in respect of the issue of any shares and includes credited as paid up;

"REGISTER OF MEMBERS"

the register to be kept by the Company in accordance with Section 40 of the Companies Law;

"SEAL"

the Common Seal of the Company including any facsimile thereof;

"SECURITIES ACT"

the Securities Act of 1933 of the United States of America, as amended, or any similar federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time;

"SHARE"

any share in the capital of the Company, including the Ordinary Shares and shares of other classes;

"SIGNED"

includes a signature or representation of a signature affixed by mechanical means or an electronic symbol or process attached to or logically associated with an electronic communication and executed or adopted by a person with the intent to sign the electronic communication;

"SPECIAL RESOLUTION"

3

a resolution passed in accordance with Section 60 of the Companies Law and includes an unanimous written resolution expressly passed as a special resolution;

"STATUTES"

the Companies Law and every other laws and regulations of the Cayman Islands for the time being in force concerning companies and affecting the Company;

"YEAR"

calendar year.

2. In these Articles, save where the context requires otherwise:

(a) words importing the singular number shall include the plural number and vice versa;

(b) words importing the masculine gender only shall include the feminine gender;

(c) words importing persons only shall include companies or associations or bodies of persons, whether corporate or not;

(d) "MAY" shall be construed as permissive and "SHALL" shall be construed as imperative;

(e) a reference to a dollar or dollars (or $) is a reference to dollars of the United States;

(f) references to a statutory enactment shall include reference to any amendment or re-enactment thereof for the time being in force;

(g) any phrase introduced by the terms "including", "include", "in particular" or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms; and

(h) Section 8 of the Electronic Transactions Law (2003 Revision) shall not reply.

3. Subject to the last two preceding Articles, any words defined in the Companies Law shall, if not inconsistent with the subject or context, bear the same meaning in these Articles.

PRELIMINARY

4. The business of the Company may be commenced as soon after incorporation as the Directors see fit, notwithstanding that only part of the shares may have been allotted or issued.

5. The registered office of the Company shall be at such address in the Cayman Islands as the Directors shall from time to time determine. The Company may in addition

4

establish and maintain such other offices and places of business and agencies in such places as the Directors may from time to time determine.

SHARE CAPITAL

6. The authorized share capital of the Company at the date of adoption of these Articles is US$50,000 divided into 450,000,000,000 ordinary shares of a nominal or par value of US$0.0000001 each and 50,000,000,000 preferred shares of a nominal or par value of US$0.0000001 each with power for the Company insofar as is permitted by law, to redeem or purchase any of its shares and to increase or reduce the said capital subject to the provisions of the Companies Law and these Articles and to issue any part of its capital, whether original, redeemed or increased with or without any preference, priority or special privilege or subject to any postponement of rights or to any conditions or restrictions and so that unless the conditions of issue shall otherwise expressly declare every issue of shares whether declared to be preference or otherwise shall be subject to the powers hereinbefore contained.

7. The Directors from time to time may, in their absolute discretion and without approval of Members, cause the Company to issue such amounts of preferred shares or other similar securities in one or more series as they deem necessary and appropriate and determine designations, powers, preferences, privileges and other rights, including dividend rights, conversion rights, terms of redemption and liquidation preferences, any or all of which may be greater than the powers and rights associated with the Ordinary Shares.

8. Subject to applicable regulatory requirements, the Directors from time to time may, in their absolute discretion and without approval of Members, cause the Company to issue additional ordinary shares without action by the Members to the extent of available authorized but unissued shares.

ISSUE OF SHARES

9. Subject to the provisions, if any, in the Articles and to any direction that may be given by the Company in a general meeting, the Directors may, in their absolute discretion and without approval of the holders of Ordinary Shares, cause the Company to issue such amounts of Ordinary Shares and/or preferred shares, grant rights over existing shares or issue other securities in one or more series as they deem necessary and appropriate and determine designations, powers, preferences, privileges and other rights, including dividend rights, conversion rights, terms of redemption and liquidation preferences, any or all of which may be greater than the powers and rights associated with the Ordinary Shares, at such times and on such other terms as they think proper. The Company shall not issue shares in bearer form.

REGISTER OF MEMBERS AND SHARE CERTIFICATES

10. The Company shall maintain a Register of its Members and every person whose name is entered as a Member in the Register of Members may, without payment, be entitled to a certificate after allotment or lodgement of transfer (or within such other period as the conditions of issue shall provide) in the form determined by the Directors if such person requests a certificate. All certificates shall specify the share or shares held by that person and the amount paid up thereon, provided that in respect of a share or

5

shares held jointly by several persons the Company shall not be bound to issue more than one certificate, and delivery of a certificate for a share to one of several joint holders shall be sufficient delivery to all. All certificates for shares shall be delivered personally or sent through the post addressed to the member entitled thereto at the Member's registered address as appearing in the register.

11. Every share certificate of the Company shall bear legends required under the applicable laws, including the Securities Act.

12. Any two or more certificates representing shares of any one class held by any Member may at the Member's request be cancelled and a single new certificate for all such shares may be issued in lieu of the cancelled certificates.

13. If a share certificate shall be damaged or defaced or alleged to have been lost, stolen or destroyed, a new certificate representing the same shares may be issued to the relevant member upon request subject to delivery up of the old certificate or (if alleged to have been lost, stolen or destroyed) compliance with such conditions as to evidence and indemnity and the payment of out-of-pocket expenses of the Company in connection with the request as the Directors may think fit.

14. In the event that shares are held jointly by several persons, any request may be made by any one of the joint holders and if so made shall be binding on all of the joint holders.

TRANSFER OF SHARES

15. The instrument of transfer of any share shall be in writing and shall be executed by or on behalf of the transferor and the transferor shall be deemed to remain the holder of a share until the name of the transferee is entered in the register in respect thereof.

16. The Directors may, in their absolute discretion (except with respect to a transfer from a Member to its Affiliate(s)), decline to register any transfer of shares without assigning any reason therefor. If the Directors refuse to register a transfer they shall notify the transferee within two months of such refusal. Notwithstanding the foregoing, if a transfer complies with the holder's transfer obligations and restrictions set forth under applicable law (including but not limited to U.S. securities law provisions related to insider trading) and these Articles, Directors shall promptly register such transfer. Further, any Director is authorized to confirm in writing addressed to the registered office to authorize a share transfer and to instruct that the register of members be updated accordingly, provided that the transfer complies with the holder's transfer obligations and restrictions set forth under applicable law and these Articles and such holder is not the Director who authorizes the transfer or an entity affiliated with such Director. Any Director is authorized to execute a share certificate in respect of such shares for and on behalf of the Company

17. The registration of transfers may be suspended at such time and for such periods as the Directors may from time to time determine, provided always that such registration shall not be suspended for more than forty-five days in any year.

REDEMPTION AND PURCHASE OF OWN SHARES

6

18. Subject to the provisions of the Statutes and these Articles, the Company may:

(a) issue shares on terms that they are to be redeemed or are liable to be redeemed at the option of the Company on such terms and in such manner as the Company may determine;

(b) purchase its own shares (including any redeemable shares) on such terms and in such manner as the Directors may determine; and

(c) make a payment in respect of the redemption or purchase of its own shares otherwise than out of profits or the proceeds of a fresh issue of shares.

19. Any share in respect of which notice of redemption has been given shall not be entitled to participate in the profits of the Company in respect of the period after the date specified as the date of redemption in the notice of redemption.

20. The redemption or purchase of any share shall not be deemed to give rise to the redemption or purchase of any other share.

21. The Directors may when making payments in respect of redemption or purchase of shares, if authorized by the terms of issue of the shares being redeemed or purchased or with the agreement of the holder of such shares, make such payment in any form of consideration permitted by the Statutes.

VARIATION OF RIGHTS ATTACHING TO SHARES

22. If at any time the share capital is divided into different classes of shares, the rights attaching to any class (unless otherwise provided by the terms of issue of the shares of that class) may, subject to these Articles, be varied or abrogated with the consent in writing of the holders of a majority of the issued shares of that class or with the sanction of a Special Resolution passed at a general meeting of the holders of the shares of that class.

23. The provisions of these Articles relating to general meetings shall apply to every such general meeting of the holders of one class of shares except that the necessary quorum shall be one person holding or representing by proxy at least one-third of the issued shares of the class and that any holder of shares of the class present in person or by proxy may demand a poll.

24. Notwithstanding Articles 22 and 23 above, the rights conferred upon the holders of the shares of any class issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the shares of that class, be deemed to be varied by the creation or issue of further shares ranking in priority to or pari passu therewith. Further, notwithstanding Articles 22 and 23 above, the rights of the holders of ordinary shares shall not be deemed varied by the creation or issue of shares with preferred or other rights, which may be effected by the Directors as provided in these Articles without any vote or consent of the holders of ordinary shares.

COMMISSION ON SALE OF SHARES

25. The Company may in so far as the Statutes from time to time permit pay a commission to any person in consideration of his subscribing or agreeing to subscribe

7

whether absolutely or conditionally for any shares of the Company. Such commissions may be satisfied by the payment of cash or the lodgement of fully or partly paid-up shares or partly in one way and partly in the other. The Company may also on any issue of shares pay such brokerage as may be lawful.

NON-RECOGNITION OF TRUSTS

26. No person shall be recognised by the Company as holding any share upon any trust and the Company shall not be bound by or be compelled in any way to recognise (even when having notice thereof) any equitable, contingent, future, or partial interest in any share, or any interest in any fractional part of a share, or (except only as is otherwise provided by these Articles or the Statutes) any other rights in respect of any share except an absolute right to the entirety thereof in the registered holder.

LIEN ON SHARES

27. The Company shall have a first and paramount lien and charge on all shares (whether fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether presently payable or not) by such Member or his estate, either alone or jointly with any other person, whether a Member or not, but the Directors may at any time declare any share to be wholly or in part exempt from the provisions of this Article. The registration of a transfer of any such share shall operate as a waiver of the Company's lien (if any) thereon. The Company's lien (if any) on a share shall extend to all dividends or other monies payable in respect thereof.

28. The Company may sell, in such manner as the Directors think fit, any shares on which the Company has a lien, but no sale shall be made unless some sum in respect of which the lien exists is presently payable nor until the expiration of 14 calendar days after a notice in writing, stating and demanding payment of such part of the amount in respect of which the lien exists as is presently payable, has been given to the registered holder for the time being of the share, or the persons entitled thereto by reason of his death or bankruptcy.

29. For giving effect to any such sale the Directors may authorise some person to transfer the shares sold to the purchaser thereof. The purchaser shall be registered as the holder of the shares comprised in any such transfer and he shall not be bound to see to the application of the purchase money, nor shall his title to the shares be affected by any irregularity or invalidity in the proceedings in reference to the sale.

30. The proceeds of the sale shall be received by the Company and applied in payment of such part of the amount in respect of which the lien exists as is presently payable, and the residue shall (subject to a like lien for sums not presently payable as existed upon the shares prior to the sale) be paid to the person entitled to the shares at the date of the sale.

CALLS ON SHARES

31. The Directors may from time to time make calls upon the Members in respect of any money unpaid on their shares, and each member shall (subject to receiving at least 14 calendar days notice specifying the time or times of payment) pay to the Company at

8

the time or times so specified the amount called on his shares. A call shall be deemed to have been made at the time when the resolution of the Directors authorising such call was passed.

32. The joint holders of a share shall be jointly and severally liable to pay calls in respect thereof.

33. If a sum called in respect of a share is not paid before or on the day appointed for payment thereof, the person from whom the sum is due shall pay interest upon the sum at the rate of eight percent per annum from the day appointed for the payment thereof to the time of the actual payment, but the Directors shall be at liberty to waive payment of that interest wholly or in part.

34. The provisions of these Articles as to the liability of joint holders and as to payment of interest shall apply in the case of non-payment of any sum which, by the terms of issue of a share, becomes payable at a fixed time, whether on account of the amount of the share, or by way of premium, as if the same had become payable by virtue of a call duly made and notified.

35. The Directors may make arrangements on the issue of shares for a difference between the Members, or the particular shares, in the amount of calls to be paid and in the times of payment.

36. The Directors may, if they think fit, receive from any member willing to advance the same all or any part of the moneys uncalled and unpaid upon any shares held by him, and upon all or any of the moneys so advanced may (until the same would, but for such advance, become presently payable) pay interest at such rate (not exceeding without the sanction of an Ordinary Resolution, eight percent. per annum) as may be agreed upon between the Member paying the sum in advance and the Directors. No such sum paid in advance of calls shall entitle the member paying such sum to any portion of a dividend declared in respect of any period prior to the date upon which such sum would, but for such payment, become presently payable.

FORFEITURE OF SHARES

37. If a Member fails to pay any call or installment of a call on the day appointed for payment thereof, the Directors may, at any time thereafter during such time as any part of such call or installment remains unpaid, serve a notice on him requiring payment of such much of the call or installment as is unpaid, together with any interest which may have accrued.

38. The notice shall name a further day (not earlier than the expiration of 14 calendar days from the date of the notice) on or before which the payment required by the notice is to be made, and shall state that in the event of non-payment at or before the time appointed the shares in respect of which the call was made will be liable to be forfeited.

39. If the requirements of any such notice as aforesaid are not complied with, any share in respect of which the notice has been given may at any time thereafter, before the payment required by notice has been made, be forfeited by a resolution of the Directors to that effect.

9

40. A forfeited share may be sold or otherwise disposed of on such terms and in such manner as the Directors think fit, and at any time before a sale or disposition the forfeiture may be cancelled on such terms as the Directors think fit.

41. A person whose shares have been forfeited shall cease to be a Member in respect of the forfeited shares, but shall, notwithstanding, remain liable to pay to the Company all moneys which at the date of forfeiture were payable by him to the Company in respect of the shares, but his liability shall cease if and when the Company receives payment in full of the fully paid up amount of the shares.

42. A statutory declaration in writing that the declarant is a Director of the Company, and that a share in the Company has been duly forfeited on a date stated in the declaration, shall be conclusive evidence of the facts therein stated as against all persons claiming to be entitled to the share. The Company may receive the consideration, if any, given for the share or any sale or disposition thereof and may execute a transfer of the share in favour of the person to whom the share is sold or disposed of and he shall thereupon be registered as the holder of the share, and shall not be bound to see to the application of the purchase money, if any, nor shall his title to the share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the share.

43. The provisions of these Articles as to forfeiture shall apply in the case of non-payment of any sum which by the terms of issue of a share becomes due and payable, whether on account of the amount of the share, or by way of premium, as if the same had been payable by virtue of a call duly made and notified.

REGISTRATION OF EMPOWERING INSTRUMENTS

44. The Company shall be entitled to charge a fee not exceeding one dollar (US$1.00) on the registration of every probate, letters of administration, certificate of death or marriage, power of attorney, notice in lieu of distringas, or other instrument.

TRANSMISSION OF SHARES

45. The legal personal representative of a deceased sole holder of a share shall be the only person recognised by the Company as having any title to the share. In the case of a share registered in the name of two or more holders, the survivors or survivor, or the legal personal representatives of the deceased survivor, shall be the only person recognised by the Company as having any title to the share.

46. Any person becoming entitled to a share in consequence of the death or bankruptcy of a Member shall upon such evidence being produced as may from time to time be properly required by the Directors, have the right either to be registered as a member in respect of the share or, instead of being registered himself, to make such transfer of the share as the deceased or bankrupt person could have made. If the person so becoming entitled shall elect to be registered himself as holder he shall deliver or send to the Company a notice in writing signed by him stating that he so elects.

47. A person becoming entitled to a share by reason of the death or bankruptcy of the holder shall be entitled to the same dividends and other advantages to which he would be entitled if he were the registered holder of the share, except that he shall not, before

10

being registered as a Member in respect of the share, be entitled in respect of it to exercise any right conferred by membership in relation to meetings of the Company, provided however, that the Directors may at any time give notice requiring any such person to elect either to be registered himself or to transfer the share, and if the notice is not complied with within 90 calendar days, the Directors may thereafter withhold payment of all dividends, bonuses or other monies payable in respect of the share until the requirements of the notice have been complied with.

ALTERATION OF CAPITAL

48. Subject to these Articles, the Company may from time to time by Ordinary Resolution increase the share capital by such sum, to be divided into shares of such classes and amount, as the resolution shall prescribe.

49. Subject to these Articles, the Company may by Ordinary Resolution:

(a) consolidate and divide all or any of its share capital into shares of larger amount than its existing shares;

(b) sub-divide its existing shares, or any of them into shares of a smaller amount provided that in the subdivision the proportion between the amount paid and the amount, if any unpaid on each reduced share shall be the same as it was in case of the share from which the reduced share is derived;

(c) cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of its share capital by the amount of the shares so cancelled.

50. The Company may by Special Resolution reduce its share capital and any capital redemption reserve in any manner authorized by law.

51. All new shares created hereunder shall be subject to the same provisions with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise as the shares in the original share capital.

CLOSING REGISTER OF MEMBERS OR FIXING RECORD DATE

52. For the purpose of determining those Members that are entitled to receive notice of, attend or vote at any meeting of Members or any adjournment thereof, or those Members that are entitled to receive payment of any dividend, or in order to make a determination as to who is a Member for any other purpose, the Directors may provide that the Register of Members shall be closed for transfers for a stated period but not to exceed in any case 30 calendar days. If the Register of Members shall be so closed for the purpose of determining those Members that are entitled to receive notice of, attend or vote at a meeting of Members such register shall be so closed for at least 10 calendar days immediately preceding such meeting and the record date for such determination shall be the date of the closure of the Register of Members.

53. In lieu of or apart from closing the Register of Members, the Directors may fix in advance a date as the record date for any such determination of those Members that are entitled to receive notice of, attend or vote at a meeting of the Members and for the purpose of determining those Members that are entitled to receive payment of any

11

dividend, the Directors may, at or within 30calendar days prior to the date of declaration of such dividend fix a subsequent date as the record date of such determination.

54. If the Register of Members is not so closed and no record date is fixed for the determination of those Members entitled to receive notice of, attend or vote at a meeting of Members or those Members that are entitled to receive payment of a dividend, the date on which notice of the meeting is posted or the date on which the resolution of the Directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of Members. When a determination of those Members that are entitled to receive notice of, attend or vote at a meeting of Members has been made as provided in this section, such determination shall apply to any adjournment thereof.

GENERAL MEETINGS

55. All general meetings of the Company other than annual general meetings shall be called extraordinary general meetings.

56.  (a)  The Company may hold an annual general meeting but shall not (unless
          required by the Companies Law) be obliged to hold an annual general
          meeting.

     (b)  At these meetings the report of the Directors (if any) shall be
          presented.

57.  (a)  The Directors may call general meetings, and they shall on a Members
          requisition forthwith proceed to convene an extraordinary general
          meeting of the Company.

     (b)  A Members requisition is a requisition of Members of the Company
          holding at the date of deposit of the requisition not less than
          one-third of the share capital of the Company as at that date carries
          the right of voting at general meetings of the Company.

     (c)  The requisition must state the objects of the meeting and must be
          signed by the requisitionists and deposited at the Registered Office,
          and may consist of several documents in like form each signed by one
          or more requisitionists.

     (d)  If the Directors do not within 21 calendar days from the date of the
          deposit of the requisition duly proceed to convene a general meeting
          to be held within a further 21 calendar days, the requisitionists, or
          any of them representing more than one half of the total voting rights
          of all of them, may themselves convene a general meeting, but any
          meeting so convened shall not be held after the expiration of three
          months after the expiration of the second said 21 calendar days.

     (e)  A general meeting convened as aforesaid by requisitionists shall be
          convened in the same manner as nearly as possible as that in which
          general meetings are to be convened by Directors.

NOTICE OF GENERAL MEETINGS

12

58. At least 7 calendar days' notice shall be given for any general meeting. Every notice shall be exclusive of the day on which it is given or deemed to be given and of the day for which it is given and shall specify the place, the day and the hour of the meeting and the general nature of the business and shall be given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general meeting of the Company shall, whether or not the notice specified in this regulation has been given and whether or not the provisions of Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed:

(a) in the case of an annual general meeting by all the Members (or their proxies) entitled to attend and vote thereat; and

(b) in the case of an extraordinary general meeting by a majority in number of the Members (or their proxies) having a right to attend and vote at the meeting, being a majority together holding not less than seventy five (75%) per cent in par value of the shares giving that right.

59. The accidental omission to give notice of a meeting to or the non-receipt of a notice of a meeting by any Member shall not invalidate the proceedings at any meeting.

PROCEEDINGS AT GENERAL MEETINGS

60. No business shall be transacted at any general meeting unless a quorum of Members is present at the time when the meeting proceeds to business. Members holding not less than an aggregate of one-third of all voting share capital of the Company in issue present in person or by proxy and entitled to vote shall be a quorum for all purposes. A person may participate at a general meeting by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other. Participation by a person in a general meeting in this manner is treated as presence in person at that meeting.

61. If within half an hour from the time appointed for the meeting a quorum is not present, the meeting, if convened upon the requisition of Members, shall be dissolved. In any other case it shall stand adjourned to the same day in the next week, at the same time and place, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting, the meeting shall be dissolved.

62. The Chairman of the Board of Directors shall preside as chairman at every general meeting of the Company.

63. If at any meeting the Chairman of the Board of Directors is not present within fifteen minutes after the time appointed for holding the meeting or is unwilling to act as chairman, the Members present shall choose a chairman of the meeting.

64. The Chairman may with the consent of any meeting at which a quorum is present (and shall if so directed by the meeting) adjourn a meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place. When a meeting is adjourned for 10 calendar days or more, not less than seven Business Days' notice of the adjourned meeting shall be given as in the case of an

13

original meeting. Save as aforesaid it shall not be necessary to give any notice of an adjournment or of the business to be transacted at an adjourned meeting.

65. At any general meeting a resolution put to the vote of the meeting shall be decided on a show of hands, unless a poll is (before or on the declaration of the result of the show of hands) demanded by one or more Members present in person or by proxy entitled to vote and who together hold not less than 10 per cent of the paid up voting share capital of the Company, and unless a poll is so demanded, a declaration by the chairman that a resolution has, on a show of hands, been carried, or carried unanimously, or by a particular majority, or lost, and an entry to that effect in the book of the proceedings of the Company, shall be conclusive evidence of the fact, without proof of the number or proportion of the votes recorded in favour of, or against, that resolution.

66. If a poll is duly demanded it shall be taken in such manner as the chairman directs, and the result of the poll shall be deemed to be the resolution of the meeting at which the poll was demanded. The demand for a poll may be withdrawn.

67. In the case of an equality of votes, whether on a show of hands or on a poll, the chairman of the meeting at which the show of hands takes place or at which the poll is demanded, shall not be entitled to a second or casting vote.

68. A poll demanded on the election of a chairman or on a question of adjournment shall be taken forthwith. A poll demanded on any other question shall be taken at such time as the chairman of the meeting directs.

VOTES OF MEMBERS

69. Subject to any rights and restrictions for the time being attached to any class or classes of shares, every Member present in person and every person representing a Member by proxy at a general meeting of the Company shall have one vote for each share registered in his name in the Register of Members.

70. In the case of joint holders the vote of the senior who tenders a vote whether in person or by proxy shall be accepted to the exclusion of the votes of the joint holders and for this purpose seniority shall be determined by the order in which the names stand in the Register of Members.

71. A Member of unsound mind, or in respect of whom an order has been made by any court having jurisdiction in lunacy, may vote, whether on a show of hands or on a poll, by his committee, or other person in the nature of a committee appointed by that court, and any such committee or other person, may on a poll, vote by proxy.

72. No Member shall be entitled to vote at any general meeting unless all calls or other sums presently payable by him in respect of shares in the Company have been paid.

73. On a poll, votes may be given either personally or by proxy.

74. The instrument appointing a proxy shall be in writing under the hand of the appointor or of his attorney duly authorized in writing or, if the appointor is a corporation, either under seal or under the hand of an officer or attorney duly authorized. A proxy need not be a Member of the Company.

14

75. An instrument appointing a proxy may be in any usual or common form or such other form as the Directors may approve.

76. The instrument appointing a proxy shall be deemed to confer authority to demand or join in demanding a poll.

77. A resolution in writing signed by all the Members for the time being entitled to receive notice of and to attend and vote at general meetings (or being corporations by their duly authorized representatives) shall be as valid and effective as if the same had been passed at a general meeting of the Company duly convened and held.

CORPORATIONS ACTING BY REPRESENTATIVES AT MEETING

78. Any corporation which is a Member or a Director may by resolution of its directors or other governing body authorise such person as it thinks fit to act as its representative at any meeting of the Company or of any class of Members or of the Board of Directors or of a committee of Directors, and the person so authorized shall be entitled to exercise the same powers on behalf of the corporation which he represents as that corporation could exercise if it were an individual Member or Director.

CLEARING HOUSES

79. If a clearing house (or its nominee) is a member of the Company it may, by resolution of its directors or other governing body or by power of attorney, authorise such person or persons as it thinks fit to act as its representative or representatives at any general meeting of the Company or at any general meeting of any class of members of the Company provided that, if more than one person is so authorized, the authorisation shall specify the number and class of shares in respect of which each such person is so authorized. A person so authorized pursuant to this provision shall be entitled to exercise the same powers on behalf of the clearing house (or its nominee) which he represents as that clearing house (or its nominee) could exercise if it were an individual member of the Company holding the number and class of shares specified in such authorisation.

DIRECTORS

80.  (A)  Unless otherwise determined by the Company in general meeting, the
          number of Directors shall not be less than three Directors. The
          Directors shall be elected or appointed in the first place by the
          subscribers to the Memorandum of Association or by a majority of them
          and thereafter by the Members at general meeting or by the Directors
          as provided in Articles 80 (E) below.

     (B)  Each Director shall hold office until the expiration of his term and
          until his successor shall have been elected and qualified.

     (C)  The Board of Directors shall have a Chairman of the Board of Directors
          (the "Chairman") elected and appointed by a majority of the Directors
          then in office. The Directors may also elect a Co-Chairman or a
          Vice-Chairman of the Board of Directors (the "Co-Chairman"). The
          Chairman shall preside as chairman at every meeting of the Board of
          Directors. To the extent the Chairman is not present at a meeting of
          the Board of Directors, the

                                       15

          Co-Chairman, or in his absence, the attending Directors may choose one
          Director to be the chairman of the meeting. The Chairman's voting
          right as to the matters to be decided by the Board of Directors shall
          be the same as other Directors.

     (D)  Subject to these Articles and the Companies Law, the Company may by
          Ordinary Resolution elect any person to be a Director either to fill a
          casual vacancy on the Board or as an addition to the existing Board.

     (E)  The Directors by the affirmative vote of a simple majority of the
          remaining Directors present and voting at a Board meeting, or the sole
          remaining Director, shall have the power from time to time and at any
          time to appoint any person as a Director to fill a casual vacancy on
          the Board or as an addition to the existing Board, subject to the
          Company's compliance with director nomination procedures required
          under applicable NYSE corporate governance rules, as long as the
          Company's securities are trading on the New York Stock Exchange.

81. Subject to Article 80, a Director may be removed from office by Special Resolution at any time before the expiration of his term notwithstanding anything in these Articles or in any agreement between the Company and such Director (but without prejudice to any claim for damages under such agreement).

82. A vacancy on the Board created by the removal of a Director under the provisions of Article 81 above may be filled by the election or appointment by Ordinary Resolution at the meeting at which such Director is removed or by the affirmative vote of a simple majority of the remaining Directors present and voting at a Board meeting.

83. The Board may, from time to time, and except as required by applicable law or the listing rules of the recognized stock exchange or automated quotation system where the Company's securities are traded, adopt, institute, amend, modify or revoke the corporate governance policies or initiatives, which shall be intended to set forth the policies of the Company and the Board on various corporate governance related matters as the Board shall determine by resolution from time to time.

84. A Director shall not be required to hold any shares in the Company by way of qualification. A Director who is not a member of the Company shall nevertheless be entitled to receive notice of and to attend and speak at general meetings of the Company and all classes of shares of the Company.

DIRECTORS' FEES AND EXPENSES

85. The Directors may receive such remuneration as the Board may from time to time determine. The Directors may be entitled to be repaid all travelling, hotel and incidental expenses reasonably incurred or expected to be incurred by him in attending meetings of the Board or committees of the Board or general meetings or separate meetings of any class of shares or of debentures of the Company or otherwise in connection with the discharge of his duties as a Director.

86. Any Director who, by request, goes or resides abroad for any purpose of the Company or who performs services which in the opinion of the Board go beyond the ordinary

16

duties of a Director may be paid such extra remuneration (whether by way of salary, commission, participation in profits or otherwise) as the Board may determine and such extra remuneration shall be in addition to or in substitution for any ordinary remuneration provided for by or pursuant to any other Article.

ALTERNATE DIRECTOR

87. Any Director may in writing appoint another person to be his alternate to act in his place at any meeting of the Directors at which he is unable to be present. Every such alternate shall be entitled to notice of meetings of the Directors and to attend and vote thereat as a Director when the person appointing him is not personally present and where he is a Director to have a separate vote on behalf of the Director he is representing in addition to his own vote. A Director may at any time in writing revoke the appointment of an alternate appointed by him. Such alternate shall not be an officer of the Company and shall be deemed to be the agent of the Director appointing him.

88. Any Director may appoint any person, whether or not a Director, to be the proxy of that Director to attend and vote on his behalf, in accordance with instructions given by that Director, or in the absence of such instructions at the discretion of the proxy, at a meeting or meetings of the Directors which that Director is unable to attend personally. The instrument appointing the proxy shall be in writing under the hand of the appointing Director and shall be in any usual or common form or such other form as the Directors may approve, and must be lodged with the chairman of the meeting of the Directors at which such proxy is to be used, or first used, prior to the commencement of the meeting.

POWERS AND DUTIES OF DIRECTORS

89. Subject to the provisions of the Companies Law, these Articles and to any resolutions made in a general meeting, the business of the Company shall be managed by the Directors, who may pay all expenses incurred in setting up and registering the Company and may exercise all powers of the Company. No resolution made by the Company in a general meeting shall invalidate any prior act of the Directors that would have been valid if that resolution had not been made.

90. Subject to these Articles, the Directors may from time to time appoint any person, whether or not a director of the Company to hold such office in the Company as the Directors may think necessary for the administration of the Company, including without prejudice to the foregoing generality, the office of the Chief Executive Officer, one or more Vice Presidents, Chief Financial Officer, Manager or Controller, and for such term and at such remuneration (whether by way of salary or commission or participation in profits or partly in one way and partly in another), and with such powers and duties as the Directors may think fit. The Directors may also appoint one or more of their number to the office of Managing Director upon like terms, but any such appointment shall ipso facto determine if any Managing Director ceases from any cause to be a Director, or if the Company by Ordinary Resolution resolves that his tenure of office be terminated.

91. The Directors may delegate any of their powers to committees consisting of such member or members of their body as they think fit; any committee so formed shall in

17

the exercise of the powers so delegated conform to any regulations that may be imposed on it by the Directors.

92. The Directors may from time to time and at any time by power of attorney appoint any company, firm or person or body of persons, whether nominated directly or indirectly by the Directors, to be the attorney or attorneys of the Company for such purposes and with such powers, authorities and discretion (not exceeding those vested in or exercisable by the Directors under these Articles) and for such period and subject to such conditions as they may think fit, and any such power of attorney may contain such provisions for the protection and convenience of persons dealing with any such attorney as the Directors may think fit, and may also authorise any such attorney to delegate all or any of the powers, authorities and discretion vested in him.

93. The Directors may from time to time provide for the management of the affairs of the Company in such manner as they shall think fit and the provisions contained in the following paragraphs shall be without prejudice to the general powers conferred by this paragraph.

94. The Directors from time to time and at any time may establish any committees, local boards or agencies for managing any of the affairs of the Company and may appoint any persons to be members of such committees or local boards and may appoint any managers or agents of the Company and may fix the remuneration of any of the aforesaid.

95. The Directors from time to time and at any time may delegate to any such committee, local board, manager or agent any of the powers, authorities and discretions for the time being vested in the Directors and may authorise the members for the time being of any such local board, or any of them to fill up any vacancies therein and to act notwithstanding vacancies and any such appointment or delegation may be made on such terms and subject to such conditions as the Directors may think fit and the Directors may at any time remove any person so appointed and may annul or vary any such delegation, but no person dealing in good faith and without notice of any such annulment or variation shall be affected thereby.

96. Any such delegates as aforesaid may be authorized by the Directors to subdelegate all or any of the powers, authorities, and discretions for the time being vested to them.

97. The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its undertaking, property and uncalled capital or any part thereof, to issue debentures, debenture stock and other securities whenever money is borrowed or as security for any debt, liability or obligation of the Company or of any third party.

DISQUALIFICATION OF DIRECTORS

98. Subject to Article 80, the office of Director shall be vacated, if the Director:

(a) becomes bankrupt or makes any arrangement or composition with his creditors;

(b) is found to be or becomes of unsound mind;

(c) resigns his office by notice in writing to the Company;

18

(d) without special leave of absence from the Board, is absent from meetings of the Board for six consecutive months and the Board resolves that his office be vacated; or

(e) if he or she shall be removed from office pursuant to these Articles or the Statutes.

PROCEEDINGS OF DIRECTORS

99. Subject to Article 80, the Directors may meet together (whether within or outside the Cayman Islands) for the dispatch of business, adjourn, and otherwise regulate their meetings and proceedings as they think fit. Questions arising at any meeting of the Directors shall be decided by a majority of votes. In case of an equality of votes the chairman shall not have a second or casting vote. A Director may at any time summon a meeting of the Directors by at least three Business Days' notice to every other Director and alternate Director.

100. A Director or Directors may participate in any meeting of the Board of Directors, or of any committee appointed by the Board of Directors of which such Director or Directors are members, by means of telephone or similar communication equipment by way of which all persons participating in such meeting can hear each other and such participation shall be deemed to constitute presence in person at the meeting.

101. The quorum necessary for the transaction of the business of the Directors may be fixed by the Directors and unless so fixed shall be a majority of the Directors then in office, provided that a Director and his appointed alternate Director shall be considered only one person for this purpose. A meeting of the Directors at which a quorum is present when the meeting proceeds to business shall be competent to exercise all powers and discretions for the time being exercisable by the Directors. A meeting of the Directors may be held by means of telephone or teleconferencing or any other telecommunications facility provided that all participants are thereby able to communicate immediately by voice with all other participants.

102. Subject to Article 80, a Director who is in any way, whether directly or indirectly, interested in a contract or proposed contract with the Company shall declare the nature of his interest at a meeting of the Directors. A general notice given to the Directors by any Director to the effect that he is a member of any specified company or firm and is to be regarded as interested in any contract which may thereafter be made with that company or firm shall be deemed a sufficient declaration of interest in regard to any contract so made. A Director may vote in respect of any contract or proposed contract or arrangement notwithstanding that he may be interested therein and if he does so his vote shall be counted and he may be counted in the quorum at any meeting of the Directors at which any such contract or proposed contract or arrangement shall come before the meeting for consideration.

103. A Director may hold any other office or place of profit under the Company (other than the office of auditor) in conjunction with his office of Director for such period and on such terms (as to remuneration and otherwise) as the Directors may determine and no Director or intending Director shall be disqualified by his office from contracting with the Company either with regard to his tenure of any such other office or place of profit or as vendor, purchaser or otherwise, nor shall any such contract or arrangement

19

entered into by or on behalf of the Company in which any Director is in any way interested, be liable to be avoided, nor shall any Director so contracting or being so interested be liable to account to the Company for any profit realised by any such contract or arrangement by reason of such Director holding that office or of the fiduciary relation thereby established. A Director, notwithstanding his interest, may be counted in the quorum present at any meeting whereat he or any other Director is appointed to hold any such office or place of profit under the Company or whereat the terms of any such appointment are arranged and he may vote on any such appointment or arrangement.

104. Any Director may act by himself or his firm in a professional capacity for the Company, and he or his firm shall be entitled to remuneration for professional services as if he were not a Director; provided that nothing herein contained shall authorise a Director or his firm to act as auditor to the Company.

105. The Directors shall cause minutes to be made in books or loose-leaf folders provided for the purpose of recording:

(a) all appointments of officers made by the Directors;

(b) the names of the Directors present at each meeting of the Directors and of any committee of the Directors; and

(c) all resolutions and proceedings at all meetings of the Company, and of the Directors and of committees of Directors.

106. When the chairman of a meeting of the Directors signs the minutes of such meeting the same shall be deemed to have been duly held notwithstanding that all the Directors have not actually come together or that there may have been a technical defect in the proceedings.

107. A resolution signed by all the Directors shall be as valid and effectual as if it had been passed at a meeting of the Directors duly called and constituted. When signed a resolution may consist of several documents each signed by one or more of the Directors.

108. The continuing Directors may act notwithstanding any vacancy in their body but if and so long as their number is reduced below the number fixed by or pursuant to these Articles as the necessary quorum of Directors, the continuing Directors may act for the purpose of increasing the number, or of summoning a general meeting of the Company, but for no other purpose.

109. The Directors shall elect a chairman of their meetings and determine the period for which he is to hold office but if at any meeting the chairman is not present within fifteen minutes after the time appointed for holding the same, the Directors present may choose one of their number to be chairman of the meeting.

110. A committee appointed by the Directors may elect a chairman of its meetings. If no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time appointed for holding the same, the members present may choose one of their number to be chairman of the meeting.

20

111. A committee appointed by the Directors may meet and adjourn as it thinks proper. Questions arising at any meeting shall be determined by a majority of votes of the committee members present and in case of an equality of votes the chairman shall have a second or casting vote.

112. All acts done by any meeting of the Directors or of a committee of Directors, or by any person acting as a Director, shall notwithstanding that it be afterwards discovered that there was some defect in the appointment of any such Director or person acting as aforesaid, or that they or any of them were disqualified, be as valid as if every such person had been duly appointed and was qualified to be a Director.

PRESUMPTION OF ASSENT

113. A Director of the Company who is present at a meeting of the Board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless his dissent shall be entered in the Minutes of the meeting or unless he shall file his written dissent from such action with the person acting as the Chairman or Secretary of the meeting before the adjournment thereof or shall forward such dissent by registered post to such person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director who voted in favour of such action.

DIVIDENDS, DISTRIBUTIONS AND RESERVE

114. Subject to any rights and restrictions for the time being attached to any class or classes of shares and these Articles, the Directors may from time to time declare dividends (including interim dividends) and other distributions on shares in issue and authorise payment of the same out of the funds of the Company lawfully available therefor.

115. Subject to any rights and restrictions for the time being attached to any class or classes of shares and these Articles, the Company by Ordinary Resolution may declare dividends, but no dividend shall exceed the amount recommended by the Directors.

116. The Directors may, before recommending or declaring any dividend, set aside out of the funds legally available for distribution such sums as they think proper as a reserve or reserves which shall, at the discretion of the Directors be applicable for meeting contingencies, or for equalising dividends or for any other purpose to which those funds be properly applied and pending such application may, at the like discretion, either be employed in the business of the Company or be invested in such investments (other than shares of the Company) as the Directors may from time to time think fit.

117. Any dividend may be paid by cheque or wire transfer to the registered address of the Member or person entitled thereto, or in the case of joint holders, to any one of such joint holders at his registered address or to such person and such address as the Member or person entitled, or such joint holders as the case may be, may direct. Every such cheque shall be made payable to the order of the person to whom it is sent or to the order of such other person as the Member or person entitled, or such joint holders as the case may be, may direct.

21

118. The Directors when paying dividends to the Members in accordance with the foregoing provisions may make such payment either in cash or in specie.

119. No dividend shall be paid otherwise than out of profits or, subject to the restrictions of the Companies Law, the share premium account.

120. Subject to the rights of persons, if any, entitled to shares with special rights as to dividends, all dividends shall be declared and paid according to the amounts paid or credited as fully paid on the shares, but if and so long as nothing is paid up on any of the shares in the Company dividends may be declared and paid according to the amounts of the shares. No amount paid on a share in advance of calls shall, while carrying interest, be treated for the purposes of this Article as paid on the share.

121. If several persons are registered as joint holders of any share, any of them may give effectual receipts for any dividend or other moneys payable on or in respect of the share.

122. No dividend shall bear interest against the Company.

BOOK OF ACCOUNTS

123. The books of account relating to the Company's affairs shall be kept in such manner as may be determined from time to time by the Directors.

124. The books of account shall be kept at such place or places as the Directors think fit, and shall always be open to the inspection of the Directors.

125. The Directors shall from time to time determine whether and to what extent and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors, and no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by law or authorized by the Directors or by the Company by Ordinary Resolution.

126. The accounts relating to the Company's affairs shall be audited in such manner and with such financial year end as may be determined from time to time by the Company by Ordinary Resolution or failing any such determination by the Directors or failing any determination as aforesaid shall not be audited.

ANNUAL RETURNS AND FILINGS

127. The Board shall make the requisite annual returns and any other requisite filings in accordance with the Companies Law.

AUDIT

128. The Directors may appoint an Auditor of the Company who shall hold office until removed from office by a resolution of the Directors and may fix his or their remuneration.

129. Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers of the Company and shall be entitled to require from the

22

Directors and Officers of the Company such information and explanation as may be necessary for the performance of the duties of the auditors.

130. Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an ordinary company, and at the next special meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an exempted company, and at any time during their term of office, upon request of the Directors or any general meeting of the Members.

THE SEAL

131. The Seal of the Company shall not be affixed to any instrument except by the authority of a resolution of the Board of Directors provided always that such authority may be given prior to or after the affixing of the Seal and if given after may be in general form confirming a number of affixings of the Seal. The Seal shall be affixed in the presence of any one or more persons as the Directors may appoint for the purpose and every person as aforesaid shall sign every instrument to which the Seal of the Company is so affixed in their presence.

132. The Company may maintain a facsimile of its Seal in such countries or places as the Directors may appoint and such facsimile Seal shall not be affixed to any instrument except by the authority of a resolution of the Board of Directors provided always that such authority may be given prior to or after the affixing of such facsimile Seal and if given after may be in general form confirming a number of affixings of such facsimile Seal. The facsimile Seal shall be affixed in the presence of such person or persons as the Directors shall for this purpose appoint and such person or persons as aforesaid shall sign every instrument to which the facsimile Seal of the Company is so affixed in their presence of and the instrument signed by a Director or the Secretary (or an Assistant Secretary) of the Company or in the presence of any one or more persons as the Directors may appoint for the purpose.

133. Notwithstanding the foregoing, a Director shall have the authority to affix the Seal, or the facsimile Seal, to any instrument for the purposes of attesting authenticity of the matter contained therein but which does not create any obligation binding on the Company.

OFFICERS

134. Subject to Article 90, the Company may have a Chief Executive Officer, Chief Operating Officer and Chief Financial Officer, one or more Vice Presidents, Manager or Controller, appointed by the Directors. The Directors may also from time to time appoint such other officers as they consider necessary, all for such terms, at such remuneration and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors from time to time subscribe.

CAPITALISATION OF PROFITS

135. Subject to the Statutes and these Articles, the Board may, with the authority of an Ordinary Resolution:

23

(a) resolve to capitalise an amount standing to the credit of reserves (including a share premium account, capital redemption reserve and profit and loss account), whether or not available for distribution;

(b) appropriate the sum resolved to be capitalised to the Members in proportion to the nominal amount of shares (whether or not fully paid) held by them respectively and apply that sum on their behalf in or towards:

(i) paying up the amounts (if any) for the time being unpaid on shares held by them respectively; or

(ii) paying up in full unissued shares or debentures of a nominal amount equal to that sum,

and allot the shares or debentures, credited as fully paid, to the Members (or as they may direct) in those proportions, or partly in one way and partly in the other, but the share premium account, the capital redemption reserved and profits which are not available for distribution may, for the purposes of this Article, only be applied in paying up unissued shares to be allotted to Members credited as fully paid;

(c) make any arrangements it thinks fit to resolve a difficulty arising in the distribution of a capitalised reserve and in particular, without limitation, where shares or debentures become distributable in fractions the Board may deal with the fractions as it thinks fit;

(d) authorise a person to enter (on behalf of all the Members concerned) an agreement with the Company providing for either:

(i) the allotment to the Members respectively, credited as fully paid, of shares or debentures to which they may be entitled on the capitalisation, or

(ii) the payment by the Company on behalf of the Members (by the application of their respective operations of the reserves resolved to be capitalised) of the amounts or part of the amounts remaining unpaid on their existing shares,

an agreement made under the authority being effective and binding on all those Members; and

(e) generally do all acts and things required to give effect to the resolution.

NOTICES

136. Except as otherwise provided in these Articles, any notice or document may be served by the Company or by the person entitled to give notice to any Member either personally, by facsimile or by sending it through the post in a prepaid letter or via a recognised courier service, fees prepaid, addressed to the Member at his address as appearing in the Register of Members or, to the extent permitted by all applicable laws and regulations, by electronic means by transmitting it to any electronic number or address or website supplied by the member to the Company or by placing it on the

24

Company's Website. In the case of joint holders of a share, all notices shall be given to that one of the joint holders whose name stands first in the Register of Members in respect of the joint holding, and notice so given shall be sufficient notice to all the joint holders.

137. Notices posted to addresses outside the Cayman Islands shall be forwarded by prepaid airmail.

138. Any Member present, either personally or by proxy, at any meeting of the Company shall for all purposes be deemed to have received due notice of such meeting and, where requisite, of the purposes for which such meeting was convened.

139. Any notice or other document, if served by (a) post, shall be deemed to have been served five calendar days after the time when the letter containing the same is posted and if served by courier, shall be deemed to have been served five calendar days after the time when the letter containing the same is delivered to the courier (in proving such service it shall be sufficient to prove that the letter containing the notice or document was properly addressed and duly posted or delivered to the courier), or (b) facsimile, shall be deemed to have been served upon confirmation of receipt, or (c) recognised delivery service, shall be deemed to have been served 48 hours after the time when the letter containing the same is delivered to the courier service and in proving such service it shall be sufficient to provide that the letter containing the notice or documents was properly addressed and duly posted or delivered to the courier or (d) electronic means as provided herein shall be deemed to have been served and delivered on the day following that on which it is successfully transmitted or at such later time as may be prescribed by any applicable laws or regulations.

140. Any notice or document delivered or sent to any Member in accordance with the terms of these Articles shall notwithstanding that such Member be then dead or bankrupt, and whether or not the Company has notice of his death or bankruptcy, be deemed to have been duly served in respect of any share registered in the name of such Member as sole or joint holder, unless his name shall at the time of the service of the notice or document, have been removed from the Register of Members as the holder of the share, and such service shall for all purposes be deemed a sufficient service of such notice or document on all persons interested (whether jointly with or as claiming through or under him) in the share.

141. Notice of every general meeting shall be given to:

(a) all Members who have supplied to the Company an address for the giving of notices to them;

(b) every person entitled to a share in consequence of the death or bankruptcy of a Member, who but for his death or bankruptcy would be entitled to receive notice of the meeting; and

(c) each Director and Alternate Director.

No other person shall be entitled to receive notices of general meetings.

INFORMATION

25

142. No Member shall be entitled to require discovery of any information in respect of any detail of the Company's trading or any information which is or may be in the nature of a trade secret or secret process which may relate to the conduct of the business of the Company and which in the opinion of the Board would not be in the interests of the members of the Company to communicate to the public.

143. The Board shall be entitled to release or disclose any information in its possession, custody or control regarding the Company or its affairs to any of its members including, without limitation, information contained in the Register of Members and transfer books of the Company.

INDEMNITY

144. Every Director (including for the purposes of this Article any Alternate Director appointed pursuant to the provisions of these Articles) and officer of the Company for the time being and from time to time shall be indemnified and secured harmless out of the assets and funds of the Company against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by him in connection with the execution or discharge of his duties, powers, authorities or discretions as a Director or officer of the Company, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by him in defending (whether successfully or otherwise) any civil proceedings concerning the Company or its affairs in any court whether in the Cayman Islands or elsewhere.

145. No such Director or officer of the Company shall be liable to the Company for any loss or damage unless such liability arises through the willful neglect or default of such Director or officer.

FINANCIAL YEAR

146. Unless the Directors otherwise prescribe, the financial year of the Company shall end on December 31st in each year and shall begin on January 1st in each year.

WINDING UP

147. Subject to these Articles, if the Company shall be wound up the liquidator may, with the sanction of an Ordinary Resolution of the Company divide amongst the Members in specie or kind the whole or any part of the assets of the Company (whether they shall consist of property of the same kind or not) and may, for such purpose set such value as he deems fair upon any property to be divided as aforesaid and may determine how such division shall be carried out as between the Members or different classes of Members. The liquidator may, with the like sanction, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the contributories as the liquidator, with the like sanction shall think fit, but so that no Member shall be compelled to accept any shares or other securities whereon there is any liability.

AMENDMENT OF MEMORANDUM AND ARTICLES OF ASSOCIATION AND NAME OF COMPANY

148. Subject to the Companies Law and these Articles, the Company may at any time and from time to time by Special Resolution alter or amend these Articles or the

26

Memorandum of Association of the Company, in whole or in part, or change the name of the Company.

REGISTRATION BY WAY OF CONTINUATION

149. Subject to these Articles, the Company may by Special Resolution resolve to be registered by way of continuation in a jurisdiction outside the Cayman Islands or such other jurisdiction in which it is for the time being incorporated, registered or existing. In furtherance of a resolution adopted pursuant to this Article, the Directors may cause an application to be made to the Registrar of Companies to deregister the Company in the Cayman Islands or such other jurisdiction in which it is for the time being incorporated, registered or existing and may cause all such further steps as they consider appropriate to be taken to effect the transfer by way of continuation of the Company.

27

.

.
.

EXHIBIT 4.2

Name of Company:                                                 AGRIA CORPORATION
AGRIA CORPORATION                             (Incorporated under the laws of the Cayman Islands)

Number:
                     Number                                                                            Ordinary Shares
Ordinary Shares:     [    ]                                                                                 -[      ]-
-[    ]-                                                     US$50,000 Share Capital divided into
                                        500,000,000,000 Ordinary Shares of a nominal or par value of US$0.0000001 each
Issued to:
[         ]          THIS IS TO CERTIFY THAT------------------[           ]------------------is the registered holder
                     of----------------------------------------[         ]-------------------- Ordinary Shares in the
Dated                above-named Company subject to the memorandum and articles of association thereof.
[           ]
                     GIVEN UNDER the common seal of the said Company on                                     2007.
Transferred from:
                     THE COMMON SEAL of the said Company was hereunto affixed in the presence of:

                                                                    DIRECTOR _________________________________________


        TRANSFER

I                                                         (the Transferor) for the value received

DO HEREBY transfer to                                                        (the Transferee) the

                                                                shares standing in my name in the

undertaking called AGRIA CORPORATION

To hold the same unto the Transferee

Dated

Signed by the Transferor

in the presence of:


------------------------------------                          ------------------------------------
Witness                                                       Transferor


EXHIBIT 4.4

TRANSLATED FOR REFERENCE ONLY.

EXCLUSIVE TECHNOLOGY DEVELOPMENT, TECHNOLOGY SUPPORT AND
TECHNOLOGY SERVICES AGREEMENT

This "Exclusive Technology Development, Technology Support and Technology Services Agreement" (hereinafter referred to as "this Agreement") is signed by the following parties on 8 June 2007 in Beijing:

Party A: Aero-Biotech Science & Technology Co., Ltd.
Domicile: A333, 6th Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing

Party B: Primalights III Agriculture Development Co., Ltd.
Domicile: Middle Area of Highway 73, Zhuang Er Shang Village, Huanglingxiang Upper Village, Xiaodian District, Taiyuan City

WHEREAS,

(1) Party A is a wholly foreign owned enterprise duly established and registered according to the laws of People's Republic of China (hereinafter referred to as "China", in this Agreement, excluding Hong Kong Special Administrative Region, Macao Special Administrative Regions and Taiwan), its scope of business include:
research and development of biotechnology in seed growing, provide technology transfer, technical consulting, technical service and technical training in seed growing, possessing the professional staff who specialized in agricultural seed growing development technology with practical experience.

(2) Party B is a limited liability company established and registered in accordance with Chinese law in Taiyuan City, Shanxi Province, China. Its business scope includes automation control greenhouse construction; yield farmland development; demonstration plots; corn seed production; crop seeds wholesale and retail; seedling seed production and wholesale and retail; livestock; processing and marketing of agricultural side products.

(3) Party A agrees to provide exclusive technology development and related services to Party B. Party B agrees to accept such services from Party A.

NOW, THEREFORE, the parties to this Agreement, by consensus, reached this Agreement as follows:

1. EXCLUSIVE CONSULTANCY AND SERVICES; MONOPOLIZED AND EXCLUSIVE INTERESTS

1.1 During the term of this Agreement, Party A agrees to act as the exclusive technology development, consulting and services provider, pursuant to the terms and condition under this Agreement, to the extent permitted under Chinese laws, to provide Party B the technology development, technical support and the related technical services, including but not limited to :

(1) conduct research and development in biotechnology of seed growing deputed by Party B;

(2) provide technical support to Party B as required;

(3) provide regular or ad hoc technology consulting services to Party B (including but not limited to provide feasibility discussion session, technology forecast, specific technology investigation, analysis evaluation report);

(4) conduct technical training for Party B's personnel;


(5) provide on-site technology guidance to Party B when Party B needs to hire relevant technology personnel;

(6) assist Party B to carry out technology promotion, etc.

1.2 Party B agrees to accept the technology development, technical support and related technical services provided by Party A, and Party B further agrees that, unless with prior written consent of Party A, in this Agreement period, Party B shall not accept any or part of the technology development, technical support and services in connection with the abovementioned business provided by any third party.

1.3 Party B should promptly provide to Party A the plans and arrangement required for technology development, technical support or technical service.

2. CALCULATION, PAYMENT AND SECURITY OF TECHNOLOGY DEVELOPMENT AND SERVICE FEES
(HEREINAFTER REFERRED TO AS "TECHNOLOGY SERVICES FEES")

2.1 Both parties agree to calculate and pay the technical services fee under this Agreement in accordance with the calculation formula and payment method listed in Annex 1 hereto.

2.2 Both parties shall be responsible to pay their respective taxes payable in accordance with the laws for signing or performing this Agreement. Party B, at the request of Party A, shall make every effort to assist Party A to acquire the sales tax exemption treatment in connection with all or part of the technical service income under this Agreement, including but not limited to, the provision of relevant documents and written agreements, in the format complied with the requirements of the relevant science and technology authority department, entered by Party A from time to time in connection with the scope of certain services hereunder, but the execution of such documents shall be subjected to the following conditions : (1) the provisions of such written agreement shall be consistent with this Agreement in principle, and that it shall not contradict with the provisions of this Agreement; and (2) the signing of such documents shall not in violation of the laws and regulations.

2.3 The Technology Service Fees payable under this Agreement shall be secured by the shareholders of Party B pledging its equity shares in Party B.

3. INTELLECTUAL PROPERTY

3.1 Except it is otherwise stipulated by the laws and regulations in China, the technology and the information developed and prepared by Party A for Party B during the course of providing technical development and technical services, and the intellectual property rights and any derivatives of the rights that Party A acquired under the performance of this Agreement and / or other jointly signed contract for the research and development shall be exclusively owned by Party A. These rights include, but are not limited to the right of patent application, ownership of proprietary technology, technical documentation and technical information of copyright or other intellectual property rights, rights to given license to others to use such intellectual property rights or to transfer such intellectual property rights.

3.2 During the course of performing this Agreement, if Party B needs to use proprietary technologies of Party A, both parties shall enter into another contract to stipulate the scope, manner and license fees of using the related exclusive technology license.

4. REPRESENTATION AND WARRANTY

4.1 Party A hereby represent and warrants as follows:


4.1.1 Party A is a wholly foreign-owned enterprises legitimately registered, established and validly existing in accordance with Chinese laws;

4.1.2 Party A executes and performs this Agreement within the power and business scope of the company, with the necessary and appropriate corporate action and authorization, and obtained the necessary consent and approval of the government and third-party, and that it is not in violation of the restrictions or limitations under the laws and contracts binding or influential to it;

4.1.3 Once this Agreement is signed, it constitutes legal, valid, binding and enforceable obligations to Party A under the provisions of this Agreement.

4.2 Party B represents and warrants as follows:

4.2.1 Party B is a limited liability company legitimately registered, established and validly existing in accordance with Chinese laws. Its main business is agricultural forestry species development and production;

4.2.2 Party B executes and performs this Agreement within the power and business scope of the company, with the necessary and appropriate corporate action and duly authorization, and obtained the necessary consent and approval of the government and third-party, and that it is not in violation of the restrictions or limitations under the laws and contracts binding or influential to it;

4.2.3 Once this Agreement is signed, it constitutes legal, valid, binding and enforceable obligations to Party B under the provisions of this Agreement.

5. CONFIDENTIALITY

5.1 Party B agrees to make every effort to adopt all reasonable measures to protect Party A's confidential material and information (hereinafter referred to as "Confidential Information") that are known to or accessible by Party B because of the acceptance of the exclusive technology development, technology support and technology services by Party B; without the prior written consent of Party A, Party B shall not disclose, give or transfer such Confidential Information to any third party. Once this Agreement is terminated, Party B shall, at the request of Party A, return or destroy any document, information or software containing Confidential Information and delete any Confidential Information from all relevant memory device. Party B shall stop using such Confidential Information.

5.2 The parties acknowledge and confirm that any oral or written information exchanged between the parties in connection with this Agreement is confidential information. Without the written consent of the other party, both parties shall keep confidential all such information, a party shall not disclose any relevant information to any third parties, except under the following circumstances : (a) the public knows or will know such information (which is not disclosed by the information receiving party without authorization); (b) the disclosure of the information is required by the applicable laws or stock exchange rules or regulations; or (c) disclosure to the legal or financial advisors of either party in connection with the transaction described in this Agreement, and such legal or financial advisors shall comply with the similar duty of confidentiality as this provision. Any confidential information disclosed by the employees of either party or by an organization engaged by either party shall be deemed as the disclosure of such party. Such party shall assume the default responsibilities in accordance with this Agreement.

5.3 Both parties agree that regardless of whether this Agreement is invalid, modified, cancelled, terminated or non-operational, this Article 5 shall remain in effect.


6. INDEMNIFICATION

Party B should indemnify Party A for any loss, damages, obligations and costs arising from any legal action, claim or other requests as a result of Party B's consulting request and content of services, and Party B shall keep Party A harmless.

7. EFFECTIVENESS AND TERM

7.1 This Agreement shall be effective on the date written on the first page.

7.2 This Agreement shall remain effective within the operating period of Party B unless it is early terminated by the provisions of another relevant contract entered separately by both parties or by this Agreement.

8. TERMINATION

8.1 EARLY TERMINATION. During the effective term of this Agreement, unless Party A commits gross negligence, fraud, other violations of law or bankruptcy, Party B shall not early terminate this Agreement. Notwithstanding the aforesaid covenant, Party A shall have the right to terminate this Agreement at any time by giving a thirty (30) days prior written notice to Party B. During the term of this Agreement, if Party B violates this Agreement and fails to remedy such default within fourteen (14) days after receiving a written notice of default from Party A, Party A can terminate this Agreement by serving a written notice to Party B.

8.2 PROVISIONS AFTER TERMINATION. After the termination of this Agreement, the rights and obligations of both parties provided in Articles 5, 10 and 12 under this Agreement shall remain in effect.

9. GOVERNING LAW

The validity, performance, interpretation and enforceability of this Agreement shall be governed by Chinese laws.

10. DISPUTE RESOLUTION

When any dispute arises in connection with the interpretation and performance of the provisions under this Agreement, both parties shall resolve the dispute through friendly consultation. If resolution cannot be reached within thirty
(30) days after the request to resolve the dispute is made by a party, eithery party may submit such dispute to China International Economic and Trade Arbitration Commission for arbitration in accordance with its then effective arbitration rules. The arbitration venue shall be in Beijing; the language to conduct the arbitration is Chinese. The arbitral award shall be final and binding upon both parties.

11. FORCE MAJEURE

11.1 "Force majeure" refers to any event that is beyond the reasonable control of a party, it is unavoidable even under reasonable attention of the affected party, including but not limited to, acts of government, acts of nature, fire, explosion, typhoon, flood, earthquake, tidal, lightning or war. However, credit, capital or financing shortage shall not be deemed as matters beyond the party's reasonable control. The party, affected by "force majeure", seeks to be exempted from performing its responsibilities under this Agreement, shall promptly notify the other party regarding such responsibilities exemption matter and let the other party know the steps required in order to complete its performance.


11.2 When the performance of this Agreement is delayed or prevented due to the aforementioned definition of the "force majeure", the affected party shall not assume any responsibility under this Agreement to the extent that it is within the scope of the delay or prevention. The affected party shall take appropriate measures to minimize or eliminate the impact of "force majeure" and take the effort to resume performance of the obligation delayed or prevented by the event of "force majeure". Once the event of "force majeure" is removed, both parties agree to resume the performance of this Agreement with their greatest efforts.

12. NOTICE

Notices or other communications required to be given by either party under this Agreement shall be written in English or Chinese and shall be delivered by hand delivery, registered mail, postage prepaid mail, or recognized courier service or facsimile to the following address of the relevant party or parties or to the other address notified by one party to the other party from time to time or to the address of another person it designated. The actual date when a notice is deemed delivered shall be determined in accordance with the following method:
(a) notice delivered by hand delivery, the date when the hand delivery is made;
(b) if the notice is sent by mail, on the tenth (10th) day after the date of posting (as indicated by postmark) of air registered mail (postage prepaid) or if it is send by courier service, on the fourth (4th) day after it is being delivered to an internationally recognized courier service; and (c) if a notice is sent by facsimile, the receiving time as shown on the transmission confirmation of the relevant documents is regarded as the actual time delivered.

Party A: Aero-Biotech Science & Technology Co., Ltd.
Address: A333, 6th Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing
Attention: Qian Zhaohua
Fax: 010-62109899
Tel: 010 - 62109288
Postal code: 100081

Party B: Primalights III Agriculture Development Co., Ltd.
Address: Middle Area of Highway 73, Zhuang Er Shang Village, Huanglingxiang Upper Village, Xiaodian District, Taiyuan City Attention: Han Zhonglin
Fax: 0351-7123671
Tel: 0351 - 7870123
Postal Code: 030031

13. ASSIGNMENT

13.1 Party B shall not transfer its rights and undertaking of obligations under this Agreement to any third party without Party A's prior written consent.

13.2 Party B hereby agrees, under permission of Chinese law, Party A may transfer its rights and obligations under this Agreement to other third party when necessary. Party A just needs to notify Party B by written notice when the transfer occurs, no need to ask Party B's consent on such transfers.


14. INTEGRITY

Both parties confirm, once this Agreement becomes effective, it shall constitute the entire agreement and understanding between the parties regarding the contents of this Agreement. It shall supersede all prior oral and / or written agreements and understanding reached by the parties related to the content of this Agreement.

15. SEVERABILITY

If any provision of this Agreement is held invalid or unenforceable due to the inconsistency with the relevant law, then such provision shall be deemed invalid only to the extent within the scope of the related jurisdiction and that it shall not affect the legal effect of the other provisions in this Agreement.

16. AMENDMENT AND SUPPLEMENT

Both parties shall amend and supplement this Agreement by the form of a written contract. Through the proper execution of the relevant amendment agreement and supplemental agreement by the parties, such amendment and supplement agreement shall become an integral part of this Agreement with the same legal effect as this Agreement.

17. COUNTERPART

There are two original copies of this Agreement, each party hold one original copy, each original copy shall have the same legal effect.

IN WITNESS WHEREOF, the parties have caused their legal representatives, or their authorized representatives to sign this Agreement on the date first above written.


[No text in this page.]

Party A : Aero-Biotech Science & Technology Co., Ltd.

Legal Representative / Authorized Representatives: /s/ Qian Zhaohua
                                                   -----------------------------

Common seal : [Seal: Aero-Biotech Science & Technology Co., Ltd.]

Party B : Primalights III Agriculture Development Co., Ltd.

Legal Representative / Authorized Representatives: /s/ Zhang Mingshe
                                                   -----------------------------

Common seal : [Seal: Primalights III Agriculture Development Co., Ltd.]


Annex 1 : The calculation and payment method of technical services fee

1. Formula for calculation

Both parties agree that Party B shall pay 20% after-tax profits of each fiscal year as the annual Technology Service Fee.

If Party A's last year technical services period is less than one year, technical services fee shall be calculated in accordance with the following formula:

Annual fee for last year's technical services = The annual after-tax profit of such year x number of months of Party A's technical services / 12

In spite of the above, both parties agree the technical services fee for the year of 2007 shall be 20% of the after-tax profits of the second half of the year 2007.

2. Payment method

Every fiscal year Party A shall issue a settlement statement to Party B, according to the content of the services provided to Party B, and submit to Party B in writing for verification and confirmation. Party B shall pay the Technology Service Fees to Party A's designated account before April 30 annually. After the payable amount is transmitted, Party B shall facsimile or mail a copy of the remittance voucher to Party A.

3. Adjustment mechanism

If Party A deems that the pricing mechanism stipulated herein is inapplicable for some reason and that the pricing mechanism needs to be adjusted. Party A should negotiate with Party B actively and in good faith to determine a new standard or mechanism of charges, within [7] working days after Party A's written request for such adjustment.


EXHIBIT 4.5

TRANSLATED FOR REFERENCE ONLY.

EXCLUSIVE CONSULTANCY SERVICE AGREEMENT

This "Exclusive Consultancy Service Agreement" (hereinafter referred to as "this Agreement") is entered into by and between the following parties on June 8, 2007 in Beijing:

Party A: Aero-Biotech Science & Technology Co., Ltd.

Domicile: Unit A333, 6th /Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing

Party B: Primalights III Agriculture Development Co., Ltd.

Domicile: Middle Area of Highway 73, Zhuangershang Upper Village, Huangling Rural, Xiaodian District, Taiyuan City

WHEREAS:

(1) Party A is a wholly foreign owned enterprise established and registered in Beijing in accordance with laws of the People's Republic of China (hereinafter referred to as "China", in this Agreement, excluding Hong Kong Special Administrative Region, Macao Special Administrative Regions and Taiwan).

(2) Party B is a limited liability company established and registered in Taiyuan City, Shanxi Province of China under Chinese laws. Its scope of business includes automation control greenhouse construction, yield farmland development; demonstration plots set up, corn seed production; crop seeds wholesale and retail, seedling seed production, wholesale and retail, livestock, processing and marketing of agricultural and sideline products.

(3) Party A agrees to provide under this Agreement consulting services to Party B and Party B agrees to accept such consulting services from Party A.

NOW, THEREFORE, the parties to the Agreement, by consensus, reached this Agreement as follows:

1. EXCLUSIVE CONSULTANCY AND SERVICES; MONOPOLIZED AND EXCLUSIVE INTERESTS

1.1 During the term of this Agreement, Party A agrees, in accordance with the terms and conditions of this Agreement, to provide to Party B the exclusive consultancy services in the aspect of management, marketing promotion and sales, including, but not limited to:

(1) assist Party B to formulate the management model and operational plan of the company;

(2) assist Party B to formulate the marketing development plan;

(3) provide marketing and client resources information to Party B;

(4) conduct specific marketing research and survey;

(5) assist Party B to establish a sales and marketing network.

1.2 Party B agreed to accept the consulting services rendered by Party A. Party B further agrees that unless with a prior written consent of Party A, during the term of this Agreement, Party B shall not accept professional consulting and services provided by any third party.


2. CALCULATION, PAYMENT AND SECURITY OF CONSULTING SERVICE

2.1 Both parties agree to calculate and pay the consulting service fee under this Agreement according to Annex 1.

2.2 Both parties shall be responsible to pay their respective taxes for executing and performing this Agreement as legally required.

2.3 The fee of consulting services under this Agreement is secured by the shareholders of Party B pledging its equity held in Party B.

3. REPRESENTATION AND WARRANTY

3.1 Party A hereby represents and warrants as follows:

3.1.1 Party A is a wholly foreign-owned enterprises legitimately registered, established and validly existing in accordance with Chinese laws ;

3.1.2 Party A executes and performs this Agreement within the power and business scope of the company, with the necessary and appropriate corporate action and authorization, and obtained the necessary approval and consent of the government and third-party, and that this Agreement is not in violation of the restrictions or limitation under the laws and contracts binding or influential to it;

3.1.3 Once this Agreement is signed, it constitutes legal, valid, binding and enforceable obligations to Party A under the provisions of this Agreement.

3.2 Party B hereby represents and warrants as follows:

3.2.1 Party B is a limited liability company legitimately registered, established and validly existing in accordance with Chinese laws;

3.2.2 Party B performs and executes this Agreement within the power and business scope of the company, with the necessary and appropriate corporate action and authorization, and obtained the necessary approval and consent of the government and third-party, and that it is not in violation of the restriction and limitations under the laws and contracts binding or influential to it;

3.2.3 Once this Agreement is signed, it constitutes legal, valid, binding and enforceable obligations to Party B under the provisions of this Agreement.

4. CONFIDENTIALITY

Both parties hereto acknowledge and confirm that any oral or written information exchanged between the parties in connection with this Agreement are confidential information. Both parties shall keep confidential all such information, and without the prior written consent of the other party, a party shall not disclose any relevant information to any third party, except in the following circumstances: (a) the public knows or will know such information (which is not disclosed by the information receiving party without authorization); (b) the disclosure of the information is required by the applicable laws or stock exchange rules or regulations; or (c) disclosure to the legal or financial advisors of either party in connection with the transaction described in this Agreement, and such legal and financial advisors shall comply with the similar duty of confidentiality. Any confidential information disclosed by the employees of either party or by an organization engaged by either party shall be deemed as the disclosure made by such party. Such party shall be responsible for the default responsibilities in accordance with this Agreement.


5. EFFECTIVENESS AND TERM

5.1 This Agreement shall be effective on the date it is signed.

5.2 This Agreement shall remain effective within the operating term of Party B, unless it is early terminated by the provisions of another relevant contract entered separately by both parties or by the provisions of this Agreement.

6. TERMINATION

6.1 EARLY TERMINATION. During the effective term of this Agreement, unless Party A commits gross negligence, fraud, other violations of law or bankruptcy, Party B shall not early terminate this Agreement. Notwithstanding the aforesaid covenant, Party A is entitled to terminate this Agreement by giving a written notice thirty (30) days in advance to Party B at any time. During the term of this Agreement, if Party B violates this Agreement and fails to remedy such default within fourteen (14) days after receiving a written notice of default from Party A, Party A can terminate this Agreement by giving a written notice to Party B.

6.2 PROVISIONS AFTER TERMINATION. After the termination of this Agreement, the rights and obligations of both parties under Articles 4, 7 and 8 herein shall remain in effect.

7. GOVERNING LAW

The validity, performance, interpretation and enforceability of this Agreement shall be governed by Chinese laws.

8. DISPUTE RESOLUTION

When disputes arose between the parties in connection with the interpretation performance of the provisions under this Agreement, both parties shall resolve the dispute through friendly consultation. If resolution cannot be reached within thirty (30) days after the request to resolve the disputes is made by a party, either party may submit the dispute to the China International Economic and Trade Arbitration Commission to resolve the disputes, in accordance with its then effective arbitration rules. The venue of arbitration shall be in Beijing; the arbitration language shall be Chinese. The arbitral award shall be final and binding upon both sides.

9. FORCE MAJEURE

9.1 "Force majeure" refers to any event that is beyond the reasonable control of a party, it is unavoidable even the affected party has given reasonable attention to it, including but not limited to, the acts of government, acts of nature, fire, explosion, typhoon, flood, earthquake, tidal, lightning or war. However, credit, capital or financing shortage shall not be considered as matters beyond the party's reasonable control. The party, affected by the "force majeure" and seeking to remove its responsibilities of this Agreement, shall promptly notify the other party regarding such responsibilities exemption matter and let to the other party know the steps to be taken to fulfill it.

9.2 When the performance of this Agreement is delayed or prevented due to the aforementioned definition of the "force majeure", the affected party shall not assume any responsibility under this Agreement to the extent it is within the scope of the delay or prevention. The affected party shall take appropriate measures to reduce or eliminate the impact of "force majeure" and take effort to resume the performance of the obligation delayed


or prevented by the event of "force majeure ". Once the event of "force majeure" is removed, both parties agree to resume the performance of this Agreement with their greatest efforts.

10. NOTICE

Notices or other communication required to be given by either party under this Agreement shall be written in English or Chinese, and shall be delivered by hand delivery, registered mail, postage prepaid mail, or recognized courier service or facsimile to the following addresses of the relevant party or parties or to the other addresses notified by one party to the other party from time to time or to the address of another person it designated. The actual date when a notice is deemed delivered shall be determined as follows : for (a) hand delivery, the date when the hand delivery is made; (b) a notice that is sent by mail, on the tenth (10th) day after the date of posting (as indicated by the postmark) of air registered mail (postage prepaid) or if it is sent by courier service, on the fourth (4th) day after it is being delivered to an internationally recognized courier service; and (c) a notice that is sent by facsimile, the received time shown on the transmission confirmation of the relevant documents is regarded as the actual time delivered.

Party A: Aero-Biotech Science & Technology Co., Ltd.
Address: Unit A333, 6th Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing
Recipient: Qian Zhaohua
Fax: 010-62109899
Tel: 010-62109288
Zip code: 100081

Party B: Primalights III Agriculture Development Co., Ltd.
Residence: Middle Area of Highway 73, Zhuangershang Upper Village, Huangling Rural, Xiaodian District, Taiyuan City
Recipient: Han Zhonglin
Fax: 0351-7123671
Tel: 0351-7870123
Zip: 030031

11. ENTIRE AGREEMENT

Both parties confirm, once this Agreement becomes effective, it shall constitute the entire agreement and understanding between the parties regarding the contents of this Agreement. It shall supersede all prior oral and / or written agreements and understanding in connection with the content of this Agreement that the parties reached before the execution of this Agreement.

12. SEVERABILITY

If any provision of this Agreement is held invalid or unenforceable due to the inconsistency with the relevant law, then such provision shall be deemed invalid only to the extent within the scope of such related jurisdiction and it shall not affect the legal effect of the other provisions in this Agreement.

13. AMENDMENTS AND SUPPLEMENTS

Both parties shall amend and supplement this Agreement by the form of a written contract. Through the proper execution of the relevant amendment agreement and supplemental


agreement by the parties herein, such amendment agreement and supplemental agreement shall become an integral party of this Agreement and shall have the same legal effect as this Agreement.

14. COUNTERPART

There are two original copies of this Agreement, each party holds one original copy, and each original copy shall have the same legal effect.

IN WITNESS WHEREOF, both parties have caused their legal representatives, or their authorized representatives to sign this Agreement on the date mentioned in the first page.


[This page without the text.]

PARTY A : Aero-Biotech Science & Technology Co., Ltd.

Legal representative / authorized representatives : /s/ Qian Zhaohua
                                                    ----------------------------

Common seals : [Seal: Aero-Biotech Science & Technology Co., Ltd.]

PARTY B : Primalights III Agriculture Development Co., Ltd.

Legal representative / authorized representatives : /s/ Zhang Mingshe
                                                    ----------------------------

Common seals : [Seal: Primalights III Agriculture Development Co., Ltd.]


Annex 1: The calculation and payment method of consulting services fee

1. Formula for calculation

Party B shall pay RMB 3 million consulting service fee every year to Party A.

2. Payment method

i. Every fiscal year Party A will issue a settlement statement to Party B, according to the content of the services provided to Party B, and submit to Party B in writing for verification and confirmation.

ii. Party B shall pay the consulting service fee to Party A's designated account within the due date as indicated in the settlement statement provided by Party A. Party B should facsimile or mail the copy of remittance voucher to Party A.

3. Adjustment mechanism

If Party A deems that the pricing mechanism stipulated in this agreement is inapplicable for some reason that the pricing mechanism needs to be adjusted. Party A should negotiate with Party B actively and in good faith to determine a new standard or mechanism of charges, within [7] working days after Party A's written request for such adjustment.


EXHIBIT 4.6

TRANSLATED FOR REFERENCE ONLY.

PROPRIETARY TECHNOLOGY LICENSE AGREEMENT

This Proprietary Technology License Agreement (hereinafter referred to as "this Agreement") is entered into by the following parties on June 8, 2007 in Beijing:

Party A: Aero-Biotech Science & Technology Co., Ltd.
Residence: Unit A333, 6th Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing

Party B: Primalights III Agriculture Development Co., Ltd.
Residence: Middle Area of Highway 73, Zhuangershang Upper Village, Huangling Rural, Xiaodian District, Taiyuan City

WHEREAS:

(1) in accordance with the laws of the People's Republic of China (hereinafter referred to as "China", in this contract does not include the Hong Kong Special Administrative Region, Macao Special Administrative Regions and Taiwan) Party A is a wholly foreign-owned enterprise registered and established in Beijing, China, who owns non-patent technologies listed in Annex I (such technologies and related information, manual, handbook, files, etc. hereinafter referred to as "Proprietary Technology");

(2) Party B is a limited liability company registered and established in Taiyuan City, Shanxi Province of China under Chinese laws, the main businesses are development and production of agricultural seeds, tree seeds and seedlings breed;

(3) Party A agrees to grant to Party B the exclusive right to use the Proprietary Technology under this Agreement in accordance with the terms and conditions of this Agreement, and Party B agrees to accept such license in accordance with the same terms and conditions.

NOW, THEREFORE, both parties, through consultation, unanimously reach the agreements as follows:

1. PERMISSION GRANT

1.1 Proprietary Technology

1.1.1 Party A agrees, according to the terms and conditions under this Agreement, to grant to Party B, and Party B agrees to accept the right to use the Proprietary Technology in China according to the same terms and conditions. The license under this Agreement is exclusive, except with the written consent of Party A, Party B shall not transfer the Proprietary Technology to any third party, nor shall jointly share, use, develop, improve or innovate the Proprietary Technology with any third party.

1.1.2 Agreed by both parties, should there be any improvement or innovation technological achievements resulted during the course of using the Proprietary Technology by Party B, the relevant rights and ownership shall be exclusively vested


in Party A unless it is otherwise provided by Chinese laws and regulations or mutually agreed by both parties. Party B shall not hold any rights and interests.

1.2 Scope

1.2.1 The Proprietary Technology granted to Party B herein shall only be used on Party B's business in development and production of stock breeding. Unless it is otherwise stated herein, without written consent of Party A, Party B shall not use the Proprietary Technology in other purpose or re-license for the use of any third party, whether for normal application, training or commercial sharing.

1.2.2 The right granted to Party B to use the Proprietary Technology herein shall be effective only in China. Party B agrees not to use such Proprietary Technology, whether directly or indirectly, in other geographical areas.

2. PAYMENT METHOD

Party B agrees to pay the Proprietary Technology license fee (hereinafter referred to as "License Fee") to Party A. The standard License Fee shall be RMB2.72 million per year. Party B shall pay the Proprietary Technology License Fee for the current year to Party A's designated account before December 31 of each year.

The License Fee payable hereunder by Party B shall be secured by the shareholders of Party B by pledging their respective shareholding in Party B.

Both parties shall bear their respective tax liabilities in relation to this Agreement in accordance with the stipulations of laws.

3. PARTY A'S RIGHTS AND PROTECTION

3.1 In the effective term of this Agreement and thereafter, Party B agrees not to challenge or question the validity of the proprietary right and this Agreement in connection with the aforesaid Proprietary Technology; and not to perform any acts that Party A believes it will impair Party A's rights and license.

3.2 Party B agrees to provide the necessary assistance to protect Party A's rights on the Proprietary Technology. Should any third party bring an infringement claim against Party A's Proprietary Technology, at Party A's discretion, Party A may respond to such compensation litigation in its own name, in Party B's name or in both parties name. In the event any third party commits any infringement behavior in connection with such Proprietary Technology, Party B shall notify Party A immediately within its scope of knowledge; only Party A is entitled to decide whether to take action against such infringement behavior.

3.3 Party B agrees to use the Proprietary Technology only in the manner as provided in this Agreement and shall not use the Proprietary Technology in any manner which Party A deems as deceptive, misleading or other manner that may impair the Proprietary Technology or Party A's reputation.

2

4. CONFIDENTIALITY PROVISIONS

4.1 Party A's confidential material and information (hereinafter "Confidential Information") being understood or accessed by Party B as a result of accepting the Proprietary Technology license, Party B shall keep confidential; and at the time this Agreement terminates, Party B shall, at Party A's request, return to Party A any documents and materials marked Confidential Information or destroy such Confidential Information, and delete any Confidential Information from any relevant memory device, and shall discontinue using such Confidential Information. Without the written consent of Party A, Party B shall not disclose to any third party, give or transfer such Confidential Information.

4.2 Both parties agree that this Article 4 shall remain valid regardless of whether this Agreement shall become invalid, alter, discharge, terminate or unenforceable.

5. REPRESENTATION AND WARRANTY

5.1 Party A represents and warrants as follows:

5.1.1 Party A is a validly existing wholly foreign-owned enterprise legally registered in accordance with the Chinese laws.

5.1.2 Party A signs and perform this Agreement within the power and business scope of the company; adopted all necessary corporate action, duly authorized, and obtained the consent and approvals (as required) of third party or government; and not in violation of the legal and company restrictions binding or affecting upon it.

5.1.3 This Agreement, once executed, shall constitute legitimate, valid, binding and enforceable obligations on Party A under the conditions of this Agreement.

5.1.4 Party A shall hold full and complete rights towards the Proprietary Technology.

5.2 Party B represents and warrants as follows:

5.2.1 Party B is a validly existing limited liability company legally registered in accordance with the Chinese laws.

5.2.2 Party B signs and perform this Agreement within the power and business scope of the company; adopted all necessary corporate action, duly authorized, and obtained the consent and approvals (as required) of third party or government; and not in violation of the legal and company restrictions binding or affecting upon it.

5.2.3 This Agreement, once executed, shall constitute legitimate, valid, binding and enforceable obligations on Party B under the conditions of this Agreement.

3

6. EFFECTIVENESS AND TERM

6.1 This Agreement shall be effective when it is executed on the date written on the first page of this Agreement. Unless it is early terminated according to this Agreement, this Agreement shall remain effective during the operation term of Party B.

6.2 On written consent by both parties, this Agreement is renewable upon expiry and the renewal term shall be determined by both parties through consultation.

7. DEFAULT RESPONSIBILITY AND TERMINATION

7.1 Default Responsibility

If Party B fails to pay the License Fee as scheduled in accordance with the provision hereunder, Party A is entitled to issue a written reminder to remind Party B to pay the outstanding License Fee, and Party B is entitled to collect a 3% of the relevant outstanding License Fee as the default fine. Except as otherwise provided in this Agreement, either party of this Agreement fails to perform the obligations under this Agreement or fails to perform the obligations in comply with the relevant provisions of this Agreement, shall, at the request of the non-defaulting party, to continue perform, or to adopt remedy measure and to compensate the actual loss caused to the non-defaulting party.

7.2 Discharge and Termination

During the effective term of this Agreement, Party A may, at any time, by giving a thirty (30) day prior written notice to Party B, terminate this Agreement; unless as otherwise expressly provided herein, without a reason written consent of Party A, Party B shall not terminate or discharge this Agreement unilaterally.

7.3 Results of Termination or Expiration

After this Agreement terminates or expires, Party B shall no longer enjoy all the rights granted to it under this Agreement. Party B shall not, directly or indirectly, use the Proprietary Technology.

8. FORCE MAJEURE

8.1 "Event of Force Majeure" refers any event that is beyond the reasonable control of a party, and it is unavoidable even under the reasonable care of the affected party, such events shall include but not limited to: acts of government, forces of nature, fire, explosion, typhoon, floods, earthquakes, tidal, lightning or war. However, credit, capital or financing shortage shall not be considered as matters beyond a party's reasonable control. The party, affected by "Event of Force Majeure", seeks exemption from performing its responsibilities under this Agreement or under any provision of this Agreement, shall notify the other party as soon as possible regarding such matter of exemption.

4

8.2 When the performance of this Agreement is delayed or prevented due to the aforementioned definition of "Event of Force Majeure", the affected party shall not assume any responsibility under this Agreement provided that the affected party has endeavored its reasonable effort to perform the agreement and to the extent of the part of the performance being delayed or prevented. Once the cause of such liability exemption is redressed or remedied, both parties agree to resume the performance of this Agreement with their best effort. If the influence of force majeure has rendered the performance of this Agreement becomes impossible, both parties agree, at the request of Party A, to use their greatest efforts to adopt other resolutions to realize the purposes of this Agreement.

9. DISPUTE RESOLUTION

In the event dispute in relation to the interpretation and performance of this Agreement arises, both parties shall resolve such dispute through friendly consultation. Should resolution cannot be reached within thirty (30) days after the request to resolve the dispute is made by a party, either party may submit such dispute to China International Economic and Trade Arbitration Commission for arbitration in accordance with the then effective arbitration rules. The arbitration shall take place in Beijing and the language to conduct the arbitration shall be in Chinese. The arbitral award shall be final and binding upon both parties.

10. NOTICE

Notices or other communications required to be given by either party under this Agreement shall be written in English or Chinese, and shall be delivered by hand delivery, registered mail, postage prepaid mail, or a recognized courier service or facsimile to the following addresses of the relevant party or both parties or to the other address notified by one party to the other party from time to time or to the address of the other person it specified. Notice is deemed delivered based on the following criteria: (a) on the same date when hand delivery; (b) on the tenth (10th) day after the date of posting (as indicated by postmark) of air registered mail (postage preprepaid) or if it is sent by courier service, on the fourth (4th) day after it is being delivered to an internationally recognized courier service center; and (c) a notice sent by facsimile, the receiving time as shown on the transmission confirmation of the relevant documents is regarded as the actual time delivered.

Party A: Aero-Biotech Science & Technology Co., Ltd.
Address: Unit A333, 6th Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing
Attention: Zhaohua Qian
Fax: 010-62109899
Tel: 010 - 62109288
Postal code: 100081

5

Party B: Primalights III Agriculture Development Co., Ltd.
Address: Middle Area of Highway 73, Zhuangershang Upper Village, Huangling Rural, Xiaodian District, Taiyuan City
Attention: Zhonglin Han
Fax: 0351-7123671
Tel: 0351 - 7870123
Postal code: 030031

11. RETRANSFER, SUBLICENSE

Without the prior written consent of Party A, Party B shall not transfer, pledge or sublicense the rights and obligations of and under this Agreement.

12. GOVERNING LAW

The validity, performance and interpretation of this Agreement shall be governed by laws of China.

13. AMENDMENT AND SUPPLEMENT

Amendments and supplements to this Agreement shall be made in the form of a written instrument. The relevant amendment agreement and supplemental agreement to this Agreement, duly signed by both parties, shall be an integral part of this Agreement and shall have the same legal effect as this Agreement.

14. SEVERABILITY

If any provision of this Agreement is held invalid or unenforceable due to the inconsistency with the relevant laws, then such provision shall be deemed invalid only within the scope of the related jurisdiction and that it shall not affect the legality of the other provisions under this Agreement.

15. ANNEX

Any annex of this Agreement is an integral part of this Agreement, and it shall have the same legal effect.

IN WITNESS WHEREOF, both parties have caused their legal representative or authorized representative to execute this Agreement on the date first above written.

16. COUNTERPART

This Agreement is signed in duplicate, each party holds one original and each original shall have the same legal force and effect.

[No text below.]

6

[No text in this page.]

PARTY A: Aero-Biotech Science & Technology Co., Ltd.

Legal representative / authorized representative: /s/ Qian Zhaohua
                                                  ------------------------------

Common seal: [Seal: Aero-Biotech Science & Technology Co., Ltd.]

PARTY B : Primalights III Agriculture Development Co., Ltd.

Legal representative / authorized representative: /s/ Zhang Mingshe
                                                  ------------------------------

Common seal: [Seal: Primalights III Agriculture Development Co., Ltd.]

7

ANNEX I: LIST OF PROPRIETARY TECHNOLOGY

8

EXHIBIT 4.7

TRANSLATED FOR REFERENCE ONLY.

POWER OF ATTORNEY

I, Li Juan, a citizen of the People's Republic of China (hereinafter referred to as "China"), Chinese identity card number 420983197609010023, am a shareholder of Primalights III Agriculture Development Co., Ltd. (hereinafter referred to as "P3A") holding 40% of the equity interest in P3A. I hereby irrevocably authorize Mr. Qian Zhaohua to exercise the following rights within the valid term of this Power of Attorney:

I authorize Mr. Qian Zhaohua (China identity card number: 130224670510033) to represent myself with full power to exercise the shareholder's rights including voting rights at the shareholders' meeting of P3A in accordance with Chinese laws and Articles of Association of P3A, including but not limited to: execute the relevant legal documents with respect to the sale or transfer of all or part of my equity interest held in P3A; and to act as my authorized representative at the shareholders' meeting of P3A to designate and appoint a general manager of P3A.

Such authorization and designation have a prerequisite condition that Mr. Qian Zhaohua is a Chinese citizen, and that he is an employee of Aero-Biotech Science & Technology Co., Ltd. (hereinafter referred to as "Aero-Biotech") and that Aero-Biotech agrees to such authorization and designation. Once Mr. Qian Zhaohua leaves Aero-Biotech or Aero-Biotech notifies me to terminate the aforesaid authorization and designation, I will immediately recover the authorization and designation granted herein, and I will designate/ authorize another personnel nominated by Aero-Biotech and exercise all my shareholder rights including voting rights at a shareholders' meeting of P3A as a shareholder should enjoy.

In the validly existing period of P3A, unless for any reason an early termination of the "Exclusive Call Option Agreement" which is jointly signed by me, Aero-Biotech and P3A, this Power of Attorney shall remain effective throughout the operating period of P3A from the date this Power of Attorney is signed.

/s/ Li Juan
-------------------------------------
June 8, 2007


POWER OF ATTORNEY

I, Xue Zhi Xin, a citizen of the People's Republic of China (hereinafter referred to as "China"), Chinese identity card number 140102621023081, am a shareholder of Primalights III Agriculture Development Co., Ltd. (hereinafter referred to as "P3A") holding 25% of the equity interest in P3A. I hereby irrevocably authorized Mr. Qian Zhaohua to exercise the following rights within the valid term of this Power of Attorney:

I authorize Mr. Qian Zhaohua (China identity card number: 130224670510033) to represent myself with full power to exercise the shareholder's right including vote right at the shareholders' meeting of P3A in accordance with Chinese law and Articles of Association of P3A, including but not limited to: to execute the relevant legal documents with respect to the sale or transfer of all or part of my equity interest held in P3A; and to act as my authorized representative at the shareholders' meeting of P3A to designate and appoint a general manager of P3A.

Such authorization and designation have a prerequisite condition that Mr. Qian Zhaohua is a Chinese citizen, and that he is an employee of Aero-Biotech Science & Technology Co., Ltd. (hereinafter referred to as "Aero-Biotech") and that Aero-Biotech agrees to such authorization and designation. Once Mr. Qian Zhaohua leaves Aero-Biotech or Aero-Biotech notifies me to terminate the aforesaid authorization and designation, I will immediately recover the authorization and designation granted herein, and I will designate/ authorize another personnel nominated by Aero-Biotech and exercise all my shareholder's rights including voting rights at a shareholders' meeting of P3A as a shareholder should enjoy.

In the validly existing period of P3A, unless for any reason an early termination of the "Exclusive Call Option Agreement" which is jointly signed by me, Aero-Biotech and P3A, this Power of Attorney shall remain effective throughout the operating period of P3A from the date this Power of Attorney is signed.

/s/ Xue Zhi Xin
---------------
June 8, 2007


POWER OF ATTORNEY

I, Zhang Ming She, a citizen of the People's Republic of China (hereinafter referred to as "China"), Chinese identity card number 140104710212037, am a shareholder of Primalights III Agriculture Development Co., Ltd. (hereinafter referred to as "P3A") holding 5% of the equity interest in P3A. I hereby irrevocably authorized Mr. Qian Zhaohua to exercise the following rights within the valid term of this Power of Attorney:

I authorize Mr. Qian Zhaohua (China identity card number: 130224670510033) to represent me with full power to exercise the shareholder's right including voting right at the shareholders' meeting of P3A in accordance with Chinese law and Articles of Association of P3A, including but not limited to: to execute the relevant legal documents with respect to the sale or transfer of all or part of my equity interest held in P3A; and to act as my authorized representative at the shareholders' meeting of P3A to designate and appoint a general manager of P3A.

Such authorization and designation have a prerequisite condition that Mr. Qian Zhaohua is a Chinese citizen, and that he is an employee of Aero-Biotech Science and Technology Company Limited (hereinafter referred to as "Aero-Biotech") and that Aero-Biotech agrees to such authorization and designation. Once Mr. Qian Zhaohua leaves Aero-Biotech or Aero-Biotech notifies me to the terminate the aforesaid authorization and designation, I will immediately recover the authorization and designation granted herein, and I will designate / authorize another personnel nominated by Aero-Biotech and exercise all my shareholder's rights including voting rights at a shareholders' meeting of P3A as a shareholder should enjoy.

In the validly existing period of P3A, unless for any reason an early termination of the "Exclusive Call Option Agreement" which is jointly signed by me, Aero-Biotech and P3A, this power of attorney shall remain effective throughout the operating period of P3A from the date this Power of Attorney is signed.

/s/ Zhang Ming She
-------------------------------------
June 8, 2007


EXHIBIT 4.8

TRANSLATED FOR REFERENCE ONLY.

EQUITY PLEDGE AGREEMENT

This Equity Pledege Agreement (this "Agreement") is entered into by and among the following parties on June 8, 2007 in Beijing:

Party A: Aero-Biotech Science & Technology Co., Ltd.
Domicile: A333, 6th Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing (the "Pledgee");

Party B: Li Juan, a Chinese citizen, identity card number: 420983197609010023;

Party C: Qian Zhaohua, a Chinese citizen, identity card number: 130224670510033;

Party D: Xue Zhixin, a Chinese citizen, identity card number: 140102621023081;

Party E: Zhang Mingshe, a Chinese citizen, identity card number:
140104710212037;

(Parties B, C, D and E above individually or collectively referred to as the "Pledgor(s)")

Party F: Primalights III Agriculture Development Co., Ltd.
Domicile: Middle Area of Highway 73, Zhuang Er Shang Village, Huang Ling Rural Area, Xiaodian District, Taiyuan City (hereinafter referred to as "P3A").

WHEREAS:

1. P3A, i.e. Party F, is a limited liability company registered, established and validly existing in Taiyuan City, Shanxi Province, PRC under the laws of the People's Republic of China (hereinafter referred to as "China", excluding Hong Kong Special Administrative Region, Macao Special Administrative Regions and Taiwan in this Agreement);

2. The Pledgors are the legal and valid shareholders of P3A and hold all the equity interest in P3A legally whereby Parties B, C, D and E own 40%, 30%, 25% and 5% of the equity interest, respectively;

3. The Pledgee is a wholly foreign owned enterprise legally established and validly existing under the laws of China. It provides technical support, technology consulting and related services to P3A. It has become a major cooperative partner of P3A;

4. On June 8, 2007, the Pledgee and P3A have entered into the "Exclusive Technology Development, Technology Support and Technology Service Agreement", "Proprietary Technology License Agreement" and "Exclusive Consultancy Service Agreement". The Pledgors agree to pledge their equity interest in P3A as a security for the performance of all P3A's obligations under the aforementioned agreements;


5. On June 8, 2007, the Pledgee and the Pledgors and P3A have signed the "Exclusive Call Option Agreement". The Pledgors agree to pledge their equity interest in P3A as a security for the performance of all the obligations of P3A and themselves under such "Exclusive Call Option Agreement";

NOW, THEREFORE, the Pledgee and the Pledgors, through friendly consultation, reach the agreement as follows.

ARTICLE 1 DEFINITIONS

Except as otherwise stipulated herein, the following terms shall mean:

1.1 "Pledge" refers to the full content of Article 2 hereunder.

1.2 "Equity " means the entire equity interest in P3A which legally held by the Pledgors.

1.3 "Main Contract" includes "Proprietary Technology License Agreement", "Exclusive Technology Development, Technology Support and Technology Service Agreement", "Exclusive Consultancy Service Agreement", "Exclusive Call Option Agreement" and any amendment and supplement thereof.

1.4 "Secured Party" refers to other contract party under each Main Contract except the Pledgee.

1.5 "Secured Debt" means all contractual obligations under each Main Contract, including (but not limited to) interest, default fine, compensation, expenses incurred by the Pledgee in realizing the debt.

1.6 "Event of Default" refers to any event specified in Article 7.1 hereof.

1.7 "Notice of Default" means the notice of default to be issued by the Pledgee pursuant to this Agreement.

ARTICLE 2 PLEDGE

The Pledgors hereby pledges all equity interest it owns in P3A to the Pledgee as a security for the performance of the Secured Debt under Main Contract by the Secured Party. Accordingly, the Pledgee enjoys the Pledge of all the Equity of the Pledgor in P3A. "Pledge" refers to the rights owned by the Pledgee, who is entitled to a priority in receiving payment by the evaluation or proceeds from the auction or sale of the Equity pledged by the Pledgor to the Pledgee.

ARTICLE 3 REGISTRATION OF PLEDGE

3.1 Within one (1) week after the signing of this Agreement, P3A shall, and the Pledgor shall cause P3A, to record the Pledge specified in Article 2 above, on the Register of Shareholders of P3A, and deliver the copy of the Register of


Shareholders chopped with the official seal of P3A and the original of equity contribution certificate of P3A to the Pledgee for custody.

3.2 After the signing of this Agreement, the Pledgors shall, in accordance with the Pledgee's written request which may be made by the Pledgee from time to time, together with the Pledgee, notarize this Agreement as well as the Pledgee's Pledage Right recorded in the Register of Shareholders and equity contribution certificate as set forth in Article 3.1 hereof at a local notary public office where P3A is domiciled.

3.3 The parties agree to take it best effort to cause the pledge under this Agreement to be registered at the industrial and commercial administrative departments where P3A is registered. The parties confirm that, unless the registration in the industrial and commercial administrative of the pledge is mandatory in law, the effectiveness and validity of the Pledge stipulate in Article 2 above shall not be affected after all parties signed this Agreement, even if the Pledge under this Agreement cannot be registered at the industry and commerce administration departments where P3A is registered.

ARTICLE 4 RIGHTS OF THE PLEDGEE

4.1 When the Secured Party does not perform any obligation under the Main Contract, the Pledgee is entitled to be first compensated from money converted from or the proceeds from the auction or sale of the pledged Equity of P3A.

4.2 The Pledgee is entitled to receive the dividends and other property distribution arising from the pledged Equity.

ARTICLE 5 REPRESENTATION AND WARRANTY OF PLEDGORS

5.1 Pledgors are the legitimate owners of the Equity;

5.2 Pledgors fully understands the contents of the Main Contract. The signing and the performance of this Agreement are voluntary, and it is expressing true meaning. The Pledgors are legally authorized to sign;

5.3 All documents, information, statements and other evidence which Pledgors provided to the Pledgee are accurate and true, complete and valid;

5.4 Pledgors admit that the Pledgee has the right to dispose and transfer the Pledge, according to the method stipulated in this Agreement and within the scope of the legal restrictions in China;

5.5 Except for the interest of the Pledgee, Pledgors have not placed other pledge, any other kinds of rights or any third party right on the Equity;

5.6 Every Pledgor has already obtained the consent of the other shareholders of P3A to pledge the Equity. And all the shareholders have unanimously consent

that,


when Pledgee exercises the right of the Pledge, the shareholders will not interfere by any means, and that they will not exercise the pre-emptive right.

ARTICLE 6 UNDERTAKING OF PLEDGORS

In addition to the obligations specified in this Agreement, the Pledgor undertakes as follows:

6.1 During the duration of this Agreement, the Pledgors' promise to the Pledgee for its benefit that the Pledgors shall:

6.1.1 Except for transferring the Equity to the Pledgee, without the prior written consent of Pledgee, Pledgors cannot transfer the Equity, cannot create or permit the existence of any pledge which may affect the rights and interests of Pledgee, or cause the shareholders meeting of P3A to pass any resolution to sell / transfer / pledge or by means of other way to dispose any Equity of the company, or to allow the creation of any other security interests; unless prior written consent of the Pledgee, Pledgors shall vote / cause his nominated P3A Directors to vote at P3A's board meeting and/or by other means to object P3A to sell / transfer / pledge or by other way of disposing of any major assets, including (but not limited to) any intellectual property rights.

6.1.2 If the pledged Equity under this Agreement is subjected to any compulsory measures implemented by a court or other departments for any reason, the Pledgors shall use all efforts, including (but not limited to) provide other security or adopt other measure to the court, in order to dismiss the compulsory measures taken by the Court or other departments over the pledged Equity.

6.1.3 The Pledgors shall comply with and implement all relevant laws and regulations regarding the rights for pledge. Within five (5) days upon receipt of any competent authority's notice, order or suggestion about the Pledge, the Pledgors shall deliver such notice, order or suggestion to the Pledgee, and comply with such notice, order or suggestion, or raised objections and representations in accordance with the Pledgee's reasonable request or the consent on the foregoing matters.

6.1.4 The Pledgors shall timely notify the Pledgee of any event or received notice which may affect the Pledgor's Equity or any part of its right, and any event or any received notice which may change any of the Pledgor's warranty and obligation under this Agreement.

6.2 The Pledgors agree that, when the Pledgee exercises its rights on the Pledge in accordance with the provisions under this Agreement and within the scope permitted by the Chinese laws, the Pledgee's right shall not be suspended or inhibited by any legal procedure launched by the Pledgors or any successors of the Pledgors or any person authorized by the Pledgors or any other person.

6.3 The Pledgors promise to the Pledgee that, in order to protect or perfect the security for the Secured Debt, the Pledgors shall execute in good faith and cause


other parties who have interests in the Pledge to sign all the title certificates, contracts, and / or perform and cause other parties who have interest to take action as required by the Pledgee; and provide convenient access to exercise the rights and authorization vested in the Pledgee under this Agreement.

6.4 The Pledgors promise to the Pledgee that they will execute all amendment documents (if applicable and necessary) in connection to the Certificate of Equity with the Pledgee or its designated person (natural person/legal person) and provide all the notice, order or decision related to the Pledge to the Pledgee by who considers to be necessary within a reasonable time.

6.5 The Pledgors promise to the Pledgee to comply with and perform all the guarantees, undertakings, contracts, representations and conditions for the benefits of the Pledgee. If the Pledgors do not perform or do not fully perform its guarantees, undertakings, contracts, representations and conditions, the Pledgors shall compensate the Pledgee for all the losses suffered by the Pledgee.

ARTICLE 7 EVENT OF DEFAULT

7.1 The following events are regarded as events of default:

7.1.1 The Secured Party fails to perform as due, fully perform any one of the Secured Debt Failure under the Main Contract;

7.1.2 The statements or guarantees made by the Pledgors, specified in Article 5, contain any material misleading or false information, and/or the Pledgor's breach of the any waranties set forth in Article 5;

7.1.3 The Pledgor's breach of the undertakings specified in Article 6;

7.1.4 The Pledgor's breach of any other provisions herein;

7.1.5 The Pledgor waives the pledged Equity or transfer the pledged Equity without Pledgee's prior written consent;

7.1.6 Any other external borrowing, warrant, compensation, undertakings or other liabilities of the Pledgors: (1) is required for an early repayment or performance prior to the scheduled date due to any breach; or (2) is due but can not be repaid or perform as scheduled, which causes the Pledgee to believe that the Pledgors' capacity to perform the obligations under this Agreement is affected;

7.1.7 P3A is incapable to repay the general debts unsecured or other debts;

7.1.8 This Agreement becomes illegal or the Pledgor fails to continue perform its obligations under this Agreement due to any reason with the exception of force majeure;


7.1.9 An adverse change occurs to the property owned by the Pledgor, which causes the Pledgee to believe that the Pledgor's capability to perform the obligations under this Agreement is affected;

7.1.10 A material adverse change occurs to the assets, operation result or finance of P3A;

7.1.11 The successor or agent of P3A can only perform part of the Main Contract or refuse to perform the Main Contract;

7.1.12 The Pledgor breaches other provisions of this Agreement through any act or omission of act.

7.2 If the Pledgor knows or is aware of any events set forth in Article 7.1 herein or any events which may result in the foregoing events has happened or is going on, the Pledgor shall give written notice to the Pledgee immediately.

7.3 Unless the events of default set forth in Article 7.1 herein have been resolved to the Pledgee's satisfaction, the Pledgee may give written notice of default to the Pledgor at any time after the occurrence of such events of default and require the Pledgor to repay the debts or other payables under the Main Contract immediately or exercise its Pledge as specified in Article 8 herein.

ARTICLE 8 EXERCISE OF THE PLEDGE

8.1 Subject to the stipulation set forth in Article 6.1.1 herein, before the Secured Party has fully performed its obligation under the Main Contract, the Pledgor shall not transfer the pledged Equity without the Pledgee's written consent.

8.2 The Pledgee shall give notice of default to the Pledgor when the Pledgee exercises the right of Pledge.

8.3 Subject to Article 7.3 herein, the Pledgee may exercise its right of disposal of the Pledge at the time or at any time after the notice of default is issued in accordance of Article 7.3.

8.4 The Pledgee is entitled to a priority in receiving payment by the evaluation or proceeds from the auction or sale of whole or part of the Equity pledged herein in accordance with legal procedure until the outstanding debt and all other payables of the Pledgor under the Main Contract are repaid.

8.5 The Pledgor shall not hinder any obstacle when the Pledgee execute his disposal right hereunder. The Pledgor shall provide necessary assistance so that the Pledgee could realize his Pledge.

ARTICLE 9 ASSIGNMENT OF CONTRACT


9.1 The Pledgor or P3A shall not transfer any right and obligation under this Agreement, unless agreed by the Pledgee in advance.

9.2 This Agreement shall be binding upon the Pledgor and its successors, and this Agreement shall also be binding upon the Pledgee and each of its successor and permitted assignee.

9.3 The Pledgee may transfer all or any rights and obligations hereunder to designated assigners (natural person/ legal person) with the permit by applicable law, in which case the assignee shall enjoy and undertake the same rights and obligations herein of the Pledgee as if the rights and obligations shall be enjoyed and born by any party of this Agreement. When the Pledgee transfers the rights and obligations under the Main Contract, and such transfer shall only need to serve a written notice to the Pledgor, and the Pledgor shall sign the relevant contracts and/or documents as requested by the Pledgee.

9.4 A new pledge contract shall be signed between the new parties to the pledge after the change of Pledgee caused by the pledge transfer.

ARTICLE 10 EFFECTIVENESS

This Agreement is signed on the date set forth in the first page and shall become effective on the day on which the Pledge is recorded on the Register of Shareholder of P3A.

ARTICLE 11 TERMINATION

This Agreement terminates when the Secured Debt under the Main Contract has been repaid and the Pledgor will not undertake any obligations under the Main Contract. The Pledgee shall provide necessary assistance in dealing with the formalities for releasing the Pledge on the Equity within the earliest reasonable and practicable time.

ARTICLE 12 FORMALITIES FEES AND OTHER CHARGES

12.1 All the fees and actual expenses incurred due to the conclusion and performance of this Agreement, including but not limited to, legal fee, cost of production, stamp duty, and any other taxes and charges, etc shall be payable and borne by the Pledgor. If the Pledgee pays the relevant taxes in accordance with laws, the Pledgor shall fully indemnify the Pledgee such taxes paid by the Pledgee.

12.2 The Pledgee may seek recourse against the Pledgor by any means or any ways if the Pledgor fails to pay any payable taxes, expenses or charges for other reasons in accordance with this Agreement. The Pledgor shall be responsible for all the fees incurred, including but not limited to, all kinds of taxes, formalities fees, management fees, litigation fees, attorney's fees and various insurance premiums in connection with the disposition of the Pledge, etc., by the Pledgor.


ARTICLE 13 FORCE MAJEURE

13.1 "Force majeure" means any event beyond the reasonable control of the party and cannot be prevented with reasonable care of the affected party, such event of Force Majeure includes, but is not limited to, acts of government, acts of nature, fire, explosion, typhoon, floods, earthquake, tidal wave, lightning or war. Nevertheless, lack of credit, capital or finance shall not be considered as an event beyond a party's reasonable control. The affected party shall notify the other parties of such event resulting in exemption without any delay.

13.2 Shall either party hereto be delayed or prevented from performing its obligations hereunder due to Force Majeure events as defined in Article 13.1, the affected party may be exempted from performing its obligation hereunder to the extent delayed or prevented by Force Majeure events. The affected party shall take reasonable endeavors to minimize or remove the effects of the events of Force Majeure and attempt to resume performance of the obligations delayed or prevented by the events of Force Majeure. The parties agree to use reasonable efforts to resume the performance of the obligation whenever and to the extent the causes are removed.

ARTICLE 14 CONFIDENTIALITY

Undersigned hereby acknowledge and confirm that any oral or written materials exchanged hereto are confidential information. The parties shall keep all confidential information in confidence and shall not disclose any item of confidential information to any third party, without other party's prior written consent, however, either of the following cases shall be excepted: (a) the information is already or to be make known to the public (the disclosure is not made by the recipient without authorization; (b) the information is disclosed as required by applicable laws or rules and regulations of stock exchange; or (c) the information disclosed by any party to its legal consultant or financial advisors in connection with or in the execution of this Agreement. It is also necessary for the legal consultant and financial advisors to undertake confidentiality obligations and liabilities. The breach of confidentiality of any party's employees, agents or advisers shall be deemed as the act of the party; therefore, it shall be liable for the breaching responsibilities in accordance with this Agreement.

ARTICLE 15 DISPUTE RESOLUTION

15.1 This Agreement shall be construed and governed by the laws and regulations of the People's Republic of China.

15.2 All the disputes in connection with or in the execution of this Agreement shall be settled by the parties through friendly consultations. In case no settlement to the disputes can be reached by the parties through such consultations, the disputes shall be submitted to China International Economic and Trade Arbitration Commission for arbitration. The arbitration shall take place in Beijing, China, and be conducted in Chinese according to the provisional procedures and rules of


the China International Economic and Trade Arbitration Commission. The arbitration award shall be final and binding on the parties.

ARTICLE 16 NOTICE

Notices required to be given by the parties for the purpose of performing the rights and obligations pursuant to this Agreement shall be in writing, including facsimile transmission. The dates of receipt of such notices shall be determined as follows:

(a) Notices sent by personal delivery shall be deemed effectively delivered on the date of personal delivery;

(b) Notices sent by facsimile transmission shall be deemed effectively delivered when dispatched on its transmittal or on the first business day following the date of transmission when it is not a business day or received after the business hours.

Address for notices is the address set forth in the first page or other address may be designated through notification to the other parties.

Party A: Aero-Biotech Science & Technology Co., Ltd.
Address: A333, 6th Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road,

         Haidian District
Fax:     010-6210 9899
Tel:     010-6210 9288

Party B: Li Juan
Address: Units 1& 8, 17th  Floor,  Duty-free  Business  Building,  No.6 Fu Hua
         First  Road,  Futian District, Shenzhen City
Fax      0755-8276 6965
Tel:     0755-8276 6980

Party C: Qian Zhaohua
Address: Room 716, Huan Tai Building, South Street, Zhong Guan Cun, Haidian
         District, Beijing
Fax:     010-62109298
Tel:     010-62109299

Party D: Xue Zhixin
Address: 25th Floor, Jin Gang Hotel, No.91 Bing Zhou North Road, Taiyuan City,
         Shanxi Province
Fax:     0351-4727112
Tel:     0351-4727118

Party E: Zhang Mingshe
Address: 25th Floor, Jin Gang Hotel, No.91 Bing Zhou North Road, Taiyuan City,
         Shanxi Province
Fax:     0351-472 7111
Tel:     0351-472 7111

Party F: Primalights III Agriculture Development Co., Ltd.

Address: Middle of Highway 73, Zhuang Er Shang Village,  Huang Ling Rural
         Area, Xiaodian District, Taiyuan City
Fax      0351-712 3671
Tel:     0351-787 0123

ARTICLE 17 INTEGRATION OF CONTRACT

Notwithstanding Article 10, the parties agree that this Agreement constitute the entire agreement and understanding of the parties, superseding any and all prior written and oral representations, understandings, agreements and arrangements related thereto.

ARTICLE 18 SEVERABILITY

If and to the extent any provision of this Agreement is held invalid or unenforceable under applicable law, such provision thereof shall be ineffective as to the jurisdiction in which it is invalid or unenforceable. The invalidity or unenforceability of such provision in that jurisdiction shall not in any way affect the validity or enforceability of any other provision in any jurisdiction.

ARTICLE 19 AMENDMENT AND SUPPLEMENT

19.1 Parties may amend and supplement this Agreement with a written agreement. The amendment and supplement duly executed and signed by the parties shall be part of this Agreement and shall have the same legal effect as this Agreement.

19.2 This Agreement together with any amendments, supplements or modifications to this Agreement shall be in written form and become effective on the date when stamped and signed by the parties.

ARTICLE 20 COUNTERPARTS

This Agreement is executed by Chinese in nine copies, each of which has the same legal effect. The Pledgee, each Pledgor and P3A shall hold one copy and the remaining three copies shall be provided to relevant government departments.

IN WITNESS WHEREOF, the Parties executed this Agreement on the date first above written.

(No text below)


Party A: Aero-Biotech Science & Technology Co., Ltd.

Legal representative/authorized representative: /s/ Qian Zhaohua
                                                --------------------------------

Seals: [Seal: Aero-Biotech Science & Technology Co., Ltd.]

Party B: Li Juan

Signature: /s/ Li Juan
          ---------------------------

Party C: Qian Zhaohua

Signature: /s/ Qian Zhaohua
          ---------------------------

Party D: Xue Zhixin

Signature: /s/ Xue Zhixin
          ---------------------------

Party E: Zhang Mingshe

Signature: /s/ Zhang Mingshe
          ---------------------------

Party F: Primalights III Agriculture Development Co., Ltd.

Legal representative/authorized representative: /s/
                                                --------------------------------

Seals: [Seal: Primalights III Agriculture Development Co., Ltd.]


EXHIBIT 4.9

TRANSLATED FOR REFERENCE ONLY.

EXCLUSIVE CALL OPTION AGREEMENT

This "Exclusive Call Option Agreement" (hereinafter referred to as "this Agreement") was signed by the following parties on June 8, 2007 in Beijing:

Party A: Aero-Biotech Science & Technology Co., Ltd.
Domicile: No. A333 Sixth Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing

Party B: Li Juan, the ID card number : 420983197609010023;

Party C: Qian Zhao Hua, the ID card number : 130224670510033;

Party D: Xue Zhi Xin, the ID card number: 140102621023081;

Party E: Zhang Ming She, the ID card number: 140104710212037;

(Parties B, C, D, E above individually or collectively referred to as "the Shareholder(s)")

Party F: Primalights III Agricultural Development Co. Ltd. (hereinafter referred to as "P3A")
Domicile: Middle Area of Highway 73, Zhuang Er Shang Village, Huang Ling Rural Area, Xiao Dian District , Taiyuan City

WHEREAS:

1. Party A is a wholly foreign owned enterprise registered and established in China in accordance with the laws of the People's Republic of China (hereinafter referred to as "China". In this Agreement, it does not include the Hong Kong Special Administration Region, Macao Special Administration Region and Taiwan Region);

2. P3A is a limited liability company duly registered and established and validly existing in Taiyuan City, Shanxi Province of China;

3. Parties B, C, D, and E are Chinese citizens, who hold 40%, 30%, 25% and 5%, respectively, of equity interest in P3A;

4. The Shareholders intend to grant an exclusive purchase option to Party A so that Party A may request the Shareholders to sell their equity interest to it upon certain conditions are satisfied.

NOW, THEREFORE, the parties to this Agreement, through unanimous agreement, hereby agree as follows:

CHAPTER 1: PURCHASE AND SALE OF EQUITY

1.1 Granting of Rights


The Shareholder hereby irrevocably grants to Party A an option to purchase or causes any person or persons designated by Party A (hereinafter the "Designee") to purchase from the Shareholders at any time, to the extent permitted by the laws of China and according to the steps determined by Party A at its own discretion, all or part of the equity interests in P3A (hereinafter the "Call Option"), at the price specified in Article 1.3 of this Agreement. Except for Party A and/or the Designee, the Shareholder shall not sell, offer to sell, transfer, donate equity, pledge any equity interest of P3A to any other third party. P3A hereby agrees the Shareholders to grant Party A and/or the Designee the Call Option. The "person" sets forth in this clause and this Agreement includes an individual, corporation, joint venture, partnership, enterprise, trust or non-corporation organization.

1.2 Exercise Steps

Subject to PRC laws and regulations, Party A and/or the Designee may exercise Call Option by issuing a written notice (hereinafter referred to as "Equity Purchase Notice") to the Shareholders and specifying the amount of equity interest to be purchased (the "Purchased Equity") from the Shareholder(s) and the manner of purchase.

1.3 Purchase Price

1.3.1 When Party A exercises the Call Option, unless the applicable Chinese laws and regulations require an appraisal of the equity interest or have other restriction on the equity price, Party A shall pay RMB100,000 to the Shareholders of P3A as the purchase price ("Purchase Price") for all the equity interest.

1.3.2 If the applicable PRC laws and regulations require appraisal of the equity interests or have other restrictions on the purchase price of the equity interests at the time Party A exercises the Call Option, the Parties agree that the Purchase Price shall be the lowest price allowed by the applicable laws.

1.3.3 If Party A chooses to purchase part of the equity interests, the purchase price should be adjusted according to the ratio of the Purchased Equity to the whole equity interests of P3A.

1.4 Transfer of the Purchased Equity

At each exercise of Call Option:

1.4.1 Shareholders shall cause P3A to hold the shareholders' meeting in a timely manner. The meeting should pass a resolution to approve the transfer of equity interest from Shareholders to Party A and/or the Designee, and cause other shareholders to waive pre-emptive right on the Purchased Equity in writing;

1.4.2 Shareholders and Party A and/or the Designee (as applicable) should enter into an equity transfer contract each time the share is transferred in accordance with


the stipulations of this Agreement and the Equity Purchase Notice related to the Purchased Equity;

1.4.3 The related parties should sign all other requisite contracts, agreements or documents, obtain all requisite government approvals and consents, and take all necessary actions, without any security interests, grant the valid ownership of the Purchased Equity to Party A and/or the Designee and cause Party A and/or the Designee to be the registered owner of the Purchased Equity. In this clause and in this Agreement, "security interests" includes guarantees, mortgages, pledges, the third-party rights or interests, any share option, right of acquisition, right of first refusal, right of offset, ownership detainment or other security arrangements. But it does not include the security interest arising from the Equity Pledge Agreement signed on June 8, 2007 by Party A, Shareholders and P3A (hereinafter "Equity Pledge Agreement").

1.5 Payment

The Purchase Price and the payment method shall be negotiated and decided by Party A and/or the Designee and the Shareholders according to the prevailing laws at the time the Call Option is exercised.

CHAPTER 2: UNDERTAKING RELATING TO EQUITY

2.1 Undertaking relating to P3A

The Shareholders and P3A hereby jointly undertake as follows:

2.1.1 Without the prior written consent of Party A, the articles of association of P3A should not be added, revised or modified in any forms; or the paid-in capital should not be increased or decreased; or the capital structure should not be changed in any way;

2.1.2 P3A should keep good financial and commercial standards and practices to maintain the existence of the company, operate its business and handle affairs prudently and effectively, try its best to keep all necessary permits, licenses and certificate valid and ensure that such permits, licenses and forth will not be canceled, and do its best to maintain the existing company structure, senior management staff, and relationship with the customers so that after the delivery of shares, there will not be material adverse effect on the goodwill and business of P3A;

2.1.3 Without the prior written consent of Party A, P3A should not sell, transfer, pledge or by other means dispose any assets, business and revenue of the company, or allow the settlement of any other security interests on it at any time after this Agreement is signed;

2.1.4 Without the prior written consent of Party A, P3A will not inherit, guarantee or permit the existence of any debt, except: (i) debts arising from normal or ordinary course of business operation except for loans; and
(ii) debts that have been disclosed to and obtained written consent from Party A;


2.1.5 P3A will keep all existing business under normal operation to maintain the asset value of the company. Action or omission that will affect its business operation and asset value is not allowed;

2.1.6 Without the prior written consent of Party A, P3A shall not enter into any material contract, other than the agreements in the normal course of business (for the purposes of this paragraph, if a contract value is more than RMB 1 million, such contract will be deemed material);

2.1.7 Without the prior written consent of Party A, P3A should not provide any loans or credit to anyone;

2.1.8 At the request of Party A, P3A should provide related operational and financial information;

2.1.9 P3A should purchase and maintain the insurance from a insurance company which is recognized by Party A. The amount and type of insurance should be the same as those of the insurance normally procured by other companies in the same region, engaged in similar business or possessing similar property or assets;

2.1.10 Without the prior written consent of Party A, P3A shall not merge or consolidate with anyone, or shall not acquire or invest in anyone;

2.1.11 P3A should inform Party A immediately any pending or threatened lawsuits, arbitration or administrative proceedings relating to the assets, business and revenue of P3A;

2.1.12 In order to maintain its ownership over all the assets, P3A should sign all necessary or appropriate documents, take all necessary or appropriate actions, bring forward all necessary or appropriate claims, or make all necessary and appropriate defenses against all claims;

2.1.13 Without the prior written consent of Party A, P3A shall not distribute dividends to its shareholders in any form. However, at the request of Party A, all or part of the distributable profits shall be immediately distributed to its Shareholders.

2.1.14 During the valid term of this Agreement, all business shall comply with all applicable Chinese laws and regulations, administrative rules and regulations, and shall not impose any material adverse impact on the business or asset structure due to the violation of any above rules;

2.1.15 If Party A choose to exercise the Call Option according to the condition of this Agreement, P3A shall procure its best effort to obtain all necessary governmental approvals and other consent (if applicable) as soon as possible to complete the transfer of the equity ownership;

2.1.16 At the request of Party A, appoint the person nominated by Party A as the director of P3A.


2.2 Undertakings relating to Shareholders

Shareholders hereby undertake:

2.2.1 Without the prior written consent of Party A, Shareholders shall not sell, transfer, pledge or by other means dispose of any legitimate or beneficial interest of equity interest, or allow any other security interests to be created on at any time after this Agreement is signed, with the exception of the pledge under "Equity Pledge Agreement";

2.2.2 Without the prior written consent of Party A, Shareholders shall not cause any shareholder resolutions at the shareholders' meeting to approve the sale, transfer, pledge or otherwise dispose of any shares or benefit from the legitimate rights or beneficial interests, or to allow the establishment of any other security interest, but this is not applicable when the subject is Party A or its designee;

2.2.3 Without the prior written consent of Party A, Shareholders shall not vote to agree or support or sign any shareholder resolutions at the shareholders' meeting to approve P3A to merge or consolidate with anyone, or acquire or invest in anyone;

2.2.4 Notify Party A immediately of any litigation, arbitration or administrative proceedings pending or threatening against its equity;

2.2.5 To cause the shareholders' meeting to vote and approve the transfer of the Purchased Equity under this Agreement;

2.2.6 In order to maintain its ownership over the equity interest, Shareholders shall sign all necessary or appropriate documents, take all necessary or appropriate actions, bring forward all necessary or appropriate claims, or make all necessary and appropriate defenses against all claims;

2.2.7 At the request of Party A, appoint the person nominated by Party A as the director of P3A;

2.2.8 At request of Party A from time to time, Shareholders should transfer their shares to Party A and/or the Designee unconditionally and immediately, and waive the pre-emptive right toward other transferred equity;

2.2.9 Shareholders shall strictly comply with the provisions of this Agreement and other contracts which are jointly or individually signed by the Shareholders, P3A and Party A, effectively perform the obligations under these agreements, and do not do any act/omission that will affect the validity and enforceability of these agreements.


CHAPTER 3: REPRESENTATION AND WARRANTIES

Shareholders and P3A hereby represent and warrant the followings to Party A on the day this Agreement is signed and on each transferring day:

3.1 They have the rights to sign and deliver this Agreement and any equity share-transferring contracts ("Transfer Agreement") according to this Agreement, of which we are one party. And we have the right to perform the obligations under this Agreement and any Transfer Agreement. Once this Agreement and any Transfer Agreement, of which we are one party, are signed, this Agreement will become legal, valid and binding obligations and it can be enforceable in accordance with its terms.

3.2 Either the execution and delivery of this Agreement or any Transfer Agreement or carrying out of the obligations under this Agreement or any Transfer Agreement will not: (i) violate any relevant Chinese laws and regulations; (ii) conflict with the articles of association or other organizational documents; (iii) violate or default under any contract or instrument to which it is a party or that binds upon it; (iv) violate any approval or permit granted to it a and/or condition remaining in force; or
(v) cause any permit or approval granted to it to be suspended, cancelled or attached with additional conditions;

3.3 P3A holds good and salable ownership over all assets. P3A has not set any security interest on the said assets;

3.4 P3A has no outstanding debts except (i) debts arising from its normal course of business; and (ii) debts that have been disclosed to and approved by Party A in writing;

3.5 P3A shall comply with all Chinese Laws and regulations applicable to the acquisition of assets;

3.6 There is no existing, pending or threatening litigation, arbitration or administrative proceedings relating to equity and assets of P3A; and

3.7 Shareholders hold good and salable ownership over all its equity and complete and valid disposition right (except for restriction under Chinese laws and regulations) over the equity interest. Apart from the security interest defined in Equity Pledge Agreement, no other security interest on such equity has been created, and it is free from any third party claims.

CHAPTER 4: TRANSFER OF AGREEMENT

4.1 Shareholders and P3A shall not transfer their rights and obligations under this Agreement to any third party unless prior written consent is obtained from Party A.

4.2 Shareholders and P3A hereby agree that Party A is entitled to transfer all its rights and obligations under this Agreement to a third party if it considers it is necessary.


If such transfer happens, Party A only needs to notify Shareholders and P3A in writing and do not need to seek consent of Shareholders and P3A.

CHAPTER 5: EFFECTIVE DATE AND TERM

5.1 This Agreement shall become effective on the date first above written.

5.2 This Agreement shall be terminated automatically only when Party A exercises its purchase right over all equities of P3A according to the provisions of this Agreement, unless it is early terminated in accordance with the provisions of this Agreement or other related agreements signed by the parties.

5.3 If the operation term of Party A or P3A expire or Party A or P3A terminates due to other reasons during the period defined in Article 5.2 above, this Agreement will be terminated accordingly, except that Party A has transferred its rights and obligations according to Article 4.2.

CHAPTER 6: APPLICABLE LAW, DISPUTE RESOLUTION AND DEFAULT LIABILITIES

6.1 Applicable Law

The formation, validity, interpretation, performance of this Agreement and dispute resolution under this Agreement shall be governed by Chinese laws.

6.2 Dispute Resolution

If dispute over the interpretation and performance of the provisions under this Agreement arises, all parties shall resolve the dispute in good faith through amicable negotiations. If the dispute cannot be resolved within thirty (30) days after the request to solve the dispute is raised, any party may submit the dispute to China International Economic and Trade Arbitration Commission for arbitration according to the then effective arbitration rules. The arbitration venue shall be in Beijing and the applicable language shall be in Chinese. The arbitral award shall be final and binding upon all parties.

6.3 Default Liabilities

If any party of this Agreement violates the provisions of this Agreement, fails to fully perform this Agreement, or provides any false, significant omission and misstatement on any undertakings and statement and guarantee, refuses to perform the undertakings, statement and guarantee, these will constitute a default. The Defaulting Party shall bear all legal responsibility correspondingly.

CHAPTER 7: TAXES AND EXPENSES

Each party shall bear any and all transfer and registration taxes and expenses occurring to or levied on it with respect to the preparation and execution of this Agreement and each Transfer Agreement and its consummation of the transaction contemplated hereunder and each Transfer Agreement in accordance with Chinese laws.


CHAPTER 8: NOTICES

Notices or other communications required to be given by any party pursuant to this Agreement shall be written in English or Chinese and delivered by hand delivery or sent by mail or by facsimile transmission to the address of each relevant party set forth below or to other specified address of each relevant party notified by such party from time to time. The date when the notice is deemed to be duly served shall be determined as follows: (a) a notice delivered by hand is deemed duly received upon the date of delivery; (b) a notice sent by mail is deemed duly received on the tenth (10th) day after the date when the air registered mail with postage prepaid has been sent out (as indicated on the postmark), or the fourth (4th) day after the delivery date to an internationally recognized courier service; and (c) a notice sent by facsimile transmission is deemed duly received upon the receiving time as indicated on the transmission confirmation of relevant documents.

Party A: Aero-Biotech Science & Technology Co., Ltd.
Address: No. A333 Sixth Floor, Golden Resources Shopping Mall, No. 1 Yuanda Road, Haidian District, Beijing
Fax: 010-62109899
Tel: 010-62109288

Party B: Li Juan
Address: Unit 1 & 8, 17th Floor, Duty-free Business Building, No.6 Fu Hua 1st Road, Futian District, Shenzhen City
Fax: 0755-82766965
Tel: 0755-82766980

Party C: Qian Zhaohua
Address: Room 716, Huan Tai Building, South Street, Zhong Guan Cun, Haidian District, Beijing
Fax: 010-62109298
Tel: 010-62109299

Party D: Xue Zhixin
Address: 25th Floor, Jin Gang Hotel, No.91 Bing Zhou North Road, Taiyuan City, Shanxi Province
Fax: 0351-4727112
Tel: 0351-4727118

Party E: Zhang Mingshe
Address: 25th Floor, Jin Gang Hotel, No.91 Bing Zhou North Road, Taiyuan City, Shanxi Province
Fax: 0351-4727111
Tel: 0351-4727111

Party F: Primalights III Agricultural Development Co, Ltd.
Address: Middle Area of Highway 73, Zhuang Er Shang Village, Huang Ling Rural Area, Xiao Dian District Taiyuan City
Fax: 0351-7123671
Tel: 0351-7870123


CHAPTER 9: CONFIDENTIALITY

The parties acknowledge and confirm that any oral and written materials exchanged pursuant to this Agreement are confidential information. The parties shall keep confidential all such information and shall not disclose any such information to any third party without prior written consent from the other parties except under the following circumstances: (a) the public knows or will know such information (provided that it is not disclosed without permission by any party who received the information); (b) applicable laws or related stock exchange rules or regulations that require the disclosure of the information; or
(c) if any party need to consult the transaction with its legal or financial consultant, the consultant shall also comply with the responsibility on confidentiality similar to those as stated here. Disclosure of information from either the staff or the consulting firm engaged by it shall be deemed as a breach by such party and such party shall bear all defaulting liabilities under this Agreement. This provision shall survive even if this Agreement becomes invalid, cancel, terminate or unenforceable for any reason.

CHAPTER 10: FURTHER WARRANTIES

The parties agree to promptly execute all necessary and favorable documents for the purpose of performing this Agreement, and take further necessary and favorable actions for the purpose of performing this Agreement.

CHAPTER 11: MISCELLANEOUS

11.1 Amendment, Modification and Supplement

The parties may amend and supplement this Agreement by a written instrument. Amendment and supplement will become an integral part of this Agreement after proper execution by the parties and have same legal effect as this Agreement.

11.2 Integrity of this Agreement

The parties hereby confirm that once this Agreement becomes effective, it shall constitute the entire agreement and understanding on all contents of this Agreement. And this Agreement supersedes all prior oral and/or written agreements and understanding reached by the parties with respect to the subject matter hereof.

11.3 Severability

If any provision or provisions of this Agreement is held invalid, illegal or unenforceable in any respect by applicable laws or regulations, the validity, legality or enforceability of the remaining provisions of this Agreement shall not be affected or impaired in any respect. The parties shall, through amicable negotiations, replace those invalid, illegal or unenforceable provision or provisions with valid provision or provisions for the purpose of obtaining similar economic effect to those from the invalid, illegal or unenforceable provisions.


11.4 Headings

The headings of this Agreement are to facilitate the reading of this Agreement and shall not be used for interpreting, illustrating or influencing in any other way the meaning of the provisions of this Agreement.

11.5 Language and Counterparts

This Agreement is written in Chinese. There are nine original copies and each copy shall have same legal effect. Each party shall hold one copy and the remaining three copies shall be provided to relevant government departments.

11.6 Successor

This Agreement shall bind on and inure to the benefit of each party's successor or the permitted transferee of the parties.

11.7 Survival

Any accrued or outstanding obligations arising from this Agreement before the expiration or early termination of this Agreement shall survive such expiration or early termination of this Agreement. The provisions in Chapter 6, Chapter 8, Chapter 9 and Article 11.7 shall survive after the termination of this Agreement.

11.8 Waiver

Any party may waiver the terms and conditions of this Agreement by a written instrument signed by the parties. No waiver by a party of the breach by the other parties in a specific case shall operate as a waiver by such party of any similar breach by the other parties in other cases.

IN WITNESS WHEREOF, the parties have signed this Agreement on the date first above written.

[No text below.]


[No text on this page.]

Party A: Aero-Biotech Science & Technology Co., Ltd.

Legal representative / authorized representative: /s/  Qian Zhaohua
                                                  ------------------------------
Common Seal: [Seal: Aero-Biotech Science & Technology Co., Ltd.]

Party B: Li Juan

Signature  /s/ Li Juan
           -------------------------------

Party C: Qian Zhaohua

Signature: /s/ Qian Zhaohua
           -------------------------------

Party D: Xue Zhixin

Signature: /s/ Xue Zhixin
           -------------------------------

Party E: Zhang Mingshe

Signature: /s/ Zhang Mingshe
           -------------------------------

Party F: Primalights III Agricultural Development Co. Ltd.
Legal representative / authorized representative:


/s/ Zhang Mingshe
-------------------------------
Common Seal: [Seal: Primalights III Agricultural Development Co. Ltd.]


EXHIBIT 4.10

TRANSLATED FOR REFERENCE ONLY.

AGREEMENT ON EQUITY INTEREST OF PRIMALIGHTS III
AGRICULTURE DEVELOPMENT CO., LTD.

This "Agreement on Equity Interest of Primalights III Agriculture Development Co., Ltd." (hereinafter referred as" this Agreement ") is signed by the following parties on June 8, 2007 in Beijing :

PARTY A : China Victory International Holdings Limited (Chinese Characters), is a comPANY Incorporated under the laws of Hong Kong Special Administrative Region. Its registered address is Room B, 12th Floor, Ritz Plaza, 122 Austin Road, Tsimshatsui, Kowloon, Hong Kong;

PARTY B : Primalights III Agriculture Development Co., Ltd. (hereinafter may be referred to as "P3A"), is a company established under the laws of People's Republic of China (hereinafter referred to as "China"). Its registered address is Middle Area of Highway 73, Zhuangershang Upper Village, Huangling Rural, Xiaodian District, Taiyuan, Shanxi Province;

PARTY C : Taiyuan Relord Enterprise Development Group Co., Ltd. (Chinese Characters), is A company established under the laws of China. Its registered address is 142 Garden West Street, Yingze District, Taiyuan City;

PARTY D : Shanxi Chuanglong Technology Investment Co., Ltd. (Chinese Characters), is a company registered under the laws of China. Its registered address is 5th Floor, West Building, 142 Changzhi Road, High-tech Zone, Taiyuan City;

PARTY E : Zhang Mingshe, a Chinese citizen, ID card number: 140104710212037;

PARTY F : Yan Lv, a Chinese citizen, ID card number : 140102196405264837;

PARTY G : Liu Jinbin, a Chinese citizen, ID card number: 140104196809082290;

PARTY H : Qian Zhaohua, a Chinese citizen, ID card number: 130224670510033;

PARTY I : Xue Zhixin, a Chinese citizen, ID card number: 140102621023081; and

PARTY J : Li Juan, a Chinese citizen, ID card number: 420983197609010023.

WHEREAS :

1. Party A and Party B (hereinafter referred to as "P3A") signed a "Purchase Agreement" ( hereinafter referred to as the "Purchase Agreement ") on October 2, 2003;

2. At the time the "Purchase Agreement" is signed, Parties C, D, E, F and G were P3A's shareholders, together holding 100% shares of P3A;

Now, the parties, by friendly consultations, have reached unanimity regarding the equity shares of P3A as follows:

I. Party A, P3A, Parties C, D, E, F and G jointly state, represent and confirm that:


i. Parties C, D, E, F and G (hereinafter collectively as the "Original Shareholders"), according to the request of Party A, signed the share transfer agreement with Parties E, H, I and J (Parties E, H, I and J hereinafter may be referred to as the "Designee"), and completed the procedures of change of business registration. The Designees have become the legal equity owners of P3A, in which, Party E holds 5%, Party H holds 30%, Party I holds 25%, Party J holds 40%.

ii. From January 1, 2004 to the completion of the aforesaid share transfer, Original Shareholders of each party, when exercising its related equity right of P3A's equity (including, but not limited to, voting in the shareholders meeting of P3A regarding the appointment of P3A directors, etc.), have sought for and executed under Party A's instructions. Each Original Shareholders, after receiving the allocated dividends or other distributions from P3A, have transferred all such dividends and other distributions to Party A voluntarily; and

iii. Party A has already performed the obligations under any agreements entered by and among Party A and any party or parties of the Original Shareholders regarding P3A's equity; including but not limited to, the Original Shareholders have already received all the equity transfer fee involving the sale of 100% of P3A's equity shares. The Original Shareholders further confirm that, if Party A owes any obligations to the Original Shareholders under any related agreements that Party A requires to perform but have not performed or have not completely performed, the Original Shareholders have already exempted Party A from such obligations and waived any and all related rights. Since October 2, 2003, no event of default or expected event of default has occurred among the parties;

iv. Party A and Party B confirm that the obligations under the "Purchase Agreement" have either been performed or exempted by the other side until the date that this Agreement is signed for any pending or performed obligations under the "Purchase Agreement" (except otherwise specified herein). From October 2, 2003 until now, no event of default or expected event of default has occurred among the parties.

II. Parties E, H, I and J shall elect and cause the candidate nominated by Aero-Biotech Science and Technology Co., Ltd. ("Aero-Biotech"), Party A's wholly-owned subsidiary, to be appointed as the director of P3A, and grant the shareholder voting rights in the shareholders meeting to the designated persons designated by Aero-Biotech for execution. Meanwhile, without the prior written consent of Party A, Parties E, H, I and J shall not engage in the following activities:

i. Sell or transfer his equity share in P3A;

ii. Create a pledge, other security interest or other third party rights over P3A's equity;

iii. Dispose P3A's equity in any other way.

III. Within the permitted scope and extent of Chinese laws and with reference to the normal arrangements of similar transactions of this kind, Parties E, H, I and J shall, at the request of Aero-Biotech, enter with Aero-Biotech and cause P3A and Aero-Biotech to enter into a service agreement, equity pledge agreement, exclusive call option agreement, etc. satisfactory to Aero-Biotech. For example, Parties E, H, I, J and P3A should undertake the following undertakings in the relevant agreements:

Except for the contracts entered during the normal course of business, P3A shall not enter into any material contracts without the prior written consent of Aero-Biotech;


P3A shall not distribute dividends in any form to its shareholders without the prior written consent of Aero-Biotech; Parties E, H, I and J shall appoint the person nominated by Aero-Biotech as a director of P3A.

IV. This Agreement shall become effective immediately after the signing by each parties. After it becomes effective, it shall supersede all P3A-related oral or written agreements, understandings or arrangements reached by any party or parties of Party A and P3A, Original Shareholders or the Designee, including, but not limited to the "Purchase Agreement".

V. This Agreement shall be governed and construed by Chinese laws.

VI. In the event any disputes arising out of this Agreement, each party shall resolve such dispute through amicable consultation. Should the relevant resolution cannot be reached, the parties may submit the case to China International Economic and Trade Arbitration Commission, in accordance with its then effective arbitration rules, for arbitration. The venue of the arbitration shall be in Beijing. The arbitral award shall be final and binding upon all parties.

(No text below.)


IN WITNESS WHEREOF, this Agreement is executed by all parties or their legal representative or authorized representative on the date first above written.

Party A : China Victory International Holdings Limited

Signed /s/
       ----------------------------------------
[Seal: China Victory International Holdings Limited]
Name :
Title :

Party B : Primalights III Agriculture Development Co., Ltd.

Signed /s/
       ----------------------------------------
[Seal: Primalights III Agriculture Development Co., Ltd.]
Name :
Title :

Party C : Taiyuan Relord Enterprise Development Group Co., Ltd.

Signed /s/
       ----------------------------------------
[Seal: Taiyuan Relord Enterprise Development Group Co., Ltd.]
Name :
Title :

Party D : Shanxi Chuanglong Technology Investment Co., Ltd.

Signed /s/
       ----------------------------------------
[Seal: Shanxi Chuanglong Technology Investment Co., Ltd.]
Name :
Title :

Party E : Zhang Mingshe

/s/ Zhang Mingshe
----------------------------------------

Party F : Yan Lv

/s/ Yan Lv
----------------------------------------

Party G : Liu Jinbin

/s/ Liu Jinbin
----------------------------------------

Party H : Qian Zhaohua

/s/ Qian Zhaohua
----------------------------------------


Party I : Xue Zhixin

/s/ Xue Zhixin
----------------------------------------

Party J : Li Juan

/s/ Li Juan
----------------------------------------


EXHIBIT 4.11

TRANSLATED FOR REFERENCE ONLY.

LETTER OF UNDERTAKING

Li Juan, Citizen of The People's Republic of China (hereinafter called "China"), with Chinese ID card number 420983197609010023, and is holding 40% equity shares of Primalights III Agriculture Development Co., Ltd. (hereinafter called "P3A").

Qian Zhaohua, Citizen of China, with Chinese ID card number 130224670510033, is holding 30% equity shares of P3A.

Xue Zhixin, Citizen of China, with Chinese ID card number 140102621023081, is holding 25% equity shares of P3A.

Zhang Mingshe, Citizen of China, with Chinese ID card number 140104710212037, is holding 5% equity shares of P3A.

All the above mentioned shareholders hereby irrevocably undertake the following promise to Aero-Biotech Science & Technology Co., Ltd (herein after called "Aero-Biotech"):

If, as a shareholder of P3A, I receive any dividends, interests or other distributions from P3A, unless restricted by laws, regulations or legal procedures, I will remit all such income to Aero-Biotech without compensation after paying the corresponding income tax.

Signature:

/s/ Li Juan
-------------------------------


/s/ Qian Zhaohua
-------------------------------


/s/ Xue Zhixin
-------------------------------


/s/ Zhang Mingshe
-------------------------------

                                                           Date: 2007-07-13


EXHIBIT 4.12

TRANSLATED FOR REFERENCE ONLY.

THE STATEMENT OF SPOUSE

Name: Lai Guanglin

ID Number/Passport Number: S2630389C

This is to confirm that I, as the spouse of Li Juan, hereby unconditionally and irrevocably consent to Primalights III Agriculture Development Co., Ltd. and Aero-Biotech Science & Technology Co., Ltd. as follows:

The equity shares hold by Li Juan in Primalights III Agriculture Development Co., Ltd., and any dividends, interests or other distributions derived from such shares, are Li Juan's personal property, and shall not be the husband-and-wife common property of Li Juan and myself at any time.

Signature: /s/ Lai Guanglin
           -----------------------------

Date: 2007.07.13


EXHIBIT 4.12

TRANSLATED FOR REFERENCE ONLY.

THE STATEMENT OF SPOUSE

Name: Xue Wei

ID Number/Passport Number: 110103197102201527

This is to confirm that I, as the spouse of Qian Zhaohua, hereby unconditionally and irrevocably consent to Primalights III Agriculture Development Co., Ltd. and Aero-Biotech Science & Technology Co., Ltd. as follows:

The equity shares hold by Qian Zhaohua in Primalights III Agriculture Development Co., Ltd., and any dividends, interests or other distributions derived from such shares, are Qian Zhaohua's personal property, and shall not be the husband-and-wife common property of Qian Zhaohua and myself at any time.

Signature: /s/ Xue Wei
           -----------------------------

Date: 2007.07.13


EXHIBIT 4.12

TRANSLATED FOR REFERENCE ONLY.

THE STATEMENT OF SPOUSE

Name: Sun Liqun

ID Number/Passport Number: 14010319700515332X

This is to confirm that I, as the spouse of Xue Zhixin, hereby unconditionally and irrevocably consent to Primalights III Agriculture Development Co., Ltd. and Aero-Biotech Science & Technology Co., Ltd. as follows:

The equity shares hold by Xue Zhixin in Primalights III Agriculture Development Co., Ltd., and any dividends, interests or other distributions derived from such shares, are Xue Zhixin's personal property, and shall not be the husband-and-wife common property of Xue Zhixin and myself at any time.

Signature: /s/ Sun Liqun
           -----------------------------

Date: 2007.07.13


EXHIBIT 4.12

TRANSLATED FOR REFERENCE ONLY.

THE STATEMENT OF SPOUSE

Name: Meng Jiangping

ID Number/Passport Number: 140102196211083245

This is to confirm that I, as the spouse of Zhang Mingshe, hereby unconditionally and irrevocably consent to Primalights III Agriculture Development Co., Ltd. and Aero-Biotech Science and Technology Co., Ltd. as follows:

The equity shares hold by Zhang Mingshe in Primalights III Agriculture Development Co., Ltd., and any dividends, interests or other distributions derived from such shares, are Zhang Mingshe's personal property, and shall not be the husband-and-wife common property of Zhang Mingshe and myself at any time.

Signature: /s/ Meng Jiangping
           -----------------------------

Date: 2007.07.13


EXHIBIT 4.13

EXECUTION COPY

SHARE PURCHASE AGREEMENT

AMONG

TPG GROWTH AC LTD.

TPG BIOTECH II, LTD.

AGRIA CORPORATION

CHINA VICTORY INTERNATIONAL HOLDINGS LIMITED

AERO BIOTECH SCIENCE & TECHNOLOGY CO., LTD. (Chinese Characters)

PRIMALIGHTS III AGRICULTURE DEVELOPMENT CO., LTD. (Chinese Characters)

AND

BROTHERS CAPITAL LIMITED

JUNE 22, 2007


TABLE OF CONTENTS

1. PURCHASE AND SALE OF SHARES.............................................    1
   1.1  SALE AND ISSUANCE OF SERIES A PREFERRED SHARES AND ORDINARY
        SHARES.............................................................    1
   1.2  CLOSING............................................................    1
   1.3  OWNERSHIP ADJUSTMENT...............................................    2
2. REPRESENTATIONS AND WARRANTIES OF THE SELLING SHAREHOLDER...............    3
   2.1  TITLE TO THE SHARES................................................    3
   2.2  AUTHORIZATION......................................................    3
   2.3  NO VIOLATIONS......................................................    3
   2.4  CONSENTS AND APPROVALS.............................................    4
   2.5  LITIGATION.........................................................    4
3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND THE COMPANY
   WARRANTORS..............................................................    4
   3.1  ORGANIZATION, GOOD STANDING AND QUALIFICATION......................    4
   3.2  CAPITALIZATION AND VOTING RIGHTS...................................    5
   3.3  SUBSIDIARIES.......................................................    5
   3.4  AUTHORIZATION......................................................    6
   3.5  VALID ISSUANCE OF SECURITIES.......................................    6
   3.6  GOVERNMENTAL APPROVALS.............................................    7
   3.7  CONSENTS...........................................................    7
   3.8  PRODUCT LIABILITY..................................................    7
   3.9  LITIGATION.........................................................    7
   3.10 KEY EMPLOYEES......................................................    8
   3.11 INTELLECTUAL PROPERTY..............................................    8
   3.12 COMPLIANCE WITH ORGANIZATIONAL DOCUMENTS AND WITH APPLICABLE LAWS..    9
   3.13 AGREEMENTS; ACTION.................................................   10
   3.14 RELATED-PARTY TRANSACTIONS.........................................   11
   3.15 LICENSES...........................................................   11
   3.16 MANUFACTURING AND MARKETING RIGHTS.................................   11
   3.17 REGISTRATION RIGHTS AND OTHER SHAREHOLDER RIGHTS...................   12
   3.18 REAL PROPERTY......................................................   12
   3.19 PERSONAL PROPERTY..................................................   13
   3.20 STATE ASSETS.......................................................   13
   3.21 FINANCIAL STATEMENTS...............................................   13
   3.22 EMPLOYEE BENEFIT PLANS.............................................   14
   3.23 TAX RETURNS, PAYMENTS AND ELECTIONS................................   14
   3.24 MINUTE BOOKS.......................................................   15
   3.25 LABOR AGREEMENTS AND ACTIONS; EMPLOYEE COMPENSATION................   15
   3.26 NON-US SUBSIDIARIES AND AFFILIATES.................................   16
   3.27 BROKERS............................................................   16
   3.28 SIGNIFICANT CUSTOMERS AND SUPPLIERS................................   16
   3.29 CHANGES............................................................   16
   3.30 BOOKS AND RECORDS..................................................   17
   3.31 ENTIRE BUSINESS....................................................   18
   3.32 AVAILABILITY AND TRANSFER OF FOREIGN CURRENCY......................   18
4. REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS........................   17
   4.1  ORGANIZATION, GOOD STANDING AND QUALIFICATION......................   17
   4.2  AUTHORIZATION......................................................   17
   4.3  COMPLIANCE WITH OTHER INSTRUMENTS AND APPLICABLE LAW...............   18

i

TABLE OF CONTENTS

   4.4  EXPERIENCE.........................................................   18
   4.5  LEGENDS............................................................   18
5. CONDITIONS AT THE CLOSING OF THE SALE AND ISSUANCE OF THE SHARES........   19
   5.1  CONDITIONS TO EACH PARTY'S OBLIGATIONS.............................   19
   5.2  CONDITIONS OF PURCHASERS' OBLIGATIONS..............................   20
   5.3  CONDITIONS OF SELLERS' OBLIGATIONS.................................   21
6. INDEMNIFICATION.........................................................   22
   6.1  INDEMNIFICATION....................................................   22
   6.2  INDEMNIFICATION PROCEDURES.........................................   22
   6.3  LIMITATION ON LIABILITY............................................   24
   6.4  CALCULATION OF LOSSES..............................................   24
   6.5  CERTAIN DAMAGES....................................................   24
   6.6  TAX TREATMENT......................................................   24
7. MISCELLANEOUS...........................................................   25
   7.1  SURVIVAL OF WARRANTIES.............................................   25
   7.2  SUCCESSORS AND ASSIGNS.............................................   25
   7.3  GOVERNING LAW......................................................   25
   7.4  DISPUTE RESOLUTION.................................................   25
   7.5  COUNTERPARTS AND FACSIMILE EXECUTION...............................   26
   7.6  TITLES AND SUBTITLES; REFERENCES...................................   26
   7.7  NOTICES............................................................   27
   7.8  AMENDMENTS AND WAIVERS.............................................   27
   7.9  SEVERABILITY.......................................................   27
   7.10 ENTIRE AGREEMENT...................................................   27
   7.11 EXPENSES AND TRANSFER TAXES........................................   28
   7.12 EXCLUSIVITY........................................................   28
   7.13 CONFIDENTIALITY....................................................   28
   7.14 FURTHER ASSURANCES.................................................   29
   7.15 INTERPRETATION.....................................................   29
   7.16 NO PRESUMPTION.....................................................   29
   7.17 SPECIFIC PERFORMANCE...............................................   29
   7.18 EXCULPATION AMONG PURCHASERS.......................................   29

Schedule 1.1 Company Warrantors
Schedule 1.2 List of Purchasers and Purchase Amount

Exhibit A    Amended and Restated Memorandum and Articles of Association
Exhibit B    Shareholders Agreement
Exhibit C    Registration Rights Agreement
Exhibit D    Post-Closing Shareholding Structure
Exhibit E    Disclosure Schedules
Exhibit F    Existing Equityholders
Exhibit G    Financial Statements
Exhibit H    PRC Opinion
Exhibit H-1  Cayman Opinion
Exhibit I    VIE Contracts
Exhibit J    Mr. Lai Guanglin's Undertaking

ii

SHARE PURCHASE AGREEMENT

This SHARE PURCHASE AGREEMENT (this "Agreement") is made as of June 22, 2007 by and among Agria Corporation, an exempted company incorporated in the Cayman Islands (the "Company"), each of the parties set forth in Schedule 1.1 (each, a "Company Warrantor" and collectively, the "Company Warrantors"), Brothers Capital Limited, a company organized and existing under the laws of the British Virgin Islands and a shareholder of the Company, in its capacity as a selling shareholder (the "Selling Shareholder," together with the Company, the "Sellers," and each, a "Seller") and each party listed as a "Purchaser" in Schedule 1.2 (collectively, the "Purchasers"). The Company, each Company Warrantor, the Selling Shareholder and each Purchaser are referred to herein as "Parties" collectively and a "Party" individually.

THE PARTIES HEREBY AGREE AS FOLLOWS:

1. PURCHASE AND SALE OF SHARES

1.1 SALE AND ISSUANCE OF SERIES A PREFERRED SHARES AND SALE OF THE ORDINARY SHARES

(a) Subject to the terms and conditions of this Agreement, at the Closing (as defined below), the Purchasers agree, severally and not jointly, to purchase from the Company, and the Company agrees to sell and issue to such Purchasers, 240 Series A Preferred Shares (as defined below), representing approximately 2.344% of the Company's total equity interests on a fully-diluted, as converted basis, at a purchase price of US$41,667 per share (the "Per New Share Purchase Price"); and the Purchasers agree, severally and not jointly, to purchase from the Selling Shareholder, and the Selling Shareholder agrees to sell to the Purchasers, 625 ordinary shares of the Company, par value US$0.001 per share (the "Ordinary Shares"), representing approximately 6.104% of the Company's total equity interests on a fully-diluted basis, at a purchase price to be mutually agreed by the Selling Shareholder and the Purchasers (the "Per Old Share Purchase Price"). The Series A Preferred Shares to be issued and sold pursuant to this Agreement shall be referred to collectively as the "New Shares." The total consideration payable by the Purchasers to the Company in respect of the New Shares shall be US$10,000,000 (the "New Shares Purchase Price"). The total consideration payable by the Purchasers to the Selling Shareholder in respect of the Old Shares is hereinafter referred to as the "Old Shares Purchase Price" and, together with the New Shares Purchase Price, the "Purchase Price". The Ordinary Shares to be sold by the Selling Shareholder pursuant to this Agreement shall be referred to collectively as the "Old Shares", and the Old Shares, together with the New Shares shall be referred to collectively as the "Shares."

(b) On or prior to the Closing Date (as defined below), the Company shall have authorized the sale and issuance of (i) the New Shares, and (ii) 240 Ordinary Shares to be issued upon conversion of the New Shares (the "Conversion Shares"). The New Shares and the Conversion Shares shall have the rights, preferences, privileges and restrictions set forth in the Amended and Restated Memorandum and Articles of Association, adopted and filed by the Company with the Registrar of Companies of the Cayman Islands on or before the Closing Date in the form attached as Exhibit A (the "Restated M&A"), including the right of each New Share to an annual dividend in the amount of 8% of the Per New Share Purchase Price prior to the occurrence of a Qualifying IPO (as defined in the Restated M&A), provided, that if a Qualifying IPO occurs before July 31, 2008, then such New Shares shall not be entitled to receive such 8% annual dividend. If a Qualifying IPO does not occur

1

before July 31, 2008, then such New Shares shall be entitled to receive such 8% annual dividend from and after July 31, 2008.

1.2 CLOSING

(a) Subject to the terms and conditions of this Agreement, the closing of the purchase and sale of the Shares (the "Closing") shall be held at the offices of Cleary Gottlieb Steen & Hamilton LLP, 39/F, Bank of China Tower, 1 Garden Road, Hong Kong, at 9:00pm (local time) on June 22, 2007 (the "Closing Date"), or at such other time and place as the Sellers and the Purchasers may mutually agree upon. At the Closing, each Purchaser shall purchase the number of Shares designated opposite such Purchaser's name on Schedule 1.2 for the aggregate purchase price set forth opposite such Purchaser's name on Schedule 1.2.

(b) At the Closing, the Company shall deliver to the Purchasers certificates representing the New Shares being purchased by the Purchasers in the amounts set forth for each Purchaser in Schedule 1.2 against delivery to the Company by such Purchasers at the Closing of (i) an executed counterpart of this Agreement, the shareholders agreement substantially in the form attached as Exhibit B dated as of the date hereof (the "Shareholders Agreement") and the registration rights agreement in substantially the form attached as Exhibit C dated as of the date hereof (the "Registration Rights Agreement" and, together with this Agreement and the Shareholders Agreement, the "Transaction Documents") and (ii) the New Shares Purchase Price and the Reimbursement Amount in the form of a wire transfer of immediately available funds.

(c) At the Closing, the Selling Shareholder shall deliver to the Purchasers certificates representing the Old Shares being purchased by the Purchasers in the amounts set forth for each Purchaser in Schedule 1.2 against delivery to the Selling Shareholder by such Purchasers at the Closing of (i) an executed counterpart of this Agreement and the Shareholders Agreement and (ii) the Old Shares Purchase Price in the form of a wire transfer of immediately available funds.

(d) Exhibit D sets forth the shareholding structure of the Company and its Subsidiaries (as defined in the Restated M&A) immediately following the Closing.

1.3 OWNERSHIP ADJUSTMENT

(a) As soon as practicable following the Closing Date, the Parties shall cause audited financial statements of the Company as of and for the year ended December 31, 2006 to be prepared in accordance with the generally accepted accounting principles of the United States ("US GAAP") and audited by one of Deloitte Touche Tohmatsu, Ernst & Young, KPMG or PricewaterhouseCoopers (collectively, the "Big Four Accounting Firms") (the "2006 Audited Financial Statements"). The 2006 Audited Financial Statements shall be delivered to the Purchasers in draft form and the Purchasers shall have an opportunity to review and comment on the draft prior to its finalization. Any comments provided by the Purchasers shall be considered in good faith by the Company. The final 2006 Audited Financial Statements shall be promptly delivered to the Parties when such final 2006 Audited Financial Statements become available. The cost of preparation of the 2006 Audited Financial Statements and of such audit shall be borne by the Company.

(b) If the Company's consolidated net income for the year ended December 31, 2006 as set forth in the 2006 Audited Financial Statements, excluding the effect of (i) extraordinary recurring gains and losses, and (ii) share-based compensation charges, if any

2

(the "2006 Reference Earnings"), is less than US$32,000,000 (the "2006 Expected Earnings"), the Per New Share Purchase Price shall be adjusted downward, such that the Per New Share Purchase Price following such adjustment shall be equal to (i) the Per New Share Purchase Price, multiplied by (ii) a fraction, the numerator of which shall be the 2006 Reference Earnings, and the denominator of which shall be the 2006 Expected Earnings. If the 2006 Reference Earnings are less than the 2006 Expected Earnings, the Company shall, within 10 days of the delivery of the 2006 Audited Financial Statements, pay to the Purchasers the adjustment amounts resulting from the adjustment specified in the preceding sentence in the form of a wire transfer of immediately available funds. If the final 2006 Audited Financial Statements are not available within 30 days after the Closing Date, the Company shall promptly deliver to the Purchasers an updated draft of the 2006 Audited Financial Statements, and the Purchasers shall be entitled to an interim adjustment to the Per New Share Purchase Price in accordance with the formula provided above and such updated draft, provided that when and if the final 2006 Audited Financial Statements are available, the interim adjustment shall be further adjusted in accordance with such final 2006 Audited Financial Statements.

2. REPRESENTATIONS AND WARRANTIES OF THE SELLING SHAREHOLDER

The Selling Shareholder represents and warrants to the Purchasers, as specified in this Article 2, as of the date hereof and as of the Closing Date, except to the extent any representation or warranty below expressly refers to another time or period. For purposes of this Article 2 and Article 3, where any statement in the representations and warranties under this Agreement is expressed to be given or made to a Party's "knowledge," "knowledge" shall mean the actual knowledge of such Party after due inquiry of such Party's officers (including chief executive officer, chief financial officer, chief technology officer and chief operating officer) and directors reasonably believed to have knowledge of the matter in question, prior to the date hereof and prior to the Closing, according to the context.

2.1 TITLE TO THE SHARES

The Selling Shareholder has the unrestricted right to sell, transfer and deliver to the Purchasers and the Purchasers will acquire at the Closing good, valid and marketable title to the Old Shares, free and clear of any Encumbrances (as defined below) other than those contemplated under the Transaction Documents and applicable Law (as defined below).

2.2 AUTHORIZATION

All corporate action on the part of the Selling Shareholder, its officers, directors and equityholders necessary for the authorization, execution and delivery of this Agreement and the performance of all obligations of the Selling Shareholder under this Agreement have been taken or will be taken prior to the Closing Date, the Selling Shareholder has duly and validly executed and delivered this Agreement, and this Agreement constitutes a valid and legally binding obligation of the Selling Shareholder, enforceable in accordance with its terms, subject to the Enforceability Exceptions (as defined below).

2.3 NO VIOLATIONS

Assuming that all consents, approvals, orders, authorizations, registrations, qualifications, notifications or filings listed under Schedule 2.3 of the Disclosure Schedules (as defined below) have been obtained or made, the execution, delivery and performance of this Agreement, and the consummation of the transactions contemplated hereby will not (i)

3

result in any violation of any provision of the Organizational Documents (as defined below) of the Selling Shareholder, (ii) result in any violation of or be in conflict with or constitute, with or without the passage of time and giving of notice, a default under, or otherwise give any other contracting party the right to terminate, accelerate or cancel, any provision under any contracts, agreements, commitments, instruments, mortgages, indentures to which the Selling Shareholder is a party or by which it is bound, or result in the creation of any lien, charge or other Encumbrance upon any assets or properties of the Selling Shareholder or the suspension, revocation, forfeiture or cancellation of any material permit, license, authorization or approval applicable to the Selling Shareholder, its business or operations or any of its assets or properties, or
(iii) result in a violation of any applicable Law except, in the case of clauses
(ii) and (iii), as would not, individually or in the aggregate, have a Material Adverse Effect (as defined below).

2.4 CONSENTS AND APPROVALS

Except as set forth in Schedule 2.4 of the Disclosure Schedules, the execution, delivery and performance of this Agreement by the Selling Shareholder does not and will not, require any Governmental Authorization (as defined below) or consent, approval, authorization or other action by or notification to any third party.

2.5 LITIGATION

There is no action, suit, proceeding, claim, arbitration or investigation (civil, criminal, regulatory or otherwise) pending before any Governmental Authority (as defined below) or, to the knowledge of the Selling Shareholder, currently threatened, against the Selling Shareholder or its activities, properties or assets that, individually or in the aggregate, would have a Material Adverse Effect, or would affect the legality, validity or enforceability of this Agreement or the consummation of the transactions contemplated hereby. The Selling Shareholder is not a party or subject to the provisions of any judgment, order, writ, decree or injunction of any Governmental Authority.

3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND THE COMPANY WARRANTORS

Except as set forth in the Disclosure Schedules attached to this Agreement as Exhibit E (the "Disclosure Schedules"), the Company and each of the Company Warrantors hereby jointly and severally represent and warrant to each of the Purchasers, as specified in this Article 3, as of the date hereof and as of the Closing Date, except to the extent any representation or warranty below expressly refers to another time or period.

3.1 ORGANIZATION, GOOD STANDING AND QUALIFICATION

The Company is an exempted company duly incorporated and organized, validly existing and in good standing under the laws of the Cayman Islands and each Company Warrantor is duly incorporated and organized, validly existing and in good standing under the laws of the jurisdiction where it purports to exist. The Company and each of the Company Warrantors have all requisite power, corporate or otherwise, and authority to own, lease and operate their properties and assets and to carry on their respective business as now being conducted, to execute and deliver the Transaction Documents, and to perform their obligations under the Transaction Documents. The Company and each of the Company Warrantors are duly qualified to transact business and are in good standing in each jurisdiction in which the properties or assets owned, leased or operated by them or the nature of the business conducted by them makes such qualification necessary, unless the failure to

4

so qualify or to be in good standing, individually or in the aggregate, would not have a Material Adverse Effect. Exhibit A contains a true, complete and accurate copy of the Restated M&A, as amended as of the date hereof.

3.2 CAPITALIZATION AND VOTING RIGHTS

Immediately prior to the Closing Date, the authorized capital of the Company will consist of:

(a) Series A Preferred Shares. 10,000 Series A Preferred Shares, par value US$0.001 per share (the "Series A Preferred Shares"), none of which are issued and outstanding prior to the Closing Date. The rights, privileges and preferences of the Series A Preferred Shares are as stated in the Restated M&A. From and after the Closing Date, each Series A Preferred Share is convertible into one Ordinary Share, subject to the Restated M&A.

(b) Ordinary Shares. 49,990,000 Ordinary Shares, of which 10,000 shares are issued and outstanding, 1,500 shares are authorized for issuance under the Company's stock option plan to be implemented following the Closing (the "2007 Stock Option Plan") and 10,000 Conversion Shares. The rights, privileges and preferences of the Ordinary Shares are as stated in the Restated M&A.

(c) The outstanding Ordinary Shares are owned by the shareholders and in the numbers specified in Exhibit F.

(d) Other than the shares authorized for issuance under the 2007 Stock Option Plan and the Conversion Shares, all outstanding Ordinary Shares are duly and validly authorized and issued, fully paid and nonassessable, and have been approved by all requisite shareholder action.

(e) Except as set forth in Schedule 3.2(e) of the Disclosure Schedules, there are no outstanding options, securities, warrants, rights (including conversion or preemptive rights, rights of first refusal or similar rights) or agreements obligating the Company or any of its Subsidiaries to issue, deliver or sell, or cause to be issued, delivered or sold, any shares of its capital stock or any securities convertible into or ultimately exchangeable or exercisable for the capital stock. Except for the Transaction Documents and as set forth in Schedule 3.2(e) of the Disclosure Schedules, there is no agreement, arrangement or obligation of any kind obligating the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any outstanding shares of its capital stock or any securities convertible into or ultimately exchangeable or exercisable for the capital stock. Except as set forth in Schedule 3.2(e) of the Disclosure Schedules, neither the Company nor any of its Subsidiaries is a party or subject to any agreement or understanding, and, to the knowledge of the Company and the Company Warrantors, there is no agreement or understanding between any persons and/or entities, that affects or relates to the holding, transfer, voting or giving of written consents with respect to any security of the Company or any of its Subsidiaries or by a director of the Company or any of its Subsidiaries.

3.3 SUBSIDIARIES

(a) The Company has the power to direct the management, operations and policies of its Subsidiaries, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise. Schedule 3.3(a) of the Disclosure Schedules lists each Subsidiary,

5

and correctly sets forth the capitalization of such Subsidiary, the Company's ownership interest therein, the ownership interest of any other person or entity therein, the nature of legal entity that the Subsidiary constitutes and the jurisdiction in which the Subsidiary was organized and exists. Except as set forth in Schedule 3.3(a) of the Disclosure Schedules, each Subsidiary (A) is duly organized and validly existing under the laws of the People's Republic of China (the "PRC", and each such Subsidiary, a "PRC Subsidiary") and (B) possesses all requisite power and authority (corporate or otherwise), and has obtained all material Governmental Authorizations, including business licenses, production, operation and distribution certificates necessary to carry on its business as now conducted.

(b) Other than the Subsidiaries, none of the Company or the Subsidiaries has any subsidiaries, nor does it presently own or control, directly or indirectly, any interest in any other corporation, association, trust, or other entity. Except as set forth in Schedule 3.3(b) of the Disclosure Schedules, none of the Company or the Subsidiaries is a participant in any joint venture, partnership or similar arrangement. Except as set forth in Schedule 3.3(b) of the Disclosure Schedules, none of the Company or the Subsidiaries maintains any offices or any branches.

(c) In respect of any ownership interest held in a Subsidiary (if any) by the Company or another Subsidiary, (i) the Company or such other Subsidiary holds good and valid title to such ownership interest free and clear of all restrictions on transfer or other Encumbrances, other than those restrictions on transfer or other Encumbrances created by the Transaction Documents or the constitutive documents of that entity and (ii) there are no outstanding options or rights for the purchase or acquisition from the Company or such other Subsidiary of such ownership interest.

For purposes of this Agreement, "Encumbrance" means any claim, charge, easement, encumbrance, lease, covenant, security, deed of trust, lien, pledge, rights of others, security interest or restriction (whether on voting, sale, transfer, disposition, or otherwise), whether imposed by contract, agreement, understanding, law, equity or otherwise.

3.4 AUTHORIZATION

All corporate action on the part of each of the Company and the Company Warrantors, their respective officers, directors and equityholders necessary for the authorization, execution and delivery of the Transaction Documents and the performance of all obligations of each of the Company and the Company Warrantors under the Transaction Documents has been taken or will be taken prior to the Closing Date, each of the Company and the Company Warrantors has duly and validly executed and delivered each Transaction Document to which it is a party, and the Transaction Documents constitute valid and legally binding obligations of each of the Company and the Company Warrantors, enforceable in accordance with their terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting enforcement of creditors' rights generally and (ii) as limited by general principles of equity (whether considered in a proceeding in equity or at law) ((i) and (ii), the "Enforceability Exceptions") .

3.5 VALID ISSUANCE OF SECURITIES

The Shares that are being purchased by the Purchasers under this Agreement, when issued, sold and delivered in accordance with the terms of this Agreement for the consideration expressed herein, will be duly authorized and validly issued, fully paid, and nonassessable, and will be free of any Encumbrances other than those contemplated under the

6

Transaction Documents and applicable Laws. The Conversion Shares have been duly and validly authorized for issuance and upon issuance in accordance with the terms of this Agreement and the Restated M&A, will be duly authorized and validly issued, fully paid, and nonassessable and will be free of any Encumbrances other than those contemplated under the Transaction Documents and applicable Laws.

3.6 GOVERNMENTAL APPROVALS

No license from, consent, approval, order or authorization of, or registration, qualification, notification or filing with, any court, governmental agency, regulatory authority or political subdivision thereof, or any other administrative authority (the "Governmental Authority" and such matters, "Governmental Authorizations") on the part of the Company, any of its Subsidiaries or any Company Warrantor is and will be required in connection with the execution, delivery and performance by the Company and any of the Company Warrantors of the Transaction Documents to which it is a party in order to consummate the transactions contemplated by the Transaction Documents, except
(i) as set forth in Schedule 3.6 of the Disclosure Schedules, (ii) the filing of the Restated M&A, and (iii) filings required by the securities laws of those jurisdictions in which the Purchasers reside, if any.

3.7 CONSENTS

Except as set forth in Schedule 3.7 of the Disclosure Schedules, the execution, delivery and performance by the Company and any of the Company Warrantors of the Transaction Documents to which it is a party in order to consummate the transactions contemplated by the Transaction Documents does not and will not require any consent, approval, authorization or other action by or notification to any third party.

3.8 PRODUCT LIABILITY

Except as set forth in Schedule 3.8 of the Disclosure Schedules, during the three-year period before Closing, neither the Company nor any of its Subsidiaries has had any liability and there is no basis for any present, or to the knowledge of the Company, future action, suit, claim or complaint against the Company or any of its Subsidiaries concerning its products and/or services that, in each case, individually or in aggregate, would have a material adverse effect on the business, financial condition, operations, assets, properties or liabilities of the Company and its Subsidiaries, taken as a whole (a "Material Adverse Effect"; it being agreed that for purposes of the Transaction Documents "Material Adverse Effect" shall be deemed not to include the impact of (i) the public disclosure of the transactions contemplated hereby, (ii) changes in Laws,
(iii) changes in accounting principles generally applicable to comparable companies, (iv) changes in the agricultural industry in the PRC, or (v) changes in general economic and market conditions).

3.9 LITIGATION

Except as set forth in Schedule 3.9 of the Disclosure Schedules, there is no action, suit, proceeding, claim, arbitration or investigation (civil, criminal, regulatory or otherwise) pending before any Governmental Authority or, to the knowledge of either the Company or the Company Warrantors, currently threatened, against the Company or any of its Subsidiaries or their respective activities, properties or assets that, individually or in the aggregate, would have a Material Adverse Effect, or would affect the legality, validity or enforceability of this Agreement or any other Transaction Document or the consummation of the transactions contemplated hereby or thereby. Neither the Company nor any of its

7

Subsidiaries is a party or subject to the provisions of any judgment, order, writ, decree or injunction of any Governmental Authority. There is no material action, suit, proceeding, claim, arbitration or investigation (civil, criminal, regulatory or otherwise) by the Company or a Subsidiary currently pending or that the Company or any of its Subsidiaries intends to initiate.

3.10 KEY EMPLOYEES

Each person listed in Schedule 3.10 of the Disclosure Schedules has executed (or will have executed, prior to the earlier of (i) a Qualifying IPO and (ii) December 31, 2007) an employment agreement with the Company or the Subsidiary listed in Schedule 3.10 that contains non-disclosure and non-competition PROVISIONS.

3.11 INTELLECTUAL PROPERTY

(a) Schedule 3.11(a) of the Disclosure Schedules contains a true, correct and complete list of all material patents, patent applications, trademarks, service marks, trade names, plant variety rights, URLs, domain names, copyrights, trade secrets, proprietary rights, processes and other items of intangible property (such rights are collectively referred to herein as the "Intellectual Property") that are used for the business of the Company and its Subsidiaries as currently conducted (the "Company Intellectual Property").

(A) Schedule 3.11(a)(A) of the Disclosure Schedules contains a true, correct and complete list of all Company Intellectual Property that was developed by the Company or the Company's Subsidiaries or Affiliates or Shanxi Primalights III Biotech Engineer Academy (Chinese Characters) (the "Self Developed IP") To the knowledge of the Company and the Company Warrantors, neither the development nor the use of the Self Developed IP conflicts with or infringes on the rights of others. To the knowledge of the Company and Company Warrantors, none of the Self Developed IP has expired, been cancelled or abandoned or is the subject of any opposition, cancellation, reissue, re-examination, interference or equivalent proceeding.

(B) Schedule 3.11(a)(B) of the Disclosure Schedules contains a true, correct and complete list of all Company Intellectual Property that was collaboratively developed by the Company or the Company's Subsidiaries with third parties (the "Collaborative IP") and includes the identification of each such third party in respect of each item of the Collaborative IP. Each of the collaborative development contracts with respect to the Collaborative IP has been provided to the Purchasers or their legal advisors prior to the date hereof, or will be provided within 15 days of the date hereof, and constitutes valid and legally binding obligations of the Company or its Subsidiaries and, to the knowledge of the Company and the Company Warrantors, the other parties thereto, enforceable against the Company or the Company's Subsidiaries (and, to the knowledge of the Company and the Company Warrantors, the other parties thereto) in accordance with its terms, subject to the Enforceability Exceptions. Each of the Company and its Subsidiaries listed in Schedule 3.11(a)(B) has a good and valid contractual right under such collaborative development contracts to use the Collaborative IP in accordance with the terms of such collaborative development contract (such right, the "Commercialization Right"). To the knowledge of the Company and the Company Warrantors, any exercise of any such Commercialization Right of any the Collaborative IP by the Company or its Subsidiaries has not and will not result in any conflict with or infringement of the rights of others.

8

(C) Schedule 3.11(a)(C) of the Disclosure Schedules contains a true, correct and complete list of all Company Intellectual Property that was purchased by the Company or the Company's Subsidiaries from third parties (such Intellectual Property, the "Purchased IP"). Each of the purchase contracts with respect to the Purchased IP has been provided to the Purchasers or their legal advisors prior to the date hereof, or will be provided within 15 days of the date hereof. Each of such purchase contracts pursuant to which the Company or its Subsidiaries purchased the Purchased IP constitutes valid and legally binding obligations of the Company or its Subsidiaries, (and, to the knowledge of the Company and the Company Warrantors, the other parties thereto), enforceable against the Company or the Company's Subsidiaries (and, to the knowledge of the Company and the Company Warrantors, the other parties thereto) in accordance with its terms (subject to the Enforceability Exceptions), and to the knowledge of the Company and the Company Warrantors, the Company or one of its Subsidiaries can exercise its rights under such purchase contracts without any conflict with or infringement of the rights of others.

(b) Schedule 3.11(b) of the Disclosure Schedules contains a true, correct and complete list of each agreement pursuant to which the Company or any of its Subsidiaries uses any Company Intellectual Property owned by a third party, or pursuant to which a third party uses any Intellectual Property owned by the Company or any of its Subsidiaries. None of the Company or any of its Subsidiaries is party to an agreement that materially restricts or limits the use by the Company and its Subsidiaries of any Company Intellectual Property (except where such restriction is imposed pursuant to an agreement or license as disclosed in Schedule 3.11(b) of the Disclosure Schedules).

(c) To the knowledge of the Company and the Company Warrantors, none of the rights of the Company and its Subsidiaries with respect to the Company Intellectual Property is being infringed by third parties. No action, suit, proceeding, claim or arbitration is pending before any Governmental Authority or, to the knowledge of the Company and the Company Warrantors, threatened against the Company or any of its Subsidiaries by any person with respect to the ownership, validity, enforceability, effectiveness or use of any Company Intellectual Property. Neither the Company nor any of its Subsidiaries has received any written notice that the Company or any of its Subsidiaries has violated or is violating any of the Intellectual Property of any other person.

(d) To the knowledge of the Company and the Company Warrantors, none of the Company's or any Subsidiary's key employees is obligated under any contract or commitment, or subject to any judgment, order, writ, decree or injunction of any court or administrative agency, that would interfere with the performance of his or her employment obligations to the Company or such Subsidiary.

3.12 COMPLIANCE WITH OTHER INSTRUMENTS AND APPLICABLE LAW

(a) Except as set forth in Schedule 3.12(a) of the Disclosure Schedules, neither the Company nor any of its Subsidiaries is in violation or default (i) of any provision of its respective certificate of incorporation, memorandum and articles of association or bylaws or similar documents in the jurisdiction of its incorporation (collectively, the "Organizational Documents"), or (ii) in any material respect of any Material Contract (as defined below), or (iii) of any provision of any national, provincial, federal, state or local law, statute, rule, regulation, judgment, order, writ, decree or injunction in each case as in effect as of the date hereof (the "Law") applicable to the Company or any of its Subsidiaries or any of their respective properties or assets, except, in the case of clauses (ii) and (iii), such violations or

9

defaults that, individually or in the aggregate, would not have a Material Adverse Effect; provided that this exception for violations of Law that would not have a Material Adverse Effect shall not apply to any Law applicable to the Company or its Subsidiaries in respect of improper or illegal payments to government or political party officials.

(b) Assuming that (i) all consents, approvals, orders, authorizations, registrations, qualifications, notifications or filings listed under Schedule 3.6 of the Disclosure Schedules have been obtained or made, and (ii) all consents, approvals, authorizations or other actions or notifications listed under Schedule 3.7 of the Disclosure Schedules have been obtained, the execution, delivery and performance of this Agreement and the other Transaction Documents, and the consummation of the transactions contemplated hereby or thereby will not (i) result in any violation of any provision of the Organizational Documents of the Company or any of its Subsidiaries, (ii) result in any violation of or be in conflict with or constitute, with or without the passage of time and giving of notice, a default under, or otherwise give any other contracting party the right to terminate, accelerate, modify or cancel, any provision under any contracts, agreements, commitments, instruments, mortgages, indentures to which the Company or any of its Subsidiaries is a party or by which it is bound, or result in the creation of any lien, charge or other Encumbrance upon any assets or properties of the Company or any of its Subsidiaries or the suspension, revocation, forfeiture or cancellation of any material permit, license, authorization or approval applicable to the Company or any of its Subsidiaries, their respective business or operations or any of their respective assets or properties, or (iii) result in a violation of any Law applicable to the Company or any of its Subsidiaries except, in the case of clauses (ii) and (iii) as would not, individually or in the aggregate, have a Material Adverse Effect.

3.13 AGREEMENTS; ACTION

(a) Except for agreements described in Schedule 3.13(a) of the Disclosure Schedules and the VIE Contracts (as defined below), there are no contracts, agreements, commitments, instruments, mortgages or indentures, written or oral, to which the Company or a Subsidiary is a party or by which it is bound that may involve (i) indebtedness for money borrowed or assumed by the Company or any of its Subsidiaries in excess of US$50,000 individually or US$200,000 in the aggregate, (ii) other obligations (contingent or otherwise) of the Company or a Subsidiary involving annual expenditures or liabilities in excess of US$200,000, or that extend for more than one year beyond the date hereof and that are not cancelable without material penalty with 90 days, (iii) the lending of money by the Company or any of its Subsidiaries, whether as lender or guarantor, in excess of US$50,000 individually or US$200,000 in the aggregate, (iv) indemnification by the Company or a Subsidiary with respect to infringements of proprietary rights, (v) the grant of a power of attorney, (vi) transactions outside the ordinary course of business, or (vii) any restriction on the Company's or any of its Subsidiaries' ability to compete or operate at any location (each instrument described under clauses (i) through (vii), a "Material Contract").

(b) True and complete copies of all written Material Contracts, including any amendments or supplements thereto, have been made available for review by each of the Purchasers or their legal advisors prior to the date hereof, or will be provided within 15 days of the date hereof.

(c) None of the Company or any of its Subsidiaries is, or has received any notice of or has any knowledge that any other party is, in breach or default in any material respect under any Material Contract, and, to the knowledge of the Company and the Company Warrantors, there has not occurred any event which would (with the passage of time, notice

10

or both) constitute such a breach or default under any of the Material Contracts by the Company or any of its Subsidiaries, as the case may be, or any other party with respect thereto.

3.14 RELATED-PARTY TRANSACTIONS

Except as set forth in Schedule 3.14 of the Disclosure Schedules and the VIE Contracts, neither the Company nor any of its Subsidiaries is a party to any contract, agreement, arrangement or understanding with any Affiliate (as defined below), officer, Director or any person in which any Affiliate, shareholder, officer or director of the Company or any of its Subsidiaries, or any member of the immediate family of any of the foregoing, has an interest that exceeds 5% of the equity of such person (each, a "Related Party"). To the knowledge of the Company and the Company Warrantors and except as disclosed in Schedule 3.14 of the Disclosure Schedules and the VIE Contracts, all the transactions with Related Parties were made on terms and conditions as favorable to the Company or such Subsidiary as would have been obtainable by it at the time in a comparable arm's-length transaction with an unrelated party.

To the knowledge of the Company and the Company Warrantors, no Related Party has any ownership interest in any firm or corporation with which the Company or any of its Subsidiaries has a material business relationship, or any firm or corporation that competes with the Company or any of its Subsidiaries.

For purposes of this Agreement, "Affiliate" of any person shall mean any person that, alone or together with any other person, directly or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, such person. For purposes of this definition, "control" means, when used with respect to any person, the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person, whether through the ownership of voting securities, by contract, or otherwise, and the terms "controlling" and "controlled" have meanings correlative to the foregoing.

3.15 LICENSES

Except as set forth in Schedule 3.15 of the Disclosure Schedules, each of the Company and its Subsidiaries has obtained all material franchises, permits, licenses, exemptions, registrations, approvals and any similar authority necessary for the conduct of its business as now being conducted by it (the "Licenses"), except as would not have, individually or in the aggregate, a Material Adverse Effect. Copies of all such Licenses have been provided to the Purchasers or their legal advisors prior to the date hereof or will be provided within 15 days of the date hereof. Except as set forth in Schedule 3.15 of the Disclosure Schedules, the Licenses are in full force and effect and neither the Company nor any of its Subsidiaries is in default in any material respect under any of its Licenses or has received any written notice relating to the suspension, alleged breach or revocation of any such Licenses.

3.16 MANUFACTURING AND MARKETING RIGHTS

Neither the Company nor any of its Subsidiaries is bound by any agreement that affects its right to develop, manufacture, assemble, license, distribute, market or sell its products or services.

11

3.17 REGISTRATION RIGHTS AND OTHER SHAREHOLDER RIGHTS

Except as set forth in Schedule 3.17 of the Disclosure Schedules, neither the Company nor any of its Subsidiaries has granted or agreed to grant or been under any obligation to grant any registration rights, including demand or "piggyback" rights other than such registration rights as granted in the Registration Rights Agreement.

3.18 REAL PROPERTY

(a) Schedule 3.18(a) of the Disclosure Schedules contains a true, correct and complete list of the street address and area of each parcel of real property in which the Company or any of its Subsidiaries holds land use rights (the "Land Use Rights").

(A) Except as set forth in Schedule 3.18(a)(A) of the Disclosure Schedules, the Company or a Subsidiary holds good and valid title to such Land Use Rights free and clear of all Encumbrances, except for Permitted Encumbrances.

(B) Except as set forth in Schedule 3.18(a)(B) of the Disclosure Schedules, the Company or a Subsidiary has paid in full any and all of the land grant premium required under applicable Laws in connection with securing such Land Use Rights.

(C) Except as set forth in Schedule 3.18(a)(C) of the Disclosure Schedules, none of the land with respect to which the Land Use Rights relate constitutes "arable land" (as defined under Chinese law) that has been converted to other uses.

(b) Schedule 3.18(b) of the Disclosure Schedules contains a true, correct and complete list of each leasehold interest pursuant to which the Company or any of its Subsidiaries holds any real property (each, a "Lease"). Each of the Leases listed in Schedule 3.18(b) has been provided to the Purchasers or their legal advisors prior to the date hereof or will be provided within 15 days of the date hereof. Each Lease constitutes the entire agreement to which the Company or any of its Subsidiaries is party with respect to the property leased thereunder. Each of the Company and its Subsidiaries has performed all of their respective obligations in all material respects under such Leases. Except as set forth in Schedule 3.18(b), there is no pending, or to the knowledge of the Company and the Company Warrantors, threatened action, suit, proceeding or claim before any Governmental Authority by others against the Company's or the Company's Subsidiaries' use of the land under such Leases.

(c) Except as set forth in Schedule 3.18(c) of the Disclosure Schedules, none of the Company or its Subsidiaries uses any material real property in the conduct of its business except insofar as it holds valid Land Use Rights or has executed a Lease with respect thereto.

(d) Except as set forth in Schedule 3.18(d) of the Disclosure Schedules, each of the Company and the Subsidiaries has obtained property ownership certification for the material plants, buildings and improvements located on all land with respect to which it holds Land Use Rights (collectively, the "Improvements") and holds good and valid title to such Improvements free and clear of all Encumbrances, except for Permitted Encumbrances. Except as set forth in Schedule 3.18(d) of the Disclosure Schedules, the Improvements do not
(i) contravene any applicable Law relating to zoning or building or (ii) violate any restrictive covenant, in the case of either (i) or (ii), the effect of which would materially interfere with or prevent the continued use of such Improvements for the purposes for which they are now being used. All of the Improvements are in reasonable operating condition and in a state of

12

reasonable maintenance and repair (except for ordinary wear and tear) and are adequate for the purposes for which they are currently being used.

(e) A true and complete copy of each of the agreements relating to the Encumbrances identified in Schedule 3.18(c) and Schedule 3.18(d) of the Disclosure Schedules (the "Mortgages") has been made available for review by each of the Purchasers or their legal advisors prior to the date hereof.

(f) No event that, with the giving of notice or passage of time or both, would constitute a default or event of default of a material nature by the Company or any Subsidiary or, to the knowledge of the Company and the Subsidiaries, by any other party, has occurred and is continuing unremedied or unwaived under the terms of any of the Land Use Rights, the Leases or Mortgages. There exists no pending or, to the knowledge of the Company and Company Warrantors, threatened condemnation, confiscation, dispute, claim, demand or similar proceeding before any Governmental Authority with respect to, or that could materially and adversely affect, the continued use and enjoyment of any Land Use Right, Lease or Improvement.

For purposes of this Agreement, "Permitted Encumbrances" means (a) Encumbrances reflected or reserved against in the most recent balance sheet delivered to the Purchasers pursuant to Section 3.21, (b) Encumbrances for Taxes not in default and payable without penalty and interest, (c) mechanics', materialmen's, carriers', workers', repairers', landlords' and similar Encumbrances arising out of or incurred in the ordinary course of business, and
(d) other Encumbrances which do not materially interfere with the Company's and any of its Subsidiaries' use of the applicable property or asset.

3.19 PERSONAL PROPERTY

All personal property and assets of each of the Company and the Subsidiaries that are reflected in the most recent balance sheet delivered to the Purchasers under Section 3.21 or that have been acquired by the Company or any of its Subsidiaries since the date of such balance sheet and that have not been disposed of in the ordinary course of the Company's or such Subsidiary's business are owned by the Company or such Subsidiary free and clear of any Encumbrances except for Permitted Encumbrances. All assets, machinery, tools and equipment of the Company or any of its Subsidiaries currently in use and necessary for the operation of the business are in a state of reasonable maintenance and repair (except for ordinary wear and tear).

3.20 STATE ASSETS

Except as set forth in Schedule 3.20 of the Disclosure Schedules, none of the assets owned or leased by the Company or any of the Subsidiaries constitute state-owned assets and are not and were not required to undergo any form of valuation under applicable Laws of the PRC. In respect of the state-owned assets leased or otherwise used by the Company or any of its Subsidiaries as set forth in Schedule 3.20 of the Disclosure Schedules, the Company and such Subsidiary have undergone all valuation procedures required under application Laws of the PRC and/or relevant Governmental Authority and obtained all necessary Governmental Authorizations to lease and use such assets.

3.21 FINANCIAL STATEMENTS

13

Exhibit G (the "Financial Statements") contains in substantially completed (to the knowledge of the Company and the Company Warrantors) draft form (i) the audited consolidated balance sheet of the Company as of December 31, 2006 (the "Balance Sheet Date") and the related audited consolidated income statement and audited consolidated cash flow statement for the year ended the Balance Sheet Date, and (ii) the audited consolidated balance sheet of the Company as of December 31, 2005 and the related audited consolidated income statement and audited consolidated cash flow statement for the year ended December 31, 2005 audited by one of the Big Four Accounting Firms, together with the notes to such financial statements. Except as set forth in the Financial Statements or in the notes to the Financial Statements, the Financial Statements have been prepared in conformity with US GAAP consistently applied, and present fairly the financial position and results of operations and cash flow of the Company as of their respective dates and for the respective periods covered thereby. Except as set forth in the Financial Statements, neither the Company nor any of its Subsidiaries has any material liabilities, contingent or otherwise which would be required to be recorded or reflected on a balance sheet or in the notes thereto under US GAAP, other than liabilities incurred in the ordinary course of business since the Balance Sheet Date and that have not had and would not have, individually or in the aggregate, a Material Adverse Effect.

3.22 EMPLOYEE BENEFIT PLANS

Except as set forth in Schedule 3.22 of the Disclosure Schedules, none of the Company or any of its Subsidiaries has any employee benefit plans.

3.23 TAX RETURNS, PAYMENTS AND ELECTIONS

(a) For purposes of this Agreement,

(A) "Tax" or "Taxes" shall mean any national, provincial, federal, state, local, foreign or other taxes (including income (net or gross), gross receipts, profits, alternative or add-on minimum, franchise, license, capital, capital stock, intangible, services, premium, mining, transfer, sales, use, ad valorem, payroll, wage, severance, employment, occupation, property (real or personal), windfall profits, social security, import, excise, value-added, custom, stamp, withholding or estimated taxes), fees, duties, assessments, withholdings or governmental charges in the nature of taxes of any kind whatsoever (including interest, penalties or additions to tax with respect to such items); and

(B) "Returns" shall mean all returns, declarations, reports, estimates, information returns and statements of any nature regarding Taxes required to be filed by the Company or any of its Subsidiaries;

Except as set forth in Schedule 3.23(a) of the Disclosure Schedules, the Company and each of its Subsidiaries have filed on a timely basis all material Returns as required by law to be filed by it. These Returns were correct and complete in all material respects. The Company and each of its Subsidiaries have timely paid all material Taxes due, except those contested by it in good faith that are listed in Schedule 3.23(a) of the Disclosure Schedules and for which an appropriate reserve has been established on the Financial Statements in accordance with US GAAP.

(b) Neither the Company nor any of its Subsidiaries has made an entity classification election for United States federal income tax purposes.

14

(c) Neither the Company nor any of its Subsidiaries has ever had any material Tax deficiency assessed in writing against it or, to the knowledge of the Company, proposed, or executed any waiver of any statute of limitations on the assessment or collection of any Tax or governmental charges.

(d) None of the Returns of the Company or its Subsidiaries have ever been audited by any Governmental Authorities nor has the Company or any of its Subsidiaries received any written notice in respect thereof, for the assessment or the proposed assessment or for the collection of any Taxes. No claim has ever been made in writing by any appropriate Governmental Authority in a jurisdiction where neither the Company nor any of its Subsidiaries filed or was obligated to file Tax returns that it is or may be subject to taxation by that jurisdiction.

(e) Neither the Company nor any Subsidiary is a party to any agreement providing for the allocation or sharing of Taxes.

(f) There are no liens for material Taxes that are due and unpaid on any of the properties or assets of the Company or any of its Subsidiaries.

(g) Schedule 3.23(g) lists each jurisdiction in which the Company or any of its Subsidiaries benefits from (i) exemptions from taxation, Tax holidays, reduction in Tax rate or similar forms of Tax relief and (ii) other material financial grants, subsidies or similar incentives granted by a governmental entity, whether or not relating to Taxes (together with the Tax incentives described in subclause (i), the "Incentives") and describes the details of such Incentives. The Company and its Subsidiaries are in compliance in all material respects with all terms and conditions of any agreement or order relating to such Incentives in such jurisdictions where such Incentives are available, and have received no written notice from any Governmental Authority claiming that such Incentives were not, or will not in the future be, available.

(h) Neither the Company nor any of its Subsidiaries has, to the knowledge of the Company, engaged in a transaction which is reportable, within the meaning of Section 6111 of the Internal Revenue Code of 1986, as amended (the "Code") and Treasury Regulations promulgated thereunder, or which is required to be disclosed to any appropriate Governmental Authority under similar legislation pursuant to applicable Law.

3.24 MINUTE BOOKS

Copies of the minute books of the Company and its Subsidiaries have been provided to the Purchasers or their legal advisors prior to the date hereof, or will be provided within 15 days of the date hereof, and are true, correct and complete copies.

3.25 LABOR AGREEMENTS AND ACTIONS; EMPLOYEE COMPENSATION

(a) Except as set forth in Schedule 3.25(a) of the Disclosure Schedules, neither the Company nor any of its Subsidiaries is bound by or subject to any collective bargaining or similar agreement with any labor union, and no collective bargaining agreement is currently being negotiated by the Company or its Subsidiaries. There is no strike or other labor dispute involving the Company or any of its Subsidiaries pending nor, to the knowledge of the Company and the Company Warrantors, threatened, that would have a Material Adverse Effect.

15

(b) Except as set forth in Schedule 3.25(b) of the Disclosure Schedules, there are no employment, consulting, severance or other employee compensation agreements or plans providing for payment in excess of RMB1,000,000 in the aggregate. Neither the execution, delivery and performance of this Agreement or any other Transaction Document, nor the consummation of the transactions contemplated hereby or thereby will result in any payment (whether of severance pay or otherwise) becoming due from the Company or any of its Subsidiaries to any director, officer, employee or shareholder thereof.

(c) Except as set forth in Schedule 3.25(c) of the Disclosure Schedules, subsequent to December 31, 2006 no senior executive officer or key employee of the Company or any of its Subsidiaries has terminated, nor has the Company or any of its Subsidiaries received any written notice that any such officer or employee is intending to terminate, his or her employment with the Company or such Subsidiary.

(d) Except as set forth in Schedule 3.25(d) of the Disclosure Schedules, each of the Company and its Subsidiaries has complied in all material respects with all applicable national, provincial, federal, state, local and foreign equal employment opportunity and other laws related to employment, except as would not have, individually or in the aggregate, a Material Adverse Effect. Except as set forth in Schedule 3.25(d) of the Disclosure Schedules, each Subsidiary has obtained the Social Security Registration Certificate issued by the relevant local labor bureau in the PRC.

3.26 NON-US SUBSIDIARIES AND AFFILIATES

None of the Company or its Subsidiaries is, nor will become as a result of the sale of Shares to the Purchasers contemplated by this Agreement, a controlled foreign corporation (as defined in the Code). The Company does not expect that it will be treated as a "passive foreign investment company" ("PFIC") (as defined in the Code) for its current taxable year, and the Company does not expect to conduct its business in a manner that would reasonably be expected to result in the Company becoming a PFIC in the foreseeable future under current law.

3.27 BROKERS

Neither the Company nor any of its Subsidiaries has any contract, agreement, arrangement or understanding with any broker, finder or similar agent with respect to the transactions contemplated by this Agreement or the other Transaction Agreements.

3.28 SIGNIFICANT CUSTOMERS AND SUPPLIERS

No customer of the Company or its Subsidiaries that comprised 10% or more of the Company's consolidated net sales during each of the years covered by the Financial Statements, and no supplier that comprised 10% or more of the Company's or any Subsidiary's consolidated purchases for each of the years covered by the Financial Statements, has since December 31, 2006 terminated, materially reduced or threatened to terminate or materially reduce its purchases from or provision of products or services to the Company or any of its Subsidiaries, as the case may be.

3.29 CHANGES

Since the Balance Sheet Date, there has not been:

16

(a) any change, condition, circumstance or occurrence or nonoccurrence of any event that, individually and in the aggregate, has had or would have a Material Adverse Effect; or

(b) any declaration or payment or other distribution in respect of any of the Company's or any of its Subsidiaries' capital stock, or any redemption, purchase or other acquisition of any of such stock by the Company or any of its Subsidiaries.

3.30 BOOKS AND RECORDS

(a) A certified copy of the true and correct Memorandum of Association and Articles of Association of the Company as in effect immediately prior to the Closing Date is attached as Schedule 3.30(A) of the Disclosure Schedules. A copy of the true and correct register of members of the Company as in effect immediately prior to the Closing Date is attached as Schedule 3.30(B) of the Disclosure Schedules.

(b) The Company and its Subsidiaries have maintained in all material respects the books and records required to be maintained pursuant to applicable Law.

3.31 ENTIRE BUSINESS

Except as set forth in Schedule 3.31 of the Disclosure Schedules, there are no material facilities, services, assets or properties shared (i) by the Company with any other person or entity that is not a Subsidiary or (ii) by any of its Subsidiaries with any other person or entity that is not the Company or another Subsidiary.

3.32 AVAILABILITY AND TRANSFER OF FOREIGN CURRENCY

Except as set forth in Schedule 3.32 of the Disclosure Schedules, all requisite foreign exchange control approvals and other authorizations, if any, by any Governmental Authority have been validly obtained and are in full force and effect to assure the ability of the Company to make any and all payments (x) to the Purchasers for dividend payments on either the Shares or the Conversion Shares as and when declared by the Board of Directors (as defined in the Restated M&A) or (y) to any other party in order to conduct its business as now conducted. The Company shall use commercially reasonable efforts to promptly obtain all the required SAFE Registrations listed on Schedule 3.32 of the Disclosure Schedules.

4. REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS

Each Purchaser hereby represents and warrants severally to the Company and the Selling Shareholder, as of the date hereof and as of the Closing Date, except to the extent any representation or warranty below expressly refers to another time or period, as follows:

4.1 ORGANIZATION, GOOD STANDING AND QUALIFICATION

Such Purchaser is duly incorporated and validly existing and in good standing under the laws of its jurisdiction of its incorporation. Such Purchaser has all requisite power and authority to own, lease and operate its properties and assets and to carry on its business as currently conducted, and to execute, deliver and perform its obligations under the Transaction Documents.

4.2 AUTHORIZATION

17

All corporate action on the part of such Purchaser, its officers, directors, and equityholders necessary for the authorization, execution and delivery of the Transaction Documents and the performance of all obligations of such Purchaser under the Transaction Documents has been taken or will be taken prior to the Closing Date, and the Transaction Documents constitute valid and legally binding obligations of such Purchaser, enforceable in accordance with their terms, subject to the Enforceability Exceptions.

4.3 COMPLIANCE WITH OTHER INSTRUMENTS AND APPLICABLE LAW

The execution, delivery and performance of this Agreement and the other Transaction Documents, and the consummation of the transactions contemplated hereby or thereby will not (i) result in any violation of any provision of the Organizational Documents of such Purchaser, (ii) result in any violation of or be in conflict with or constitute, with or without the passage of time and giving of notice, a default under, or otherwise give any other contracting party the right to terminate, accelerate or cancel, any provision under any contracts, agreements, arrangement, understandings, commitments, instruments, mortgages, indentures to which such Purchaser is a party or by which it is bound, or result in the creation of any lien, charge or other Encumbrance upon any assets or properties of such Purchaser or the suspension, revocation or cancellation of any material permit, license, authorization or approval applicable to such Purchaser, its business or operations or any of its assets or properties, or (iii) result in a violation of any Law applicable to such Purchaser, except, in the case of clauses (ii) and (iii), such violations or defaults that, individually or in the aggregate, would not have a Material Adverse Effect; provided that this exception for violations of Law that would not have a Material Adverse Effect shall not apply to any Law applicable to such Purchaser in respect of improper or illegal payments to government or political party officials.

4.4 EXPERIENCE

(a) Such Purchaser has sufficient knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of its prospective investment in the Company. It has the ability to bear the economic risks of its prospective investment. The foregoing, however, does not limit or modify the representations and warranties of the Selling Shareholder, the Company and Company Warrantors in Articles 2 and 3 of this Agreement or the right of such Purchaser to rely thereon.

(b) At the time such Purchaser was offered the Shares that it is purchasing pursuant to this Agreement, it was, and it is, an "accredited investor" as defined in Rule 501(a)(1), (a)(2), (a)(3) (a)(7) or (a)(8) of the Securities Act or 1933, as amended (the "Securities Act").

(c) Such Purchaser has no direct or indirect arrangement, or understanding with any other persons to distribute, or regarding the distribution of the Shares, in violation of the Securities Act or any other applicable state securities law.

(d) Such Purchaser acknowledges that the Shares have not been registered under the Securities Act or any applicable state securities law.

4.5 LEGENDS

Such Purchaser understands that the certificates evidencing the securities issued pursuant to this Agreement will bear the following legend:

18

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER THE SECURITIES ACT OR PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION REQUIREMENTS.

IN ADDITION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE RESTRICTIONS CONTAINED IN A SHAREHOLDERS AGREEMENT AMONG CERTAIN SHAREHOLDERS OF AGRIA CORPORATION DATED AS OF JUNE 22, 2007, AS AMENDED FROM TIME TO TIME, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL EXECUTIVE OFFICE OF THE COMPANY AND MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE COMPANY AT THE PRINCIPAL EXECUTIVE OFFICE OF THE COMPANY."

5. CONDITIONS AT THE CLOSING OF THE SALE AND ISSUANCE OF THE SHARES

5.1 CONDITIONS TO EACH PARTY'S OBLIGATIONS

The respective obligations of each Party to effect the transactions to be effected by it at the Closing are subject to the fulfillment or waiver (which shall be in writing), on or before the Closing Date, of each of the following conditions:

(a) The Company, its Subsidiaries and the Company Warrantors shall have received all Governmental Authorizations set forth in Schedule 3.6 of the Disclosure Schedules, and all consents, approvals, authorizations or other actions by or notification to any non-governmental third party as forth in Schedule 3.7 of the Disclosure Schedules, which are required in connection with the execution, delivery and performance of the Transaction Documents and the consummation of the transactions contemplated by the Transaction Documents, except where the failure to obtain such license, consent, approval, order, authorization, registration, qualification, notification, filing or other action would not have a Material Adverse Effect or materially affect the ability of any of the Parties to effect the transactions contemplated by the Transaction Documents. The Selling Shareholder shall have received all Governmental Authorizations and all consents, approvals, authorizations or other actions by or notification to any non-governmental third party set forth in Schedule 2.4 of the Disclosure Schedules, which are required in connection with the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated by this Agreement, except where the failure to obtain such consent, approval, authorization, notification, or other action would not have a Material Adverse Effect or materially affect the ability of any of the Selling Shareholder or the Purchasers to effect the transactions contemplated by the Transaction Documents.

(b) There shall not be in effect any Law that makes illegal or enjoins or prevents the consummation of the transactions contemplated under the Transaction Documents, and no action, suit, proceeding, claim, arbitration or investigation (civil, criminal, regulatory or otherwise) shall be pending or threatened which seeks any of the foregoing results.

(c) The Shareholders Agreement shall have been entered into among the Company, the Selling Shareholder and the Purchasers, and the Registration Rights Agreement shall have been entered into among the Company and the Purchasers.

19

(d) The Restated M&A shall have been adopted and shall remain in full force and effect.

(e) The Company shall have produced a business plan and budget (the "Business Plan") that shall be mutually agreed by the Purchasers and the Company.

5.2 CONDITIONS OF PURCHASERS' OBLIGATIONS

The obligations of each Purchaser to purchase the Shares pursuant to this Agreement are subject to the fulfillment or waiver, on or before the Closing Date, of each of the following conditions, the waiver of which shall be in writing and shall not be effective against any Purchaser who does not consent to such waiver, which consent must be given in writing:

(a) The representations and warranties of the Company and the Company Warrantors contained in Article 3 which are qualified as to materiality shall be true and correct, and each such representation and warranty that is not so qualified shall be true and correct, in all material respects, in each case, on and as of the Closing Date as if made on and as of the Closing Date (except for such representations and warranties expressly stated herein to be applicable solely as to a specified date which were true and correct as of such date). The representations and warranties of the Selling Shareholder contained in Article 2 which are qualified as to materiality shall be true and correct, and each such representation and warranty that is not so qualified shall be true and correct, in all material respects, in each case, on and as of the Closing Date as if made on and as of the Closing Date (except for such representations and warranties expressly stated herein to be applicable solely as to a specified date which were true and correct as of such date).

(b) Each of the Company, the Selling Shareholder and the Company Warrantors shall have performed and complied with, in all material respects, all agreements, obligations and conditions contained in the Transaction Documents that are required to be performed or complied with by it on or before the Closing Date.

(c) The Company shall have delivered to the Purchasers (i) a certificate of an officer of the Company regarding the Restated M&A and Board of Directors and shareholders resolutions relating to the transactions contemplated under the Transaction Documents, and (ii) good standing certificates of the Company and its Subsidiaries (to the extent applicable). The Selling Shareholder shall have delivered to the Purchasers (i) a certificate of an officer or director of the Selling Shareholder regarding the board of directors and shareholders resolutions relating to the transactions contemplated under this Agreement and the Shareholders Agreement, and (ii) a good standing certificate of the Selling Shareholder (to the extent applicable).

(d) The Chief Executive Officer of the Company and an officer or a director of each Company Warrantor shall have delivered to the Purchasers at the Closing, a certificate dated the Closing Date stating that the conditions specified in Sections 5.2(a) and 5.2(b) above (insofar as such conditions pertain to the Company and the Company Warrantors) have been fulfilled. An officer or director of the Selling Shareholder shall have delivered to the Purchasers at the Closing a certificate dated the Closing Date stating that the conditions specified in Sections 5.2(a) and 5.2(b) above (insofar as such conditions pertain to the Selling Shareholder) have been fulfilled.

20

(e) The Purchasers shall have received from PRC counsel to the Company, an opinion dated as of the Closing Date (the "PRC Opinion") and from Cayman Islands counsel to the Sellers, an opinion dated as of the Closing Date (the "Caymans Opinion"). Each of the PRC Opinion and the Caymans Opinion shall be in substantially the form attached hereto as Exhibit H and Exhibit H-1, respectively.

(f) To the extent applicable, the requisite number of shareholders of the Company shall have executed and delivered a written consent and waiver as of the Closing Date, in form and substance reasonably satisfactory to the Purchasers, on behalf of all shareholders of the Company, approving the transactions contemplated under the Transaction Documents and waiving all rights any such shareholder may have to receipt of notice of the transactions contemplated under the Transaction Documents and any applicable rights of consent, pre-emptive or participation rights, rights of first offer, rights of first refusal, co-sale rights or other similar rights any such shareholder may have with respect to the transactions contemplated under the Transaction Documents.

(g) All agreements in connection with the restructuring by the Company (the "Restructuring") including, without limitation, those listed in Exhibit I (each such an agreement, a "VIE Contract", and collectively, the "VIE Contracts"), shall have been duly executed and delivered by the parties thereto and shall remain in full force and effect.

(h) The Company shall have provided the Investors with (A) substantially completed (to the knowledge of the Company and the Company's Warrantors) drafts of the audited financial statements of the Company as of and for the years ended December 31, 2006 and 2005, to be prepared in accordance with US GAAP and audited by one of the Big Four Accounting Firms, and (B) unaudited management accounts for each subsequent quarter up to the Closing.

(i) The Purchasers shall have completed their business, legal and financial due diligence to their reasonable satisfaction.

(j) Mr. Lai Guanglin shall have duly signed and delivered an undertaking substantially in the form attached hereto as Exhibit J.

5.3 CONDITIONS OF SELLERS' OBLIGATIONS

The obligations of each Seller to each Purchaser at the Closing Date under this Agreement are subject to the fulfillment or waiver (which shall be in writing) on or before the Closing Date of each of the following conditions:

(a) The representations and warranties of such Purchaser contained in Article 4 which are qualified as to materiality shall be true and correct, and each such representation that is not so qualified shall be true and correct, in all material respects, in each case on and as of the Closing Date as if made on and as of the Closing Date (except for such representations and warranties expressly stated herein to be applicable solely as to a specified date which were true and correct as of such date).

(b) Such Purchaser shall have performed and complied with, in all material respects, all agreements, obligations and conditions contained in the Transaction Documents that are required to be performed or complied with by it on or before the Closing.

21

(c) Such Purchaser shall have delivered the Old Shares Purchase Price and the New Shares Purchase Price for the Old Shares and the New Shares (as applicable) being purchased by it at the Closing and the reimbursement to the Company of the fees and disbursements not to exceed US$50,000 (the "Reimbursement Amount") of its PRC counsel and Caymans counsel related to the preparation of the PRC Opinion and the Caymans Opinion referenced in Section 5.2(e).

6. INDEMNIFICATION

6.1 INDEMNIFICATION

(a) The Company and each Company Warrantor, jointly and severally, shall indemnify and hold harmless the Purchasers and their respective equityholders, subsidiaries, Affiliates, officers, directors, employees, agents and authorized representatives and each of their successors and assigns (each, a "Purchaser Indemnified Party") against any and all liabilities, obligations, losses, damages, penalties, claims, actions, costs and expenses (including reasonable legal fees) of whatever kind and nature ("Losses"), which are actually incurred by any Purchaser Indemnified Party arising out of the Company's or any Company Warrantor's breach of any of its warranties or representations in Article 3 of this Agreement.

(b) The Selling Shareholder shall indemnify and hold harmless the Purchaser Indemnified Parties against any and all Losses which are actually incurred by any Purchaser Indemnified Party arising out of the Selling Shareholder's breach of any of its warranties or representations in Article 2 of this Agreement.

(c) Each Purchaser, severally but not jointly, shall indemnify and hold harmless the Company, the Company Warrantors and their respective equityholders, subsidiaries, Affiliates, officers, directors, employees, agents and representatives and each of their successors and assigns (each, a "Company Indemnified Party") against any and all Losses which are actually incurred by any Company Indemnified Party arising out of such Purchaser's breach of any of its warranties or representations in Article 4 of this Agreement.

(d) Each Purchaser, severally but not jointly, shall indemnify and hold harmless the Selling Shareholder and its equityholders, subsidiaries, Affiliates, officers, directors, employees, agents and representatives and each of their successors and assigns (each, a "Selling Shareholder Indemnified Party") against any and all Losses which are actually incurred by any Selling Shareholder Indemnified Party arising out of such Purchaser's breach of any of its warranties or representations in Article 4 of this Agreement.

6.2 INDEMNIFICATION PROCEDURES

(a) Promptly after receipt by an indemnified party (an "Indemnified Party") under this Article 6 of notice of the commencement of any action or proceeding by any third party (including any Governmental Authority) (a "Third Party Claim"), such Indemnified Party will, if a claim in respect thereof is to be made against any indemnifying party under this Article 6, deliver to the indemnifying party a written notice of the commencement of such Third Party Claim containing reasonable detail of the Third Party Claim (a "Claim Notice") and transmit to the indemnifying party a copy of all notices and documents received by the Indemnified Party pursuant to the Third Party Claim; provided that the failure to deliver a Claim Notice or the failure to transmit a copy of such notices and documents to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified Party under this

22

Article 6, except to the extent that the indemnifying party is actually prejudiced by such failure to give notice. If the indemnifying party notifies the Indemnified Party that the indemnifying party elects to assume the defense of the Third Party Claim, the indemnifying party shall have the right, jointly with any other indemnifying party similarly noticed, to assume the defense of such Third Party Claim at its own expense with counsel reasonably satisfactory to the Indemnified Party; provided, however, that an Indemnified Party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the reasonable fees and expenses to be paid by the indemnifying party, if in the written opinion of counsel to the Indemnified Party there is a reasonable likelihood of a conflict of interest between the indemnifying party and the Indemnified Party. The indemnifying party shall have full control of such defense and proceedings, including any compromise or settlement thereof, provided that the indemnifying party shall not consent to the entry of a judgment or enter into any settlement with respect to the matter without the prior written consent of the Indemnified Party, which consent shall not be unreasonably withheld or delayed. If requested by the indemnifying party, the Indemnified Party agrees, at the sole cost and expense of the indemnifying party, to cooperate with the indemnifying party and its counsel in contesting any Third Party Claim which the indemnifying party elects to contest, including the making of any related counterclaim against the Person asserting the Third Party Claim or any cross complaint against any Person.

(b) If the indemnifying party fails to notify the Indemnified Party within 30 days after receipt of any Claim Notice that the indemnifying party elects to defend the Third Party Claim pursuant to Section 6.2(a), or if the indemnifying party elects to defend the Third Party Claim pursuant to Section 6.2(a) but fails to diligently defend such claim, then the Indemnified Party shall have the right to defend, at the sole cost and expense of the indemnifying party, the Third Party Claim by all appropriate proceedings. The Indemnified Party shall have full control over such defense and proceedings; provided, however, that the Indemnified Party shall not consent to the entry of any judgment or enter into any settlement in any Third Party Claim with respect to which indemnification is to be sought hereunder from an indemnifying party without the written consent of such indemnifying party, which consent shall not be unreasonably withheld or delayed. An indemnifying party may participate in, but may not control, any defense or settlement controlled by the Indemnified Party pursuant to this
Section 6.2(b), and the indemnifying party shall bear its own costs and expenses with respect to such participation.

(c) In the event that any Indemnified Party should have a claim against any indemnifying party under this Article 6 that does not involve a Third Party Claim, the Indemnified Party will promptly deliver to the indemnifying party a written notice containing reasonable detail of nature of the claim (an "Indemnification Notice"); provided that the failure to deliver an Indemnification Notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified Party under this Article 6, except to the extent that the indemnifying party is actually prejudiced by such failure to give notice. If the indemnifying party does not notify the Indemnified Party within 30 days from its receipt of the Indemnification Notice that the indemnifying party disputes such claim, the indemnifying party shall be deemed to have accepted and agreed with such claim. If the indemnifying party has disputed such claim, the indemnifying party and the Indemnified Party shall proceed in good faith to resolve such dispute and, if such dispute cannot be resolved in 30 days after delivery of the Indemnification Notice, the parties may pursue remedies in accordance with Section 7.4.

23

6.3 LIMITATION ON LIABILITY

(a) Notwithstanding anything to the contrary in this Agreement, in the absence of fraud, (i) (x) the Company and the Company Warrantors shall not be obligated to indemnify a Purchaser Indemnified Party under Section 6.1(a) and the Selling Shareholder shall not be obligated to indemnify a Purchaser Indemnified Party under Section 6.1(b) and (y) the Purchasers shall not be obligated to indemnify a Company Indemnified Party under Section 6.1(c) or a Selling Shareholder Indemnified Party under Section 6.1(d), except if and to the extent that the aggregate amount of Losses incurred by such Indemnified Party that would otherwise be subject to indemnification under Section 6.1(a) and
Section 6.1(b) on the one hand, or Section 6.1(c) and Section 6.1(d), on the other hand, exceeds 5% of the Purchase Price (the "Basket Amount"), and then such Indemnified Party shall be entitled to indemnification for all of its Losses in excess of the Basket Amount, and (ii) neither the aggregate liability of the Company, the Company Warrantors and the Selling Shareholder to the Purchaser Indemnified Parties, nor the aggregate liability of the Purchasers to the Company Indemnified Parties and the Selling Shareholder Indemnified Parties, for indemnification under this Article 6 shall exceed 110% of the Purchase Price. Notwithstanding the foregoing, none of the limitations on liability set forth in this Section 6.3(a) shall in any way limit any claim for (A) fraud arising under or relating to the transactions contemplated by any Transaction Document, and (B) any indemnification for Losses related to or as a result of the breach of any representation or warranty of the Company or any Company Warrantor under Sections 3.23 and 3.26.

(b) Except as otherwise provided in Section 7.17 of this Agreement, the indemnification provisions of this Article 6 shall be the sole and exclusive remedy with respect to any and all claims relating to this Agreement and shall preclude assertion by an Indemnified Party of any other remedies against an indemnifying party for claims relating to this Agreement.

6.4 CALCULATION OF LOSSES

In calculating the amount of Losses to any Indemnified Party under this Article 6, the amount of any Loss shall be net of (i) any amounts actually recovered by the Indemnified Party from any third Party (including insurance proceeds) as a result of the facts or circumstances giving rise to the Losses, and (ii) any Tax benefits or Tax losses that are actually realized by the Indemnified Party as a result of the incurrence of the Losses for which indemnification is sought. An Indemnified Party's right to indemnification pursuant to this Article 6 shall not be conditioned upon the payment of amounts by such Indemnified Party.

6.5 CERTAIN DAMAGES

In no event shall the indemnification obligations under this Agreement (including under this Article 6) or the term "Losses" cover or include consequential, incidental, special, indirect or punitive damages or lost profits suffered by an Indemnified Party, whether based on statute, contract, tort or otherwise, and whether or not arising from the indemnifying party's sole, joint or concurrent negligence, strict liability or other fault.

6.6 TAX TREATMENT

The Parties hereto agree to treat all payments made by a Seller or a Company Warrantor to or for the benefit of an indemnified Party under this Article 6 as adjustments to

24

the Old Shares Purchase Price or the New Shares Purchase Price (as the case may be) for Tax purposes and that such treatment shall govern for purposes hereof.

7. MISCELLANEOUS

7.1 SURVIVAL OF WARRANTIES

The representations and warranties of the Parties contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and shall survive for 12 months after the Closing Date, except that the representations and warranties under Sections 3.23 and 3.26 shall survive the Closing Date until 30 days after the expiration of the applicable statute of limitations (giving effect to any waiver, mitigation or extension thereof) on assessment of the relevant Tax. If a notice of a claim with respect to a breach of a representation or warranty is asserted in writing and delivered prior to the applicable time set forth above, then such representation or warranty shall survive in connection with such claim until such time as such claim is resolved in accordance with this Agreement.

7.2 SUCCESSORS AND ASSIGNS

Except as otherwise provided in this Agreement, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and permitted assigns of the Parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the Parties hereto or their respective successors and permitted assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Each Purchaser may assign or transfer any of its rights and obligations under this Agreement to any direct or indirect subsidiary or Affiliate of such Purchaser, including any fund managed by a subsidiary of the Purchaser, which assignee shall agree in writing to be bound by the terms hereof, with prior written notice being provided to the Company and the Selling Shareholder, but no such assignment shall relieve such Purchaser of its obligations under this Agreement. Any attempted assignment in contravention hereof shall be null and void.

7.3 GOVERNING LAW

This Agreement and, to the fullest extent permitted by applicable Law, all matters arising out of or relating to this Agreement, shall be governed by and construed in accordance with the law of the State of New York, United States of America.

7.4 DISPUTE RESOLUTION

(a) Any dispute, controversy or claim (each, a "Dispute") arising out of or relating to this Agreement, or the interpretation, breach, termination or validity hereof, shall be resolved at the first instance through consultation between the parties to such Dispute. Such consultation shall begin immediately after any Party has delivered written notice to any other Party to the Dispute requesting such consultation.

(b) If the Dispute is not resolved within 60 days following the date on which such notice is given, the Dispute shall be submitted to arbitration upon the request of any Party to the Dispute with notice to each other Party to the Dispute (the "Arbitration Notice").

(c) The arbitration shall be conducted in Hong Kong Special Administrative Region ("Hong Kong") under the auspices of the Hong Kong International Arbitration Centre

25

(the "Centre"). There shall be three arbitrators. The claimants in the Dispute shall collectively choose one arbitrator, and the respondents shall collectively choose one arbitrator. The Secretary General of the Centre shall select the third arbitrator, who shall be qualified to practice law in the State of New York. If any of the members of the arbitral tribunal have not been appointed within 30 days after the Arbitration Notice is given, the relevant appointment shall be made by the Secretary General of the Centre.

(d) The arbitration proceedings shall be conducted in English. The arbitration tribunal shall apply the Arbitration Rules of the United Nations Commission on International Trade Law, as in effect at the time of the arbitration, which rules shall be deemed to have been incorporated by reference into this Section 7.4. However, if such rules are in conflict with the provisions of this Section 7.4, including the provisions concerning the appointment of arbitrator, the provisions of this Section 7.4 shall prevail.

(e) Each Party to the arbitration shall cooperate with each other Party to the arbitration in making full disclosure of and providing complete access to all information and documents requested by such other party in connection with such arbitration proceedings, subject only to any confidentiality obligations binding on such Party.

(f) The award of the arbitration tribunal shall be final and binding upon the Parties, and the prevailing Party may apply to a court of competent jurisdiction for enforcement of such award.

(g) Any party to the Dispute shall be entitled to seek preliminary injunctive relief, if possible, from any court of competent jurisdiction pending the constitution of the arbitral tribunal.

(h) During the course of the arbitration tribunal's adjudication of the dispute, this Agreement shall continue to be performed except with respect to the part in dispute and under adjudication.

(i) The cost of arbitration (including legal, accounting and other professional fees and expenses reasonably incurred by any prevailing party with respect to the investigation, collection, prosecution and/or defense of any claim in the Dispute) shall be borne by the losing Party or Parties unless otherwise determined by the arbitration award.

7.5 COUNTERPARTS AND FACSIMILE EXECUTION

This Agreement and any amendment hereto or any other agreement (or document) delivered pursuant hereto may be executed in any number of counterparts, each of which shall be an original but all of such counterparts together shall constitute one and the same instrument and shall become effective (unless otherwise provided therein) when all counterparts have been signed by all relevant parties and delivered to the other parties. Any counterpart or other signature delivered by a Party by facsimile shall be deemed for all purposes as being a good and valid execution and delivery of this Agreement by that Party.

7.6 TITLES AND SUBTITLES; REFERENCES

The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement, nor as evidence of the intention of the Parties hereto. Except where otherwise indicated, all references in this

26

Agreement to Schedules, Exhibits, Articles or Sections refer to Schedules or Exhibits to or Articles or Sections of this Agreement.

7.7 NOTICES

Any and all notices required or permitted to be given to a Party pursuant to the provisions of this Agreement will be in writing and will be effective and deemed to provide such Party sufficient notice under this Agreement on the earliest of the following: (i) at the time of personal delivery, if delivery is in person; (ii) at the time of transmission by facsimile, addressed to such Party at the facsimile number indicated for such Party on the signature page of this Agreement (or hereafter modified by subsequent notice to the Parties hereto), with confirmation of receipt made by both telephone and printed confirmation sheet verifying successful transmission of the facsimile; (ii) two business days after deposit with an express overnight courier for deliveries within a country, or three business days after such deposit for international deliveries or (iv) three business days after deposit in mail by certified mail (return receipt requested) or equivalent for deliveries within a country. For the purposes of this Section, a delivery between Hong Kong and any other point in the PRC shall be considered an international delivery.

All notices for international delivery will be sent by facsimile or by express courier. All notices not delivered personally or by facsimile will be sent with postage and/or other charges prepaid and properly addressed to the Party to be notified at the address or facsimile number indicated for such Party on the signature page of this Agreement or at such other address or facsimile number as such Party may designate by giving ten days advance written notice by one of the indicated means of notice provided in this Agreement to the other Parties hereto. Notices by facsimile shall be machine verified as received.

Any Party hereto (and such Party's permitted assigns) may by notice so given change its address for future notices under this Agreement. Notice shall conclusively be deemed to have been given in the manner set forth above.

7.8 AMENDMENTS AND WAIVERS

Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only by the written consent of the Parties. No waiver of any provision nor consent to any exception to the terms of this Agreement shall be effective unless in writing and signed by the Party to be bound and then only to the specific purpose, extent and instance so provided. Any amendment or waiver effected in accordance with this Section 7.8 shall be binding upon each of the Parties hereto and their successors and permitted assigns.

7.9 SEVERABILITY

If any provision of this Agreement shall be held to be unenforceable under applicable Law, such provision shall be excluded from this Agreement and the remaining provisions of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.

7.10 ENTIRE AGREEMENT

This Agreement, the Exhibits and Schedules to this Agreement, the other Transaction Documents and all other documents referred to in this Agreement (except for the letter

27

agreement dated as of the date hereof, among the Sellers and the Purchasers) constitute the entire agreement and understanding among the Parties with respect to the subject matter hereof and supersede any and all prior negotiations, correspondence, agreements, understandings, duties or obligations between the Parties with respect to the subject matter hereof and no Party shall be liable or bound to any other Party in any manner by any warranties, representations, or covenants except as specifically set forth herein.

7.11 EXPENSES AND TRANSFER TAXES

Irrespective of whether the Closing is effected, the Company shall pay all costs and expenses that it incurs with respect to the negotiation, execution, delivery and performance of the Transaction Documents, except as otherwise provided in this Agreement.

The Sellers shall pay, or reimburse the Purchasers on demand for, all sales, use, real property transfer, transfer, stamp, registration, documentary, recording, filing or similar Taxes, if any, together with any interest thereon, penalties, fines, costs, fees, additions to Tax or additional amounts with respect thereto (collectively, "Transfer Taxes") incurred in connection with the issuance and sale of the Shares pursuant to this Agreement. The Sellers shall be responsible for preparing and timely filing any Returns required with respect to any such Transfer Taxes.

If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing Party shall be entitled to be reimbursed by the other Parties for reasonable attorney's fees, costs and necessary disbursements in addition to any other relief to which such Party may be entitled.

7.12 EXCLUSIVITY

From the date hereof until the earlier of (i) the Closing Date, and (ii) the termination of this Agreement, other than the transactions contemplated under the Transaction Documents, none of the Company nor any Company Warrantor, nor their respective Affiliates or representatives shall, directly or indirectly, (A) solicit, initiate or encourage any inquiry, discussion or proposal for, (B) propose, continue or participate in any discussions or negotiations regarding, (C) furnish to any person any information with respect to, or take any other action to facilitate any inquiries or the making of any offer or proposal with respect to, or (D) authorize, engage in, or enter into any agreement or understanding with respect to, any issuance or sale of any equity or equity-linked securities of the Company or any of it Subsidiaries or any transaction that would preclude or materially restrict or delay the transactions contemplated under the Transaction Documents.

7.13 CONFIDENTIALITY

None of the Parties (and their respective officers, directors, employees and agents) will disclose any information about the Transaction Documents or the transactions contemplated by the Transaction Documents other than that which is within the public domain (through no fault of such Party) to any outside party other than their respective employees, approved legal and other relevant consultants who are bound by confidentiality obligations and also as required by applicable statutory requirements, court orders or decrees after providing notice thereof to the other Parties. No announcements regarding any Purchaser's investment in the Company may be made by any Party hereto in any press conference, professional or trade publication, marketing materials, references on or links to

28

websites or otherwise disclosing such Purchaser's investment in the Company to the public in any manner without the prior written consent of such Purchaser.

7.14 FURTHER ASSURANCES

From and after the date of this Agreement, upon the reasonable request of any Purchaser, the Selling Shareholder or the Company, the Company, the Selling Shareholder and the Purchasers (as the case may be) shall execute and deliver such instruments, documents or other writings to satisfy their obligations hereunder.

7.15 INTERPRETATION

Unless a provision in this Agreement expressly provides otherwise: (i) the term "or" is not exclusive; (ii) words in the singular include the plural, and words in the plural include the singular; (iii) the terms "herein," "hereof," and other similar words refer to this Agreement as a whole and not to any particular section, subsection, paragraph, clause, or other subdivision; (iv) the term "including" will be deemed to be followed by ", but not limited to,";
(v) the masculine, feminine, and neuter genders will each be deemed to include the others; (vi) the terms "shall," "will," and "agrees" are mandatory, and the term "may" is permissive; (vii) the term "day" means "calendar day," and (viii) all references to "$" and "dollars" are to currency of the United States of America.

7.16 NO PRESUMPTION

The Parties acknowledge that any applicable Law that would require interpretation of any claimed ambiguities in this Agreement against the Party that drafted it has no application and is expressly waived. If any claim is made by a Party relating to any conflict, omission or ambiguity in the provisions of this Agreement, no presumption or burden of proof or persuasion will be implied because this Agreement was prepared by or at the request of any Party or its counsel.

7.17 SPECIFIC PERFORMANCE

Each of the Parties hereto recognizes and acknowledges that a breach by it of any covenants or agreements contained in this Agreement will cause the other Party to sustain damage for which it would not have an adequate remedy at law for money damages, and therefore each of the Parties hereto agrees that in the event of any such breach the aggrieved Party shall be entitled to the remedy of specific performance of such covenants and agreements and injunctive and other equitable relief in addition to any other remedy to which it may be entitled, at law or in equity.

7.18 EXCULPATION AMONG PURCHASERS

Each Purchaser acknowledges and agrees that it has, independently and without reliance on any other Purchaser, made its own evaluation and decision to purchase the Shares. Each Purchaser further acknowledges that it is not relying upon any other Purchaser in making its investment or decision to invest in the Company.

7.19 TERM

This Agreement is effective upon the Company's receipt of the New Shares Purchase Price and the Reimbursement Amount from the Purchasers and the Selling Shareholder's

29

receipt of the Old Shares Purchase Price from the Purchasers, in accordance with
Section 1.1 hereof.

[THE REMAINDER OF THIS PAGE HAS BEEN INTENTIONALLY LEFT BLANK.]

30

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above written.

THE COMPANY: AGRIA CORPORATION

By: /s/ Lai Guanglin
    ---------------------------------------
Name:
Title:

COMPANY WARRANTORS:

CHINA VICTORY INTERNATIONAL HOLDINGS
LIMITED

By: /s/ Lai Guanglin
    ---------------------------------------
Name:
Title:

AERO BIOTECH SCIENCE & TECHNOLOGY CO., LTD.
(Chinese Characters)

By: /s/ Qian Zhaohua
    ---------------------------------------
Name:
Title:

PRIMALIGHTS III AGRICULTURE DEVELOPMENT
CO., LTD. (Chinese Characters)

By: /s/ Qian Zhaohua
    ---------------------------------------
Name:
Title:

BROTHERS CAPITAL LIMITED

By: /s/ Lai Guanglin
    ---------------------------------------
Name:
Title:

SIGNATURE PAGE TO AGRIA CORPORATION SHARE PURCHASE AGREEMENT


SELLING SHAREHOLDER:

BROTHERS CAPITAL LIMITED

By: /s/ Lai Guanglin
    ---------------------------------------
Name:
Title:

PURCHASERS:

TPG GROWTH AC LTD.

By: /s/ Clive Bode
    ---------------------------------------
Name: Clive Bode
Title: Vice President and Secretary

TPG BIOTECH II, LTD.

By: /s/ Clive Bode
    ---------------------------------------
Name: Clive Bode
Title: Vice President and Secretary

SIGNATURE PAGE TO AGRIA CORPORATION SHARE PURCHASE AGREEMENT


SCHEDULE 1.1

COMPANY WARRANTORS

1. China Victory International Holding Limited ("China Victory"), a limited liability company organized and existing under the laws of the Hong Kong.

2. Aero Biotech Science & Technology Co., Ltd. (Chinese Characters) ("Beijing Aero"), a wholly foreign-owned enterprise with limited liability organized and existing under the laws of the PRC.

3. Primalights III Agriculture Development Co., Ltd. (Chinese Characters) ("P3A"), a domestically-funded limited liability company organized and existing under the laws of the PRC.

4. Brothers Capital Limited, a BVI Business Company incorporated and existing under the laws of the British Virgin Islands.

S-1

SCHEDULE 1.2

LIST OF PURCHASERS AND PURCHASE AMOUNT

PURCHASERS             NUMBER OF SHARES PURCHASED
----------             --------------------------
TPG Growth AC Ltd.     160 Preferred Shares and 417 Ordinary Shares
TPG Biotech II, Ltd.   80 Preferred Shares and 208 Ordinary Shares

S-2

EXHIBIT A

AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

A-1

EXHIBIT B

SHAREHOLDERS AGREEMENT

B-1

EXHIBIT C

REGISTRATION RIGHTS AGREEMENT

C-1

EXHIBIT D

POST-CLOSING SHAREHOLDING STRUCTURE

D-1

EXHIBIT E

DISCLOSURE SCHEDULES

F-1

EXHIBIT F

EXISTING EQUITYHOLDERS

EQUITYHOLDER                     PENCENTAGE OF ORDINARY SHARES HELD
------------                     ----------------------------------
Brothers Capital Limited                       72.88%
Morgan Finanz Capital Limited                     10%
Ariya Capital Partners Limited                    10%
Dubai Investment Group                          6.60%
Planetcorp Group Limited                        0.52%

F-1

EXHIBIT G

FINANCIAL STATEMENTS

G-1

EXHIBIT H

PRC OPINION

LETTERHEAD OF COMMERCE & FINANCE

To:

TPG Biotech II, Ltd.
TPG Growth AC Ltd.

Dear Sirs:

We are qualified lawyers of the People's Republic of China ("PRC") and are qualified to issue an opinion on the laws and regulations of the PRC.

We have acted as PRC counsel for China Victory International Holding Limited.(the "COMPANY"), a company incorporated under the laws of Hong Kong. We have been requested to give this opinion on, inter alia, the legal ownership structure of Primalights III Agriculture Development Co., Ltd. ("P3A") and Aero Biotech Science & Technology Co., Ltd. ("BEIJING AERO"), the legality and validity of the arrangements under the relevant agreements referenced in Exhibit A hereinafter (the "VIE CONTRACT").

In so acting, we have examined the originals or copies certified or otherwise identified to our satisfaction, of documents provided to us by the Company and such other documents, corporate records, certificates issued by governmental authorities in the PRC and officers of the Company and other instruments as we have deemed necessary or advisable for the purposes of rendering this opinion.

In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity with authentic original documents submitted to us as copies. We have also assumed the documents as they were presented to us up to the date of this legal opinion and that none of the documents has been revoked, amended, varied or supplemented. We have further assumed the accuracy and completeness of all factual statements in the documents. Where important facts were not independently established to us, we have relied upon certificates issued by governmental agents and representatives of the Company with proper authority and upon representations.

The following terms as used in this opinion are defined as follows:

(a) "GOVERNMENTAL AGENCIES" mean any court, governmental agency or body or any stock exchange authorities of the PRC;

(b) "GOVERNMENTAL AUTHORIZATIONS" mean all approvals, consents, waivers, sanctions, authorizations, filings, registrations, exemptions, permissions, endorsements, annual inspections, qualifications and licenses required by Governmental Agencies;

(c) "MATERIAL ADVERSE EFFECT" means any material adverse change, in or affecting the general affairs, management, business, financial position, shareholders' equity, results of operation, or prospects of the Company and its Subsidiaries taken as a whole;

H-1

(d) "PRC LAWS" mean all laws, regulations, statutes, orders, decrees, guidelines, notices, judicial interpretations, sub-ordinary legislations of the PRC which are publicly available (other than the laws of the Hong Kong Special Administrative Region, Macao Special Administrative Region and Taiwan Province);

Other capitalized terms used herein but not defined shall have the same meaning as given to them in the share purchase agreement dated [_], 2007, among TPG Growth AC Ltd., TPG Biotech II, Ltd., Agria Corporation, the Company, Beijing Aero and P3A (the "Share Purchase Agreement").

Based on the foregoing, we are of the opinion that:

(a) Beijing Aero has been incorporated and exists as a wholly foreign owned enterprise with limited liability under PRC Laws; the Company has not paid up any of the registered capital of Beijing Aero it is obligated to pay for under Bejing Aero's articles of association. According to Beijing Aero's articles of association, the Company should pay USD29,200,000 to Beijing Aero before June 29, 2007. Upon the completion of the capital contribution and relevant registration procedures in respect of such contribution, all of the registered capital fully paid up into Beijing Aero will be owned by the Company. The articles of association and business license of Beijing Aero comply with the requirements of applicable PRC Laws and are in full force and effect;

(b) P3A has been duly incorporated and is validly existing as a limited liability company under PRC Laws; 40%, 30%, 25% and 5% of the equity interests of P3A are owned by Li Juan, Qian Zhaohua, Xue Zhixin and Zhang Mingshe (the "P3A Shareholders"), respectively, and, to the best of our knowledge, except for the Exclusive Call Option Agreement, dated June 8, 2007, among Beijing Aero, the P3A Shareholders and P3A, the Equity Pledge Agreement, dated June 8, 2007, among Beijing Aero, the P3A Shareholders and P3A, and the Proxies, each dated June 8, 2007 and issued by each of the P3A Shareholders (except for Mr. Qian Zhaohua himself is a P3A Shareholder), such equity interests are free and clear of all liens, encumbrances, security interest, mortgage, pledge, equities or claims or any third-party right; each of the P3A Shareholders is a PRC citizen; all of the registered capital of P3A has been fully paid; the articles of association and business license of P3A comply with the requirements of applicable PRC Laws and are in full force and effect; except as described in the Disclosure Schedule of the Share Purchase Agreement, P3A has full power and authority (corporate and other) to own, lease and operate its properties and assets and to conduct its business within its scope of business;

(c) To the best of our knowledge after due inquiry, and except as described in the Disclosure Schedule of the Share Purchase Agreement, Beijing Aero is not(i) in violation of its articles of association, business license or any other organizational document, (ii) in violation or contravention of any PRC Law, or (iii) in violation of or in default under any contracts, agreements, arrangement, understandings, commitments, instruments, mortgage, indentures which are governed by PRC Law and to which it is a party or by which it is bound, except, in the case of clause (ii) or (iii), where such violation or default would not, individually or in the aggregate, to the reasonably expected extent, have a Material Adverse Effect;

H-2

(d) Subject to that [all direct and indirect shareholders of the Company who are qualified PRC residents should duly make foreign exchange registration of foreign investment under the SAFE's Notice on Relevant Issues Concerning Foreign Exchange Administration for PRC Residents to Engage in Financing and Inbound Investment via Overseas Special Purpose Vehicles[Hui Fa (2005) 75] (Chinese Characters)] and that the Company has fully paid up Beijing Aero's registered capital, in accordance with applicable PRC laws, all dividends and other distributions paid to China Victory from Beijing Aero may under the law and regulations of the PRC be exchanged into foreign currency and may be freely transferred out of the PRC by Beijing Aero to China Victory without the necessity of obtaining any Governmental Authorization in the PRC;

(e) To the best of our knowledge after due inquiry, there are no legal or governmental proceedings pending before any Governmental Authority in the PRC to which the Company, Beijing Aero or P3A is a party or of which any property of the Company or any of its Subsidiaries is the subject which, if determined adversely to the Company or any of its Subsidiaries, individually or in the aggregate, would have a Material Adverse Effect;

(f) To the best of our knowledge after due inquiry, neither Beijing Aero nor P3A has taken any action nor have any steps been taken or legal or administrative proceedings been commenced or threatened for the winding up, dissolution or liquidation of Beijing Aero or P3A, or the suspension, revocation, withdrawal or adverse modification of the business license of Beijing Aero or P3A;

(g) Neither Beijing Aero nor P3A is entitled to any immunity from any legal proceedings or other legal process or from enforcement, execution or attachment in respect of their obligations under any VIE contract;

(h) The choice of New York law as the governing law of each Transaction Document will be recognized by PRC courts; each of the PRC Subsidiaries can sue and be sued in its own name under the laws of the PRC.

(i) PRC courts may recognize and enforce arbitration awards of the Hong Kong International Arbitration Centre in accordance with the requirements of PRC Civil Procedures Law based on arrangements between China and Hong Kong.

(j) The ownership structure of Beijing Aero and P3A as set forth in Exhibit B hereinafter, each element individually and in the aggregate, complies with, and immediately after the Closing will comply with PRC Laws;

(k) Beijing Aero and P3A has the corporate power to enter into and perform its obligations under each of the VIE contract to which it is a party and has taken all necessary corporate action to authorize the execution, delivery and performance of each such VIE contract;

(l) Each VIE contract has been duly authorized, executed and delivered by the parties thereto, and constitutes a valid and binding agreement of the parties thereto;

H-3

(m) The execution and delivery of each VIE contract by the parties thereto and the performance by such parties of their obligations thereunder, and the consummation of the transactions contemplated by the VIE contract do not, and will not, (i) conflict with, or result in a breach or violation of, any provision of the Organizational Documents of Beijing Aero and P3A, (ii) to the best of our knowledge, result in any violation of or be in conflict with any material obligation, indenture, mortgage, deed of trust, bank loan or credit agreement or other evidence of indebtedness governed by PRC laws or any material obligation, license, lease, contract or other agreement or instrument governed by PRC laws, or (iii) result in a violation of any PRC Law;

(n) Each VIE contract is, and all of the VIE contract taken as a whole are, legal, valid and admissible as evidence under PRC Laws; except that the Equity Pledge Agreement has not been filed with the bureau of industrial and commerce, each VIE contract is in proper legal form under PRC Laws for the enforcement thereof against the parties thereto in the PRC without further action by any of the parties thereto; and to ensure the legality, validity, enforceability or admissibility in evidence of each VIE contract in the PRC, all required filings and recordings in respect of any VIE contract with any Governmental Authority have been performed;

(o) Except that the Equity Pledge Agreement has not been filed with the bureau of industrial and commerce, all Governmental Authorizations in the PRC and all consents, approvals, authorizations or other actions by or notification to any non-governmental third party required in connection with the transactions contemplated by the VIE contract (such Governmental Authorizations and third-party consents, the "Restructuring Consents") have been duly obtained and are in full force and effect, except that failure to obtain Restructuring Consents will not reasonably cause Material Adverse Effect. No Restructuring Consent has been suspended, revoked, withdrawn or adversely modified or is subject to any condition precedent which has not been fulfilled or performed and, to the best of our knowledge after due inquiry, no circumstance exists which might lead to the suspension, revocation, withdrawal or adverse modification of any such Governmental Authorization;

(p) The Restructuring ("the performance of all agreements listed in Exhibit A by the Company and/or its subsidiary and/or P3A) has been effected in compliance with all applicable PRC laws. To the extent governed by PRC laws, the Restructuring constitutes binding transactions completed by the parties to each VIE contract;

(q) To the best of our knowledge after due inquiry, neither Beijing Aero nor P3A has been notified any action, suit, proceeding, claim, arbitration or investigation (civil, criminal, regulatory or otherwise) pending before or by any Governmental Authority of the PRC or, currently threatened, against the Company or any of its Subsidiaries or their respective activities, properties or assets challenging the effectiveness or validity of any VIE contract.

(r) Assuming that each signature on behalf of each party to the collaborative development contracts with respect to the Collaborative IP is that of a person authorized to execute the same, and each of such collaborative development contracts has been duly authorized, executed and delivered, each of such collaborative development contracts with respect to the Collaborative IP constitutes valid and

H-4

legally binding obligations of the parties thereto, enforceable in accordance with its terms, subject to the Enforceability Exceptions. Each of the Company and its Subsidiaries listed in Schedule 3.11(a)(B) has a good and valid Commercialization Right under each such contract with respect to each such item of Collaborative IP. To the best of our knowledge, any exercise of any such Commercialization Right in respect of any of the Collaborative IP by the Company or its Subsidiaries has not and will not result in any conflict with or infringement of the rights of others.

(s) Assuming that each signature on behalf of each party to purchase contracts with respect to the Purchased IP is that of a person authorized to execute the same, and each of such purchase contracts has been duly authorized, executed and delivered, each of such purchase contracts with respect to the Purchased IP constitutes valid and legally binding obligations of the contractual counterparty, enforceable in accordance with its terms (subject to the Enforceability Exceptions), and to the best of our knowledge, the Company or one of its Subsidiaries can exercise its rights under such purchase contracts without any conflict with or infringement of the rights of others.

This opinion relates to the PRC Laws in effect on the date hereof.

This opinion is given solely for the benefit of the Company despite that the persons to whom it is addressed, upon the request by and in the capacity as the PRC legal counsel for the Company, include the persons other than the Company. It may not, except with the prior permit from the Company's and our prior written permission, be relied upon by anyone except for the Company in connection with this opinion or used for any other purpose.

Yours sincerely,

Commerce & Finance Law Offices

H-5

EXHIBIT A

VIE CONTRACTS

1. Agreement Related to the Shares of P3A, dated June 8, 2007, among the Company, P3A, Taiyuan Renlong Enterprise Group Co., Ltd., Shanxi Chuanglong Technology Investment Co., Ltd., Yan Lv, Liu Jinbin, Zhang Minshe, Qian Zhaohua, Xue Zhixin and Li Jian.

2. 7 share transfer agreements among Taiyuan Renlong Enterprise Group Co., Ltd., Shanxi Chuanglong Technology Investment Co., Ltd., Yan Lv, Liu Jinbin, Zhang Minshe, Qian Zhaohua, Xue Zhixin and Li Jian, each dated April 7, 2007

3. Proxy, dated June 8, 2007, issued by Li Juan

4. Proxy, dated June 8, 2007, issued by Xue Zhixin

5. Proxy, dated June 8, 2007, issued by Zhang Mingshe

6. Technology Transfer Agreement, dated June 8, 2007, between P3A and Beijing Aero

7. Technology License Agreement, dated June 8, 2007, between Beijing Aero and P3A

8. Exclusive Consultancy Service Agreement, dated June 8, 2007, between Beijing Aero and P3A

9. Exclusive Technology Development, Technical Support and Service Agreement, dated June 8, 2007, between Beijing Aero and P3A

10. Equity Pledge Agreement, dated June 8, 2007, among Beijing Aero, Li Juan, Qian Zhaohua, Xue Zhixin, Zhang Mingshe and P3A

11. Exclusive Call Option Agreement, dated June 8, 2007, among Beijing Aero, Li Juan, Qian Zhaohua, Xue Zhixin, Zhang Mingshe and P3A

12. Technology Transfer Agreement, dated June 8, 2007, between P3A and Shanxi Primalights Bioengineering Research Institute

H-6

EXHIBIT B

H-7

EXHIBIT H-1

CAYMAN OPINION

Our ref RJT/630408/2060499/v3

Your ref                                        Subject to review and amendment

TPG Growth AC Ltd.                     Direct: +852 2971 3007
TPG Biotech II, Ltd.                   Mobile: +852 9020 8007
                                       E-mail: richard.thorp@maplesandcalder.com


                                                                   [_] June 2007

Dear Sir

AGRIA CORPORATION (the "COMPANY")

We have acted as counsel as to Cayman Islands law to the Company, and have been asked to provide you with the opinions set out herein.

1 DOCUMENTS REVIEWED

We have reviewed originals, copies, drafts or conformed copies of the following documents:

1.1 the certificate of incorporation of the Company dated 14 May 2007[, the memorandum and articles of association of the Company registered on 14 May 2007] and the amended and restated memorandum and articles of association of the Company (the "RESTATED M&A") as [conditionally] adopted by Special Resolution passed on [__] June 2007;

1.2 the written resolutions of the board of directors of the Company dated [__] June 2007;

1.3 the written resolutions of the shareholders dated [__] June 2007 and the corporate records and statutory registers maintained at the registered office in the Cayman Islands;

1.4 the Certificate of Good Standing in relation to the Company issued by the Registrar of Companies;

1.5 a certificate from a director of the Company, a copy of which is attached hereto (the "DIRECTOR'S CERTIFICATE"); and

1.6 the transaction documents entered into or to be entered into by the Company and listed in the First Schedule (the "TRANSACTION DOCUMENTS").

2 ASSUMPTIONS

The following opinion is given only as to, and based on, circumstances and matters of fact existing and known to us on the date of this opinion. This opinion only relates to the laws of the Cayman Islands which are in force at the date of this opinion. In giving this opinion, we have relied (without further verification) upon the accuracy of the Director's Certificate and

I-1

the Certificate of Good Standing. We have relied upon the following assumptions, which we have not independently verified:

2.1 the Transaction Documents have been or, as the case may be, will be authorised and duly executed and delivered by or on behalf of all relevant parties in accordance with all relevant laws (other than, with respect to the Company, the laws of the Cayman Islands);

2.2 the Transaction Documents are, or will be legal, valid, binding and enforceable against all relevant parties in accordance with their terms under the law of the State of New York ("NEW YORK LAW") and all other relevant laws (other than the laws of the Cayman Islands);

2.3 the choice of New York law as the governing law of the Transaction Documents has been made in good faith and would be regarded as a valid and binding selection which will be upheld by the courts of the State of New York as a matter of New York law and all other relevant laws (other than the laws of the Cayman Islands);

2.4 copy documents, conformed copies or drafts of documents provided to us are true and complete copies of, or in the final forms of, the originals;

2.5 all signatures, initials and seals are genuine;

2.6 the power, authority and legal right of all parties under all relevant laws and regulations (other than, as a matter of Cayman Islands law, the Company) to enter into, execute, deliver and perform their respective obligations under the Transaction Documents; and

2.7 there is nothing under any law (other than the laws of the Cayman Islands) which would or might affect the opinions hereinafter appearing. Specifically, we have made no independent investigation of New York law.

3 OPINIONS

Based upon, and subject to, the foregoing and the qualifications set out below, and having regard to such legal considerations as we deem relevant, we are of the opinion that:

3.1 The Company has been duly incorporated as an exempted company with limited liability for an unlimited duration and is validly existing and in good standing under the laws of the Cayman Islands.

3.2 The Company has full power and authority under its Memorandum and Articles of Association to enter into, execute and perform its obligations under the Transaction Documents.

3.3 The execution and delivery of the Transaction Documents and the performance by the Company of its obligations thereunder does not conflict with or result in a breach of any of the terms or provisions of the Memorandum and Articles of Association of the Company or any law, public rule or regulation applicable to the Company in the Cayman Islands currently in force.

H-2

3.4 The execution, delivery and performance of the Transaction Documents has been authorised by and on behalf of the Company and, assuming the Transaction Documents have been executed and delivered by [NAME PERSON AUTHORISED TO EXECUTE TRANSACTION DOCUMENTS IN THE RESOLUTIONS], the Transaction Documents have been duly executed and delivered on behalf of the Company and constitute the legal, valid and binding obligations of the Company enforceable in accordance with their terms.

3.5 Other than the shares reserved for the 2007 Stock Option Plan (as defined in the Transaction Documents) and the Conversion Shares (as defined in the Transaction Documents), all outstanding Ordinary Shares (as defined in the Transaction Documents) are duly and validly authorized and issued as fully paid and nonassessable.

3.6 The Ordinary Shares and Preferred Shares (as defined in the Transaction Documents) that are being purchased by the TPG Growth AC Ltd. and TPG Biotech II, Ltd. under the Transaction Documents, when issued, sold and delivered in accordance with the terms of thereof for the consideration expressed therein, will be duly authorized and validly issued as fully paid and nonassessable. The Conversion Shares have been duly and validly authorised for issuance and upon issuance in accordance with the terms of the Transaction Documents and the Restated M&A, will be duly authorized and validly issued as fully paid and nonassessable.

3.7 No authorisations, consents, approvals, licenses, validations or exemptions are required by law from any governmental authorities or agencies or other official bodies in the Cayman Islands in connection with:

3.7.1 the creation, execution or delivery of the Transaction Documents by the Company;

3.7.2 subject to the payment of the appropriate stamp duty, enforcement of the Transaction Documents against the Company; or

3.7.3 the performance by the Company of its obligations under any of the Transaction Documents.

3.8 No taxes, fees or charges (other than stamp duty) are payable (either by direct assessment or withholding) to the government or other taxing authority in the Cayman Islands under the laws of the Cayman Islands in respect of:

3.8.1 the execution or delivery of the Transaction Documents;

3.8.2 the enforcement of the Transaction Documents; or

3.8.3 payments made under, or pursuant to, the Transaction Documents.

The Cayman Islands currently have no form of income, corporate or capital gains tax and no estate duty, inheritance tax or gift tax.

3.9 The courts of the Cayman Islands will observe and give effect to the choice of New York law as the governing law of the Transaction Documents.

H-3

3.10 Based solely on our inspection on [__] June 2007 of the Register of Writs and Other Originating Process in the Grand Court of the Cayman Islands, there were no actions or petitions pending against the Company in the Grand Court of the Cayman Islands.

3.11 Although there is no statutory enforcement in the Cayman Islands of foreign judgments in Hong Kong, the courts of the Cayman Islands will recognise a foreign judgment as the basis for a claim at common law in the Cayman Islands provided such judgment:

3.11.1 is given by a competent foreign court;

3.11.2 imposes on the judgment debtor a liability to pay a liquidated sum for which the judgment has been given;

3.11.3 is final;

3.11.4 is not in respect of taxes, a fine or a penalty; and

3.11.5 was not obtained in a manner and is not of a kind the enforcement of which is contrary to the public policy of the Cayman Islands.

4 QUALIFICATIONS

The opinions expressed above are subject to the following qualifications:

4.1 The term "enforceable" as used above means that the obligations assumed by the Company under the Transaction Documents are of a type which the courts of the Cayman Islands will enforce. It does not mean that those obligations will necessarily be enforced in all circumstances in accordance with their terms. In particular:

4.1.1 enforcement may be limited by bankruptcy, insolvency, liquidation, reorganisation, readjustment of debts or moratorium or other laws of general application relating to or affecting the rights of creditors;

4.1.2 enforcement may be limited by general principles of equity. For example, equitable remedies such as specific performance may not be available, inter alia, where damages are considered to be an adequate remedy;

4.1.3 some claims may become barred under the statutes of limitation or may be or become subject to defences of set off, counterclaim, estoppel and similar defences;

4.1.4 where obligations are to be performed in a jurisdiction outside the Cayman Islands, they may not be enforceable in the Cayman Islands to the extent that performance would be illegal under the laws of that jurisdiction;

4.1.5 the Cayman Islands court has jurisdiction to give judgment in the currency of the relevant obligation and statutory rates of interest payable upon judgments will vary according to the currency of the judgment. If the Company becomes insolvent and is made subject to a liquidation proceeding, the Cayman Islands court will require all debts to be proved in a common currency, which is likely to be the "functional currency" of the Company determined in accordance with

H-4

applicable accounting principles. Currency indemnity provisions have not been tested, so far as we are aware, in the courts of the Cayman Islands;

4.1.6 obligations to make payments that may be regarded as penalties will not be enforceable; and

4.1.7 the courts of the Cayman Islands may decline to exercise jurisdiction in relation to substantive proceedings brought under or in relation to the Transaction Documents in matters where they determine that such proceedings may be tried in a more appropriate forum.

4.2 Cayman Islands stamp duty may be payable if the original Transaction Documents are brought to or executed in the Cayman Islands.

4.3 To maintain the Company in good standing under the laws of the Cayman Islands, annual filing fees must be paid and returns made to the Registrar of Companies.

4.4 The obligations of the Company may be subject to restrictions pursuant to United Nations sanctions as implemented under the laws of the Cayman Islands.

4.5 A certificate, determination, calculation or designation of any party to the Transaction Documents as to any matter provided therein might be held by a Cayman Islands court not to be conclusive final and binding if, for example, it could be shown to have an unreasonable or arbitrary basis, or in the event of manifest error.

4.6 In principle a Cayman Islands court will award costs and disbursements in litigation in accordance with the relevant contractual provisions but there remains some uncertainty as to the way in which the rules of the Grand Court will be applied in practice. Whilst it is clear that costs incurred prior to judgment can be recovered in accordance with the contract, it is likely that post-judgment costs (to the extent recoverable at all) will be subject to taxation in accordance with Grand court Rules Order 62.

4.7 We reserve our opinion as to the extent to which a Cayman Islands court would, in the event of any relevant illegality, sever the offending provisions and enforce the remainder of the transaction of which such provisions form a part, notwithstanding any express provisions in this regard.

4.8 We make no comment with regard to the references to foreign statutes in the Transaction Documents.

4.9 We express no view as to the commercial terms of the Transaction Documents or whether such terms represent the intentions of the parties, and make no comment with regard to the representations which may be made by the Company.

This opinion is addressed to and for the benefit solely of the addressees and may not be relied upon by any other person for any purpose, nor may it be transmitted or disclosed to any other person without our prior written consent.

Yours faithfully

H-5

MAPLES and CALDER

H-6

FIRST SCHEDULE

1. A share purchase agreement among TPG Growth AC Ltd., TPG Biotech II, Ltd., the Company, China Victory International Holdings Limited, Aero Biotech Science & Technology Co., Ltd., Primalights III Agriculture Development Co., Ltd. and Brothers Capital Limited to be dated on or about [__] June 2007.

2. A shareholders agreement among TPG Growth AC Ltd., TPG Biotech II, Ltd., the Company and Brothers Capital Limited to be dated on or about [__] June 2007.

3. A registration rights agreement among TPG Growth AC Ltd., TPG Biotech II, Ltd. and the Company to be dated on or about [__] June 2007.

H-7

AGRIA CORPORATION
PO Box 309GT, Ugland House
South Church Street, George Town
Grand Cayman, Cayman Islands

[__] June 2007

To: Maples and Calder
1504 One International Finance Centre 1 Harbour View Street
Hong Kong

Dear Sirs

AGRIA CORPORATION (the "COMPANY")

I, [__________], being a director of the Company, am aware that you are being asked to provide a legal opinion (the "OPINION") in relation to certain aspects of Cayman Islands law. Capitalised terms used in this certificate have the meaning given to them in the Opinion. I hereby certify that:

1 The Memorandum and Articles of Association of the Company as adopted or registered on [__________] 2007 remain in full force and effect and are unamended [save for the amendments [conditionally] made by special resolution passed on [__] June 2007].

5 The written resolutions (the "RESOLUTIONS") of the board of directors dated
[DATE] were signed by all the directors in the manner prescribed in the Articles of Association of the Company.

6 The shareholders of the Company have not restricted or limited the powers of the directors in any way. There is no contractual or other prohibition (other than as arising under Cayman Islands law) binding on the Company prohibiting it from entering into and performing its obligations under the Transaction Documents.

7 The Resolutions were duly adopted, are in full force and effect at the date hereof and have not been amended, varied or revoked in any respect.

8 The directors of the Company at the date of Resolutions and at the date hereof were and are as follows:

[__________]
[__________]
[__________]

9 [Other than the shares reserved for the 2007 Stock Option Plan (as defined in the Transaction Documents) and the Conversion Shares (as defined in the Transaction Documents), all outstanding Ordinary Shares (as defined in the Transaction Documents) are free and clear of any Encumbrances (as defined in the Transaction Documents). The Ordinary Shares and Preferred Shares (as defined in the Transaction Documents) that are being purchased by the TPG Growth AC Ltd. and TPG Biotech II, Ltd. under the Transaction Documents, when issued, sold and

H-8

delivered in accordance with the terms of thereof for the consideration expressed therein, will be free and clear of any Encumbrances other than those contemplated under the Transaction Documents and applicable laws. The Conversion Shares, upon issuance in accordance with the terms of the Transaction Documents and the Restated M&A, will be free of any Encumbrances other than those contemplated under the Transaction Documents and applicable laws.]

10 The minute book and corporate records of the Company as maintained at its registered office in the Cayman Islands and made available to you are complete and accurate in all material respects, and all minutes and resolutions filed therein represent a complete and accurate record of all meetings of the shareholders and directors (or any committee thereof) (duly convened in accordance with the Articles of Association of the Company) and all resolutions passed at the meetings, or passed by written consent as the case may be.

11 Each director considers the transactions contemplated by the Transaction Documents to be of commercial benefit to the Company and has acted bona fide in the best interests of the Company, and for a proper purpose of the Company, in relation to the transactions the subject of the Opinion.

12 To the best of my knowledge and belief, having made due inquiry, the Company is not the subject of legal, arbitral, administrative or other proceedings in any jurisdiction. Nor have the directors or shareholders taken any steps to have the Company struck off or placed in liquidation, nor have any steps been taken to wind up the Company. Nor has any receiver been appointed over any of the Company's property or assets.

13 The Company is not a central bank, monetary authority or other sovereign entity of any state.

I confirm that you may continue to rely on this Certificate as being true and correct on the day that you issue the Opinion unless I shall have previously notified you personally (Attn: Mr. Richard Thorp) to the contrary.

Signature:
[Director]

H-9

EXHIBIT I

VIE CONTRACTS

1. Agreement Related to the Shares of P3A, dated June 8, 2007, among the Company, P3A, Taiyuan Renlong Enterprise Group Co., Ltd., Shanxi Chuanglong Technology Investment Co., Ltd., Yan Lu, Liu Jinbin, Zhang Mingshe, Qian Zhaohua, Xue Zhixin and Li Juan, which amended the Share Acquisition Agreement, dated October 2, 2003, between the Company and P3A

2. 7 share transfer agreements among Taiyuan Renlong Enterprise Group Co., Ltd., Shanxi Chuanglong Technology Investment Co., Ltd., Yan Lv, Liu Jinbin, Zhang Minshe, Qian Zhaohua, Xue Zhixin and Li Jian, each dated April 7, 2007

3. Proxy, dated June 8, 2007, issued by Li Juan

4. Proxy, dated June 8, 2007, issued by Xue Zhixin

5. Proxy, dated June 8, 2007, issued by Zhang Mingshe

6. Technology Transfer Agreement, dated June 8, 2007, between P3A and Beijing Aero

7. Proprietary Technology License Agreement, dated June 8, 2007, between Beijing Aero and P3A

8. Exclusive Consultancy Service Agreement, dated June 8, 2007, between Beijing Aero and P3A

9. Exclusive Technology Development, Technology Support and Service Agreement, dated June 8, 2007, between Beijing Aero and P3A

10. Equity Pledge Agreement, dated June 8, 2007, among Beijing Aero, Li Juan, Qian Zhaohua, Xue Zhixin, Zhang Mingshe and P3A

11. Exclusive Call Option Agreement, dated June 8, 2007, among Beijing Aero, Li Juan, Qian Zhaohua, Xue Zhixin, Zhang Mingshe and P3A

12. Technology Transfer Agreement, dated June 8, 2007, between P3A and Shanxi Primalights Bioengineering Research Institute

I-1

EXHIBIT J

MR. LAI'S UNDERTAKING

June [_], 2007

To TPG Growth AC Ltd. and TPG Biotech II, Ltd.:

This undertaking (the "Undertaking") is made in connection with the investment by TPG Growth AC Ltd. and TPG Biotech II, Ltd. (collectively, the "Investors") in Agria Corporation (the "Company"), and constitutes the legal, valid, binding and enforceable obligation of the undersigned, subject to the Enforceability Exceptions. All the terms used herein and not defined shall have the meanings assigned to them in the Share Purchase Agreement, dated June [_], 2007, among the Company, Brothers Capital Limited ("Brothers Capital") and the Investors (the "Share Purchase Agreement").

I hereby irrevocably and unconditionally undertake, agree and covenant that:

1. I will cause Brothers Capital and the Company to honor their respective obligations set forth in the Transaction Documents (it being understood and agreed that in doing so I shall not be personally obligated to assume any financial or other obligation of Brothers Capital or the Company);

2. I will own not less than [50]% of the ownership interests of Brothers Capital; and

3. I will not relinquish the actual and continued effective control of Brothers Capital, and I will not engage in any conduct which would result, or could be reasonably expected to result in, the loss of my actual effective control of Brothers Capital.

All of my obligations under this Undertaking shall immediately terminate at the earlier of (i) when the Investors cease to own Shares representing, in the aggregate, at least 25% of the Shares purchased by the Investors pursuant to the Share Purchase Agreement or (ii) the occurrence of a Qualifying IPO.

This Undertaking and, to the fullest extent permitted by applicable Law, all matters arising out of or relating to this Undertaking, shall be governed by and construed in accordance with the law of the State of New York, United States of America.

1

Very truly yours,

Lai Guanglin


ACKNOWLEDGED AND AGREED TO:

TPG Growth AC Ltd.

By:
Name: Clive Bode
Title: Vice President and Secretary

TPG Biotech II, Ltd.

By:
Name: Clive Bode
Title: Vice President and Secretary

Signature Page to Mr. Lai's Undertaking


EXHIBIT 4.14

Execution Copy

SHAREHOLDERS AGREEMENT

AMONG

TPG GROWTH AC LTD.

TPG BIOTECH II, LTD.

BROTHERS CAPITAL LIMITED

AND

AGRIA CORPORATION

JUNE 22, 2007


TABLE OF CONTENTS

1. Definitions.............................................................    1

2. Board of Directors; Preferred Protective Provisions.....................    1
   2.1  Board of Directors.................................................    1
   2.2  Preferred Protective Provisions....................................    3
   2.3  Additional Preferred Protective Provisions.........................    5
   2.4  Limitation on the Rights of the Investors..........................    6
   2.5  Certain Dividends..................................................    6

3. Restrictions on Transfer................................................    6
   3.1  General Provisions; Restrictions...................................    6
   3.2  Rights of First Refusal............................................    8
   3.3  Co-Sale Rights.....................................................    9
   3.4  Excluded Transactions..............................................   11
   3.5  Lock-up Agreements.................................................   11

4. Preemptive Rights.......................................................   12
   4.1  Sale Notice........................................................   12
   4.2  Exercise of Preemptive Rights......................................   12
   4.3  Non-Exercise.......................................................   12
   4.4  Excluded Transactions..............................................   12
   4.5  Limitations........................................................   13

5. Redemption Rights.......................................................   13
   5.1  Investors' Redemption Rights.......................................   13

6. Affirmative Covenants of the Company....................................   14
   6.1  Other Shareholders Agreements......................................   14
   6.2  Business Practices.................................................   14
   6.3  Financial Information..............................................   15
   6.4  Access to Information..............................................   15
   6.5  Tax................................................................   15
   6.6  Stock Option Plans.................................................   16
   6.7  No Public Disclosure...............................................   17
   6.8  Further Actions....................................................   17
   6.9  Qualifying IPO.....................................................   17
   6.10 Limitations........................................................   17
   6.11 Additional Covenants relating to Restructuring.....................   17

i

7. Restrictive Legends and Stop-Transfer Orders............................   18
   7.1  Legend.............................................................   18
   7.2  Stop Transfer Instructions.........................................   18

8. Representations, Warranties and Covenants...............................   19
   8.1  Representations and Warranties of the Shareholders.................   19
   8.2  Additional Representations, Warranties and Covenants of
        Brothers Capital...................................................   19
9. General.................................................................   20
   9.1  Amendments; Waivers................................................   20
   9.2  Commercially Reasonable Efforts; Further Assurances................   21
   9.3  Governing Law......................................................   21
   9.4  Dispute Resolution.................................................   21
   9.5  Obligations of Transferees.........................................   22
   9.6  Termination........................................................   22
   9.7  Titles and Subtitles; References...................................   23
   9.8  Counterparts.......................................................   23
   9.9  Parties in Interest................................................   23
   9.10 Notices............................................................   23
   9.11 Attorney's Fees....................................................   24
   9.12 Specific Performance...............................................   24
   9.13 Severability.......................................................   24
   9.14 Entire Agreement...................................................   24
   9.15 No Presumption.....................................................   24
   9.16 Aggregation of Stock...............................................   25
   9.17 Interpretation.....................................................   25

Schedule 8.2 - List of Shareholder Agreements between Brothers Capital Limited and third parties prior to the date of this Agreement

ii

SHAREHOLDERS AGREEMENT

This SHAREHOLDERS AGREEMENT (this "Agreement") is made as of June 22, 2007 by and among Agria Corporation, an exempted company incorporated in the Cayman Islands (the "Company"), Brothers Capital Limited, a company organized and existing under the laws of the British Virgin Islands and a shareholder of the Company ("Brothers Capital"), and the entities listed under the heading "Investors" on Exhibit A (each an "Investor," and together the "Investors", and together with Brothers Capital, the "Shareholders"). The Company, Brothers Capital and the Investors are referred to herein as "Parties" collectively and a "Party" individually.

RECITALS

A. The Company desires to sell Series A Preferred Shares and Brothers Capital desires to sell Ordinary Shares to the Investors pursuant to that certain share purchase agreement among the Company, the Investors and certain other parties dated June 22, 2007 (the "Share Purchase Agreement");

B. The execution of this Agreement is a condition precedent under the Share Purchase Agreement; and

C. The Shareholders desire to set forth certain agreements among themselves as shareholders of the Company.

NOW THEREFORE, in consideration of the foregoing and of the mutual promises, covenants and conditions contained herein, the Parties hereto agree as follows:

1. DEFINITIONS

Capitalized terms used in this Agreement but not otherwise defined herein shall have the meanings ascribed to them in the Share Purchase Agreement.

2. BOARD OF DIRECTORS; PREFERRED PROTECTIVE PROVISIONS

2.1 Board of Directors.

(a) Election of Directors.

(i) Directors Nominated by Brothers Capital. Each Shareholder agrees that it will vote, or cause to be voted, all Shares and other voting securities of the Company now owned or hereafter acquired by it so as to elect to the Board of Directors (as defined in the Restated M&A) five designees (the "Brothers Capital Designees"), nominated by Brothers Capital. To effectuate this Agreement, the Company shall not record any vote contrary to the terms of this Section 2.1(a)(i) without the written consent of Brothers Capital.

(ii) Director Nominated by the Investors. Each Shareholder agrees that it will vote, or cause to be voted, all Shares and other voting securities of the Company now

1

owned or hereafter acquired by it so as to elect to the Board of Directors one designee (the "Investor Designee") of the Investors, nominated by the Investors. To effectuate this Agreement, the Company shall not record any vote contrary to the terms of this Section 2.1(a)(ii) without the written consent of all Investors.

(iii) Investors' Right to Nominate Independent Director. The Investors shall have the right to nominate one independent director, subject to the approval by the Board of Directors.

(b) Removal. If any of Brothers Capital or the Investors shall notify the other Shareholders of its decision to remove its designated designee(s), each Shareholder agrees that it will vote all of the Shares and other voting securities of the Company owned or held of record by it so as to remove such director. Except as provided in the immediately preceding sentence, no director designated by any of Brothers Capital or the Investors shall be removed from the Board of Directors unless the designating party of such director consents to such removal.

(c) Successors. If a Brothers Capital Designee or the Investor Designee shall cease to serve on the Board of Directors (whether by reason of death, resignation, removal or otherwise), the party that designated such director shall be entitled to designate a successor director, nominated in accordance with Section 2.1(a), to fill the vacancy created thereby. Each Shareholder agrees that it will vote all of the Shares and other voting securities of the Company owned or held of record by it so as to elect such designee as a director.

(d) Proxy. For so long as this Agreement is in effect, if any Shareholder fails or refuses to vote that Shareholder's Shares as provided in this Section 2.1, without further action by such Shareholder, such Shareholder shall be deemed to have granted an irrevocable proxy to the Company to be "present" at any meeting relating to such a vote and to vote the Shares owned by such Shareholder in accordance with this Agreement, and each Shareholder hereby grants to the Company such irrevocable proxy. The Company hereby agrees to vote such proxy Shares in accordance to this Section 2.1.

(e) Board of Directors for Subsidiaries. The Company hereby agrees to exercise its rights and to vote, to the extent applicable, its shares in each of its Subsidiaries (as defined in the Restated M&A), except for Primalights III Agriculture Development Co., with respect to the election of the members of the board of directors of each Subsidiary in accordance with this Section 2 and cause the composition of the board of directors of each Subsidiary to be identical to that of the Company's Board of Directors, except as specifically consented to by the majority vote of the Brothers Capital Designees and the Investor Designee, voting together.

(f) Observer. One nominee of the Investors (the "Observer"), nominated by the Investors shall be entitled to attend and observe, in a non-voting capacity, all meetings of the Board of Directors and any committee thereof, and shall receive notice of all such meetings as if the Observer were a Director of the Company, or a member of such committee, as applicable.

(g) The Investors agree and shall hold in confidence and not use or disclose, and shall cause the Observer (and his or her successors) and the Investor Designee (and his or her respective successors) to hold in confidence and not use or disclose, any confidential

2

information provided to or acquired by any of the foregoing in connection with the provisions of this Agreement, other than solely in respect of the Investors' role as investors in the Company. Without limiting the foregoing, the Investors shall not use or disclose any such confidential information in connection with any investment by the Investors or any Affiliates or related parties of the Investors in a competitor of the Company or any subsidiaries of such competitor.

(h) Liability Insurance and Indemnity.

(i) As soon as commercially reasonable, the Company shall purchase and maintain a policy of directors and officers' liability insurance ("D&O Insurance"), including employment practices liability coverage, with a carrier and in an amount to be approved by the Board of Directors and reasonably satisfactory to the Investors.

(ii) In the event of a merger or sale of the Company in which the Company is not the survivor, the Company shall use its commercially reasonable efforts to provide in the agreements in connection with such merger or sale that the successor assumes the Company's obligations to purchase and maintain the D&O Insurance pursuant to this Section 2.1(h).

2.2 Preferred Protective Provisions.

Subject to Section 2.4 and applicable laws, the Company shall not take and shall prevent its Subsidiaries from taking, and each Shareholder shall take all such action as a shareholder of the Company necessary to prevent the Company and its Subsidiaries from taking, any of the following actions or any action directly or indirectly in furtherance of any of the following actions, in each case unless such action is approved by the Investors:

(a) any amendment of the memorandum of association, articles of association, articles of incorporation, certificate of incorporation, bylaws and any charter, partnership agreements, joint venture agreement or other organizational documents (together, "Organizational Documents") of any of the Company's Subsidiaries that will adversely affect the rights of the Investors, any material change in the purposes of the establishment or business scope of the Company or any of its Subsidiaries, or any change in the place of incorporation of the Company or any of its Subsidiaries;

(b) any merger, consolidation, business combination, spin-off or recapitalization of the Company or any of its Subsidiaries, or the sale or lease of all or substantially all of the assets of the Company or any of its Subsidiaries, in one transaction or a series of transactions;

(c) the liquidation, dissolution or winding up of, or the suspension of payments or assignment to creditors by any of the Company's Subsidiaries;

(d) any filing of a voluntary petition in bankruptcy or commencement of a voluntary legal procedure for reorganization, arrangement, adjustment, relief or composition of indebtedness, the consent to the entry of an order for relief in an involuntary case or the application for or consent to the appointment of a receiver, liquidator, assignee, custodian or trustee or similar official of any of the Subsidiaries of the Company;

3

(e) any change in the capital stock of any of the Company's Subsidiaries, or the authorization, issuance, sale or entering into of any agreement related to the issuance of any equity or equity-linked securities (or any instruments convertible into or exchangeable for any such securities, or any options, rights or warrants to acquire any such securities or instruments) of any of the Company's Subsidiaries, or the amendment of any term of any equity securities of any of the Company's Subsidiaries;

(f) any sale, transfer, pledge or disposition, in one transaction or a series of transactions, by the Company of any capital shares or other equity interests of any of its Subsidiaries;

(g) any redemption, purchase or other acquisition by the Company or any of its Subsidiaries of any of its securities;

(h) any payment or declaration of any distribution or dividend on or with respect to any capital shares or other equity interests of the Company or any of its Subsidiaries, except pursuant to Section 2.5 hereof;

(i) except for arrangements with Taiyuan Renlong Enterprise Development Group Co., Ltd. (Chinese characters) relating to seedlings, any transaction or a series of related transactions exceeding US$50,000 in any 12-month period between the Company or any of its Subsidiaries on the one hand, and any employee, officer, director or equityholder of the Company or any of its Subsidiaries, or any member of his or her immediate family, or any Affiliate (as defined below) of an equityholder of the Company or any Subsidiary on the other, except for compensatory transactions approved by the Board of Directors;

(j) any purchase by the Company or any of its Subsidiaries of the capital stock of any corporation, the voting interest in any partnership, joint venture or other entity, or material assets of another entity, or the making of any loan or advance to any such entity, unless the total consideration (including cash, equity issued and debt assumed) to be paid by the Company or its Subsidiaries does not exceed US$3,000,000;

(k) other than in the ordinary course of business, any sale, transfer, pledge or disposition of, in one transaction or a series of related transactions, any assets of the Company or any of its Subsidiaries exceeding US$1,000,000;

(l) other than in the ordinary course of business, any creation, assumption or incurrence of any Encumbrance on the assets of the Company or any of its Subsidiaries in one transaction or a series of related transactions with a value in excess of US$1,000,000;

(m) any sale, transfer, assignment, pledge or disposition of, in one transaction or a series of related transactions, any material permit or license used in the businesses of the Company or any of its Subsidiaries;

(n) the incurrence, creation or guarantee or the entering into of any agreement for the incurrence, creation or guarantee, in one transaction or a series of related transactions, by the Company or any of its Subsidiaries of any long-term or short-term indebtedness, obligations

4

or liabilities (but excluding from the foregoing any trade debts) which individually or in the aggregate exceeds US$1,000,000, or the entering into of any off-balance sheet transaction by the Company or any of its Subsidiaries, or the amendment of any material term of such indebtedness, obligations or liabilities or off-balance sheet transactions in a manner adverse to the Company or any of its Subsidiaries;

(o) any change in the Company's or any of its Subsidiaries' fiscal year, accounting method or accounting practices, except such changes as are necessary to comply with changes to the generally accepted accounting principles adopted by the Company or such Subsidiary;

(p) the establishment of the annual budgets of the Company and any of its Subsidiaries, which shall be presented to the Investors in accordance
Section 6.3(c), and any capital expenditure not provided for in such budgets in excess of US$1,000,000;

(q) the selection or change of the Company's independent accountants (which as of the date hereof is Ernst & Young); or

(r) any matter related to the Company's initial public offering, including (i) the choice of the listing venue, provided that the Investors hereby consent to the selection of the New York Stock Exchange or the Nasdaq Stock Market as the listing venue, and (ii) the selection of underwriters, which shall be made by the Company but which shall be reasonably acceptable to the Investors.

2.3 Additional Preferred Protective Provisions.

Subject to Section 2.4 and applicable Laws, and notwithstanding anything to the contrary in the Restated M&A, the Shareholders agree among themselves (to the exclusion of the Company) that they shall each take all steps necessary and within their power to ensure that the Company shall not adopt, approve or carry out any of the following actions, unless approved by the Investors:

(a) any amendment of the memorandum or articles of association of the Company that will adversely affect the rights of the Investors, any material change in the purposes of the establishment or business scope of the Company, or any change in the place of incorporation of the Company;

(b) any filing of a voluntary petition in bankruptcy or commencement of a voluntary legal procedure for reorganization, arrangement, adjustment, relief or composition of indebtedness, the consent to the entry of an order for relief in an involuntary case or the application for or consent to the appointment of a receiver, liquidator, assignee, custodian or trustee or similar official of the Company;

(c) the liquidation, dissolution or winding up of, or the suspension of payments or assignment to creditors by the Company; or

(d) other than (i) the issuance of any securities or options to acquire securities by the Company to its directors, officers, employees or consultants pursuant to the 2007 Stock

5

Option Plan or pursuant to the second sentence of Section 6.6 and (ii) the issuance of any equity or equity-linked securities (or any instruments convertible into or exchangeable for any such securities) not to exceed in the aggregate 20% of the Ordinary Shares outstanding (on an as-converted basis), any change in the capital stock of the Company, or the authorization, issuance, sale or entering into of any agreement related to the issuance of any equity or equity-linked securities (or any instruments convertible into or exchangeable for any such securities, or any options, rights or warrants to acquire any such securities or instruments) of the Company, or the amendment of any term of equity securities of the Company.

2.4 Limitation on the Rights of the Investors.

The rights of the Investors provided in Sections 2.1, 2.2 and 2.3 shall terminate at the earlier of (i) the occurrence of a Qualifying IPO, or
(ii) when the Investors cease to own Shares representing, in the aggregate, at least 50% of the Shares purchased by the Investors pursuant to the Share Purchase Agreement provided that the obligations of the Investors set forth in
Section 2.1(g) shall continue until the later of (i) a Qualifying IPO, (ii) such time as there shall no longer be the Investor Designee on the Board of Directors or the board of directors of any Subsidiary and the Investors shall no longer be entitled to appoint any Investor Designee to the Board of Directors or the board of directors of any Subsidiary and (iii) such time as the Investors shall cease to own at least 25% of the Shares purchased by the Investors pursuant to the Share Purchase Agreement.

2.5 Certain Dividends.

(a) To the extent any Pre-Closing Retained Earnings (as defined below) have not been distributed to the Eligible Ordinary Shareholders (as defined below) as of the Closing Date ("Undistributed Pre-Closing Retained Earnings"), the Company may, after the Closing, distribute such Undistributed Pre-Closing Retained Earnings to the Eligible Ordinary Shareholders, by way of one or more interim dividends or otherwise.

(b) The Investors agree that they shall not be entitled to participate in, or approve or disapprove, the declaration and payment of any Undistributed Pre-Closing Retained Earnings, irrespective of whether or not the Investors have converted any or all of their Series A Preferred Shares to Ordinary Shares prior to such declaration or payment.

(c) For purposes of this Agreement (i) "Eligible Ordinary Shareholders" shall mean the entities or individuals that hold Ordinary Shares of the Company both immediately prior to the Closing and as of the date of any distribution of Pre-Closing Retained Earnings as described herein and (ii) "Pre-Closing Retained Earnings" shall mean the retained earnings of the Company as of the last day of the calendar month preceding the Closing. The amount of the Pre-Closing Retained Earnings shall be determined by an interim review by the Company's independent accountants.

3. RESTRICTIONS ON TRANSFER

3.1 General Provisions; Restrictions.

(a) Subject to any applicable laws and except as otherwise provided in this

6

Agreement or the Restated M&A, the Ordinary Shares and Series A Preferred Shares shall be freely transferable, provided that any transferee provides the registered office of the Company with know-your-client anti-money-laundering due diligence documentation reasonably requested by it.

Notwithstanding any other provision of this Agreement, during the period commencing on the Closing Date and ending on the closing of the Qualifying IPO (the "Restricted Period"), Brothers Capital shall not (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of (whether with or without consideration, directly or indirectly, voluntarily or involuntarily, by operation of law or otherwise) any Shares now owned or hereafter acquired by it to any person (whether such Shares or any such securities are then owned by such person or are thereafter acquired), or (ii) enter into any swap, derivative or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Shares or such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Shares or such other securities, in cash or otherwise (each such action described in clause (i) or (ii) above, a "Transfer"), other than (i) a Transfer made pursuant to Section 3.2 or Section 3.3, (ii) a Transfer to any individual that is a member of such Shareholder's (or, if such Shareholder is not a natural person, the ultimate beneficial owner of such Shareholder) immediate family (i.e., spouses, parents and children), any trust, tax shelter or other entity established for bona fide estate or tax planning purposes of such Shareholder (or, if such Shareholder is not a natural person, the ultimate beneficial owner of such Shareholder) or any member of such Shareholder's (or, if such Shareholder is not a natural person, the ultimate beneficial owner of such Shareholder) immediate family, or any Affiliate, or
(iii) a Transfer to Mr. Qian Zhaohua or an entity wholly-owned by Mr. Qian Zhaohua (each, a "Permitted Transferee"); provided, however, that any Permitted Transferee, simultaneously with such Transfer, agrees in writing to be bound as a Shareholder by all of the provisions of this Agreement in accordance with
Section 9.5, provided, further, that if any Permitted Transferee to whom any Shares have been transferred ceases to be a Permitted Transferee of the transferring Shareholder, such Shares shall be transferred back to the transferring Shareholder immediately prior to the time such person ceases to be a Permitted Transferee of such transferring Shareholder. In addition to any Transfers pursuant to clauses (i), (ii) and (iii) of this paragraph, prior to a Qualifying IPO, Brothers Capital may Transfer Ordinary Shares, not to exceed in the aggregate 20% of the Ordinary Shares outstanding immediately following the Closing, in one or more Transfers. Any Transfer or Transfers in accordance with the preceding sentence may be made without complying with Section 3.2 or Section 3.3.

Prior to the end of the Restricted Period, no Investor shall Transfer any Shares now owned or hereafter acquired by it to any person, other than (i) a Transfer made pursuant to Section 3.2 or Section 3.3, (ii) a Transfer to a Permitted Transferee or (iii) a Transfer made pursuant to Section 5.1. Notwithstanding anything to the contrary in this Agreement, no Investor shall, and each Investor shall cause any Permitted Transferee not to, Transfer any Shares now owned or hereafter acquired by it to any direct or indirect competitor of the Company or any of its Subsidiaries. The preceding sentence shall survive the termination of this Agreement.

For purposes of this Agreement, "Affiliate" of any person shall mean any person that, alone or together with any other person, directly or indirectly through one or more

7

intermediaries, controls or is controlled by, or is under common control with, such person. For purposes of this definition, "control" means, when used with respect to any person, the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person, whether through the ownership of voting securities, by contract, or otherwise, and the terms "controlling" and "controlled" have meanings correlative to the foregoing.

3.2 Rights of First Refusal.

(a) Brothers Capital hereby grants to each of the Investors, and each of the Investors hereby grants to Brothers Capital, a right of first refusal (the "Right of First Refusal") with respect to sales during the Restricted Period by such granting Shareholder (an "Offering Shareholder") of Shares now owned or hereafter acquired by it. During the Restricted Period, each time that an Offering Shareholder proposes to Transfer all or part of its Shares to any other person (the "Proposed Transferee"), such Offering Shareholder shall, prior to consummating any such Transfer, give written notice (the "Offer Notice") to each of the Shareholders entitled to the Right of First Refusal (the "Offeree Shareholders") in accordance with the following provisions.

(b) The Offering Shareholder shall deliver an Offer Notice to each of the Offeree Shareholders stating (i) that the Offering Shareholder has received a binding offer from the Proposed Transferee(s), (ii) the number and description of the Shares proposed to be transferred pursuant to the binding offer from the Proposed Transferee(s), (iii) the proposed price and terms and conditions upon which each Proposed Transferee offers to purchase such Shares, (iv) the name and address of each Proposed Transferee, and (v) an offer to sell to the Offeree Shareholders such Shares set forth in the Offer Notice at the same price per Share and on the same terms and conditions as offered by the Proposed Transferee(s). The Offer Notice shall also include a copy of any written proposal, term sheet or letter of intent or other agreement relating to the proposed Transfer.

(c) By delivering a written notification to the Offering Shareholder within 15 calendar days after receipt of the Offer Notice (the "Exercise Period"), each Offeree Shareholder may elect to purchase, at the price and on the terms and conditions specified in the Offer Notice, up to its percentage share of the total number of Shares proposed to be transferred as specified in the Offer Notice, which shall be equal to the number of such Shares, multiplied by a fraction, the numerator of which shall be the number of Shares (on an as-converted basis) then owned by such Offeree Shareholder and the denominator of which shall be the total number of Shares (on an as-converted basis) then owned by all of the Offeree Shareholders. The Offering Shareholder shall promptly, in writing, inform each Offeree Shareholder that elects to purchase all the Shares available to it (a "Fully-Exercising Shareholder") of any other Offeree Shareholder's failure to do likewise. During the five-day period commencing after such information is given, each Fully-Exercising Shareholder may elect to purchase up to its share of any unsubscribed Shares, which shall be equal to the number of such unsubscribed Shares multiplied by a fraction, the numerator of which shall be the number of Shares (on an as-converted basis) then owned by such Fully-Exercising Shareholder and the denominator of which shall be the total number of Shares (on an as-converted basis) then owned by all of the Fully-Exercising Shareholders. The Offering Shareholder shall repeat the process set forth in the immediately preceding two sentences until there remains either
(i) no unsubscribed Shares, or (ii) no Fully-Exercising Shareholder electing

8

to purchase its proportionate share of the unsubscribed Shares during such five-day period.

(d) If all Shares that the Offeree Shareholders are entitled to purchase pursuant to this Section 3.2 are not elected to be purchased as provided in Section 3.2(c), the Offering Shareholder may, subject to the Co-Sale Rights (as defined below) provided in Section 3.3, during the 90-day period following the expiration of the last offering period provided in Section 3.2(c), sell the remaining unsubscribed portion of such Shares to the Proposed Transferee(s) at a price not less than, and upon terms and conditions no more favorable to the Proposed Transferee(s) than, those specified in the Offer Notice. If the Offering Shareholder does not sell the Shares within such 90-day period, the Right of First Refusal provided hereunder shall be deemed to be revived and such Shares may not be offered unless first reoffered to the Offeree Shareholders in accordance herewith.

(e) Valuation of Property.

(i) Should the purchase price offered by the Proposed Transferee(s) as specified in the Offer Notice be payable in property other than cash or cancellation of existing indebtedness, the Offeree Shareholders shall have the right to pay the purchase price in cash, with such payment to be equal in amount to the fair market value of such property.

(ii) If the Offering Shareholder and the Offeree Shareholders cannot agree on the fair market value of such property within 10 days after the receipt of the Offer Notice by the Offeree Shareholders, the valuation shall be made by an appraiser of internationally recognized standing jointly selected by the Offering Shareholder and the majority in interest of the Offeree Shareholders, if any, exercising their Right of First Refusal (voting together on an as-converted basis) within 15 days after the receipt of the Offer Notice by the Offeree Shareholders, or, if they cannot agree on an appraiser within 15 days after the receipt of the Offer Notice by the Offeree Shareholders, each shall select an appraiser of internationally recognized standing and the two appraisers shall designate an additional appraiser of internationally recognized standing, who shall make the valuation within 30 days after the receipt of the Offer Notice by the Offeree Shareholders, and whose appraisal shall be determinative of such value.

(iii) The cost of such appraisal shall be borne 50% by the Offering Shareholder and 50% by the Offeree Shareholders, with that portion of the cost borne by the Offeree Shareholders to be borne pro rata by each, based on the number of offered Shares (on an as-converted basis) such Offeree Shareholder has elected to purchase pursuant to this Section 3.2.

(iv) If the value of the purchase price offered by the Proposed Transferee(s) and specified in the Offer Notice is not determined within the Exercise Period specified in Section 3.2(c) above, the Exercise Period shall be extended to the 10th day following the date the appraisal is made pursuant to this Section 3.2(e).

3.3 Co-Sale Rights.

(a) Brothers Capital hereby grants to each of the Investors, and each of the

9

Investors hereby grants to Brothers Capital, a right of co-sale (the "Co-Sale Right") with respect to sales during the Restricted Period by such granting Shareholder (a "Proposed Transferor") of Shares now owned or hereafter acquired by it. During the Restricted Period, if any Proposed Transferor proposes to Transfer any Shares now owned or hereafter acquired by it to any Proposed Transferee in any transaction after complying with Section 3.2, to the extent the Offeree Shareholders do not exercise their Rights of First Refusal as to all of the Shares offered pursuant to Section 3.2, each Shareholder entitled to the Co-Sale Right (a "Co-Seller") shall have the right to sell to the Proposed Transferee, at the same price per Share and upon the same terms and conditions as the Transfer by the Proposed Transferor, up to the number of whole Shares that is equal to the number derived by multiplying (i) the aggregate number of Shares (on an as-converted basis) to be acquired by the Proposed Transferee in the Transfer by (ii) a fraction, the numerator of which is the aggregate number of Shares (on an as-converted basis) held by such Co-Seller, and the denominator of which is the aggregate number of Shares (on an as-converted basis) held by the Proposed Transferor plus the aggregate number of Shares (on an as-converted basis) held by all Co-Sellers. The Proposed Transferor shall notify all Co-Sellers in writing of each such proposed Transfer promptly following the expiration of the last offering period provided in Section 3.2(c). Such notice (the "Transfer Notice") shall set forth: (w) the description and number of Shares proposed to be transferred, (x) the name and address of each Proposed Transferee, (y) the proposed amount of consideration and terms and conditions offered by each Proposed Transferee, and (z) that the Proposed Transferee has been informed of the Co-Sale Right provided for in this Section 3.3 and has agreed to purchase the Shares in accordance with the terms hereof. Each Shareholder of then currently convertible, exchangeable or exercisable rights to acquire Shares shall be given an opportunity to exercise such rights prior to the consummation of any proposed Transfer subject to the terms of this Section 3.3 and participate in such Transfer as a Shareholder.

(b) The Co-Sale Right may be exercised by a Co-Seller by delivery of a written notice to the Proposed Transferor (the "Co-Sale Notice") within 15 days following its receipt of the Transfer Notice (the "Co-Sale Period"). The Co-Sale Notice shall state the number and description of Shares that such Co-Seller proposes to include in such Transfer to the Proposed Transferee determined as aforesaid. If the Proposed Transferee does not purchase Shares from such Co-Seller at the same price and on the same terms and conditions as purchases from the Proposed Transferor, then the Proposed Transferor shall not be permitted to Transfer any Shares to the Proposed Transferee in the proposed Transfer unless and until, simultaneously with such Transfer, the Proposed Transferor shall purchase from such Co-Seller such Shares that such Co-Seller would otherwise be entitled to sell to the Proposed Transferee pursuant to its Co-Sale Rights for the same consideration and on the same terms and conditions as the Transfer described in the Transfer Notice.

(c) At the expiration of the Co-Sale Period, the Proposed Transferor shall have the right to transfer to the Proposed Transferee(s) the number of Shares proposed to be transferred, less the number of Shares to be sold by the Co-Seller(s) pursuant to the Co-sale Notice(s), on terms and conditions no more favorable to the Proposed Transferor than those stated in the Transfer Notice specified in Section 3.3(a). If such Transfer is not consummated within the 90-day period provided in Section 3.2(d), any Shares that continue to be held by the Proposed Transferor after such period shall again be subject to the provisions of this Section 3.3.

10

(d) The share certificate or certificates and instruments of transfer of each participating Co-Seller shall be transferred to the Proposed Transferee in consummation of the sale of the Shares pursuant to the terms and conditions specified in the Transfer Notice and the agreement for the Transfer of the Shares, and the Proposed Transferee shall concurrently therewith remit to each such Co-Seller that portion of the sale proceeds to which such Co-Seller is entitled by reason of its participation in such sale. The Company shall be obliged to register the transfer upon delivery by the Proposed Transferee of the relevant share certificate or certificates and instruments of transfer.

(e) Costs. All costs and expenses incurred by any seller (including the Proposed Transferor) in connection with a Transfer under this Section 3.3, including, without limitation, all attorneys' fees, costs and disbursements and any finders' fees or brokerage commissions, shall be borne by such seller.

3.4 Excluded Transactions.

Anything to the contrary herein notwithstanding, the provisions of Sections 3.2 and 3.3 shall not apply to (i) Transfers pursuant to a Qualifying IPO, (ii) Transfers by any Shareholder to any of its Permitted Transferees that agrees in writing to be bound as a Shareholder by all of the provisions of this Agreement in accordance with Section 9.5, provided, however, that if any Permitted Transferee to whom any Shares have been transferred ceases to be a Permitted Transferee of the transferring Shareholder, such Shares shall be transferred back to the transferring Shareholder immediately prior to the time such person ceases to be a Permitted Transferee of such transferring Shareholder, or (iii) in the case of the Investors, Transfers pursuant to the Investors' exercise of their Redemption Rights under Section 5.1.

3.5 Lock-up Agreements.

Each Shareholder (including the Investors) hereby agrees that it will not, for a period of 180 days following the date of the closing of the Company's Qualifying IPO, Transfer any Shares now owned or hereafter acquired by it to any person.

Each of the Company and the Shareholders hereby agrees that it will comply with a reasonable lock-up period as may be determined in good faith by the lead underwriter(s) in the Qualifying IPO.

This Section 3.5 shall not apply to (x) any Transfer by a Shareholder to a Permitted Transferee of such Shareholder or (y) the sale of any Shares by the Company or a Shareholder to an underwriter pursuant to an underwriting agreement in connection with the Company's Qualifying IPO. In addition, this
Section 3.5 shall not apply to Transfers by the Company (A) in connection with registrations on Form F-4 or S-8 or any successor or similar forms thereto, (B) in connection with registrations for the offer and sale to employees pursuant to any employee stock plan or other employee benefit plan arrangement as unanimously approved by the Board of Directors and (C) of securities to be issued solely in an acquisition or business combination. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters for the Qualifying IPO shall apply to all

11

Shareholders subject to such agreements pro rata based on the number of Shares subject to such agreements.

4. PREEMPTIVE RIGHTS

The Company hereby grants to the Investors a preemptive right (the "Preemptive Right") with respect to future sales by the Company of its Shares or other voting securities during the Restricted Period. Each time during the Restricted Period that the Company proposes to offer any Shares or other voting securities, the Company shall first make an offering of such Shares or other securities to the Investors in accordance with the following provisions:

4.1 Sale Notice.

The Company shall deliver to the Investors a notice stating its bona fide intention to offer such Shares or other voting securities, the description and number of such Shares or other voting securities to be offered, the full description thereof and the price and terms and conditions upon which it proposes to offer such Shares or other voting securities (the "Sale Notice").

4.2 Exercise of Preemptive Rights.

Within 15 calendar days after receipt of the Sale Notice, by written notification to the Company, each Investor may elect to purchase, at the price and on the terms and conditions specified in the Sale Notice, up to such electing Investor's share of the Shares or other voting securities offered, which shall be equal to such number of Shares or other voting securities multiplied by a fraction, the numerator of which shall be the number of Ordinary Shares (on an as-converted basis) then owned by such electing Investor and the denominator of which shall be the total number of Ordinary Shares (on an as-converted basis) then issued and outstanding.

4.3 Non-Exercise.

If an Investor does not elect to obtain all Shares or other voting securities that such Investor is entitled to obtain pursuant to Section 4.2, the Company may, during the 90-day period following the expiration of the period provided in Section 4.2, offer the remaining unsubscribed portion of such Shares or other voting securities to any person at a price not less than, and upon terms and conditions no more favorable to the offeree than those specified in the Sale Notice. If the Company does not enter into an agreement for the sale of such Shares or other voting securities within such period, or if such sale is not consummated within 90 days of the execution of such agreement, the Preemptive Right provided hereunder shall be deemed to be revived and such Shares or other voting securities shall not be offered unless first reoffered to the Investors in accordance with this Article 4.

4.4 Excluded Transactions.

The Preemptive Right in this Article 4 shall not be applicable to the issuance of (i) securities issued pursuant to a Qualifying IPO; (ii) options to purchase Ordinary Shares (and any Ordinary Shares issued upon the exercise thereof), share appreciation rights, dividend equivalent rights, restricted shares, restricted share units, share payments and deferred shares to

12

officers, directors and employees of the Company, pursuant to share incentive plans designated and approved by the Board of Directors; (iii) Ordinary Shares issued as a dividend or distributed with respect to, or upon conversion of, the Series A Preferred Shares; (iv) Ordinary Shares issued in connection with any merger or acquisition transaction approved by the Board of Directors; (v) future issuances in connection with the establishment of a strategic business relationship approved by the Board of Directors; (vi) Series A Preferred Shares issued pursuant to the Share Purchase Agreement and (vii) securities issued pursuant to Section 2.3(d)(ii) hereof.

4.5 Limitations.

The Preemptive Right in this Article 4 shall terminate at the earlier of (i) the occurrence of a Qualifying IPO, or (ii) when the Investors cease to own Shares representing, in the aggregate, at least 25% of the Shares purchased by the Investors pursuant to the Share Purchase Agreement.

5. REDEMPTION RIGHTS

5.1 Investors' Redemption Rights.

(a) If for any reason the Company has not completed a Qualifying IPO on or prior to December 31, 2008, the Investors, acting jointly, shall have the right (the "Redemption Right") at any time to require the Company and, thereafter (if the Company fails to redeem the Redemption Shares (as hereafter defined) in accordance with Section 5.1(e)), Brothers Capital, severally but not jointly, to redeem or purchase all Shares purchased by the Investors pursuant to the Share Purchase Agreement and any Ordinary Shares issued upon conversion of the Series A Preferred Shares (collectively, the "Redemption Shares") by delivering a written notice to the Company and, thereafter (if the Company fails to redeem the Redemption Shares in accordance with Section 5.1(e)), Brothers Capital, specifying their intention to exercise the Redemption Right (the "Redemption Notice").

(b) The Investors' right to exercise the Redemption Right with respect to Section 5.1(a) shall terminate 90 days following December 31, 2008. The Redemption Right is solely for the benefit of the Investors in respect of the Shares purchased pursuant to the Share Purchase Agreement (and Ordinary Shares issued upon conversion of the Series A Preferred Shares). Other than in the case of a Transfer to an Affiliate pursuant to Section 3.1 and in accordance with
Section 9.5, if the Investors Transfer any such shares to a third party (it being understood and agreed that any such transfer is subject to the provisions of Article 3 hereof) the Redemption Right will irrevocably terminate with respect to such shares.

(c) Withdrawal of a Redemption Notice. Within 10 days after the delivery of a Redemption Notice, the Investors may, upon written notice to the Company or Brothers Capital, as the case may be, who have been delivered the Redemption Notice, withdraw and rescind the Redemption Notice, whereupon the Redemption Right shall be deemed not to have been exercised and neither the Investors nor the Company nor Brothers Capital, shall be obligated to satisfy their respective obligations under this Section 5.1.

(d) Redemption Price. The aggregate purchase price for all Redemption Shares (the "Redemption Price") shall be equal to (i) 100% of the Purchase Price plus (ii) an

13

amount equal to all accrued but unpaid dividends on all such Redemption Shares, provided that the Redemption Price shall be ratably reduced to take account of any previous Transfers by the Investors in accordance with Article 3 of this Agreement.

(e) Redemption Closing. The Company shall redeem and the Investors shall sell all Redemption Shares within 60 days after the delivery of the Redemption Notice at a place designated by the Investors (the "Redemption Closing"). At the Redemption Closing, the Company shall cause the Company's registered office to make the corresponding entries in its register of members and the Investors shall deliver to the Company original certificate(s) representing the Redemption Shares redeemed by the Company and the Company shall deliver to an account designated by the Investors the Redemption Price in U.S. dollars in immediately available funds. If the Company fails to redeem any or all of the Redemption Shares in accordance with this Section 5.1(e), the Investors may require Brothers Capital to purchase such Redemption Shares and the provisions of this Section 5.1(e) shall apply, mutatis mutandis, to such purchase.

(f) Waiver by Brothers Capital. BROTHERS CAPITAL IRREVOCABLY WAIVES
ANY AND ALL RIGHTS THAT IT HAS OR MAY HAVE, UNDER APPLICABLE LAW OR OTHERWISE, TO REQUIRE THE COMPANY OR ANY OTHER SHAREHOLDER TO REDEEM OR PURCHASE ANY SHARES HELD BY IT IN CONNECTION WITH ANY EXERCISE BY THE INVESTORS OF THE REDEMPTION RIGHT.

6. AFFIRMATIVE COVENANTS OF THE COMPANY

6.1 Other Shareholders Agreements.

The Company will not enter into any agreement relating to the holding, voting, disposition or redemption of any capital stock of the Company.

6.2 Business Practices.

Neither the Company or any of its Subsidiaries nor any director, officer, agent, employee, or representative of the Company or any of its Subsidiaries, shall offer, promise, authorize or make, directly or indirectly,
(i) any unlawful payments or (ii) payments or other inducements (whether lawful or unlawful) to any Government Official, with the intent or purpose of (w) influencing any act or decision of such Government Official in his official capacity, (x) inducing such Government Official to do or omit to do any act in violation of the lawful duty of such Government Official, (y) securing any improper advantage, or (z) inducing such Government Official to use his influence with any government or instrumentality thereof, political party or international organization to affect or influence any act or decision of such government or instrumentality, political party or international organization, in each case of (w), (x), (y) and (z) above, in order to assist the Company or any of its Subsidiaries in obtaining or retaining business for or with, or directing business to, any person.

Notwithstanding anything else in this Section 6.5, any facilitating or expediting payment made to a Government Official for the purpose of expediting or securing the

14

performance of a routine governmental action by a Government Official shall not constitute a breach of the covenant made in this Section 6.5.

6.3 Financial Information.

The Company shall deliver to the Investors:

(a) as soon as practicable, but in any event within 180 days after the end of each fiscal year of the Company, consolidated income statement and statement of cash flows of the Company and its Subsidiaries for such fiscal year and consolidated balance sheet of the Company and its Subsidiaries and statement of shareholders' equity of the Company as of the end of such year, such year-end financial reports to be all prepared in English and in accordance with the generally accepted accounting principles of the United States ("US GAAP"), and audited and certified by one of Deloitte Touche Tohmatsu, Ernst & Young, KPMG or PricewaterhouseCoopers (collectively, the "Big Four Accounting Firms");

(b) as soon as practicable, but in any event within 60 days after the end of each quarter of each fiscal year of the Company, an unaudited consolidated income statement and a statement of cash flows of the Company and its Subsidiaries for such fiscal quarter and an unaudited consolidated balance sheet of the Company and its Subsidiaries and an unaudited statement of shareholders' equity of the Company as of the end of such fiscal quarter, all prepared in English and in accordance with US GAAP; and

(c) as soon as practicable, but in any event at least 30 days prior to the end of each fiscal year, a budget and business plan for the next fiscal year for the Company and its Subsidiaries, prepared on a monthly basis, including income statements for such months.

(d) the final 2006 Audited Financial Statements promptly when such final 2006 Audited Financial Statements become available.

The Company's obligation to provide the financial information pursuant to Section 6.3(a) shall commence with respect to the fiscal year, ending immediately following the Closing. The Company's obligation to provide the financial information pursuant to Section 6.3(b) shall commence with respect to the quarter following the quarter during which the Closing occurred.

6.4 Access to Information.

The Company shall permit, and shall cause each of its Subsidiaries to permit, each Investor, by itself or through its authorized agent, reasonable access, to visit and inspect the properties of the Company and any Subsidiary, to examine the books of account and records of the Company and any Subsidiary, and to discuss the affairs, finances and accounts of the Company and any Subsidiary with the directors, officers, management employees and accountants of such entities, upon reasonable notice during normal business hours.

6.5 Tax.

(a) The Company shall comply and shall cause each of its Subsidiaries to

15

comply with the reasonable written request of the Investors regarding the record-keeping and reporting requirements any of the Investors inform the Company are necessary to enable the respective Investor to comply with any applicable United States federal income tax law. The Company shall also provide each Investor with the information reasonably requested in writing by such Investor to enable such party to comply with any applicable U.S. federal income tax law.

(b) Upon the reasonable written request of the Investors, the Company shall provide the Investors with access to such information of the Company as may be required by the Investors to determine the Company's status as a controlled foreign corporation (a "CFC") as defined in the Code, to determine whether each Investor is required to report its pro rata portion of the Company's "Subpart F income" (as defined in the Code) on its United States federal income tax return, or to allow the Investors to otherwise comply with applicable United States federal income tax laws. In the event that the Company is determined by counsel or accountants for the Investors to be a CFC with respect to the shares held by any Investor, for so long as the relevant Investor (or direct or indirect equityholder of the Investor) is a "United States shareholder" as defined in the Code, the Company agrees to use reasonable efforts to avoid generating, for any taxable year in which the Company is a CFC, "Subpart F income," as such term is defined in Section 952 of the Code.

(c) The Company shall use reasonable efforts to ensure that the Company will not be or become a "passive foreign investment company" (as defined in section 1297 of the Code) (a "PFIC") for the current and any future taxable year. After the end of each taxable year, upon the reasonable written request of the Investors, the Company shall provide the Investors with the information of the Company as may be reasonably necessary to allow the Investors to determine the Company's status as a PFIC. To the extent the Company is a PFIC for a taxable year, the Company will comply with the reasonable written request of the Investors to provide the Investors the information as may be reasonably necessary to allow the Investors to make a qualified electing fund election pursuant to Section 1295 of the Code, and to make annual filings on the United States federal income tax returns of the relevant Investors with respect to that election. If any information to be provided pursuant to this Section 6.5(c) is not readily available to the Company, and the Company incurs additional expense in providing it to the Investors, the Investors shall reimburse the Company for such expense.

(d) Except to the extent that a majority in interest of the Investors elects to allow the Company not to comply with this provision, the Company shall not make an election to be treated as a partnership for United States federal income tax purposes without consulting the Investors in good faith beforehand.

6.6 Stock Option Plans.

All shares or options to be issued under the Company's employee stock option plans, including the 2007 Stock Option Plan, shall not be at a price lower than the Per Share Purchase Price for the Series A Preferred Shares (as adjusted for any combinations or splits or similar events). After the Company's 2007 Stock Option Plan is fully granted to the employees, any additional issuance of options under the Company's stock option plans shall not exceed in

16

the aggregate 5% of the fully diluted capital immediately following the Closing, subject to approval by the Board of Directors.

6.7 No Public Disclosure.

The Company shall not, nor shall the Company permit any of its Subsidiaries to, disclose the Investors' names or identify either Investor as a holder of the Company's equity securities in (i) business transactions with third parties, (ii) any press release or other public announcement, or (iii) any document or other materials filed with any governmental entity, without the prior written consent of the Investors, unless such disclosure is in the reasonable judgment of counsel to the Company required by applicable law or by an order of a court of competent jurisdiction, in which case, prior to making such disclosure, the Company and any applicable Subsidiary shall to the extent reasonably practicable (i) give written notice to the Investors, which notice shall describe in reasonable detail the proposed content of such disclosure, and
(ii) permit the Investors to review and comment upon the form and substance of such disclosure.

6.8 Further Actions.

Each party hereto agrees to promptly and duly execute and deliver such documents and to take such further action that may be required under applicable law in order to perform its obligations pursuant to this Agreement.

6.9 Qualifying IPO.

The Company agrees to use its commercially reasonable efforts, and each of the other Parties hereto agrees to use its commercially reasonable efforts, to cause the Company to complete a Qualifying IPO prior to the end of 2008. If a Qualifying IPO is not completed by the end of 2008, the Investors shall have the right to demand that the Company takes, and the Company agrees to use its commercially reasonable efforts to take, all necessary actions to effect a Qualifying IPO as soon thereafter as practicable.

6.10 Limitations.

The rights in Sections 6.3 (Financial Information), 6.4 (Access to Information), and 6.6 (Stock Option Plans) shall terminate at the earlier of (i) the occurrence of a Qualifying IPO, or (ii) when the Investors cease to own Shares representing, in the aggregate, at least 25% of the Shares purchased by the Investors pursuant to the Share Purchase Agreement.

6.11 Additional Covenants relating to Restructuring.

The Company shall, or shall cause each of its Subsidiaries to (as the case may be), prior to the earlier of (i) a Qualifying IPO and (ii) December 31, 2007.

(i) enter into express assignment contracts with their respective employees, consultants and independent contractors (to the extent any such employee, consultant or independent contract or has been involved in the development of any Self Developed IP or other Company Intellectual Property), pursuant to which (a) such employees, consultants and

17

independent contractors shall assign to the Company or its Subsidiaries such Company Intellectual Property as they developed or own, and (b) each of such Company Intellectual Properties constitutes "work made for hire" with the Company being the person for whom the work was prepared.

(ii) establish confidentiality and protection procedures and maintain all Company Intellectual Property that is material to the Company's or any of its Subsidiaries' business in confidence in accordance with such procedures.

(iii) make in full any and all social security (including basic pension, basic medical insurance, unemployment insurance, work-related injury insurance and maternity insurance) and housing fund contributions for their respective employees, provided such employees are still employed by the Company or such Subsidiary at the time such contributions are to be made.

(iv) pay in the full amount of the registered capital for Aero Biotech Science & Technology Co., Ltd.

7. RESTRICTIVE LEGENDS AND STOP-TRANSFER ORDERS

7.1 Legend.

Each Shareholder agrees that substantially the following legends shall be placed on the certificates representing any Shares held by such Shareholder (other than Shares that have previously been sold pursuant to a registration statement under the Act or pursuant to Rule 144 under the Act):

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER THE SECURITIES ACT OR PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION REQUIREMENTS.

IN ADDITION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE RESTRICTIONS CONTAINED IN A SHAREHOLDERS AGREEMENT DATED AS OF JUNE 22, 2007, AS AMENDED FROM TIME TO TIME, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL EXECUTIVE OFFICE OF THE COMPANY AND MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE COMPANY AT THE PRINCIPAL EXECUTIVE OFFICE OF THE COMPANY."

7.2 Stop Transfer Instructions.

In order to ensure compliance with the restrictions referred to herein, each Shareholder agrees that the Company may issue appropriate "stop transfer" certificates or instructions.

18

8. REPRESENTATIONS, WARRANTIES AND COVENANTS

8.1 Representations and Warranties of the Shareholders.

Each Shareholder hereby represents, as of the date hereof or, if different, as of the date of such Shareholder's execution of a counterpart of this Agreement, as follows:

(a) If such Shareholder is an entity, that it is duly incorporated or formed and validly existing in its jurisdiction of incorporation or formation, with full power, authority and right to enter into this Agreement and perform its obligations hereunder;

(b) Such Shareholder has duly authorized, validly executed and delivered this Agreement, and this Agreement is valid, binding and enforceable against such Shareholder in accordance with its terms, subject to the Enforceability Exceptions;

(c) The execution, delivery and performance of this Agreement will not
(i) violate, conflict with or result in a breach of or default under any provisions of any Organizational Document of such Shareholder, (ii) violate, conflict with, constitute, with or without the passage of time and giving of notice, a default under or result in the breach, acceleration or termination of, or otherwise give any other contracting party the right to terminate, accelerate or cancel any of the terms, provisions, or conditions of, any contract, agreement, arrangement, understanding, commitment, instrument, mortgage or indenture to which such Shareholder is a party or by which it or its assets are bound, or result in the creation of any lien, charge or other Encumbrance upon any assets of such Shareholder or the suspension, revocation or forfeiture of any material permit, license or authorization applicable to such Shareholder, its business or operations or any of its assets or properties, or (iii) constitute a violation of any provision of any Law applicable to such Shareholder, except, in each scenario described in subclauses (ii) and (iii) of this Section 8.1(c), such as would not have a material adverse effect on the business, financial condition, operations, assets, properties or liabilities of such Shareholder or that would not have a material adverse effect on the ability of such Shareholder to consummate the transactions contemplated under the Transaction Documents (as defined in Section 9.14 hereof) to which it is a party;

(d) Except as set forth in Schedule 8.1(d) of the Disclosure Schedules, no Governmental Authorization on the part of such Shareholder is or will be required in connection with the execution, delivery and performance by such Shareholder of the Transaction Documents to which it is a party in order to consummate the transactions contemplated by such Transaction Documents; and

(e) The execution, delivery and performance by such Shareholder of the Transaction Documents to which it is a party does not and will not require any consent, approval, authorization or other action by or notification to any third party.

8.2 Additional Representations, Warranties and Covenants of Brothers Capital.

Brothers Capital hereby represents, as of the date hereof or, if different, as of the date of its execution of a counterpart of this Agreement, as follows:

19

(a) Except as disclosed in Schedule 8.2 to this Agreement, it is not a party to, nor will it enter into, any agreement relating to the holding, voting, disposition or redemption of any capital stock of the Company without the Investors' prior written consent;

(b) It is not and, for as long as it owns any Shares and for a period of 12 months thereafter, will not be, without the written consent of the Investors, (i) engaged in or otherwise employed by, (ii) acting as consultant or lender to, (iii) serving as a director, officer, employee, principal or agent of, (iv) owning in excess of 10% of the equity interests of, (v) permitting its name to be used in connection with the activities of, (vi) obtaining any benefit or receiving any promise, agreement, arrangement or understanding to receive any benefit from, any other business or organization in the PRC which competes or intends to compete with the business of the Company or any of its Subsidiaries;

(c) Neither Brothers Capital nor any of its director, officer, agent, employee or representative, has offered, promised, authorized or made, nor shall any of such persons offer, promise, authorize or make, directly or indirectly,
(i) any unlawful payments or (ii) payments or other inducements (whether lawful or unlawful) to any Government Official, with the intent or purpose of (w) influencing any act or decision of such Government Official in his official capacity, (x) inducing such Government Official to do or omit to do any act in violation of the lawful duty of such Government Official, (y) securing any improper advantage, or (z) inducing such Government Official to use his influence with any government or instrumentality thereof, political party or international organization to affect or influence any act or decision of such government or instrumentality, political party or international organization, in each case of (w), (x), (y) and (z) above, in order to assist the Company or any of its Subsidiaries in obtaining or retaining business for or with, or directing business to, any person; provided, however, that, any facilitating or expediting payment made to a Government Official for the purpose of expediting or securing the performance of a routine governmental action by a Government Official shall not constitute a breach of this Section 8.2; and

(d) It is not a "United States Shareholder" of the Company or its Subsidiaries as this term is defined in section 951 of the Code. To the extent it becomes a "United States Shareholder" it will promptly notify the Company and the Investors.

9. GENERAL

9.1 Amendments; Waivers.

This Agreement may be amended and the observance of any term may be waived (either generally or in a particular instance and either retroactively or prospectively) only by agreement in writing of (i) Brothers Capital, (ii) the Investors, and (iii) the Company. No waiver of any provision nor consent to any exception to the terms of this Agreement shall be effective unless in writing and signed by the Party to be bound and then only to the specific purpose, extent and instance so provided. Any amendment or waiver effected in accordance with this Section 9.1 shall be binding upon each of the Parties hereto and their successors and permitted assigns. Without limiting the foregoing, any Shareholder may by writing waive any right that it individually holds hereunder without seeking the prior consent of any other Party hereto.

20

9.2 Commercially Reasonable Efforts; Further Assurances.

Each Party hereto shall use its commercially reasonable efforts to perform and fulfill all obligations on its part to be performed and fulfilled under this Agreement to the end that the transactions contemplated by this Agreement shall be effected substantially in accordance with its terms. Each Party shall deliver such further documents and take such other actions as may be necessary to perform its obligations hereunder, provided that this Section 9.2 shall not require any party to incur any material expense.

9.3 Governing Law.

This Agreement and, to the fullest extent permitted by applicable law, all matters arising out of or relating to this Agreement, shall be governed by and construed in accordance with the law of the State of New York, United States of America.

9.4 Dispute Resolution.

(a) Any dispute, controversy or claim (each, a "Dispute") arising out of or relating to this Agreement, or the interpretation, breach, termination or validity hereof, shall be resolved at the first instance through consultation between the parties to such Dispute. Such consultation shall begin immediately after any Party has delivered written notice to any other Party to the Dispute requesting such consultation.

(b) If the Dispute is not resolved within 60 days following the date on which such notice is given, the Dispute shall be submitted to arbitration upon the request of any Party to the Dispute with notice to each other Party to the Dispute (the "Arbitration Notice").

(c) The arbitration shall be conducted in Hong Kong Special Administrative Region ("Hong Kong") under the auspices of the Hong Kong International Arbitration Centre (the "Centre"). There shall be three arbitrators. The claimants in the Dispute shall collectively choose one arbitrator, and the respondents shall collectively choose one arbitrator. The Secretary General of the Centre shall select the third arbitrator, who shall be qualified to practice law in the State of New York. If any of the members of the arbitral tribunal have not been appointed within 30 days after the Arbitration Notice is given, the relevant appointment shall be made by the Secretary General of the Centre.

(d) The arbitration proceedings shall be conducted in English. The arbitration tribunal shall apply the Arbitration Rules of the United Nations Commission on International Trade Law, as in effect at the time of the arbitration, which rules shall be deemed to have been incorporated by reference into this Section 9.4. However, if such rules are in conflict with the provisions of this Section 9.4, including the provisions concerning the appointment of arbitrator, the provisions of this Section 9.4 shall prevail.

(e) Each Party to the arbitration shall cooperate with each other Party to the arbitration in making full disclosure of and providing complete access to all information and documents requested by such other party in connection with such arbitration proceedings, subject only to any confidentiality obligations binding on such Party.

21

(f) The award of the arbitration tribunal shall be final and binding upon the Parties, and the prevailing Party may apply to a court of competent jurisdiction for enforcement of such award.

(g) Any Party to the Dispute shall be entitled to seek preliminary injunctive relief, if possible, from any court of competent jurisdiction pending the constitution of the arbitral tribunal.

(h) During the course of the arbitration tribunal's adjudication of the dispute, this Agreement shall continue to be performed except with respect to the part in dispute and under adjudication.

(i) The cost of arbitration (including legal, accounting and other professional fees and expenses reasonably incurred by any prevailing party with respect to the investigation, collection, prosecution and/or defense of any claim in the Dispute) shall be borne by the losing Party or Parties unless otherwise determined by the arbitration award.

9.5 Obligations of Transferees.

(a) No party to this Agreement may assign any of its rights and obligations under this Agreement, without the prior written consent of the other parties, except that an Investor may assign any or all of its rights and obligations to an Affiliate of such Investor, which shall agree in writing to become bound by the terms hereof, provided that such Affiliate shall automatically be so bound by the terms hereof, whether or not such Affiliate shall have so agreed in writing. Any such assignment shall not relieve such Investor of its obligations hereunder. Any attempted assignment in contravention hereof shall be null and void.

(b) Subject to Section 9.5(a), if a Shareholder transfers any Shares to any person other than pursuant to a Qualifying IPO (but otherwise in accordance with this Agreement), it shall be a condition to such transfer that such transferee agrees in writing to be bound as a Shareholder by all of the terms and provisions of this Agreement; provided that any such transferee shall automatically be so bound by the terms hereof, whether or not such transferee shall have so agreed in writing.

(c) Neither this Agreement nor any rights or obligations under this Agreement are assignable except as set forth in this Section 9.5.

9.6 Termination.

Unless any provision of this Agreement specifies a different time of termination, the provisions of this Agreement shall terminate (i) in their entirety on the earlier to occur of (A) the completion of a Qualifying IPO and (B) the sale of an aggregate of at least a majority of the then outstanding Shares of the Company or a sale of all or substantially all the assets of the Company and (ii) as to any Shareholder if such Shareholder shall have disposed of all of its Shares in accordance with the terms of this Agreement.

22

9.7 Titles and Subtitles; References.

The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement, nor as evidence of the intention of the Parties hereto. Except where otherwise indicated, all references in this Agreement to Articles, Sections or Exhibits refer to Articles or Sections of or Exhibits to this Agreement.

9.8 Counterparts.

This Agreement and any amendment hereto or any other agreement (or document) delivered pursuant hereto may be executed in any number of counterparts, each of which shall be an original but all of such counterparts together shall constitute one and the same instrument and shall become effective (unless otherwise provided therein) when all counterparts have been signed by all relevant parties and delivered to the other parties. Any counterpart or other signature delivered by a Party by facsimile shall be deemed for all purposes as being a good and valid execution and delivery of this Agreement by that Party.

9.9 Parties in Interest.

Except as otherwise provided in this Agreement, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and permitted assigns of the Parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the Parties hereto or their respective successors and permitted assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Nothing in this Agreement is intended to relieve or discharge the obligation of any third person to any Party to this Agreement.

9.10 Notices.

Any and all notices required or permitted to be given to a Party pursuant to the provisions of this Agreement will be in writing and will be effective and deemed to provide such Party sufficient notice under this Agreement on the earliest of the following: (i) at the time of personal delivery, if delivery is in person; (ii) at the time of transmission by facsimile, addressed to such Party at the facsimile number indicated for such Party on the signature page of this Agreement (or hereafter modified by subsequent notice to the Parties hereto), with confirmation of receipt made by both telephone and printed confirmation sheet verifying successful transmission of the facsimile; (iii) two business days after deposit with an express overnight courier for deliveries within a country, or three business days after such deposit for international deliveries or (iv) three business days after deposit in mail by certified mail (return receipt requested) or equivalent for deliveries within a country. For the purposes of this Section, a delivery between the Hong Kong and any other point in the PRC shall be considered an international delivery.

All notices for international delivery will be sent by facsimile or by express courier. All notices not delivered personally or by facsimile will be sent with postage and/or other charges prepaid and properly addressed to the Party to be notified at the address or facsimile number indicated for such Party on the signature page of this Agreement or at such

23

other address or facsimile number as such Party may designate by giving ten days advance written notice by one of the indicated means of notice provided in this Agreement to the other Parties hereto. Notices by facsimile shall be machine verified as received.

Any Party hereto (and such Party's permitted assigns) may by notice so given change its address for future notices under this Agreement. Notice shall conclusively be deemed to have been given in the manner set forth above.

9.11 Attorney's Fees.

In the event of any action for the breach of this Agreement or misrepresentation by any Party, the prevailing Party shall be entitled to reasonable attorney's fees, costs and expenses incurred in connection with such action.

9.12 Specific Performance.

Each of the Parties acknowledge that, in view of the transactions contemplated by this Agreement, each Party would not have an adequate remedy at law for money damages in the event that this Agreement has not been performed in accordance with its terms, and therefore agrees that the non-breaching Parties shall be entitled to specific enforcement of the terms hereof and injunctive and other equitable relief in addition to any other remedy to which such non-breaching Parties may be entitled at law or in equity.

9.13 Severability.

If any provisions of this Agreement shall be held to be unenforceable under applicable law, such provisions shall be excluded from this Agreement and the remaining provisions of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.

9.14 Entire Agreement.

This Agreement, the Exhibits and Schedules to this Agreement, the Share Purchase Agreement and the Registration Rights Agreement (collectively, the "Transaction Documents") and all other documents referred to in this Agreement (except for the letter agreement dated as of the date hereof, among the Company, Brothers Capital and the Investors) constitute the entire agreement and understanding among the Parties with respect to the subject matter hereof and supersede any and all prior negotiations, correspondence, agreements, understandings, duties or obligations among the Parties with respect to the subject matter hereof and no Party shall be liable or bound to any other Party in any manner by any warranties, representations, or covenants except as specifically set forth herein or therein.

9.15 No Presumption.

The Parties acknowledge that any applicable law that would require interpretation of any claimed ambiguities in this Agreement against the Party that drafted it has no application and is expressly waived. If any claim is made by a Party relating to any conflict, omission or ambiguity in the provisions of this Agreement, no presumption or burden of proof or persuasion

24

will be implied because this Agreement was prepared by or at the request of any Party or its counsel.

9.16 Aggregation of Stock.

All Shares held or acquired by affiliated entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement.

9.17 Interpretation.

Unless a provision hereof expressly provides otherwise: (i) the term "or" is not exclusive; (ii) words in the singular include the plural, and words in the plural include the singular; (iii) the terms "herein," "hereof," and other similar words refer to this Agreement as a whole and not to any particular section, subsection, paragraph, clause, or other subdivision; (iv) the term "including" will be deemed to be followed by ", but not limited to,"; (v) the masculine, feminine, and neuter genders will each be deemed to include the others; (vi) the terms "shall," "will," and "agrees" are mandatory, and the term "may" is permissive; (vii) the term "day" means "calendar day," and (viii) all references to "dollars" are to currency of the United States of America.

[The remainder of this page has been intentionally left blank.]

25

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above written.

AGRIA CORPORATION

By /s/ Lai Guanglin
   -------------------------------------
Name:
Title:

BROTHERS CAPITAL LIMITED

By /s/ Lai Guanglin
   -------------------------------------
Name:
Title:

INVESTORS:

TPG GROWTH AC LTD.

By: /s/ Clive Bode
    ------------------------------------
Name:  Clive Bode
Title: Vice President and Secretary

TPG BIOTECH II, LTD.

By: /s/ Clive Bode
    ------------------------------------
Name:  Clive Bode
Title: Vice President and Secretary

SIGNATURE PAGE TO AGRIA CORPORATION SHAREHOLDERS AGREEMENT


EXHIBIT A

Investors

TPG Growth AC Ltd.
TPG Biotech II, Ltd.

A-1

SCHEDULE 8.2

List of Shareholder Agreements between Brothers Capital Limited and third parties prior to the date of this Agreement

1

EXHIBIT 4.15

EXECUTION COPY

REGISTRATION RIGHTS AGREEMENT

AMONG

TPG GROWTH AC LTD.

TPG BIOTECH II, LTD.

AND

AGRIA CORPORATION

JUNE 22, 2007


TABLE OF CONTENTS

1. INTERPRETATION ........................................................     1
   1.1  Certain Definitions ..............................................     1
   1.2  Interpretation ...................................................     3
   1.3  Public Offering Jurisdiction .....................................     3
2. RESTRICTIVE LEGEND ....................................................     3
3. PIGGYBACK REGISTRATION ................................................     4
   3.1  Notice ...........................................................     4
   3.2  Underwriting .....................................................     5
   3.3  Not a Demand Registration ........................................     6
4. DEMAND REGISTRATION ...................................................     6
   4.1  Request for Registration .........................................     6
   4.2  Underwriting .....................................................     6
   4.3  Limitations on Demand Registration ...............................     7
5. REGISTRATION PROCEDURES ...............................................     8
   5.1  Procedures .......................................................     8
   5.2  Restriction on Filing ............................................    11
   5.3  Reference to Holders .............................................    11
6. EXPENSES OF REGISTRATION ..............................................    12
7. INDEMNIFICATION .......................................................    12
   7.1  Indemnification by the Company ...................................    12
   7.2  Indemnification by the Holders ...................................    13
   7.3  Indemnification Procedures .......................................    13
   7.4  Contribution .....................................................    14
   7.5  Survival .........................................................    14
8. COMPANY UNDERTAKINGS ..................................................    14
   8.1  No Inconsistent Agreements .......................................    15
   8.2  Rules 144 and 144A ...............................................    15
9. MISCELLANEOUS .........................................................    15
   9.1  Term .............................................................    15
   9.2  Successors and Assigns ...........................................    15
   9.3  Governing Law ....................................................    16
   9.4  Dispute Resolution ...............................................    16
   9.5  Counterparts and Facsimile Execution .............................    17
   9.6  Titles and Subtitles; References .................................    17
   9.7  Notices ..........................................................    17

i

9.8  Attorney's Fees ..................................................    18
9.9  Amendments and Waivers ...........................................    18
9.10 Severability .....................................................    18
9.11 Entire Agreement .................................................    18
9.12 Interpretation ...................................................    19
9.13 No Presumption ...................................................    19
9.14 Specific Performance .............................................    19
9.15 Aggregation of Stock .............................................    19

ii

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is entered into as of June 22, 2007, by and among Agria Corporaiton, an exempted company incorporated in the Cayman Islands (the "Company"), and the investors listed on the signature pages hereto (collectively, the "Investors"). The Company and the Investors are referred to herein as "Parties" collectively and a "Party" individually.

RECITALS

WHEREAS, the Company desires to issue Series A Preferred Shares, par value US$0.001 per share (the "Preferred Shares"), and Brothers Capital Limited, an exempted company incorporated in the British Virgin Islands and a shareholder of the Company, desires to sell ordinary shares of the Company, par value US$0.001 per share (the "Ordinary Shares"), to the Investors pursuant to the Share Purchase Agreement (the "Share Purchase Agreement") dated as of June 22, 2007 by and among the Company, the Company Warrantors set forth in Schedule 1.1 to the Share Purchase Agreement and the Investors; and

WHEREAS, in connection with the purchase and sale of the Investor Shares pursuant to the Share Purchase Agreement, the Company and the Investors desire to enter into this Registration Rights Agreement.

NOW, THEREFORE, in consideration of the mutual promises herein contained, and other good and valuable consideration, the receipt and adequacy of which hereby is acknowledged, the parties hereto agree as follows:

1. INTERPRETATION

1.1 Certain Definitions.

As used in this Agreement, the following terms shall have the following respective meanings:

(a) "Adverse Disclosure" shall mean public disclosure of material non-public information that in the good faith judgment of a majority of the Board of Directors of the Company, after consultation with outside counsel to the Company, (i) would be required to be made in any registration statement filed by the Company so that such registration statement would be not false or misleading in any material respect, (ii) would not be required to be made at such time but for the filing or publication of such registration statement, and
(iii) the Company has a bona fide business purpose for not disclosing publicly.

(b) "Affiliate" of any person shall mean any person that, alone or together with any other person, directly or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, such person. For purposes of this definition, "control" means, when used with respect to any person, the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person, whether through the ownership of voting securities, by contract, or otherwise, and the terms "controlling" and "controlled" have meanings correlative to the foregoing.

(c) "Exchange Act" shall mean the United States Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC thereunder, all as the same shall be in effect at the time.

1

(d) "Form S-3/F-3" shall mean Form F-3 or Form S-3, as applicable, promulgated by the SEC under the Securities Act or any successor form or substantially similar form then in effect.

(e) "Free Writing Prospectus" shall mean any free writing prospectus (as defined in Rule 405 under the Securities Act) prepared by or on behalf of the Company or used or referred to by the Company in connection with any registrations pursuant to this Agreement.

(f) "Holders" shall mean the Investors and other holders of the Registrable Securities in accordance with this Agreement.

(g) "Initiating Holders" shall mean the Holders who are the holders of at least 30% of the then outstanding Registrable Securities.

(h) "Investor Shares" shall mean the Preferred Shares and the Ordinary Shares, each as purchased by the Investors in accordance with the Share Purchase Agreement.

(i) The terms "register", "registered" and "registration" refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act (or other applicable non-U.S. securities laws and regulations, as the case may be), and the declaration or ordering of the effectiveness of that registration statement.

(j) "Registrable Securities" shall mean (i) the Ordinary Shares acquired by the Investors pursuant to the Share Purchase Agreement and any Ordinary Shares hereafter acquired by any Investor prior to the initial public offering of the Ordinary Shares of the Company pursuant to an effective registration statement filed under the Securities Act, including any Ordinary Shares issuable or issued upon conversion of the Preferred Shares, and (ii) any Ordinary Shares issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect to, or by way of stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise with respect to, or in exchange for, or in replacement of, the securities referenced in (i) above. For purposes of this Agreement, Registrable Securities will cease to be Registrable Securities when; (A) they have been sold pursuant to a registration statement with respect to the sale of securities which shall have become effective under the Securities Act or other applicable non-U.S. securities laws and regulations, (B) they have been otherwise sold in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act so that (x) all transfer restrictions and restrictive legends with respect thereto are removed upon the consummation of such sale and (y) subsequent disposition of such securities shall not require registration or qualification under the Securities Act or other applicable non-U.S. securities laws and regulations or similar state law or (C) with respect to a single Holder, in the opinion of counsel reasonably satisfactory to the Company and such Holder, there is no limitation as to the volume of the Registrable Securities owned by such single Holder that may be sold in a single sale pursuant to Rule 144 under the Securities Act.

(k) "Shareholders Agreement" shall mean the shareholders agreement dated June 22, 2007, among Brothers Capital Limited, the Investors and the Company.

2

(l) "Securities Act" shall mean the United States Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder, all as the same shall be in effect at the time.

(m) "SEC" shall mean the United States Securities and Exchange Commission.

1.2 Interpretation.

For all purposes of this Agreement, except as otherwise expressly provided, the terms defined in Section 1.1 shall have the meanings assigned to them in this Section 1 and capitalized terms used in this Agreement but not otherwise defined herein shall have the meanings ascribed to them in the Share Purchase Agreement.

1.3 Public Offering Jurisdiction.

The terms of this Agreement are drafted primarily in contemplation of an offering of Ordinary Shares in the United States of America. The parties recognize, however, the possibility that securities may be qualified or registered in a jurisdiction other than the United States of America for offering to the public or that the Company might seek to effect an offering in the United States of America in the form of American Depositary Receipts or American Depositary Shares. Accordingly,

(a) It is their intention that, whenever this Agreement refers to a law or institution of the United States of America but the parties wish to effectuate qualification or Registration in a different jurisdiction, reference in this Agreement to the laws or institutions of the United States shall be read as referring, mutatis mutandis, to the comparable laws or institutions of the jurisdiction in question; and

(b) It is agreed that the Company will not undertake any listing of American Depositary Receipts, American Depositary Shares or any other security derivative of the Ordinary Shares unless arrangements have been made reasonably satisfactory to the Investors to ensure that the effect of this Agreement will be realized and that the Company is committed to take such actions as are necessary such that the Investors will enjoy rights corresponding to the rights hereunder to sell their Registrable Securities in a public offering in the United States of America as if the Company had listed Ordinary Shares in lieu of such derivative securities.

2. RESTRICTIVE LEGEND

Hereinafter, each certificate representing (i) the Investor Shares,
(ii) the Registrable Securities, and (iii) any other securities issued in respect of the Investor Shares or the Registrable Securities upon any stock split, stock dividend, combination of shares, recapitalization, merger, consolidation or similar event, shall (unless otherwise permitted below or unless the securities evidenced by such certificate shall have been registered under the Securities Act) be stamped or otherwise imprinted with a legend substantially in the following form (in addition to any legend required under applicable state securities laws):

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR

3

OTHERWISE TRANSFERRED EXCEPT PURSUANT TO A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER THE SECURITIES ACT OR PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION REQUIREMENTS.

IN ADDITION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE RESTRICTIONS CONTAINED IN A SHAREHOLDERS AGREEMENT DATED AS OF JUNE 22, 2007, AS AMENDED FROM TIME TO TIME, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL EXECUTIVE OFFICE OF THE COMPANY AND MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE COMPANY AT THE PRINCIPAL EXECUTIVE OFFICE OF THE COMPANY.

Upon request of a holder of such a certificate, the Company shall remove the foregoing legend from the certificate or issue to such holder a new certificate therefor free of any transfer legend, if, with such request, the Company shall have received either (i) a written opinion of legal counsel to the holder, addressed to the Company and reasonably satisfactory in form and substance to the Company's counsel, to the effect that the proposed transfer of such securities may be effected without registration under the Securities Act or
(ii) a "no-action" letter from the SEC to the effect that the distribution of such securities without registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto, except that any such transfer legend shall be removed in a transfer pursuant to Rule 144 or an effective registration statement, in which case no such legal opinion or "no-action" letter shall be required.

3. PIGGYBACK REGISTRATION

3.1 Notice.

If the Company at any time proposes to register (including for this purpose a registration effected by the Company for holders of its securities other than the Holders) any of its securities under the Securities Act or other applicable non-U.S. securities laws and regulations, as the case may be (other than (x) a registration relating solely to the sale of securities to participants in a Company stock plan or other employee benefit plan arrangement,
(y) a registration relating to a corporate reorganization or other transaction under Rule 145 of the Securities Act or (z) a registration on Form S-8 or any successor form to such form), the Company shall promptly, but in no event less than 30 days prior to filing any registration statement, give each Holder written notice of its intention to undertake such registration and of such Holder's rights under this Section 3.1. Upon the written request of any Holder given within 10 days after receipt of such notice, the Company shall, subject to the provisions of Section 3.2, effect the registration under the Securities Act (or other applicable non-U.S. securities laws and regulations, as the case may be) of all of the Registrable Securities that each such Holder has requested to be registered, by inclusion of such Registrable Securities in the registration statement that covers the securities that the Company proposes to register (an "Incidental Registration"). If, at any time after giving written notice of its intention to register any securities and prior to the effective date of the registration statement filed in connection with such registration, the Company shall determine

4

for any reason either not to register or to delay registration of such securities, the Company may, at its election, give written notice of such determination to each Holder and, (i) in the case of a determination not to register, shall be relieved of its obligation to register any Registrable Securities in connection with such registration (but not from its obligation to pay the Registration Expenses in connection therewith), and (ii) in the case of a determination to delay registering, shall be permitted to delay registering any Registrable Securities, for the same period as the delay in registering such other securities, provided, however, that in each case of (i) and (ii), if and when the Company shall restart or resume such registration process, each Holder shall continue to be entitled to exercise its piggyback registration rights in accordance with this Section 3 in such resumed or delayed registration of such other securities.

3.2 Underwriting.

(a) In connection with any offering involving an underwriting of the Company's securities, the Company shall not be required under this Section 3 to include any Registrable Securities of a Holder in such underwriting unless such Holder enters into an underwriting agreement in customary form with an underwriter or underwriters selected by the Company, on terms and conditions approved by the Company; provided, that such underwriting agreement shall not impair the indemnification rights of the Holders granted under Section 7; and provided further, that no Holder shall be required to make any representations or warranties to, or agreements with, the Company or any underwriter in a registration other than customary representations, warranties and agreements relating to information regarding such Holder contained in a writing furnished by such Holder to the Company expressly for use in the related registration statement or prospectus, such Holder's title to the Registrable Securities and authority to enter into the underwriting agreement, such Holder's intended method of distribution and any other representations required by applicable law.

(b) If the total amount or kind of securities, including Registrable Securities, requested by security holders to be included in such offering exceeds the amount or kind of securities that the underwriters (or, in the case of an Incidental Registration not being underwritten, the Company) determine in good faith can be sold in the offering, then the Company shall be required to include in the offering only that number or kind of securities that the underwriters (or, in the case of an Incidental Registration not being underwritten, the Company) determine in good faith will not have a material adverse effect on the price, timing or distribution of the securities to be offered. The securities of each class to be included in such registration shall be allocated as follows: (i) first, 100% of the securities that the Company has proposed to sell shall be included therein; and (ii) second, and only if all the securities referenced in clause (i) have been included, the number of Registrable Securities of such class and other securities of such class held by other persons that have a contractual right to participate in such registration that, in the opinion of such underwriters (or, in the case of an Incidental Registration not being underwritten, the Company), can be sold without having a material adverse effect on such registration shall be included therein, with such number to be allocated pro rata among the Holders and such other persons which have requested participation in the Incidental Registration (based, for each such Holder or person on the percentage derived by dividing (x) the number of Registrable Securities of such class (and other securities of such class) which such Holder (or person) has requested to include in such Incidental Registration by (y) the aggregate number of Registrable Securities of such class and other securities of such class which all such Holders and other persons have requested to include.

5

(c) If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriters, delivered at least 10 days prior to the effective date of the registration statement, provided that, the Company shall be entitled to reimbursement from the Holder of such withdrawn Registrable Securities for any SEC registration fees incurred by the Company in connection with the registration of such Registrable Securities.

3.3 Not a Demand Registration.

No registration effected under this Section 3 shall relieve the Company of its obligation to effect any registration upon request under Article 4, nor shall any such registration under this Article 3 be deemed to have been effected pursuant to Section 4. There shall be no limit on the number of times the Holders may request registration of Registrable Securities under this Article 3.

4. DEMAND REGISTRATION

4.1 Request for Registration.

Subject to the conditions of this Section 4, if the Company shall receive at any time after 180 days following the date of the closing of the Company's Qualifying IPO (or such shorter period as is agreed to by the Company through a waiver of the lock-up agreement contained in Section 3.5 of the Shareholders Agreement), a written request from the Initiating Holders that the Company file a registration statement under the Securities Act (or other applicable non-U.S. securities laws and regulations, as the case may be) covering the registration of all or part of such Initiating Holders' Registrable Securities (provided the Registrable Securities to be so registered (i) have an estimated market value of at least $20 million in the aggregate or (ii) represent all of the then outstanding Registrable Securities (provided such outstanding Registrable Securities have an estimated market value of at least $10 million in the aggregate), then the Company shall promptly give written notice of such request to all Holders, and subject to the limitations of this Article 4, use its reasonable best efforts to effect, as soon as practicable, the registration under the Securities Act (or other applicable non-U.S. securities laws and regulations, as the case may be) of all the Registrable Securities that the Initiating Holders have requested to be registered and all Registrable Securities that the other Holders request to be registered in a written request received by the Company within 45 days of the receipt of the Company's notice pursuant to this Section 4.1. The Company may also elect to include in such registration additional securities, including securities to be sold for the Company's own account or for the account of persons who are not holders of Registrable Securities.

4.2 Underwriting.

(a) If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwritten offering, they shall so advise the Company as part of their request made pursuant to Section 4.1 and the Company shall include such information in the written notice to all Holders referred to in Section 4.1. In such event the right of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder's participation in such underwritten offering and the inclusion of such Holder's Registrable Securities in such underwritten offering (unless otherwise mutually agreed by a majority in interest of the Registrable Securities held by the Initiating Holders and by such Holder).

6

The Company and all Holders proposing to distribute their securities through such underwritten offering shall enter into an underwriting agreement in customary form (including customary commercial terms) with the underwriter or underwriters selected by the Initiating Holders representing a majority in interest of the Registrable Securities held by the Initiating Holders after consulting with the Company (which underwriter or underwriters shall be reasonably acceptable to the Company). The Company shall provide such representations, warranties and other agreements as are generally prevailing in agreements of this type; provided that such underwriting agreement shall not impair the indemnification rights of the Holders granted under Section 7; and provided further, that no Holder shall be required to make any representations or warranties to, or agreements with, any underwriter(s) in a registration other than customary representations, warranties and agreements relating to information regarding such Holder contained in a writing furnished by such Holder to the Company expressly for use in the related registration statement or prospectus, such Holder's title to the Registrable Securities and authority to enter into the underwriting agreement, such Holder's intended method of distribution and any other representations required by applicable law.

(b) Notwithstanding any other provision of this Section 4, if the managing underwriter(s) advises the Company that in its opinion, the number of securities of the class requested to be included in the registration statement (including securities of the Company for its own account or for the account of other persons who are not holders of the Registrable Securities) exceeds the number which can be sold in such offering without being likely to have a significant adverse effect on the price, timing or distribution of the class of securities to be offered, then the Company shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of securities that may be included in the underwritten offering shall be reduced as required by the managing underwriter(s) and the Company will include in such registration (i) first, the maximum number of Registrable Securities requested to be included therein, pro rata among the respective Holders thereof on the basis of the amount of Registrable Securities requested to be included in such registration by each such Holder, and (ii) second, the maximum amount of other securities requested to be included therein (including any by the Company), pro rata among the holders of such other securities and the Company, if applicable, on the basis of the amount of securities requested to be included in such registration by each such holder and the Company, if applicable.

Any Registrable Securities excluded or withdrawn from such underwritten offering shall be withdrawn from the registration. If the managing underwriter(s) has not limited the number of Registrable Securities or other securities to be underwritten, the Company and other persons which are not holders of Registrable Securities may sell securities in such registered underwritten offering if the managing underwriter(s) so agrees and if the number of Registrable Securities and other securities which would otherwise have been included in such registration and underwriting will not thereby be limited.

4.3 Limitations on Demand Registration.

The Company shall not be required to effect a registration pursuant to this Section 4:

(a) after the Company has effected two registrations pursuant to this Article 4 (excluding registrations on Form F-3 (or any successor form under the Securities Act), any similar short form registration statement under applicable non-U.S. securities laws

7

or regulations or registrations pursuant to Article 3 herein, which shall have no such limit), and (A) the registration statements with respect thereto have been declared or ordered effective and remain effective for not less than 180 days (or such shorter period as will terminate when all Registrable Securities covered by such registration statement have been sold or withdrawn), or, if such registration statement relates to an underwritten offering, such period as, in the opinion of counsel for the underwriter or underwriters, is required by law for the delivery of a prospectus in connection with the sale of Registrable Securities provided that a registration which does not become effective after the Company has filed a registration statement with respect thereto solely by reason of the refusal to proceed of the Initiating Holders (other than a refusal to proceed based upon the advice of counsel relating to a matter relating primarily to the Company) shall be deemed to have been effected by the Company at the request of such Initiating Holders unless the Initiating Holders shall have elected to pay all Registration Expenses in connection with such registration, (B) such registration statements are not subject to any stop order, injunction or other order or requirement of the SEC or appropriate non-U.S. governing body for any reason, and (C) the conditions to closing specified in the underwriting agreement or purchase agreement entered into in connection with each such registration are satisfied; or

(b) if the Company shall furnish to Holders requesting a registration statement pursuant to this Article 4, a resolution of the Board of Directors stating that in the good faith judgment of the Board of Directors of the Company, effecting a registration at such time would require the Company to make an Adverse Disclosure, in which event the Company shall have the right to defer such filing for a period of not more than 40 days after receipt of the request of the Initiating Holders, provided that the Company shall not be permitted to do so more than three times in any 24-month period, with each such exercise of this right to be separated by no less than 90 days, and provided further, that during such 40 day period the Company shall not file a registration statement with respect to the public offering of securities of the Company.

5. REGISTRATION PROCEDURES

5.1 Procedures.

If and whenever the Company is required by the provisions of Articles 3 or 4 to effect the registration of any Registrable Securities under the Securities Act (or other applicable non-U.S. securities laws and regulations, as the case may be), the Company will, as expeditiously as possible:

(a) prepare and file with the SEC (or such other appropriate non-U.S. governing bodies, as the case may be) a registration statement with respect to such Registrable Securities (in the case of a registration pursuant to Article 4, such filing to be made within 60 days after the initial request of one or more Initiating Holders of Registrable Securities or such longer period agreed to in writing by the Initiating Holders representing a majority in interest of the Registrable Securities held by the Initiating Holders) and use its reasonable best efforts to cause such registration statement to become effective, and keep such registration statement effective for such period as is required by this Agreement, provided that the Company may discontinue any registration of its securities that are not Registrable Securities (and, under the circumstances specified in Section 3.1 herein, its securities that are Registrable Securities), provided, further that before filing such registration statement or any amendments or supplements thereto, the Company will furnish to counsel selected by the Holders of Registrable Securities that are to be included in such registration

8

copies of all such documents proposed to be filed, which documents will be subject to the prior review and comment of such counsel;

(b) prepare and file with the SEC (or such other appropriate non-U.S. governing bodies, as the case may be) such amendments and supplements to such registration statement and the prospectus and all Free Writing Prospectus, if any, used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act (or other applicable non-U.S. securities laws and regulations, as the case may be) with respect to the disposition of all securities covered by such registration statement;

(c) furnish to the Holders of Registrable Securities included in such registration and each underwriter, if any, of the securities being sold by such Holders, such number of conformed copies of such registration statement and of each amendment and supplement thereto (in each case including all schedules and exhibits), copies of the prospectus, including a preliminary prospectus, and any Free Writing Prospectus related to such registration statement, in conformity with the requirements of the Securities Act (or other applicable non-U.S. securities laws and regulations, as the case may be);

(d) use its reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities or blue sky laws of such jurisdictions as shall be reasonably requested in writing by the Holders of the Registrable Securities included in such registration statement and any underwriter of such securities, and take any other action which may be reasonably necessary or advisable to keep such registration or qualification in effect so as to enable such selling Holders and underwriters to consummate the disposition in such jurisdictions of the securities owned by such selling Holder, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify generally to do business as a foreign corporation or to file a general consent to service of process in any such jurisdictions or to take any action which would subject it to taxation in any such jurisdiction where it is not then so subject;

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement with the managing underwriter of such offering;

(f) furnish:

(i) to each Holder of Registrable Securities included in such registration statement a signed counterpart, addressed to such selling Holders and the underwriters, if any, of an opinion or opinions of counsel for the Company, dated the effective date of such registration statement (or, if such registration includes an underwritten public offering, an opinion or opinions dated the date of the closing under the underwriting agreement), reasonably satisfactory in form and substance to a majority of such selling Holders and underwriters, if any, covering such matters as are customarily covered in opinions of issuer's counsel; and

(ii) to the underwriters, if any, a signed counterpart (with copies to the Holders of the Registrable Securities included in such registration statement) of a "comfort" letter (or, in the case of any such person which does not satisfy the conditions for receipt of a "comfort" letter specified in Statement on Auditing Standards No. 72, as amended, an "agreed upon procedures" letter), dated the effective date of such registration statement and a "bring-down" letter of like kind dated the date of the closing under the

9

underwriting agreement, signed by the independent public accountants who have certified the Company's financial statements included in such registration statement, covering substantially the same matters with respect to such registration statement (and the prospectus included therein and any Free Writing Prospectus related to such registration statement) and with respect to events subsequent to the date of such financial statements, as are customarily covered in accountants' letters delivered to the underwriters in underwritten public offerings of securities (with, in the case of an "agreed upon procedures" letter, such modifications or deletions as may be required under Statement on Auditing Standards No. 35, as amended);

(g) notify the Holders of Registrable Securities included in such registration statement and each underwriter, if any, promptly and confirm such advice in writing promptly thereafter:

(i) when the registration statement, any prospectus or any Free Writing Prospectus related thereto or post-effective amendment to the registration statement has been filed, and, with respect to the registration statement or any post-effective amendment thereto, when the same has become effective;

(ii) of any request by the SEC or appropriate non-U.S. governing bodies for amendments or supplements to the registration statement or the prospectus or any Free Writing Prospectus or for additional information;

(iii) of the issuance by the SEC or appropriate non-U.S. governing authority of any stop order suspending the effectiveness of the registration statement or the initiation of any proceedings by any person for that purpose;

(iv) if at any time the representations and warranties of the Company made as contemplated by Section 3.2(a) or 4.2(a) cease to be true and correct; or

(v) of the receipt by the Company of any notification with respect to the suspension of the qualification of any Registrable Securities for sale under the securities or blue sky laws of any jurisdiction or the initiation or threat of any proceeding for such purpose;

(h) notify each Holder of Registrable Securities included in such registration statement and each underwriter at any time when a prospectus relating thereto is required to be delivered under the Securities Act (or other applicable non-U.S. securities laws and regulations, as the case may be) upon the Company's discovery that, or upon the happening of any event as a result of which, the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and at the request of each such Holder or underwriter prepare and furnish to such Holder and underwriter a reasonable number of copies of a supplement to or amendment of such prospectus or a Free Writing Prospectus as may be necessary so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not include an untrue statement of a material fact or omit to state of material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing;

(i) otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the SEC or appropriate non-U.S. governing bodies, and make

10

available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least 12 months, beginning with the first full calendar month after the effective date of such registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder or any other applicable non-U.S. securities laws and regulations, and will furnish to each selling Holder at least five business days prior to the filing thereof a copy of any such earnings statement and shall not make available to security holders any such earnings statement to which Holders of at least a majority of the Registrable Securities included in such registration statement shall have reasonably objected on the grounds that such earnings statement does not comply in all material respects with the requirements of the Securities Act or other applicable non-U.S. securities laws or regulations;

(j) make available, upon reasonable advance notice and at reasonable times, for inspection by a representative appointed by the Holders of a majority of the Registrable Securities, any managing underwriter(s) participating in any disposition pursuant to the registration statement and any attorney or accountant retained by such selling Holders or managing underwriter(s), all financial and other records, pertinent corporate documents and properties of the Company and cause the Company's officers, directors and employees to supply all information reasonably requested by any such person in connection with such registration as shall be necessary to permit a reasonable investigation within the meaning of Section 11 of the Securities Act (subject to the entry by each party referred to in this clause (j) into customary confidentiality agreements in a form reasonably acceptable to the Company);

(k) use its reasonable best efforts to obtain the withdrawal of any order suspending the effectiveness of the registration statement at the earliest possible moment;

(l) use its reasonable best efforts to cause all such Registrable Securities registered under such registration statement to be listed and quoted on each securities exchange and each inter-dealer quotation system on which similar securities issued by the Company are then listed; and

(m) provide and maintain a transfer agent and registrar for all Registrable Securities registered under the registration statement and use its reasonable best efforts to provide a Committee on Uniform Security Identification Procedures number for all such Registrable Securities, in each case from and after a date no later than the effective date of such registration statement.

5.2 Restriction on Filing.

The Company will not file any registration statement pursuant to Article 4 or amendment thereto or any prospectus or Free Writing Prospectus (including such documents incorporated by reference and proposed to be filed after the initial filing of the registration statement) to which the Holders of at least a majority of the Registrable Securities included in such registration statement or the underwriter or underwriters, if any, shall reasonably object, provided that the Company may file such document in a form required by applicable law or upon the advice of its counsel.

5.3 Reference to Holders.

11

If any such registration statement refers to any Holder of Registrable Securities by name or otherwise as the holder of any securities of the Company, then such Holder shall have the right to require (i) the insertion therein of language, in form and substance satisfactory to such Holder, to the effect that the holding by such Holder of such securities is not to be construed as a recommendation by such Holder of the investment quality of the Company's securities covered thereby and that such holding does not imply that such Holder will assist in meeting any future financial requirements of the Company, or (ii) in the event that such reference to such Holder by name or otherwise is not required by the Securities Act or other applicable non-U.S. securities laws or regulations then in force, the deletion of the reference to such Holder.

6. EXPENSES OF REGISTRATION

The Company shall pay all expenses (other than underwriting discounts and commissions) incurred in connection with registrations of Registrable Securities pursuant to this Agreement and set forth in this paragraph ("Registration Expenses"). Such expenses are: all registration and filing fees, all stock exchange listing fees, all fees associated with filings required to be made with the National Association of Securities Dealers, Inc., all fees and expenses of complying with state securities or blue sky laws, printers' fees, fees and disbursement of the independent public accountants for the Company (including the expenses of any comfort letters required by the Company's performance of and compliance with its obligations under this Agreement) and fees and disbursements of counsel for the Company.

7. INDEMNIFICATION

7.1 Indemnification by the Company.

The Company will indemnify and hold harmless each Holder of Registrable Securities covered by any registration provided in this Agreement, subsidiaries, Affiliates, officers, directors, employees, agents and representatives of each such Holder and each person, if any, who controls such Holder within the meaning of the Securities Act or the Exchange Act, against any and all liabilities, obligations, losses, damages, penalties, claims (or actions or proceedings in respect thereof), costs and expenses (including reasonable legal fees) ("Losses"), arising out of or based upon (i) any untrue statement or alleged untrue statement of any material fact contained in any registration statement under which such securities were registered under the Securities Act or other applicable non-U.S. securities laws, any preliminary prospectus contained therein, or any Free Writing Prospectus with respect to any securities that are subject to any such registration statement or any "issuer information" filed or required to be filed pursuant to Rule 433(d) under the Securities Act or (ii) any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that the Company shall not be liable in any such case for any such Loss to the extent that it arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in a registration statement or prospectus or any amendment or supplement thereto in reliance upon and in conformity with written information furnished by such Holder expressly for use therein. Such indemnity shall survive the transfer by such Holder of the securities it holds in the Company in accordance with
Section 9.2 and the other provisions of this Agreement.

12

7.2 Indemnification by the Holders.

To the full extent permitted by law, each Holder selling Registrable Securities pursuant to a registration provided in this Agreement, severally and not jointly, will indemnify and hold harmless the Company, its subsidiaries, its Affiliates, each of its directors, each of its officers, employees, agents and representatives, any underwriter retained by the Company and each person, if any, who controls the Company or such underwriter within the meaning of the Securities Act or the Exchange Act, any other Holder selling securities pursuant to such registration and any of such other Holder's subsidiaries, Affiliates, officers, directors, employees, agents and representatives and each of their successors and assigns and each person, if any, who controls such other Holder within the meaning of the Securities Act or the Exchange Act, against any Losses which are imposed on, incurred by or asserted against any such indemnified party under the Securities Act, the Exchange Act or any securities laws or other laws of any jurisdiction, common law or otherwise, in connection with the registration of securities provided in this Agreement, in each case to the extent (and only to the extent) that such Losses arise out of or are based upon an untrue statement or alleged untrue statement in, or omission or alleged omission from, a registration statement or prospectus or any amendment or supplement thereto, or any Free Writing Prospectus with respect thereto, in conformity with written information furnished by such Holder expressly for use therein; provided, however, that in no event shall any indemnity under this
Section 7.2, together with any amounts payable under Section 7.3, exceed the net proceeds received by such indemnifying Holder from the offering out of which such Losses arise.

7.3 Indemnification Procedures.

Promptly after receipt by an indemnified party under this Article 7 of notice of the commencement of any action or proceeding by any third party (including any governmental action or proceeding) (a "Third Party Claim"), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Article 7, deliver to the indemnifying party a written notice of the commencement of such Third Party Claim containing reasonable detail of the Third Party Claim (a "Claim Notice") and transmit to the indemnifying party a copy of all notices and documents received by the indemnified party pursuant to the Third Party Claim; provided that the failure to deliver a Claim Notice or the failure to transmit a copy of such notices and documents to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the indemnified party under this Article 7, except to the extent that the indemnifying party is actually prejudiced by such failure to give notice. The indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense of such Third Party Claim at its own expense with counsel selected by the indemnifying party and reasonably satisfactory to the indemnified parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate, based on the advice of counsel to the indemnified party, due to a conflict of interest between such indemnified party and the indemnifying party. No indemnifying party shall, without the written consent of the indemnified party (which shall not be unreasonably withheld), consent to the entry of any judgment or enter into any settlement of any Third Party Claim (whether or not the indemnified party is an actual or potential party to such action or claim) if such judgment or settlement includes a statement as to an admission of fault, culpability or a

13

failure to act on behalf of any indemnified party. No indemnifying party shall consent to entry of any judgment or enter into any settlement which does not include an unconditional release of each indemnified party from all liability in respect to such Third Party Claim. No indemnified party shall consent to the entry of any judgment or enter into any settlement in any Third Party Claim, the defense of which has been assumed by an indemnifying party, without the written consent of such indemnifying party.

7.4 Contribution.

If the indemnification provided for in this Section 7 is unavailable to or insufficient to hold harmless an indemnified party referred to in Section 7.1 or 7.2 with respect to any Loss referred to therein, then each indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such Loss in such proportion as is appropriate to reflect the relative benefits received by the indemnifying party on the one hand and by the indemnified party on the other from the offering out of which the Losses arise. If the allocation provided by the immediately preceding sentence is unavailable with respect to any Loss for any reason, the indemnifying party and the indemnified party severally shall contribute in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the indemnifying party on the one hand and the indemnified party on the other in connection with the Losses, as well as any other relevant equitable considerations. Relative benefits received by a party shall be deemed to be in the same proportion as the net proceeds from the offering (before deducting expenses) received by such party bear to the aggregate public offering price of the securities offered in the offering. Relative fault shall be determined by reference to, among other things, whether any untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the indemnifying party on the one hand or the indemnified party on the other, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Parties agree that it would not be just and equitable if contribution were determined by pro rata allocation (even if the Holders were treated as one entity for such purpose) or any other method of allocation that does not take account of the equitable considerations referred to above. The amount paid or payable by an indemnified party as a result of any Loss shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding any other provisions of this Section 7.4, no Holder will be required to contribute under this Article 7 any amount in excess of the amount by which the net proceeds received by such Holder in the offering exceed the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue statement or alleged untrue statement or omission or alleged omission; and (b) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentations.

7.5 Survival.

The obligations of the Company and Holders under this Section 7 shall survive the completion of any offering of Registrable Securities in a registration statement under this Agreement, and otherwise.

8. COMPANY UNDERTAKINGS

14

8.1 No Inconsistent Agreements.

The Company shall not enter into any agreement with respect to its securities that is inconsistent with the rights granted to the Holders of the Registrable Securities in this Agreement.

8.2 Rules 144 and 144A.

(a) So long as the Company shall not have filed a registration statement pursuant to Section 12 of the Exchange Act or a registration statement pursuant to the requirements of the Securities Act, the Company shall, at any time and from time to time, upon the request of any Holder of Registrable Securities, furnish in writing to such Holder, a statement as of a date not earlier than 12 months prior to the date of such request of the nature of the business of the Company and the products and services it offers and copies of the Company's most recent balance sheet and profit and loss and retained earnings statements, together with similar financial statements for such part of the two preceding fiscal years as the Company shall have been in operation, all such financial statements to be audited to the extent audited statements are reasonably available, provided that, in any event the most recent financial statements so furnished shall include a balance sheet as of a date less than 12 months prior to the date of such request, statements of profit and loss and retained earnings for the 12 months preceding the date of such balance sheet, and, if such balance sheet is not as of a date less than 6 months prior to the date of such request, additional statements of profit and loss and retained earnings for the period from the date of such balance sheet to a date less than 6 months prior to the date of such request.

(b) If the Company shall have filed a registration statement pursuant to the requirements of Section 12 of the Exchange Act or a registration statement pursuant to the requirements of the Securities Act, the Company shall timely file the reports required to be filed by it under the Securities Act and the Exchange Act (including but not limited to the reports under sections 13 and 15(d) of the Exchange Act referred to in subparagraph (c) of Rule 144) and the rules and regulations adopted by the SEC thereunder (or, if the Company is not required to file such reports, will, upon the request of any Holder of Registrable Securities, make publicly available other information except for such material non-public information as the Company has a valid business purpose for not disclosing publicly) and will take such further action as any Holder of Registrable Securities may reasonably request, all to the extent required from time to time to enable such Holder to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (a) Rule 144, Rule 144A or Regulation S, or (b) any similar rule or regulation hereafter adopted by the SEC.

9. MISCELLANEOUS

9.1 Term

This Agreement shall terminate upon the earlier of (i) the date as of which all of the Registrable Securities have been sold pursuant to a registration statement or (ii) when the Holders are permitted to sell their Registrable Securities under Rule 144(k) under the Securities Act (or any similar provision then in force permitting the sale of restricted securities without limitation on the amount of securities sold or the manner of sale).

9.2 Successors and Assigns.

15

(a) The registration rights of any Holder under this Agreement with respect to any Registrable Securities may be transferred and assigned, provided, however that no such assignment shall be binding upon or obligate the Company with respect to any such assignee unless and until (i) the Company shall have received notice of such assignment as herein provided and a written agreement of such assignee to be bound by the provisions of this Agreement and (ii) such assignee acquires Registrable Securities with an estimated aggregate market value of $10 million or more.

(b) This Agreement shall be binding upon and inure to the benefit of and be enforceable by the Parties hereto and their respective successors and assigns.

9.3 Governing Law.

This Agreement and, to the fullest extent permitted by applicable law, all matters arising out of or relating to this Agreement, shall be governed by and construed in accordance with the law of the State of New York, United States of America.

9.4 Dispute Resolution.

(a) Any dispute, controversy or claim (each, a "Dispute") arising out of or relating to this Agreement, or the interpretation, breach, termination or validity hereof, shall be resolved at the first instance through consultation between the parties to such Dispute. Such consultation shall begin immediately after any Party has delivered written notice to any other Party to the Dispute requesting such consultation.

(b) If the Dispute is not resolved within 60 days following the date on which such notice is given, the Dispute shall be submitted to arbitration upon the request of any Party to the Dispute with notice to each other Party to the Dispute (the "Arbitration Notice").

(c) The arbitration shall be conducted in Hong Kong Special Administrative Region ("Hong Kong") under the auspices of the Hong Kong International Arbitration Centre (the "Centre"). There shall be three arbitrators. The claimants in the Dispute shall collectively choose one arbitrator, and the respondents shall collectively choose one arbitrator. The Secretary General of the Centre shall select the third arbitrator, who shall be qualified to practice law in the State of New York. If any of the members of the arbitral tribunal have not been appointed within 30 days after the Arbitration Notice is given, the relevant appointment shall be made by the Secretary General of the Centre.

(d) The arbitration proceedings shall be conducted in English. The arbitration tribunal shall apply the Arbitration Rules of the United Nations Commission on International Trade Law, as in effect at the time of the arbitration, which rules shall be deemed to have been incorporated by reference into this Section 9.4. However, if such rules are in conflict with the provisions of this Section 9.4, including the provisions concerning the appointment of arbitrator, the provisions of this Section 9.4 shall prevail.

(e) Each Party to the arbitration shall cooperate with each other Party to the arbitration in making full disclosure of and providing complete access to all information and documents requested by such other party in connection with such arbitration proceedings, subject only to any confidentiality obligations binding on such Party.

16

(f) The award of the arbitration tribunal shall be final and binding upon the Parties, and the prevailing Party may apply to a court of competent jurisdiction for enforcement of such award.

(g) Any party to the Dispute shall be entitled to seek preliminary injunctive relief, if possible, from any court of competent jurisdiction pending the constitution of the arbitral tribunal.

(h) During the course of the arbitration tribunal's adjudication of the dispute, this Agreement shall continue to be performed except with respect to the part in dispute and under adjudication.

(i) The cost of arbitration (including legal, accounting and other professional fees and expenses reasonably incurred by any prevailing party with respect to the investigation, collection, prosecution and/or defense of any claim in the Dispute) shall be borne by the losing Party or Parties unless otherwise determined by the arbitration award.

9.5 Counterparts and Facsimile Execution.

This Agreement and any amendment hereto or any other agreement (or document) delivered pursuant hereto may be executed in any number of counterparts, each of which shall be an original but all of such counterparts together shall constitute one and the same instrument and shall become effective (unless otherwise provided therein) when all counterparts have been signed by all relevant parties and delivered to the other parties. Any counterpart or other signature delivered by a Party by facsimile shall be deemed for all purposes as being a good and valid execution and delivery of this Agreement by that Party.

9.6 Titles and Subtitles; References.

The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement, nor as evidence of the intention of the Parties hereto. Except where otherwise indicated, all references in this Agreement to Articles or Sections refer to Articles or Sections of this Agreement,

9.7 Notices.

Any and all notices required or permitted to be given to a Party pursuant to the provisions of this Agreement will be in writing and will be effective and deemed to provide such Party sufficient notice under this Agreement on the earliest of the following: (i) at the time of personal delivery, if delivery is in person; (ii) at the time of transmission by facsimile, addressed to such Party at the facsimile number indicated for such Party on the signature page of this Agreement (or hereafter modified by subsequent notice to the Parties hereto, or, in the case of a subsequent Holder of any Restristrable Securities, at the facsimile number furnished by such subsequent Holder to the Company and the other Holders in writing), with confirmation of receipt made by both telephone and printed confirmation sheet verifying successful transmission of the facsimile; (ii) two business day after deposit with an express overnight courier for deliveries within a country, or three business days after such deposit for international deliveries or (iv) three business days after deposit in mail by certified mail (return receipt requested) or equivalent for deliveries within a country. For the purposes of this Section, a delivery between the Hong Kong and any other point in the PRC shall be considered an international delivery.

17

All notices for international delivery will be sent by facsimile or by express courier. All notices not delivered personally or by facsimile will be sent with postage and/or other charges prepaid and properly addressed to the Party to be notified at the address or facsimile number indicated for such Party on the signature page of this Agreement or at such other address or facsimile number as such Party may designate by giving ten days advance written notice by one of the indicated means of notice provided in this Agreement to the other Parties hereto, or, in the case of a subsequent Holder of any Registrable Securities, at the address or facsimile number furnished by such subsequent Holder to the Company and the other Holders in writing. Notices by facsimile shall be machine verified as received.

Any Party hereto (and such Party's permitted assigns) may by notice so given change its address for future notices under this Agreement. Notice shall conclusively be deemed to have been given in the manner set forth above.

9.8 Attorney's Fees.

In the event of any action for the breach of this Agreement or misrepresentation by any Party, the prevailing Party shall be entitled to reasonable attorney's fees, costs and expenses incurred in connection with such action.

9.9 Amendments and Waivers.

Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only by the written consent of the Parties and each subsequent Holder of any Registrable Securities. No delay or omission to exercise any right, power, or remedy accruing to any Party, upon any breach, default or noncompliance by another Party under this Agreement shall impair any such right, power, or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of any similar breach, default or noncompliance thereafter occurring. No waiver of any provision nor consent to any exception to the terms of this Agreement shall be effective unless in writing and signed by the Party to be bound and then only to the specific purpose, extent and instance so provided. Any amendment or waiver effected in accordance with this Section 9.9 shall be binding upon each of the Parties hereto and their successors and permitted assigns. All remedies, either under this Agreement, by law, or otherwise afforded to any Party shall be cumulative and not alternative.

9.10 Severability.

If any provisions of this Agreement shall be held to be unenforceable under applicable law, such provision shall be excluded from this Agreement and the remaining provisions of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.

9.11 Entire Agreement.

This Agreement, the other Transaction Documents and all other documents referred to in this Agreement (except for the letter agreement dated as of the date hereof, among the Company, Brothers Capital Limited and the Investors) constitute the entire agreement and understanding among the Parties with respect to the subject matter hereof and supersedes any and all prior negotiations, correspondence, agreements, understandings, duties

18

or obligations between the Parties with respect to the subject matter hereof and no Party shall be liable or bound to any other Party in any manner by any warranties, representations, or covenants except as specifically set forth herein or therein.

9.12 Interpretation.

Unless a provision in this Agreement expressly provides otherwise: (i) the term "or" is not exclusive; (ii) words in the singular include the plural, and words in the plural include the singular; (iii) the terms "herein," "hereof," and other similar words refer to this Agreement as a whole and not to any particular section, subsection, paragraph, clause, or other subdivision;
(iv) the term "including" will be deemed to be followed by ", but not limited to,"; (v) the masculine, feminine, and neuter genders will each be deemed to include the others; (vi) the terms "shall," "will," and "agrees" are mandatory, and the term "may" is permissive; (vii) the term "day" means "calendar day," and
(viii) all references to "dollars" are to currency of the United States of America.

9.13 No Presumption.

The Parties acknowledge that any applicable law that would require interpretation of any claimed ambiguities in this Agreement against the Party that drafted it has no application and is expressly waived. If any claim is made by a Party relating to any conflict, omission or ambiguity in the provisions of this Agreement, no presumption or burden of proof or persuasion will be implied because this Agreement was prepared by or at the request of any Party or its counsel.

9.14 Specific Performance.

Each of the Parties hereto recognizes and acknowledges that a breach by it of any covenants or agreements contained in this Agreement will cause the other Party to sustain damage for which it would not have an adequate remedy at law for money damages, and therefore each of the Parties hereto agrees that in the event of any such breach the aggrieved Party shall be entitled to the remedy of specific performance of such covenants and agreements and injunctive and other equitable relief in addition to any other remedy to which it may be entitled, at law or in equity.

9.15 Aggregation of Stock.

All Registrable Securities held or acquired by affiliated entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement.

[The remainder of this page has been intentionally left blank.]

19

IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed by its duly authorized officers as of the day and year first above written.

AGRIA CORPORATION

By /s/ Lai Guanglin
   -------------------------------------
Name:
Title:

TPG GROWTH AC LTD.

By /s/ Clive Bode
   -------------------------------------
Name: Clive Bode
Title: Vice President and Secretary

TPG BIOTECH II, LTD.

By /s/ Clive Bode
   -------------------------------------
Name: Clive Bode
Title: Vice President and Secretary

SIGNATURE PAGE TO THE REGISTRATION RIGHTS AGREEMENT


EXHIBIT 4.16

EXECUTION COPY

June 22, 2007

UNDERTAKING LETTER

To:

Brothers Capital Limited
TPG Growth AC Ltd.
TPG Biotech II, Ltd.

This letter agreement is being delivered by the undersigned in connection with your investment in Agria Corporation (the "Company").

We hereby agree to the following:

1. Each signatory will use reasonable best efforts to, and the Company will use its reasonable best efforts to cause each shareholder of the Company
(including TPG Growth AC Ltd., TPG Biotech II, Ltd. and Dubai Investment Group) to, enter into a new agreement regarding share transfers, the memorandum and articles of association of the Company (the "M&A") and a new registration rights agreement, in each case, that supplements prior similar agreements or the relevant provisions of each such agreements to which such shareholder is a party, as soon as possible but no later than the public filing date of the Company's Registration Statement on Form F-1 with the United States Securities and Exchange Commission (or the public filing date of the Company's offering circulars in other jurisdictions). The parties intend that the agreement regarding share transfers and the M&A will grant each shareholder of the Company substantially similar co-sale rights, rights of first refusal and pre-emptive rights and will impose on each shareholder of the Company substantially similar restrictions on transfer of its shares as well as (to the extent applicable to such shareholder) clarify the relationship between the M&A and the investment agreements of certain of the shareholders. The parties intend that the registration rights agreement will grant each shareholder of the Company equivalent piggyback and demand registration rights (to the extent such shareholder currently enjoys demand registration rights). The rights of TPG Growth AC Ltd. and TPG Biotech II, Ltd as holders of the preferred shares of the Company will not be changed. Each party's put right (or redemption right) and rights with respect to the Company's corporate governance will not be changed.

2. This letter agreement and, to the fullest extent permitted by applicable law, all matters arising out of or relating to this letter agreement, shall be governed by and construed in accordance with the law of the State of New York, United States of America.

3. Any dispute, controversy or claim (each, a "Dispute") arising out of or relating to this letter agreement, or the interpretation, breach, termination or validity hereof, shall be resolved at the first instance through consultation between the parties to such Dispute. Such consultation shall begin immediately after any party has delivered written notice to any other

1

party to the Dispute requesting such consultation. If the Dispute is not resolved within 60 days following the date on which such notice is given, the Dispute shall be submitted to arbitration upon the request of any party to the Dispute with notice to each other party to the Dispute (the "Arbitration Notice"). The arbitration shall be conducted in Hong Kong under the auspices of the Hong Kong International Arbitration Centre (the "Centre"). There shall be three arbitrators. The claimants in the Dispute shall collectively choose one arbitrator, and the respondents shall collectively choose one arbitrator. The Secretary General of the Centre shall select the third arbitrator, who shall be qualified to practice law in the State of New York. If any of the members of the arbitral tribunal have not been appointed within 30 days after the Arbitration Notice is given, the relevant appointment shall be made by the Secretary General of the Centre. The arbitration proceedings shall be conducted in English. The arbitration tribunal shall apply the Arbitration Rules of the United Nations Commission on International Trade Law, as in effect at the time of the arbitration, which rules shall be deemed to have been incorporated by reference into this section. However, if such rules are in conflict with the provisions of this section, including the provisions concerning the appointment of arbitrator, the provisions of this section shall prevail. Each party to the arbitration shall cooperate with each other party to the arbitration in making full disclosure of and providing complete access to all information and documents requested by such other party in connection with such arbitration proceedings, subject only to any confidentiality obligations binding on such party. The award of the arbitration tribunal shall be final and binding upon the parties, and the prevailing party may apply to a court of competent jurisdiction for enforcement of such award. Any party to the Dispute shall be entitled to seek preliminary injunctive relief, if possible, from any court of competent jurisdiction pending the constitution of the arbitral tribunal. During the course of the arbitration tribunal's adjudication of the dispute, this letter agreement shall continue to be performed except with respect to the part in dispute and under adjudication. The cost of arbitration (including legal, accounting and other professional fees and expenses reasonably incurred by any prevailing party with respect to the investigation, collection, prosecution and/or defense of any claim in the Dispute) shall be borne by the losing party or parties unless otherwise determined by the arbitration award.

Please indicate your acceptance of the provisions hereof by signing the enclosed copy of this letter agreement and returning to the Company.

[Signature page to follow]

2

Very truly yours,

Agria Corporation

By: /s/
    ------------------------------------
Name:
Title:
Date

ACKNOWLEDGED AND AGREED TO:

Brothers Capital Limited

By: /s/
    ---------------------------------
Name:
Title:

TPG Growth AC Ltd.

By: /s/ Clive Bode
    ---------------------------------
Name: Clive Bode
Title: Vice President and Secretary

TPG Biotech II, Ltd.

By: /s/ Clive Bode
    ---------------------------------
Name: Clive Bode
Title: Vice President and Secretary

Signature Page to the Undertaking Letter


EXHIBIT 4.17

EXECUTION COPY

DEED OF ADHERENCE

THIS DEED OF ADHERENCE (this "Agreement") dated as of August 30, 2007 is made by and between Dubai Investment Group L.L.C, a company incorporated in the Cayman Islands with its registered office at c/o Paget Brown Trust Company Ltd, West Wind Building, Harbour Drive, P.O. Box 1111, George Town, Grand Cayman, British West Indies ("DIG"), and Agria Corporation, an exempted company incorporated in the Cayman Islands (the "Company").

WHEREAS, the Company, TPG Growth AC Ltd. and TPG Biotech II, Ltd. have entered into that certain registration rights agreement dated as of June 22, 2007 (the "Registration Rights Agreement").

WHEREAS, TPG Growth AC Ltd. and TPG Biotech II, Ltd. (together, "TPG"), the Company and DIG have agreed that DIG shall execute this Agreement confirming its agreement to be bound by the provisions of the Registration Rights Agreement, with all of the rights and obligations of a Holder of Registrable Securities thereunder (as such terms are defined in the Registration Rights Agreement).

NOW IT IS AGREED AS FOLLOWS:

Section 1. Adherence to Registration Rights Agreement. DIG hereby agrees with each party to the Registration Rights Agreement that it will comply with and be bound by all of the provisions of the Registration Rights Agreement (a copy of which has been delivered to DIG and which has been initialed by DIG and is attached hereto for identification) in all respects as if DIG were a party to the Registration Rights Agreement and were named therein as a party, and on the basis that references therein to "Holder(s)" shall include a separate reference to DIG, and the ordinary shares (and any other shares of capital stock) held by DIG shall constitute "Registrable Securities" as defined therein.

Section 2. Entire Agreement. This Agreement sets forth the entire understanding and agreement of DIG and the Company with respect to the transactions contemplated hereby and supersedes and replaces any prior understanding, agreement or statement of intent, in each case written or oral, of any kind and every nature with respect hereto (including, without limitation, the provisions relating to registration rights contained in: (i) that certain placement agreement dated as of June 22, 2007 among Brothers Capital Limited, DIG and the Company, (ii) that certain investment agreement dated as of March 7, 2007 between Brothers Capital Limited and DIG and (iii) that certain supplemental agreement dated as of June 21, 2007 among Brothers Capital Limited, DIG and the Company. Any provision of this Agreement can only be amended or modified in whole or in part by an agreement in writing executed by the Company, TPG and DIG.

Section 3. Governing Law. THIS AGREEMENT AND THE RIGHTS AND
OBLIGATIONS UNDER IT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

1

IN WITNESS WHEREOF DIG has executed this Agreement as of the date first above written.

DUBAI INVESTMENT GROUP L.L.C.

By: /s/
    ------------------------------------
Name:
Title:

AGRIA CORPORATION

By: /s/ Lai Guanglin
    ------------------------------------
Name: Lai Guanglin
Title: Chairman

Agreed to and Accepted:

TPG GROWTH AC LTD.

By /s/ Clive Bode
   ----------------------------------
Name: Clive Bode
Title: Vice President and Secretary

TPG BIOTECH II, LTD.

By /s/ Clive Bode
   ----------------------------------
Name: Clive Bode
Title: Vice President and Secretary

2

EXHIBIT 4.18

TRANSLATED FOR REFERENCE ONLY.

ENCLOSURE 12.5 (I)

LEASE OF LAND

Party A (Transferor): Taiyuan Relord Enterprise Development Group Co., Ltd.

Party B (Transferee): Primalights III Agriculture Development Co., Ltd.

Taiyuan Relord Enterprise Development Group Co., Ltd. (hereinafter referred to as "Party A") and Primalights III Agriculture Development Co., Ltd. (hereinafter referred to as "Party B") in compliance with the relevant laws and regulations of the People's Republic of China, through negotiation with the principle of mutual benefit and equality, in connection with the matters in transferring the forest ownership of Party A to Party B in red dates economic forest located at Shihou Village, Jiaochen County, entered into this agreement as follows:

(1) Location and Boundary

The forest land is located at Shihou Village, Jiaochen County, which includes four pieces of red date tree economic land with the total of 1,001 acres.

The size of first piece of land Huanchangdi is 260 acres, with boundary north to Jiabannian, south to Jianandi, west to Weizhedi and east to Jiaochendao.

The second piece of land Jianandi has total size of 260 acres, with boundary north to Huanlundi, south to Laopidi, west to Weizhedi, and east to Jiaochendao.

The third piece of land Laopidi has a total size of 332 acres, with boundary north to Jianandi, south to Ershisimudi, west to Weizhedi, and east to Jiaochendao.

The fourth piece of land Weizhedi has a total size of 149 acres, with boundary north to Jiabannian, south to Qianduozhe, west to Wayaohe and east to Jianandi.

(2) Transfer Fee and Payment

1. Ownership of the Forest.

Party A has already planted and grown a total of 200,200 date tress on the forest including 81,600 Junzao date trees and 118,600 pear date trees, whereby Party A managed to obtain the relevant ownership right certificate and holds full property right. Now, Party A transfers the ownership right of such forest that worth the full amount of RMB 43.6 million to Party B. Party B shall pay 50% of the total amount (i.e. RMB 21.8 million) to Party A within three months after the contact becomes effective. The remaining 50% of the total amount shall be paid off within half year after the contract becomes effective.

2. Fixed Assets and Land Lease Fee

Party B shall pay Party A the fixed assets and land rental fee of Shihou forest in the amount of RMB 1.2 million for the then current year before 13 November of each year starting from year 2007.


(3) Closing Time

The closing date of the transfer is 13 November 2006.

(4) Responsibilities, Rights and Obligations

1. Responsibilities and Obligations

a. Party A is obliged to assist Party B with relevant legal procedures and administer this transfer;

b. Party B is obliged to pay the transfer fee and rental fee as scheduled and in full amount.

2. Rights

a. Party A is entitled to receive the full amount of the transfer fee and rental fee;

b. Party B is entitled to the overall planning and development of the forest

(5) Default

Both parties must be abided by this Agreement. The defaulting party shall compensate the non-defaulting party for all losses thus incurred.

(6) Dispute and Resolution

All disputes arises during the execution period thereof shall be settled by friendly consultation. If no settlement can be reached through consultation, both parties shall resolve the case through legal proceedings in the judicial authority of Taiyuan, Shanxi Province.

(7) This Agreement is signed in quadruplicates, and each party hereto shall hold two copies. This Agreement shall be effective after it is sighed and sealed by both parties.

Taiyuan Relord Enterprise Development Group Co., Ltd.

Signature: /s/


Primalights III Agriculture Development Co., Ltd.


Signature: /s/ Zhang Mingshe

                                                                October 25, 2006


.

.
.
Exhibit 5.1

Our ref RJT\630408\2177971v7
Your ref

Agria Corporation                                                         Direct:    +852 2971 3007
Room 706, 7/F, Huantai Building, No. 12A                                  Mobile:    +852 9020 8007
South Street Zhongguancun                                                 E-mail:    richard.thorp@maplesandcalder.com
Haidian District, Beijing 100081
People's Republic of China

18 October 2007

Dear Sirs

AGRIA CORPORATION

We have acted as Cayman Islands legal advisers to Agria Corporation (the "COMPANY") in connection with the Company's registration statement on Form F-1, including all amendments or supplements thereto (the "REGISTRATION STATEMENT"), confidentially submitted with the Securities and Exchange Commission under the U.S. Securities Act of 1933 on 16 July 2007 and as amended on 31 August 2007 and 4 October 2007, relating to the offering by the Company and the sale by the selling shareholders (the "SELLING SHAREHOLDERS") of certain American Depositary Shares representing the Company's Ordinary Shares of par value US$0.0000001 each (the "ORDINARY SHARES"). We are furnishing this opinion as Exhibit 5.1 to the Registration Statement.

1 DOCUMENTS REVIEWED

For the purposes of this opinion, we have reviewed only originals, copies or final drafts of the following documents:

1.1 the Certificate of Incorporation dated 14 May 2007, the Amended and Restated Memorandum and Articles of Association of the Company as adopted by a special resolution passed on 22 June 2007, as amended on by an ordinary resolution passed on 15 August 2007 and the Amended and Restated Memorandum and Articles of Association of the Company as conditionally adopted by special resolution passed on 5 October 2007 (the "MEMORANDUM AND ARTICLES OF ASSOCIATION");

1.2 the register of members of the Company;

1.3 the written resolutions of the board of Directors dated 29 September 2007;

1.4 a certificate from a Director of the Company addressed to this firm dated 9 October 2007, a copy of which is attached hereto (the "DIRECTOR'S CERTIFICATE"); and

1.5 the Registration Statement.


2

2 ASSUMPTIONS

Save as aforesaid we have not been instructed to undertake and have not undertaken any further enquiry or due diligence in relation to the transaction the subject of this opinion. The following opinions are given only as to and based on circumstances and matters of fact existing at the date hereof and of which we are aware consequent upon the instructions we have received in relation to the matter the subject of this opinion and as to the laws of the Cayman Islands as the same are in force at the date hereof. In giving this opinion, we have relied upon the completeness and accuracy (and assumed the continuing completeness and accuracy as at the date hereof) of the Director's Certificate as to matters of fact without further verification and have relied upon the following assumptions, which we have not independently verified:

(i) Copy documents or drafts of documents provided to us are true and complete copies of, or in the final forms of, the originals.

(ii) The genuineness of all signatures and seals.

3 OPINION

The following opinions are given only as to matters of Cayman Islands law and we have assumed that there is nothing under any other law that would affect or vary the following opinions.

Based upon the foregoing and subject to the qualifications set out below and having regard to such legal considerations as we deem relevant, we are of the opinion that:

3.1 The Company has been duly incorporated as an exempted company with limited liability for an unlimited duration and is validly existing under the laws of the Cayman Islands.

3.2 The authorised share capital of the Company is US$50,000 divided into (i) 499,900,000,000 ordinary shares of par value US$0.0000001 each and (ii) 100,000,000 preferred shares of par value US$0.0000001 each.

3.3 The issue and allotment of the Ordinary Shares has been duly authorised. When allotted, issued and paid for as contemplated in the Registration Statement and registered in the register of members (shareholders), the Ordinary Shares will be legally issued and allotted, fully paid and non-assessable.

3.4 Ordinary Shares to be sold by the Selling Shareholders have been legally and validly issued as fully paid and non-assessable.

3.5 The statements under the caption "Taxation" in the prospectus forming part of the Registration Statement, to the extent that they constitute statements of Cayman Islands law, are accurate in all material respects and that such statements constitute our opinion.


3

4 QUALIFICATIONS

Except as specifically stated herein, we make no comment with respect to any representations and warranties which may be made by or with respect to the Company in the Registration Statement or otherwise with respect to the commercial terms of the transactions the subject of this opinion.

We hereby consent to the use of this opinion in, and the filing hereof as an Exhibit to, the Registration Statement and to the reference to our name under the headings "Enforceability of Civil Liabilities", "Taxation" and "Legal Matters" and elsewhere in the prospectus included in the Registration Statement. In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the U.S. Securities Act of 1933, as amended, or the Rules and Regulations of the Commission thereunder.

Yours faithfully

/s/  MAPLES and CALDER
MAPLES AND CALDER


AGRIA CORPORATION
PO Box 309GT, Ugland House
South Church Street, George Town,
Grand Cayman, Cayman Islands

Maples and Calder
1504 One International Finance Centre
1 Harbour View Street
Hong Kong
9 October 2007

Dear Sirs

AGRIA CORPORATION (THE "COMPANY")

I, Gary Kim Ting Yeung, being a director of the Company, am aware that you are being asked to provide a legal opinion (the "OPINION") in relation to certain aspects of Cayman Islands law. Capitalized terms used in this certificate have the meaning given to them in the Opinion. I hereby certify that:

1 The amended and restated memorandum and articles of association of the Company as adopted by a special resolution passed on 22 June 2007, as amended by ordinary resolutions passed on 15 August 2007 and the further amended and restated memorandum and articles of association as adopted conditionally on the IPO by a special resolution passed on 5 October 2007 remain in full force and effect and are otherwise unamended.

2 The written resolutions of Directors dated 29 September 2007 (the "DIRECTORS' RESOLUTIONS") were signed by all the Directors in the manner prescribed in the Articles of Association of the Company.

3 The written resolutions of the shareholders of the Company dated 5 October 2007 (this together with the Directors' Resolutions are referred to as "RESOLUTIONS") were signed by all the shareholders in the manner prescribed in the Articles of Association of the Company.

4 The shareholders of the Company have not restricted or limited the powers of the directors in any way. There is no contractual or other prohibition (other than as arising under Cayman Islands law binding on the Company prohibiting it from entering into and performing its obligations under the Agreements.

5 The resolutions passed in the Resolutions were duly adopted, are in full force and effect at the date hereof and have not been amended, varied or revoked in any respect.

6 The ordinary shares held by the Selling Shareholders have been issued as fully paid.

Signature:   /s/ Gary Kim Ting Yeung
           ---------------------------
             Director


EXHIBIT 8.1

53rd at Third
885 Third Avenue
New York, New York 10022-4834
Tel: (212) 906-1200
Fax: (212) 751-4864
www.lw.com

(LATHAM & WATKINS LLP LOGO) FIRM / AFFILIATE OFFICES

                                           Barcelona     New Jersey
                                           Brussels      New York
                                           Chicago       Northern Virginia
October 18, 2007                           Frankfurt     Orange County
                                           Hamburg       Paris
                                           Hong Kong     San Diego
                                           London        San Francisco
Agria Corporation                          Los Angeles   Shanghai
Room 706, 7/F, Huantai Building, No. 12A   Madrid        Silicon Valley
South Street Zhongguancun                  Milan         Singapore
Haidian District, Beijing 100081           Moscow        Tokyo
People's Republic of China                 Munich        Washington, D.C.

Re: American Depositary Shares of Agria Corporation (the "Company")

Ladies and Gentlemen:

In connection with the public offering of American Depositary Shares ("ADSs") representing ordinary shares (the "Ordinary Shares") of the Company pursuant to the registration statement on Form F-1 under the Securities Act of 1933, as amended (the "Act"), originally filed by the Company with the Securities and Exchange Commission (the "Commission") on October 18, 2007 (the "Registration Statement"), you have requested our opinion concerning the statements in the Registration Statement under the caption "Taxation--United States Federal Income Taxation."

The facts, as we understand them, and upon which with your permission we rely in rendering the opinion herein, are set forth in the Registration Statement and the Company's responses to our examinations and inquiries.

In our capacity as counsel to the Company, we have made such legal and factual examinations and inquiries, including an examination of originals or copies certified or otherwise identified to our satisfaction of such documents, corporate records and other instruments as we have deemed necessary or appropriate for purposes of this opinion. In our examination, we have assumed the authenticity of all documents submitted to us as originals, the genuineness of all signatures thereon, the legal capacity of natural persons executing such documents and the conformity to authentic original documents of all documents submitted to us as copies. For the purpose of our opinion, we have not made an independent investigation, or audit of the facts set forth in the above-referenced documents.

We are opining herein as to the effect on the subject transaction only of the federal income tax laws of the United States and we express no opinion with respect to the applicability thereto, or the effect thereon, of other federal laws, the laws of any state or any


October 18, 2007

PAGE 2

(LATHAM & WATKINS LLP LOGO)

other jurisdiction or as to any matters of municipal law or the laws of any other local agencies within any state.

Based on such facts and subject to the limitations set forth in the Registration Statement, the statements of law or legal conclusions in the Registration Statement under the caption "Taxation--United States Federal Income Taxation" constitute the opinion of Latham & Watkins LLP as to the material United States federal income tax consequences of an investment in the ADSs or the Ordinary Shares.

No opinion is expressed as to any matter not discussed herein.

This opinion is rendered to you as of the date of this letter, and we undertake no obligation to update this opinion subsequent to the date hereof. This opinion is based on various statutory provisions, regulations promulgated thereunder and interpretations thereof by the Internal Revenue Service and the courts having jurisdiction over such matters, all of which are subject to change either prospectively or retroactively. Also, any variation or difference in the facts from those set forth in the Registration Statement may affect the conclusions stated herein.

This opinion is furnished to you, and is for your use in connection with the transactions set forth in the Registration Statement. This opinion may not be relied upon by you for any other purpose. However, this opinion may be relied upon by persons entitled to rely on it pursuant to applicable provisions of federal securities law.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of our name under the captions "Legal Matters" and "Taxation" in the Registration Statement. In giving such consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act or the rules or regulations of the Commission promulgated thereunder.

Very truly yours,

/s/ Latham & Watkins LLP
Latham & Watkins LLP


EXHIBIT 10.1

AGRIA CORPORATION

2007 SHARE INCENTIVE PLAN

ARTICLE 1

PURPOSE

The purpose of this 2007 Share Incentive Plan (the "Plan") is to promote the success and enhance the value of Agria Corporation, a company formed under the laws of the Cayman Islands (the "Company") by linking the personal interests of the members of the Board, Employees, and Consultants to those of the Company shareholders and by providing such individuals with an incentive for outstanding performance to generate superior returns to the Company shareholders. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract, and retain the services of members of the Board, Employees, and Consultants upon whose judgment, interest, and special effort the successful conduct of the Company's operation is largely dependent.

ARTICLE 2

DEFINITIONS AND CONSTRUCTION

Wherever the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates otherwise. The singular pronoun shall include the plural where the context so indicates.

2.1 "Applicable Laws" means the legal requirements relating to the Plan and the Awards under applicable provisions of the corporate, securities, tax and other laws, rules, regulations and government orders, and the rules of any applicable Share exchange or national market system, of any jurisdiction applicable to Awards granted to residents therein.

2.2 "Award" means an Option, a Restricted Share award, a Share Appreciation Right award, a Dividend Equivalents award, a Share Payment award, a Deferred Share award, or a Restricted Share Unit award granted to a Participant pursuant to the Plan.

2.3 "Award Agreement" means any written agreement, contract, or other instrument or document evidencing an Award, including through electronic medium.

2.4 "Board" means the Board of Directors of the Company.

2.5 "Change in Control" means a change in ownership or control of the Company effected through either of the following transactions:

(a) the direct or indirect acquisition by any person or related group of persons (other than an acquisition from or by the Company or by a Company-sponsored employee benefit plan or by a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) of beneficial ownership (within the meaning of Rule 13d-3


of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company's outstanding securities pursuant to a tender or exchange offer made directly to the Company's shareholders which a majority of the Incumbent Board (as defined below) who are not affiliates or associates of the offeror under Rule 12b-2 promulgated under the Exchange Act do not recommend such shareholders accept, or

(b) the individuals who, as of the Effective Date, are members of the Board (the "Incumbent Board"), cease for any reason to constitute at least fifty percent (50%) of the Board; provided that if the election, or nomination for election by the Company's shareholders, of any new member of the Board is approved by a vote of at least fifty percent (50%) of the Incumbent Board, such new member of the Board shall be considered as a member of the Incumbent Board.

2.6 "Code" means the Internal Revenue Code of 1986 of the United States, as amended.

2.7 "Committee" means the committee of the Board described in Article 11.

2.8 "Consultant" means any consultant or adviser if: (a) the consultant or adviser renders bona fide services to a Service Recipient; (b) the services rendered by the consultant or adviser are not in connection with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the Company's securities; and (c) the consultant or adviser is a natural person who has contracted directly with the Service Recipient to render such services.

2.9 "Corporate Transaction" means any of the following transactions, provided, however, that the Committee shall determine under (d) and (e) whether multiple transactions are related, and its determination shall be final, binding and conclusive:

(a) an amalgamation, arrangement or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the jurisdiction in which the Company is incorporated;

(b) the sale, transfer or other disposition of all or substantially all of the assets of the Company;

(c) the complete liquidation or dissolution of the Company;

(d) any reverse takeover or series of related transactions culminating in a reverse takeover (including, but not limited to, a tender offer followed by a reverse takeover) in which the Company is the surviving entity but (A) the Ordinary Shares outstanding immediately prior to such takeover are converted or exchanged by virtue of the takeover into other property, whether in the form of securities, cash or otherwise, or (B) in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company's outstanding securities are transferred to a person or persons different from those who held such securities immediately prior to such takeover or the initial transaction culminating in such takeover, but excluding any such transaction or series of related transactions that the Committee determines shall not be a Corporate Transaction; or

2

(e) acquisition in a single or series of related transactions by any person or related group of persons (other than the Company or by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company's outstanding securities but excluding any such transaction or series of related transactions that the Committee determines shall not be a Corporate Transaction.

2.10 "Deferred Share" means a right to receive a specified number of Shares during specified time periods pursuant to Article 8.

2.11 "Disability" means that the Participant qualifies to receive long-term disability payments under the Service Recipient's long-term disability insurance program, as it may be amended from time to time, to which the Participant provides services regardless of whether the Participant is covered by such policy. If the Service Recipient to which the Participant provides service does not have a long-term disability plan in place, "Disability" means that a Participant is unable to carry out the responsibilities and functions of the position held by the Participant by reason of any medically determinable physical or mental impairment for a period of not less than ninety (90) consecutive days. A Participant will not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to satisfy the Committee in its discretion.

2.12 "Dividend Equivalents" means a right granted to a Participant pursuant to Article 8 to receive the equivalent value (in cash or Share) of dividends paid on Share.

2.13 "Effective Date" shall have the meaning set forth in Section 12.1.

2.14 "Employee" means any person, including an officer or member of the Board of the Company, any Parent or Subsidiary of the Company, who is in the employ of a Service Recipient, subject to the control and direction of the Service Recipient as to both the work to be performed and the manner and method of performance. The payment of a director's fee by a Service Recipient shall not be sufficient to constitute "employment" by the Service Recipient.

2.15 "Exchange Act" means the Securities Exchange Act of 1934 of the United States, as amended.

2.16 "Fair Market Value" means, as of any date, the value of Shares determined as follows:

(a) If the Shares are listed on one or more established Share exchanges or national market systems, including without limitation, The New York Stock Exchange, The Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Share Market, its Fair Market Value shall be the closing sales price for such shares (or the closing bid, if no sales were reported) as quoted on the principal exchange or system on which the Shares are listed (as determined by the Committee) on the date of determination (or, if no closing sales price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid was reported), as reported in The Wall Street Journal or such other source as the Committee deems reliable;

3

(b) If the Shares are regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities dealer, its Fair Market Value shall be the closing sales price for such shares as quoted on such system or by such securities dealer on the date of determination, but if selling prices are not reported, the Fair Market Value of a Share shall be the mean between the high bid and low asked prices for the Shares on the date of determination (or, if no such prices were reported on that date, on the last date such prices were reported), as reported in The Wall Street Journal or such other source as the Committee deems reliable; or

(c) In the absence of an established market for the Shares of the type described in (i) and (ii), above, the Fair Market Value thereof shall be determined by the Committee in good faith by reference to the placing price of the latest private placement of the Shares and the development of the Company's business operations and the general economic and market conditions since such latest private placement.

2.17 "Incentive Share Option" means an Option that is intended to meet the requirements of Section 422 of the Code or any successor provision thereto.

2.18 "Independent Director" means a member of the Board who is not an Employee of the Company.

2.19 "Non-Employee Director" means a member of the Board who qualifies as a "Non-Employee Director" as defined in Rule 16b-3(b)(3) of the Exchange Act, or any successor definition adopted by the Board.

2.20 "Non-Qualified Share Option" means an Option that is not intended to be an Incentive Share Option.

2.21 "Option" means a right granted to a Participant pursuant to Article 5 of the Plan to purchase a specified number of Shares at a specified price during specified time periods. An Option may be either an Incentive Share Option or a Non-Qualified Share Option.

2.22 "Participant" means a person who, as a member of the Board, Consultant or Employee, has been granted an Award pursuant to the Plan.

2.23 "Parent" means a parent corporation under Section 424(e) of the Code.

2.24 "Plan" means this Agria Corporation Share Incentive Plan, as it may be amended from time to time.

2.25 "PRC" means the People's Republic of China.

2.26 "Related Entity" means any business, corporation, partnership, limited liability company or other entity in which the Company, a Parent or Subsidiary of the Company holds a substantial ownership interest, directly or indirectly but which is not a Subsidiary and which the Board designates as a Related Entity for purposes of the Plan.

4

2.27 "Restricted Share" means a Share awarded to a Participant pursuant to Article 6 that is subject to certain restrictions and may be subject to risk of forfeiture.

2.28 "Restricted Share Unit" means an Award granted pursuant to Section 8.6.

2.29 "Securities Act" means the Securities Act of 1933 of the United States, as amended.

2.30 "Service Recipient" means the Company, any Parent or Subsidiary of the Company and any Related Entity to which a Participant provides services as an Employee, Consultant or as a Director.

2.31 "Share" means the ordinary share capital of the Company, par value $0.001 per share, and such other securities of the Company that may be substituted for Shares pursuant to Article 10.

2.32 "Share Appreciation Right" or "SAR" means a right granted pursuant to Article 7 to receive a payment equal to the excess of the Fair Market Value of a specified number of Shares on the date the SAR is exercised over the Fair Market Value on the date the SAR was granted as set forth in the applicable Award Agreement.

2.33 "Share Payment" means (a) a payment in the form of Shares, or (b) an option or other right to purchase Shares, as part of any bonus, deferred compensation or other arrangement, made in lieu of all or any portion of the compensation, granted pursuant to Article 8.

2.34 "Subsidiary" means any corporation or other entity of which a majority of the outstanding voting shares or voting power is beneficially owned directly or indirectly by the Company.

2.35 "Trading Date" means the closing of the first sale to the general public of the Shares pursuant to a registration statement filed with and declared effective by the U.S. Securities and Exchange Commission under the Securities Act.

ARTICLE 3

SHARES SUBJECT TO THE PLAN

3.1 Number of Shares.

(a) Subject to the provisions of Article 10 and Section 3.1(b), the maximum aggregate number of Shares which may be issued pursuant to all Awards is 1,500 Shares (the "Initial Pool"), plus an increase of 500 Shares when and if the Initial Pool has been fully used pursuant to the Awards granted under the Plan and the Board approves such increase.

(b) To the extent that an Award terminates, expires, or lapses for any reason, any Shares subject to the Award shall again be available for the grant of an Award pursuant to the Plan. To the extent permitted by Applicable Law, Shares issued in assumption of, or in

5

substitution for, any outstanding awards of any entity acquired in any form or combination by the Company or any Parent or Subsidiary of the Company shall not be counted against Shares available for grant pursuant to the Plan. Shares delivered by the Participant or withheld by the Company upon the exercise of any Award under the Plan, in payment of the exercise price thereof or tax withholding thereon, may again be optioned, granted or awarded hereunder, subject to the limitations of Section 3.1(a), If any Restricted Shares are forfeited by the Participant or repurchased by the Company, such Shares may again be optioned, granted or awarded hereunder, subject to the limitations of
Section 3.1(a). Notwithstanding the provisions of this Section 3.1(b), no Shares may again be optioned, granted or awarded if such action would cause an Incentive Share Option to fail to qualify as an incentive share option under
Section 422 of the Code.

3.2 Shares Distributed. Any Shares distributed pursuant to an Award may consist, in whole or in part, of authorized and unissued Shares, treasury or Shares purchased on the open market. Additionally, in the discretion of the Committee, American Depository Shares in an amount equal to the number of Shares which otherwise would be distributed pursuant to an Award may be distributed in lieu of Shares in settlement of any Award. If the number of Shares represented by an American Depository Share is other than on a one-to-one basis, the limitations of Section 3.1 shall be adjusted to reflect the distribution of American Depository Shares in lieu of Shares.

ARTICLE 4

ELIGIBILITY AND PARTICIPATION

4.1 Eligibility. Persons eligible to participate in this Plan include Employees, Consultants and all members of the Board, as determined by the Committee.

4.2 Participation. Subject to the provisions of the Plan, the Committee may, from time to time, select from among all eligible individuals, those to whom Awards shall be granted and shall determine the nature and amount of each Award. No individual shall have any right to be granted an Award pursuant to this Plan.

4.3 Jurisdictions. In order to assure the viability of Awards granted to Participants employed in various jurisdictions, the Committee may provide for such special terms as it may consider necessary or appropriate to accommodate differences in local law, tax policy, or custom applicable in the jurisdiction in which the Participant resides or is employed. Moreover, the Committee may approve such supplements to, or amendments, restatements, or alternative versions of, the Plan as it may consider necessary or appropriate for such purposes without thereby affecting the terms of the Plan as in effect for any other purpose; provided, however, that no such supplements, amendments, restatements, or alternative versions shall increase the share limitations contained in Section 3.1 of the Plan. Notwithstanding the foregoing, the Committee may not take any actions hereunder, and no Awards shall be granted, that would violate any Applicable Laws.

6

ARTICLE 5

OPTIONS

5.1 General. The Committee is authorized to grant Options to Participants on the following terms and conditions:

(a) Exercise Price. The exercise price per Share subject to an Option shall be determined by the Committee and set forth in the Award Agreement which may be a fixed or variable price related to the Fair Market Value of the Shares; provided, however, that no Option may be granted to an individual subject to taxation in the United States at less than the Fair Market Value on the date of grant.

(b) Time and Conditions of Exercise. The Committee shall determine the time or times at which an Option may be exercised in whole or in part, including exercise prior to vesting; provided that the term of any Option granted under the Plan shall not exceed ten years, except as provided in Section 12.2. The Committee shall also determine any conditions, if any, that must be satisfied before all or part of an Option may be exercised. Upon exercise of an Option pursuant to the terms of this Plan and the related Award Agreement, only Shares but not any other form of securities or consideration may be issued or given to a Participant.

(c) Payment. The Committee shall determine the methods by which the exercise price of an Option may be paid, the form of payment, including, without limitation (i) cash or check denominated in U.S. Dollars, (ii) cash or check in Chinese Renminbi, (iii) cash or check denominated in any other local currency as approved by the Committee, (iv) Shares held for such period of time as may be required by the Committee in order to avoid adverse financial accounting consequences and having a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option or exercised portion thereof, (v) after the Trading Date the delivery of a notice that the Participant has placed a market sell order with a broker with respect to Shares then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the Option exercise price; provided that payment of such proceeds is then made to the Company upon settlement of such sale), and the methods by which Shares shall be delivered or deemed to be delivered to Participants (vi) other property acceptable to the Committee with a Fair Market Value equal to the exercise price, or (vii) any combination of the foregoing. Notwithstanding any other provision of the Plan to the contrary, no Participant who is a member of the Board or an "executive officer" of the Company within the meaning of Section 13(k) of the Exchange Act shall be permitted to pay the exercise price of an Option in any method which would violate Section 13(k) of the Exchange Act.

(d) Evidence of Grant. All Options shall be evidenced by an Award Agreement between the Company and the Participant. The Award Agreement shall include such additional provisions as may be specified by the Committee.

5.2 Incentive Share Options. Incentive Share Options shall be granted only to Employees of the Company, a Parent or Subsidiary of the Company. Incentive Share Options may not be granted to Employees of a Related Entity. The terms of any Incentive Share Options

7

granted pursuant to the Plan, in addition to the requirements of Section 5.1, must comply with the following additional provisions of this Section 5.2:

(a) Expiration of Option. An Incentive Share Option may not be exercised to any extent by anyone after the first to occur of the following events:

(i) Ten years from the date it is granted, unless an earlier time is set in the Award Agreement;

(ii) Three months after the Participant's termination of employment as an Employee; and

(iii) One year after the date of the Participant's termination of employment or service on account of Disability or death. Upon the Participant's Disability or death, any Incentive Share Options exercisable at the Participant's Disability or death may be exercised by the Participant's legal representative or representatives, by the person or persons entitled to do so pursuant to the Participant's last will and testament, or, if the Participant fails to make testamentary disposition of such Incentive Share Option or dies intestate, by the person or persons entitled to receive the Incentive Share Option pursuant to the applicable laws of descent and distribution.

(b) Individual Dollar Limitation. The aggregate Fair Market Value (determined as of the time the Option is granted) of all Shares with respect to which Incentive Share Options are first exercisable by a Participant in any calendar year may not exceed $100,000 or such other limitation as imposed by
Section 422(d) of the Code, or any successor provision. To the extent that Incentive Share Options are first exercisable by a Participant in excess of such limitation, the excess shall be considered Non-Qualified Share Options.

(c) Ten Percent Owners. An Incentive Share Option shall be granted to any individual who, at the date of grant, owns Shares possessing more than ten percent of the total combined voting power of all classes of shares of the Company only if such Option is granted at a price that is not less than 110% of Fair Market Value on the date of grant and the Option is exercisable for no more than five years from the date of grant.

(d) Transfer Restriction. The Participant shall give the Company prompt notice of any disposition of Shares acquired by exercise of an Incentive Share Option within (i) two years from the date of grant of such Incentive Share Option or (ii) one year after the transfer of such Shares to the Participant.

(e) Expiration of Incentive Share Options. No Award of an Incentive Share Option may be made pursuant to this Plan after the tenth anniversary of the Effective Date.

(f) Right to Exercise. During a Participant's lifetime, an Incentive Share Option may be exercised only by the Participant.

8

ARTICLE 6

RESTRICTED SHARES

6.1 Grant of Restricted Shares. The Committee is authorized to make Awards of Restricted Shares to any Participant selected by the Committee in such amounts and subject to such terms and conditions as determined by the Committee. All Awards of Restricted Shares shall be evidenced by an Award Agreement.

6.2 Issuance and Restrictions. Restricted Shares shall be subject to such restrictions on transferability and other restrictions as the Committee may impose (including, without limitation, limitations on the right to vote Restricted Shares or the right to receive dividends on the Restricted Share). These restrictions may lapse separately or in combination at such times, pursuant to such circumstances, in such installments, or otherwise, as the Committee determines at the time of the grant of the Award or thereafter.

6.3 Forfeiture. Except as otherwise determined by the Committee at the time of the grant of the Award or thereafter, upon termination of employment or service during the applicable restriction period, Restricted Shares that are at that time subject to restrictions shall be forfeited; provided, however, the Committee may (a) provide in any Restricted Share Award Agreement that restrictions or forfeiture conditions relating to Restricted Shares will be waived in whole or in part in the event of terminations resulting from specified causes, and (b) in other cases waive in whole or in part restrictions or forfeiture conditions relating to Restricted Shares.

6.4 Certificates for Restricted Shares. Restricted Shares granted pursuant to the Plan may be evidenced in such manner as the Committee shall determine. If certificates representing Restricted Shares are registered in the name of the Participant, certificates must bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted Shares, and the Company may, at its discretion, retain physical possession of the certificate until such time as all applicable restrictions lapse.

ARTICLE 7

SHARE APPRECIATION RIGHTS

7.1 Grant of Share Appreciation Rights.

(a) A Share Appreciation Right may be granted to any Participant selected by the Committee. A Share Appreciation Right shall be subject to such terms and conditions not inconsistent with the Plan as the Committee shall impose and shall be evidenced by an Award Agreement.

(b) A Share Appreciation Right shall entitle the Participant (or other person entitled to exercise the Share Appreciation Right pursuant to the Plan) to exercise all or a specified portion of the Share Appreciation Right (to the extent then exercisable pursuant to its terms) and to receive from the Company an amount determined by multiplying the difference obtained by subtracting the exercise price per share of the Share Appreciation Right from the Fair Market Value of a Share on the date of exercise of the Share Appreciation Right by the

9

number of Shares with respect to which the Share Appreciation Right shall have been exercised, subject to any limitations the Committee may impose.

7.2 Payment and Limitations on Exercise.

(a) Payment of the amounts determined under Section 7.1(b) above shall be in cash, in Shares (based on its Fair Market Value as of the date the Share Appreciation Right is exercised) or a combination of both, as determined by the Committee in the Award Agreement.

(b) To the extent any payment under Section 7.1(b) is effected in Shares it shall be made subject to satisfaction of all provisions of Article 5 above pertaining to Options.

ARTICLE 8

OTHER TYPES OF AWARDS

8.1 Dividend Equivalents. Any Participant selected by the Committee may be granted Dividend Equivalents based on the dividends declared on the Shares that are subject to any Award, to be credited as of dividend payment dates, during the period between the date the Award is granted and the date the Award is exercised, vests or expires, as determined by the Committee. Such Dividend Equivalents shall be converted to cash or additional Shares by such formula and at such time and subject to such limitations as may be determined by the Committee.

8.2 Share Payments. Any Participant selected by the Committee may receive Share Payments in the manner determined from time to time by the Committee; provided, that unless otherwise determined by the Committee such Share Payments shall be made in lieu of base salary, bonus, or other cash compensation otherwise payable to such Participant. The number of shares shall be determined by the Committee and may be based upon the Performance Criteria or other specific criteria determined appropriate by the Committee, determined on the date such Share Payment is made or on any date thereafter.

8.3 Deferred Shares. Any Participant selected by the Committee may be granted an award of Deferred Shares in the manner determined from time to time by the Committee. The number of shares of Deferred Shares shall be determined by the Committee and may be linked to such specific criteria determined to be appropriate by the Committee, in each case on a specified date or dates or over any period or periods determined by the Committee. Shares underlying a Deferred Share award will not be issued until the Deferred Share award has vested, pursuant to a vesting schedule or criteria set by the Committee. Unless otherwise provided by the Committee, a Participant awarded Deferred Shares shall have no rights as a Company shareholder with respect to such Deferred Shares until such time as the Deferred Share Award has vested and the Shares underlying the Deferred Share Award has been issued.

8.4 Restricted Share Units. The Committee is authorized to make Awards of Restricted Share Units to any Participant selected by the Committee in such amounts and subject to such terms and conditions as determined by the Committee. At the time of grant, the Committee shall specify the date or dates on which the Restricted Share Units shall become fully vested and nonforfeitable, and may specify such conditions to vesting as it deems appropriate.

10

At the time of grant, the Committee shall specify the maturity date applicable to each grant of Restricted Share Units which shall be no earlier than the vesting date or dates of the Award and may be determined at the election of the grantee. On the maturity date, the Company shall transfer to the Participant one unrestricted, fully transferable Share for each Restricted Share Unit scheduled to be paid out on such date and not previously forfeited. The Committee shall specify the purchase price, if any, to be paid by the grantee to the Company for such Shares.

8.5 Term. Except as otherwise provided herein, the term of any Award of Dividend Equivalents, Share Payments, Deferred Share, or Restricted Share Units shall be set by the Committee in its discretion.

8.6 Exercise or Purchase Price. The Committee may establish the exercise or purchase price, if any, of any Award of Deferred Share, Share Payments or Restricted Share Units; provided, however, that such price shall not be less than the par value of a Share, unless otherwise permitted by Applicable Law.

8.7 Exercise Upon Termination of Employment or Service. An Award of Dividend Equivalents, Deferred Share, Share Payments, and Restricted Share Units shall only be exercisable or payable while the Participant is an Employee, Consultant or a member of the Board, as applicable; provided, however, that the Committee in its sole and absolute discretion may provide that an Award of Dividend Equivalents, Share Payments, Deferred Share, or Restricted Share Units may be exercised or paid subsequent to a termination of employment or service, as applicable, or following a Change of Control of the Company, or because of the Participant's retirement, death or Disability, or otherwise.

8.8 Form of Payment. Payments with respect to any Awards granted under this Article 8 shall be made in cash, in Shares or a combination of both, as determined by the Committee.

8.9 Award Agreement. All Awards under this Article 8 shall be subject to such additional terms and conditions as determined by the Committee and shall be evidenced by an Award Agreement.

ARTICLE 9

PROVISIONS APPLICABLE TO AWARDS

9.1 Stand-Alone and Tandem Awards. Awards granted pursuant to the Plan may, in the discretion of the Committee, be granted either alone, in addition to, or in tandem with, any other Award granted pursuant to the Plan. Awards granted in addition to or in tandem with other Awards may be granted either at the same time as or at a different time from the grant of such other Awards.

9.2 Award Agreement. Awards under the Plan shall be evidenced by Award Agreements that set forth the terms, conditions and limitations for each Award which may include the term of an Award, the provisions applicable in the event the Participant's employment or service terminates, and the Company's authority to unilaterally or bilaterally amend, modify, suspend, cancel or rescind an Award.

11

9.3 Limits on Transfer. No right or interest of a Participant in any Award may be pledged, encumbered, or hypothecated to or in favor of any party other than the Company or a Subsidiary, or shall be subject to any lien, obligation, or liability of such Participant to any other party other than the Company or a Subsidiary. Except as otherwise provided by the Committee, no Award shall be assigned, transferred, or otherwise disposed of by a Participant other than by will or the laws of descent and distribution. The Committee by express provision in the Award or an amendment thereto may permit an Award (other than an Incentive Share Option) to be transferred to, exercised by and paid to certain persons or entities related to the Participant, including but not limited to members of the Participant's family, charitable institutions, or trusts or other entities whose beneficiaries or beneficial owners are members of the Participant's family and/or charitable institutions, or to such other persons or entities as may be expressly approved by the Committee, pursuant to such conditions and procedures as the Committee may establish. Any permitted transfer shall be subject to the condition that the Committee receive evidence satisfactory to it that the transfer is being made for estate and/or tax planning purposes (or to a "blind trust" in connection with the Participant's termination of employment or service with the Company or a Subsidiary to assume a position with a governmental, charitable, educational or similar non-profit institution) and on a basis consistent with the Company's lawful issue of securities.

9.4 Beneficiaries. Notwithstanding Section 9.3, a Participant may, in the manner determined by the Committee, designate a beneficiary to exercise the rights of the Participant and to receive any distribution with respect to any Award upon the Participant's death. A beneficiary, legal guardian, legal representative, or other person claiming any rights pursuant to the Plan is subject to all terms and conditions of the Plan and any Award Agreement applicable to the Participant, except to the extent the Plan and Award Agreement otherwise provide, and to any additional restrictions deemed necessary or appropriate by the Committee. If the Participant is married and resides in a community property state, a designation of a person other than the Participant's spouse as his or her beneficiary with respect to more than 50% of the Participant's interest in the Award shall not be effective without the prior written consent of the Participant's spouse. If no beneficiary has been designated or survives the Participant, payment shall be made to the person entitled thereto pursuant to the Participant's will or the laws of descent and distribution. Subject to the foregoing, a beneficiary designation may be changed or revoked by a Participant at any time provided the change or revocation is filed with the Committee.

9.5 Share Certificates. Notwithstanding anything herein to the contrary, the Company shall not be required to issue or deliver any certificates evidencing shares of Share pursuant to the exercise of any Award, unless and until the Board has determined, with advice of counsel, that the issuance and delivery of such certificates is in compliance with all Applicable Laws, regulations of governmental authorities and, if applicable, the requirements of any exchange on which the Shares are listed or traded. All Share certificates delivered pursuant to the Plan are subject to any stop-transfer orders and other restrictions as the Committee deems necessary or advisable to comply with federal, state, or foreign jurisdiction, securities or other laws, rules and regulations and the rules of any national securities exchange or automated quotation system on which the Shares are listed, quoted, or traded. The Committee may place legends on any Share certificate to reference restrictions applicable to the Share. In addition to the terms and conditions provided herein, the Board may require that a Participant make such reasonable covenants, agreements, and representations as the Board, in its discretion, deems advisable in

12

order to comply with any such laws, regulations, or requirements. The Committee shall have the right to require any Participant to comply with any timing or other restrictions with respect to the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Committee.

9.6 Paperless Administration. Subject to Applicable Laws, the Committee may make Awards, provide applicable disclosure and procedures for exercise of Awards by an internet website or interactive voice response system for the paperless administration of Awards.

9.7 Foreign Currency. A Participant may be required to provide evidence that any currency used to pay the exercise price of any Award was acquired and taken out of the jurisdiction in which the Participant resides in accordance with Applicable Laws, including foreign exchange control laws and regulations. In the event the exercise price for an Award is paid in Chinese Renminbi or other foreign currency, as permitted by the Committee, the amount payable will be determined by conversion from U.S. dollars at the official rate promulgated by the People's Bank of China for Chinese Renminbi, or for jurisdictions other than the PRC, the exchange rate as selected by the Committee on the date of exercise.

ARTICLE 10

CHANGES IN CAPITAL STRUCTURE

10.1 Adjustments. In the event of any dividend, share split, combination or exchange of Shares, amalgamation, arrangement or consolidation, spin-off, recapitalization or other distribution (other than normal cash dividends) of Company assets to its shareholders, or any other change affecting the shares of Shares or the share price of a Share, the Committee shall make such proportionate and equity adjustments, if any, as the Committee in its discretion may deem appropriate to reflect such change with respect to (a) the aggregate number and type of shares that may be issued under the Plan (including, but not limited to, adjustments of the limitations in Section 3.1); (b) the terms and conditions of any outstanding Awards (including, without limitation, any applicable performance targets or criteria with respect thereto); and (c) the grant or exercise price per share for any outstanding Awards under the Plan.

10.2 Acceleration upon a Change of Control. Except as may otherwise be provided in any Award Agreement or any other written agreement entered into by and between the Company and a Participant, if a Change of Control occurs and a Participant's Options, Restricted Share or Share Appreciation Rights settled in Shares are not converted, assumed, or replaced by a successor, such Awards shall become fully exercisable and all forfeiture restrictions on such Awards shall lapse. Upon, or in anticipation of, a Change of Control, the Committee may in its sole discretion provide for (i) any and all Awards outstanding hereunder to terminate at a specific time in the future and shall give each Participant the right to exercise such Awards during a period of time as the Committee shall determine, (ii) either the purchase of any Award for an amount of cash equal to the amount that could have been attained upon the exercise of such Award or realization of the Participant's rights had such Award been currently exercisable or payable or fully vested (and, for the avoidance of doubt, if as of such date the Committee determines in good faith that no amount would have been attained upon the exercise of such Award or realization of the Participant' s rights, then such Award may be terminated by

13

the Company without payment), (iii) the replacement of such Award with other rights or property selected by the Committee in its sole discretion the assumption of or substitution of such Award by the successor or surviving corporation, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of Shares and prices, or (iv) provide for payment of Awards in cash based on the value of Shares on the date of the Change of Control plus reasonable interest on the Award through the date such Award would otherwise be vested or have been paid in accordance with its original terms, if necessary to comply with Section 409A of the Code.

10.3 Outstanding Awards - Corporate Transactions. In the event of a Corporate Transaction, each Award will terminate upon the consummation of the Corporate Transaction, unless the Award is assumed by the successor entity or Parent thereof in connection with the Corporate Transaction. . Except as provided otherwise in an individual Award Agreement, in the event of a Corporate Transaction and:

(a) the Award either is (x) assumed by the successor entity or Parent thereof or replaced with a comparable Award (as determined by the Committee) with respect to shares of the capital stock of the successor entity or Parent thereof or (y) replaced with a cash incentive program of the successor entity which preserves the compensation element of such Award existing at the time of the Corporate Transaction and provides for subsequent payout in accordance with the same vesting schedule applicable to such Award, then such Award (if assumed), the replacement Award (if replaced), or the cash incentive program automatically shall become fully vested, exercisable and payable and be released from any restrictions on transfer (other than transfer restrictions applicable to Options) and repurchase or forfeiture rights, immediately upon termination of the Participant's employment or service with all Service Recipient within twelve
(12) months of the Corporate Transaction without cause; and

(b) For each Award that is neither assumed nor replaced, such portion of the Award shall automatically become fully vested and exercisable and be released from any repurchase or forfeiture rights (other than repurchase rights exercisable at Fair Market Value) for all of the Shares at the time represented by such portion of the Award, immediately prior to the specified effective date of such Corporate Transaction, provided that the Participant remains an Employee, Consultant or Director on the effective date of the Corporate Transaction.

10.4 Outstanding Awards - Other Changes. In the event of any other change in the capitalization of the Company or corporate change other than those specifically referred to in this Article 10, the Committee may, in its absolute discretion, make such adjustments in the number and class of shares subject to Awards outstanding on the date on which such change occurs and in the per share grant or exercise price of each Award as the Committee may consider appropriate to prevent dilution or enlargement of rights.

10.5 No Other Rights. Except as expressly provided in the Plan, no Participant shall have any rights by reason of any subdivision or consolidation of Shares of any class, the payment of any dividend, any increase or decrease in the number of shares of any class or any dissolution, liquidation, merger, or consolidation of the Company or any other corporation. Except as expressly provided in the Plan or pursuant to action of the Committee under the Plan, no issuance by the Company of shares of any class, or securities convertible into shares of any

14

class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number of shares subject to an Award or the grant or exercise price of any Award.

ARTICLE 11

ADMINISTRATION

11.1 Committee. The Plan shall be administered by the Compensation Committee of the Board; provided, however that the Compensation Committee may delegate to a committee of one or more members of the Board the authority to grant or amend Awards to Participants other than Independent Directors and executive officers of the Company (such committee being the "Committee"). The Committee shall consist of at least two individuals, each of whom qualifies as a Non-Employee Director. Reference to the Committee shall refer to the Board if the Compensation Committee does not yet exist or ceases to exist and the Board does not appoint a successor Committee. Notwithstanding the foregoing, the full Board, acting by majority of its members in office shall conduct the general administration of the Plan if required by Applicable Law, if the Board has not established a Compensation Committee and with respect to Awards granted to Independent Directors and for purposes of such Awards the term "Committee" as used in the Plan shall be deemed to refer to the Board.

11.2 Action by the Committee. A majority of the Committee shall constitute a quorum. The acts of a majority of the members present at any meeting at which a quorum is present, and acts approved in writing by a majority of the Committee in lieu of a meeting, shall be deemed the acts of the Committee. Each member of the Committee is entitled to, in good faith, rely or act upon any report or other information furnished to that member by any officer or other employee of the Company or any Subsidiary, the Company's independent certified public accountants, or any executive compensation consultant or other professional retained by the Company to assist in the administration of the Plan.

11.3 Authority of Committee. Subject to any specific designation in the Plan, the Committee has the exclusive power, authority and discretion to:

(a) Designate Participants to receive Awards;

(b) Determine the type or types of Awards to be granted to each Participant;

(c) Determine the number of Awards to be granted and the number of Shares to which an Award will relate;

(d) Determine the terms and conditions of any Award granted pursuant to the Plan, including, but not limited to, the exercise price, grant price, or purchase price, any restrictions or limitations on the Award, any schedule for lapse of forfeiture restrictions or restrictions on the exercisability of an Award, and accelerations or waivers thereof, any provisions related to non-competition and recapture of gain on an Award, based in each case on such considerations as the Committee in its sole discretion determines;

(e) Determine whether, to what extent, and pursuant to what circumstances an Award may be settled in, or the exercise price of an Award may be paid in, cash, Shares, other

15

Awards, or other property, or an Award may be canceled, forfeited, or surrendered;

(f) Prescribe the form of each Award Agreement, which need not be identical for each Participant;

(g) Decide all other matters that must be determined in connection with an Award;

(h) Establish, adopt, or revise any rules and regulations as it may deem necessary or advisable to administer the Plan;

(i) Interpret the terms of, and any matter arising pursuant to, the Plan or any Award Agreement; and

(j) Make all other decisions and determinations that may be required pursuant to the Plan or as the Committee deems necessary or advisable to administer the Plan.

11.4 Decisions Binding. The Committee's interpretation of the Plan, any Awards granted pursuant to the Plan, any Award Agreement and all decisions and determinations by the Committee with respect to the Plan are final, binding, and conclusive on all parties.

ARTICLE 12

EFFECTIVE AND EXPIRATION DATE

12.1 Effective Date. The Plan is effective as of the date the Plan is approved by the Company's shareholders (the "Effective Date"). The Plan will be deemed to be approved by the shareholders if it receives the affirmative vote of the holders of a majority of the share capital of the Company present or represented and entitled to vote at a meeting duly held in accordance with the applicable provisions of the Company's Memorandum of Association and Articles of Association.

12.2 Expiration Date. The Plan will expire on, and no Award may be granted pursuant to the Plan after, the tenth anniversary of the Effective Date. Any Awards that are outstanding on the tenth anniversary of the Effective Date shall remain in force according to the terms of the Plan and the applicable Award Agreement.

ARTICLE 13

AMENDMENT, MODIFICATION, AND TERMINATION

13.1 Amendment, Modification, And Termination. With the approval of the Board, at any time and from time to time, the Committee may terminate, amend or modify the Plan; provided, however, that (a) to the extent necessary and desirable to comply with any applicable law, regulation, or stock exchange rule, the Company shall obtain shareholder approval of any Plan amendment in such a manner and to such a degree as required, and (b) shareholder approval is required for any amendment to the Plan that (i) increases the number of Shares available under the Plan (other than any adjustment as provided by Article 10),
(ii) permits the Committee to

16

grant Options with an exercise price that is below Fair Market Value on the date of grant, (iii) permits the Committee to extend the exercise period for an Option beyond ten years from the date of grant, or (iv) results in a material increase in benefits or a change in eligibility requirements.

13.2 Awards Previously Granted. Except with respect to amendments made pursuant to Section 13.1, no termination, amendment, or modification of the Plan shall adversely affect in any material way any Award previously granted pursuant to the Plan without the prior written consent of the Participant.

ARTICLE 14

GENERAL PROVISIONS

14.1 No Rights to Awards. No Participant, employee, or other person shall have any claim to be granted any Award pursuant to the Plan, and neither the Company nor the Committee is obligated to treat Participants, employees, and other persons uniformly.

14.2 No Shareholders Rights. No Award gives the Participant any of the rights of a Shareholder of the Company unless and until Shares are in fact issued to such person in connection with such Award.

14.3 Taxes. No Shares shall be delivered under the Plan to any Participant until such Participant has made arrangements acceptable to the Committee for the satisfaction of any income and employment tax withholding obligations under Applicable Laws. The Company or any Subsidiary shall have the authority and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy federal, state, local and foreign taxes (including the Participant's payroll tax obligations) required by law to be withheld with respect to any taxable event concerning a Participant arising as a result of this Plan. The Committee may in its discretion and in satisfaction of the foregoing requirement allow a Participant to elect to have the Company withhold Shares otherwise issuable under an Award (or allow the return of Shares) having a Fair Market Value equal to the sums required to be withheld. Notwithstanding any other provision of the Plan, the number of Shares which may be withheld with respect to the issuance, vesting, exercise or payment of any Award (or which may be repurchased from the Participant of such Award after such Shares were acquired by the Participant from the Company) in order to satisfy the Participant's federal, state, local and foreign income and payroll tax liabilities with respect to the issuance, vesting, exercise or payment of the Award shall, unless specifically approved by the Committee, be limited to the number of Shares which have a Fair Market Value on the date of withholding or repurchase equal to the aggregate amount of such liabilities based on the minimum statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes that are applicable to such supplemental taxable income.

14.4 No Right to Employment or Services. Nothing in the Plan or any Award Agreement shall interfere with or limit in any way the right of the Service Recipient to terminate any Participant's employment or services at any time, nor confer upon any Participant any right to continue in the employ or service of any Service Recipient.

17

14.5 Unfunded Status of Awards. The Plan is intended to be an "unfunded" plan for incentive compensation. With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give the Participant any rights that are greater than those of a general creditor of the Company or any Subsidiary.

14.6 Indemnification. To the extent allowable pursuant to applicable law, each member of the Committee or of the Board shall be indemnified and held harmless by the Company from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by such member in connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action or failure to act pursuant to the Plan and against and from any and all amounts paid by him or her in satisfaction of judgment in such action, suit, or proceeding against him or her; provided he or she gives the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled pursuant to the Company's Memorandum of Association and Articles of Association,, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.

14.7 Relationship to other Benefits. No payment pursuant to the Plan shall be taken into account in determining any benefits pursuant to any pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any Subsidiary except to the extent otherwise expressly provided in writing in such other plan or an agreement thereunder.

14.8 Expenses. The expenses of administering the Plan shall be borne by the Company and its Subsidiaries.

14.9 Titles and Headings. The titles and headings of the Sections in the Plan are for convenience of reference only and, in the event of any conflict, the text of the Plan, rather than such titles or headings, shall control.

14.10 Fractional Shares. No fractional shares of Share shall be issued and the Committee shall determine, in its discretion, whether cash shall be given in lieu of fractional shares or whether such fractional shares shall be eliminated by rounding up or down as appropriate.

14.11 Government and Other Regulations. The obligation of the Company to make payment of awards in Share or otherwise shall be subject to all Applicable Laws, rules, and regulations, and to such approvals by government agencies as may be required. The Company shall be under no obligation to register any of the Shares paid pursuant to the Plan under the Securities Act or any other similar law in any applicable jurisdiction. If the Shares paid pursuant to the Plan may in certain circumstances be exempt from registration pursuant to the Securities Actor other Applicable Laws the Company may restrict the transfer of such shares in such manner as it deems advisable to ensure the availability of any such exemption.

14.12 Governing Law. The Plan and all Award Agreements shall be construed in

18

accordance with and governed by the laws of the Cayman Islands.

14.13 Section 409A. To the extent that the Committee determines that any Award granted under the Plan is or may become subject to Section 409A of the Code, the Award Agreement evidencing such Award shall incorporate the terms and conditions required by Section 409A of the Code. To the extent applicable, the Plan and the Award Agreements shall be interpreted in accordance with Section 409A of the Code and the U.S. Department of Treasury regulations and other interpretative guidance issued thereunder, including without limitation any such regulation r or other guidance that may be issued after the Effective Date. Notwithstanding any provision of the Plan to the contrary, in the event that following the Effective Date the Committee determines that any Award may be subject to Section 409A of the Code and related Department of Treasury guidance (including such Department of Treasury guidance as may be issued after the Effective Date), the Committee may adopt such amendments to the Plan and the applicable Award agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Committee determines is necessary or appropriate to (a) exempt the Award from Section 409A of the Code and /or preserve the intended tax treatment of the benefits provided with respect to the Award, or (b) comply with the requirements of Section 409A of the Code and related U.S. Department of Treasury guidance.

14.14 Appendices. The Committee may approve such supplements, amendments or appendices to the Plan as it may consider necessary or appropriate for purposes of compliance with applicable laws or otherwise and such supplements, amendments or appendices shall be considered a part of the Plan; provided, however, that no such supplements shall increase the share limitations contained in Sections 3.1 and 3.3 of the Plan.

* * * * *

I hereby certify that the foregoing Plan was duly adopted by the Board of Directors of Agria Corporation on _______________, 2007.

* * * * *

I hereby certify that the foregoing Plan was approved by the shareholders of Agria Corporation on _______________, 2007.

Executed on ________________, 2007.


Corporate Secretary

19

EXHIBIT 10.2

INDEMNIFICATION AGREEMENT

This Indemnification Agreement (the "Agreement") is entered into as of __________, 2007 by and between Agria Corporation, a British Virgin Islands company (the "Company") and the undersigned, a director and/or an officer of the Company ("Indemnitee").

RECITALS

1. The Company recognizes that highly competent persons are becoming more reluctant to serve corporations as directors or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification against risks of claims and actions against them arising out of their services to the corporation.

2. The Board of Directors of the Company (the "Board") has determined that the inability to attract and retain highly competent persons to serve the Company is detrimental to the best interests of the Company and its shareholders and that it is reasonable and necessary for the Company to provide adequate protection to such persons against risks of claims and actions against them arising out of their services to the corporation.

3. The Indemnitee does not regard the indemnities available under the Company's current memorandum and articles of association (the "Articles of Association") as adequate to protect him against the risks associated with his service to the Company.

4. The Company is willing to indemnify Indemnitee to the fullest extent permitted by applicable law, and Indemnitee is willing to serve and continue to serve the Company on the condition that he be so indemnified.

AGREEMENT

In consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

A. DEFINITIONS

The following terms shall have the meanings defined below:

Expenses shall include damages, judgments, fines, penalties, settlements and costs, attorneys' fees and disbursements and costs of attachment or similar bond, investigations, and any expenses paid or incurred in connection with investigating, defending, being a witness in, participating in (including on appeal), or preparing for any of the foregoing in, any Proceeding.

Indemnifiable Event means any event or occurrence that takes place either before or after the execution of this Agreement, related to the fact that Indemnitee is or was a director or an officer of the Company or any of its subsidiaries, or is or was serving at the request of the Company as a director or officer of another corporation, partnership, joint venture or other entity, or related to anything done or not done by Indemnitee in any such capacity.

Participant means a person who is a party to, or witness or participant (including on appeal) in, a Proceeding.


Proceeding means any threatened, pending, or completed action, suit or proceeding, or any inquiry, hearing or investigation, whether civil, criminal, administrative, investigative or other, in which Indemnitee may be or may have been involved as a party or otherwise by reason of an Indemnifiable Event, including, without limitation, any threatened, pending, or completed action, suit or proceeding by or in the right of the Company.

B. AGREEMENT TO INDEMNIFY

1. General Agreement. In the event Indemnitee was, is, or becomes a Participant in, or is threatened to be made a Participant in, a Proceeding, the Company shall indemnify the Indemnitee from and against any and all Expenses which Indemnitee incurs or becomes obligated to incur in connection with such Proceeding, to the fullest extent permitted by applicable law.

2. Indemnification of Expenses of Successful Party. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee has been successful on the merits in defense of any Proceeding or in defense of any claim, issue or matter in such Proceeding, Indemnitee shall be indemnified against all Expenses incurred in connection with such Proceeding or such claim, issue or matter, as the case may be, offset by the amount of cash, if any, received by the Indemnitee resulting from his/her success therein.

3. Partial Indemnification. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for a portion of Expenses, but not for the total amount of Expenses, the Company shall indemnify the Indemnitee for the portion of such Expenses to which Indemnitee is entitled.

4. Exclusions. Notwithstanding anything in this Agreement to the contrary, Indemnitee shall not be entitled to indemnification under this Agreement:

(a) to the extent that payment is actually made to Indemnitee under a valid, enforceable and collectible insurance policy;

(b) to the extent that Indemnitee is indemnified and actually paid other than pursuant to this Agreement;

(c) in connection with a judicial action by or in the right of the Company, in respect of any claim, issue or matter as to which the Indemnitee shall have been adjudicated by final judgment in a court of law to be liable for gross negligence or misconduct in the performance of his duty to the Company unless and only to the extent that any court in which such action was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for such Expenses as such court shall deem proper;

(d) in connection with any Proceeding initiated by Indemnitee against the Company, any director or officer of the Company or any other party, and not by way of defense, unless (i) the Company has joined in or the Reviewing Party (as hereinafter defined) has consented to the initiation of such Proceeding; or (ii) the Proceeding is one to enforce indemnification rights under this Agreement or any applicable law;

2

(e) for a disgorgement of profits made from the purchase and sale by the Indemnitee of securities pursuant to Section 16(b) of the Exchange Act or similar provisions of any applicable U.S. state statutory law or common law;

(f) brought about by the dishonesty or fraud of the Indemnitee seeking payment hereunder; provided, however, that the Indemnitee shall be protected under this Agreement as to any claims upon which suit may be brought against him by reason of any alleged dishonesty on his part, unless a judgment or other final adjudication thereof adverse to the Indemnitee establishes that he committed (i) acts of active and deliberate dishonesty, (ii) with actual dishonest purpose and intent, and (iii) which acts were material to the cause of action so adjudicated;

(g) for any judgment, fine or penalty which the Company is prohibited by applicable law from paying as indemnity;

(h) arising out of Indemnitee's personal tax matter; or

(i) arising out of Indemnitee's breach of an employment agreement with the Company (if any) or any other agreement with the Company or any of its subsidiaries.

5. No Employment Rights. Nothing in this Agreement is intended to create in Indemnitee any right to continued employment with the Company.

6. Contribution. If the indemnification provided in this Agreement is unavailable and may not be paid to Indemnitee for any reason other than those set forth in Section 4, then the Company shall contribute to the amount of Expenses paid in settlement actually and reasonably incurred and paid or payable by Indemnitee in such proportion as is appropriate to reflect (i) the relative benefits received by the Company on the one hand and by the Indemnitee on the other hand from the transaction from which such Proceeding arose, and (ii) the relative fault of the Company on the one hand and of the Indemnitee on the other hand in connection with the events which resulted in such Expenses, as well as any other relevant equitable considerations. The relative fault of the Company on the one hand and of the Indemnitee on the other hand shall be determined by reference to, among other things, the parties' relative intent, knowledge, access to information and opportunity to correct or prevent the circumstances resulting in such Expenses, judgments, fines or settlement amounts. The Company agrees that it would not be just and equitable if contribution pursuant to this
Section 6 were determined by pro rata allocation or any other method of allocation which does not take account of the foregoing equitable considerations.

C. INDEMNIFICATION PROCESS

1. Notice and Cooperation By Indemnitee. Indemnitee shall, as a condition precedent to his right to be indemnified under this Agreement, give the Company notice in writing as soon as practicable of any claim made against Indemnitee for which indemnification will or could be sought under this Agreement. Notice to the Company shall be given in accordance with Section F.7 below. In addition, Indemnitee shall give the Company such information and cooperation as the Company may reasonably request.

2. Indemnification Payment.

3

(a) Advancement of Expenses. Indemnitee may submit a written request with reasonable particulars to the Company requesting that the Company advance to Indemnitee all Expenses that may be reasonably incurred by Indemnitee in connection with a Proceeding. The Company shall, within ten (10) business days of receiving such a written request by Indemnitee, advance all requested Expenses to Indemnitee. Any excess of the advanced Expenses over the actual Expenses will be repaid to the Company.

(b) Reimbursement of Expenses. To the extent Indemnitee has not requested any advanced payment of Expenses from the Company, Indemnitee shall be entitled to receive reimbursement for the Expenses incurred in connection with a Proceeding from the Company as soon as practicable after Indemnitee makes a written request to the Company for reimbursement.

(c) Determination by the Reviewing Party. Notwithstanding anything foregoing to the contrary, in the event the Reviewing Party informs the Company that Indemnitee is not entitled to indemnification in connection with a Proceeding under this Agreement or applicable law, the Company shall be entitled to be reimbursed by Indemnitee for all the Expenses previously advanced or otherwise paid to Indemnitee in connection with such Proceeding; provided, however, that Indemnitee may bring a suit to enforce his indemnification right in accordance with Section C.3 below.

3. Suit to Enforce Rights. Regardless of any action by the Reviewing Party, if Indemnitee has not received full indemnification within 30 days after making a written demand in accordance with Section C.2 above, Indemnitee shall have the right to enforce its indemnification rights under this Agreement by commencing litigation in any court of competent jurisdiction seeking a determination by the court or challenging any determination by the Reviewing Party or any breach in any aspect of this Agreement. Any determination by the Reviewing Party not challenged by Indemnitee and any judgment entered by the court shall be binding on the Company and Indemnitee.

4. Assumption of Defense. In the event the Company is obligated under this Agreement to advance or bear any Expenses for any Proceeding against Indemnitee, the Company shall be entitled to assume the defense of such Proceeding, with counsel approved by Indemnitee, upon delivery to Indemnitee of written notice of its election to do so. After delivery of such notice, approval of such counsel by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently incurred by Indemnitee with respect to the same Proceeding, unless
(i) the employment of counsel by Indemnitee has been previously authorized by the Company, (ii) Indemnitee shall have reasonably concluded, based on written advice of counsel, that there may be a conflict of interest of such counsel retained by the Company between the Company and Indemnitee in the conduct of any such defense, or (iii) the Company ceases or terminates the employment of such counsel with respect to the defense of such Proceeding, in any of which events the fees and expenses of Indemnitee's counsel shall be at the expense of the Company. At all times, Indemnitee shall have the right to employ counsel in any Proceeding at Indemnitee's expense.

5. Defense to Indemnification, Burden of Proof and Presumptions. It shall be a defense to any action brought by Indemnitee against the Company to enforce this Agreement that it is not permissible under this Agreement or applicable law for the Company to indemnify the Indemnitee for the amount claimed. In connection with any such action or any

4

determination by the Reviewing Party or otherwise as to whether Indemnitee is entitled to be indemnified under this Agreement, the burden of proving such a defense or determination shall be on the Company. Neither the failure of the Reviewing Party or the Company to have made a determination prior to the commencement of such action by Indemnitee that indemnification is proper under the circumstances because Indemnitee has met the standard of conduct set forth in applicable law, nor an actual determination by the Reviewing Party or the Company that Indemnitee had not met such applicable standard of conduct shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.

6. No Settlement Without Consent. Neither party to this Agreement shall settle any Proceeding in any manner that would impose any damage, loss, penalty or limitation on Indemnitee without the other party's written consent. Neither the Company nor Indemnitee shall unreasonably withhold its consent to any proposed settlement.

7. Company Participation. Subject to Section B.6, the Company shall not be liable to indemnify the Indemnitee under this Agreement with regard to any judicial action if the Company was not given a reasonable and timely opportunity, at its expense, to participate in the defense, conduct and/or settlement of such action.

8. Reviewing Party.

(a) For purposes of this Agreement, the Reviewing Party with respect to each indemnification request of Indemnitee shall be (A) the Board of Directors by a majority vote of a quorum consisting of Disinterested Directors (as hereinafter defined), or (B) if a quorum of the Board of Directors consisting of Disinterested Directors is not obtainable or, even if obtainable, said Disinterested Directors so direct, Independent Counsel in a written opinion to the Board of Directors, a copy of which shall be delivered to Indemnitee; and, if it is determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee's entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any Independent Counsel or member of the Board of Directors shall act reasonably and in good faith in making a determination under this Agreement of the Indemnitee's entitlement to indemnification. Any reasonable costs or expenses (including reasonable attorneys' fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee's entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom to the extent as aforesaid. "Disinterested Director" means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.

(b) If the determination of entitlement to indemnification is to be made by Independent Counsel, the Independent Counsel shall be selected as provided in this Section 8(b). The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board of Directors, in which event the Board of Directors by a majority vote of a quorum consisting of Disinterested Directors shall

5

select), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may be, may, within 10 days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of "Independent Counsel" as defined in Section 8(d) of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If the determination of entitlement to indemnification is to be made by Independent Counsel, but within 20 days after submission by Indemnitee of a written request for indemnification, no Independent Counsel shall have been selected and not objected to, then the Board of Directors by a majority vote shall select the Independent Counsel. The Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in connection with acting under this Agreement, and the Company shall pay all reasonable fees and expenses incident to the procedures of this Section
8(b), regardless of the manner in which such Independent Counsel was selected or appointed.

(c) In making a determination with respect to entitlement to indemnification hereunder, the Reviewing Party shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with this Agreement, and the Company shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement (with or without court approval), conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his conduct was unlawful. For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee's action is based on the records or books of account of the Company and any other corporation, partnership, joint venture or other entity of which Indemnitee is or was serving at the written request of the Company as a director, officer, employee, agent or fiduciary, including financial statements, or on information supplied to Indemnitee by the officers and directors of the Company or such other corporation, partnership, joint venture or other entity in the course of their duties, or on the advice of legal counsel for the Company or such other corporation, partnership, joint venture or other entity or on information or records given or reports made to the Company or such other corporation, partnership, joint venture or other entity by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Company or such other corporation, partnership, joint venture or other entity. In addition, the knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the Company or such other corporation, partnership, joint venture or other entity shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. The provisions of this Section 8(c) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the

6

Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.

(d) "Independent Counsel" means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five (5) years has been, retained to represent (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term "Independent Counsel" shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee's rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel referred to above.

D. DIRECTOR AND OFFICER LIABILITY INSURANCE

1. Good Faith Determination. The Company shall from time to time make the good faith determination whether or not it is practicable for the Company to obtain and maintain a policy or policies of insurance with reputable insurance companies providing the officers and directors of the Company with coverage for losses incurred in connection with their services to the Company or to ensure the Company's performance of its indemnification obligations under this Agreement.

2. Coverage of Indemnitee. To the extent the Company maintains an insurance policy or policies providing directors' and officers' liability insurance, Indemnitee shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available for any of the Company's directors or officers.

3. No Obligation. Notwithstanding the foregoing, the Company shall have no obligation to obtain or maintain any director and officer insurance policy if the Company determines in good faith that such insurance is not reasonably available in the case that (i) premium costs for such insurance are disproportionate to the amount of coverage provided, (ii) the coverage provided by such insurance is limited by exclusions so as to provide an insufficient benefit, or (iii) Indemnitee is covered by similar insurance maintained by a parent or subsidiary of the Company.

E. NON-EXCLUSIVITY; FEDERAL PREEMPTION; TERM

1. Non-Exclusivity. The indemnification provided by this Agreement shall not be deemed exclusive of any rights to which Indemnitee may be entitled under the Articles of Association, applicable law or any written agreement between Indemnitee and the Company (including its subsidiaries and affiliates). The indemnification provided under this Agreement shall continue to be available to Indemnitee for any action taken or not taken while serving in an indemnified capacity even though he may have ceased to serve in any such capacity at the time of any Proceeding.

2. Federal Preemption. Notwithstanding the foregoing, both the Company and Indemnitee acknowledge that in certain instances, U.S. federal law or public policy may override applicable law and prohibit the Company from indemnifying its directors and

7

officers under this Agreement or otherwise. Such instances include, but are not limited to, the U.S. Securities and Exchange Commission's prohibition on indemnification for liabilities arising under certain U.S. federal securities laws. Indemnitee understands and acknowledges that the Company has undertaken or may be required in the future to undertake with the SEC to submit the question of indemnification to a court in certain circumstances for a determination of the Company's right under public policy to indemnify Indemnitee.

3. Duration of Agreement. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is an officer and/or a director of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise) and shall continue thereafter so long as Indemnitee shall be subject to any Proceeding by reason of his former or current capacity at the Company or any other enterprise at the Company's request, whether or not he is acting or serving in any such capacity at the time any Expense is incurred for which indemnification can be provided under this Agreement. This Agreement shall continue in effect regardless of whether Indemnitee continues to serve as an officer and/or a director of the Company or any other enterprise at the Company's request.

F. MISCELLANEOUS

1. Amendment of this Agreement. No supplement, modification, or amendment of this Agreement shall be binding unless executed in writing by the parties hereto. No waiver of any of the provisions of this Agreement shall operate as a waiver of any other provisions (whether or not similar), nor shall such waiver constitute a continuing waiver. Except as specifically provided in this Agreement, no failure to exercise or any delay in exercising any right or remedy shall constitute a waiver.

2. Subrogation. In the event of payment to Indemnitee by the Company under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and shall do everything that may be necessary to secure such rights, including the execution of such documents necessary to enable the Company to bring suit to enforce such rights.

3. Assignment; Binding Effect. Neither this Agreement nor any of the rights or obligations hereunder may be assigned by either party hereto without the prior written consent of the other party; except that the Company may, without such consent, assign all such rights and obligations to a successor in interest to the Company which assumes all obligations of the Company under this Agreement. Notwithstanding the foregoing, this Agreement shall be binding upon and inure to the benefit of and be enforceable by and against the parties hereto and the Company's successors (including any direct or indirect successor by purchase, merger, consolidation, or otherwise to all or substantially all of the business and/or assets of the Company) and assigns, as well as Indemnitee's spouses, heirs, and personal and legal representatives.

4. Severability and Construction. Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to do any act in violation of applicable law. The Company's inability, pursuant to a court order, to perform its obligations under this Agreement shall not constitute a breach of this Agreement. In addition, if any portion of this Agreement shall be held by a court of competent jurisdiction to be

8

invalid, void, or otherwise unenforceable, the remaining provisions shall remain enforceable to the fullest extent permitted by applicable law. The parties hereto acknowledge that they each have opportunities to have their respective counsels review this Agreement. Accordingly, this Agreement shall be deemed to be the product of both of the parties hereto, and no ambiguity shall be construed in favor of or against either of the parties hereto.

5. Counterparts. This Agreement may be executed in two counterparts, both of which taken together shall constitute one instrument.

6. Governing Law. This agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of New York, U.S.A., without giving effect to conflicts of law provisions thereof.

7. Notices. All notices, demands, and other communications required or permitted under this Agreement shall be made in writing and shall be deemed to have been duly given if delivered by hand, against receipt, or mailed, postage prepaid, certified or registered mail, return receipt requested, and addressed to the Company at:

Agria Corporation
Room 706, 7/F, Huantai Building No. 12A, South Street Zhongguancun Haidian District, Beijing 100081 People's Republic of China

Attention: Guanglin Lai

and to Indemnitee at his or her address last known to the Company.

8. Entire Agreement. This Agreement constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, between the parties with respect to the subject matter hereof.

(Signature page follows)

9

IN WITNESS WHEREOF, the parties hereto execute this Agreement as of the date first written above.

COMPANY

AGRIA CORPORATION


Name:
Title:

INDEMNITEE


Name:

EXHIBIT 10.3

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (the "Agreement"), is entered into as of ____________, 2007 by and between Agria Corporation, a company incorporated and existing under the laws of the Cayman Islands (the "Company"), and ____________, an individual (the "Executive"). Except with respect to the direct employment of the Executive by the Company, the term "Company" as used herein with respect to all obligations of the Executive hereunder shall be deemed to include the Company and all of its direct or indirect parent companies, subsidiaries, affiliates, or subsidiaries or affiliates (collectively, the "Group").

RECITALS

A. The Company desires to employ the Executive as its ____________________ and to assure itself of the services of the Executive during the term of Employment (as defined below).

B. The Executive desires to be employed by the Company as its ___________________ during the term of Employment and upon the terms and conditions of this Agreement.

AGREEMENT

The parties hereto agree as follows:

1. POSITION

The Executive hereby accepts a position of ____________________ of the Company (the "Employment").

2. TERM

Subject to the terms and conditions of this Agreement, the initial term of the Employment shall be three years, commencing on ________________, 2007 (the "Effective Date"), until ____________________, 2010, unless terminated earlier pursuant to the terms of this Agreement. Upon expiration of the initial three-year term, the Employment shall be automatically extended for successive one-year terms unless either party gives the other party hereto a one-month prior written notice to terminate the Employment prior to the expiration of such one-year term or unless terminated earlier pursuant to the terms of this Agreement.

3. LOCATION

The Executive acknowledges that the Company's principal executive offices are currently located in Room 706, 7/F, Huantai Building, No. 12A, South Street Zhongguancun, Haidian District, Beijing 100081, Peoples' Republic of China. The Executive's principal place of employment shall be the Company's principal executive offices. The Executive agrees that he will be regularly present at the Company's principal executive offices. The Executive acknowledges that he may be required to travel from time to time in the course of performing his duties for the Company.

1

4. PROBATION

No probationary period.

5. DUTIES AND RESPONSIBILITIES

The Executive's duties at the Company will include all jobs assigned by the Company's Board of Directors (the "Board") of the Company.

The Executive shall devote all of his working time, attention and skills to the performance of his duties at the Company and shall faithfully and diligently serve the Company in accordance with this Agreement, the Memorandum and Articles of Association of the Company (the "Articles of Association"), and the guidelines, policies and procedures of the Company approved from time to time by the Board.

The Executive shall use his best efforts to perform his duties hereunder. The Executive shall not hold any other employment, and shall not be concerned or interested in any business or entity that directly or indirectly competes with the Group (any such business or entity, a "Competitor"), provided that nothing in this clause shall preclude the Executive from holding up to 5% of shares or other securities of any Competitor that is listed on any securities exchange or recognized securities market anywhere, provided however, that the Executive shall notify the Company in writing prior to his obtaining a proposed interest in such shares or securities in a timely manner and with such details and particulars as the Company may reasonably require. The Company shall have the right to require the Executive to resign from any board or similar body which he may then serve if the Board reasonably determines in writing that the Executive's service on such board or body interferes with the effective discharge of the Executive's duties and responsibilities to the Company or that any business related to such service is then in competition with any Business (as defined below under Section 12) of the Company or any of its subsidiaries or affiliates.

6. NO BREACH OF CONTRACT

The Executive hereby represents to the Company that: (i) the execution and delivery of this Agreement by the Executive and the performance by the Executive of the Executive's duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any other agreement or policy to which the Executive is a party or otherwise bound, except for agreements that are required to be entered into by and between the Executive and any member of the Group pursuant to applicable law of the jurisdiction where the Executive is based, if any; (ii) that the Executive has no information
(including, without limitation, confidential information and trade secrets)
relating to any other person or entity which would prevent, or be violated by, the Executive entering into this Agreement or carrying out his duties hereunder; (iii) that the Executive is not bound by any confidentiality, trade secret or similar agreement (other than this) with any other person or entity except for other member(s) of the Group, as the case may be.

2

7. COMPENSATION AND BENEFITS

(a) Cash Compensation. The Executive's salary shall be provided by the Company pursuant to Schedule A hereto, subject to annual review and adjustment by the Company.

(b) Equity Incentives. Once the Board and the shareholders of the Company adopt a share incentive plan of the Company, the Executive will be eligible for receiving awards under the share incentive plan and upon such terms as determined by the Board.

(c) Benefits. The Executive is eligible for participation in any standard employee benefit plan of the Company that currently exists or may be adopted by the Company in the future, including, but not limited to, any retirement plan, life insurance plan, health insurance plan and travel/holiday plan.

8. TERMINATION OF THE AGREEMENT

(a) By the Company. The Company may terminate the Employment for cause, at any time, without notice or remuneration, if (1) the Executive is convicted or pleads guilty to a crime which the Board reasonably believes has had or will have a detrimental effect on the Company's reputation or business, (2) the Executive has been negligent or acted dishonestly to the detriment of the Company, (3) the Executive has engaged in actions amounting to misconduct or failed to perform his duties hereunder and such failure continues after the Executive is afforded a reasonable opportunity to cure such failure, (4) the Executive has died, or (5) the Executive has a disability which shall mean a physical or mental impairment which, as reasonably determined by the Board, renders the Executive unable to perform the essential functions of his employment with the Company, even with reasonable accommodation that does not impose an undue hardship on the Company, for more than 180 days in any 12-month period, unless a longer period is required by applicable law, in which case that longer period would apply. In addition, the Company may terminate the Employment without cause, at any time, upon one month written notice, and upon termination without cause, the Company shall provide compensation to the Executive only to the minimum extent expressly required by applicable law of the jurisdiction where the Executive is based.

(b) By the Executive. The Executive may terminate the Employment at any time with a one-month prior written notice to the Company, if (1) there is a material reduction in the Executive's authority, duties and responsibilities, or (2) there is a material reduction in the Executive's annual salary before the next annual salary review. In addition, the Executive may resign prior to the expiration of the Agreement if such resignation or an alternative arrangement with respect to the Employment is approved by the Board.

(c) Notice of Termination. Any termination of the Executive's employment under this Agreement shall be communicated by written notice of termination from the terminating party to the other party. The notice of termination shall indicate the specific provision(s) of this Agreement relied upon in effecting the termination.

3

9. CONFIDENTIALITY AND NONDISCLOSURE

(a) Confidentiality and Non-disclosure.The Executive hereby agrees at all times during the term of his employment and after termination, to hold in the strictest confidence, and not to use, except for the benefit of the Group, or to disclose to any person, corporation or other entity without written consent of the Company, any Confidential Information. The Executive understands that "Confidential Information" means any proprietary or confidential information of the Group, its affiliates, their clients, customers or partners, and the Group's licensors, including, without limitation, technical data, trade secrets, research and development information, product plans, services, customer lists and customers (including, but not limited to, customers of the Group on whom the Executive called or with whom the Executive became acquainted during the term of his employment), supplier lists and suppliers, software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, personnel information, marketing, finances, information about the suppliers, joint ventures, licensors, licensees, distributors and other persons with whom the Group does business, information regarding the skills and compensation of other employees of the Group or other business information disclosed to the Executive by or obtained by the Executive from the Group, its affiliates, or their clients, customers or partners either directly or indirectly in writing, orally or by drawings or observation of parts or equipment, if specifically indicated to be confidential or reasonably expected to be confidential. Notwithstanding the foregoing, Confidential Information shall not include information that is generally available and known to the public through no fault of the Executive.

(b) Company Property. The Executive understands that all documents (including computer records, facsimile and e-mail) and materials created, received or transmitted in connection with his work or using the facilities of the Group are property of the Group and subject to inspection by the Group, at any time. Upon termination of the Executive's employment with the Company (or at any other time when requested by the Company), the Executive will promptly deliver to the Company all documents and materials of any nature pertaining to his work with the Company and will provide written certification of his compliance with this Agreement. Under no circumstances will the Executive have, following his termination, in his possession any property of the Group, or any documents or materials or copies thereof containing any Confidential Information.

(c) Former Employer Information. The Executive agrees that he has not and will not, during the term of his employment, (i) improperly use or disclose any proprietary information or trade secrets of any former employer or other person or entity with which the Executive has an agreement or duty to keep in confidence information acquired by Executive, if any, or (ii) bring into the premises of the Group any document or confidential or proprietary information belonging to such former employer, person or entity unless consented to in writing by such former employer, person or entity. The Executive will indemnify the Group and hold it harmless from and against all

4

claims, liabilities, damages and expenses, including reasonable attorneys' fees and costs of suit, arising out of or in connection with any violation of the foregoing.

(d) Third Party Information. The Executive recognizes that the Group may have received, and in the future may receive, from third parties their confidential or proprietary information subject to a duty on the Group's part to maintain the confidentiality of such information and to use it only for certain limited purposes. The Executive agrees that the Executive owes the Group and such third parties, during the Executive's employment by the Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person or firm and to use it in a manner consistent with, and for the limited purposes permitted by, the Group's agreement with such third party.

This Section 9 shall survive the termination of this Agreement for any reason. In the event the Executive breaches this Section 9, the Company shall have right to seek remedies permissible under applicable law.

10. INVENTIONS

(a) Inventions Retained and Licensed. The Executive has attached hereto, as Schedule B, a list describing all inventions, ideas, improvements, designs and discoveries, whether or not patentable and whether or not reduced to practice, original works of authorship and trade secrets made or conceived by or belonging to the Executive (whether made solely by the Executive or jointly with others) that (i) were developed by Executive prior to the Executive's employment by the Company (collectively, "Prior Inventions"), (ii) relate to the Group's actual or proposed business, products or research and development, and
(iii) are not assigned to the Group hereunder; or, if no such list is attached, the Executive represents that there are no such Prior Inventions. Except to the extent set forth in Schedule B, the Executive hereby acknowledges and represents that, if in the course of his service for the Group, the Executive incorporates into a Group product, process or machine a Prior Invention owned by the Executive or in which he has an interest, (a) the Group is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide right and license (which may be freely transferred by the Group to any other person or entity) to make, have made, modify, use, sell, sublicense and otherwise distribute such Prior Invention as part of or in connection with such product, process or machine, and (b) he has all necessary rights, powers and authorization to use such Prior Invention in the manner it is used and such use will not infringe any right of any company, entity or person. The Executive hereby agrees to indemnify the Group and hold it harmless from all claims, liabilities, damages and expenses, including reasonable legal fees and costs for resolving disputes arising out of or in connection with any violation or claimed violation of a third party's rights resulting from any use, sub-licensing, modification, transfer or sale by the Group of such Prior Invention.

(b) Disclosure and Assignment of Inventions. The Executive understands that the Company engages in research and development and other activities in

5

connection with its business and that, as an essential part of the Employment, the Executive is expected to make new contributions to and create inventions of value for the Company.

From and after the Effective Date, the Executive shall make full written disclosure in confidence to the Company all inventions, improvements, designs, original works of authorship, formulas, processes, compositions of matter, computer software programs, databases, mask works, concepts and trade secrets, whether or not patentable or registrable under patent, copyright, circuit layout design or similar laws in China or anywhere else in the world, which the Executive may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the period of the Executive's Employment at the Company (whether or not during business hours) that are either related to the scope of his Employment at the Company or make use, in any manner, of the resources of the Group (collectively, the "Inventions")The Executive hereby acknowledges that the Company or the Group shall be the sole owner of all rights, title and interest in the Inventions created hereunder. In the event the foregoing assignment of Inventions to the Company or the Group is ineffective for any reason, each member of the Group is hereby granted and shall have a royalty-free, sub-licensable, transferable, irrevocable, perpetual, worldwide license to make, have made, modify, use, and sell such Inventions as part of or in connection with any product, process or machine. Such exclusive license shall continue in effect for the maximum term as may now or hereafter be permissible under applicable law. Upon expiration, such license, without further consent or action on the Executive's part, shall automatically be renewed for the maximum term as is then permissible under applicable law, unless, within the six-month period prior to such expiration, the Company and the Executive have agreed that such license will not be renewed. The Executive also hereby forever waives and agrees never to assert any and all rights he may have in or with respect to any Inventions even after termination of his employment with the Company. The Executive hereby further acknowledges that all Inventions created by him (solely or jointly with others) are, to the extent permitted by applicable law, "works made for hire" or "inventions made for hire," as those terms are defined in the People's Republic of China ("PRC") Copyright Law, the PRC Patent Law and the Regulations on Computer Software Protection, respectively, and all titles, rights and interests in or to such Inventions are or shall be vested in the Company.

(c) Patent and Copyright Registration. The Executive agrees to assist the Company or its designees in every proper way to obtain for the Company and enforce patents, copyrights, mask work rights, trade secret rights, and other legal protection for the Inventions in any and all countries. The Executive will execute any documents that the Company may reasonably request for use in obtaining or enforcing such patents, copyrights, mask work rights, trade secrets and other legal protections. The Executive's obligations under this paragraph will continue beyond the termination of the Employment with the Company, provided that the Company will reasonably compensate the Executive after such termination for time or expenses actually spent by the Executive at the Company's request on such assistance. The Executive

6

appoints the Company and its duly authorized officers and agents as the Executive's attorney-in-fact to execute documents on the Executive's behalf for this purpose.

(d) Remuneration. The Executive hereby agrees that the remuneration received by the Executive pursuant to this Agreement with the Company includes any remuneration which the Executive may be entitled to under applicable PRC law for any "works made for hire," "inventions made for hire" or other Inventions assigned to the Company pursuant to this Agreement.

(e) Return of Confidential Material. In the event of the Executive's termination of employment with the Company for any reason whatsoever, Executive agrees promptly to surrender and deliver to the Company all records, materials, equipment, drawings, documents and data of any nature pertaining to any confidential information or to his employment, and Executive will not retain or take with him any tangible materials or electronically stored data, containing or pertaining to any confidential information that Executive may produce, acquire or obtain access to during the course of his employment.

This Section 10 shall survive the termination of this Agreement for any reason. In the event the Executive breaches this Section 10, the Company shall have right to seek remedies permissible under applicable law.

11. CONFLICTING EMPLOYMENT.

The Executive hereby agrees that, during the term of his employment with the Company, he will not engage in any other employment, occupation, consulting or other business activity related to the business in which the Group is now involved or becomes involved during the term of the Executive's employment, nor will the Executive engage in any other activities that conflict with his obligations to the Company without the prior written consent of the Company.

12. NON-COMPETITION AND NON-SOLICITATION

In consideration of the salary paid to the Executive by the Company, the Executive undertakes that for a period of two (2) years after he ceases to be employed by the Company, he will not, without the prior written consent of the Company:

(a) in the territory of the PRC (for the purpose of this Section 12, the PRC shall include Hong Kong, Macau and Taiwan) (the "Territory"), either on his own account or through any of his affiliates, or in conjunction with or on behalf of any other person, carry on or be engaged, concerned or interested directly or indirectly whether as shareholder, director, employee, partner, agent or otherwise carry on any business in direct competition with the business of the Group (the "Business");

For purpose of this Agreement, "Business" shall mean the following business that the Group conducts, i.e., research and development, production and distribution of corn seeds, sheep breeding products including breeder sheep, sheep semen and embryos, and blackberry, raspberry, date and white bark pine tree seedlings.

7

(b) either on his own account or through any of his affiliates or in conjunction with or on behalf of any other person, solicit or entice away or attempt to solicit or entice away from the Group, any person, firm, company or organization who is or shall at any time within two
(2) years prior to such cessation have been a customer, client, representative or agent of the Group or in the habit of dealing with the Group;

(c) either on his own account or through any of his affiliates or in conjunction with or on behalf of any other person, employ, solicit or entice away or attempt to employ, solicit or entice away from the Group any person who is or shall have been at the date of or within twelve (12) months prior to such cessation of employment an officer, manager, consultant or employee of any such the Group whether or not such person would commit a breach of contract by reason of leaving such employment; or

(d) either on his own account or through any of his affiliates or in conjunction with or on behalf of any other person, in relation to any trade, business or company use a name including the words "Agria", "AeroBiotech", "Primalights" or any other words hereafter used by the Group in its name or in the name of any of its products, services or their derivative terms, or the Chinese or English equivalent or any similar word in such a way as to be capable of or likely to be confused with the name of the Group or the product or services or any other products or services of the Group, and shall use all reasonable endeavors to procure that no such name shall be used by any of his affiliates or otherwise by any person with which he is connected.

Each and every obligation under Section 12 shall be treated as a separate obligation and shall be severally enforceable as such and in the event of any obligation or obligations being or becoming unenforceable in whole or in part, such part or parts which are unenforceable shall be deleted from such section and any such deletion shall not affect the enforceability of the remainder parts of such section.

The Executive agrees that in light of the circumstances, the restrictive covenants contained in Section 12 are reasonable and necessary for the protection of the Group, and further agrees that having regard to those circumstances the said covenants and are not excessive or unduly onerous upon the Executive. However, it is recognized that restrictions of the nature in question may fail for technical reasons currently unforeseen and accordingly it is hereby agreed and declared that if any of such restrictions shall be adjudged to be void as going beyond what is reasonable, in light of the circumstances, for the protection of the Group, but would be valid if part of the wording thereof were deleted or the periods thereof reduced or the range of activities or area dealt with thereby reduced in scope, the said restriction shall apply with such modification as may be necessary to make it valid and effective.

This Section 12 shall survive the termination of this Agreement for any reason. In the event the Executive breaches this Section 12, the Executive acknowledges that there will be no adequate remedy at law, and the Company shall be entitled to injunctive relief and/or a decree for specific performance, and such other relief as may be proper (including monetary damages if appropriate). In any event, the Company shall have right to seek all remedies permissible under applicable law.

8

13. WITHHOLDING TAXES

Notwithstanding anything else herein to the contrary, the Company may withhold (or cause there to be withheld, as the case may be) from any amounts otherwise due or payable under or pursuant to this Agreement such national, provincial, local or any other income, employment, or other taxes as may be required to be withheld pursuant to any applicable law or regulation.

14. NOTIFICATION OF NEW EMPLOYER

In the event that the Executive leaves the employ of the Company, the Executive hereby grants consent to notification by the Company to his or her new employer about his or her rights and obligations under this Agreement.

15. ASSIGNMENT

This Agreement is personal in its nature and neither of the parties hereto shall, without the consent of the other, assign or transfer this Agreement or any rights or obligations hereunder; provided, however, that (i) the Company may assign or transfer this Agreement or any rights or obligations hereunder to any member of the Group without such consent, and (ii) in the event of a merger, consolidation, or transfer or sale of all or substantially all of the assets of the company with or to any other individual(s) or entity, this Agreement shall, subject to the provisions hereof, be binding upon and inure to the benefit of such successor and such successor shall discharge and perform all the promises, covenants, duties, and obligations of the Company hereunder.

15. SEVERABILITY

If any provision of this Agreement or the application thereof is held invalid, the invalidity shall not affect other provisions or applications of this Agreement which can be given effect without the invalid provisions or applications and to this end the provisions of this Agreement are declared to be severable.

16. ENTIRE AGREEMENT

This Agreement constitutes the entire agreement and understanding between the Executive and the Company regarding the terms of the Employment and supersedes all prior or contemporaneous oral or written agreements concerning such subject matter. The Executive acknowledges that he has not entered into this Agreement in reliance upon any representation, warranty or undertaking which is not set forth in this Agreement. Any amendment to this Agreement must be in writing and signed by the Executive and the Company.

17. REPRESENTATIONS

The Executive hereby agrees to execute any proper oath or verify any proper document required to carry out the terms of this Agreement. The Executive hereby represents that the Executive's performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by the Executive in confidence or in trust prior to his or her employment by the

9

Company. The Executive has not entered into, and hereby agrees that he or she will not enter into, any oral or written agreement in conflict with this Section 17.

18. GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the law of the State of New York, USA.

19. AMENDMENT

This Agreement may not be amended, modified or changed (in whole or in part), except by a formal, definitive written agreement expressly referring to this Agreement, which agreement is executed by both of the parties hereto.

20. WAIVER

Neither the failure nor any delay on the part of a party to exercise any right, remedy, power or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with respect to any other occurrence. No waiver shall be effective unless it is in writing and is signed by the party asserted to have granted such waiver.

21. NOTICES

All notices, requests, demands and other communications required or permitted under this Agreement shall be in writing and shall be deemed to have been duly given and made if (i) delivered by hand, (ii) otherwise delivered against receipt therefor, or (iii) sent by a recognized courier with next-day or second-day delivery to the last known address of the other party.

22. COUNTERPARTS

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon, and all of which together shall constitute one and the same instrument. This Agreement shall become binding when one or more counterparts hereof, individually or taken together, shall bear the signatures of all of the parties reflected hereon as the signatories. Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose.

23. NO INTERPRETATION AGAINST DRAFTER

Each party recognizes that this Agreement is a legally binding contract and acknowledges that it, he has had the opportunity to consult with legal counsel of choice. In any construction of the terms of this Agreement, the same shall not be construed against either party on the basis of that party being the drafter of such terms. The Executive agrees and acknowledges that he has read and understands this

10

Agreement, is entering into it freely and voluntarily, and has been advised to seek counsel prior to entering into this Agreement and has ample opportunity to do so.

[Remainder of this page intentionally has been intentionally left blank.]

11

IN WITNESS WHEREOF, this Agreement has been executed as of the date first written above.

AGRIA CORPORATION

By:

Name:


Title:

EXECUTIVE

Signature:
Name:

Schedule A

CASH COMPENSATION

                AMOUNT         PAY PERIOD
                ------         ----------
SALARY   RMB _______________   Monthly
         annually


Schedule B

LIST OF PRIOR INVENTIONS

                                             IDENTIFYING NUMBER
TITLE                   DATE                OR BRIEF DESCRIPTION
-----                   ----                --------------------

______ No inventions or improvements

______ Additional Sheets Attached

Signature of Executive:

Print Name of Executive: Date: __________________, 2007

.

.
.

EXHIBIT 21.1

LIST OF SUBSIDIARIES

Wholly-Owned Subsidiaries

                                                  PLACE OF INCORPORATION
                                                  ----------------------
1. Aero-Biotech Group Limited                     British Virgin Islands
2. China Victory International Holdings Limited          Hong Kong
3. Aero-Biotech Science & Technology Co., Ltd.              PRC

Consolidated Variable Interest Entity

Primalights III, Agriculture Development Co., Ltd. PRC


EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the captions "Our Summary Consolidated Financial Data", "Selected Consolidated Financial Data" and "Experts" and to the use of our report dated July 15, 2007, in the Registration Statement (Form F-1) and related Prospectus of Agria Corporation dated October 18, 2007.

/s/ Ernst & Young Hua Ming

Shenzhen, People's Republic of China
October 18, 2007


EXHIBIT 23.5

October 18, 2007

Mr. Gary Yeung
Chief Financial Officer
Agria Corporation
17/F, Dutyfree Business Building,
Fuhua First Road,
CBD, Futian District, Shenzhen, China

SUBJECT: WRITTEN CONSENT TO REFERENCE SALLMANNS (FAR EAST) LIMITED IN SEC FILINGS OF AGRIA CORPORATION

Dear Mr.Yeung,

We hereby consent to the references to our name, valuation methodologies, assumptions and value conclusions for accounting purposes, with respect to our appraisal reports addressed to the board of Agria Corporation (the "Company") in the Company's Registration Statement on Form F-1 (together with any amendments thereto, the "Registration Statement") to be filed with the U.S. Securities and Exchange Commission.

In the preparation of our valuation reports, we relied on the accuracy and completeness of the financial information and other data related to the Company provided to us by the Company and its representatives. We did not audit or independently verify such financial information or other data relating to the Company and take no responsibility for the accuracy of such information. The responsibility for determining fair value rests solely with the Company and our valuation reports were only used as part of the Company's analysis in reaching their conclusion of value.

Yours sincerely,
For and on behalf of
SALLMANNS (FAR EAST) LIMITED

/s/ Simon M.K. Chan
----------------------------
Simon M.K. Chan
Director


EXHIBIT 23.6

October 10, 2007

Agria Corporation
Room 706, 7/F, Huantai Building, No. 12A South Street Zhongguancun
Haidian District, Beijing 100081
People's Republic of China

Ladies and Gentlemen:

Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as an independent director appointee of Agria Corporation (the "Company"), effective immediately after the completion of the initial public offering of the Company's ordinary shares represented by American depositary shares.

Sincerely yours,

/s/ Terry McCarthy
------------------
Terry McCarthy


EXHIBIT 23.7

October 18, 2007

Agria Corporation
Room 706, 7/F, Huantai Building, No. 12A South Street Zhongguancun
Haidian District, Beijing 100081
People's Republic of China

Ladies and Gentlemen:

Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as an independent director appointee of Agria Corporation (the "Company"), effective immediately upon the effectiveness of the Company's registration statement on Form F-1 originally filed by the Company on October 18, 2007 with the Securities and Exchange Commission.

Sincerely yours,

/s/ Shangzhong Xu
----------------------------------
Shangzhong Xu


Exhibit 23.8

October 18, 2007

Agria Corporation
Room 706, 7/F, Huantai Building, No. 12A South Street Zhongguancun
Haidian District, Beijing 100081
People's Republic of China

Ladies and Gentlemen:

Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as an independent director appointee of Agria Corporation (the "Company"), effective immediately upon the effectiveness of the Company's registration statement on Form F-1 originally filed by the Company on October 18, 2007 with the Securities and Exchange Commission.

Sincerely yours,

/s/ Jiuran Zhao
---------------------------
Jiuran Zhao


EXHIBIT 99.1

AGRIA CORPORATION
CODE OF BUSINESS CONDUCT AND ETHICS

PURPOSE

This Code of Business Conduct and Ethics (the "Code") contains general guidelines for conducting the business of Agria Corporation (the "Company") consistent with the highest standards of business ethics, and is intended to qualify as a "code of ethics" within the meaning of Section 406 of the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder. To the extent this Code requires a higher standard than required by commercial practice or applicable laws, rules or regulations, we adhere to these higher standards. The Company shall include all the subsidiaries consolidated into the Company's financial statement prepared in accordance with generally accepted accounting principles in the U.S. ("U.S. GAAP"), including but not limited to, its subsidiaries.

This Code is designed to deter wrongdoing and to promote:

- honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

- full, fair, accurate, timely, and understandable disclosure in reports and documents that the Company will file with, or submit to, the U.S. Securities and Exchange Commission (the "SEC") and in other public communications made by the Company;

- compliance with applicable laws, rules and regulations;

- prompt internal reporting of violations of the Code; and

- accountability for adherence to the Code.

APPLICABILITY

This Code applies to all of the directors, officers, employees, consultants and advisors of the Company, whether they work for the Company on a full-time, part-time, consultative, or temporary basis (each an "employee" and collectively, the "employees"). Certain provisions of the Code apply specifically to our chief executive officer, chief financial officer, controller, vice presidents and any other persons who perform similar functions for the Company (each, a "senior officer," and collectively, "senior officers").

The Board of Directors of the Company (the "Board") has appointed Gary Kim Ting Yeung, chief financial officer, as the Compliance Officer for the Company. If you have any questions regarding the Code or would like to report any violation of the Code, please call the Compliance Officer at (86-10) 6210 9288 or e-mail him at gary.yeung@agriacorp.com.

This Code was adopted by the Board on September 29, 2007. The Code shall become effective (the "Effective Time") concurrently with the Company's first public filing of a registration statement on Form F-1 with the SEC relating to the Company's initial public offering (the "IPO").


COMPETITION AND FAIR DEALING

The Company seeks to outperform its competitors fairly and honestly, through superior performance but not through unethical or illegal business practices. Infringement upon third-parties' intellectual property rights, including copyrights, trademarks, trade names and trade secrets, or inducing or encouraging such infringement activities by past or present employees of other companies are strictly prohibited. Every employee of the Company shall endeavor to respect the rights of and deal fairly with the Company's customers, suppliers and competitors. No employee shall take unfair advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of material facts, or any other illegal trade practice.

CONFLICTS OF INTEREST

IDENTIFYING CONFLICTS OF INTEREST

A conflict of interest occurs when an employee's private interest interferes, or appears to interfere, in any way with the interests of the Company as a whole. You should actively avoid any private interest that may influence your ability to act in the interests of the Company or that may make it difficult to perform your work objectively and effectively. In general, the following should be considered conflicts of interest:

- Competing Business. No employee may be concurrently employed by a business that competes with the Company or deprives it of any business.

- Corporate Opportunity. No employee should use corporate property, information or his or her position with the Company to secure a business opportunity that would otherwise be available to the Company. If you discover a business opportunity that is in the Company's line of business, through the use of the Company's property, information or position, you must first present the business opportunity to the Company before pursuing the opportunity in your individual capacity.

- Financial Interests.

(i) No employee may have any financial interest (ownership or otherwise), either directly or indirectly through a spouse or other family member, in any other business entity if such financial interest adversely affects the employee's performance of duties or responsibilities to the Company, or requires the employee to devote certain time during such employee's working hours at the Company;

(ii) No employee may hold any ownership interest in a privately-held company that is in competition with the Company;

(iii) An employee may hold up to but no more than 5% ownership interest in a publicly traded company that is in competition with the Company;

(iv) No employee may hold any ownership interest in a company that has a business relationship with the Company if such employee's duties at the Company include managing or supervising the Company's business relations with that company

2

If an employee's ownership interest in a business entity described in clause (iii) above increases to more than 5%, the employee must immediately report such ownership to the Compliance Officer.

- Loans or Other Financial Transactions. No employee may obtain loans or guarantees of personal obligations from, or enter into any other personal financial transaction with, any company that is a material customer, supplier or competitor of the Company. This guideline does not prohibit arms-length transactions with recognized banks or other financial institutions.

- Service on Boards and Committees. No employee should serve on a board of directors or trustees or on a committee of any entity (whether profit or not-for-profit) whose interests reasonably could be expected to conflict with those of the Company. Employees must obtain prior approval from the Board before accepting any such board or committee position. The Company may revisit its approval of any such position at any time to determine whether service in such position is still appropriate.

It is difficult to list all of the ways in which a conflict of interest may arise, and we have provided only a few, limited examples. If you are faced with a difficult business decision that is not addressed above, ask yourself the following questions:

- Is it legal?

- Is it honest and fair?

- Is it in the best interests of the Company?

DISCLOSURE OF CONFLICTS OF INTEREST

The Company requires that employees fully disclose any situations that reasonably could be expected to give rise to a conflict of interest. If you suspect that you have a conflict of interest, or something that others could reasonably perceive as a conflict of interest, you must report it immediately to the Compliance Officer. Conflicts of interest may only be waived by the Board, or the appropriate committee of the Board, and will be promptly disclosed to the public to the extent required by law.

FAMILY MEMBERS AND WORK

The actions of family members outside the workplace may also give rise to conflicts of interest because they may influence an employee's objectivity in making decisions on behalf of the Company. If a member of an employee's family is interested in doing business with the Company, the criteria as to whether to enter into or continue the business relationship, and the terms and conditions of the relationship, must be no less favorable to the Company compared with those that would apply to a non-relative seeking to do business with the Company under similar circumstances.

Employees should report any situation involving family members that could reasonably be expected to give rise to a conflict of interest to their supervisor or the Compliance Officer. For purposes of this Code, "family members" or "members of your family" include your spouse, brothers, sisters and parents, in-laws and children.

3

GIFTS AND ENTERTAINMENT

The giving and receiving of gifts is common business practice. Appropriate business gifts and entertainment are welcome courtesies designed to build relationships and understanding among business partners. However, gifts and entertainment should never compromise, or appear to compromise, your ability to make objective and fair business decisions.

It is the responsibility of employees to use good judgment in this area. As a general rule, employees may give or receive gifts or entertainment to or from customers or suppliers only if the gift or entertainment could not be viewed as an inducement to any particular business decision. All gifts and entertainment expenses made on behalf of the Company must be properly accounted for on expense reports.

Employees may only accept appropriate gifts. We encourage employees to submit gifts received to the Company. While it is not mandatory to submit small gifts, gifts of over RMB200 must be submitted immediately to the administration department of the Company.

The Company's business conduct is founded on the principle of "fair transaction." Therefore, no employee may receive kickbacks, bribe others, or secretly receive commissions or any other personal benefits.

FCPA COMPLIANCE

The U.S. Foreign Corrupt Practices Act ("FCPA") prohibits giving anything of value, directly or indirectly, to officials of foreign governments or foreign political candidates in order to obtain or retain business. A violation of FCPA no only violates the Company's policy but is also a civil or criminal offense under FCPA which the Company is subject to after the Effective Time. No employee shall give or authorize directly or indirectly any illegal payments to government officials of any country. While the FCPA does, in certain limited circumstances, allow nominal "facilitating payments" to be made, any such payment must be discussed with and approved by your supervisor in advance before it can be made.

PROTECTION AND USE OF COMPANY ASSETS

Employees should protect the Company's assets and ensure their efficient use for legitimate business purposes only. Theft, carelessness and waste have a direct impact on the Company's profitability. The use of the funds or assets of the Company, whether for personal gain or not, for any unlawful or improper purpose is strictly prohibited.

To ensure the protection and proper use of the Company's assets, each employee should:

- Exercise reasonable care to prevent theft, damage or misuse of Company property;

- Promptly report the actual or suspected theft, damage or misuse of Company property;

- Safeguard all electronic programs, data, communications and written materials from inadvertent access by others; and

- Use Company property only for legitimate business purposes.

4

Except as approved in advance by the Chief Executive Officer or Chief Financial Officer of the Company, the Company prohibits political contributions (directly or through trade associations) by any employee on behalf of the Company. Prohibited political contribution activities include:

- any contributions of Company funds or other assets for political purposes,

- encouraging individual employees to make any such contribution;

- reimbursing an employee for any political contribution.

INTELLECTUAL PROPERTY AND CONFIDENTIALITY

- All inventions, creative works, computer software, and technical or trade secrets developed by an employee in the course of performing the employee's duties or primarily through the use of the Company's materials and technical resources while working at the Company, shall be the property of the Company.

- The Company maintains a strict confidentiality policy. During an employee's term of employment, the employee shall comply with any and all written or unwritten rules and policies concerning confidentiality and shall fulfill the duties and responsibilities concerning confidentiality applicable to the employee.

- In addition to fulfilling the responsibilities associated with his position in the Company, an employee shall not, without first obtaining approval from the Company, disclose, announce or publish trade secrets or other confidential business information of the Company, nor shall an employee use such confidential information outside the course of his duties to the Company.

- Even outside the work environment, an employee must maintain vigilance and refrain from disclosing important information regarding the Company or its business, customers or employees.

- An employee's duty of confidentiality with respect to the confidential information of the Company survives the termination of such employee's employment with the Company for any reason until such time as the Company discloses such information publicly or the information otherwise becomes available in the public sphere through no fault of the employee.

- Upon termination of employment, or at such time as the Company requests, an employee must return to the Company all of its property without exception, including all forms of medium containing confidential information, and may not retain duplicate materials.

ACCURACY OF FINANCIAL REPORTS AND OTHER PUBLIC COMMUNICATIONS

Upon the completion of the IPO, the Company will be required to report its financial results and other material information about its business to the public and the SEC. It is the Company's policy to promptly disclose accurate and complete information regarding its business, financial condition and results of operations. Employees must strictly comply with all applicable standards, laws, regulations and policies for accounting and financial reporting of transactions, estimates and forecasts. Inaccurate,

5

incomplete or untimely reporting will not be tolerated and can severely damage the Company and result in legal liability.

Employees should be on guard for, and promptly report, any possibility of inaccurate or incomplete financial reporting. Particular attention should be paid to:

- Financial results that seem inconsistent with the performance of the underlying business;

- Transactions that do not seem to have an obvious business purpose; and

- Requests to circumvent ordinary review and approval procedures.

The Company's senior financial officers and other employees working in the Finance Department have a special responsibility to ensure that all of the Company's financial disclosures are full, fair, accurate, timely and understandable. Any practice or situation that might undermine this objective should be reported to the Compliance Officer.

Employees are prohibited from directly or indirectly taking any action to coerce, manipulate, mislead or fraudulently influence the Company's independent auditors for the purpose of rendering the financial statements of the Company materially misleading. Prohibited actions include but are not limited to those actions taken to coerce, manipulate, mislead or fraudulently influence an auditor:

- to issue or reissue a report on the Company's financial statements that is not warranted in the circumstances (due to material violations of U.S. GAAP, generally accepted auditing standards or other professional or regulatory standards);

- not to perform audit, review or other procedures required by generally accepted auditing standards or other professional standards;

- not to withdraw an issued report; or

- not to communicate matters to the Company's Audit Committee.

COMPANY RECORDS

Accurate and reliable records are crucial to the Company's business and form the basis of its earnings statements, financial reports and other disclosures to the public. The Company's records are the source of essential data that guides business decision-making and strategic planning. Company records include, but are not limited to, booking information, payroll, timecards, travel and expense reports, e-mails, accounting and financial data, measurement and performance records, electronic data files and all other records maintained in the ordinary course of our business.

All Company records must be complete, accurate and reliable in all material respects. There is never an acceptable reason to make false or misleading entries. Undisclosed or unrecorded funds, payments or receipts are strictly prohibited. You are responsible for understanding and complying with the Company's record keeping policy. Contact the Compliance Officer if you have any questions regarding the record keeping policy.

6

COMPLIANCE WITH LAWS AND REGULATIONS

Each employee has an obligation to comply with the laws of the cities, provinces, regions and countries in which the Company operates. This includes, without limitation, laws covering commercial bribery and kickbacks, copyrights, trademarks and trade secrets, information privacy, insider trading, offering or receiving gratuities, employment harassment, environmental protection, occupational health and safety, false or misleading financial information, misuse of corporate assets and foreign currency exchange activities. Employees are expected to understand and comply with all laws, rules and regulations that apply to your position at the Company. If any doubt exists about whether a course of action is lawful, you should seek advice immediately from the Compliance Officer.

MISCELLANEOUS

DISCRIMINATION AND HARASSMENT

The Company is firmly committed to providing equal opportunity in all aspects of employment and will not tolerate any illegal discrimination or harassment based on race, ethnicity, religion, gender, age, national origin or any other protected class. For further information, you should consult the Compliance Officer.

HEALTH AND SAFETY

The Company strives to provide employees with a safe and healthy work environment. Each employee has responsibility for maintaining a safe and healthy workplace for other employees by following environmental, safety and health rules and practices and reporting accidents, injuries and unsafe equipment, practices or conditions. Violence and threatening behavior are not permitted.

Each employee is expected to perform his or her duty to the Company in a safe manner, free of the influences of alcohol, illegal drugs or other controlled substances. The use of illegal drugs or other controlled substances in the workplace is prohibited.

VIOLATIONS OF THE CODE

All employees have a duty to report any known or suspected violation of this Code, including any violation of laws, rules, regulations or policies that apply to the Company. Reporting a known or suspected violation of this Code by others will not be considered an act of disloyalty, but an action to safeguard the reputation and integrity of the Company and its employees.

If you know of or suspect a violation of this Code, it is your responsibility to immediately report the violation to the Compliance Officer, who will work with you to investigate your concern. All questions and reports of known or suspected violations of this Code will be treated with sensitivity and discretion. The Compliance Officer and the Company will protect your confidentiality to the extent possible, consistent with the law and the Company's need to investigate your concern.

It is the Company's policy that any employee who violates this Code will be subject to appropriate discipline, including termination of employment, based upon the facts and circumstances of each particular situation. Your conduct as an employee of the Company, if it does not comply with the law or with this Code, can result in serious consequences for both you and the Company.

The Company strictly prohibits retaliation against an employee who, in good faith, seeks help or reports known or suspected violations. An employee inflicting reprisal or retaliation against another

7

employee for reporting a known or suspected violation will be subject to disciplinary action up to and including termination of employment.

WAIVERS OF THE CODE

Waivers of this Code will be granted on a case-by-case basis and only in extraordinary circumstances. Waivers of this Code may be made only by the Board, or the appropriate committee of the Board, and will be promptly disclosed to the public.

CONCLUSION

This Code contains general guidelines for conducting the business of the Company consistent with the highest standards of business ethics. If you have any questions about these guidelines, please contact the Compliance Officer. We expect all employees to adhere to these standards. Each employee is separately responsible for his or her actions. Conduct that violates the law or this Code cannot be justified by claiming that it was ordered by a supervisor or someone in higher management. If you engage in conduct prohibited by the law or this Code, you will be deemed to have acted outside the scope of your employment. Such conduct will subject you to disciplinary action, including termination of employment.

* * * * * * * * * * * * *

8

EXHIBIT 99.2

[LETTERHEAD OF COMMERCE & FINANCE]

October 18, 2007

Agria Corporation
M&C, Corporation Services Limited
PO Box 309GT, Ugland House,
South Church Street, George Town, Grand
Cayman, Cayman Islands

Dear Sirs,

We are qualified lawyers of the People's Republic of China (the 'PRC") and are qualified to issue opinions on the laws and regulations of the PRC.

We have acted as PRC counsel for Agria Corporation, a company incorporated under the laws of the Cayman Islands (the "Company"), in connection with (i) the Company's registration statement on Form F-1, including all amendments or supplements thereto (the "Registration Statement"), originally filed with the Securities and Exchange Commission (the "SEC"), under the U.S. Securities Act of 1933, as amended (the "Securities Act"), on October 18, 2007, relating to the offering by the Company of American Depositary Shares ("ADSs") representing ordinary shares of the Company (together with the ADSs, the "Offered Securities") and (ii) the Company's proposed listing of the ADSs on the New York Stock Exchange.

In rendering this opinion, we have examined the originals, or copies certified or otherwise identified to our satisfaction, of documents provided to us by the Company and such other documents, corporate records, certificates issued by governmental authorities in the PRC and officers of the Company and other instruments as we have deemed necessary or advisable for the purposes of rendering this opinion.

In rendering this opinion, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity with authentic original documents submitted to us as copies and the completeness of the documents provided to us. We have also assumed that no amendments, revisions, modifications or other changes have been made with respect to any of the documents after they were submitted to us for purposes of this opinion. We have further assumed the accuracy and completeness of all factual statements in the documents.

As used herein, (a) "PRC LAWS" means all laws, regulations, statutes, orders, decrees, guidelines, notices, judicial interpretations, subordinary legislations of the PRC which are publicly available(other than the laws of the Hong Kong Special Administrative Region, Macao Special Administrative Region and Taiwan Province); (b) "GOVERNMENTAL AGENCIES" means any court, governmental agency or body or any stock exchange authorities of the PRC (other than the Hong Kong Special Administrative Region, Macao Special Administrative Region and Taiwan Province); (c) "GOVERNMENTAL APPROVALS" means all approvals, consents, waivers, sanctions, authorizations, declarations, filings, registrations, exemptions, permissions, endorsements, annual inspections, qualifications, licenses, certificates and permits required by Governmental Agencies; (d) "MATERIAL ADVERSE EFFECT" means a material adverse effect on the condition (financial or other), business, properties, results of operations or prospects of the Company and the PRC Companies (as defined


herein below) taken as a whole; and (e) "PROSPECTUS" means the prospectus, including all amendments or supplements thereto, that forms part of the Registration Statement.

1. On August 8, 2006, six PRC regulatory agencies, namely, the PRC Ministry of Commerce ("MOFCOM"), the State Assets Supervision and Administration Commission, the State Administration for Taxation, the State Administration for Industry and Commerce, the China Securities Regulatory Commission ("CSRC"), and the State Administration of Foreign Exchange, jointly adopted the Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors (the "NEW M&A RULE"), which became effective on September 8, 2006. The New M&A Rule purports, among other things, to require offshore special purpose vehicles, or SPVS, formed for overseas listing purposes through acquisitions of PRC domestic companies and controlled by PRC companies or individuals, to obtain the approval of the CSRC prior to publicly listing their securities on an overseas stock exchange. On September 21, 2006, pursuant to the New M&A Rule and other PRC laws and regulations, the CSRC, in its official website, promulgated relevant guidance with respect to the issues of listing and trading of domestic enterprises' securities on overseas stock exchanges, including a list of application materials with respect to the listing on overseas stock exchanges by SPVs. Based on our understanding of current PRC Laws, we believe that the New M&A Rule does not require the Company, which is not a special purpose vehicle formed or controlled by PRC companies or PRC individuals and established its PRC subsidiary by means of direct investment other than merger and acquisition of PRC domestic companies, to obtain the MOFCOM approval for (1) its establishment of Aero Biotech Science & Technology Co., Ltd. ("AGRIA CHINA"), (2)Agria China's entering into and consummation of contractual arrangements with Primalights III Agricultural Development Co., Ltd. ("P3A") and P3A's shareholders as described in the Section "Corporate History and Structure" of the Registration Statement, or (3)require the Company to obtain the CSRC approval in connection with this Offering. No other Governmental Approval is required for this offering.

2. The ownership structures of the Agria China and P3A, both currently and immediately after giving effect to the Offering, are in compliance with the PRC laws; the contractual arrangements among Agria China, P3A and P3A's shareholders governed by PRC law as described in the Registration Statement are valid, binding and enforceable, and will not result in any violation of PRC Laws; and the business operations of Agria China and P3A, as described in the Registration Statement, are in compliance with existing PRC laws and regulations in all material respects.

This opinion relates to the PRC Laws in effect on the date hereof.

We hereby consent to the use of this opinion in, and the filing hereof as an exhibit to, the above-mentioned Registration Statement and to the reference to our firm's name under the sections of the Prospectus entitled "Risk Factors", "Enforceability of Civil Liabilities", "Regulation", and "Legal Matters" included in the Registration Statement. In giving such consent, we do not thereby admit that we fall within the category of the person whose consent is required under Section 7 of the U.S. Securities Act of 1933, as amended, or the regulations promulgated thereunder.

Yours sincerely,

/s/ Commerce & Finance Law Offices
Commerce & Finance Law Offices

2